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Abstract 
S-nitrosation has emerged as a ubiquitous endogenous protein posttranslational 
modification that significantly impacts cellular protein function through a variety of 
mechanisms. Despite the advent of chemical and proteomic methods to study S-
nitrosation, the subset of cellular cysteine residues that show uniquely high reactivity to 
endogenous transnitrosation donors is poorly characterized. To further these existing 
global studies, a cysteine-reactivity profiling strategy was applied herein to rank ~600 
cysteine residues by sensitivity to S-nitrosoglutathione. These proteomic studies revealed 
several previously uncharacterized sites of S-nitrosation, including Cys58 in HADH2. 
Further characterization revealed that HADH2 catalytic activity is allosterically regulated 
by S-nitrosation, and this modification occurs in cells at (patho)physiological levels of 
nitrosative stress. Functional role of Cys58 and its regulation by S-nitrosation facilitated 
the identification of RB-21-CA as a potential covalent Cys58 inhibitor. Global analysis of 
GSNO, S-nitroso-Coenzyme A and Thioredoxin-C73-SNO transnitrosation identified 756 
cysteines with different sensitivity to each of three SNO donors. Systematic evaluation on 
transnitrosation selectivity revealed that specific interaction of transnitrosation donor 
with its protein target is a key component governing the selective transnitrosation of a 
specific cysteine residue. Together, these studies illustrated the potential of cysteine-
reactivity profiling strategy for evaluating the substrate specificity of transnitrosation 
donors and enable the identification of previously uncharacterized, functionally relevant 
! !
sites of S-nitrosation. 
Another cysteine oxoform, S-glutathionylation, is the disulfide formation of a 
protein cysteine residue with glutathione. Although glucose starvation is known to induce 
redox-disturbance, global and individual protein S-glutathionylation in response to 
glucose metabolism or mitochondrial activity remains largely unknown. By using a 
clickable glutathione approach, which forms clickable glutathione by the use of a mutant 
of glutathione synthetase, we found that protein S-glutathionylation is readily induced in 
response to glucose starvation when mitochondrial reactive oxygen species are elevated 
in cells, and glucose is the major determinant for inducing reversible glutathionylation. 
Application of a proteomic mass spectrometry platform identified over 1,300 S-
glutathionylated. Confirmation of S-glutathionylation for selected proteins by in gel 
analysis further validated the mass spectrometry results, and highlights the dynamic 
change of S-glutathionylation on an individual protein level. 
In order to expand on the understanding of the functional role of the cysteine 
residues in biological systems, we evaluated a panel of 1,3,5-triazine- and 4-
aminopiperidine-based cysteine-reactive small-molecules on two proteins, apoptosis 
signal-regulating kinase 1 (ASK1) and peroxiredoxin 1 (Prdx1), between which a 
intermolecular disulfide forms and results in the activation of mitogen-activated protein 
kinase pathway. In-gel fluorescence revealed that RB-11-CA and SMC-1, both of which 
contain an n-octyl group as a diversity element, showed greatest selectivity and potency 
to ASK1 and Prdx1, respectively. Further mass spectrometry analysis identified cysteine 
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Figure 1-1. Structures of thiol (protonated, left) and thiolate (deprotonated, right) 
forms of cysteine residues within proteins with an “unperturbed” pKa of ~8.5.  
Figure 1-2. Common posttranslational modifications of cysteines.  
Figure 1-3. Cysteine S-nitrosation. (A) S-Nitrosation is the transfer of a nitroso-
group onto cysteine residues. (B) Formation of S-nitrosation can occur through 
three key pathways: reaction with N2O3, reaction with thiyl radicals, or transition 
metal catalyzed addition of NO to thiols. .  
Figure 1-4. The biotin-switch technique (BST) involves capping of reduced thiols 
with MMTS, followed by selective reduction of S-nitrosated cysteines with 
ascorbate. The resulting newly-formed thiols are then capped with biotin-HPDP 
for enrichment of S-nitrosated proteins.  
Figure 1-5. Chemical probes for S-nitrosation rely on the use of phosphine esters 
to form: (1) thio-aza-ylides; (2) sulfenamides; (3) traceless disulfides; (4) traceless 




Figure 2-1. In-gel fluorescence to visualize protein sensitivity to transnitrosation. 
(A) Experimental workflow. (B) Structure of GSNO. (C) Structure of the 
iodoacetamide alkyne probe. (D) Fluorescent gel of A.  
Figure 2-2. A competitive cysteine-profiling strategy to quantify sensitivity to 
transnitrosation. (A) Structure of the Azo-L/Azo-H tags. (B) and (C), Schematic 
showing the application of the Azo-L and Azo-H tags for quantitative proteomics 
in control and GSNO treated experiments. . 
Figure 2-3. Identifying cysteines sensitive to modification by GSNO. (A) 
Heavy:Light ratios (R) are shown for 609 cysteine residues identified in GSNO-
treated (in red; light: 500 µM GSNO; heavy: buffer;) and control (in black; light: 
buffer; heavy: buffer) MS analysis. (B) Average R-values are shown for 609 





Figure 2-4. Gene ontology (GO) analysis (From data in Appendix I, Table 2A-1). 
Biological process (A) and molecular function (B) are shown for all proteins (left) 
and proteins containing the 27 cysteines with greatest GSNO sensitivity (right) (R 
>3) from the cysteine-reactivity profiling analyses.  
Figure 2-5. Measurement of transnitrosation sensitivity at the level of individual 
cysteine residues within the same protein. (A) Cysteine 54, 109, 158 and 194 of 
PCBP1. (B) Cysteine 24, 178 and 223 of CLIC1.  
Figure 2-6. (A) Manual interrogation of the MS2 fragmentation data assigned 
Cys152 of GAPDH as the modified residue. (B) IA probe was completely 
consumed before click chemistry in our analysis platform.  
Figure 2-7. Systematic analysis of cysteine-reactivity upon GSNO treatment. (A) 
Concentration-dependent analysis with 0, 50, 100, 200, or 500 µM GSNO 
treatment. (B) R values are plotted with increasing GSNO concentration for six 
cysteine residues (from CLIC4, GSTO1, DCXR, HADH2, CTSD, and GAPDH) 
with varying sensitivity to GSNO transnitrosation. (C) Corroboration of the MS-
based identification of cysteine sensitivity and insensitivity using a gel-based 
assay for GSTO1 or CTSD. (D) Time-dependent analysis with increasing 500 µM 
GSNO incubation time for three cysteine residues (from GAPDH Cys152, 
TUBA4A Cys376 and Trx Cys73) representative of cysteines that are 
characterized by a variety of kinetic patterns of GSNO transnitrosation and 
lifetime of the S-nitrosated species.  
Figure 2-8. HADH2 is selectively S-nitrosated at Cys58. (A) Pathway of β–
oxidation of fatty acids. (B) Structure of HADH2 (PDB: 2O23) with NAD+ 
bound in the active site. (C) HADH2 is not glutathionylated when treated with 
100 µM GSSG, 100 µM GSH, or 6-100 µM GSNO. (D) Purified HADH2 WT 
and C58S mutant. (E) S-nitrosation of recombinantly expressed and purified 
HADH2 WT treated with varying concentrations of GSNO or DEA NONOate. 
(F) S-nitrosation of recombinantly expressed and purified HADH2 WT and C58A 
treated with varying concentrations of GSNO or Cys-SNO. (G) S-nitrosation of 
recombinantly expressed and purified HADH2 WT pretreated with GSNO and 
then treated with increasing concentration of S-methylglutathione. (H) S-
nitrosation of recombinantly expressed and purified HADH2 WT and C58S 
treated with 100 µM GSNO. (I) HADH2 S-nitrosation in lysates from HEK293T 
cells overexpressing mock (empty vector), HADH2 WT, or HADH2 C58S treated 
with 100 µM GSNO. (J) Immunofluorescence staining of the mitochondrial 
localization of endogenous HADH2 and overexpressed Myc/His tagged HADH2. 
(K) HADH2 S-nitrosation in HEK293T cells overexpressing mock (empty 
vector), HADH2 WT, or HADH2 C58S were treated with DMSO (control), L-
NAME (pan-NOS inhibitor), or 1400W (iNOS-selective inhibitor). (L) HADH2 
S-nitrosation in A549 cells overexpressing HADH2 WT or HADH2 C58A were 




Figure 2-9. Functional characterization of Cys58 of HADH2. (A) HADH2-
catalyzed reduction of acetoacetyl-CoA by NADH monitored in vitro by a 
decrease in absorbance at 340 nm. (B) Catalytic efficiency (kcat/KM) for WT and 
C58A-mutant HADH2 with varying acetoacetyl-CoA concentrations in the 
presence of 100 µM GSNO or GSH. (C) Effect of GSNO on WT HADH2 
activity. (D) Catalytic efficiency (kcat/KM) for WT and C58S mutant HADH2 with 
varying acetoacetyl-CoA concentrations. (E) Effect of cysteine oxidants on 
HADH2 activity.  
 
Chapter 3. 
Figure 3-1. Protein S-nitrosation, transnitrosation and denitrosation systems. 
Figure 3-2. Structure of transnitrosation donors: (A) S-nitrosoglutathione 
(GSNO), (B) Thioredoxin-C73-SNO (Trx-SNO), and (C) S-nitroso-Coenzyme A 
(CoA-SNO). (D) Transnitrosation reaction proceeding through a nitroxyl disulfide 
intermediate. 
Figure 3-3. A competitive cysteine-profiling strategy to quantify sensitivity to 
transnitrosation. 
Figure 3-4. Identifying cysteines sensitive to transnitrosation by GSNO, CoA-
SNO and Trx-SNO. Quantitative MS analysis of GSNO (A), CoA-SNO (B), and 
Trx-SNO (C) -treated cell lysates. (D) Distribution of R-values for the GSNO, 
CoA-SNO and Trx-SNOtreated samples. 
Figure 3-5. Biological process (A) and molecular function (B) are shown for all 
proteins and proteins containing the 50 cysteines with most or least 
transnitrosation sensitivity from the cysteine-reactivity profiling analyses.  
Figure 3-6. Sequence conservation flanking sites of cysteine transnitrosation. 
Figure 3-7. Surface-exposure (A) and pKa (B) analysis of cysteines that were 
identified as sensitive and insensitive to transnitrosation. 
Figure 3-8. Correlation of cysteine reactivity with transnitrosation sensitivity.  
Figure 3-9. Venn diagram of the proteins carrying 50 most sensitive 
transnitrosation cysteines to GSNO, CoA-SNO and Trx-SNO. 
Figure 3-10. Heatmap of relative sensitivity across all 756 cysteines (left) or the 
50 most sensitive cysteines (right) ranked by GSNO transnitrosation. 
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Figure 3-11. MeGSH pre-treatment desensitizes GSNO transnitrosation on 
cysteine 58 of HADH2. (A). Structures of GSNO (left) and MeGSH (right). (B) 
Structure of HADH2 (PDB: 2O23) with NAD+ bound in the active site. (C) R 
ratios of cysteine 58 of HADH2 in both control and MeGSH-treated sample are 
plotted. (D) S-nitrosation of recombinantly expressed and purified HADH2 WT 
pretreated with GSNO and then treated with increasing concentration of MeGSH. 
Figure 3-12. ATP pre-treatment desensitizes CoA-SNO transnitrosation on 
cysteine 360 and 641 of PFKP. (A). Structures of CoA-SNO (top) and ATP 
(bottom). (B) R ratios of cysteine 360 and 641 of PFKP in both control and 




Figure 4-1. A workflow using a clickable azido-glutathione approach for 
detecting protein glutathionylation. 
Figure 4-2. Glucose starvation readily induces global glutathionylation in the 
presence of an electron transport chain blocker in time- (A) and dose- (B) 
dependent manners, but no treated with glucose starvation alone (C), and 
antimycin A alone (D).  
 Figure 4-3. Glutathionylation is reversed by re-addition of glucose.  
Figure 4-4. Proteomic analysis of glutathionylated proteins. (A) Approach for 
pull-down and mass analysis. (B) Analysis of enriched proteins in indicated 
conditions.  
Figure 4-5. Systematic analysis of identified glutahionylated protein. (A) The 
number of glutathionylated proteins in indicated conditions by LC-MS/MS. (B-D) 
Gene ontology analysis of identified glutathionylated proteome.  
Figure 4-6. Proteomic data analysis of glutathionylated proteins. (A) Identified 
proteins in glucose starvation with or without antimycin A. (B) The range of 
spectral count for all proteins identified in LC- MS/MS.  




Figure 5-1. 1,3,5-triazines and 4-aminopiperidine scaffolds were utilized to 
generate cysteine-reactive small-molecule libraries. Each scaffold was 
!! xi 
functionalized with a cysteine-reactive electrophile (R1), an alkyne handle (R2) 
and a diversity element (R3). Structures of R1, R2 and R3 groups for a number of 
the compounds evaluated in this study are shown.  
Figure 5-2. In-gel fluorescence and MS proteomic analysis for target 
identification of Prdx1 and ASK1-28.  
 Figure 5-3. In-gel fluorescence analysis of small molecule labeling of ASK1-28 
and Prdx1. (A) Prdx1 and ASK1 treated by small molecules were resolved by 
fluorescent gel using IA probe as labeling control. (B) Band intensity relative to 
IA probe treatment was calculated. (C) Structure of RB-11-CA and SMC-1 that 
demonstrated greatest labeling for ASK1-28 and Prdx1, respectively.  
Figure 5-4. Modification of HADH2 cysteine 58 by RB-21-CA and IA probe. (A) 
RB- 21-CA labeled HADH WT in a concentration-dependent manner. This 
labeling diminished for the C58S mutant. (B) Kinetic study of RB-21-CA on 
HADH2 WT with IC50 of 20.47 µM. (C) Structure of RB-21-CA and IA probe. 
(D) IA probe labeling events were increased in HADH2 C58A mutant than that of 










Table 3-1. The 20 most CoA-SNO sensitive cysteine containing proteins that 
were also detected in a 1 mM ATP pre-treatment mass spectrometry experiment 









Table 2A-1. R-values from transnitrosation experiment at 500 µM GSNO. 
 
Table 2A-2. Evaluation of the data obtained by the current cysteine-profiling 
platform within the context of previously identified sites of S-nitrosation. 
 
Table 2A-3. R-values from transnitrosation experiment at 0, 50, 100, 200 and 500 
µM GSNO.  
 
Table 2A-4. R-values from time-dependent transnitrosation experiment at 500 
µM GSNO (0, 5, 10, 20, 30 and 60 mins treatment).  
 
Table 2A-5. Primers used for sub-cloning and mutagenesis of GSTO1, HADH2 
and CTSD.  
 
Table 3A-1. R-values from transnitrosation experiment at 500 µM GSNO. 
 
Table 3A-2. R-values from transnitrosation experiment at 500 µM CoA-SNO.  
 
Table 3A-3. R-values from transnitrosation experiment at 90 µM Trx-SNO.  
  
Table 3A-4. R-values of cysteines (* denotes labeled cysteine) identified from 
transnitrosation experiments at 500 µM GSNO, 500 µM CoA-SNO, and 90 µM 
Trx- SNO.  
 
Table 3A-5. PDB codes, solvent-accessible surface area (SASA) and pKa values 
for 19 of the most-sensitive and insensitive cysteines to GSNO, CoA-SNO and 
Trx-SNO transnitrosation respectively. 
 




Table 3A-7. R-values from 1 mM MeGSH competitive transnitrosation 
experiment at 500 µM GSNO.  
 
Table 3A-8. R-values from 1 mM ATP competitive transnitrosation experiment at 
500 µM CoA-SNO.  
 
Table 4A-1. A list of glutathionylated proteins identified in mass analysis that 








List of Abbreviations 
 
 
Standard 3-letter and 1-letter codes are used for the 20 natural amino acids 
 
 
1400W N-[[3-(aminomethyl)phenyl]methyl]-ethanimidamide, dihydrochloride 
Acr acrylamide 
AKT1 protein kinase B 
AMPK AMP-activated kinase  
ASK1 apoptosis signal-regulating kinase 1  
Azo-H azobenzene heavy mass spectrometry tag 
Azo-L azobenzene light mass spectrometry tag 
BCA bicinchoninic acid  
biotin-HPDP N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide 
BSA bovine serium albumin 
BST biotin-switch technique  
CA chloroacetamide 
Casp caspase (Cysteine-dependent aspartate directed proteases) 
cGMP cyclic GMP  
CLIC1 chloride intracellular channel protein 1  
CLIC4 chloride intracellular channel protein 4  
CNB chloronitrobenzyl 
CoA Coenzyme A 
CTSD cathepsin D 
CuAAC copper (I)-catalyzed azide alkyne cycloaddition  
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Cys-SNO S-nitrosocysteine  
CysNO S-nitrosocycsteine 
DCXR L-xylulose reductase  
DEA diethylamine 
DMEM Dulbecco's Modified Eagle Medium 
DMSO dimethylsulfoxide 
DNA-PK DNA-activated protein kinase  
DTT  dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
eNOS endothelial NOS  
ER endoplasmic reticulum 
GAPDH glyceraldehyde-3-phosphate dehydrogenase  
GCL γ-glutamylcysteine ligase  
GO gene ontology 
GRX glutaredoxin 
Griess buffer (0.6% w/v sulfanilamide, 30% v/v acetic acid, 0.05% w/v N-1-
naphthyl-ethylenediamine-HCl)  
GSNOR GSNO reductase  
GS glutathione synthetase  
GSH glutathione (reduced) 
GSNO S-nitrosoglutathione  
GSSG glutathione (oxidezed) 
GSTO1 glutathione S-transferase omega 1 
!! xvii 
GSTP glutathione-S-transferase pi  
HADH2 3-Hydroxyacyl-CoA dehydrogenase type-2 
HDAK2 histone deacetylase 2  
HEN buffer (125 mM HEPES pH 7.7, 1 mM EDTA, 0.1 mM neocuproine) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC high-performance liquid chromatography 
HRP horseradish peroxidase 
Hsp90 heat shock protein 90  
IA-alkyne/IA iodoacetamide alkyne probe (N-(hex-5-yn-1-yl)-2-iodoacetamide) 
IAM iodoacetamide 
ICAT isotope-coded affinity tags  
IKK IκB kinase 
iNOS inducible NOS 
IPTG isopropyl β-D-1-thiogalactopyranoside 
isoTOP-ABPP isotopic tandem orthogonal proteolysis-activity-base protein profiling 
iTRAQ isobaric tags for relative and absolute quantification 
JNK c-Jun N-terminal kinase  
L-NAME  L-N-nitroarginine methyl ester 
LC liquid chromatography 
LDE lipid-derived electrophile 
MAP2K MAPK kinase 
MAP3K MAPK kinase kinase 
MAPK Mitogen-activated protein kinase 
!! xviii 
MAPK Mitogen-activated protein kinase  
MeGSH S-methylglutathione  
MMTS methyl methanethiosulfonate 
mROS mitochondrial reactive oxygen species  
MS mass spectrometry 
MudPIT Multi-dimensional Protein Identification Technology 
N3GSH azido-glutathione 
NAD+ nicotinamide adenine dinucleotide, oxidized 
NADH nicotinamide adenine dinucleotide, reduced 
NADP+ nicotinamide-adenine dinucleotide phosphate, oxidized 
NADPH nicotinamide-adenine dinucleotide phosphate, reduced 
NEM N-ethylmaleimide  
NLS nuclear localization signal 
nNOS neuronal NOS 
NO nitric oxide 
NOS NO synthases  
PAGE polyacrylamide gel electrophoresis 
PBS phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, pH 7.4) 
PCBP1 poly(rC)-binding protein 1 
PDI protein disulfide isomerase protein family 
Pen/Strep penicillin/streptomycin 
PFKP 6-phosphofructokinase, platelet type  
PP2cα Protein phosphatase 2cα  
!! xix 
Prdx peroxiredoxin 
Psmd2 26S proteasome non-ATPase regulatory subunit 2 
PTM posttranslational modification 
PTP1B protein tyrosine phosphatase 1B 
R heavy:light ratio  
RBC red blood cell 
Rh rhodamine 
RNS reactive nitrogen species 
ROS reactive oxygen species 
RPMI Roswell Park Memorial Institute media 
S100-A9 protein S100-A9 
S100A8 protein S100-A8 
SASA solvent-accessible surface area 
SCX strong cation exchange resin 
SDS sodium dodecyl sulfate 
sGC soluble guanylate cyclase 
SHP2 Src-homology phosphatase 2  
SILAC Stable isotope labeling by amino acid in cell culture  
SIRT1 sirtuin 1 
TBTA tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
TCA trichloroacetic acid precipitation 
TCEP tris(2-carboxyethyl)phosphine hydrochloride 
TMT tandem mass tags 
!! xx 
TOF time-of-flight mass analyzer 
Tris tris(hydroxymethyl)aminomethane 
Trx thioredoxin 

































A significant portion of the work described in this chapter has been published in: 
 
Couvertier S. M., Zhou Y., and Weerapana E., Chemical-proteomic strategies to 
investigate cysteine posttranslational modifications. Biochim. Biophys. Acta., 2014, 1844, 
2315-2330. 
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Among the twenty common amino acids, cysteine (Cys) is one of two sulfur-
containing amino acids. Cysteine is encoded by 3.28% of all codons, yet with typically 
only 2.2% or less in the proteomic level, which makes it one of the least abundant amino 
acids incorporated into proteins.1 The thiol group (R-SH) of cysteine is subject to 
oxidation to multiple higher oxidation state. It is also reversibly deprotonated generate a 
thiolate group (R-S-) with higher nucleophilicity compared with the protonated thiol 
form.2 These properties render cysteine diverse roles on its biological function. 
 
Chemical properties of cysteine 
Though highly conserved within proteins (typically above 90%), the chemical and 
physical properties of cysteine allow it to function in diverse biological roles, attributing 
to its concentration in functional loci within proteins.  
Compared to the oxygen on serine, sulfur has a larger atomic radius and is less 
electronegative. As a result, the free thiol group on cysteine, without involvement of the 
structural microenvironment, is more acidic and nucleophilic than the hydroxyl group on 
serine.1 An “unperturbed” cysteine has a typical pKa of ~8.5.3, 4 (Figure 1-1) This value, 
however, is easily altered by the protein local environment and by other factors. For 
example, through stabilizing the negatively charged thiolate, a hydrogen bond donor 
could lower the pKa, while an electronegative environment destabilizing the thiolate, can 
lead to an increased pKa.5, 6 On the other hand, although both have donor electron pairs, 
the thiolate form is more nucleophilic than the thiol, which shares this electron pair with 
hydrogen in a sigma bond. As a result, the nucleophilicity of a cysteine is largely 
! 3!
dependent on the protein local environment that affects its pKa, and thus the availability 
and stability of the thiolate forms.  
Figure 1-1. Structures of thiol (protonated, left) and thiolate (deprotonated, right) forms 
of cysteine residues within proteins with an “unperturbed” pKa of ~8.5. 
 
When it comes into contact with a suitable electron acceptor (oxidant), the sulfur 
can donate electrons and become oxidized to a range of oxidation states. These oxidized 
forms of cysteine include intra- or inter-molecular disulfide bonds (RSSR) with protein 
thiols or low-molecular-weight thiols. The disulfide bond is not “locked”, and is capable 
of undergoing disulfide-exchange with other thiols. This migration of dithiols and 
disulfides occurs within cellular redox systems, e.g. Thioredoxin/ Thioredoxin Reductase 
(Trx/TrxR) pairs. Additionally, a strong oxidant can sequentially oxidize a thiol to 
sulfenic, sulfinic or sulfonic acids.7 Overall, the cysteine nucleophilicity and redox 
activity are often correlated with low pKa of thiolate anion and its microenvironment. 
 
Biological functions of cysteine 
The tunable reactivity of cysteine enables it to serve a wide range of roles in 
protein functions. Cysteines could be in the catalytic sites of enzymes such as 
oxidoreductases, transferases, hydrolases, isomerases and ligases, and act as essential 
catalytic residues in both redox and nucleophilic catalysis.1 In addition, a number of 
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copper. These cysteine complexes with metal ions directly participate in catalysis, 
regulate protein structure, form binding motifs for nucleic acid, and maintain metal ion 
homeostasis.8 Cysteines involved in structural disulfide bonds play essential roles 
maintaining structural integrity and protein folding.9 Moreover, the unique chemical 
property of cysteine thiol enables its roles in regulating protein functions, as most of 
these regulatory roles are facilitated by cysteine posttranslational modifications (PTMs). 
In particular, cysteine undergoes a variety of enzymatic and non-enzymatic PTMs to 
form reversible or irreversible covalent products. Besides oxidation by reactive oxygen 
species (ROS) and disulfide exchange as mentioned above, cysteine reacts with reactive  
Figure 1-2. Common posttranslational modifications of cysteines. 
 
nitrogen species (RNS), hydrogen sulfide, glutathione (GSH) and lipid-derived 
electrophiles (LDEs) to produce nitrosothiol,10 cysteine persulfide,11 glutathionylated 
! 5!
cysteine12 and Michael adducts13 respectively. Cysteine PTMs also include methylation, 
phosphorylation14, prenylation15 and palmitoylation16, the enzymatic addition of lipid or 
isoprenoid moiety from an active donor to a cysteine thiol. (Figure 1-2) These diverse 
cysteine PTMs occur on specific protein targets, and regulate diverse cellular functions 
like protein activity and localization, and dysregulation! of these PTMs are critical in 
driving a variety of proliferative and degenerative diseases.17-19 
 
Cysteine S-nitrosation 
Cysteine S-nitrosation is the conversion of a cysteine thiol to a S-nitrosothiol 
(SNO) by the covalent addition or transfer of a NO moiety to the reactive thiol group on a 
cysteine residue. (Figure 1-3, A) Currently, over 3000 peptides and proteins have been 
identified and studied as potential SNO targets.20, 21 Increasing studies on protein SNO 
indicate that, besides acting as an endogenous source of NO storage and transport, this 
dynamic PTM is also involved in protein redox regulation, mediating protein function 
and activity. 
 
1. Nitric oxide and cysteine S-nitrosothiol formation 
Recognized as an omnipresent inter- and intra-cellular signaling molecule, nitric 
oxide (NO) provides the primary source of cysteine S-nitrosation. Cellular NO is 
generated by three types of NO synthases (NOS):  endothelial NOS (eNOS), neuronal 
NOS (nNOS) and inducible NOS (iNOS). NOS oxidize L-arginine to afford NO and L-
citrulline.22 Named from their cell types where they were initially found, eNOS and 
nNOS synthesize NO in nanomolar concentrations for a short span of time, and in a Ca2+ 
dependent manner. iNOS was first described in mouse macrophages. It is only expressed 
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in the presence of acute injury and inflammation and is Ca2+ independent. During 
microbial infections, inflammation and some states of physiological stimulation, iNOS is 
expressed in various cells, leading to a sustained production of micromolar 
concentrations NO lasting for hours or days. This excessive production of NO plays an 
important role in antimicrobial defense.  
The canonical NO signaling pathway involves NO binding to the heme of soluble 
guanylate cyclase (sGC) to activate it, which leads to the production of secondary 
messenger cyclic GMP (cGMP) that participates in downstream signal transduction.10 
The inductive and inhibitive roles of NO in signal transduction have been shown in the 
regulation of the circulatory and cardiovascular systems, and control of the nervous, 
respiratory and immune systems.  
In parallel, NO serves as a reactive nitrogen species to selectively modify cysteine 
residues. Besides the radical form of NO, RNS includes nitroxyl radicals (NO−) and 
nitrosonium cation (NO+), formed by NO gaining or losing electrons, and the products of 
the reaction between NO and ROS, such as peroxynitrite (ONOO−) and the NOx 
compounds (e.g. NO2, N2O3, and N2O4).23 SNO synthesis in cells can result from three 
distinct pathways (Figure 1-3): (1) reaction of cysteine thiols with N2O3 resulting from 
autooxidation of NO; (2) recombination of NO with thiyl radicals; and, (3) transition 
metal-catalyzed addition of NO to a thiol. In particular, to generate nitrosothiols, NO is 
first oxidized to nitrogen dioxide radical directly by O2 or via ONOO- pathway. The 
nitrogen dioxide radical recombines another NO radical to form dinitrogen trioxide 
(N2O3), which then reacts with thiolate RS- to produce nitrosothiol. On the other hand, 
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thiolate RS- can transfer an electron to NO2 radical to generate nitrite and thiyl radical 
RS·, resulting in radical recombination with NO radical and nitrosothiol formation.23   
Figure 1-3. Cysteine S-nitrosation. (A) S-Nitrosation is the transfer of a nitroso-group 
onto cysteine residues. (B) Formation of S-nitrosation can occur through three key 
pathways: reaction with N2O3, reaction with thiyl radicals, or transition metal catalyzed 
addition of NO to thiols. 
 
SNO formation can also occur by transnitrosation via transfer of a NO group from 
low-molecular weight SNOs (e.g. S-nitrosocysteine (Cys-SNO), S-nitrosoglutathione 
(GSNO)) or other proteins. Such NO exchange reactions demonstrate the cellular 
dynamic equilibrium of nitrosothiols. The factors driving the transfer of NO in one 
direction is largely dependent on the direct interaction and appropriate redox potentials 
between the nitrosothiol and attacking thiol. Specifically, a protein containing a 
nitrosothiol possesses a higher redox potential compared to a protein with free thiol, and 
can be reduced by gaining an electron via transferring NO group to an adjacent free 
thiol.24, 25  
The reactive and unstable nature of the S-N bond renders S-nitrosothiols 
susceptible to undergo photolytic decomposition via hemolytic cleavage, highlighting the 
reversible nature of S-nitrosation. Transnitrosation, featured by NO exchange between 
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two cysteine residues, is a proof of this biological reversibility. Reducing species in 
biological environment such as GSH and reduced metals would facilitate SNO 
cleavage.26 At concentration ~10-6 M, Cu (I) ions can catalyze homolytic decomposition 
of RSNO to NO. Heterolytic cleavage of RSNO is facilitated by metal ions like Hg+2 to 
generate the free thiol and nitrous acid. High cellular concentration of GSH (millimolar 
level) maintains an intracellular reducing environment and results in RSNO 
decomposition by transnitrosation to generate GSNO, which can be subsequently reduced 
by GSNO reductase (GSNOR) and carbonyl reductase 1 (CBR1).25  
The abundance of cysteine residues on proteins is comparatively low (~2% of all 
amino acids in the proteomes). A study to measure the S-nitrosation occupancy level in 
an ischemic reperfusion injury model identified that, under physiological conditions, 1-10% 
of the proteome are occupied by S-nitrosothiol at a specific cysteine site.27 Thus, only 
selected free thiol cysteine residues are S-nitrosated, indicating the low level of SNO and 
its specific selectivity. Protein stability, denitrosation, compartmentalization of SNO 
proteins and limitations of detection methods could contribute to the underestimation of 
S-nitrosation occupancy.10 To date, studies reveal that several determinants might 
contribute to the endogenous selectivity of SNO formation, yet no sequence motif or pKa 
trend has been observed across these identified sites of S-nitrosation.28-30  
 
2.  Biological function of cysteine S-nitrosation  
Cysteine S-nitrosation is often considered as functional PTM analogous to 
phosphorylation. The role of protein SNO in regulation of protein function and in cell 
signaling pathway are demonstrated by directly inhibiting catalytic cysteines, by affecting 
protein-protein interactions or by controlling regulatory cysteines.  
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In order to directly modulate enzyme function, active-site cysteine residues are 
often utilized as SNO targets.  For example, Caspase-3, which is a cysteine protease and 
important in apoptotic cell death, is generated as the inactive zymogen, procaspase-3. 
Upon stimulation, Caspase-3 is cleaved to initiate the cell apoptosis pathway. Procaspase-
3 is shown to be constitutively S-nitrosated at its active site Cys163, which results in 
functional inhibition. Stamler et al. identified that Trx1 can effectively denitrosate 
cytosolic SNO-Caspase-3 and control the cellular steady-state amount of Caspase-3.  
Moreover, upon cell death stimulation, mitochondrial specific Trx2 facilitates 
denitrosation of SNO-Caspase-3 to promote cell death.31 The mechanism of denitrosation 
of SNO-Caspase-3 by Trx might be via an intermolecular disulfide formation between 
Trx-Cys32 and Caspase-3-Cys163 followed by attack of neighboring Trx-Cys35 to 
generate an intramolecular disulfide bond on Trx and free Caspase-3-Cys163. Another 
possibility is the direct transnitrosation of Trx-Cys32 by SNO-Caspase-3. Interestingly, 
Trx with a S-nitrosated Cys73, a non-active site cysteine, was reported to specifically 
transnitrosate Cys163 on Caspase-3, resulting in inactivation of that enzyme.25, 32 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) presents another example 
of active-site cysteine S-nitrosation. Besides its important role in glycolysis, GAPDH is 
associated with the nuclear apoptotic signaling pathway. The inherited lacking of a 
nuclear localization signal (NLS) as well as its bulky 150 kDa homo-tetramer needed for 
reactivity in nucleus block its translocation from cytosol to nucleus where it mediates cell 
apoptosis. Hara et al. found a cell death cascade initiated by iNOS induced S-nitrosation 
of a catalytic Cys150 on GAPDH. SNO modification of GAPDH increased its binding to 
Siah1, which is an E3 ubiquitin ligase and contains an NLS signal. Once bound, Siah1 
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facilitated GAPDH translocation to nucleus, where GAPDH in turn stabilized Siah1. 
Collected nuclear Siah1 triggered protein degradation and cell death. Thus, GAPDH 
reacted as a sensor of RNS to regulate cell death upon cellular stress.33 Furthermore, 
Kornberg et al. showed that S-nitrosated GAPDH could transnitrosate nuclear proteins 
including histone deacetylase 2 (HDAC2), DNA-activated protein kinase (DNA-PK) and 
deacetylating enzyme sirtuin 1 (SIRT1). The inhibition of SIRT1 by transnitrosation from 
SNO-GAPDH resulted in decreased transcriptional activity of peroxisome proliferator-
activated receptor-gamma coactivator PGC1α, suggesting a role of SNO-GAPDH on 
regulating PGC1α in metabolic pathway.34 
The c-Jun N-terminal kinase (JNK) belongs to mitogen-activated protein kinases 
(MAPKs), a family of serine/threonine kinase. Park et al. demonstrated that via induction 
of iNOS by IFN in vivo or via treatment with NO donor in vitro, JNK-mediated 
phosphorylation of c-Jun was inhibited. Site-specific studies showed that JNK inhibition 
was regulated by a thiol-redox mechanism where a regulatory thiol Cys116 on JNK was 
S-nitrosated, consequently suppressing the JNK-dependent trans-activating function of c-
Jun. This cysteine SNO mediated protein interaction serves as evidence of the ability of 
S-nitrosation to regulate gene transcription.35, 36 
 
3. Strategies to detect cysteine S-nitrosation 
Despite the significant progress in studying the structural consequences and 
related biological importance of S-nitrosation, the low abundance and labile property of 
endogenous cysteine S-nitrosation adducts have challenged the direct detection and 
enrichment of these modified species.23 From a methodology standpoint, methods for 
SNO detection need to address the following: (1) high accuracy and selectivity for 
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cysteine S-nitrosation sites; (2) chemical tagging and enrichment approaches; (3) 
quantitative analysis at the proteomic level; and (4) in-depth S-nitrosation sensitivity 
profiling.37 The following content is a brief overview of the chemical strategies to 
investigate cysteine S-nitrosation in a biological context, emphasizing proteomic methods 
that can identify S-nitrosation sites within the context of a complex proteome. 
3. 1. Detection of NO-related products 
The inherent instability of protein SNO lies on the weak bond strength of S-N and 
its sensitivity to trace metal ion catalyzed decomposition.10 The lability of the S-N bond, 
though making SNO detection difficult, has been used widely to develop methods for 
detection of liberated NO products after homolytic or heterolytic S-N cleavage.  
Chemiluminescence-based assays are widely used for its relatively easy and fast 
selective detection of SNOs in a complex biological system. This reductive method 
measures NO released using the intensity of generated chemiluminescence during the 
ozone-dependent oxidation of NO to NO2* followed by relaxing to ground state (NO2).  
Briefly, light induces homolytic cleavage of SNO by irradiation with a 200W mercury 
vapor lamp.  Released NO gas is purged into the ozonator chamber following 
condensation of impurities (liquid and organic traces) in cold traps.38, 39 Tri-iodide (I3-) is 
quantitatively used to reduce SNO to NO. The contribution of iron nitrosyls and 
nitrosamines to the chemiluminescent signals can be diminished by treating the sample 
with 10% of 100 mM sulfanilamide/ HCl solution.40 
 Copper-based detection methods utilize copper salt (CuCl2), cysteine and CO gas 
to transnitrosate RSNO to Cys-SNO, which is then reduced to Cys-SH and NO by Cu (I). 
Samples are treated with or without HgCl2 at neutral pH and the difference of peak areas 
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are converted to RSNO concentration. The CO gas serves to prevent auto-capture of NO 
by heme, making it suitable in blood sample detection. However, the pre-purification of 
CO gas is needed while special safety protection is required. Besides, this method is 
modified by pretreatment of sample with nitrite stabilization solution (K3FeCN6/ 
NEM/DTPA) to oxidize heme to ferric heme and to block free thiols.38, 41, 42 
While chemiluminescence methods provide an accurate means to detect global 
SNO in a biological system, these methods are limited in the inability to assign the SNO 
modification to a particular protein.38 Moreover, these methods do not provide any 
information on the specific cysteine residue that is modified, therefore failing to 
differentiate SNO sites of specific protein as well as identify novel SNO proteins.30  
3. 2. Biotin-switch technique and its improvements 
The biotin-switch technique (BST) is the most widely used method to detect 
protein S-nitrosation. It was initially presented in 2001 by Jaffrey et al. and was applied 
extensively in different biological systems.  BST includes three basic steps (Figure 1-4): 
(1) block free cysteine thiols with a thiol-specific alkylating agent methyl 
methanethiosulfonate (MMTS); (2) selectively reduce SNOs to free thiols by 
decomposing S-N bond with ascorbate; and (3) label the nascent thiols with a 
biotinylating cysteine-reactive reagent N-[6-(biotinamido)hexyl]-3’-(2’-
pyridyldithio)propionamide (biotin-HPDP). Biotinylated proteins can be detected by 
immunoblotting with a biotin-specific antibody, or subjected to avidin enrichment, 
trypsin digestion and analysis by mass spectrometry to further identify SNO proteins.43, 44 
Using this method,  ~15 proteins were identified in rat cerebellum, including metabolic 
proteins (GAPDH), signaling proteins (heat-shock protein 72, Hsp72), ion channels (N-
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methyl-D-aspartate receptor 1, NR1) and structural proteins (α- and β- tubulin). The 
advent of BST has enabled numerous biological studies that have illustrated the 
ubiquitous role of cysteine S-nitrosation in cellular function. A recent study utilized BST 
in red blood cells (RBCs) to show that NO generated by NOS is critical to maintain 
deformability in RBCs.45 The cellular targets of NO in RBCs included several 
cytoskeleton proteins, such as α- and β-spectrins. S-nitrosation of these cytoskeletal 
proteins was shown to be important to maintaining RBC deformation. Similarly, BST 
was critical for identifying proteins that mediate the NO-induced resistance of melanoma 
cells to anticancer agents such as cisplatin.46 Several nitrosated proteins were identified, 
including Caspase-3 and prolyl-hydroxylase-2, which are both inhibited by S-nitrosation. 
S-nitrosation of these and other proteins is thought to be directly involved in generating 
resistance to cisplatin. 
Figure 1-4. The biotin-switch technique (BST) involves capping of reduced thiols with 
MMTS, followed by selective reduction of S-nitrosated cysteines with ascorbate. The 
resulting newly-formed thiols are then capped with biotin-HPDP for enrichment of S-
nitrosated proteins.  
 
BST has been applied extensively in different biological systems since its 




























thiols in the initial alkylation step; incomplete alkylation will result in false positives. 
Furthermore, the sample preparation includes several processing steps, increasing the 
time lengthy so as the likelihood of SNO decomposition and scrambling of sites of S-
nitrosation through disulfide exchange, thus affecting the assay accuracy. For the 
cleavage of the S-N bond, BST relies on the selective and complete reduction of S-NO to 
SH with ascorbate. However, the selectivity of ascorbate for reducing SNO cysteines 
relies on a mechanism postulated as an indirect reduction, whereby ascorbate does not 
directly donate electrons to the nitrosothiol, but instead undergoes a transnitrosation 
reaction.47 This selectivity for SNO has been brought into question by the observation of 
artifacts that are generated due to reduction of sulfenic acid and disulfide bridges of low 
molecular weight disulfides like DTNB and glutathione disulfide with ascorbate in BST, 
which is accelerated by indirect sunlight.48, 49 Huang et al. found that BST method gave 
false-positive signals of SNO even on pre-reduced bovine serium albumin (BSA), upon 
ascorbate treatment.49 In response to the observed non-specificity reported for BST, 
Stamler et al. showed that the ascorbate-mediated reduction was highly specific, and 
inadvertent exposure to sunlight was the cause of false positives. It was suggested that 
analysis of a sample in which all SNO species were photolyzed prior to processing could 
act as an additional control to reduce false positives in BST experiments.50 
Given the low abundance of cysteine S-nitrosation modification, this low level of 
inaccuracy would affect the sensitivity of detection methods dramatically and remains a 
challenge for its development. To improve the accuracy and sensitivity of SNO detection, 
various optimization of BST have been made. These improvements have facilitated the 
generation of increasing information related to different SNO functions. 
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MMTS, used in BST as the free thiol-blocking reagent, is a reversible alkylating 
agent. It was replaced with N-ethylmaleimide (NEM) and iodoacetamide (IA), which 
could react with free thiols irreversibly to form a thioether bond instead of a disulfide 
bond.38, 51 In another study, Wang et al. found that the 1 mM ascorbate used in the 
original BST was not sufficiently fast at reducing RSNO and modified the assay by 
introducing copper “contaminants”. This ascorbate/copper system was shown to be able 
to accelerate S-NO reduction while keeping endogenous disulfides untouched, thus 
improving assay specificity.52  
Tagging the nascent thiol is critical to sample purification and RSNO 
identification. Forrester et al. modified BST by replacing thiol-reactive biotin with a 
thiol-reactive resin, termed S-nitrosation using resin-assisted capture (SNO-RAC). After 
MMTS blocking of free thiol and ascorbate reduction, nascent thiols were labeled with 
resin-bound disulfides. Newly generated disulfides were eluted by reducing reagent for 
further gel-based analysis, or by trypsin digestion on resin and subjected to 
isotopic/isobaric MS analysis on a peptide level. Using this method, novel SNO proteins 
like peroxiredoxin-1 (Prdx1) were identified. Compared to BST, SNO-RAC has higher 
sensitivity for high mass (>100 kDa) proteins and also has fewer steps to its workflow.53 
Alternatively, Camerini et al. set up a modified method termed His-tag switch by 
replacing thiol-reactive biotin with a synthetic His-tag that irreversibly bound to a 
cysteine thiol. Free thiols were initially irreversibly alkylated by NEM followed by 
ascorbate reduction of SNO cysteine residues. The second alkylation by synthetic peptide 
(I-CH2-CO-Gly-AArg-Ala-His6) on the nascent thiol groups facilitated purification on a 
Ni column. After trypsin digestion, eluted peptides were subjected to MS analysis with a 
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final mass shift of 271.12 Da. Using this method, 19 proteins from rat cerebral cortex, 
including 28 precise SNO modified peptides, were identified by MALDI-TOF or by 
nanoLC-MS/MS.54 To further overcome the interference from intermolecular disulfide 
bonds, which lead to false detection of SNO protein by BST, Huang et al. developed an 
irreversible biotinylation procedure (IBP) by using a non-disulfide-based biotin reagent 
(biotin-maleimide or biotin-PEO-maleimide) and by adding a new step of selective 
reduction of intermolecular disulfide bonds with dithiothreitol (DTT) before avidin 
purification. This strategy eliminated false positive identifications from intermolecular 
disulfide bound proteins, and was able to detect SNO protein as well as specific SNO 
cysteine residues.55 
Coupled with two-dimensional gel electrophoresis (2-DE), modified BST was 
applied to the selective detection of protein S-nitrosation. In a “fluorescent switch” 
method, after NEM blocking and ascorbate reduction, S-nitrosated targets were labeled 
by fluorescent maleimide and resolved in a 2-DE gel. It allowed easier identification of 
SNO proteins using a limited amount of protein extract, therefore increasing sensitivity. 
Using this method, 11 SNO proteins were identified in RAW264.7 cells, including novel 
targets like 26S proteasome non-ATPase regulatory subunit 2 (Psmd2).56 Similar to 
“fluorescent switch”, another combination of BST with 2-DE is SNO-DIGE (S-
nitrosothiol difference in gel electrophoresis) method. The mitochondrial S-nitrosothiols 
(MitoSNO) were specifically reduced by copper (II) and ascorbate following NEM 
blocking. Control and MitoSNO proteomes were then incubated with two thiol-reactive 
Cy-dye systems (Cy3 and Cy5), which allowed differential fluorescence detection of 
SNO proteins by 2-DE. As a result, 13 novel mitochondrial SNO proteins were identified, 
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the majority of which are enzymes involved in mitochondrial metabolism. SNO-DIGE 
overcomes the non-specific reduction conditions by using copper (II) and ascorbate, 
improving detection sensitivity in access to low-abundance SNO proteins.57 Similarly, in 
another study, Santhanam et al. described a modified BST named Selective Fluorescent 
Labeling Of S-nitrosothiols (S-FLOS). After blocking and reduction steps identical to 
BST, Cy-maleimide dye adduction was performed with the nascent thiol at pH 7. By 
bypassing immunoblotting or avidin enrichment steps, direct comparison of the 
fluorescent intensities between labeled proteins on the same 2D gel or in the same 1D gel 
lane was achieved by two Cy-dye systems (Cy3 and Cy5), allowing the detection of 
relative changes in SNO level of individual protein and quantification of SNO proteins. 
This detection method has low background and high signal to noise and sensitivity to 
allow for direct visualization of SNO content.58 
3. 3. Direct detection of SNO by phosphine 
Due to the limitations and artifacts associated with BST analysis, significant efforts have 
been invested in developing chemical probes with selectivity for S-nitrosothiols over 
other cysteine oxoforms (Figure 1-5). Analogous to the Staudinger ligation,59 where 
phosphines react selectively with azides to generate aza-ylides, S-nitrosothiols can 
directly react with triarylphosphines to form thiol-aza-ylides.60 This reaction inspired 
investigation of a series of phosphine-based molecules to probe SNO residues. Structural 
changes by introducing different electrophilic groups on the phosphine induced the thiol-
aza-ylide to undergo an intramolecular reaction and generate stable products. Wang et al. 
developed a reductive ligation by the use of a phosphine ester in place of phosphine, 
resulting in rearrangement of the aza-ylide intermediate to form a stable sulfenamide.60 
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This “one-step” conversion of SNO to stable conjugates was compatible with biological 
systems. However, excess phosphine was considered as a source of reductive 
fragmentation to cleave ligation products. Further engineering by Zhang et al. resulted in 
a “traceless” version of reductive SNO ligation with the use of phosphine ester or 
thioester derivatives.61 Specifically, if a tertiary RSNO was treated with phosphine 
thioester to undergo an intramolecular aza-Witting reaction, a stable thioimidate product 
was generated and the original S-N bond was maintained, while treatment of the 
relatively unstable but biologically relevant primary RSNO with a thioester thioester 
generated the stable disulfide iminophosphorane. A bis-ligation mechanism was proposed 
including initial thio-aza-ylide formation, followed by intramolecular acyl transfer from 
the thioester to the nitrogen on the thio-aza-ylide, and spontaneous intermolecular 
phenylthiolate nucleophilic attack onto the pseudo-sulfonamide to break the original S-N 
 
Figure 1-5. Chemical probes for S-nitrosation rely on the use of phosphine esters to form: 
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(1) thio-aza-ylides; (2) sulfenamides; (3) traceless disulfides; (4) traceless sulfonamides; 
(5) bis-ligation products and (6) adducts with water-soluble TXPTS. 
bond, producing phosphine oxide and a relative simple and more stable disulfide.61, 62 
Without bulky phosphine adducts, the disulfide products were more suitable for 
biological systems and downstream analytical platforms. Together with a biotin-linked 
phosphine probe and western blot, this modification was successfully applied in the 
identification of SNO proteins from Cys-SNO treated COS-7 cells.63  
To circumvent the poor water solubility of the phosphine reagents, tris(4,6-
dimethyl-3-sulfonatophenyl)phosphine trisodium salt hydrate (TXPTS) was reported by 
Bechtold et al. as the first water-soluble triarylphosphine that specifically and directly 
reacted with S-nitrosothiols to form the corresponding azo-ylide. The proposed 
mechanisms included the formation of S-substituted aza-ylide followed by reaction with 
another equivalent of phosphine, and the direct nucleophilic attack of TXPTS on the SNO 
sulfur to displace the HNO from RSNO. TXPTS reacts with alkyl hydroperoxide 
reductase C (AhpC-SNO), which contains an S-nitrosation sensitive active site Cys46 
with high efficiency. The resulting covalent S-alkylphosphonium product was detectable 
by ESI-TOF MS, and was stable under denaturing conditions at room temperature over 
several days.64 To further improve the aqueous compatibility and robustness of these 
reactions, Tannenbaum and coworkers developed a panel of derivatized 
triphenylphosphines with sulfonate esters and tertiary amines to facilitate water solubility 
and MS ionization.65 These modified probes were utilized to measure cellular GSNO 
levels using multiple reactions monitoring (MRM)-MS in malignant cancer cells and 
macrophages. These studies were the first to demonstrate the successful application of 
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phosphine probes for S-nitrosothiols within a complex biological sample. The limitations, 
however, remain that only low molecular-weight thiols were analyzed, and there are no 
reports on the application of phosphine probes for the enrichment of protein SNO from a 
complex proteome. With continued effort, the rates of reaction, water solubility of the 
phosphine reagent, stability of the resulting adducts and chemo-selectivity of the 
phosphine-nitrosothiol reaction will likely improve and enable the application of these 
probes to complex biological samples. 
3. 4. Direct detection by organomercury-based method  
An alternative approach to directly detect SNO was designed by Doulias et al. by 
developing a novel organomecury-based labeling and enrichment method. This method 
exploits the reaction of phenylmercury with SNO to form stable thiol-mercury conjugates 
by applying a synthetic phenylmercury compound coupled to either agarose 
(organomercury-conjugated resin, MRC) or biotin (phenylmercury-polyethyleneglycol-
biotin, mPEGb) for subsequent MRC or avidin enrichment. Free cysteine thiols within 
the sample are blocked with MMTS, and S-nitrosated proteins are selectively captured 
and enriched on the MRC resin or mPEGb and subsequently released using performic 
acid or β–mercaptoethanol which concurrently oxidizes newly released thiols to sulfonic 
acids. The eluted peptides are then analyzed by LC-MS/MS, where the unique mass shift 
of the sulfonic acid modification (+48 Da) enables identification of SNO proteins and the 
exact site of S-nitrosation. Using this method, 328 endogenous modified SNO peptides 
from 192 proteins were identified with a large range of molecular weights (13-272 kDa) 
and wide cellular distribution in mouse liver.29 Further systematic analysis of various 
mouse tissues using MRC uncovered 1011 SNO sites in 647 proteins across mouse liver, 
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brain, heart, kidney and lung. These identified S-nitrosated proteins participate in diverse 
metabolic processes including glycolysis, gluconeogenesis, oxidative phosphorylation, 
amino-acid metabolism and the tricarboxylic acid cycle. For example, about 70% of the 
SNO sites from heart tissue were annotated as mitochondrial proteins. In particular, S-
nitrosation of Cys238 in very long chain acyl-coenzyme A dehydrogenase (VLCAD) was 
shown to activate the enzyme, thereby illustrating the role of S-nitrosation in regulating 
fatty-acid beta oxidation. This method demonstrated a high level of sensitivity and 
accurcy due to its direct capture of SNO sites by bypassing ascorbate reduction and its 
conversion of SNO to a sulfonic acid with a unique MS shift for proteomic annotation.66 
With data larger subset of SNO sites identified, the biochemical, biophysical and 
structural properties of cysteine SNO modification can be further analyzed .  
Recently, Lee et al. developed an approach combining BST and MRC in a protein 
microarray platform. BST analysis was sequentially performed on a GSNO pretreated 
high-density protein microarray chip containing 16,368 unique GST-tagged full-length 
human proteins. S-nitrosated sites were biotinylated by BST, following by detection and 
quantification by immunobloting with an anti-biotin antibody coupled with a fluorescent 
Cy5 secondary antibody. Of the 834 SNO proteins identified, a subset was recombinantly 
expressed, purified with GST-tag, subject to organomercury MRC enrichment and 
subsequent MS analysis to identify the sites of S-nitrosation, including 113 novel SNO 
cysteine sites.67 The combining of orthogonal methods like BST and MRC to identify S-
nitrosation provides increased confidence in the identified targets and serves to mitigate 
the limitations associated with each of the methods. 
3. 5. Quantitative mass-spectrometry methods 
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Two-dimensional gel electrophoresis (2DE) method has been extensively used for 
protein separation and comparisons of protein abundance. However, drawbacks of 2DE 
are existed, such as poor reproducibility, low resolution and accuracy, incompatibility 
with hydrophobic proteins, incapability of analyzing low abundant protein/PTMs and 
time and labor-consuming, greatly limit its analytical application on biological samples.68 
From the ground-breaking development in sample preparation, peptide fragmentation, 
accuracy and sensitivity of instrumentation and bioinformatics pipeline, the most 
common quantitative proteomic analysis on protein and its PTMs has shifted from 2DE-
based methods to Mass Spectrometry-based technology, especially isotopic labeling-
derived quantitative shotgun proteomics. Importantly, these MS improvements greatly 
facilitate quantitative measurement of protein S-nitrosation, allowing the analysis of the 
modification occupancy and dynamics, the characterization of specific modified cysteine 
residues, and the exploration of deeper cellular relationship.  
Stable isotope labeling by amino acid in cell culture (SILAC) is an MS1-based 
isotopic labeling method and is used for relative protein quantification widely.30 Benhar 
et al. applied BST coupled SILAC to identify a specific subset proteins. Two identical 
Jurkat cell populations were cultured in SILAC medium containing either light amino 
acid (Arg0 (12C614N4) and Lys0 (12C614N2)) or heavy amino acid (Arg10 (13C615N4) and 
Lys8 (13C615N2)). After cytosolic extraction and nitrosation, the light cultured cell lysate 
underwent denitrosation by Trx system (Trx/TrxR/NADPH) and heavy cultured remained 
untreated as a control. Then the endogenously nitrosated proteins were detected by BST 
and LC-MS. Proteomic annotation showed that 145 proteins out of a total of ~280 SNO 
proteins were identified in both heavy and light samples. Out of these 145 SNO proteins, 
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46 were lower in terms of Light to Heavy ratio (≤0.65) than control after denitrosation, 
and thus were considered as substrates of Trx1. Detailed study showed that these proteins 
participate in a broad range of cellular processes like metabolism, signal transduction and 
protein folding.69  
Instead of metabolic labeling by isotopes as in SILAC, a chemical labeling 
method, termed isotope-coded affinity tags (ICAT) was developed. This method, utilizing 
the ICAT reagent including a thiol reactive group, a biotin affinity tag and a heavy or 
light isotopic linker, expands upon a shotgun proteomic strategy and directly interface 
differential cysteine labeling with MS. 70 Cysteine containing proteins selectively 
captured by light or heavy ICAT reagents are enriched on streptavidin affinity beads to 
purify ICAT-coded proteins, which are subject to trypsin digestion, mixing and analysis 
by quantitative MS, whereby the tagged cysteine-containing peptides can be identified 
and the relative abundance between the light- and heavy-labeled samples can be 
quantified.71 When coupled with ICAT, Sinha et al. developed a “d-switch” method by 
adapting BST to identify SNO targets and quantify the percentage of SNO level. The free 
thiol was block by d-NEM instead of MMTS. After ascorbate/Cu(I) reduction, newly-
formed free thiols were labeled by d5-NEM. Subsequent in-gel tryptic digestion and MS 
analysis identified SNO proteins. Quantification of relative amount of peptides from 
isotopic d-NEM/d5-NEM labeling related to peptide-SH vesus peptide-SNO. Using this 
method, investigation of GST-P1 SNO by five classes of NO donors showed different 
SNO sensitivities.72  
Isobaric tags are commonly used for multiplexed peptide quantification and 
include three functional parts: an amine-reactive group, a unique mass reporter group and 
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a cleavable linker as a mass balancer. Digested peptides from different biological samples 
are labeled with a set of multiplex isobaric tags by the reaction of the amine-reactive 
group on the tag with the peptide N-terminus or lysine residues of the peptides. Using a 
balancer moiety to compensate for the mass shift, all sets of multiplex isobaric tags are 
identical in total molecular weights but contain different reporter weights. These isobaric 
tags enable co-elution of peptides during LC as well as co-isolation for fragmentation of 
the linker during MS2, resulting in release of the reporter group. Importantly, the 
intensity of the reporter group serves as signature ions on MS spectra and represents the 
relative abundance of the original peptide, the feature used to quantify protein 
modification/expression levels.30 This MS2 (MS/MS)-dependent isobaric labeling is able 
to analyze multiple peptide pools in a single analysis, using 8-plex iTRAQ (isobaric tags 
for relative and absolute quantification) and 6-plex TMT (tandem mass tags).68 Instead of 
traditional iTRAQ assays where proteins were first digested to peptides and then labeled, 
Murray et al. developed a new isotope coded cysteine thiol-reactive multiplex reagent 
(cysTMT6), coupled with BST to detect SNO proteins and quantify specific cysteine 
SNO reactivity. Similar to iTRAQ, the cysTMT6 includes a mass reporter (126-131 Da), 
a cysteine pyridyldithiol reactive group and a mass normalizer. Once blocked by NEM 
and reduced by ascorbate/copper, samples were labeled by cysTMT6 (cysTMT126-131) and 
subjected to SDS-PAGE or trypsin digestion. TMT labeled peptides were enriched on 
TMT affinity resin and eluted with acid under low pH to be further analyzed by 
LC/MS/MS. The MS/MS fragmentation of reporter groups allowed analysis of up to six 
samples at the same time, thus study of the extent of SNO at each cysteine residue and 
the SNO site occupancy could be achieved.73-75 
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Recently, an isotopic tandem orthogonal proteolysis-activity-base protein 
profiling (isoTOP-ABPP) proteomic method was developed by Cravatt et al. to globally 
quantify cysteine reactivity and characterize cysteine functionality. This method included 
a cysteine reactive probe, idoacetamide-alkyne (IA-alkyne) that covalently labels free 
cysteine thiol, and an azide-functionalized TEV-protease recognition peptide with a 
biotin tag for streptavidin enrichment. IA-alkyne-captured proteins were conjugated to 
the biotin tag through a bioorthogonal “click-chemistry” reaction between the alkyne 
handle and azide. After enrichment, on-bead trypsin digestion and TEV protease cleavage, 
peptides were released and analyzed by LC-MS/MS, allowing the identification of the 
cysteine containing proteins and the specific probe-labeled cysteine residue. The 
isotopically labeled valine containing tags further facilitated quantitative measurement of 
cysteine reactivity.76 A comparative analysis of IA-alkyne-reactive cysteines and SNO 
cysteines in WT mouse heart revealed that 38 out of 119 proteins were both SNO reactive 
and IA reactive, including 32 cysteine residues both sensitive to SNO and IA. This 15% 
coverage (32 of 211 cysteine SNO residue) suggested the selective reactivity to different 
modification on the same cysteine.10 Therefore, the isoTOP-ABPP method bypassing free 
thiol blocking and SNO conversion procedures in BST, would serve as a potential 
quantitative identification strategy of cysteine S-nitrosation. 
 
Conclusion 
Despite being one of the least abundant amino acids on proteins, cysteine is 
frequently identified as a highly conserved functional site within the proteome. The 
unique characteristics of the cysteine thiol or thiolate group (nucleophilicity, high-affinity 
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to several metal/metal clusters and disulfide bond formation/exchange) that are 
commonly influenced by the intrinsic properties of the sulfur pKa, redox potential and the 
local microenvironment, largely contribute to its catalytic, metal binding, structural as 
well as redox-dependent regulatory roles.9 Cysteine could undergo a diverse set of 
posttranslational modifications, and often it is the cysteine PTMs that exert a significant 
impact on its proteomic functions. 
Cysteine S-nitrosation, a covalent addiction of a NO moiety on the cysteine thiol, 
is emerging as an important PTM in regulation of protein function, translocation, 
degradation and signaling pathways. The low abundance, high dynamic and labile nature 
of cysteine SNO complicates the identification of SNO protein and specific SNO cysteine 
residues. Detection methods, from the chemiluminescence and chemical reduction assays, 
to the Biotin Switch Technique and its improvements, alongside phosphine and 
organomercury-based direct detection methods have been intensively used to identify and 
characterize SNO protein and cysteines. With advances in mass spectrometry-based 
proteomic technology, featured by metabolic or chemical isotopic coding, quantitative 
proteomic analysis on both the protein expression level and amino acid PTM level have 
been achieved.  
With respect to cysteine SNO, this thesis is focused on the development of a MS-
based platform to explore! the extent of modification at individual cysteine residues 
(Chapter 2) in order to facilitate the identification of novel cysteine sites that regulate 
protein function (Chapter 3). A parallel comparison of cysteine sensitivity to different 
transnitrosating reagents reveals specific sets of SNO modification targets correlated with 
each transnitrosation donor (Chapter 4). Upon the successful application of this platform 
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to identify novel regulatory cysteines, we aimed to identify small molecule modifiers for 
these and other characterized regulatory cysteines. , Screening a small-molecule library 
against these cysteine-containing proteins enabled the discovery of cysteine-reactive 
irreversible inhibitors, which allow for pharmacological modulation of proteins 
containing regulatory cysteines (Chapter 5). 
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Introduction 
Nitric oxide (NO) plays critical roles in mammalian physiology. In the immune 
response, cytotoxic NO concentrations are generated by inducible NOS (iNOS) at 
infection sites.1 In cardiovascular and neuronal signaling, endothelial nitric oxide 
synthase (eNOS) and neuronal NOS (nNOS)1 produce local bursts of NO that activate 
soluble guanylate cyclase2 and mediate intercellular communication. Recently, an 
alternate NO signaling pathway has emerged involving modification of cysteine residues 
to form S-nitrosothiols (S-nitrosation)3, 4. The majority of cellular S-nitrosothiols are 
formed via a transnitrosation mechanism, whereby S-nitrosothiols are transferred through 
formation of specific protein-small molecule or protein-protein interactions and 
subsequent nucleophilic attack of a thiolate at the nitrogen of the S-nitrosothiol.5, 6 
Cellular transnitrosation is predominately mediated by abundant thiol containing small 
molecules or proteins, such as glutathione (GSH) and thioredoxin (Trx), which form the 
corresponding S-nitrosated species, GSNO and Trx-SNO, respectively.4, 7 GSNO is the 
primary small molecule S-nitrosothiol in eukaryotes, and cellular GSNO concentrations 
range from high nanomolar in cells with basal NOS activity to micromolar in cells where 
NOS has been activated.8 
Over 3000 sites of protein S-nitrosation have been identified including cysteine 
residues within two NOS isoforms (eNOS and iNOS), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), and Caspase-3 (Casp3).9-13 In many cases, S-nitrosation alters 
subcellular localization or enzymatic activity, underscoring the importance of this 
posttranslational modification in the regulation of protein activity. Transnitrosation of the 
active-site cysteine of Casp3 by Trx-SNO inhibits protease activity and directly governs 
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the initiation of apoptosis.14 Similarly, S-nitrosation of GAPDH at Cys152 triggers 
GAPDH translocation to the nucleus and subsequent transnitrosation of nuclear proteins 
and initiation of apoptosis.15, 16 Dysregulation of S-nitrosation is implicated in a variety of 
diseases including cystic fibrosis, asthma, hypertension, cancer, and neurodegeneration.17 
Importantly, small-molecule inhibitors of GSNO reductase, the primary enzyme that 
catalyzes the cellular degradation of GSNO, are currently in clinical development for 
treatment of cystic fibrosis, asthma, and other diseases that exhibit decreased endogenous 
S-nitrosothiol levels.18 
Although the endogenous regulation of protein function through S-nitrosation is 
well established, the properties of an individual cysteine residue that govern sensitivity to 
S-nitrosation are poorly characterized.12, 19-21 The lack of a sequence or structural motif 
that dictates the substrate selectivity of each transnitrosation donor necessitates 
experimental methods for quantitative assessment of the sensitivity of cellular cysteine 
residues to undergo transnitrosation by donors such as GSNO.  
The most widely utilized platform for identifying S-nitrosated proteins in complex 
proteomes is the Biotin-Switch Technique (BST), 22 which is comprised of three main 
steps: (1) blocking free cysteine residues with a thiol-reactive agent such as 
iodoacetamide, N-ethylmaleimide, or methyl methanethiosulfonate; (2) selective 
reduction of S-nitrosothiols with ascorbate; and (3) labeling the newly reduced cysteine 
residues with a biotinylated thiol-reactive agent. Since the initial development of the 
BST, several modifications to this platform have been developed. These include the 
SNO-RAC and d-Switch methodologies, which introduce resin-assisted capture and 
isotopic labeling to identify and quantify S-nitrosated species from proteomes. 23-25 
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Similarly, enrichment of S-nitrosothiols with mercury resin has enabled the identification 
of S-nitrosated species from cells.12, 13 More recently, chemical probes selective for S-
nitrosothiols have been developed, including a variety of phosphine reagents that undergo 
a Staudinger-type reaction with S-nitrosothiols 26-28 and biotinylated sulfinic acids that 
form stable thiosulfonates upon reaction with S-nitrosothiols29. 
A significant limitation of existing methods to monitor S-nitrosation is the 
inability to quantitatively determine the extent of S-nitrosation for each individual 
cysteine residue, and thereby evaluate the sensitivity of a particular cysteine to a given 
transnitrosation donor. In this study, this limitation is addressed by implementing a 
competitive cysteine-labeling strategy to concurrently and quantitatively monitor the 
sensitivity to transnitrosation of hundreds of cysteine residues within the human 
proteome. Specifically, 609 cysteine residues in the human proteome were screened in 
parallel to determine the stoichiometry of S-nitrosation upon treatment with GSNO. From 
this data, a subset of cysteine residues with high sensitivity to GSNO-mediated 
transnitrosation was identified. To evaluate the functional consequences of S-nitrosation, 
two proteins that demonstrated high sensitivity to GSNO transnitrosation, 3-
Hydroxyacyl-CoA dehydrogenase type-2 (HADH2) and Cathepsin D (CTSD), were 
selected for further biochemical evaluation. In both cases, S-nitrosation regulates protein 
function through a unique mechanism, thereby revealing previously uncharacterized 







Visualization of protein sensitivity to transitrosation by in-gel fluorescence 
In order to visualize protein sensitivity to transnitrosation, we took the advantage 
of in-gel fluorescence as well as a multifunctional cysteine-reactive probe. This 
iodoacetamide alkyne (IA) probe is composed of an iodoacetamide electrophile to 
covalently modify reactive cysteine residues, and a terminal alkyne that can be further 
functionalized through click chemistry. (Figure 2-1, C) The widely used click chemistry 
reaction is the bioorthogonal copper (I)-catalyzed azide alkyne cycloaddition (CuAAC) 
reaction to generate a 1,4-disubstituted 1,2,3-triazole.30, 31 The CuAAC reaction, derived 
from the Huisgen 1,3-dipolar cycloaddition, is ideal for biological applications due to the 
high stability of azides to water, ambient oxygen and a wide-variety of synthetic 
transformations. Moreover, the synthetic ease of incorporating azides and alkynes into 
biological probes, coupled with the minimal steric disruption caused by these 
functionalities, has further promoted its application in probing expanded enzyme classes, 
enabling cellular and in vivo studies, and providing technological platforms to 
quantitatively monitor protein activities in complex biological systems.32 
MCF7 breast cancer-cell lysates were transitrosated by increasing concentrations 
of GSNO (50, 100, 200 and 500 µM) at 37°C for 1 hr. Cysteine reactivity was probed by 
IA, and CuAAC was performed with rhodamine-azide (Rh-N3) as a fluorescent reporter 
group. The resulting fluorescence-tagged lysates were subjected to SDS-PAGE 
separation and imaged by in-gel fluorescence. (Figure 2-1, A) Comparing untreated to 
GSNO-treated lysates identified a subset of cysteines that showed a loss in reactivity 
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upon GSNO treatment. Similarly, monitoring cysteine reactivity upon increasing the 
GSNO concentration showed that proteins can have variable sensitivities to GSNO. Some 
labeling number of protein bands showed no detectable changes in cysteine reactivity 
with increasing GSNO, whereas other bands showed significant changes in reactivity 
upon increasing GSNO concentrations.  
 
Figure 2-1. In-gel fluorescence to visualize protein sensitivity to transnitrosation. (A) 1 
mg/mL MCF7 cell lysates were treated either with buffer or GSNO (50, 100, 200 and 500 
µM) at 37°C for 1 hr, then labeled by 1 µM IA and conjugated to rhodamine azide using 
CuAAC. Samples were separated by SDS-PAGE and visualized by in-gel fluorescence. 
(B) Structure of GSNO. (C) Structure of the iodoacetamide alkyne probe. (D) Fluorescent 























A competitive cysteine-labeling strategy to quantitatively measure cysteine 
sensitivity to GSNO 
The extent of cysteine S-nitrosation was quantitatively monitored using a mass 
spectrometry (MS)-based proteomic platform that exploits the characteristic loss in 
nucleophilicity of a cysteine thiol upon conversion to a S-nitrosothiol, which is reflected 
in decreased reactivity with the IA probe. This platform is derived from the previously 
reported isotopic tandem orthogonal proteolysis-ABPP (isoTOP-ABPP) method,31, 33 
which reliably and quantitatively monitors the intrinsic reactivity of 500-1000 cysteine 
residues concurrently within cell and tissue proteomes generated without protein 
denaturation. To date, the isoTOP-ABPP method and derivatives thereof have been 
successfully applied to quantitatively measure the loss in cysteine reactivity upon 
oxidation,34 reaction with lipid-derived electrophiles,35 and metal binding.36 These studies 
identified cysteine residues that are highly sensitive to these cysteine-modifying agents, 
resulting in the discovery of functional cysteine residues that regulate protein activity. 
Therefore, the isoTOP-ABPP platform and its derivatives are ideally suited to quantify 
the extent of modification by transnitrosation donors (e.g. GSNO) for hundreds of 
cysteine residues concurrently within a cell proteome. In this approach (Figure 2-2), a 
cell lysate is exposed to GSNO or a buffer control. Both proteomes are then treated with 
a cysteine-reactive IA probe, which covalently modifies hundreds of reactive and 
functional cysteine residues within the proteome. Following alkylation by the 
iodoacetamide of the IA probe, the terminal alkyne of the IA probe can be further 
functionalized through (CuAAC) reactions.30, 31 The IA probe-labeled proteins are 
covalently linked to light (GSNO-treated sample) or heavy (buffer treated sample) biotin-
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azide tags (Azo-L and Azo-H) that contain an azobenzene linker for reductive cleavage 
by sodium dithionite33 (Figure 2-2. A). The light and heavy samples are then combined 
and subjected to streptavidin enrichment, on-bead trypsin digestion, and sodium 
dithionite cleavage to afford a mixture of light and heavy-labeled peptides for MS 
analysis. These cysteine-containing isotopically labeled peptides are identified using the 
fragmentation (MS/MS or MS2) spectra and the relative abundance between the GSNO 
and control samples is measured by the heavy:light ratio (R) that reflects the intensity of 
these species in the parent ion (MS1) spectra. An R-value of ~1 signifies a cysteine 
residue that was unaffected by GSNO treatment, whereas R-values greater than one 
indicate modification of that cysteine residue by GSNO. A larger R-value reflects a 
greater percentage of cysteine modification. 
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Figure 2-2. A competitive cysteine-profiling strategy to quantify sensitivity to 
transnitrosation.  (A) Structure of the Azo-L/Azo-H tags. The atoms 12C and 14N on the 
valine residue of Azo-L indicated are replaced by 13C and 15N in Azo-H, providing a 
mass difference of 6 Da between the Azo-L and Azo-H tags. (B) and (C), Schematic 
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showing the application of the Azo-L and Azo-H tags for quantitative proteomics. Cell 
lysates are either treated with only buffer (B), or treated with a transnitrosation donor 
(e.g. GSNO) or a buffer control (C), labeled with the IA probe, and subjected to CuAAC 
to append either the Azo-L (buffer (B), GSNO (C)) or Azo-H (buffer (B and C)) biotin-
azide tags. The resulting isotopically tagged proteomes are mixed together and subjected 
to streptavidin enrichment and on-bead trypsin digestion. The probe-labeled peptides are 
eluted by reductive cleavage of the azobenzene with sodium dithionite and analyzed by 
high resolution LC/LC-MS/MS to identify (MS2) and quantify (MS1) the IA-probe 
reacted cysteine residues within each sample. A loss in cysteine reactivity is indicative of 
transnitrosation donor-mediated S-nitrosation or other cysteine modification.  
 
Quantitatively measuring cysteine sensitivity to GSNO 
MCF-7 breast cancer-cell lysate proteomes were subjected to the following 
treatments; (1) 500 µM GSNO (light) versus no GSNO added (heavy) as the experimental 
sample (n=5) (Figure 2-2, C); and (2) both the light and heavy samples left untreated by 
GSNO as a control (n=2) to verify the quantitative accuracy of the MS approach (Figure 
2-2, B). In total, 609 cysteine residues were identified with accurate heavy:light ratios in 
all of the experimental and control samples (Figures 2-3, A and B). The full dataset is 
presented in Appendix I as Table 2A-1. As expected, the control samples showed a 
limited distribution of R-values, closely centered on R = 1. In contrast, the experimental 
samples showed a wider distribution of R-values, where the majority of cysteine residues 
exhibited R-values > 1 (Figure 2-3, C). These higher R values are reflective of a loss in 
reactivity for cysteine residues in the GSNO-treated (light) sample. The majority of 
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cysteines (583 out of 609; 96%) were minimally affected by GSNO treatment with R-
values < 3. However, a small subset of cysteines (27 out of 609) showed high sensitivity 
(R > 3) to GSNO treatment. P values (Appendix I, Table 2A-1, 2-way ANOVA analysis) 
indicate the high confidence in the observed decrease in cysteine reactivity for those with 
ratios >3, which is the cut-off we placed for cysteines that are highly sensitive to GSNO. 
The proteins containing these GSNO-sensitive cysteines serve diverse cellular functions, 
and are found in all subcellular compartments (cytoplasm, nucleus, ER, mitochondria, 
etc.), with the majority located on enzymes or structural proteins according to gene 
ontology (GO) analysis (Figure 2-4).  
 
Figure 2-3. Identifying cysteines sensitive to modification by GSNO. (A) Heavy:light 
ratios (R) are shown for 609 cysteine residues identified in GSNO-treated (in red; light: 
500 µM GSNO; heavy: buffer;) and control (in black; light: buffer; heavy: buffer) MS 




























































































R~1, whereas R-values from the experimental sample show a large proportion of cysteine 
residues with R>>1, indicating a loss in the free reduced form of individual cysteine 
residues upon GSNO treatment. A greater R-value is indicative of a higher extent of 
cysteine modification. Representative extracted ion chromatograms and isotopic 
envelopes (light: red; heavy: blue) are shown for three cysteine residues with high, 
moderate, and low sensitivity to GSNO. Ratio values are averaged across the different 
charge states identified, but displayed chromatograms are for a single representative 
charge state. The data shown here are for a representative dataset of GSNO and control 
proteomes. (B) Quantitative MS analysis of GSNO-treated cell lysates. Average 
heavy:light ratios (R) are shown for 609 cysteine residues identified in 5 GSNO-treated 
(in red; light: 500 µM GSNO; heavy: buffer;) and 2 control (in black; light: buffer; 
heavy: buffer) MS analyses. Error bars represent standard deviation from the mean across 
the replicate analyses. A complete list of all identified cysteines are displayed in 
Appendix I as Table 2A-1 and gene ontology (GO) analyses for cysteine residues 
sensitive and insensitive to GSNO are shown in Figure 2-4. (C) Distribution of R-values 
for the control and GSNO-treated (500 µM) samples. 
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Figure 2-4. Gene ontology (GO) analysis (From data in Appendix I, Table 2A-1). 
Biological process (A) and molecular function (B) are shown for all proteins (left) and 
proteins containing the 27 cysteines with greatest GSNO sensitivity (right) (R >3) from 
the cysteine-reactivity profiling analyses. GO analysis was performed using PANTHER 
(www.pantherdb.org). 
 
To evaluate the data obtained here within the context of previously identified sites 
of S-nitrosation, a comparison to the dbSNO database37 was performed, which integrates 
data from 219 research articles to generate a list of >3000 S-nitrosation sites obtained 
through global proteomic analyses. Of the 27 cysteine residues observed to be highly 
sensitive to GSNO transnitrosation, 14 were previously identified sites of S-nitrosation 
according to the dbSNO database (Appendix I, Table 2A-2). This comparison highlights 
the ability of this cysteine-profiling platform to identify both known and previously 
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uncharacterized putative S-nitrosation sites. Furthermore, since this platform monitors a 
loss in cysteine reactivity, it enables the identification of other cysteine modifications 
(e.g. S-glutathionylation) beyond S-nitrosation triggered by GSNO treatment. 
To evaluate the data obtained here within the context of cysteine functionality, the 
function of each cysteine residue (active site, metal-binding, redox-active, etc) and its 
conservation in six different species were denoted as annotated in the UniProt database 
(Appendix I, Table 2A-1). Several of the cysteines that were highly sensitive to S-
nitrosation (e.g. AKT1, CTSD, DLD) were annotated as part of a redox-active disulfide 
according to the UniProt , but there was no significant enrichment in functional cysteines 
within the subset of residues we identified to be highly susceptible to GSNO-mediated 
transnitrosation. Moreover, no correlation between cysteine conservation and sensitivity 
to S-nitrosation was observed. Furthermore, in a previous study, it was demonstrated that 
ratios obtained in such comparative analyses of cysteine reactivity are independent of 
protein abundance.31 Because we were comparing the population of unmodified reactive 
cysteines across two samples and were not looking at absolute amounts of modified 
protein, the relative abundance of the protein did not contribute to the ratio value 
obtained. 
Importantly, since this platform measures the extent of modification at the level of 
individual cysteine residues, the sensitivity of multiple cysteine residues within the same 
protein can be measured in a single experiment. For example, Cys194 in the poly(rC)-
binding protein 1 (PCBP1), is highly sensitive to GSNO (R = 3.4) whereas three other 
observed cysteines, Cys54 (R = 1.2), Cys109 (R = 1.2), and Cys158 (R = 1.0), are 
insensitive to GSNO (Figure 2-6). In contrast, the three cysteine residues observed for the 
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chloride intracellular channel protein 1 (CLIC1), Cys24 (R = 1.1), Cys178 (R = 0.8), and 
Cys223 (R = 1.0), are all insensitive to GSNO (Figure 2-5). 
 
Figure 2-5. Measurement of transnitrosation sensitivity at the level of individual cysteine 
residues within the same protein. (A) Of the four cysteine residues identified in PCBP1, 
Cys194 demonstrated high sensitivity to GSNO transnitrosation (R=3.4), whereas Cys54, 
Cys109, and Cys158 were insensitive (R~1). (B) All three cysteine residues identified in 
CLIC1 were insensitive to GSNO transnitrosation compared to the control (0 µM GSNO) 
sample (R~1). 
 
Of the GSNO-sensitive cysteines, one of the highest R-values of 4.9 was observed 
for the active-site cysteine, Cys152, in GAPDH, which is indicative of ~80% S-
nitrosation of this cysteine residue when exposed to 500 µM GSNO. Cys152 is the 
active-site nucleophile of GAPDH and a well-characterized biologically relevant site of 
S-nitrosation,15, 16 thereby validating the ability of this platform to detect functionally 
important sites of S-nitrosation. Since the active-site cysteine containing peptide of 
GAPDH contains two cysteine residues (IISNASC(152)TTNCLAPLAK), we assigned 












































data (Figure 2-6, A). We did not find any MS2 spectra that contain the modification at the 
second cysteine on this peptide.  
 To alleviate concerns that the TCEP used in the CuAAC reaction could reduce S-
nitrosated cysteines, which could subsequently react with residual IA remaining in 
solution, we sought to demonstrate that the IA probe is a limiting reagent and no free IA 
remains after the initial 1 hr incubation step. It is important to note that we performed all 
labeling at 100 µM IA probe, which was significantly less than the ~5-10 mM 
iodoacetamide required to alkylate all cysteines within a proteome in typical proteomic 
analyses. To confirm that IA is limiting, we performed an experiment (Figure 2-6, B) 
where we added a purified reactive-cysteine containing protein, protein disulfide 
isomerase A1 (PDIA1), to a lysate before (lane 3) or after (lane 2) IA labeling. As shown 
in the fluorescence gel image, negligible PDIA1 labeling was observed when PDIA1 was 
added after the 1 hour IA incubation step, indicating there was no free IA probe 
remaining after the 1 hour incubation time. Therefore, it was unlikely that any IA probe is 







Figure 2-6. (A) Manual interrogation of the MS2 fragmentation data assigned the exact 
site of modification for peptides with two or more cysteines. MS2 fragmentation of 
peptide IISNASCTTNCLAPLAK of GAPDH was interpreted to assign the b and y ions, 
with Cys152 as the modified residue. (B) IA probe was completely consumed before 
click chemistry in our analysis platform. Purified PDIA1 was added to a lysate before 
(lane 3) or after (lane 2) IA labeling, or not added (lane 1), then clicked on Rh-N3 and 
resolved in SDS-PAGE. As shown in the fluorescence gel image (left), negligible PDIA1 
labeling was observed when PDIA1 was added after the 1 hour IA incubation step, 
indicating there was no free IA probe remaining after the 1 hour incubation time. 
Coomassie stain (right) showed the total proteome loaded on the gel. 
 
To further quantify cysteine sensitivity to GSNO, proteomes were treated with 
varying GSNO concentrations (0, 50, 100, 200, 500 µM) followed by labeling with the 
IA probe and Azo tags and subsequent MS analysis. R values were quantified at each 
GSNO concentration for 576 cysteine residues. The full dataset is presented in Appendix 
I as Table 2A-3. 2-way ANOVA analysis (for P value) was not performed for these data, 
but since there are five concentrations analyzed, we focus on those cysteines that show 
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the expected concentration-dependent increases in ratio. Cysteine residues that were 
highly sensitive to transnitrosation at 500 µM GSNO, such as Cys329 in cathepsin D 
(CTSD) and Cys58 in HADH2, showed a concentration-dependent increase in 
modification at increasing GSNO concentrations (Figure 2-7, A). In contrast, Cys32 in 
glutathione-S-transferase omega 1 (GSTO1) showed a R-value of ~1 at all GSNO 
concentrations (Figure 2-7, A), confirming GSNO insensitivity. A wide array of GSNO 
transnitrosation sensitivities were observed as exemplified by plotting the R values at 
increasing GSNO concentrations for cysteine residues from six different proteins 
(GAPDH, CTSD, HADH2, L-xylulose reductase (DCXR), GSTO1 and chloride 
intracellular channel protein 4 (CLIC4)) (Figure 2-7, B). 
Two proteins from the list, one highly sensitive to GSNO (CTSD) and one 
completely insensitive to GSNO (GSTO1), were selected for verification using a 
secondary detection method. According to the MS data (Appendix I, Table 2A-1 and 2), 
both CTSD and GSTO1 were selectively labeled by the IA probe at a single cysteine 
residue. For secondary verification, CTSD and GSTO1 were overexpressed by transient 
transfection in HEK293T cells with a C-terminal Myc/His tag. The CTSD and GSTO1 
overexpressing cells were lysed and the resulting proteomes were split into five aliquots 
and treated with four GSNO concentrations or left untreated. These samples were then 
treated with the IA probe followed by CuAAC and enrichment steps identical to that used 
for the MS analysis. After the streptavidin enrichment, proteins were eluted from the 
streptavidin beads with sodium dithionite, separated by SDS-PAGE, and analyzed by 
immunoblotting with an anti-Myc antibody. Protein cysteine modification is expected to 
decrease IA-probe labeling, reflected by reduced protein detection in the immunoblot. In 
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agreement with the MS data, GSTO1 enrichment was not affected by GSNO treatment 
(Figure 2-7, C), confirming the insensitivity of GSTO1 to GSNO. In contrast, CTSD 
enrichment showed a concentration-dependent decrease upon GSNO treatment, mirroring 
the increasing R values observed in the MS studies for CTSD Cys329 at increasing 
GSNO concentrations (Figure 2-7, C). These immunoblotting studies, therefore, provide 
a secondary verification of the quantitative MS platform. 
 
Figure 2-7. Systematic analysis of cysteine-reactivity upon GSNO treatment. (A) 
Concentration-dependent analysis. The light-tagged proteomes were treated with 0, 50, 
100, 200, or 500 µM GSNO and compared to a buffer-treated heavy-tagged sample. 
Heavy:light ratio values (R) were obtained for each identified cysteine residue at every 
GSNO concentration (Appendix I, Table 2A-3). Representative extracted ion 
chromatograms (light:red; heavy:blue) are shown for a cysteine residue that is insensitive 
to GSNO (GSTO1) and two cysteine residues with high GSNO sensitivity (CTSD and 
HADH2). Cysteine residues with high sensitivity to GSNO show a clear concentration-
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concentration for six cysteine residues (from CLIC4, GSTO1, DCXR, HADH2, CTSD, 
and GAPDH) with varying sensitivity to GSNO transnitrosation. The quantitative nature 
of the analysis allows ranking of cysteine residues by their sensitivity to GSNO 
transnitrosation. (C) Corroboration of the MS-based identification of cysteine sensitivity 
and insensitivity using a gel-based assay for two proteins. Myc/His-tagged GSTO1 or 
CTSD overexpressing cell lysates were treated with varying GSNO concentrations, 
followed by IA labeling. IA-labeled proteins were tagged with biotin using CuAAC and 
subjected to streptavidin enrichment, SDS-PAGE analysis, and immunoblotting with an 
anti-Myc antibody. A decrease in CTSD enrichment was observed at increasing GSNO 
concentrations, indicative of decreased cysteine reactivity and therefore IA labeling upon 
GSNO treatment. In contrast, no change in IA labeling and GSTO1 enrichment was 
observed at increasing GSNO concentrations, indicating insensitivity of the GSTO1 
cysteine residues to GSNO. (D) Time-dependent analysis. R values are plotted with 
increasing 500 µM GSNO incubation time for three cysteine residues (from GAPDH 
Cys152, TUBA4A Cys376 and Trx Cys73) representative of cysteines that are 
characterized by a variety of kinetic patterns of GSNO transnitrosation and lifetime of the 
S-nitrosated species.  
 
In addition to the concentration-dependent labeling experiment, a time-dependent 
analysis was performed to explore how the abundance of the various S-nitrosated species 
changes within a 60-min incubation period with GSNO (Appendix I, Table 2A-4). In this 
analysis, 191 cysteine-containing peptides were identified with ratios at 5 different time 
points (5, 10, 20, 30 and 60 mins). These cysteines could be categorized into three classes 
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that indicate the kinetics of S-nitrosation and the lifetime of each species within cell 
lysates: (1) a gradual increase in cysteine modification with time; (2) an initial increase in 
modification that stays constant with time; and (3) an increase in modification at a short 
time point that then decreases with time (Figure 2-7, D). The active-site cysteine in 
GAPDH falls into the first category, whereby a steady increase in modification is 
observed over time. Interestingly, Cys73 of thioredoxin (Trx) falls into the third category, 
where maximal modification is observed at 10 mins (R = 4.5) followed by a decrease in 
modification at 60 mins (R = 1.6). This observation suggests that S-nitrosated Cys73 in 
thioredoxin has a short lifetime in cell lysates relative to the other S-nitrosated species we 
identify, and agrees well with the previously characterized role of Cys73 S-nitrosated 
thioredoxin as a transnitrosating agent that is able to S-nitrosate a variety of cellular 
proteins.10 
 
Functional characterization of Cys58 in HADH2 
To identify previously uncharacterized cysteine residues on enzymes within the 
human proteome that are posttranslationally regulated by S-nitrosation, the GSNO 
proteomics data was searched for cysteine residues that satisfied the following criteria: 
(1) demonstrated high sensitivity and clear concentration-dependence to GSNO 
transnitrosation (R > 1.3 at 50 µM GSNO, R > 1.5 at 100 µM GSNO, and R > 3 at 200 
µM GSNO); (2) were not known active-site or regulatory cysteine residues; (3) were 
located distal to the active site of the enzyme; and (4) were found on enzymes implicated 
in human disease. Only two cysteine residues satisfied these four criteria–HADH2 Cys58 
and CTSD Cys329–and were characterized further.  
! 58!
HADH2 (a.k.a. HSD17B10, HCD2, ERAB, MRPP2, SCHAD, and XH98G2), 
encoded by the HSD17B10 gene, is a mitochondrial multifunctional protein. Due to the 
flexible accommodation of its active site to diverse substrates, HADH2 is involved in a 
variety of metabolic pathways, catalyzing the oxidation of several neuroactive steroids 
(e.g. 17β-oestradiol, 3α-androstanediol and oestrone)38, sex hormones such as androgens 
and estrogens39, isoleucine and xenobiotics40. Importantly, it is characterized as a short-
chain L-Hydroxyacyl-CoA dehydrogenase (SCHAD) to catalyze the third step in fatty 
acid beta-oxidation (Figure 2-8, A).39, 41 HADH2 also has several non-catalytic functions, 
including forming a complex with mitochondrial ribonuclease P and amyloid-beta.42, 43 
Studies showed that missense mutations of HADH2 led to aberrant enzyme activity, 
abolishing the catalytic function in the degradation of isoleucine, affecting the 
homeostasis of neuroactive steroid metabolism and biogenesis of brain cells. The 
abnormality caused by HADH2 dysfunction is implicated in altered mitochondrial 
structure and functions,38 attributing to the cause of neurological disorders such as 
Alzheimer’s disease and Parkinson’s disease.42-44 Furthermore, inherited HADH2 
mutations lead to 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, which is 
characterized by neurological abnormalities.45 
Since the cysteine-profiling platform indirectly measures S-nitrosation through 
loss in cysteine reactivity, and since GSNO can result in both S-nitrosation or 
glutathionylation, the ability of GSNO to S-nitrosate and glutathionylate HADH2 were 
directly compared. Recombinantly expressed and purified HADH2 (Figure 2-8, D) was 
treated in vitro with increasing GSNO concentrations and split into two samples for 
analysis of glutathionylation and S-nitrosation. While HADH2 glutathionylation was not 
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observed under these conditions, a clear concentration-dependent increase in HADH2 S-
nitrosation was observed by the BST (Figure 2-8, C) indicating that GSNO treatment of 
HADH2 selectively results in S-nitrosation. To ascertain the relative sensitivity of 
HADH2 cysteine residues towards GSNO, NO (released from DEA NONOate), and the 
alternative transnitrosating agent S-nitrosocysteine (Cys-SNO) was determined. Purified 
HADH2 protein (Figure 2-8, D) was treated in vitro with increasing concentrations of 
GSNO, DEA NONOate, or Cys-SNO and then monitored for S-nitrosation by the BST. 
HADH2 showed increasing levels of S-nitrosation up to 30 µM GSNO without further 
increases in S-nitrosation at up to 100 µM GSNO (Figure 2-8, C and E). Conversely, 
DEA NONOate treatment did not result in low levels of S-nitrosation near the detection 
limit of the BST (Figure 2-8, F), indicating HADH2 is uniquely sensitive to GSNO 
transnitrosation compared to NO-derived reactive nitrogen species. The observed 
HADH2 S-nitrosation signal was ascorbate-dependent, further confirming GSNO 
treatment results in S-nitrosation (Figure 2-8, E and F). To determine if HADH2 
possesses a GSNO binding site that is necessary for transnitrosation, S-methylglutathione 
(MeGSH) was used as a competitive inhibitor. Increasing S-methylglutathione 
concentrations partially diminished GSNO transition of HADH2 consistent with GSNO 
transnitrosation of HADH2 preceding through a GSNO-binding step (Figure 2-8, G). The 
inability of S-methylglutathione to fully compete against GSNO transnitrosation even at 
concentrations up to 3 mM may be due to the irreversibility of S-nitrosation under these 
conditions. 
Although HADH2 contains four cysteine residues, the concentration-dependent 
cysteine-profiling studies identified Cys58 as the only cysteine residue in HADH2 
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sensitive to increasing GSNO concentrations (Appendix I, Table 2A-3). Cys58 is located 
distal to the HADH2 active site within a hydrophobic pocket flanked by two leucine 
residues (Leu39 and Leu54) (Figure Figure 2-8, B). To investigate the functional 
consequences of Cys58 modification, this cysteine was first confirmed to be a target of S-
nitrosation both in vitro and in cells. HADH2 transnitrosation by GSNO was dependent 
on the presence of Cys58 (Figure 2-8, F and H), confirming that GSNO selectively 
modifies HADH2 at only one cysteine residue, Cys58. To confirm HADH2 is selectively 
S-nitrosated at Cys58 in the context of a proteome, HEK293T cell lysates overexpressing 
HADH2 with a C-terminal Myc/His tag were treated with GSNO, and as seen with 
recombinant HADH2, HADH2 WT but not HADH2 C58S was S-nitrosated under these 
conditions (Figure 2-8, I). Overexpressed Myc/His tagged HADH2 exhibited 
immunofluorescence staining consistent with the mitochondrial localization of 
endogenous HADH2 (Figure 2-8, J). As HADH2 contains four cysteine residues, the 
BST data both confirms that HADH2 is transnitrosated at low micromolar GSNO 
concentrations and that GSNO selectively modifies only one cysteine residue, Cys58, 
which was identified in the concentration-dependent cysteine-profiling studies as the only 
cysteine residue in HADH2 sensitive to increasing GSNO concentrations (Appendix I, 
Table 2A-3).  
 To determine if HADH2 is selectively S-nitrosated in intact cells and if this S-
nitrosation requires endogenous nitric oxide synthase (NOS) activity, HEK293T cells 
overexpressing HADH2 WT or C58S were treated with a pan-NOS inhibitor (L-N-
nitroarginine methyl ester; L-NAME), an iNOS specific inhibitor (1400W), or left 
untreated, and HADH2 S-nitrosation was monitored using the BST. S-nitrosation of 
! 61!
HADH2 WT but not HADH2 C58S was observed in cells without exogenous NO or S-
nitrosothiol addition (Figure 2-8, K). Although the exact cellular GSNO concentrations 
are unknown, previous studies showed that endogenous levels of GSNO in a variety of 
cell lines ranges from ~1-4 µM, and macrophages activation results in a  ~2-fold increase 
in cellular GSNO concentrations.8 Furthermore, NOS inhibition resulted in decreased 
HADH2 WT S-nitrosation for the pan-NOS inhibitor (L-NAME) but not the iNOS 
specific inhibitor (1400W) (Figure 2-8, K), indicating that HADH2 is endogenously S-
nitrosated at Cys58 by eNOS or nNOS activity and that either iNOS activity does not 
lead to HADH2 S-nitrosation or iNOS is not expressed under these conditions. Gene 
expression profiling studies show the presence of both eNOS and nNOS transcript in 
HEK293T cells, but the relative protein levels of eNOS and nNOS are unknown. To 
determine if HADH2 is S-nitrosated by NO endogenously generated by iNOS, HADH2 
S-nitrosation was monitored in A549 cells, a human adenocarcinoma line in which iNOS 
can be induced with cytokines. A549 cells overexpressing HADH2 WT or C58A were 
treated with cytokines (IFNγ, TNF-α and IL-1β) with and without the pan-NOS inhibitor 
L-NAME, and HADH2 S-nitrosation was monitored using the BST. Cytokine-treated 
HADH2 WT was S-nitrosated under these conditions; S-nitrosation was diminished in the 
presence of L-NAME, in the absence of cytokines, by omitting ascorbate in the BST in 
cells transfected with HADH2 WT, and by removal of Cys58 in the HADH2 C58A 
mutant (Figure 2-8, F). These results in A549 cells are consistent with the results in 
HEK293T cells, where HADH2 is selectively S-nitrosated at Cys58 by endogenous NOS 
activity. Furthermore, these results suggest that NO synthesized by NOS, while not 
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capable of directly S-nitrosating HADH2 (Figure 2-8, E), generates transnitrosating 
agents (e.g. GSNO) that then transnitrosate HADH2. 
 
Figure 2-8. HADH2 is selectively S-nitrosated at Cys58. (A) Pathway of β–oxidation of 


























































































































































































































































































































































































which undergoes a hydration reaction to make a Hydroacyl-CoA. The second oxidation, 
catalyzed by HADH2, is then taken place to oxidize the hydroxyl group at the beta 
position to a Ketoacyl-CoA.  The pathway is terminated by thiolase to cleave the beta 
Ketoacyl-CoA and produce an acetyl-CoA and a fatty acid that is shortened by two 
carbons. (B) Structure of HADH2 (PDB: 2O23) with NAD+ bound in the active site. The 
GSNO transnitrosation-sensitive cysteine, Cys58, is located distal to the active site within 
a hydrophobic pocket flanked by Leu39 and Leu54 (inset). (C) HADH2 is not 
glutathionylated when treated with 100 µM GSSG, 100 µM GSH, or 6-100 µM GSNO. 
GAPDH treated with 100 µM GSH and 100 µM H2O2 is used as a positive control for 
glutathionylation. In contrast, the same HADH2 samples analyzed by the BSM show 
increasing S-nitrosation at increasing concentrations of GSNO. SYPRO Ruby stained 
gels are shown to control for protein loading. (D) Purified HADH2 WT and C58S 
mutant. Silver-stained gel shows HADH2 that was recombinantly expressed and purified 
as described in Experimental Procedures. (E) S-nitrosation of recombinantly expressed 
and purified HADH2 WT treated with varying concentrations of GSNO or DEA 
NONOate. Silver-stained gel of purified HADH2 WT and C58S is shown in D. (F) S-
nitrosation of recombinantly expressed and purified HADH2 WT and C58A treated with 
varying concentrations of GSNO or Cys-SNO. (G) S-nitrosation of recombinantly 
expressed and purified HADH2 WT pretreated with GSNO and then treated with 
increasing concentration of S-methylglutathione. (H) S-nitrosation of recombinantly 
expressed and purified HADH2 WT and C58S treated with 100 µM GSNO. (I) HADH2 
S-nitrosation in lysates from HEK293T cells overexpressing mock (empty vector), 
HADH2 WT, or HADH2 C58S treated with 100 µM GSNO. (J) Immunofluorescence 
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staining of the mitochondrial localization of endogenous HADH2 and overexpressed 
Myc/His tagged HADH2. (K) HADH2 S-nitrosation in HEK293T cells overexpressing 
mock (empty vector), HADH2 WT, or HADH2 C58S were treated with DMSO (control), 
L-NAME (pan-NOS inhibitor), or 1400W (iNOS-selective inhibitor). (L) HADH2 S-
nitrosation in A549 cells overexpressing HADH2 WT or HADH2 C58A were treated 
with cytokines (IFNγ, TNF-α, IL-1β) and/or L-NAME. In panels B-L, S-nitrosation was 
monitored using the biotin-switch technique as detailed under Experimental Procedures.  
 
Upon confirming that Cys58 in HADH2 is targeted by S-nitrosation, the effect of 
S-nitrosation on HADH2 enzymatic activity was investigated (Figure 2-9, A). Initially, 
the activities of recombinant HADH2 WT and C58A (Figure 2-9, B) were compared. The 
catalytic efficiency (kcat/KM) at varying acetoacetyl-CoA concentrations for HADH2 
C58A (923 ± 90 M-1s-1) was indistinguishable from that of HADH2 WT (888 ± 37 M-1s-
1). Treatment with GSNO led to a significant ~50% decrease (p = 0.005) in catalytic 
efficiency for the HADH2 WT protein (456 ± 27 M-1s-1), whereas HADH2 C58A activity 
was unaffected by GSNO treatment (906 ± 149 M-1s-1). Further kinetic analysis at sub-
saturating substrate concentrations demonstrated clear GSNO concentration-dependent 
inhibition of HADH2 WT (Figure 2-9, C). Therefore, HADH2 S-nitrosation affects the 
ability of acetoacetyl-CoA to bind or form a catalytically productive complex, likely 
through long-range structural perturbations that disrupt active-site recognition or 
positioning of the acetoacetyl-CoA substrate for catalysis. Interestingly, a ~75% decrease 
in catalytic efficiency (kcat/KM) at varying acetoacetyl-CoA concentrations was observed 
for HADH2 C58S (196 ± 41 M-1s-1) relative to HADH2 WT, even in the absence of 
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GSNO (Figure 4-9, D). Replacement of Cys58 by the more polar serine likely disrupts 
the hydrophobic pocket defined by Leu39 and Leu54, in which Cys58 is located (Figure 
2-8, B). S-nitrosated Cys58 is likely similarly poorly accommodated within this 
hydrophobic pocket, resulting in structural alterations that are transmitted to the active 
site. To determine if HADH2 activity is uniquely sensitive to GSNO compared to other 
cysteine-oxidizing agents, HADH2 WT was treated with varying concentrations of 
GSNO, NO (released from DEA NONOate), peroxynitrite (released from SIN-1), 
oxidized glutathione (GSSG), and hydrogen peroxide. Kinetic analyses at sub-saturating 
acetoacetyl-CoA concentrations demonstrated clear concentration-dependent inhibition of 
HADH2 WT by GSNO, but inhibition was not observed for HADH2 WT treated with the 
other oxidants or HADH2 C58A treated with GSNO (Figure 2-9, E). Taken together, 
these studies identify a previously uncharacterized site of GSNO transnitrosation and 




Figure 2-9. Functional characterization of Cys58 of HADH2.  (A) HADH2-catalyzed 
reduction of acetoacetyl-CoA by NADH monitored in vitro by a decrease in absorbance 
at 340 nm. (B) Catalytic efficiency (kcat/KM) for WT and C58A-mutant HADH2 with 
varying acetoacetyl-CoA concentrations in the presence of 100 µM GSNO or GSH. (C) 
Effect of GSNO on WT HADH2 activity. HADH2 WT activity was monitored as 
described in Methods in the presence of increasing concentrations of GSNO. Error bars 
represent standard deviation from the mean. (D) Catalytic efficiency (kcat/KM) for WT and 
C58S mutant HADH2 with varying acetoacetyl-CoA concentrations. (E) Effect of 
cysteine oxidants on HADH2 activity. HADH2 WT and C58A activity was monitored as 
described in Experimental Procedures in the presence of increasing concentrations of 
GSNO, DEA NONOate, SIN-1, GSSG, or H2O2. Error bars represent standard error from 







































































































With the advent of proteomic methods to study S-nitrosation within complex 
proteomes ~3,000 cysteine residues targeted by S-nitrosation have been identified, which 
testifies to the ubiquity of this modification as a potential redox-regulatory signaling 
mechanism. However, the majority of these proteomic methods are qualitative and unable 
to differentiate between an abundant protein with a low percentage of S-nitrosation and a 
low-abundance protein with a high percentage of S-nitrosation. To discover functionally 
relevant S-nitrosation sites, a competitive cysteine-profiling strategy was utilized to 
concurrently and quantitatively rank 609 cysteine residues by their sensitivity to GSNO 
(Figure 2-3). In validation of this approach, one of the most sensitive cysteine residues to 
GSNO was the active-site cysteine of GAPDH, which is a well-established site of S-
nitrosation that leads to GAPDH nuclear translocation, transnitrosation of nuclear 
proteins, and induction of apoptosis.11, 15, 16 The cysteine-profiling platform described 
herein affords several advantages over the BST, primarily the ability to quantify the 
extent of modification of individual cysteine residues. However, several limitations 
currently exist that may be improved in subsequent iterations of this platform. The 
platform is optimized for analysis of cell lysates treated with exogenous GSNO at largely 
physiological concentrations. The data obtained provide important insight into the 
sensitivity of hundreds of cysteines to GSNO treatment, and for HADH2 in particular, the 
in vitro data correlated with cellular data (Figure 2-8 and 2-9). However, some targets 
may not be S-nitrosated to the extent predicted by the cysteine profiling platform either 
due to lower cellular GSNO levels or different reducing environments in distinct cellular 
compartments that could reduce the resulting S-nitrosothiol. Furthermore, the sensitivity 
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of the current platform does not allow accurate quantification where the stoichiometry of 
modification is less than 5%. 
This cysteine-profiling platform enabled identification and functional annotation 
of an uncharacterized mode of regulation through S-nitrosation. The dehydrogenase 
HADH2 was shown to be S-nitrosated at Cys58 and S-nitrosation of this distal cysteine 
allosterically inhibited HADH2 enzymatic activity. S-nitrosation of Cys58 is 
hypothesized to disrupt the hydrophobic interactions surrounding this cysteine residue 
(Figure 2-8, B) resulting in long-range structural perturbations that reduce the ability of 
the acetoacetyl-CoA substrate to bind or form a productive catalytic complex in the 
HADH2 active site. Further studies are needed to determine if increased HADH2 S-
nitrosation contributes to Alzheimer’s disease and other neurological disorders42-44 that 
exhibit decreased HADH2 activity. Importantly, even though the initial proteomic studies 
that indicated HADH2 is highly sensitive to GSNO were performed at supraphysiological 
GSNO concentrations, follow-up characterization demonstrated Cys58 of HADH2 is S-
nitrosated under physiologically relevant and endogenously generated nitrosative stress. 
This observation further underscores the promise of translating GSNO sensitivity data 
acquired through cysteine-reactivity profiling in cell lysates to (patho)physiologically 
relevant sites of S-nitrosation. 
In conclusion, the application of a competitive cysteine reactivity profiling 
strategy to investigate transnitrosation unearthed two previously uncharacterized and 
mechanistically distinct modes of allosteric protein regulation through S-nitrosation. 
Future studies will focus on further functional characterization of unannotated S-
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nitrosation-sensitive cysteine residues identified in these global MS studies, as well as 
expansion of this platform to other biologically relevant transnitrosation donors. 
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Reagents and general procedures.  
All materials were purchased from Sigma Aldrich (Milwaukee, WI) unless 
otherwise noted. RPMI 1640 medium, DMEM/High glucose medium, phosphate buffered 
saline (PBS), 2% Trypsin-EDTA and penicillin/streptomycin (Pen/Strep) were purchased 
from Fisher Scientific (Pittsburgh, PA). Rabbit-anti-Myc (2278S), rabbit-anti-CTSD 
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(2284S), and goat-anti-rabbit HRP-conjugated IgG (7074S) were purchased from Cell 
Signaling (Danvers, MA). Rabbit anti-Myc (MA5-15125) and goat anti-rabbit HRP-
conjugated IgG (31463), goat anti-mouse HRP-conjugated IgG (31439) were purchased 
from Pierce/ThermoFisher Scientific (Grand Island, NY). Mouse-anti-His6 antibody 
(AM1010A) was purchased from ABgent (San Diego, CA). Cathepsin D Activity Assay 
Kit was purchased from BioVision (Mountain View, CA). X-tremeGENE 9 DNA 
transfection reagent was purchased from Roche (Indianapolis, IN). Polyethylenimine 
MW25K (PEI) transfection reagent was purchased from Polyscience, Inc (Warrington, 
PA). Protein concentrations were determined using a Bio-Rad DC protein assay or 
Bradford Protein Concentration assay from Bio-Rad Life Science (Hercules, CA) or a 
bicinchoninic acid (BCA) assay from Pierce. Streptavidin-agarose beads, Ni-NTA beads 
and SuperSignal West Pico Chemiluminescent Substrate were purchased from Thermo 
Scientific (Armarillo, TX). QuikChange Site-Directed Mutagenesis Kit was purchased 
from Agilent Technologies (Santa Clara, CA). Illustra Nap-5 Columns were purchased 
from GE Healthcare Bio-Sciences (Piscataway, NJ). Micro BioSpin-6 desalting columns 
were purchased from Bio-Rad Life Science (Hercules, CA). Ni-NTA Magnetic Agarose 
Beads were purchased from QIAGEN (Valencia, CA). GSNO, DEA NONOate, and L-
NAME were purchased from Cayman Chemicals (Ann Arbor, MI). 
 
Cell Culture.  
MCF7 and HEK293T cells were maintained in RPMI1640 medium and DMEM 
medium (with 2 mM glutamine), respectively. Media was supplemented with 10% fetal 
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bovine serum (FBS) and 1% Pen/Strep. Cells were grown at 37 °C under an atmosphere 
of 5% CO2. 
 
Preparation of MCF7 cell lysates.  
Cells were grown to 100% confluency and harvested by scraping. The cells were 
washed three times with PBS, resuspended in an appropriate volume of PBS and 
sonicated to obtain whole-cell lysates. The lysates were then separated by 
ultracentrifugation at 45,000 rpm at 4 °C under high vacuum for 45 min. The resulting 
supernatant was collected as the soluble proteome. Protein concentrations were 
determined using the Bradford Protein Concentration Assay. 
 
Mass-spectrometry analysis of GSNO-treated MCF7 lysates.  
S-nitrosoglutathione (GSNO) was dissolved in freshly-made HEN buffer (125 
mM HEPES pH 7.7, 1 mM EDTA, 0.1 mM neocuproine). The GSNO concentration was 
determined by measuring the UV absorbance at 336 nm based on an extinction 
coefficient of 0.9 mM-1cm-1. MCF7 cell lysates (4 mg total protein/mL) were aliquoted to 
500 µL and incubated with 5 µL HEN buffer or 5 µL of GSNO (50 µM, 100 µM, 200 
µM, or 500 µM final concentration) in HEN buffer at 37 °C for 1 hr. Excess GSNO was 
then removed by filtration through a Nap-5 column. Proteins were eluted with 1 mL PBS 
and aliquoted to produce two 500 µL samples. 
Each 500 µL sample was treated with 100 µM IA probe using 5 µL of a 10 mM 
stock in DMSO. The labeling reactions were incubated at room temperature for 1 hr. 
Click chemistry was performed by the addition of either Azo-L or Azo-H (100 µM, 5 
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mM stock in DMSO), tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (1 mM, fresh 
50 mM stock in water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA ligand)  
(100 µM, 17× stock in DMSO:t-Butanol 1:4) and CuSO4 (1 mM, 50 mM stock in water). 
Samples were allowed to react at room temperature for 1 hr. The Azo-L and Azo-H 
samples were mixed together immediately following click chemistry. Precipitated 
proteins were pelleted by centrifugation at 6500 × g (10 min, 4 °C). The pellets were 
washed twice by resuspending the pellet in cold methanol, after which the pellets were 
solubilized in PBS containing 1.2% w/v SDS via sonication and heating (5 min, 80 °C).  
The SDS-solubilized, probe-labeled proteome samples were diluted with PBS to a 
final SDS concentration of 0.2% w/v. The solutions were incubated with 100 µL 
streptavidin-agarose beads at 4 °C for 16 hr, followed by incubation at room temperature 
for 2.5 hr. The beads were washed sequentially with 0.2% w/v SDS/PBS, PBS, and 
water, and pelleted by centrifugation (1300 × g, 2 min) between washes. 
The washed beads were suspended in 500 µL 6 M urea/PBS and 10 mM 
dithiothreitol (DTT, from 200 mM stock in water) and placed in a 65 °C heat block for 15 
min. 20 mM iodoacetamide (from 1 M stock in water) was then added and incubated at 
37 °C for 30 min. Following reduction and alkylation the beads were pelleted by 
centrifugation (1300 × g, 2 min), re-suspended in 200 µL of 2 M urea/PBS, 1 mM CaCl2 
(100 mM stock in water) and trypsin (2 µg), and digested overnight at 37 °C. The digest 
was washed with PBS and water. The azobenzene linker was cleaved with 50 mL of fresh 
25 mM sodium dithionite/PBS for 30 min at room temperature on a rotator, followed by 
centrifugation to collect supernatant. The sodium dithionite cleavage was repeated twice 
and then the beads were washed with water (2 × 75 µL). All supernatants and washes 
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were combined and acidified with 15 µL formic acid. The samples were stored at -20 °C 
until mass spectrometry analysis. 
LC/LC-MS/MS analysis was performed on an Agilent 1200 series HPLC coupled 
to an LTQ-Orbitrap Discovery mass spectrometer (ThermoFisher). Peptide digests were 
pressure loaded onto a 250 µm fused silica desalting column packed with 4 cm of Aqua 
C18 reverse-phase resin (Phenomenex). The peptides were eluted onto a biphasic column 
(100 µm fused silica with a 5 µm tip, packed with 10 cm Aqua C18 reverse-phase resin 
(Phenomenex) and 3 cm Partisphere strong-cation-exchange resin (SCX, Whatman) using 
a gradient 5-100% Buffer B in Buffer A (Buffer A: 95% water, 5% acetonitrile, 0.1% 
formic acid; Buffer B: 20% water, 80% acetonitrile, 0.1% formic acid). The peptides 
were then eluted from the SCX onto the C18 resin and into the mass spectrometer using 
four salt steps as previously described 31, 58. The flow rate through the column was set to 
~0.25 mL/min and the spray voltage was set to 2.75 kV. One full MS scan (FTMS) (400-
1800 m/z) was followed by 18 data dependent scans (ITMS) of the nth most intense ions 
with dynamic exclusion enabled. 
 
Mass-spectrometry analysis of time-dependent GSNO-treated MCF7 lysates.  
GSNO was dissolved in freshly-made HEN buffer and the concentration was 
determined as described above. MCF7 cell lysates (4 mg/mL) were aliquoted to 500 µL 
and incubated with 5 µL HEN buffer at 37 °C for 1 hr, or 5 µL of GSNO (500 µM final 
concentration) in HEN buffer at 37 °C for 5 mins, 10 mins, 20 mins, 30 mins and 1 hr, 
respectively. Excess GSNO was then removed by filtration through a Nap-5 column. 
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Proteins were eluted with 1 mL PBS and aliquoted to produce two 500 µL samples. The 
IA probing and rest mass-spectrometry preparation steps were as described above. 
 
 
Mass-spectrometry data analyses.  
The generated tandem MS data were searched using the SEQUEST algorithm 
against the human IPI database. A static modification of +57.02146 on cysteine was 
specified to account for iodoacetamide alkylation and differential modifications of 
+456.2849 (Azo-L modification) and +462.2987 (Azo-H modification) were specified on 
cysteine to account for probe modifications. SEQUEST output files were filtered using 
DTASelect 2.0. Quantification of heavy:light ratios (R) was performed using the 
CIMAGE quantification package as previously described 31. 
 
Gel-based analysis of GSTO1 and CTSD.  
The cDNA constructs for GSTO1 and CTSD were purchased as full-length 
expressed sequence tags (Open Biosystems) and subcloned into a pcDNA3.1-Myc/His 
mammalian-expression vector using the primers indicated for PCR amplification 
(Appendix I. Table 2A-5). All constructs were verified by DNA sequencing (Genewiz, 
Cambridge, MA). HEK293T cells were transfected with GSTO1 or CTSD using the X-
tremeGENE DNA transfection reagent. The cells were incubated at 37 °C for 48 hr after 
transfection, harvested and then lysed in PBS. The concentrations of soluble proteins 
were normalized. Protein overexpression was then analyzed by immunoblot using an 
anti-Myc antibody (2278S).  
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HADH2 and PDIA1 subcloning.  
The cDNA for HADH2 PDIA1 were subcloned into a pET23a-T7/His bacterial 
expression vector. Site-directed mutagenesis was performed to obtain cysteine to serine 
or cysteine to alanine mutants using the Quikchange procedure (Agilent, Santa Clara, 
CA) with the appropriate primers (Appendix I. Table 2A-5). All constructs were verified 
by DNA sequencing (Genewiz, Cambridge, MA or La Jolla, CA). 
 
HADH2 expression and purification.  
HADH2 (WT, C58S, or C58A) was expressed in Escherichia coli BL21 (DE3) 
cells. Cells were inoculated in 5 mL LB medium containing 100 µM ampicillin at 37 °C 
overnight. The overnight culture was added to 500 mL LB or 1 L 2×YT medium 
containing 100 µM ampicillin and allowed to grow at 37 °C until OD600 ~ 0.6-0.8. 
Expression was then induced by the addition of 1 mM IPTG for 4 hr at 30 °C. Cells were 
harvested and lysed in PBS or 20 mM Tris pH 8.0 at 4 °C with 200 mM NaCl. The 
expressed fusion protein was purified using a Ni-NTA packed chromatography column. 
After loading the cell lysate onto the column, the Ni-NTA resin was washed with 50 mM 
imidazole in PBS or 10 mM imidazole in 20 mM Tris pH 8.0 at 4 °C with 200 mM NaCl 
and HADH2 was eluted with 500 mM imidazole in PBS or 300 mM imidazole in 20 mM 
Tris pH 8.0 at 4 °C with 200 mM NaCl. Protein purity was then assessed by 10% SDS-
PAGE and Silver staining. Excess imidazole was then removed by use of a Nap-5 column 
and eluting the purified protein with 20 mM potassium phosphate, pH 7.4, with 5% v/v 
glycerol and 5 mM β-mercaptoethanol, and stored at -80 °C 59. Alternatively, the purified 
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protein was dialyzed against 20 mM Tris pH 8.0 at 4 °C with 200 mM NaCl, 10% v/v 
glycerol, and 1 mM TCEP.  
 
PDIA1 expression and purification. 
PDIA1 was expressed in Escherichia coli BL21 (DE3) cells. Cells were 
inoculated in 5 mL LB medium containing 100 µM ampicillin at 37 °C overnight. The 
overnight culture was added to 250 mL LB containing 100 µM ampicillin and allowed to 
grow at 37 °C until OD600 ~ 0.6-0.8. Expression was then induced by the addition of 0.3 
mM IPTG for ~ 18 hrs at 30 °C. Cells were harvested and lysed in PBS. The expressed 
fusion protein was purified using a Ni-NTA packed chromatography column. After 
loading the cell lysate onto the column, the Ni-NTA resin was washed with 25 mM 
imidazole in PBS PDIA1 was eluted with 500 mM imidazole in PBS. Protein purity was 
then assessed by 10% SDS-PAGE and silver staining. Excess imidazole was removed by 
use of a Nap-5 column and the purified protein was stored at 4 °C. 
 
Gel-based analysis of IA probe consumption before performing click chemistry.  
Purified concentrated PDIA1 (3.25 mg/mL) in PBS or equal amount of PBS were 
added to MCF7 cell lysates with a final concentration of 2 mg total protein/mL MCF7 
cell lysate and 0.1 mg/mL PDIA1. The mixture was aliquoted to 50 µL. Each aliquot was 
treated with 10 µM IA probe using 1 µL of a 500 µM stock in DMSO. The labeling 
reactions were incubated at room temperature for 1 hr. Then same concentrated PDIA1 
was added to none-PDIA1-containing aliquot to a final concentration of 0.1 mg/mL and 
equal amount of PBS was added to PDIA1-containg aliquot or none-PDIA1-containg 
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aliquot as a control. Click chemistry was performed by the addition of 20 µM rhodamine 
azide (Rh-N3), TCEP (1 mM, fresh 50 mM stock in water), TBTA ligand (100 µM, 17× 
stock in DMSO:t-Butanol 1:4) and CuSO4 (1 mM, 50 mM stock in water). Samples were 
allowed to react at room temperature for 1 hr followed by adding 50 µL 2X SDS-PAGE 
loading buffer (reducing). 12.5 µL of each of this mixture solutions was separated by 
10% SDS-PAGE under 100 volts for 2 hrs. Gel was visualized on a Hitachi FMBIO II 
multiview flatbed laser- induced fluorescent scanner. After analysis, gel underwent a 
typical procedure for Coomassie staining and destaining. Stained gel was visualized on a 
ChemiDoc MP Imaging System (BioRad). 
 
In vitro biotin switch assay of purified HADH2.  
All biotin switch assays were conducted similar to previously described60 with 
modifications as detailed below. Briefly, S-nitrosated purified protein or cell lysates were 
alkylated with iodoacetamide, proteins were precipitated with acetone, and the resulting 
pellets resuspended into label buffer (PBS containing SDS, ascorbate, and biotin 
iodoacetamide). Labeling reactions were quenched with DTT and analyzed by 
immunoblotting for biotin. 
All biotin switch assays were conducted under low ambient light conditions. 
Purified HADH2 WT or C58S proteins (50 µM) were incubated with 100 µM TCEP for 
15 min at room temperature and then desalted with a Micro BioSpin-6 column (Bio-Rad, 
Hercules, CA). Desalted HADH2 WT or C58S (5 µM) was incubated with 6-100 µM 
GSNO, 100 µM GSH, or the molar equivalent of DEA NONOate for 60 min at 37ºC in 
HEN buffer (250 mM HEPES pH 7.7, 1 mM EDTA, 0.1 mM neocuproine) in 100 µL 
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total volume. Free thiols were alkylated with an equal volume of blocking buffer (HEN 
buffer with 1% w/v SDS and 200 mM iodoacetamide) for 1 hr at 37ºC. Proteins were 
precipitated with 1.2 mL ice-cold high-purity acetone and incubated at -80ºC for 15 
minutes. Precipitated protein was pelleted at >12,000 × g at 4ºC and the supernatant was 
discarded. Pellets were washed once more with acetone, pelleted by centrifugation, and 
the supernatant removed. Pellets were air dried for 15 min at room temperature and then 
resuspended into label buffer (PBS containing 1% w/v SDS, 30 mM ascorbate, 200 µM 
EZ-link biotin iodoacetamide). Controls were run as detailed above except ascorbate was 
omitted from the nitrosothiol reduction and labeling step. After 1 hr at 37ºC, the reactions 
were quenched with 6× Laemmli Sample Buffer (LSB) containing 100 mM DTT and 30 
µL of each sample was loaded onto a Bio-Rad (Hercules, CA) TGX AnyKD Stain-Free 
gel. Equal protein loading was verified by imaging under UV light on a ChemiDoc MP 
gel imager (Bio-Rad, Hercules, CA). Proteins were transferred to a nitrocellulose 
membrane using a TransBlot Turbo semi-dry transfer system (Bio-Rad, Hercules, CA). 
The membrane was blocked for 1 hr at room temperature in PBS containing 1% v/v 
TWEEN-20 (PBS-T) and 2.5% w/v dry milk. The membrane was washed 3 × 5 min with 
PBS-T. Biotin-labeled proteins were then rocked for one hour at room temperature with 
the VectaStain ABC kit (Vector Laboratories, Burlingame, CA) where reagents A and B 
were diluted into 15 mL PBS-T. The membrane was again washed 3 × 5 min in PBST. 
The membrane was then imaged using 2 mL of Luminata Classico HRP Substrate (EMD 
Millipore, Billerica, MA) and the chemiluminescence settings on a ChemiDoc MP gel 
imager (Bio-Rad, Hercules, CA). Protein loading controls for GSNO and DEA NONOate 
titrations were obtained by stripping the nitrocellulose membrane in mild strip buffer 
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(200 mM glycine, 1 % v/v TWEEN-20, 0.1 % w/v SDS), re-blocking in PBS-T with 
2.5% w/v milk, and re-probing with anti-His6 antibody (1:1000 dilution in PBS-T with 
2.5% w/v milk) for 2 hours at room temperature. The membrane was washed with PBS-T 
3× for 10 minutes and incubated in goat anti-mouse-HRP secondary antibody (1:5000 
dilution in PBS-T with 2.5% w/v milk) for 2 hours at room temperature. Blot was washed 
with PBS-T 3× for 10 minutes and imaged with chemiluminescent substrate. Protein 
loading controls for HADH2 WT and C58S were obtained by running an accompanying 
gel with the same protein amounts and staining with Coomassie blue. 
 
HADH2 cellular lysate biotin switch.  
HEK293T cells were plated onto 60 mm dishes at 106 cells. Upon reaching ~80% 
confluency, cells were transfected with 2 µg of Myc-tagged pcDNA3.1(+) HADH2 (WT 
or C58S) in the presence of 800 ng of PEI dissolved in serum-free DMEM. After 8 hr, 
cells were harvested by scraping and lysed via sonication into 200 µL PBS supplemented 
with 100 µM GSNO. Insoluble cellular debris was pelleted at maximum speed in a 
microcentrifuge. The supernatant was transferred to a fresh tube and incubated at 37ºC 
for 1 hr. Blocking conditions, acetone precipitation, and labeling steps were the same as 
described above for purified HADH2 biotin switch, except for the following 
modifications. Biotin-HPDP (200 µM, Pierce) was used in place of EZ-link biotin 
iodoacetamide and a second acetone precipitation was performed after biotin-HPDP 
labeling as described above to remove labeling buffer components. Following 15 min of 
air drying, the pellets were resuspended in 100 µL of PBS with 1% w/v SDS and protein 
concentrations were normalized between samples using a BCA assay. A small aliquot of 
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each sample was set aside to run a protein loading control gel. The remainder was diluted 
to yield a final SDS concentration of 0.1% w/v. Biotin-labeled proteins were pulled down 
by addition of 50 µL of a 50% slurry of streptavidin-conjugated agarose beads pre-
equilibrated with PBS. The samples were rocked 16 hr at 4ºC. Beads containing bound 
biotin-labeled proteins were spun down for 5 min at 2500 × g and washed with 3 × 1 mL 
of PBS. Biotin-labeled proteins were eluted from beads by addition of 50 µL of 2× LSB 
containing DTT. Beads were heated at 95ºC for 5 min and spun for 1 min at ≥12,000 × g 
before loading the supernatant on a TGX AnyKD Stain Free gel followed by transfer to a 
nitrocellulose membrane, blocking, and washing as described above for HADH2 purified 
protein biotin switch. Membranes were probed with rabbit anti-Myc antibody (Pierce, 
MA5-15125) for 16 hr at 4ºC diluted 1:1000 in PBS-T with 2.5% w/v milk. Membranes 
were washed 3× with PBS-T, then probed with goat anti-rabbit antibody (Pierce, #31463) 
diluted 1:5000 in PBS-T with 2.5% w/v milk for 1 hr at room temperature. Blots were 
washed 3× with PBS-T and imaged by chemiluminescence as described above. 
 
HADH2 endogenous S-nitrosation biotin switch.  
HEK293T cells were plated and transfected as described for cellular lysate biotin 
switch. 8 hours post-transfection, Cys-SNO was added to each dish to a final 
concentration of 100 µM. Cys-SNO was prepared by incubating 10 mM L-cysteine in 10 
mM NaNO3, 10 mM HCl, and 1 mM EDTA for 1 hr in the dark. Cys-SNO concentration 
was determined using UV absorption at 336 nm and an extinction coefficient of 0.9 mM-
1cm-1. The remainder of the biotin switch procedure was completed as described above 
for cellular lysate biotin switch. 
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HADH2 cellular biotin switch with NOS inhibitors.  
HEK293T cells were plated and transfected with HADH2 WT or HADH2 C58S 
in the Myc-tagged pcDNA3.1(+) vector as described above. After 8 hr, cells were treated 
with 100 µM L-NAME, 100 µM 1400W, or DMSO vehicle control and incubated for 16 
hr at 37 °C. Cells were washed 3× with PBS, collected, and lysed by sonication in block 
buffer. The biotin switch procedure was carried out as described above for cellular lysate 
biotin switch.  
 
HADH2 cellular switch with cytokine-mediated iNOS induction. 
A549 cells (8.5 x 106 cells) were plated on 150 mm dishes. The following day, 
cells were transfected with 16 µg of Myc-tagged pcDNA3.1(+) HADH2 (WT or C58S) in 
the presence of 32 µg PEI. After 24 hours, the media was changed and cytokine mix was 
added (human IFNγ, 2000 U/mL; human TNF-α, 10 ng/mL; human IL-1β, 25 ng/mL). L-
NAME was added to 100 µM from a freshly made stock. Cells were incubated for 48 hr 
at 37 °C prior to harvest. Due to risks of degradation of L-NAME during the 48 hr 
cytokine/L-NAME treatment, the media was replaced after 24 hr with fresh media 
containing 100 µM L-NAME. Production of nitric oxide was assessed via the Griess 
Assay for nitrite detection in the media 61. Briefly, in triplicate, aliquots were taken from 
each dish, mixed in equal volume with freshly-prepared Griess buffer (0.6% w/v 
sulfanilamide, 30% v/v acetic acid, 0.05% w/v N-1-naphthyl-ethylenediamine-HCl) and 
an absorbance taken at 540 nm. Nitrite concentrations were deduced by comparison with 
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a freshly-prepared sodium nitrite standard curve. Cells were then harvested and processed 
using the BST as described above for HEK293T cells. 
 
HADH2 activity assays.  
The purified HADH2 enzyme was assayed as described previously 62, where 
HADH2 activity was measured spectrophotometrically using the decrease in absorbance 
at 340 nm due to NADH oxidation. Purified HADH2 (WT or C58S) in 20 mM potassium 
phosphate, pH 7.4, with 5% v/v glycerol and 5 mM β-mercaptoethanol, was pre-
incubated in a mixture of 100 mM potassium phosphate (pH 7) and 100 µM NADH at 
room temperature for 30 min. The kinetic assay was initiated by adding varying 
acetoacetyl-CoA concentrations up to 100 µM. The reaction was carried out at 30 °C and 
the absorbance at 340 nm was measured using a Molecular Devices Spectramax M5 plate 
reader. Relative activity was determined as the slope of the absorbance vs. time curve 
within the linear range.  
To evaluate the concentration dependence of GSNO on enzyme activity, HADH2 
WT (0.5 µM) was pre-incubated with varying GSNO concentrations in HEN buffer (pH 
7.7) at room temperature for 30 minutes. HADH2 was added to the kinetic assay to a 
final concentration of 0.1 µM. Kinetic assays were carried out at 30 °C in 100 mM 
sodium phosphate buffer pH 7.0 and were initiated by addition of 100 µM NADH and 
acetoacetyl-CoA. Rates were monitored at 340 nm for 10 minutes. 
The assay was initiated by addition of 100 µM acetoacetyl-CoA. To determine the 
effect of GSNO treatment on the catalytic efficiency (kcat/KM), HADH2 WT and C58A 
(100 µL of 25 µM HADH2 in HEN buffer) was reduced with 100 µL of a 50% slurry of 
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TCEP immobilized reducing resin (Pierce) for 20-25 min at room temperature. The 
TCEP resin was removed by centrifugation (1000 × g for 1 min). The reduced HADH2 
supernatant was diluted to 2.5 µM and incubated with 100 µM GSNO or GSH in HEN 
buffer at room temperature. After 30 min, HADH2 activity (0.5 µM final concentration) 
was assayed by monitoring the absorbance at 340 nm as described above in 150 µL 
reactions containing 400 µM NADH, 100 mM sodium phosphate pH 7.5, and varying 
acetoacetyl-CoA concentrations from 50 µM to 1 mM. 
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 Nitric oxide (NO) plays critical roles in mammalian physiology by participating 
in cell signaling pathways that regulate broad aspects of cellular function. These effects 
are achieved by activation of guanylate cyclase to form cGMP as a secondary messenger 
molecule, or alternately by S-nitrosation of regulatory cysteines within proteins.1-3 Three 
isoforms of nitric oxide synthases (NOSs) have been identified, constitutively active 
eNOS and nNOS, and iNOS, which is cytokine-inducible.4, 5 NO generated from NOS 
diffuses and efficiently S-nitrosates nearby proteins near the diffusion-controlled limit.6 
Once formed, S-nitrosothiols can be transferred through formation of specific protein-
small molecule or protein-protein interactions and subsequent nucleophilic attack of the 
thiolate at the S-nitrosothiol nitrogen atom.7-9 (Figure 3-1) In particular, abundant thiol 
containing small molecules or proteins, such as glutathione (GSH), thioredoxin (Trx) and 
Coezyme A (CoA), form the corresponding S-nitrosated species, GSNO, Trx-SNO and 
CoA-SNO, which can transnitrosate a variety of protein cysteine residues. (Figure 3-2) 2, 
10, 11 This transnitrosation between proteins and between proteins and small molecules 
appears to be an important cellular mechanism of S-nitrosation and thus protein-SNO 
production, imparting the necessary selectivity for protein S-nitrosation to be a viable 
cellular signaling mechanism.2 Moreover, the significant impact of transnitrosation on 
cellular functions has been intensively studied. In many cases, S-nitrosation causes 
significant changes in protein activity or subcellular localization. 
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Figure 3-1. Protein S-nitrosation, transnitrosation and denitrosation systems. S-
nitrosothiols can be formed upon the direct interaction with NO or could rely on the 
reaction between a thiolate and low molecular weight NO donor (e.g. GSNO). Due to the 
reversibility of the process, GSNO also similarly promotes S-nitrosation reactions, 
generating a delicate equilibrium between the redox couples GSH/GSNO and protein-
SH/protein-SNO that are strictly maintained by GSNO reductase (GSNOR) activity. 
GSNOR converts GSNO to glutathione disulfide (GSSG), thereby deeply affecting S-
nitrosothiol concentrations. The concerted activity of glutaredoxin (GRX), by reducing 
GSSG back to GSH, contributes to the maintenance of the system. The NO moiety can 
also be transferred directly among proteins (transnitrosation). Nitrosothiol homeostasis 
also relies on the activity of the thioredoxin/thioredoxin reductase (Trx/TrxR) system. 
NADPH-dependent Trx-mediated reduction of protein-SNO to thiols directs NO release 
and tunes many NO-mediated signaling pathways. 
































 Glutathione (GSH), present at millimolar concentrations in mammalian cells, is a 
major cellular antioxidant, and plays an important role in maintaining a reduced 
intracellular environment. It is involved in a number of cellular functions such as 
defending against oxidative stress, redox signaling, and modulating immune functions, 
cell proliferation and apoptosis.12, 13 GSNO, found both intra- and extracellularly, is the 
most abundant cellular low-molecular-weight SNO with a concentration range of 1-5 
µM.14 GSNO is formed by the direct S-nitrosation on GSH, or through GSH-mediated 
denitrosation of cellular SNOs. Once formed, GSNO can react as a transnitrosation 
reagent to modify specific cysteine thiols, or undergo reduction by GSNO Reductase 
(GSNOR) using NADH as an electron donor. GSNOR is widely expressed in both 
prokaryotic and eukaryotic organisms. The GSH/GSNOR system plays a central role in 
maintaining the equilibrium of cellular GSNO with other SNOs.9, 15 
Trx is a 12 kDa cytosolic protein with five cysteine residues: two redox-active 
cysteines (32 and 35) and three non-active-site cysteines (62, 69 and 73). The conserved 
CGPC active site of Trx functions as a protein disulfide oxidoreductase, and the 
functional disulfide formation and reduction between active site cysteine 32 and 35 is 
NADPH-dependent. In parallel with GSH/GSNOR, Trx, coupled with Trx reductase 
(Trx/TrxR), is also considered an evolutionarily conserved mechanism to regulate protein 
SNOs. It regulates multiple cellular processes and plays a key role in protection from 
oxidative stress. For example, Caspase-3, a cysteine protease that is important for cell 
apoptotic death, is found constitutively S-nitrosated on active site cysteine 163, thus 
inhibiting its enzyme activity. However, in unstressed conditions, Trx is able to 
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selectively denitrosate SNO-Cys163 on Caspase-3, revealing the active site cysteine in 
order to regulate protein function.16 Similarly, Trx/TrxR1 was found to denitrosate eNOS, 
as well as protein Tyr phosphatase 1b and GAPDH under resting conditions. 17, 18 Besides 
the involvement of Trx/TrxR in protein denitrosation, Trx is also identified as a target of 
S-nitrosation, and nitrosated Trx is able to transnitrosate specific cysteine residues, thus 
expanding its functional roles in regulating protein S-nitrosation. Though all five 
cysteines on Trx have been reported as S-nitrosation targets, a detailed kinetic analysis on 
the SNO selectivity under physiologically relevant concentration suggested that reduced 
Trx was S-nitrosated primarily and rapidly on cysteine 62 by GSNO, whereas cysteine 73 
was the only SNO target of oxidized Trx. Trx cysteine 73 is located on opposite face of 
Trx from cysteine 62, and is the most surface accessible cysteine on Trx. This specificity 
of nitrosation for Trx was thought to be controlled by protein conformational changes 
while binding GSNO, or by the different local dynamics of the two redox states.14 
Interestingly, once nitrosated, Trx-Cys73-SNO possesses transnitrosation activity to 
many protein targets, including the active site of Caspase-3 cysteine 163. Trx-Cys73-
SNO was showed to reversibly transnitrosate Caspase-3 120-fold faster than GSNO, 
inactivating Caspase-3 and directly governing the initiation of apoptosis. Loss of cysteine 
73 or of nearby residues prevents binding to Caspase-3 and results in decreased Caspase-
3 SNO levels, highlighting the regulatory role of Cys73-SNO transnitrosation events.19, 20 
 Coenzyme A (CoA) is another small-molecular-weight thiol and plays a central 
role in cellular metabolism.21 CoA is found to be nitrosated to form S-nitroso-CoA (CoA-
SNO). In yeast, CoA-SNO regulates metabolism by transnitrosation of a subset of 
proteins. The levels of CoA-SNO is regulated by a CoA-SNO reductase, Ad6.22 Thus, 
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CoA-SNO could serve as a targeted source of transnitrosation to regulate specific protein 
S-nitrosation events. 
 
Figure 3-2. Structure of transnitrosation donors: (A) S-nitrosoglutathione (GSNO), (B) 
Thioredoxin-C73-SNO (Trx-SNO), and (C) S-nitroso-Coenzyme A (CoA-SNO). (D) 
Transnitrosation reaction proceeding through a nitroxyl disulfide intermediate. 
 
Although the endogenous regulation of protein function through S-nitrosation is 
well established, only a small subset of reactive cysteines were showed to be modified in 
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an individual cysteine residue that govern its sensitivity to S-nitrosation are poorly 
characterized. Potential contributors to S-nitrosation selectivity include primary sequence, 
cysteine pKa, cysteine reactivity, direct interaction with NOS or other transnitrosation 
donors, local concentrations of transnitrosation donors, and the potential to be 
denitrosated by GSH or Trx. While it is established that selectivity for the vast majority 
of S-nitrosated cysteine residues is not governed by the surrounding primary sequence23, 
a transnitrosase complex comprised of iNOS, S100A8, and S100A9 was recently shown 
to specifically nitrosate cysteine residues within a I/L-X-C-X-D/E consensus sequence24. 
However, the subset of known S-nitrosation sites containing this sequence is small, 
suggesting the majority of S-nitrosated proteins are not generated via this complex.  
Factors such as pKa and proximal protein environment that can dictate cysteine reactivity 
in vitro do not correlate with the S-nitrosation selectivity observed in vivo 25. One 
defining characteristic of known S-nitrosated cysteines is the presence of charged 
residues within 6-8 Å26; however, these charged residues are positioned too distant to 
directly activate cysteines toward S-nitrosation. Instead, cysteines near charged residues 
are more likely to be surface exposed and therefore provide hotspots for transnitrosation 
reactions.  
Despite the advent of chemical and proteomic methods to study S-nitrosation, the 
subset of cellular cysteine residues that show uniquely high reactivity to endogenous 
transnitrosation donors is poorly characterized. To further these existing global studies, in 
chapter 2, a competitive cysteine-reactivity profiling strategy was implemented to 
quantitatively measure the sensitivity of >600 cysteine residues to transnitrosation by 
GSNO. These proteomic studies revealed several previously uncharacterized sites of S-
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nitrosation with high propensity for GSNO-mediated transnitrosation. Here, by applying 
the same proteomic platform, the selectivity determinants for GSNO, CoA-SNO and Trx-
SNO transnitrosation will be explored in detail via systematic evaluation of the 




A competitive cysteine-labeling strategy to quantitatively measure sensitivity to 
transnitrosating agents 
The extent of cysteine S-nitrosation was quantitatively monitored using a mass 
spectrometry (MS)-based proteomic platform derived from the previously reported 
isotopic tandem orthogonal proteolysis-ABPP (isoTOP-ABPP) method.27, 28 This 
platform exploits the characteristic loss in nucleophilicity of a cysteine thiol upon 
conversion to a S-nitrosothiol, which is reflected in blocked reactivity with a cysteine-
reactive chemical probe. In this approach (Figure 3-3), a cell lysate is exposed to one of 
three different transnitrosation donors (GSNO, CoA-SNO or Trx-Cys73-SNO) or a buffer 
control. Both proteomes are then treated with a cysteine-reactive IA probe, which 
covalently modifies hundreds of reactive and functional cysteine residues within the 
proteome. Following alkylation by the iodoacetamide of the IA probe, the terminal 
alkyne of the IA probe can be further functionalized through (CuAAC) reactions.28, 29 The 
IA probe-labeled proteins are covalently linked to light (SNO-treated sample) or heavy 
(buffer treated control sample) biotin-azide tags (Azo-L and Azo-H) that contains an 
azobenzene linker for reductive cleavage by sodium dithionite.27 The light and heavy 
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samples are then combined and subjected to streptavidin enrichment, on-bead trypsin 
digestion, and sodium dithionite cleavage to afford a mixture of light- and heavy-labeled 
peptides for MS analysis. These cysteine-containing isotopically labeled peptides are 
identified using the fragmentation (MS/MS or MS2) spectra and the relative abundance 
between the SNO and control samples is measured by the heavy:light ratio (R) that 
reflects the intensity of these species in the parent ion (MS1) spectra. An R-value of ~1 
signifies a cysteine residue that was unaffected by SNO treatment, whereas R-values 
greater than one indicate modification of that cysteine residue by the transnitrosating 
agent. A larger R-value reflects a greater percentage of cysteine modification. 
 
Quantitatively measuring cysteine sensitivity to different transnitrosation donors 
MCF-7 breast cancer-cell proteomes were initially evaluated using either GSNO, 
CoA-SNO and Trx-SNO as the transnitrosation donors. To ensure selective S-nitrosation 
of Cys73 in these experiments, a Trx C62/69S double mutant was transnitrosated by 
GSNO and desalted to remove excess GSNO and GSH. Furthermore, the active-site 
cysteines of Trx (Cys32 and Cys35) were oxidized to ensure that any observed effects 
were not due to reactivity with these thiols. 31 This Trx-C73-SNO (Trx-SNO) was then 
used as a transnitrosation donor. Similarly, fresh CoA-SNO was generated by addition of 
sodium nitrite to equal amount of CoA in acidic solution.  
Initially, MCF-7 breast cancer-cell lysate proteomes were subjected to the 
following treatments: (1) 500 µM GSNO (light) versus no GSNO added (heavy) as 
GSNO transnitrosation sample (n=5), (2) 500 µM CoA-SNO (light) versus no CoA-SNO 
added (heavy) as CoA-SNO transnitrosation sample (n=5),  (3) 90 µM Trx-SNO (light) 
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versus no Trx-SNO added (heavy) as Trx-SNO transnitrosation sample (n=5); and (2) for 
each transnitrosation experiment above, both the light and heavy samples left untreated 
by SNO as a control for the quantitative capacity of the MS approach (n=2). In total, 610 
(GSNO treated), 477 (CoA-SNO treated) and 379 (Trx-SNO treated) cysteine residues 
were identified with accurate heavy:light ratios in at least three of all five experimental 
samples. The full datasets are listed in Appendix I as Table 3A-1 (GSNO), 2 (CoA-SNO) 
and 3 (Trx-SNO), respectively. As expected, the control sample showed a limited 
distribution of R-values, closely centered on R = 1. In contrast, the experimental sample 
showed a wider distribution of R-values, where the majority of cysteine residues 
exhibited R-values >>1. These high R values are reflective of a loss in reactivity for 
cysteine residues subject to transnitrosation in the SNO-treated (light) sample, where P 
values (Appendix I, Table 3A-1, 2 and 3, 2-way ANOVA analysis) indicate the high  
 
Figure 3-3. A competitive cysteine-profiling strategy to quantify sensitivity to 
transnitrosation. Cell lysates are treated with a transnitrosation donor (inset, GSNO, CoA-
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SNO and Trx-SNO) or a buffer control, labeled with the IA probe and subjected to 
CuAAC to append either the Azo-L (SNO) or Azo-H (buffer) biotin-azide tags. The 
resulting isotopically tagged proteomes are mixed together and subjected to streptavidin 
enrichment and on-bead trypsin digestion. The probe-labeled peptides are eluted by 
reductive cleavage of the azobenzene with sodium dithionite and analyzed by high 
resolution LC/LC-MS/MS to identify (MS2) and quantify (MS1) the IA-probe labeled 
cysteine residues within each sample. A loss in cysteine reactivity is indicative of 
transnitrosation donor-mediated S-nitrosation. 
 
To facilitate further parallel analysis, these three sets of transitrosated cysteines 
were compared in parallel, resulting in an overlapping peptide list of 756 cysteine 
residues (Figures 3-4, A, B and C; Appendix I, Table 3A-4). This overlapping peptide list 
is featured by individual cysteine with specific heavy:light ratios towards three 
transnitrosation donors, highlighting the different degree of a single cysteine to undergo 
transnitrosation by distinct transnitrosation donors. The R values for each donor, 
however, distribute widely to different degree, with GSNO showing R smaller than 5 and 
Trx-SNO distributing most widely up to R~20. (Figure 3-4, D). The top 50 sensitive 
cysteine residues have R ratios > 2.6 (GSNO), 5.1 (CoA-SNO) and 7.5 (Trx-SNO). P 
values (Appendix I, Table 3A-1, 2 and 3, 2-way ANOVA analysis) indicate the high 
confidence in the observed decrease in cysteine reactivity for these ratios, which are the 
cut-off we placed for cysteines that are highly sensitive to transnitrosation. The proteins 
containing these transnitrosation-sensitive cysteines serve diverse cellular functions, and 
are found in all subcellular compartments (cytoplasm, nucleus, ER, mitochondria, etc.), 
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with the majority located on enzymes, binding or structural proteins, and concentrated in 
the metabolic and cellular process according to gene ontology (GO) analysis (Figure 3-5).  
 
Figure 3-4. Identifying cysteines sensitive to transnitrosation by GSNO, CoA-
SNO and Trx-SNO. Quantitative MS analysis of GSNO (A), CoA-SNO (B), and Trx-
SNO (C) -treated cell lysates. Average heavy:light ratios (R) are shown for 756 cysteine 
residues identified in all three transnitrosation donor-treated (light: SNO; heavy: buffer;) 
MS analyses (Appendix I, Table 3A-4). Error bars represent standard deviation from the 
mean across the replicate analyses. (D) Distribution of R-values for the GSNO, CoA-



































































































Figure 3-5. Biological process (A) and molecular function (B) are shown for all proteins 
and proteins containing the 50 cysteines with most or least transnitrosation sensitivity 
from the cysteine-reactivity profiling analyses (Appendix I, Table 3A-4). GO analysis 
was performed using PANTHER (www.pantherdb.org). 
 
Identifying factors that dictate cysteine sensitivity to transnitrosation 
To identify factors that unify the subset of cysteine residues highly sensitive to 
transnitrosation, the importance of primary sequence, cysteine pKa, surface exposure, 
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Figure 3-6. Sequence conservation flanking sites of cysteine transnitrosation. The ten 
amino-acids N- and C-terminal to the observed cysteine were aligned to identify primary 
sequence motifs for the 50 cysteines most (top) and least (down) sensitive to GSNO (A), 
CoA-SNO (B) and Trx-SNO (C) transnitrosation. Sequence alignments and plots 
generated using Two Sample Logo software (http://www.twosamplelogo.org/index.html) 
using default settings and the following tailored parameters: First position number: -10; 
Logo Range: -10, 10; Show residue if p-value < 1.30 
 
First, the 50 most sensitive and the 50 least GSNO, CoA-SNO and Trx-SNO 
sensitive cysteine residues were analyzed for primary sequence motifs. Alignment of the 
ten N- and C-terminal residues to the transnitrosated cysteine did not reveal a consensus 
sequence that dictates transnitrosation sensitivity (Figure 3-6). The lack of a clear 
primary sequence motif is in agreement with previous analyses of S-nitrosation sites from 
a conglomerate of proteomic studies23, 26, and suggests that transnitrosation by GSNO, 
CoA-SNO and Trx-SNO is not driven by a primary sequence motif in contrast to proteins 
S-nitrosated by the iNOS-S100A8/A9 complex24.  
Furthermore, analysis of surface exposure (solvent-accessible surface area, 
SASA) and pKa distribution indicate that no trends in cysteine pKa and surface exposure 
were identified across cysteines sensitive and insensitive to GSNO, CoA-SNO and Trx-
SNO transnitrosation (Figure 3-7; Appendix I, Table 3A-5).  
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Figure 3-7. Surface-exposure (A) and pKa (B) analysis of cysteines that were identified 
as sensitive and insensitive to transnitrosation. PDB files were obtained for 19 cysteine 
residues with high and low sensitivity to transnitrosation (Appendix I, Table 3A-5). 
Prediction of pKa values for each cysteine residue was performed by VegaZZ 
implemented with PropKa (version 3.0.5.12, http://nova.disfarm.unimi.it/cms/index.php) 
using default settings. Solvent accessible surface area (SASA) calculations were 
performed using Naccess (Hubbard,S.J. & Thornton, J.M. (1993), 'NACCESS', Computer 
Program, Department of Biochemistry and Molecular Biology, University College 
London.). Naccess calculates atomic accessible surface areas using a previously reported 
method (Lee & Richards 1971, J. Mol. Biol., 55, 379-400) in which a spherical probe is 
rolled over the entire Van der Waal’s surface of the macromolecule. The accessible 
surface area is then calculated from the path traced out from the center of the spherical 
probe, usually using the radius of water, which is 1.4 Å. The SASA of individual atoms is 
achieved through using thin slices of the molecular volume and these slices are used to 
calculate an approximation of the accessibility of each individual atom to the accessible 
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Figure 3-8. Correlation of cysteine reactivity with transnitrosation sensitivity. To 
correlate sensitivity to GSNO transnitrosation with cysteine reactivity, the 30 most 
reactive cysteine residues28 are highlighted (in red) across the range of R-values 
measured for GSNO (A), CoA-SNO (B) and Trx-SNO (C) sensitivity (Appendix I, Table 
3A-6).  
 
The role of inherent cysteine reactivity in directing transnitrosation donor towards 
particular cysteine residues was also evaluated. Previously, the IA probe was used in a 
global proteomic study to rank cysteine residues by reactivity, as reflected by the extent 
of IA-probe modification measured using both time and concentration-dependent 
analysis28. This reactivity data was correlated with the transnitrosation data (Appendix I, 
Table 3A-6) to determine if the cysteine residues most sensitive to transnitrosation are 
also highly reactive. Cysteine reactivity did not correlate with transnitrosation sensitivity. 
Indeed, for each transnitrosation donor, the top 30 most reactive cysteine residues from 
this previous study span the entire spectrum of transnitrosation sensitivity (Figure 3-8), 
suggesting that transnitrosation is not primarily driven by cysteine reactivity. However, it 
is important to note that this measure of reactivity is potentially biased toward cysteine 
residues that preferentially react with the IA probe, since different electrophiles target 






Global analysis of binding interaction effects on cysteine sensitivity to 
transnitrosation 
A potential determinant of the cysteine selective sensitivity to transnitrosation, is 
the specific binding interaction between the target protein and the transnitrosation donor, 
directing S-nitrosation to cysteine residues within the binding interface. To interrogate 
this possibility, a direct analysis across three subsets of proteins carrying the 50 most 
sensitive cysteines to GSNO, CoA-SNO and Trx-SNO transnitrosation were directly 
compared, demonstrating clear relationships between these protein subsets. (Figure 3-9). 
14 proteins are common to all three subsets, indicative of their high sensitivity and 
promiscuity toward all three transnitrosation donors. Importantly, each subset contains 
10-15 proteins that are exclusive from the other subsets, indicating their inherent 
selectivity to a specific transnitrosation donor. Next, to evaluate the selectivity at the 
amino acid level, the relative sensitivity across all 756 cysteines or the 50 most sensitive 
cysteines ranked by GSNO transnitrosation were compared to the other two 
transnitrosation donors. Importantly, sensitivity to either CoA-SNO or Trx-SNO 
transnitrosation did not correlate with sensitivity to GSNO transnitrosation. Specifically, 
the top 50 CoA-SNO-sensitive cysteine residues spanned the entire range of observed 
GSNO sensitivities (Figure 3-10; Appendix I, Table 3A-4). Similarly, the top 50 Trx-
SNO-sensitive cysteine residues demonstrated variable GSNO sensitivity (Figure 3-10). 
Taken together, these results suggest that specific interactions between the protein target 
and the transnitrosation donor or specific properties of the transnitrosation donor itself are 




Figure 3-9. Venn diagram of the proteins carrying 50 most sensitive transnitrosation 
cysteines to GSNO, CoA-SNO and Trx-SNO. Proteins in the specific subsets are listed 
using the same color mode. Purple: only highly sensitive to GSNO; yellow, only highly 
sensitive to CoA-SNO; green: only highly sensitive to Trx-SNO; black: highly sensitive 
to all three donors. 
 
To globally investigate the potential role of binding interactions on cysteine 
transnitrosation selectivity and sensitivity, we revised the quantitative proteomic strategy 
and performed a competitive cysteine transnitrosation analysis.  We hypothesized that if 
the binding interaction between the target protein and the transnitrosation donor dictates 
selective transnitrosation of a specific cysteine residue, that cysteine would show an 
altered sensitivity toward the transnitrosation donor upon pretreatment with small 
molecules that are either structurally similar to the transnitrosation donor, or serves as a 
protein binding substrate. Interestingly, indeed, among the 20 most CoA-SNO sensitive 
cysteines, most are within proteins that use ATP as a binding substrate (Table 3-1). ATP 
shares the same adenine and ribose ring structures with CoA-SNO (Figure 3-12, A), 
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which serves as a good binding competitor of CoA-SNO. S-methyl-glutathione 
(MeGSH), a glutathione (GSH) derivative with a methylated cysteine thiol (Figure 3-11, 
A), was found to be released upon hypoxia and depolarization in extracellular space of 
the brain.32 MeGSH, is incapable of conversion to GSNO and is therefore an ideal 
competitor for investigating binding effect on GSNO transnitrosation.  
 
Figure 3-10. Heatmap of relative sensitivity across all 756 cysteines (left) or the 50 most 
sensitive cysteines (right) ranked by GSNO transnitrosation. Each line represents a single 
cysteine residue (Appendix I, Table 3A-4) with its relative sensitivity to CoA-SNO and 
Trx-SNO lined up in parallel. Sensitivity to either CoA-SNO or Trx-SNO transnitrosation 




























Table 3-1. The 20 most CoA-SNO sensitive cysteine containing proteins that were also 
detected in a 1 mM ATP pre-treatment mass spectrometry experiment (mass 
spectrometry data in Appendix I, Table 3A-4 and 3A-8) with their annotated cofactors, 
substrates or binding partners. The data were sorted by ratio (R) in 500 µM CoA-SNO 
(light) treated cell lysate. Gray-colored proteins contain CoA-SNO transnitrosated 
cysteines whose sensitivity to CoA-SNO decreased upon 1 mM ATP pre-treatment.  
 
In detail, MCF7 cell lysates were pre-treated with 1 mM small molecule 
competitor (light, MeGSH for GSNO sample or ATP for CoA-SNO sample), or left 
untreated as a control (heavy). Both samples were then transnitrosated by 500 µM GSNO 







1 AKT1 RAC-alpha serine/threonine-protein kinase ATP
2 TXNDC17 Thioredoxin domain-containing protein 17 TrxR with NADPH
3 PFKP 6-phosphofructokinase type C ATP
4 GCDH Glutaryl-CoA dehydrogenase, mitochondrial Fatty-acyl-CoA 
5 FAM120A Constitutive coactivator of PPAR-gamma-like protein 1 RNA
6 RPL30 60S ribosomal protein L30 RNA, poly-A
7 ECHS1  Enoyl-CoA hydratase, mitochondrial 3-hydroxyacyl-CoA 
8 PGK1  Phosphoglycerate kinase 1 ATP
9 RPS12 40S ribosomal protein S12 RNA, poly-A
10 PREX1 Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein phospholipids
11 TK1 Thymidine kinase, cytosolic ATP
12 UBA5 Ubiquitin-like modifier-activating enzyme 5 ATP
13 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ATP, RNA
14 DSP DSP Desmoplakin RNA
15 PCBP1 Poly(rC)-binding protein 1 RNA, poly-A
17 HADH2 3-hydroxyacyl-CoA dehydrogenase type-2 NADH, NADPH, poly-A
18 PFKL 6-phosphofructokinase, liver type ATP
19 MOB4 MOB-like protein phocein Zn
20 DSP Desmoplakin RNA
21 EEF2 EEF2 Elongation factor 2 RNA, GTP
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above. In total, 554 (GSNO treated) and 848 (CoA-SNO treated) cysteine residues were 
identified with accurate heavy:light ratios (R) in both control and experimental samples 
(Appendix I, Table 3A-7 and 8). For each cysteine residue, a shifted R ratio between 
control and experimental conditions reflected the subtle change of cysteine 
transnitrosation sensitivity upon small molecule/substrate binding. Specifically, a 
decreased ratio (R) upon competitor treatment indicated that binding interaction between 
protein and the small molecule de-sensitized cysteine to undergo transnitrosation, 
therefore more cysteines became available for subsequent probe labeling in the 
experimental sample, while an increased ratio (R) signified that small molecule/substrate 
binding facilitated cysteine transnitrosation. A subset of cysteine residues showed 
decreased ratios, impling that the innate sensitivity of these cysteines toward 
transnitrosation donors is governed at some level by specific interactions between the 
protein target and the transnitrosation donor, which can be perturbed by competitive 
small molecules or substrates.  
Previous proteomic study on S-nitrosation sensitivity indicated that cysteine 58 of 
HADH2 is highly sensitive to GSNO transnitrosation. Cysteine 58 is located distal to the 
HADH2 active site and NADH binding site, within a hydrophobic pocket flanked by two 
leucine residues (Leu39 and Leu54) (Figure 3-11, B). Transnitrosation of cysteine 58 by 
GSNO led to a high ratio of 3.03. However, this ratio was partially quenched by MeGSH 
pre-treatment, resulting in a ratio of 2.35 (Figure 3-11, C). This partial loss in the 
sensitivity of cysteine 58 was well correlated with a gel-based study, where MeGSH was 
used as a competitive inhibitor and partially outcompeted GSNO binding to cysteine 58 
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in a concentration-dependent manner. Both of these studies indicate that GSNO 
















































































Figure 3-11. MeGSH pre-treatment desensitizes GSNO transnitrosation on cysteine 58 of 
HADH2. (A). Structures of GSNO (left) and MeGSH (right). (B) Structure of HADH2 
(PDB: 2O23) with NAD+ bound in the active site. The GSNO transnitrosation-sensitive 
cysteine, Cys58, is located distal to the active site within a hydrophobic pocket flanked 
by Leu39 and Leu54 (inset). (C) MCF7 cell lysate were pre-treated with 1 mM MeGSH 
(light, n=3), or left untreated as a control (heavy, n=5). Both samples were then 
transnitrosated by 500 µM GSNO and taken through the quantitative mass spectrometry 
workflow. R ratios of cysteine 58 of HADH2 in both control and MeGSH-treated sample 
are plotted. Data were presented as s.d. with nsp > 0.05 by 2-way ANOVA. (D) S-
nitrosation of recombinantly expressed and purified HADH2 WT pretreated with GSNO 
and then treated with increasing concentration of MeGSH. S-nitrosation was monitored 
using the biotin-switch technique as detailed under Experimental Procedures in chapter 2.   
 
Another strong indication of the role of binding interaction perturbations are 
cysteines 360 and 641 on ATP-dependent 6-phosphofructokinase, platelet type (PFKP). 
PFKP is involved in the first committed step of glycolysis, catalyzing the Mg-ATP 
dependent phosphorylation of D-fructose-6-phosphate to fructose-1,6-bisphosphate in 
prokaryotic and eukaryotic cells. It acts as the “gatekeeper”, the main control point of 
flux through glycolysis.33, 34 Cysteine 360 and 641 on PFKP both showed high sensitivity 
to CoA-SNO transnitrosation (R>7) (Appendix I, Table 3A-8). However, ATP binding to 
PFKP quenched this high sensitivity to a large, though different extent, on both cysteines. 
ATP pre-treatment diminished sensitivity of cysteine 360 by 50%, leading to a ratio 
decrease from 9.7 to 5.0. However, the same treatment resulted in a smaller diminishment 
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in (~25%) sensitivity for cysteine 641 with a decrease in ratio from 6.8 to 5.1 (Figure 3-
12, B). Interestingly, both cysteines are located in neither the direct substrate binding site, 
nor the allosteric activator region of PFKP. Crystal structure analysis demonstrated that 
cysteine 360 is located at an alpha helix adjacent to the ATP binding pocket (GDGS, 
position 127~130), whereas cysteine 641 is on a loop region, relatively distal to ATP 
binding site (Figure 3-12, C). As a result, binding of ATP would affect cysteine 360 more 
significantly than cysteine 641, hindering direct contact of NO moiety to cysteine thiol, 
making it much less sensitive to CoA-SNO transnitrosation. This conformational effect 
on cysteine sensitivity to transnitrosation suggests that direct binding interaction between 
cysteine residue and transnitrosation donor play an important role in governing its 
selectivity and extent of transnitrosation. 
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Figure 3-12. ATP pre-treatment desensitizes CoA-SNO transnitrosation on cysteine 360 
and 641 of PFKP. (A). Structures of CoA-SNO (top) and ATP (bottom). Structural 
similarity in these two molecules is boxed in red. (B) MCF7 cell lysate were pre-treated 
with 1 mM ATP (light, n=2), or left untreated as a control (heavy, n=5). Both samples 
were then transnitrosated by 500 µM CoA-SNO and taken through the quantitative mass 












































































S-nitroso-Coenzyme A (CoA-SNO) 
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MeGSH-treated sample are plotted. Data were presented as s.d. with ***p < 0.001 by 2-
way ANOVA. (C) Structure of PFKP binding with ATP (PDB: 4xyj). Cysteine 360 is 
located close to the ATP binding pocket, while cysteine 641 is relatively distal to the 
ATP binding region.  
 
Conclusion 
In summary, we report a competitive cysteine-profiling strategy to globally and 
quantitatively rank 609, 477 and 379 cysteine residues by their transnitrosation sensitivity 
to GSNO, CoA-SNO and Trx-SNO respectively (Appendix I, Table 3A-1, 2 and 3). This 
platform relies on monitoring a loss in cysteine reactivity induced by direct 
transnitrosation of the thiol group. The data obtained provide important insight into the 
sensitivity of hundreds of cysteines to different transnitrosation donors. Direct 
comparison of the data resulted in a list of 756 cysteine-containing peptides that were 
transnitrosated by all three donors (Appendix I, Table 3A-4). This overlapping peptide 
list features individual cysteine residues with specific heavy:light ratios (R) for all three 
transnitrosation donors, highlighting the different degree of transnitrosation that a single 
cysteine undergoes by distinct transnitrosation donors. Interestingly, different 
transnitrosation donors targeted distinct subsets of cysteine residues (Figure 3-5, 3-9), 
consistent with the hypothesis that each transnitrosation donor specifically interacts with 
its protein targets, and this interaction is a key component governing selective 
transnitrosation of a specific cysteine residue. 
The difference in redox potential between two interacting cysteine residues is 
often considered as the major determinant for protein transnitrosation.5 Specifically, the 
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cysteine with the higher redox potential tends to acquire an electron to be reduced. Thus, 
when it interacts with a free thiol with a lower redox potential within an appropriate 
microenvironment for transnitrosation, transfer of the NO moiety will occur. Here, we 
investigated more determinants that could facilitate NO transfer and unify the subset of 
cysteine residues highly sensitive to transnitrosation. A primary sequence motif, surface-
exposure, or pKa trend dictating transnitrosation by GSNO, CoA-SNO and Trx-SNO was 
not identified. Importantly, sensitivity to transnitrosation by all three transnitrosation 
donors is not solely determined by the reactivity of a cysteine residue. 
A potential determinant of cysteine selective sensitivity is specific binding 
interactions between the target protein and the transnitrosation donor that directs S-
nitrosation to cysteine residues within the binding interface. To investigate this 
possibility, we performed a global proteomic analysis, where the transnitrosation reaction 
was performed after pre-treatment with a small molecule competitor, either structurally 
related to the transnitrosation donor such as MeGSH for GSNO, or protein binding 
partner such as ATP for CoA-SNO. This competitive binding effect resulted in a broad 
range of ratio shifts with regard to non-pretreated samples, indicating that binding 
interactions globally affect cysteine transnitrosation. In particular, cysteine 58 on 
HADH2, which was shown to be highly sensitivity to GSNO, was desensitized by 
MeGSH binding, leading to a ratio decrease of ~0.7. This ratio shift was consistent with 
the partially diminished band intensity of HADH2 transnitrosation after MeGSH 
competitive pre-treatment, indicating that GSNO transnitrosation of HADH2 precedes 
through a GSNO-binding step. Similarly, cysteine 360 and 641 on PFKP, both highly 
sensitive to CoA-SNO, were desensitized by ATP binding to a large, though different 
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degree. Compared to ~25% decrease of cysteine 641, a significant reduction (50%) of 
cysteine 360 sensitivity to CoA-SNO was observed upon ATP pre-treatment. Structural 
analysis revealed that cysteine 360 is located adjacent to the ATP binding pocket while 
cysteine 641 is relatively distal to this binding region. Thus ATP binding could 
potentially interrupt the accurate positioning of transnitrosation donor to cysteine thiol, 
resulting in decreased transnitrosation.  
The two examples above demonstrated that the donor-protein binding interactions 
play an important role in transnitrosation selectivity. Moreover, direct association of the 
SNO donor and its target is also thought to alter protein conformation, affecting the 
microenvironment of specific cysteine residues and activating their ability to undergo 
transnitrosation. As a result, only a specific subset of proteins are transnitrosated, 
resulting in selective activation/inhibition of particular signaling pathways. This finding 
further supports the regulatory role of S-nitrosation modification in cell signaling and 
other cellular functions.  
Taken together, the cysteine-profiling platform described here was used to 
interrogate the driving forces that dictate the selectivity of transnitrosation within 
proteomes, by allowing for a direct and quantitative comparison of the effects of distinct 
transnitrosation donors on their respective targets. These global studies enable a deeper 
understanding of the factors that dictate cysteine sensitivity to transnitrosation, consistent 
with the hypothesis that each transnitrosation donor specifically interacts with its protein 
targets, and this interaction is a key component governing selective transnitrosation of a 
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Reagents and general procedures.  
All materials were purchased from Sigma Aldrich (Milwaukee, WI) unless 
otherwise noted. RPMI 1640 medium, phosphate buffered saline (PBS), 2% Trypsin-
EDTA and penicillin/streptomycin (Pen/Strep) were purchased from Fisher Scientific 
(Pittsburgh, PA). Protein concentrations were determined by Bradford Protein 
Concentration assay from Bio-Rad Life Science (Hercules, CA). Streptavidin-agarose 
beads and Ni-NTA beads were purchased from Thermo Scientific (Armarillo, TX). Nap-
5 Columns were purchased from GE Healthcare Bio-Sciences (Piscataway, NJ). Micro 
BioSpin-6 desalting columns were purchased from Bio-Rad Life Science (Hercules, CA). 
Ni-NTA Magnetic Agarose Beads were purchased from QIAGEN (Valencia, CA). 
GSNO were purchased from Cayman Chemicals (Ann Arbor, MI). 
 
MCF7 cell culture and lysate preparation. 
! 123!
MCF7 cells were maintained in RPMI1640 medium. Media was supplemented 
with 10% fetal bovine serum (FBS) and 1% Pen/Strep. Cells were grown at 37 °C under 
an atmosphere of 5% CO2. 
Cells were grown to 100% confluency and harvested by scraping. The cells were 
washed three times with PBS, resuspended in an appropriate volume of PBS and 
sonicated to obtain whole-cell lysates. The lysates were then separated by 
ultracentrifugation at 45,000 rpm at 4 °C under high vacuum for 45 min. The resulting 
supernatant was collected as the soluble proteome. Protein concentrations were 
determined using the Bradford Protein Concentration Assay. 
 
MCF7 lysates transnitrosation and mass-spectrometry analysis. 
GSNO was dissolved in freshly-made HEN buffer (125 mM HEPES pH 7.7, 1 
mM EDTA, 0.1 mM neocuproine). The GSNO concentration was determined by 
measuring the UV absorbance at 336 nm (extinction coefficient: 0.9 mM-1cm-1.).  
To generate Thioredoxin-SNO (Trx-C73-SNO), human Trx C62S/C69S was 
expressed and purified as previously described35. Trx C62S/C69S was reduced with 2.5 
mM TCEP at room temperature for 15 min. A small excess of bovine insulin (1.2 
equivalents) was then added to the mixture at room temperature for 30 min in order to 
oxidize the active-site cysteines of Trx (Cys32 and Cys35) to a disulfide. Finally Cys73 
of Trx was S-nitrosated with two equivalents of GSNO at 37°C for 30 min. At the end of 
each step, Trx was desalted by Micro Bio-Spin Columns P-6 to remove extra reagent, and 
eluted with PBS. The concentration of Trx-C73-SNO was determined by measuring the 
UV absorbance at 336 nm, using an extinction coefficient of 0.9 mM-1cm-1. For protein 
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transnitrosation by Trx-C73-SNO, 250 µL aliquots of MCF7 lysate (4 mg/mL) were 
incubated with 250 µL PBS or 250 µL Trx-C73-SNO at 30°C for 30 min. Excess Trx-
C73-SNO was then captured by Ni-NTA Magnetic Agarose Beads at room temperature 
for 30 min due to the presence of the His10-tag on Trx-C73-SNO. The beads were 
separated using a QIAGEN 12-Tube Magnet. The supernatant was prepared for MS 
analysis as described above. 
To generate fresh CoA-SNO, 0.1 M CoA in 1 M HCl was mixed with 0.1 M 
sodium nitrite (NaNO2) in buffer (100uM EDTA and 100 uM DTPA (pH 8~9.5)) on ice. 
The CoA-SNO concentration was determined by measuring the UV absorbance at 340 
nm based on an extinction coefficient of 0.92 mM-1cm-1. 
MCF7 cell lysates (4 mg/mL) were aliquoted to 500 µL and incubated with 5 µL 
buffer or 5 µL of NO donor (100X stock concentration: 50 mM GSNO, 50 mM CoA-
SNO and 9 mM Trx-SNO) in buffer at 37 °C for 1 hr. Excess SNO was then removed by 
filtration through a Nap-5 column. Proteins were eluted with 1 mL PBS and aliquoted to 
produce two 500 µL samples. 
Each 500 µL sample was treated with 100 µM IA probe using 5 µL of a 10 mM 
stock in DMSO. The labeling reactions were incubated at room temperature for 1 hr. 
Click chemistry was performed by the addition of either Azo-L or Azo-H (100 µM, 5 
mM stock in DMSO), tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (1 mM, fresh 
50 mM stock in water), tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA ligand)  
(100 µM, 17× stock in DMSO:t-Butanol 1:4) and CuSO4 (1 mM, 50 mM stock in water). 
Samples were allowed to react at room temperature for 1 hr. The Azo-L and Azo-H 
samples were mixed together immediately following click chemistry. Precipitated 
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proteins were pelleted by centrifugation at 6500 × g (10 min, 4 °C). The pellets were 
washed twice by resuspending the pellet in cold methanol, after which the pellets were 
solubilized in PBS containing 1.2% w/v SDS via sonication and heating (5 min, 80 °C).  
The SDS-solubilized, probe-labeled proteome samples were diluted with PBS to a 
final SDS concentration of 0.2% w/v. The solutions were incubated with 100 µL 
streptavidin-agarose beads at 4 °C for 16 hr, followed by incubation at room temperature 
for 2.5 hr. The beads were washed sequentially with 0.2% w/v SDS/PBS, PBS, and 
water, and pelleted by centrifugation (1300 × g, 2 min) between washes. 
The washed beads were suspended in 500 µL 6 M urea/PBS and 10 mM 
dithiothreitol (DTT, from 200 mM stock in water) and placed in a 65 °C heat block for 15 
min. 20 mM iodoacetamide (from 1 M stock in water) was then added and incubated at 
37 °C for 30 min. Following reduction and alkylation the beads were pelleted by 
centrifugation (1300 × g, 2 min), re-suspended in 200 µL of 2 M urea/PBS, 1 mM CaCl2 
(100 mM stock in water) and trypsin (2 µg), and digested overnight at 37 °C. The digest 
was washed with PBS and water. The azobenzene linker was cleaved with 50 mL of fresh 
25 mM sodium dithionite/PBS for 30 min at room temperature on a rotator, followed by 
centrifugation to collect supernatant. The sodium dithionite cleavage was repeated twice 
and then the beads were washed with water (2 × 75 µL). All supernatants and washes 
were combined and acidified with 15 µL formic acid. The samples were stored at -20 °C 
until mass spectrometry analysis. 
LC/LC-MS/MS analysis was performed on an Agilent 1200 series HPLC coupled 
to an LTQ-Orbitrap Discovery mass spectrometer (ThermoFisher). Peptide digests were 
pressure loaded onto a 250 µm fused silica desalting column packed with 4 cm of Aqua 
! 126!
C18 reverse-phase resin (Phenomenex). The peptides were eluted onto a biphasic column 
(100 µm fused silica with a 5 µm tip, packed with 10 cm Aqua C18 reverse-phase resin 
(Phenomenex) and 3 cm Partisphere strong-cation-exchange resin (SCX, Whatman) using 
a gradient 5-100% Buffer B in Buffer A (Buffer A: 95% water, 5% acetonitrile, 0.1% 
formic acid; Buffer B: 20% water, 80% acetonitrile, 0.1% formic acid). The peptides 
were then eluted from the SCX onto the C18 resin and into the mass spectrometer using 
four salt steps as previously described 28, 36. The flow rate through the column was set to 
~0.25 mL/min and the spray voltage was set to 2.75 kV. One full MS scan (FTMS) (400-
1800 m/z) was followed by 18 data dependent scans (ITMS) of the nth most intense ions 
with dynamic exclusion enabled. 
 
Mass-spectrometry analysis of small molecule binding effect on transnitrosation  
GSNO and CoA-SNO was freshly-made as described above. MCF7 cell lysates (4 
mg/mL) were aliquoted to 500 µL and incubated with 5 µL water at 37 °C for 1 hr 
(control), or 5 µL of small molecule (100X stock: 100 mM MeGSH or 100 mM ATP, 1 
mM final concentration) in water at 37 °C for 1 hr (sample), respectively. Each sample 
was then incubated with 5 µL of NO donor (100X stock concentration: 50 mM GSNO or 
50 mM CoA-SNO, final concentration: 500 µM) in buffer at 37 °C for 1 hr. Then Excess 
NO donor was then removed by filtration through a Nap-5 column. Proteins were eluted 
with 1 mL PBS and aliquoted to produce two 500 µL samples. The IA probing and rest 
mass-spectrometry preparation steps were as described above. 
 
Mass-spectrometry data analyses.  
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The generated tandem MS data was searched using the SEQUEST algorithm 
against the human IPI database. A static modification of +57.02146 on cysteine was 
specified to account for iodoacetamide alkylation and differential modifications of 
+456.2849 (Azo-L modification) and +462.2987 (Azo-H modification) were specified on 
cysteine to account for probe modifications. SEQUEST output files were filtered using 
DTASelect 2.0. Quantification of heavy:light ratios (R) was performed using the 
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Introduction 
Regulation of cellular redox environment is important for normal cellular 
physiology, and its alteration is known to induce different biological states of cells, 
including proliferation, differentiation, and apoptosis. The reactive oxygen and nitrogen 
species (ROS and RNS) generated from various sources, including the normal activity of 
mitochondrial enzymes, act as signaling molecules in redox signaling, and are sensed by 
cysteine residues, which undergo various types of oxidative modifications, such as S-
nitrosation, S-glutathionylation, and disulfide bond formation. These oxidative cysteine 
modifications profoundly influence physiological functions of many proteins, serving as 
regulatory switches for many cellular processes. Consequently, its aberrant regulation 
often correlates with many disease conditions. 
Among the various oxoforms, S-glutathionylation is the disulfide formation of a 
protein cysteine residue with glutathione.1 Glutathione (GSH), an abundant tripeptide 
made of γGlu-Cys-Gly (L-γ-glutamyl-L-cysteinylglycine) is primarily found in the 
cytosol in both a reduced (GSH) and oxidized form (GSSG) (Figure 3A).2, 3 GSH is 
biosynthesized by two ATP-dependent enzymes, γ-glutamylcysteine ligase (GCL) and 
glutathione synthetase (GS). GCL, the rate limiting step of GSH formation, ligates Glu 
and Cys to generate γGlu-Cys. Subsequently, GS catalyzes the coupling of γGlu-Cys to 
Gly to form glutathione.  
The formation of S-glutathionylated proteins is dependent on the cellular 
GSH/GSSG ratio and involves a thiol/disulfide exchange between a protein thiol and 
GSSG and can also result from the reaction of S-nitrosated cysteines or sulfenic acids 
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with glutathione.4 This process is highly reversible and the removal of glutathionylated 
adducts is driven by thiol/disulfide exchange with free GSH, or enzymatically by 
glutaredoxin. Several important cellular pathways are regulated through 
glutathionylation. These include the NF-κB survival pathway, whereby S-
glutathionylation of a critical DNA-binding cysteine on NF-κB inhibits DNA binding and 
downstream transcriptional activation.5 Other key proteins in this pathway such as IκB 
kinase (IKK) are also known to be glutathionylated,6 rendering the NF-κB response 
system highly sensitive to oxidative stress and changes in cellular GSH/GSSG ratios. 7 
Numerous studies have demonstrated that glutathionylation serves as an important 
regulatory switch of protein function in response to ROS in physiological redox signaling 
and pathological diseases.1 
Mitochondria are the central organelle for cellular metabolism and their metabolic 
activity directly correlates with cellular fate, such as growth, differentiation, and 
apoptosis.1,2 Glucose, a major nutrient for mitochondrial metabolism is converted via 
glycolysis to pyruvate for production of ATP, which is accompanied by a large 
consumption of oxygen and production of mitochondrial ROS (mROS).4 However, when 
cells are subjected to glucose starvation, mitochondrial respiration and redox homeostasis 
is disturbed, including an increase of mROS, a decrease in NADPH levels, and an 
increased ratio of oxidized over reduced glutathione in cells.6,7 Glucose starvation 
decreases the production of NADPH due to the decreased flux of glucose to the pentose 
phosphate pathway.6 NADPH is an essential cofactor for both removing ROS and 
maintaining the normal redox environment. This redox disturbance by glucose starvation 
induces various other cellular processes such as apoptosis when metabolic stress is 
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severe.8 Importantly, many of these cellular pathways are partially regulated by 
mechanisms involving mROS-mediated redox regulation.8, 9 
Despite the fact that glucose starvation induces redox disturbances of various 
cellular processes mediated by mROS, 6,7 the role of dynamic protein glutathionylation in 
response to glucose metabolism remains unknown. Recently, Ahn et al. reported a 
chemical approach for chemoselective detection of protein glutathionylation using a 
glutathione synthetase mutant (GS M4). 10 GS M4 catalyzes the condensation of azido-
Ala with γGlu-Cys in place of Gly, which produces clickable azido-glutathione (γGlu-
Cys-azido-Ala) in situ in cells upon transfection of GS M4 and incubation with azido-Ala 
(Figure 4-1).10 In response to ROS,  glutathionylation of proteins by azido-glutathione, 
and subsequent click chemistry allows for effective enrichment and identification of 
glutathionylated proteins (Figure 1).10 This small versatile azide handle can conjugate 
with biotin for purification in proteomics, or click with fluorophores for imaging 
applications. Thus, here we sought to use clickable glutathione approach for detection 
and identification of protein glutathionylation in response to glucose starvation.  
 
Results  
Clickable glutathione is catalyzed by enzymes implicated in glutathionylation  
In order to analyze the cellular reversible change of protein glutathionylation in 
response to glucose metabolism, the ability of clickable glutathione to detect the 
reversible change of glutathionylation was determined. Several major enzymes are 
known to be involved in the processes of cellular glutathionylation. Glutathione-S-
transferase pi (GSTP) catalyzes the transfer of glutathione to proteins, while glutaredoxin 
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1 (Grx1), glutathione reductase (GSNOR), together with Glutathione-S-transferase 
Omega 1(GSTO1) catalyze the deglutathionylation (removal of S-glutathione adducts) of 
proteins. To determine whether azido-glutathione can be accepted as a substrate for these 
enzymes involved in glutathionylation events, the catalytic efficiency of these enzymes 
was compared using substrates containing either endogenous glutathione (GSH) or azido-
glutathione (N3GSH). Similar KM and kcat values confirmed that the small size of the 
azide-group on N3GSH could be tolerated by these enzymes involved in cellular 
glutathionylation.!
!
Figure 1. A workflow using a clickable azido-glutathione approach for detecting protein 
glutathionylation. Incubation of azido-Ala forms azido-glutathione (γGlu-Cys-azido-Ala) 
in situ in HEK293 cells stably expressing GS M4, which uses azido-Ala in place of Gly. 
In response to stimulus, proteins are oxidized by azido-glutathione instead of GSH. 
Subsequent click chemistry allows for identifying these glutathionylated proteins.  
 
Cellular studies demonstrated that glucose starvation alone was not able to induce 
glutathionylation (Figure 4-2). However, in the presence of electron transport chain 
blocker (e.g. antimycin A and rotenone), glucose starvation readily induces a high level 
of global glutathionylation in a time- and concentration-dependent manner, (Figure 4-2, 
A, B) which was restored back to low level by addition of glucose or pyruvate in cells 
(Figure 4-3).  Both antimycin A and rotenone stimulated mitochondrial dysfunction and 
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increased mROS by inhibiting complex III and I, respectively. Likewise, antimycin A or 
rotenone alone was not capable of inducing global glutathionylation. (Figure 4-2, C, D)  
This result was in agreement with previous reports that glucose starvation in combination 
with electron transport blockers induces the higher mROS and lower cell viability. 
 
Figure 4-2. Glucose starvation readily induces global glutathionylation in the presence of 
an electron transport chain blocker. After incubation of azido-Ala to HEK293/GS M4 
cells for 20 h, cells were subjected to the following stimulus: glucose starvation with 
treatment of antimycin A in time- (A) and dose- (B) dependent manners, glucose 
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starvation alone (C), and antimycin A alone (D). After stimulus, cell lysates were 
subjected to click chemsitry with rhodamine-alkyne, and analyzed for fluorescence and 
Coomassie stain. Here, a proteomic mass spectrometry platform was utilized to identify 
gutathionylated protein targets induced by glucose starvation in combination with 
antimycin A or rotenone treatment. 
 
Figure 4-3. Glutathionylation is reversed by re-addition of glucose. After incubation of 
azido-Ala to HEK293/GS M4 cells for 20 h, glutathionylation was induced by glucose 
starvation with treatment of antimycin A for 2 h. Subsequently, glucose (5 mM) or 
pyruvate (5 mM) was added to the cells for the indicated time period. Cell lysates were 
subjected to click reaction with rhodamine-alkyne, and analyzed for fluorescence and 
Coomassie stain. 
 
Identification of glutathionylated proteins in response to glucose starvation with 
mROS production.  
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The strong signals induced by glucose starvation with treatment of antimycin A 
indicate that a significant number of proteins are glutathionylated. To determine the 
identity of these glutathionylated proteins, a gel-based separation was performed, 
followed by click chemistry with biotin-alkyne, to enrich glutathionylated on 
streptavidin-beads. Labeled proteins were eluted, run on a gel, and detected by silver 
staining (Figure 4-4). Strong signals, indicative of glutathionylation, were observed under 
glucose starvation with antimycin A treatment (Figure 4-4, B lane 4). In control samples, 
relatively weak band intensity was observed with glucose, glucose starvation, or 
antimycin A alone (Figure 4-4, B lane 1-3). For proteins in lane 1 (negative) and 4 
(positive) in Figure 4-4 B, an on-bead trypsin digestion was performed, followed by a 
standard LC/LC-MS/MS workflow (Figure 4-4, A). Mass spectrometry analysis 
identified 278 and 1493 potential protein glutathionylation candidates from lane 1 
(negative) and 4 (positive), respectively (Figure 4-5, A). The full dataset was listed in 
Appendix I as Table 4A-1. Importantly, 1383 out of 1493 identified proteins (92.6%) had 
at least a two-fold increase in spectral counts (defined as the total number of 
fragmentation (MS2) spectra identified for a protein, average spectral count of at least 3 
replicates)11 in the positive versus negative control (Figure 4-6, A and Appendix I, Table 
4A-1), which likely corresponds to an over 2-fold enrichment of proteins in the positive 
versus negative control. Of the 1493 proteins identified in the positive samples,  ~156 
proteins afforded spectral counts above 10, indicating a significant level of enrichment 
(Figure 4-6, B). 1383 proteins that showed at least a two-fold spectral count increase in 
positive versus negative control were categorized by DAVID software12 for cellular 
localization, molecular function, and cellular processes (Figure 4-5, B-D). 
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Glutathionylated proteins are found in all major cellular compartments, and they are 
implicated in various cellular processes, including RNA processing, cell cycle, 
proteolysis, translation, stress response, glucose metabolism, and apoptosis (in the order 
of a decreasing P value, EASE score13) (Figure 4-5, B-D).  
 
Figure 4-4. Proteomic analysis of glutathionylated proteins. (A) Approach for pull-down 
and mass analysis: after click chemistry with biotin-alkyne, glutathionylated proteins 
enriched by streptavidin-agarose were eluted for silver staining or directly digested on-









































Figure 4-5. Systematic analysis of identified glutahionylated protein. (A) The number of 
glutathionylated proteins in indicated conditions by LC-MS/MS. (B-D) Gene ontology 
analysis of identified glutathionylated proteome.  
 
Figure 4-6. Proteomic data analysis of glutathionylated proteins. (A) Identified proteins 








without antimycin A (negative) were compared for the ratio of spectral counts in positive 
versus negative sample. (B) The range of spectral count for all proteins identified in LC-
MS/MS. All spectral counts are the average of at least triplicate experiments of identical 
conditions.   
 
Confirming the identity and reversibility of individual protein glutathionylation 
events.  
In order to validate the mass spectrometry data, a further confirmation of the 
identity of several glutathionylated proteins was assayed by pull-down and western blot 
analysis. Glutathionylated proteins were enrichment on streptavidin-agarose beads, and 
probed with various antibodies. A time-dependent increase of glutathionylation was 
observed for a number of individual proteins (Figure 4-7, A). Glutathionylation of heat 
shock protein 90 (Hsp90), actin, catalase, and SMYD2 was clearly observed within 1 h. 
On the other hand, glutathionylation became obvious within 2 h for protein tyrosine 
phosphatase 1B (PTP1B), Src-homology phosphatase 2 (SHP2), AMP-activated kinase 
(AMPK), and protein phosphatase 2cα (PP2cα) (Figure 4-7, B). This time-dependent 
glutathionylation may result from different protein abundances or redox-sensitivity of 
individual protein cysteine residues. Analysis of the reversibility of glutathionylation for 
several selected proteins was demonstrated upon addition of pyruvate to the cell media. 
Deglutathionylation of PTP1B, AMPK, PP2Cα, and catalase was readily observed within 
1 h, while actin glutathionylation was less significantly reduced under identical condition 
(Figure 4-7, B). This data confirmed not only glutathionylated proteins identified by mass 
! 143!
spectrometry analysis, as well as the time-dependent reversibility of glutathionylation for 
individual proteins in response to redox disturbance or glucose metabolism.  
 
Figure 4-7. Determination of glutathionylated proteins by pull-down and Western 
blotting. After incubation of azido-Ala to HEK293/GS M4 cells for 20 h, cells were 
subjected to glucose starvation with antimycin A in a time-dependent manner (A), or 
pyruvate was added to cells after glucose starvation with antimycin A for 2 h (B). After 
click chemistry with biotin-alkyne, the individual proteins were probed by specific 
antibodies before and after pull-down by streptavidin-agarose.  
 
Conclusion 
Glutathione is a major cellular thiol for redox homeostasis. Protein 
glutathionylation is thought to increase during cellular redox disturbances, and is 
considered a marker of oxidative stress. However, global and individual protein 
glutathionylation in response to glucose metabolism and mitochondrial ROS level has not 
been examined previously. A clickable glutathione approach demonstrates that protein 
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glutathionylation is readily induced in response to glucose starvation when mitochondrial 
reactive oxygen species (mROS) are elevated in cells. 
This work demonstrates the use of a proteomic mass spectrometry platform to 
determining the identity and reversibility of glutathionylated proteins in response to 
glucose metabolism. Proteomic analysis identified over 1,300 glutathionylated proteins 
including SMYD2, PP2Cα, and catalase. These proteins are involved in various cellular 
processes (Figure 4-5). Further analysis showed that many of identified proteins 
overlappped with proteins previously reported to be glutathionylated, and additionally 
overlapped with known sulfenylation events induced by addition of exogenous hydrogen 
peroxide, suggesting the fundamental redox-sensitivity for proteins under different 
stimulus. Confirmation of glutathionylation for selected proteins by in gel analysis further 
validated the mass spectrometry results, and highlights the dynamic change of 
glutathionylation on an individual protein level. Our findings highlight the ability of the 
proteomic mass spectrometry approaches to dissect complex cellular glutathionylation 
and suggest that application of this approach could yield important insights into the 
underlying mechanism of cysteine posttranslational modification in cellular function. 
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Reagents and general procedures.  
All materials were purchased from Sigma Aldrich (Milwaukee, WI) unless 
otherwise noted. Streptavidin-agarose beads were purchased from Thermo Scientific 
(Armarillo, TX). QuikChange. 
 
LC/LC-MS/MS analysis of glutathionylated protein 
After protein enrichment on streptavidin-agarose beads, the beads were pelleted 
and washed twice in DPBS. After resuspending in 50 µL 6 M urea/PBS, the beads were 
incubated at room temperature for 1 hr. 100 µL DPBS was then added to dilute the urea 
to a final concentration of 2 M. On-bead trypsin digestion was performed overnight at 37 
°C with sequencing-grade trypsin (2 µg; Promega) and 1 mM CaCl2 (100 mM stock in 
water). The peptide digests were centrifuged and the supernatant collected. The beads 
were washed twice with water (2 × 75 µL). All supernatants and washes were combined 
and acidified with 15 µL formic acid. The samples were stored at -20 °C until mass 
spectrometry analysis.  
LC/LC-MS/MS analysis was performed on an Agilent 1200 series HPLC coupled 
to an LTQ-Orbitrap Discovery mass spectrometer (ThermoFisher). Peptide digests were 
pressure loaded onto a 250 µm fused silica desalting column packed with 4 cm of Aqua 
C18 reverse-phase resin (Phenomenex). The peptides were eluted onto a biphasic column 
(100 µm fused silica with a 5 µm tip, packed with 10 cm Aqua C18 reverse-phase resin 
(Phenomenex) and 3 cm Partisphere strong-cation-exchange resin (SCX, Whatman) using 
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a gradient 5-100% Buffer B in Buffer A (Buffer A: 95% water, 5% acetonitrile, 0.1% 
formic acid; Buffer B: 20% water, 80% acetonitrile, 0.1% formic acid). The peptides 
were then eluted from the SCX onto the C18 resin and into the mass spectrometer using 
four salt steps as previously described 14, 15. The flow rate through the column was set to 
~0.25 µL/min and the spray voltage was set to 2.75 kV. One full MS scan (FTMS) (400-
1800 m/z) was followed by 8 data dependent scans (ITMS) of the nth most intense ions 
with dynamic exclusion enabled. 
 
Mass-spectrometry data analyses.  
The generated tandem MS data was searched using the SEQUEST algorithm 
against the human UniProt database. A static modification of +57.02146 on cysteine was 
specified to account for iodoacetamide alkylation. SEQUEST output files were filtered 
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Highly conserved within proteins (typically above 90%), the chemical and 
physical properties of cysteine make it one of the most functionally versatile amino acids. 
Functional cysteines can be found on a diverse array of protein families, ranging from 
oxidoreductases, to proteases and protein kinases. Functional cysteine residues tend to be 
located in protein microenvironments that perturbs their pKa and makes them somewhat 
more nucleophilic then surface-exposed non-functional cysteines within the proteome.1 
This increased nucleophilicity of the thiol side chain can be exploited in the development 
of covalent inhibitors.2 This is particularly useful in the field of protein kinases, a large 
number of which contain a reactive cysteine residue within the ATP-binding pocket. 
These cysteine residues serve important regulatory roles in a variety of cellular 
functions,3 and its reactivity has be explored by the pharmaceutical industry, resulting in 
the development of several clinically relevant drugs. In particular, covalent cysteine-
reactive inhibitors of the protein kinase EGFR are currently in clinical trials (HKI-272, 
CI-1033, EKB-569, and PF-00299804) for the treatment of lung and colon cancer. 
Additionally, Afatinib has been approved in the U.S. as a first-line treatment for 
metastatic non-small cell lung carcinoma.4, 5 These inhibitors are distinguished by the 
presence of electrophilic Michael acceptors within their scaffold, covalently reacting with 
the cysteine residue of the target kinase through an irreversible inhibition mechanism. 
In order to expand on the understanding of the functional role of the cysteine 
residues in biological systems, our lab has developed libraries of covalent small molecule 
probes to target diverse cysteine-mediated protein activities. Unlike small molecule 
libraries screened by typical chemical genetic approaches, all of our small molecules 
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were specifically designed to react covalently with functional cysteine residues. 
Downstream target identification was facilitated by incorporation of a small bio-
orthogonal alkyne handle within the small molecule probe to be used for copper-
catalyzed azide-alkyne cycloaddition (CuAAC), 6, 7 to incorporate reporter tags. 
  
Figure 5-1. 1,3,5-triazines and 4-aminopiperidine scaffolds were utilized to generate 
cysteine-reactive small-molecule libraries. Each scaffold was functionalized with a 
cysteine-reactive electrophile (R1), an alkyne handle (R2) and a diversity element (R3). 
Structures of R1, R2 and R3 groups for a number of the compounds evaluated in this study 
are shown.  
 
A library of small molecule probes based on 1,3,5-triazine as the central scaffold 
allows the incorporation of three different functionalities around the triazine ring (Figure 






R1 = cysteine reactive electrophile
R2 = alkyne handle






































(CA), chloronitrobenzyl (CNB) or acrylamide (Acr) reactive groups) to covalently 
modify a target cysteine residue, a terminal bio-orthogonal alkyne handle for CuAAC in 
order to append different reporter groups for downstream analysis, and a diversity 
element to help direct the small molecule probe towards different subsets of the 
proteome. Importantly, modification of either the diversity element or the electrophile in 
the triazine scaffold can modulate the protein targets of this small-molecule library. Gel-
based screening9 of this panel of compounds, combined with Multi-dimensional Protein 
Identification Technology (MudPIT) mass-spectrometry workflow,10 allowed for the 
identification of diverse protein targets, including highly selective covalent modifiers for 
cysteine 239 of β–tublin and cysteine 53 of protein disulfide isomerase (PDI) 
respectively. To circumvent the rigidity of the triazine scaffold, development of a second 
covalent probe library utilizing a 4-aminopiperidine scaffold allowed for increased 
conformational flexibility (Figure 5-1).11 Evaluation of this panel of compounds 
identified activity-dependent small-molecule probes for Glutathione S-transferase Omega 
1 (GSTO1) and the protein kinase Akt1. The successful application of cysteine-reactive 
covalent modifier libraries along with their target identification highlights their promising 
use in the development of site-selective small molecule probes for diverse proteins. 
 
First, we aimed to target 3-hydroxyacyl-CoA dehydrogenase (HADH2), a 
mitochondrial multifunctional protein involved in fatty acid synthesis and the oxidation 
of several neuroactive steroids and sex hormones.12-14 Previously we identified cysteine 
58 of HADH2, an uncharacterized cysteine residue located distal to the active site, as 
highly sensitivity to GSNO transnitrosation. In vitro studies demonstrated that 
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transnitrosation of this cysteine residue inhibited HADH2 dehydrogenation activity, 
highlighting the functional role of cysteine 58 as an allosteric regulator of HADH2. To 
further investigate the role of HADH2 cysteine 58, we sought to identify a selective 
covalent probe for this cysteine by screening our small-molecule libraries. 
The second protein we were interested in is ASK1, as it is involved in the 
mitogen-activated protein kinase (MAPK) pathway. The MAPK pathway is an 
intracellular signaling system, regulating various cellular functions including cell 
survival, proliferation, differentiation, apoptosis, and response to cellular stress. The 
MAPK pathway consists of a kinase cascade of three classes of protein kinases: MAPK 
kinase kinase (MAP3K), MAPK kinase (MAP2K), and MAPK. MAP2K is 
phosphorylated and activated by MAP3K, and in turn phosphorylates and activates 
MAPK. These MAPKs are the most extensively studied kinases.15 Specifically, MAP3Ks 
control the activation status of the signaling pathway, and thus are important for the 
regulation of downstream cellular responses. Apoptosis signal-regulating kinase 1 
(ASK1), a MAP3K, is activated in response to various types of physiological and 
pathological stimuli, including growth factors, pro-inflammatory cytokines, and ER and 
oxidative stress (ROS).16-18 As a result, downstream MAPKs, like stress-activated kinases 
p38 and c-Jun N-terminal kinase (JNK), responds to cellular stress by regulating 
apoptosis, inflammation, and proliferation through the phosphorylation of various targets. 
Thus, the dysregulation and excessive activation of ASK1 are closely related to various 
disease states such as cancer, diabetes, cardiovascular and neurodegenerative diseases.19-
21  
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ASK1 homooligomerizes through its C-terminal coiled-coil domain and forms a 
high molecular mass complex called the signalosome (154.5 kDa). It includes a redox-
sensitive protein, Thioredoxin 1 (Trx1), whose reduced form binds to the N-terminal 
domain of ASK1 and inhibits its kinase activity. Oxidative stimuli, like H2O2, activate 
ASK1 by oxidizing Trx1, and promoting its dissociation from the ASK1 signalosome. 
This allows ASK1 to tightly oligomerize through its N-terminal coiled-coil domain, 
leading to autophosphorylation of threonine 854 and full activation. Studies showed that 
an oligomerization step after treatment is crucial to ASK activation22. This was supported 
by a more recent study demonstrating that a H2O2-induced intermolecular disulfide bond 
between two cysteines in ASK1 molecules was involved in ASK1 oligomerization. This 
oxidation step was independent of ASK1 autophosphorylation, both of which were 
required for signal transaction.23 Moreover, a detailed study revealed that in unstressed 
cells, Trx1 covalently binds to cysteine 250 on ASK1. Stimulation by H2O2 induces the 
active ASK1 sigalosome formation by autophosphorylation and simultaneously Trx1 
dissociation from cysteine 250 as well as increased covalent interaction between Trx1 
and cysteine 22 and 30 on ASK1. This study also suggested two different thiol reductase 
activities of Trx1 on ASK1, by transient reduction of the ASK1 intermolecular disulfide 
and by reduction of cysteine 22, 30 and 250 on ASK1.24 These studies highlight the role 
of ASK1, besides its kinase activity, as an effective Trx oxidation sensor. The cysteine-
dependent regulation of ASK1 renders it a possible cysteine-reactive small molecule 
target in order to modulate its function. Mace et al. has recombinantly purified and 
crystalized ASK1-28 (amino acid sequence from 88 to 658), a truncated version of ASK1 
containing the N-terminal region where the Trx1-binding/redox active center is located. 
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In this study, we screened purified ASK1-28 against our cysteine-selective small 
molecule libraries to identify possible cysteine-reactive probes to functionally regulate 
ASK1.   
The last protein we explored is Peroxiredoxin1 (Prdx1). In cells, H2O2 can be 
efficiently scavenged by peroxiredoxins. Existing as a dimer, a typical 2-cys Prdx has 
two critical cysteine residues per monomer; the peroxidatic cysteine and the resolving 
cysteine. Upon interaction with H2O2, the peroxidatic cysteine is oxidized to a sulfenic 
acid derivative, followed by the formation of an intermolecular disulfide with the 
resolving cysteine of the other monomer to release hydroxide. This disulfide bond is 
reduced by the thioredoxin–thioredoxin reductase (Trx/TrxR) system using electrons 
from NADPH.25 In contrast, Prdx1 is an atypical 1-cys Prdx in that it conserves only the 
peroxidatic cysteine but not the resolving cysteine. Prdx1 is a small protein (22 kDa) with 
four total cysteine residues (52, 71, 83 and 173). Cysteine 52 is the redox-active site. Its 
cysteine sulfenic acid, generated on reaction with H2O2, is presumably reduced by a thiol-
containing electron donor, the identity of which is still unknown.26 Nevertheless, recent 
studies on role of Prdx1 in regulating the ASK1/p38 pathway revealed that upon 
treatment, oxidized Prdx1 could activate ASK1 via a transient formation of an 
intermolecular disulfide intermediate between Prdx1 and ASK1, followed by resolving 
and transferring the disulfide to an ASK1 protein substrate. This resulted in activation of 
downstream p38 phosphorylation. Oxidized ASK1 is subsequently reduced by the 
Trx/TrxR system.27 The presence of Prdx1 in a disulfide bond transferring cascade 




Identification of a cysteine-reactive chemical probe for ASK1-28, Prdx1, and 
HADH2  
To identify cysteine reactive probes that covalently bind to ASK1-28, Prdx1 and 
HADH2, we initially screened 1,3,5-trizine-based and 4-aminopiperidine-based probe 
libraries against purified ASK1-28 and Prdx1 protein obtained from Mace lab (University 
of Otago), and recombinantly overexpressed and purified HADH2 wild type (WT) and 
C58S mutant. Protein samples were treated with each of the probes from the library, 
followed by CuAAC to append a fluorescent Rhodamine-azide (Rh–N3) tag for 
subsequent visualization by in-gel fluorescence (Figure 5-2).  Using iodoacetamide 
alkyne (IA probe, Figure 5-4, C) as a control, ten probes from our library showed 
covalent modification of each of the proteins (Figure 5-1, R3 groups). Analysis of gel 
band intensity indicated that, relative to iodoacetamide alkyne, RB-11-CA and SMC-1, 
both of which contain an n-octyl diversity element, showed the greatest selectivity and 
potency to ASK1 and Prdx1 respectively (Figure 5-3).  
RB-21-CA (adamantine R3 diversity element) demonstrated a concentration-
dependent labeling of HADH2 WT across the small-molecule probe library (Figure 5-4 
A, C). Kinetic studies of RB-21-CA on HADH WT activity indicated an IC50 of ~ 20.5 
µM (Figure 5-4, B). However, a C58S mutant, which diminished the covalent interaction 
between the cysteine and RB-21-CA, showed no labeling, confirming that covalent 
modification of HADH2 by RB-21-CA occurs at cysteine 58. Interestingly, an IA labeled 
C58A mutant showed a concentration-dependent increase in labeling greater than that of 
the C58S mutant (Figure 5-4, D) This change in labeling pattern is possibly the result of 
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the cysteine to alanine mutation inducing a larger conformational change then that of 
cysteine to serine mutation, which could result in alternate cysteine residues available to 
interact with the IA probe.  
Figure 5-2. In-gel fluorescence and MS proteomic analysis for target identification of 
Prdx1 and ASK1-28. Small molecule treated proteins were appended to a fluorescent Rh–
N3 tag by click chemistry and subsequently visualized by in-gel fluorescence. 
Alternatively, Small molecule treated proteins were digested by trypsin and labeled 



















Figure 5-3. In-gel fluorescence analysis of small molecule labeling of ASK1-28 and 
Prdx1. (A) Prdx1 and ASK1 treated by small molecules were resolved by fluorescent gel 
using IA probe as labeling control. (B) Band intensity relative to IA probe treatment was 
calculated. (C) Structure of RB-11-CA and SMC-1 that demonstrated greatest labeling 
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Figure 5-4. Modification of HADH2 cysteine 58 by RB-21-CA and IA probe. (A) RB-
21-CA labeled HADH WT in a concentration-dependent manner. This labeling 
diminished for the C58S mutant. (B) Kinetic study of RB-21-CA on HADH2 WT with 
IC50 of 20.47 µM. (C) Structure of RB-21-CA and IA probe. (D) IA probe labeling events 
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Table 5-1.  LC-MS/MS identification of small molecule cysteine targets. (A) Cysteine 
173 of Prdx1 is the target of SMC-1. (B) Cysteine 225 of ASK1-28 is the target of RB-
11-CA. Spectral counts of the small molecule treated sample is significantly higher than 
that of DMSO control. 
 
LC-MS/MS analysis to identify the cysteine targets on ASK1-28 and Prdx1 
To identify the sites of probe labeling, RB-11-CA-labeled ASK1-28 and SMC-1-
labeled Prdx1 were precipitated and concentrated by standard trichloroacetic acid 
precipitation (TCA) and digested to peptides by trypsin. LC–MS/MS analysis was then 
performed using a targeted mass list generated by prediction of the entire potential 






































the small molecule treated samples were compared to DMSO treated control by mass 
spectrometry. This analysis enabled us to identify cysteine 173 of Prdx1 as the target of 
SMC-1 and cysteine 225 of ASK1-28 as the target of RB-11-CA, because high spectral 
counts were observed in probe treated samples (Spectral counts: the total number of 
fragmentation spectra found to correspond to peptides from a protein), while low spectral 
counts were seen in the DMSO-treated samples (Table 5-1). This confirms that RB-11-




Here we screened purified ASK1-28, Prdx1 and HADH2 against 1,3,5-triazine 
and 4-aminopiperidine scaffold based cysteine reactive small molecule libraries. In-gel 
fluorescence revealed that RB-11-CA and SMC-1, both of which contain an n-octyl 
group as a diversity element, showed greatest selectivity and potency to ASK1 and 
Prdx1, respectively. LC-MS/MS analysis further identified cysteine 225 of ASK1-28 and 
cysteine 173 of Prdx1 as the sites of covalent probe modification. Another small 
molecule, RB-21-CA with an adamantine moiety as a diversity element, demonstrated 
extensive concentration-dependent labeling on HADH2 WT with an IC50 ~ 20.5 µM. 
However, a C58S mutant diminished this labeling to a large extent, further confirming 
that covalent modification of HADH2 by RB-21-CA occurs at cysteine 58. Interestingly, 
a HADH2 C58A mutant showed a concentration-dependent increase in labeling 
compared to the C58S mutant when labeled with an IA probe, which demonstrates the 
intrinsic similarity of serine and cysteine residues.  
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Further LC-MS/MS analysis is needed to confirm that RB-21-CA is targeting 
cysteine 58 of HADH2. Systematic analysis of RB-21-CA inhibition on HADH2 by 
kinetic studies would facilitate revealing the effect of RB-21-CA on protein function and 
its relation to the regulation of protein function by S-nitrosation. Furthermore, cysteine 
225 of ASK1-28 is close to cysteine 250, which forms a disulfide bond with Trx1 in its 
inactive state23. Investigation of RB-21-CA modulation of cysteine 225 would shed light 
on the regulatory role of this cysteine residue on ASK1-28 function. Prdx1 activates 
ASK1 and its downstream target p38 by forming an inter-molecular disulfide 
intermediate with ASK1-28. A detailed study of SMC-1 on cysteine 173 of Prdx1 would 
reveal the role of cysteine 173 on the protein function and its relation to the ASK1 and 




I would like to acknowledge Professor Peter Mace (University of Otago, New 
Zealand) for providing purified ASK1-28 and Prdx1 proteins. Special thanks to Dr. Alex 
Shannon and Dr. Dan Bak for their continued help maintaining the Orbitrap mass 




Reagents and general procedures.  
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All materials were purchased from Sigma Aldrich (Milwaukee, WI) unless 
otherwise noted. Protein concentrations were determined using a Bio-Rad DC protein 
assay or Bradford Protein Concentration assay from Bio-Rad Life Science (Hercules, 
CA) or a bicinchoninic acid (BCA) assay from Pierce. QuikChange Site-Directed 
Mutagenesis Kit was purchased from Agilent Technologies (Santa Clara, CA).  
 
HADH2 subcloning.  
HADH2 cDNA were subcloned into a pET23a-T7/His bacterial expression vector. 
Site-directed mutagenesis was performed to obtain cysteine to serine or cysteine to 
alanine mutants using the Quikchange procedure (Agilent, Santa Clara, CA) with the 
appropriate primers (Appendix I, Table 2A-4). All constructs were verified by DNA 
sequencing (Genewiz, Cambridge, MA or La Jolla, CA). 
 
HADH2 expression and purification.  
HADH2 (WT, C58S, or C58A) was expressed in Escherichia coli BL21 (DE3) 
cells. Cells were inoculated in 5 mL LB medium containing 100 µM Ampicillin at 37 °C 
overnight. The overnight culture was added to 500 mL LB or 1 L 2×YT medium 
containing 100 µM ampicillin and allowed to grow at 37 °C until OD600 ~ 0.6-0.8. 
Expression was then induced by the addition of 1 mM IPTG for 4 hr at 30 °C. Cells were 
harvested and lysed in PBS (for gel analysis) or 20 mM Tris pH 8.0 at 4 °C with 200 mM 
NaCl (for kinetic analysis). The expressed fusion protein was purified using a Ni-NTA 
packed chromatography column. After loading the cell lysate onto the column, the Ni-
NTA resin was washed with 50 mM imidazole in PBS or 10 mM imidazole in 20 mM 
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Tris pH 8.0 at 4 °C with 200 mM NaCl and HADH2 was eluted with 500 mM imidazole 
in PBS or 300 mM imidazole in 20 mM Tris pH 8.0 at 4 °C with 200 mM NaCl. Protein 
purity was then assessed on a silver stained 10% SDS-PAGE gel. Excess imidazole was 
removed by use of a Nap-5 column and the purified protein was eluted in 20 mM 
potassium phosphate, pH 7.4, with 5% v/v glycerol and 5 mM β-mercaptoethanol, and 
stored at -80 °C 29. Alternatively, the purified protein was dialyzed against 20 mM Tris 
pH 8.0 at 4 °C with 200 mM NaCl, 10% v/v glycerol, and 1 mM TCEP.  
 
Small molecule screening of cysteine reactive probes  
Purified Prdx1 or Ask1-28 was aliquoted to 4 ng /25 µL in DPBS. Each sample 
was treated with 0.5 µL of a 12.5 µM stock of cysteine reactive probe (50X stock in 
DMSO, 250 nM as final concentration) for 1 hr at room temperature. Purified HADH2 
(WT, C58A and C58S) was was aliquoted to 5 µM /50 µL in DPBS. Each sample was 
treated with 1 µL a 12.5 µM stock of cysteine reactive probe (50X stock in DMSO) for 1 
hr at room temperature. Click chemistry was then performed with the addition of 
Rhodamine-azide (25 µM, 1.25 mM stock in DMSO), tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) (1 mM, fresh 50 mM stock in water), tris[(1-benzyl-1H-1,2,3-
triazol-4-yl)methyl]amine (TBTA ligand) (100 µM, 17× stock in DMSO:t-Butanol 1:4) 
and CuSO4 (1 mM, 50 mM stock in water). Samples were allowed to react at room 
temperature for 1 hr. SDS-PAGE loading buffer 2x (reducing, 25 µL) was added to the 
samples and 25 µL of labeled protein sample was separated by 10% SDS-PAGE under 
100 volts for 2 hrs. Gels were visualized on a Hitachi FMBIO II multiview flatbed laser-
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induced fluorescent scanner. After analysis, gels were Coomassie or silver stained. 
Stained gel was visualized on a ChemiDoc MP Imaging System (BioRad). 
 
HADH2 activity assays.  
The purified HADH2 enzyme was assayed as described previously 30, where 
HADH2 activity was measured spectrophotometrically by monitoring the decrease in 
absorbance at 340 nm due to NADH oxidation. Purified HADH2 (WT C58A, or C58S) in 
20 mM potassium phosphate, pH 7.4, with 5% v/v glycerol and 5 mM β-
mercaptoethanol, was pre-incubated in a mixture of 100 mM potassium phosphate (pH 
7), vary concentration of cysteine-reactive small molecule in DMSO and 100 µM NADH 
at room temperature for 30 min, using DMSO without small molecule as control reaction. 
The kinetic assay was initiated by the addition of varying concentrations of acetoacetyl-
CoA (up to 100 µM). The reaction was carried out at 30 °C and the absorbance at 340 nm 
was measured using a Molecular Devices Spectramax M5 plate reader. Relative activity 
was determined as the slope of the absorbance vs. time curve within the linear range.  
 
Mass-spectrometry analysis to identify small molecule targets 
Peptide sample preparation  
Purified Prdx1 or Ask1-28 was aliquoted to 33.5 µg /50 µL in DPBS. Each 
sample was treated with either 1 µL DMSO as a control, or 1 µL of 500 µM small 
molecule (50X stock in DMSO, 10 µM as final concentration) for 1 hr at room 
temperature. TCA protein precipitation of each small molecule labeled protein sample 
was performed in order to get proteins out of buffer and concentrate them. Specifically, 5 
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µL of freshly made 100% (w/v) trichloroacetic acid (TCA) was added to each protein 
sample, vortex and stored overnight, frozen at -80°C. Thawed samples were pelleted 
down by centrifuging for 10 minutes at top speed (15,000 rpm) at 4 °C. Supernatant was 
removed carefully in order not to disturb the pellet. Pellets were then washed by addition 
of 500 µL ice-cold acetone, re-suspended by sonication, centrifuging 10 minutes at top 
speed (15,000 rpm) at 4 °C and the supernatant carefully removed. The pellets were air 
dried and re-suspended in 30 µL of 8 M urea/DPBS by sonication. 70 µL of 100 mM 
ammonium bicarbonate was added to get a final volume of 100 µL. After addition of 1.5 
µL 1M DTT, the mixture was incubated at 65 °C for 15 mins. Then 2.5 µL of 500 mM 
iodoacetamide was added and incubated at room temperature for 30 mins. After dilution 
with 120 µL of DPBS, the sample was trypsin digested with the addition of 4 µL of 
trypsin in buffer and 2.5 µL of 100mM CaCl2, and incubated at 37 °C overnight. The 
trypsin was quenched with 10 µL of formic acid. Sample was pelleted by centrifugation 
at 15,000 rpm for 20 mins. After removing the supernatant, the samples were stored at -
20 °C until mass spectrometry analysis. 
 
Liquid chromatography-mass spectrometry (LC-MS/MS) analysis  
LC-MS/MS mass spectrometry was performed using a Thermo LTQ Orbitrap 
Discovery mass spectrometer coupled to an Agilent 1200 series HPLC. Labeled peptide 
samples were pressure loaded onto 250 um fused silica desalting column packed with 4 
cm of Aqua C18 reverse phase resin (Phenomenex). Peptides were eluted onto a 100 um 
fused silica biphasic column packed with 10 cm C18 resin and 4 cm Partisphere strong 
cation exchange resin (SCX, Whatman), using a five step multidimensional LC-MS 
! 167!
protocol (MudPIT) . Each of the five steps used a salt push (0%, 50%, 80%, 100%, and 
100%), followed by a gradient of 5-100% buffer B in Buffer A (Buffer A: 95% water, 5% 
acetonitrile, 0.1% formic acid; Buffer B: 20% water, 80% acetonitrile, 0.1% formic acid). 
The flow rate through the column was ~0.25 uL/min, with a spray voltage of 2.75 kV. 
One full MS1 scan (400-1800 MW) was followed by 8 data dependent scans of the nth 
most intense ion from the supplied mass list or if no more present, the nth most intense 
ions otherwise. For each purified protein, a targeted mass list generated by prediction of 
the entire potential cysteine-containing tryptic peptides, was used. Dynamic exclusion 
was disabled, while monoisotopic precursor selection was enabled.   
 
Mass-spectrometry data analyses. 
The tandem MS data, generated from the 5 MudPIT runs, was analyzed by the 
SEQUEST algorithm. Static modification of cysteine residues (+57.0215 m/z, 
iodoacetamide alkylation) was assumed with no enzyme specificity. The precursor-ion 
mass tolerance was set at 50 ppm while the fragment-ion mass tolerance was set to 0 
(default setting). Data was searched using a human reverse-concatenated non-redundant 
FASTA database. Datasets were independently searched with potential small molecule 
tagging parameter files; for these searches dynamic modifications on cysteine of 
+421.2764 (SMC-1 modification on Prdx1) or +462.27635 (RB-11-CA modification on 
ASK1-28) were used to account for small molecule modifications. MS2 spectra matches 
were assembled into protein identifications and filtered using DTASelect with the –
trypstat (different statistical models for tryptic, half-tryptic, and non-tryptic peptides) and 
–modstat options applied. Redundant peptides identifications from multiple proteins were 
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Table 2A-1. R-values from transnitrosation experiment at 500 µM GSNO. A list of all 
identified peptides (* denotes labeled cysteine) is presented together with calculated 
Heavy:Light Ratios (R-values) in untreated (0 µM) (n=2) versus GSNO-treated (500 µM) 
(n=5) MS analysis. Two replicates of control and five replicates of GSNO-treated 
experiments were performed. Date were sorted by their average R-values of GSNO-
treated experiments and numbered as “Peptide #”. P values, cysteine position, its 
conservation across six species and conservation ratio, and cellular location of protein 
that contains each cysteine are listed. Cysteines with high sensitivity to GSNO are 
highlighted in grey. 
176
1 2 average
1 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2 VGLIGSC*TNSSYEDMGR 0.9 1.0 0.9
2 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH IISNASC*TTNCLAPLAK 0.9 0.9 0.9
3 P13674 P4HA1 Prolyl 4-hydroxylase subunit alpha-1 P4HA1 PC*TLSELE 0.9 1.0 1.0
4 P43034 PAFAH1B1 Platelet-activating factor acetylhydrolase IB subunit alpha PAFAH1B1 PNQDGTLIASC*SNDQTVR 1.0 0.9 0.9
5 Q9H479 FN3K Fructosamine-3-kinase FN3K AFGGPGAGC*ISEGR 1.1 1.1 1.1
6 Q9BSD7 NTPCR Cancer-related nucleoside-triphosphatase NTPCR NADC*SSGPGQR 0.9 0.9 0.9
7 P07339 CTSD Cathepsin D CTSD AIGAVPLIQGEYMIPC*EK 0.8 0.9 0.9
8 Q01813 PFKP 6-phosphofructokinase type C PFKP LPLMEC*VQMTQDVQK 0.9 1.0 0.9
9 P07437 TUBB Tubulin beta chain TUBB LTTPTYGDLNHLVSATMSGVTTC*LR 1.0 1.0 1.0
10 Q06210
GFPT1 Glucosamine--fructose-6-
phosphate aminotransferase [isomerizing] 
1
GFPT1 C*QNALQQVVAR 1.0 1.0 1.0
11 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 VMTIPYQPMPASSPVIC*AGGQDR 1.0 1.0 1.0
12 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 IAC*LDFSLQK 0.9 1.1 1.0
13 Q04726 TLE3 Transducin-like enhancer protein 3 TLE3 SPISQLDC*LNR 1.0 1.0 1.0
14 Q02252
ALDH6A1 Methylmalonate-
semialdehyde dehydrogenase [acylating], 
mitochondrial
ALDH6A1 C*MALSTAVLVGEAK 0.9 1.0 1.0
15 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2
QC*PIMDPAWEAPEGVPID
AIIFGGR 0.8 1.1 1.0
16 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2-like 1 GNB2L1 VWNLANC*K 1.0 1.1 1.0
17 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A AYHEQLSVAEITNAC*FEPANQMVK 1.0 1.0 1.0
18 O00244 ATOX1 Copper transport protein ATOX1 ATOX1 VC*IESEHSMDTLLATLK 1.0 1.1 1.0
19 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 TSAPITC*ELLNK 0.9 0.9 0.9
20 P49207 RPL34 60S ribosomal protein L34 RPL34 AYGGSMC*AK 0.9 1.1 1.0
21 P31749 AKT1 RAC-alpha serine/threonine-protein kinase AKT1
TFC*GTPEYLAPEVLEDND
YGR 1.0 1.0 1.0
22 P09622 DLD Dihydrolipoyl dehydrogenase, mitochondrial DLD NETLGGTC*LNVGC*IPSK 0.9 0.9 0.9
23 P04183 TK1 Thymidine kinase, cytosolic TK1 NTMEALPAC*LLR 0.9 0.9 0.9
24 Q92947 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GCDH GYGC*AGVSSVAYGLLAR 0.9 1.0 0.9
25 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A AVC*MLSNTTAIAEAWAR 0.9 1.0 0.9
26 P62140 PPP1CB Serine/threonine-protein phosphatase PP1-beta catalytic subunit PPP1CB IC*GDIHGQYTDLLR 1.1 1.0 1.0




Uniprot # Description Symbol Sequence
Heavy : Light Ratio
0 µM GSNO
177











5.5 5.1 6.8 10.7 5.3 6.7 ***  Mitochondrion {ECO 385 Yes Yes Yes Yes Yes Yes 100.0
5.4 4.8 4.2 5.0 5.1 4.9 ***  Cytoplasm, cytosol {ECO 152 Yes Yes Yes Yes Yes Yes 100.0
5.0 4.0 4.4 5.9 4.2 4.7 ***  Endoplasmic reticulum lumen. 528 Yes Yes Yes -- -- Yes 100.0
4.9 4.4 3.4 3.8 4.2 4.1 ***






252 Yes Yes Yes No No No 50.0
10.8 1.4 5.0 1.8 1.3 4.1 *** 24 Yes Yes -- -- Yes -- 100.0
3.6 3.5 3.9 4.7 4.1 3.9 *** 101 Yes No No -- No -- 25.0
3.4 3.2 4.0 4.7 3.7 3.8 ***
 Lysosome. Melanosome. 
Secreted, extracellular 
space.
329 Yes Yes Yes Yes -- Yes 100.0
3.9 3.5 3.4 4.0 3.7 3.7 ***  Cytoplasm {ECO 360 Yes Yes Yes No -- Yes 80.0
3.8 3.5 3.5 4.0 3.6 3.7 ***  Cytoplasm, cytoskeleton. 239 Yes Yes Yes No Yes Yes 83.3
4.2 3.0 3.4 4.3 2.8 3.5 *** 620 Yes Yes Yes No No No 50.0
3.2 3.2 3.4 3.9 3.4 3.4 ***  Nucleus. Cytoplasm. 194 Yes Yes No No No -- 40.0
3.8 2.9 3.4 3.5 3.2 3.4 ***




236 Yes Yes Yes Yes Yes Yes 100.0
4.6 3.4 2.3 2.9 3.5 3.3 ***  Nucleus. 528 Yes Yes Yes -- No Yes 80.0
3.0 3.2 2.8 4.2 3.4 3.3 ***  Mitochondrion. 317 Yes Yes Yes Yes Yes Yes 100.0
3.5 3.1 3.1 3.7 3.2 3.3 ***  Mitochondrion. 431 Yes Yes Yes -- -- Yes 100.0
3.0 4.1 2.6 3.3 3.5 3.3 ***  Cell membrane {ECO 182 Yes Yes Yes No Yes Yes 83.3
3.3 3.0 3.1 3.5 3.3 3.2 ***  Cytoplasm, cytoskeleton. 295 Yes Yes Yes Yes No Yes 83.3
2.8 3.1 3.6 3.1 3.5 3.2 *** 41 Yes Yes No No No No 33.3
3.8 3.3 2.4 3.3 3.3 3.2 ***  Cytoplasm, cytoskeleton. 1999 Yes Yes No No -- No 40.0
2.5 2.3 2.5 6.0 2.3 3.1 *** 83 Yes Yes Yes Yes No No 66.7
3.6 2.9 2.9 3.2 2.9 3.1 ***
 Cytoplasm. Nucleus. Cell 
membrane. tracellular 
vesicles (PubMed
310 Yes Yes Yes Yes Yes Yes 100.0
3.0 3.5 3.4 1.8 3.7 3.1 ***  Mitochondrion matrix. 80 Yes Yes Yes Yes Yes Yes 100.0
85 Yes Yes Yes Yes Yes Yes 100.0
3.0 2.4 3.0 3.7 3.1 3.0 ***  Cytoplasm. 79 Yes Yes -- -- No No 50.0
2.5 3.4 2.9 3.2 3.1 3.0 ***  Mitochondrion matrix. 115 Yes Yes Yes -- Yes Yes 100.0
3.0 2.9 2.8 3.3 3.0 3.0 ***  Cytoplasm, cytoskeleton. 376 Yes Yes Yes Yes Yes Yes 100.0
3.2 1.5 3.0 3.6 3.5 3.0 ***  Cytoplasm {ECO 61 Yes Yes Yes Yes Yes Yes 100.0
2.9 2.6 3.0 3.7 2.8 3.0 ***  Mitochondrion {ECO 58 Yes Yes No No No No 33.3















28 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 GC*DVVVIPAGVPR 0.9 0.9 0.9
29 P04183 TK1 Thymidine kinase, cytosolic TK1 YSSSFC*THDR 1.0 1.0 1.0
30 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 VDVAVNC*AGIAVASK 1.0 1.1 1.1
31 P49411 TUFM Elongation factor Tu, mitochondrial TUFM
NMITGTAPLDGC*ILVVAA
NDGPMPQTR 0.9 1.0 1.0
32 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2-like 1 GNB2L1
AEPPQC*TSLAWSADGQTL
FAGYTDNLVR 1.0 0.9 0.9
33 P07437 TUBB Tubulin beta chain TUBB NMMAAC*DPR 0.9 1.0 0.9
34 Q09028 RBBP4 Histone-binding protein RBBP4 RBBP4 YMPQNPC*IIATK 1.0 0.9 0.9
35 P49327 FASN Fatty acid synthase FASN LGMLSPEGTC*K 0.9 1.0 1.0
36 P60709 ACTB Actin, cytoplasmic 1 ACTB C*DVDIR 1.0 1.0 1.0
37 P62280 RPS11 40S ribosomal protein S11 RPS11 DVQIGDIVTVGEC*R 0.9 1.0 0.9
38 Q9Y5M8 SRPRB Signal recognition particle receptor subunit beta SRPRB NTPSFLIAC*NK 1.0 1.1 1.1





40 P51610 HCFC1 Host cell factor 1 HCFC1 VAGINAC*GR 1.0 1.0 1.0
41 P17858 PFKL 6-phosphofructokinase, liver type PFKL VFANAPDSAC*VIGLK 0.9 1.0 0.9
42 P07437 TUBB Tubulin beta chain TUBB TAVC*DIPPR 0.9 1.0 0.9
43 P29401 TKT Transketolase TKT QAFTDVATGSLGQGLGAAC*GMAYTGK 0.9 1.1 1.0
44 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta--like 1 GNB2L1 LWNTLGVC*K 1.0 1.0 1.0
45 P23396 RPS3 40S ribosomal protein S3 RPS3 GC*EVVVSGK 1.0 1.0 1.0
46 P83731 RPL24 60S ribosomal protein L24 RPL24 VELC*SFSGYK 0.9 1.1 1.0
47 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 ALC*QITDSTMLQAIER 1.0 1.0 1.0
48 P10644 PRKAR1A cAMP-dependent protein kinase type I-alpha regulatory subunit PRKAR1A EC*ELYVQK 0.9 1.0 1.0
49 Q01813 PFKP 6-phosphofructokinase type C PFKP NESC*SENYTTDFIYQLYSEEGK 1.0 1.0 1.0
50 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 SLLINAVEASC*IR 0.9 1.0 0.9
51 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP C*PTSGR 0.9 0.9 0.9
52 O95833 CLIC3 Chloride intracellular channel protein 3 CLIC3 ASEDGESVGHC*PSCQR 0.9 1.0 1.0
53 Q9BUF5 TUBB6 Tubulin beta-6 chain TUBB6 EIVHIQAGQC*GNQIGTK 0.8 1.0 0.9
54 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2-like 1 GNB2L1 FSPNSSNPIIVSC*GWDK 0.9 1.0 0.9
55 P78527 PRKDC DNA-dependent protein kinase catalytic subunit PRKDC
VEQLFQVMNGILAQDSAC
*SQR 0.9 1.0 1.0
56 P42677 RPS27 40S ribosomal protein S27 RPS27 LTEGC*SFR 0.9 1.0 0.9
57 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 VVVVQAISALC*QK 0.9 1.0 0.9
58 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 C*GLALALNK 0.9 0.9 0.9
59 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A SIQFVDWC*PTGFK 0.9 1.0 1.0
60 P11498 PC Pyruvate carboxylase, mitochondrial PC ADFAQAC*QDAGVR 1.0 0.7 0.9
61 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 C*MTNTPVVVR 1.0 1.0 1.0
62 P27635 RPL10 60S ribosomal protein L10 RPL10 MLSC*AGADR 0.9 1.0 0.9
63 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 GNB2 TFVSGAC*DASIK 0.8 1.0 0.9
179
3.3 2.5 3.0 3.6 2.2 2.9 ***  Mitochondrion matrix. 93 Yes Yes No No No No 33.3
2.8 2.6 2.8 3.0 3.1 2.9 ***  Cytoplasm. 66 Yes No -- -- No No 25.0
3.3 2.5 3.0 2.8 2.5 2.8 ***  Mitochondrion {ECO 91 Yes Yes Yes No No Yes 66.7
2.7 2.7 2.5 3.0 3.2 2.8 ***  Mitochondrion. 147 Yes Yes No No No No 33.3
2.4 2.1 2.9 3.4 3.2 2.8 ***  Cell membrane {ECO 286 Yes Yes Yes No Yes Yes 83.3
2.9 2.6 2.6 3.0 2.8 2.8 ***  Cytoplasm, cytoskeleton. 303 Yes Yes Yes No No Yes 66.7
2.5 2.9 2.6 3.0 2.9 2.8 ***  Nucleus. 138 Yes Yes Yes No No No 50.0
2.7 2.8 2.6 3.3 2.4 2.8 ***  Cytoplasm {ECO 212 Yes Yes Yes No -- Yes 80.0
2.6 2.8 2.7 3.1 2.6 2.8 ***  Cytoplasm, cytoskeleton {ECO 285 Yes Yes Yes Yes Yes Yes 100.0
2.9 2.5 2.5 3.1 2.7 2.7 *** 131 Yes Yes Yes Yes Yes Yes 100.0
2.6 1.4 2.7 3.4 3.3 2.7 ***  Endoplasmic reticulum membrane {ECO 179 Yes Yes Yes Yes Yes Yes 100.0
2.7 2.7 2.6 2.7 2.7 2.7 ***  Cytoplasm, cytoskeleton. 201 Yes Yes Yes Yes No Yes 83.3
211 Yes Yes Yes Yes Yes Yes 100.0
2.5 2.2 2.8 3.4 2.5 2.7 ***  Cytoplasm. Nucleus. 1872 Yes Yes -- -- -- -- 100.0
3.0 2.5 2.6 3.0 2.4 2.7 ***  Cytoplasm {ECO 708 Yes Yes No No -- No 40.0
2.6 2.6 2.5 2.9 2.7 2.7 ***  Cytoplasm, cytoskeleton. 354 Yes Yes Yes Yes Yes Yes 100.0
3.2 2.5 2.5 2.6 2.4 2.6 *** 133 Yes Yes No No No No 33.3
2.9 2.1 2.7 2.8 2.6 2.6 ***  Cell membrane {ECO 138 Yes Yes Yes Yes Yes Yes 100.0
2.3 3.1 2.5 2.5 2.7 2.6 ***  Cytoplasm {ECO 134 Yes Yes Yes Yes Yes No 83.3
2.6 2.5 2.1 2.6 3.2 2.6 *** 6 Yes Yes Yes No Yes Yes 83.3
2.8 2.7 2.1 3.1 2.4 2.6 ***  Cytoplasm {ECO 129 Yes Yes Yes No Yes Yes 83.3
2.2 3.1 2.4 2.5 2.8 2.6 ***  Cell membrane {ECO 18 Yes Yes Yes -- -- Yes 100.0
2.7 2.3 2.3 2.9 2.8 2.6 ***  Cytoplasm {ECO 641 Yes Yes No No -- No 40.0
2.7 2.2 2.6 2.9 2.6 2.6 ***  Mitochondrion {ECO 262 Yes Yes No -- No No 40.0
2.6 2.5 2.5 2.6 2.8 2.6 ***  Cytoplasm {ECO 144 Yes Yes -- No No No 40.0
2.4 1.8 4.2 2.3 2.3 2.6 ***
 Nucleus. Membrane; 
Single-pass membrane 
protein. Cytoplasm. 
22 Yes Yes Yes -- Yes -- 100.0
3.1 1.7 2.0 4.7 1.3 2.6 ***  Cytoplasm, cytoskeleton {ECO 12 Yes Yes Yes Yes Yes Yes 100.0
2.8 2.3 2.6 2.8 2.4 2.6 ***  Cell membrane {ECO 168 Yes Yes Yes No No No 50.0
1.8 2.0 2.5 3.5 3.0 2.6 ***  Nucleus {ECO 3781 Yes Yes No Yes No No 50.0
2.5 2.5 2.4 2.8 2.5 2.5 *** 77 Yes Yes Yes No Yes Yes 83.3
2.6 2.6 2.2 2.9 2.4 2.5 ***  Cytoplasm {ECO 387 Yes Yes Yes No Yes Yes 83.3
3.2 2.0 2.4 2.8 2.4 2.5 ***  Cytoplasm {ECO 1235 Yes Yes No No No No 33.3
2.5 2.4 2.4 2.8 2.5 2.5 ***  Cytoplasm, cytoskeleton. 347 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.7 2.7 3.7 2.9 2.5 ***  Mitochondrion matrix. 131 Yes Yes No No Yes Yes 66.7
2.7 2.4 2.5 2.7 2.3 2.5 ***  Mitochondrion {ECO 120 Yes Yes No No No No 33.3
2.4 2.2 2.5 2.9 2.5 2.5 *** 105 Yes Yes Yes Yes Yes Yes 100.0
1.8 3.0 1.7 4.1 1.9 2.5 ***  Cytoplasm, perinuclear region {ECO 204 Yes Yes Yes No Yes Yes 83.3
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64 Q9BQ52 ELAC2 Zinc phosphodiesterase ELAC protein 2 ELAC2 C*VLSGPPQLEK 0.8 0.9 0.9
65 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 GANDFMC*DEMER 0.9 0.8 0.8
66 P35250 RFC2 Replication factor C subunit 2 RFC2 VC*DEPHPLLVK 1.0 0.9 0.9
67 Q71U36 TUBA1A Tubulin alpha-1A chain TUBA1A TIQFVDWC*PTGFK 0.9 1.0 0.9
68 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 YVAAAFPSAC*GK 1.0 0.9 0.9
69 P25398 RPS12 40S ribosomal protein S12 RPS12 LGEWVGLC*K 1.0 1.0 1.0
70 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 GNB2
AC*GDSTLTQITAGLDPVG
R 1.0 0.9 0.9
71 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A YMAC*C*LLYR 0.9 1.0 1.0
72 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 SLHDALC*VVK 1.0 1.2 1.1
73 P50914 RPL14 60S ribosomal protein L14 RPL14 C*MQLTDFILK 0.9 1.0 0.9
74 Q16576 RBBP7 Histone-binding protein RBBP7 RBBP7 VHIPNDDAQFDASHC*DSDK 0.9 1.0 0.9
75 P49327 FASN Fatty acid synthase FASN AFDTAGNGYC*R 1.0 1.0 1.0
76 P53582 METAP1 Methionine aminopeptidase 1 METAP1 VCETDGC*SSEAK 0.9 1.1 1.0
77 P53597
SUCLG1 Succinyl-CoA ligase 
[ADP/GDP-forming] subunit alpha, 
mitochondrial
SUCLG1 IIC*QGFTGK 1.0 0.9 1.0
78 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 GYLGPEQLPDC*LK 0.9 0.9 0.9
79 O00567 NOP56 Nucleolar protein 56 NOP56 IINDNATYC*R 1.0 1.0 1.0
80 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma catalytic subunit PPP1CC GNHEC*ASINR 0.9 1.1 1.0
81 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 LC*PNSTGAEIR 0.9 1.0 0.9
82 P31153 MAT2A S-adenosylmethionine synthase isoform type-2 MAT2A
TC*NVLVALEQQSPDIAQG
VHLDR 1.1 1.1 1.1
83 P62280 RPS11 40S ribosomal protein S11 RPS11 C*PFTGNVSIR 1.0 1.0 1.0
84 P50914 RPL14 60S ribosomal protein L14 RPL14 ALVDGPC*TQVR 0.9 1.0 1.0
85 P40939 HADHA Trifunctional enzyme subunit alpha, mitochondrial HADHA C*LAPMMSEVIR 0.9 1.0 0.9
86 Q16555 DPYSL2 Dihydropyrimidinase-related protein 2 DPYSL2 FQLTDC*QIYEVLSVIR 1.1 0.9 1.0
87 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 GASC*QGC*PNQR 1.0 1.1 1.0
88 E9PPU0 EPPK1 Epiplakin EPPK1 LLDAQLATGGLVC*PAR 0.9 1.0 1.0
89 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 VGAFTMVC*K 0.9 1.0 1.0
90 P36578 RPL4 60S ribosomal protein L4 RPL4 SGQGAFGNMC*R 0.8 0.9 0.8
91 P11586 MTHFD1 C-1-tetrahydrofolate synthase, cytoplasmic MTHFD1 GC*LELIK 0.8 0.9 0.9
92 Q96I99 SUCLG2 Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial SUCLG2
IDATQVEVNPFGETPEGQV
VC*FDAK 1.0 1.0 1.0
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2.6 2.1 2.4 2.4 2.9 2.5 ***  Mitochondrion {ECO 136 Yes Yes No No No No 33.3
2.8 2.0 2.0 2.8 2.8 2.5 ***




385 Yes Yes Yes No No No 50.0
2.2 2.8 2.1 2.7 2.4 2.4 ***  Nucleus {ECO 255 Yes Yes Yes No Yes Yes 83.3
2.4 2.3 2.2 2.7 2.5 2.4 ***  Cytoplasm, cytoskeleton. 347 Yes Yes Yes Yes Yes Yes 100.0
2.8 2.1 2.3 2.6 2.4 2.4 ***  Mitochondrion. 306 Yes Yes Yes -- -- Yes 100.0
2.1 2.4 2.4 2.9 2.3 2.4 ***  Cytoplasm. 92 Yes Yes Yes No Yes Yes 83.3
2.6 2.2 2.2 2.7 2.3 2.4 ***  Cytoplasm, perinuclear region {ECO 25 Yes Yes No No -- No 40.0
2.4 2.3 2.3 2.6 2.4 2.4 ***  Cytoplasm, cytoskeleton. 315 Yes Yes Yes No Yes No 66.7
316 Yes Yes Yes Yes Yes Yes 100.0
1.9 2.0 2.5 3.3 2.3 2.4 ***




397 Yes Yes Yes No Yes Yes 83.3
2.5 2.3 2.2 2.5 2.4 2.4 *** 54 Yes Yes No No No No 33.3
1.7 1.6 1.4 1.9 5.3 2.4 ***  Nucleus. 97 Yes Yes No No No No 33.3
2.5 1.9 2.2 2.9 2.3 2.4 ***  Cytoplasm {ECO 223 Yes Yes No No -- Yes 60.0
2.3 2.6 1.6 2.8 2.5 2.4 ***  Cytoplasm {ECO 14 Yes Yes Yes No Yes Yes 83.3
2.0 2.3 2.4 2.6 2.5 2.4 ***  Mitochondrion. 60 Yes Yes Yes No Yes No 66.7
2.2 2.1 2.3 2.8 2.4 2.4 ***  Mitochondrion matrix. 89 Yes Yes No No No No 33.3
2.3 2.2 2.4 2.6 2.2 2.4 ***  Nucleus, nucleolus. Cytoplasm {ECO 211 Yes Yes No No No No 33.3
2.8 2.0 2.2 2.5 2.2 2.3 ***







Mitochondrion. ow and 
midbody by telophase. 
{ECO
127 Yes Yes Yes Yes Yes Yes 100.0
2.6 2.1 2.2 2.4 2.4 2.3 ***  Cytoplasm. Nucleus. Cytoplasm, P-body {ECO 377 Yes Yes Yes Yes Yes Yes 100.0
2.3 2.0 2.2 2.6 2.6 2.3 *** 104 Yes Yes Yes Yes Yes Yes 100.0
2.3 2.2 1.9 2.4 2.8 2.3 *** 60 Yes Yes Yes Yes Yes Yes 100.0
2.5 2.1 2.1 2.7 2.3 2.3 *** 42 Yes Yes No No No No 33.3
2.6 1.8 2.3 2.6 2.3 2.3 ***  Mitochondrion. 550 Yes Yes No -- No Yes 60.0
3.0 2.5 1.9 2.3 1.9 2.3 ***  Cytoplasm, cytosol {ECO 179 Yes No No No No No 16.7
2.2 2.2 2.2 2.8 2.1 2.3 ***  Cytoplasm {ECO 22/25 Yes Yes Yes Yes Yes Yes 100.0
2.5 2.1 2.4 2.2 2.3 2.3 *** Bad ID Error Error Error Error Error Error #DIV/0!
3.0 2.8 1.3 3.1 1.2 2.3 ***  Mitochondrion matrix {ECO 295 Yes Yes Yes No Yes No 66.7
1.9 2.1 2.2 2.6 2.5 2.3 *** 96 Yes Yes Yes Yes Yes Yes 100.0
1.9 1.8 2.7 2.8 2.1 2.3 ***  Cytoplasm. 152 Yes Yes Yes No -- -- 75.0
2.3 2.0 1.7 2.9 2.5 2.3 ***  Mitochondrion. 255 Yes Yes No Yes No Yes 66.7
182
93 P49411 TUFM Elongation factor Tu, mitochondrial TUFM GEETPVIVGSALC*ALEGR 1.0 0.9 1.0
94 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 C*SVLAAANSVFGR 1.3 1.0 1.1
95 P60709 ACTB Actin, cytoplasmic 1 ACTB LC*YVALDFEQEMATAASSSSLEK 0.9 1.0 1.0
96 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD GSNTC*ELIFEDC*K 1.0 0.9 1.0
97 P10589 NR2F1 COUP transcription factor 1 NR2F1 SQC*ALEEYVR 0.8 1.0 0.9
98 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 YNFFTGC*PK 0.9 1.1 1.0
99 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9 TAC*TNFMMTPYVVTR 2.7 1.0 1.9
100 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 C*LQSGTLFR 0.8 1.0 0.9
101 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 KIAA1967 VVTQNIC*QYR 0.9 0.8 0.9
102 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ALDH18A1 C*EYPAAC*NALETLLIHR 0.9 1.1 1.0
103 P13804 ETFA Electron transfer flavoprotein subunit alpha, mitochondrial ETFA LGGEVSC*LVAGTK 0.9 1.0 0.9
104 P46734 MAP2K3 Dual specificity mitogen-activated protein kinase kinase 3 MAP2K3 FSPEFVDFTAQC*LR 1.9 1.2 1.6
105 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 ALNALC*DGLIDELNQALK 0.9 1.0 1.0
106 P13804 ETFA Electron transfer flavoprotein subunit alpha, mitochondrial ETFA TIYAGNALC*TVK 1.0 1.0 1.0
107 O43719 HTATSF1 HIV Tat-specific factor 1 HTATSF1 GFEGSC*SQK 1.1 1.2 1.1
108 Q9Y399 MRPS2 28S ribosomal protein S2, mitochondrial MRPS2 DC*GEYAHTR 0.8 0.9 0.9
109 P42025 ACTR1B Beta-centractin ACTR1B AC*YLSINPQK 0.9 1.0 0.9
110 P62829 RPL23 60S ribosomal protein L23 RPL23 ISLGLPVGAVINC*ADNTGAK 0.9 1.0 1.0
111 P62249 RPS16 40S ribosomal protein S16 RPS16 TATAVAHC*K 1.0 1.0 1.0
112 Q9NZB2 FAM120A Constitutive coactivator of PPAR-gamma-like protein 1 FAM120A VAAASGHC*GAFSGSDSSR 1.0 1.1 1.0
113 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 VGILDVDLC*GPSIPR 1.0 1.0 1.0
114 P53618 COPB1 Coatomer subunit beta COPB1 ALSGYC*GFMAANLYAR 0.7 1.0 0.8
115 Q14152 EIF3A Eukaryotic translation initiation factor 3 subunit EIF3A NIC*QQVNIK 0.9 1.0 0.9
116 P62714
PPP2CB Serine/threonine-protein 
phosphatase 2A catalytic subunit beta 
isoform 
PPP2CB NVVTIFSAPNYC*YR 0.9 1.0 1.0
117 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 AC*ALQVLSAILEGSK 0.9 1.3 1.1
118 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 GQPC*SQNYR 1.5 1.3 1.4
119 P24468 NR2F2 COUP transcription factor 2 NR2F2 FGSQC*MQPNNIMGIENIC*ELAAR 1.2 1.0 1.1
120 P21333 FLNA Filamin-A FLNA LQVEPAVDTSGVQC*YGPGIEGQGVFR 1.0 1.1 1.1
121 P62888 RPL30 60S ribosomal protein L30 RPL30 VC*TLAIIDPGDSDIIR 0.9 0.9 0.9
122 P62753 RPS6 40S ribosomal protein S6 RPS6 LNISFPATGC*QK 0.9 0.9 0.9
123 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 NC*DK 1.0 1.0 1.0
124 Q1KMD3
HNRNPUL2 Heterogeneous nuclear 
ribonucleoprotein U-like pro
HNRNPUL
2 DLLVQQASQC*LSK 1.1 1.0 1.0
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2.2 2.1 2.2 2.5 2.3 2.3 ***  Mitochondrion. 222 Yes Yes Yes Yes No Yes 83.3
2.2 2.8 1.9 2.5 1.9 2.2 **  Nucleus. 482 Yes Yes Yes No No Yes 66.7
2.2 2.1 2.2 2.4 2.1 2.2 **  Cytoplasm, cytoskeleton {ECO 217 Yes Yes Yes Yes No Yes 83.3
2.2 2.1 2.2 2.5 2.0 2.2 **  Mitochondrion matrix. 251 Yes Yes Yes -- Yes Yes 100.0
258 Yes Yes No -- Yes Yes 80.0
2.1 2.0 2.1 2.5 2.4 2.2 ***  Nucleus {ECO 350 Yes Yes Yes -- -- No 75.0
2.2 2.0 2.1 2.6 2.1 2.2 **  Cytoplasm {ECO 364 Yes Yes Yes Yes Yes Yes 100.0
4.6 1.4 1.6 1.6 1.7 2.2 ns  Cytoplasm {ECO 177 Yes Yes No No No No 33.3
2.3 2.2 1.9 2.4 2.1 2.2 ***  Cytoplasm {ECO 49 Yes Yes Yes -- -- Yes 100.0
1.8 2.4 1.9 2.4 2.5 2.2 ***  Nucleus {ECO 754 Yes Yes -- -- -- -- 100.0
2.3 2.1 2.0 2.0 2.5 2.2 **  Mitochondrion inner membrane. 612 Yes Yes Yes Yes Yes Yes 100.0
606 Yes Yes Yes No No Yes 66.7
2.3 1.9 2.2 2.4 2.0 2.2 **  Mitochondrion matrix. 53 Yes Yes No No No No 33.3
1.7 2.0 2.2 2.8 2.2 2.2 ns 305 Yes Yes Yes Yes Yes Yes 100.0
2.3 2.1 2.1 2.3 2.1 2.2 **  Mitochondrion matrix. 62 Yes Yes Yes No No Yes 66.7
1.9 2.1 2.3 2.5 2.0 2.2 **  Mitochondrion matrix. 155 Yes Yes No No Yes No 50.0
1.7 1.8 2.0 2.2 3.1 2.1 ns  Nucleus {ECO 480 Yes No -- -- -- -- 50.0
1.0 1.7 2.9 2.7 2.4 2.1 ***  Mitochondrion {ECO 162 Yes Yes No No No No 33.3
2.3 2.1 1.9 2.5 1.9 2.1 **




222 Yes Yes Yes Yes Yes Yes 100.0
2.2 1.9 2.0 2.3 2.2 2.1 ** 28 Yes Yes Yes Yes Yes Yes 100.0
2.2 1.9 2.2 2.3 1.9 2.1 * 25 Yes Yes Yes No Yes Yes 83.3
2.3 1.7 2.0 2.5 2.0 2.1 *  Cytoplasm {ECO 919 Yes Yes -- -- -- -- 100.0
2.1 1.7 2.0 2.7 1.9 2.1 **  Nucleus {ECO 54 Yes Yes Yes No Yes Yes 83.3
2.1 1.5 1.9 2.3 2.3 2.0 **  Cytoplasm. Golgi apparatus membrane {ECO 888 Yes Yes Yes Yes Yes Yes 100.0
2.3 1.7 2.0 2.2 2.0 2.0 *  Cytoplasm {ECO 78 Yes Yes No No Yes No 50.0
2.3 1.8 2.2 2.0 1.9 2.0 *  Cytoplasm {ECO 266 Yes Yes Yes Yes Yes Yes 100.0
2.1 1.6 2.0 2.3 2.1 2.0 ns 476 Yes Yes No -- -- -- 66.7
1.7 1.7 2.5 2.1 2.2 2.0 ns  Mitochondrion {ECO 44 Yes No No No No No 16.7
2.2 2.1 2.2 1.7 1.9 2.0 ns  Nucleus. 200/213 Yes Yes Yes -- -- No 75.0
1.8 2.0 1.8 2.8 1.6 2.0 ns  Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. 1260 Yes Yes No -- -- No 50.0
2.1 1.9 1.8 2.2 2.0 2.0 * 92 Yes Yes Yes No No Yes 66.7
2.0 1.9 1.9 2.2 2.0 2.0 * 12 Yes Yes Yes No Yes No 66.7
2.0 2.1 1.6 2.5 1.7 2.0 ns  Cytoplasm {ECO 277 Yes Yes Yes Yes No No 66.7
2.0 1.5 2.1 2.4 1.9 2.0 ns  Nucleus {ECO 518 Yes Yes No -- -- No 50.0
184
125 Q14318 FKBP8 Peptidyl-prolyl cis-trans isomerase FKBP8 FKBP8 C*LNNLAASQLK 1.1 1.0 1.1
126 P11586 MTHFD1 C-1-tetrahydrofolate synthase, cytoplasmic MTHFD1 GDLNDC*FIPC*TPK 1.1 1.0 1.1
127 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 MLSAVSQQVQC*IQEALR 1.0 0.9 1.0
128 P15924 DSP Desmoplakin DSP YC*YLQNEVFGLFQK 1.0 1.0 1.0
129 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O NC*AQGEGSMAK 1.0 1.0 1.0
130 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 C*FIVGADNVGSK 0.9 1.0 1.0
131 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 YLLDSC*APLLR 0.8 1.3 1.0
132 Q07020 RPL18 60S ribosomal protein L18 RPL18 GC*GTVLLSGPR 0.9 1.0 1.0
133 P13639 EEF2 Elongation factor 2 EEF2 DLEEDHAC*IPIK 0.9 1.0 1.0
134 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 EMQNLSFQDC*YSSK 0.9 0.9 0.9
135 Q8TC07 TBC1D15 TBC1 domain family member 15 TBC1D15 TLLVNC*QNK 1.1 1.0 1.1
136 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X FDTGNLC*MVTGGANLGR 0.9 0.9 0.9
137 P46776 RPL27A 60S ribosomal protein L27a RPL27A NQSFC*PTVNLDK 0.9 1.0 0.9
138 P55060 CSE1L Exportin-2 CSE1L IC*AVGITK 0.9 1.0 0.9
139 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1
TFVGTPC*WMAPEVMEQV
R 1.0 1.0 1.0
140 Q68CP9 ARID2 AT-rich interactive domain-containing protein 2 ARID2 SC*SNAAFALK 0.8 1.0 0.9
141 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 AVHQC*DR 1.0 1.1 1.1
142 O14980 XPO1 Exportin-1 XPO1 DLLGLC*EQK 1.1 0.9 1.0
143 Q06203 PPAT Amidophosphoribosyltransferase PPAT C*ELENCQPFVVETLHGK 0.8 1.1 1.0
144 P27448 MARK3 MAP/microtubule affinity-regulating kinase 3 MARK3
LDTFC*GSPPYAAPELFQG
K 0.9 1.0 1.0
145 O95782 AP2A1 AP-2 complex subunit alpha-1 AP2A1 TVFEALQAPAC*HENMVK 1.0 1.1 1.1
146 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 EYLPIGGLAEFC*K 0.9 1.0 0.9
147 Q9BTZ2 DHRS4 Dehydrogenase/reductase SDR family member 4 DHRS4 VNC*LAPGLIK 0.9 1.0 1.0
148 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 LEIC*NLTPDALK 0.8 0.9 0.9
149 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7 NC*EPMIGLVPILK 0.9 0.9 0.9
150 Q04726 TLE3 Transducin-like enhancer protein 3 TLE3 FTVAESC*DR 0.9 1.0 1.0
151 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 LC*ALR 0.6 1.0 0.8
152 Q9H1K1 ISCU Iron-sulfur cluster assembly enzyme ISCU, mitochondrial ISCU NVGTGLVGAPAC*GDVMK 0.8 1.1 1.0
153 P49411 TUFM Elongation factor Tu, mitochondrial TUFM GDEC*ELLGHSK 0.9 1.0 1.0
154 P62330 ARF6 ADP-ribosylation factor 6 ARF6 NWYVQPSC*ATSGDGLYEGLTWLTSNYK 0.9 0.9 0.9
155 P51610 HCFC1 Host cell factor 1 HCFC1 AC*AAGTPAVIR 0.9 0.9 0.9
185
1.8 1.8 2.2 2.3 1.9 2.0 ns




274 Yes Yes No -- Yes -- 75.0
2.1 2.4 0.9 3.5 1.0 2.0 ns  Cytoplasm. 143 Yes Yes No No -- -- 50.0
147 Yes Yes Yes Yes -- -- 100.0
2.1 2.0 1.8 2.3 1.6 2.0 ns  Cytoplasm, cytoskeleton. 1977 Yes Yes No No -- No 40.0
2.5 1.7 1.7 2.3 1.7 2.0 ns  Cell junction, desmosome {ECO 740 Yes Yes -- -- -- No 66.7
1.3 2.0 2.5 2.3 1.6 1.9 ns  Cytoplasm {ECO 375 Yes Yes -- -- -- -- 100.0
2.0 1.8 1.9 2.1 2.0 1.9 ns  Nucleus {ECO 27 Yes Yes Yes No No Yes 66.7
1.9 1.8 2.3 1.9 1.9 1.9 ns  Cytoplasm {ECO 246 Yes Yes Yes -- No No 60.0
2.1 1.7 1.8 2.1 2.0 1.9 ns  Cytoplasm. 134 Yes No No No No No 16.7
1.8 1.8 2.0 2.3 1.8 1.9 ns  Cytoplasm. Nucleus {ECO 567 Yes Yes Yes No No Yes 66.7
2.0 1.9 1.8 2.0 1.9 1.9 *  Mitochondrion matrix. 111 Yes Yes Yes No No No 50.0
1.9 1.4 1.9 2.2 2.1 1.9 ns  Cytoplasm {ECO 197 Yes Yes No -- -- -- 66.7
2.0 1.7 2.1 2.2 1.7 1.9 *  Cytoplasm {ECO 181 Yes Yes Yes No No No 50.0
2.3 1.8 1.8 1.9 1.8 1.9 ns 70 Yes Yes No No Yes Yes 66.7
1.9 2.1 1.7 2.0 1.9 1.9 ns  Cytoplasm. Nucleus. 842 Yes Yes No No No No 33.3
1.8 1.5 1.7 2.5 2.0 1.9 ns  Cytoplasm {ECO 191 Yes Yes Yes No Yes Yes 83.3
2.2 1.6 1.4 1.9 2.5 1.9 ns  Nucleus. 82 Yes Yes Yes -- No No 60.0
2.0 1.8 1.8 2.2 1.7 1.9 ns  Nucleus {ECO 72 Yes Yes Yes No No No 50.0
2.1 1.7 1.8 1.8 2.1 1.9 ns
 Cytoplasm. Nucleus, 
nucleoplasm. Nucleus, 
Cajal body. Nucleus, 
nucleolus.
528 Yes Yes Yes No Yes Yes 83.3
1.6 1.3 1.4 1.7 3.5 1.9 ns 100 Yes Yes No No No No 33.3
1.5 1.6 1.6 3.1 1.7 1.9 ns  Cell membrane {ECO 213 Yes Yes Yes Yes Yes Yes 100.0
2.0 1.5 2.0 1.7 2.2 1.9 ns  Cell membrane {ECO 492 Yes Yes Yes No No Yes 66.7
1.6 1.8 1.9 2.3 1.7 1.9 ns  Mitochondrion matrix {ECO 106 Yes Yes No No No No 33.3
2.1 1.8 1.8 1.9 1.7 1.9 ns  Peroxisome {ECO Nucleus {ECO 209 Yes Yes Yes Yes No No 66.7
1.9 1.7 1.9 2.4 1.5 1.9 ns  Cytoplasm {ECO 351 Yes Yes Yes -- Yes Yes 100.0
2.0 1.8 1.8 1.9 1.9 1.9 ns  Mitochondrion {ECO 152 Yes Yes Yes -- No Yes 80.0
2.5 1.1 2.0 1.6 2.0 1.8 ns  Nucleus. 26 Yes Yes No -- -- No 50.0
2.0 1.5 1.8 2.0 1.9 1.8 * 38 Yes No -- -- -- -- 50.0
1.8 1.7 1.8 2.2 1.7 1.8 ns  Mitochondrion {ECO Cytoplasm. Nucleus {ECO 69 Yes Yes Yes Yes Yes Yes 100.0
1.8 1.8 1.7 2.1 1.8 1.8 ns  Mitochondrion. 290 Yes Yes Yes No No No 50.0
2.1 1.6 1.9 1.9 1.6 1.8 ns
 Golgi apparatus. Cell 





155 Yes Yes Yes Yes Yes Yes 100.0
1.5 1.9 2.0 2.0 1.9 1.8 ns  Cytoplasm. Nucleus. 1139 Yes No -- -- -- -- 50.0
186
156 P49327 FASN Fatty acid synthase FASN DPETLVGYSMVGC*QR 1.0 0.9 1.0
157 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 TIIPLISQC*TPK 0.9 1.0 0.9
158 P02795 MT2A Metallothionein-2 MT2A SC*CSCC*PVGC*AK 1.0 0.9 1.0
159 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 FC*LDNGAK 1.1 1.0 1.0
160 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 SFVQWLGC*R 1.1 0.9 1.0
161 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O
GEVPC*TVTSASPLEEATLS
ELK 1.0 1.0 1.0
162 Q27J81 INF2 Inverted formin-2 INF2 AVLLASDAQEC*TLEEVVER 0.8 0.8 0.8
163 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 AVASQLDC*NFLK 0.9 1.0 0.9
164 P82912 MRPS11 28S ribosomal protein S11, mitochondrial MRPS11
ASHNNTQIQVVSASNEPLA
FASC*GTEGFR 0.8 0.9 0.9
165 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC LVIVGDGAC*GK 1.0 0.9 1.0
166 Q1KMD3
HNRNPUL2 Heterogeneous nuclear 
ribonucleoprotein U-like pro
HNRNPUL
2 NFILDQC*NVYNSGQR 0.8 0.9 0.9
167 Q9Y5Q8 GTF3C5 General transcription factor 3C polypeptide 5 GTF3C5 VC*TNPVDR 0.9 1.1 1.0
168 Q96CM8 ACSF2 Acyl-CoA synthetase family member 2, mitochondrial ACSF2 MVSTPIGGLSYVQGC*TK 1.4 1.8 1.6
169 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 AGAIAPC*EVTVPAQNTGLGPEK 0.9 1.0 0.9
170 P00966 ASS1 Argininosuccinate synthase ASS1 FELSC*YSLAPQIK 1.1 1.0 1.0
171 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 C*AMTALSSK 0.9 1.1 1.0
172 P11802 CDK4 Cyclin-dependent kinase 4 CDK4 LMDVC*ATSR 1.0 1.0 1.0
173 Q969Z0 TBRG4 Protein TBRG4 TBRG4 LATDLLSLMPSLTSGEVAHC*AK 1.0 1.1 1.0
174 Q7Z406 MYH14 Myosin-14 MYH14 ADLLLEPC*SHYR 1.0 1.0 1.0
175 Q15019 SEPT2 Septin-2 2-Sep LTVVDTPGYGDAINC*R 1.0 1.0 1.0
176 P23396 RPS3 40S ribosomal protein S3 RPS3 GLC*AIAQAESLR 0.9 1.0 1.0
177 P43246 MSH2 DNA mismatch repair protein Msh2 MSH2 HVIEC*AK 0.9 0.6 0.7
178 P56377 AP1S2 AP-1 complex subunit sigma-2 AP1S2 MC*SFLEWR 1.0 0.9 1.0
179 Q13155
AIMP2 Aminoacyl tRNA synthase 
complex-interacting multifunctional 
protein 2
AIMP2 FSIQTMC*PIEGEGNIAR 0.9 1.0 1.0
180 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 QLC*DNAGFDATNILNK 0.9 1.1 1.0
181 P21333 FLNA Filamin-A FLNA THEAEIVEGENHTYC*IR 1.1 1.0 1.0
182 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 PMC*VESFSQYPPLGR 0.9 1.0 0.9
183 P62910 RPL32 60S ribosomal protein L32 RPL32 SYC*AEIAHNVSSK 0.8 1.0 0.9
184 Q8WTW3
COG1 Conserved oligomeric Golgi 
complex subunit 1 COG1 AQAISPC*VQNFCSALDSK 0.9 1.0 0.9
185 Q13542 EIF4EBP2 Eukaryotic translation initiation factor 4E-binding protein 2 EIF4EBP2
TVAISDAAQLPHDYC*TTP
GGTLFSTTPGGTR 0.8 0.7 0.7
186 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 C*SPIGVYTSGK 1.0 1.0 1.0
187 A6NDG6 PGP Phosphoglycolate phosphatase PGP NNQESDC*VSK 1.0 1.0 1.0
188 P62318 SNRPD3 Small nuclear ribonucleoprotein Sm D3 SNRPD3
VLHEAEGHIVTC*ETNTGE
VYR 0.9 1.0 0.9
187
1.8 1.8 1.6 2.0 1.8 1.8 ns  Cytoplasm {ECO 135 Yes Yes Yes No -- Yes 80.0
1.7 1.8 1.9 1.9 1.8 1.8 ns  Mitochondrion matrix. 212 Yes Yes No No No No 33.3
1.4 1.6 1.8 2.7 1.6 1.8 ns 33/37/41 Yes Yes -- -- -- -- 100.0
0.8 2.6 2.4 0.8 2.5 1.8 ns  Cytoplasm. 50 Yes Yes No No No No 33.3
1.7 1.6 1.8 1.8 2.1 1.8 ns  Nucleus {ECO Cytoplasm {ECO 663 Yes Yes -- -- -- No 66.7
3.3 1.5 1.3 1.5 1.5 1.8 ns  Mitochondrion {ECO 141 Yes Yes Yes No No No 50.0
1.8 0.9 2.0 2.7 1.5 1.8 ns  Cytoplasm, perinuclear region {ECO 332 Yes -- -- -- -- No 50.0
1.7 1.8 1.7 1.9 1.7 1.8 ns  Cytoplasm {ECO 193 Yes Yes No No No Yes 50.0
2.0 1.3 1.8 2.2 1.5 1.8 ns  Mitochondrion {ECO 112 Yes Yes Yes -- No Yes 80.0
2.3 1.6 1.6 1.8 1.6 1.8 ns  Cell membrane {ECO 16 Yes Yes Yes Yes No Yes 83.3
1.7 1.5 1.7 2.2 1.8 1.8 ns  Nucleus {ECO 538 Yes Yes No -- -- No 50.0
1.6 1.1 1.7 2.0 2.4 1.8 ns  Nucleus. 242 Yes Yes No -- No Yes 60.0
1.9 1.8 1.6 1.8 1.7 1.8 ns  Mitochondrion {ECO 64 Yes No No -- -- Yes 50.0
1.8 1.6 1.7 2.0 1.8 1.8 ns  Nucleus {ECO 119 Yes Yes No No No Yes 50.0
2.1 1.7 1.6 1.6 1.8 1.8 ns 132 Yes Yes No No No -- 40.0
1.8 2.4 1.5 1.7 1.4 1.8 ns  Cytoplasm {ECO 158 Yes Yes Yes Yes Yes Yes 100.0
1.7 2.0 1.6 2.0 1.5 1.8 ns  Cytoplasm. Nucleus. Membrane. 78 Yes Yes Yes No No No 50.0
1.7 1.8 1.7 2.0 1.6 1.7 ns  Mitochondrion {ECO 335 Yes Yes No -- -- -- 66.7
1.7 1.8 1.6 1.9 1.8 1.7 ns 324 Yes Yes No No No No 33.3
1.8 1.6 1.6 1.9 1.8 1.7 ns  Cytoplasm {ECO 111 Yes Yes No No -- No 40.0
1.8 1.7 1.6 1.8 1.8 1.7 ns  Cytoplasm {ECO 97 Yes Yes Yes No Yes Yes 83.3
1.8 1.8 1.2 2.0 1.9 1.7 ns  Nucleus {ECO 843 Yes Yes No No No No 33.3
2.0 1.5 1.5 2.2 1.5 1.7 ns







46 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.6 1.8 2.0 1.7 1.7 ns  Cytoplasm, cytosol {ECO 205 Yes Yes No -- -- -- 66.7
1.7 1.9 1.8 1.9 1.4 1.7 ns  Cytoplasm {ECO 450 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.6 1.6 2.3 1.4 1.7 ns  Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. 2199 Yes Yes No -- -- No 50.0
1.6 1.6 1.8 1.9 1.6 1.7 ns  Nucleus {ECO 411 Yes Yes Yes Yes No Yes 83.3
1.6 1.7 1.7 1.7 1.8 1.7 ns 96 Yes Yes Yes No Yes No 66.7
1.6 1.7 1.6 2.0 1.5 1.7 ns  Golgi apparatus membrane {ECO 513 Yes Yes No -- No -- 50.0
1.5 1.4 1.9 2.1 1.7 1.7 ns 35 Yes Yes No -- -- -- 66.7
2.1 1.7 1.2 2.2 1.3 1.7 ns  Nucleus. 397 Yes Yes No No No No 33.3
1.7 1.7 1.6 1.8 1.8 1.7 ns 297 Yes Yes No No No No 33.3






PAPSS2 VWGTTC*TK 0.9 0.9 0.9
190 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 C*ATITPDEAR 0.8 1.0 0.9
191 P15880 RPS2 40S ribosomal protein S2 RPS2 GC*TATLGNFAK 1.0 1.0 1.0
192 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 C*TPSVISFGSK 0.9 1.0 0.9
193 P24385 CCND1 G1/S-specific cyclin-D1 CCND1 AEETC*APSVSYFK 0.8 1.1 1.0
194 P46782 RPS5 40S ribosomal protein S5 RPS5 TIAEC*LADELINAAK 0.9 1.0 0.9
195 Q53H96 PYCRL Pyrroline-5-carboxylate reductase 3 PYCRL
SDVC*TPGGTTIYGLHALE
QGGLR 1.0 1.0 1.0
196 P53597
SUCLG1 Succinyl-CoA ligase 
[ADP/GDP-forming] subunit alpha, 
mitochondrial
SUCLG1 LIGPNC*PGVINPGEC*K 1.0 0.9 1.0
197 P35125 USP6 Ubiquitin carboxyl-terminal hydrolase 6 USP6 SGTSC*PSSK 0.9 1.0 0.9
198 O95685 PPP1R3D Protein phosphatase 1 regulatory subunit 3D PPP1R3D APPPTPAPSGC*DPR 0.9 1.4 1.1
199 Q9Y508 RNF114 RING finger protein 114 RNF114 DC*GGAAQLAGPAAEADPLGR 1.0 1.1 1.0
200 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 LQGATC*NNNK 0.9 0.9 0.9
201 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L GC*ALQC*AILSPAFK 0.9 0.9 0.9
202 Q9UHD8 SEPT9 Septin-9 9-Sep
LTVIDTPGFGDHINNENC*
WQPIMK 0.9 0.9 0.9
203 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC ISAFGYLEC*SAK 0.7 0.7 0.7
204 Q9H1K1 ISCU Iron-sulfur cluster assembly enzyme ISCU, mitochondrial ISCU LHC*SMLAEDAIK 0.9 1.0 1.0
205 P15924 DSP Desmoplakin DSP DANSENC*NK 0.8 1.0 0.9
206 Q99836 MYD88 Myeloid differentiation primary response protein MyD88 MYD88 FITVCDYTNPC*TK 0.9 0.9 0.9
207 P37198 NUP62 Nuclear pore glycoprotein p62 NUP62 DIIEHLNTSGAPADTSDPLQQIC*K 0.7 0.9 0.8
208 P10599 TXN Thioredoxin TXN C*MPTFQFFK 1.0 1.0 1.0
209 P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT
VVC*SSGAVGNYSGGLAV
K 1.0 1.0 1.0
210 Q96RQ3 MCCC1 Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial MCCC1 ESLC*QAALGLILK 1.0 0.9 1.0
211 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2 VLVVGAGGIGC*ELLK 0.9 0.9 0.9
212 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ALDH18A1 GDEC*GLALGR 1.0 1.0 1.0
213 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 C*SFDVVK 0.8 0.9 0.8
214 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 VVLLGEGC*VGK 1.1 1.0 1.1
215 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 GNVC*GDSK 0.8 1.0 0.9
216 Q66K14 TBC1D9B TBC1 domain family member 9B TBC1D9B NEC*YR 1.1 1.2 1.2
217 Q02252
ALDH6A1 Methylmalonate-
semialdehyde dehydrogenase [acylating], 
mitochondrial
ALDH6A1 AEMDAAIASC*K 0.9 1.0 1.0
218 P10599 TXN Thioredoxin TXN LVVVDFSATWC*GPC*K 1.1 1.0 1.0
219 Q96CD2 PPCDC Phosphopantothenoylcysteine decarboxylase PPCDC ASC*PAAAPLMER 1.0 1.2 1.1
189
1.8 1.7 1.3 1.9 1.8 1.7 ns 350 Yes No No -- No No 20.0
1.7 1.5 1.9 1.8 1.6 1.7 ns  Mitochondrion. 113 Yes Yes Yes Yes Yes Yes 100.0
1.8 1.7 1.6 1.7 1.7 1.7 ns 229 Yes Yes No No No No 33.3
1.6 1.6 1.6 1.8 1.7 1.7 ns  Cytoplasm {ECO 34 Yes Yes No No No No 33.3
1.8 1.5 2.4 1.8 0.9 1.7 ns  Nucleus {ECO 38 Yes Yes No No -- No 40.0
1.7 1.6 1.6 1.8 1.7 1.7 ns 172 Yes Yes Yes No Yes Yes 83.3
1.6 1.6 1.7 1.8 1.7 1.7 ns 235 Yes No No Yes No No 33.3
1.7 1.6 1.6 1.7 1.8 1.7 ns  Mitochondrion. 172 Yes Yes Yes Yes Yes Yes 100.0
181 Yes Yes Yes No Yes Yes 83.3
1.5 1.5 1.9 1.8 1.6 1.7 ns  Cell membrane. Cytoplasm. Endosome. 1185 Yes Yes -- -- -- -- 100.0
1.0 3.1 1.1 0.8 2.2 1.6 ns 60 Yes Yes -- -- -- -- 100.0
1.6 1.8 1.5 1.6 1.7 1.6 ns  Cytoplasm {ECO 8 Yes No -- -- -- -- 50.0
1.8 1.9 1.5 2.2 0.7 1.6 ns  Cytoplasm, cytoskeleton. 4570 Yes Yes Yes -- -- No 75.0
1.7 1.7 1.5 1.5 1.7 1.6 ns  Cytoplasm {ECO 376 Yes Yes No No Yes No 50.0
380 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.7 1.6 1.7 1.5 1.6 ns  Cytoplasm, cytoskeleton {ECO 375 Yes Yes No No -- Yes 60.0
1.9 1.2 1.8 1.8 1.5 1.6 ns  Cell membrane {ECO 159 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.3 1.6 1.9 1.7 1.6 ns  Mitochondrion {ECO Cytoplasm. Nucleus {ECO 138 Yes Yes Yes Yes Yes Yes 100.0
1.2 1.6 1.8 2.1 1.4 1.6 ns  Cell junction, desmosome {ECO 1052 Yes Yes -- -- -- -- 100.0
1.9 1.4 1.7 1.6 1.5 1.6 ns  Cytoplasm {ECO 280 Yes Yes No -- -- -- 66.7
1.8 1.6 1.5 1.7 1.6 1.6 ns
 Nucleus, nuclear pore 
complex. Cytoplasm, 
cytoskeleton, spindle pole.
475 Yes Yes No No No -- 40.0
1.4 1.2 2.2 1.7 1.5 1.6 ns  Nucleus {ECO 73 Yes Yes No No No No 33.3
1.7 1.6 1.4 1.6 1.7 1.6 ns  Nucleus. 150 Yes No No No -- No 20.0
1.4 2.0 1.4 1.6 1.6 1.6 ns  Mitochondrion matrix {ECO 509 Yes Yes No -- No No 40.0
1.6 1.5 1.6 1.7 1.5 1.6 ns  Cytoplasm. Nucleus. 30 Yes Yes Yes No Yes Yes 83.3
1.7 1.5 1.5 1.7 1.6 1.6 ns  Mitochondrion inner membrane. 88 Yes Yes No -- No Yes 60.0
1.7 1.3 1.5 1.8 1.7 1.6 ns  Cytoplasm {ECO 169 Yes Yes No No No No 33.3
1.8 1.4 1.5 1.6 1.6 1.6 ns  Endoplasmic reticulum membrane {ECO 29 Yes Yes Yes No No Yes 66.7
1.5 1.5 1.6 1.9 1.4 1.6 ns  Nucleus {ECO 326 Yes Yes No Yes No Yes 66.7
1.4 1.6 1.4 1.7 1.8 1.6 ns  Membrane {ECO 289 Yes Yes No No -- No 40.0
1.5 1.6 1.6 1.9 1.5 1.6 ns  Mitochondrion. 86 Yes Yes No No No No 33.3
1.5 1.2 2.1 1.7 1.4 1.6 ns  Nucleus {ECO 32/35 Yes Yes Yes Yes Yes Yes 100.0
1.4 1.5 1.7 1.8 1.6 1.6 ns 7 Yes Yes -- -- -- -- 100.0
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220 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 GC*AFVTFTTR 1.0 1.1 1.1
221 P61758 VBP1 Prefoldin subunit 3 VBP1 DSC*GK 0.9 0.9 0.9
222 A0MZ66 KIAA1598 Shootin-1 KIAA1598 VTFQPPSSIGC*R 1.0 1.1 1.0
223 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 ANSSVVSVNC*K 0.9 1.0 1.0
224 Q8NFA0 USP32 Ubiquitin carboxyl-terminal hydrolase 32 USP32 VLAYTGC*FSR 1.0 0.9 0.9
225 Q9P2R7 SUCLA2 Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial SUCLA2 ILAC*DDLDEAAR 0.7 1.0 0.9
226 P20810 CAST Calpastatin CAST AAAPAPVSEAVC*R 1.0 0.9 0.9
227 P62244 RPS15A 40S ribosomal protein S15a RPS15A C*GVISPR 0.9 0.9 0.9
228 P46782 RPS5 40S ribosomal protein S5 RPS5 AQC*PIVER 0.9 0.9 0.9
229 Q9NZA1 CLIC5 Chloride intracellular channel protein 5 CLIC5 AGIDGESIGNC*PFSQR 1.0 1.0 1.0
230 P38606 ATP6V1A V-type proton ATPase catalytic subunit A ATP6V1A
VLDALFPCVQGGTTAIPGA
FGC*GK 1.0 1.0 1.0
231 Q96I99 SUCLG2 Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial SUCLG2
SC*NGPVLVGSPQGGVDIE
EVAASNPELIFK 0.8 1.0 0.9
232 Q6PKG0 LARP1 La-related protein 1 LARP1 TASISSSPSEGTPTVGSYGC*TPQSLPK 0.9 1.0 0.9
233 Q7Z2W4 ZC3HAV1 Zinc finger CCCH-type antiviral protein 1 ZC3HAV1 NSNVDSSYLESLYQSC*PR 1.0 1.2 1.1
234 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 VC*VETVESGAMTK 0.9 0.9 0.9
235 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA VNLQMVYDSPLC*R 0.9 0.9 0.9
236 P60981 DSTN Destrin DSTN HEC*QANGPEDLNR 1.2 1.0 1.1
237 O75439 PMPCB Mitochondrial-processing peptidase subunit beta PMPCB LC*TSVTESEVAR 1.1 0.9 1.0
238 P55263 ADK Adenosine kinase ADK TGC*TFPEK 1.0 1.0 1.0
239 P61247 RPS3A 40S ribosomal protein S3a RPS3A LFC*VGFTK 1.0 0.9 1.0
240 P35914 HMGCL Hydroxymethylglutaryl-CoA lyase, mitochondrial HMGCL LLEAGNFIC*QALNR 0.8 1.0 0.9
241 P19838 NFKB1 Nuclear factor NF-kappa-B p105 subunit NFKB1 YVC*EGPSHGGLPGASSEK 0.9 0.8 0.8
242 E9PPU0 EPPK1 Epiplakin EPPK1 YLC*GLGAVGGVR 1.0 1.0 1.0
243 Q9BUL9 RPP25 Ribonuclease P protein subunit p25 RPP25
SEEAPAGC*GAEGGGPGSG
PFADLAPGAVHMR 1.1 1.0 1.0
244 Q9BUH6 C9orf142 Uncharacterized protein C9orf142 C9orf142 C*PGESLINPGFK 1.0 1.0 1.0
245 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1 AIC*TEAGLMALR 1.0 1.0 1.0
246 P22102 GART Trifunctional purine biosynthetic protein adenosine-3 GART QVLVAPGNAGTAC*SEK 0.8 0.8 0.8
247 P55809 OXCT1 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OXCT1 C*TLPLTGK 0.8 1.0 0.9
248 Q13155
AIMP2 Aminoacyl tRNA synthase 
complex-interacting multifunctional 
protein 2
AIMP2 SC*ENLAPFNTALK 0.9 1.0 0.9
249 Q93052 LPP Lipoma-preferred partner LPP TYITDPVSAPC*APPLQPK 1.0 1.1 1.0
250 Q8TEX9 IPO4 Importin-4 IPO4 APAALPALC*DLLASAADPQIR 1.0 1.1 1.0
251 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD TQVC*GILR 0.9 1.0 0.9
191
1.8 1.5 1.5 1.5 1.7 1.6 ns  Nucleus {ECO 150 Yes Yes Yes No Yes Yes 83.3
3.5 1.0 1.2 1.1 1.1 1.6 ns  Cytoplasm. Nucleus. 8 Yes Yes -- -- -- -- 100.0
1.5 1.7 1.7 1.5 1.5 1.6 ns  Perikaryon {ECO 565 Yes No -- -- -- -- 50.0
1.7 1.4 1.4 1.8 1.7 1.6 ns  Nucleus {ECO Cytoplasm {ECO 596 Yes Yes -- -- -- No 66.7
1.7 1.2 1.5 1.8 1.7 1.6 ns  Membrane {ECO 641 Yes Yes No -- No Yes 60.0
1.2 1.7 1.4 2.1 1.5 1.6 ns  Mitochondrion. 430 Yes Yes No No No Yes 50.0
1.6 1.5 1.6 1.6 1.5 1.6 ns 408 Yes No -- -- -- -- 50.0
1.6 1.7 1.5 1.4 1.6 1.6 ns 72 Yes Yes Yes Yes Yes No 83.3
1.6 1.6 1.3 1.7 1.6 1.6 ns 66 Yes Yes Yes Yes Yes Yes 100.0
1.6 1.5 1.5 1.7 1.5 1.6 ns
 Cytoplasm, cell cortex 






191 Yes Yes Yes -- Yes No 80.0
1.6 1.6 1.4 1.6 1.6 1.5 ns 254 Yes Yes Yes -- Yes Yes 100.0
1.6 1.4 1.4 1.7 1.6 1.5 ns  Mitochondrion. 162 Yes No No No No No 16.7
1.4 1.5 1.4 1.9 1.6 1.5 ns  Cytoplasm {ECO 864 Yes Yes No -- No No 40.0
1.2 1.3 1.6 1.9 1.7 1.5 ns  Cytoplasm. Nucleus. 645 Yes Yes -- -- -- -- 100.0
1.4 1.4 1.4 2.0 1.5 1.5 ns  Mitochondrion. 402 Yes Yes Yes No Yes Yes 83.3
1.1 1.5 1.6 2.0 1.6 1.5 ns  Cytoplasm {ECO 493 Yes Yes Yes No Yes Yes 83.3
1.5 1.4 1.7 1.6 1.5 1.5 ns 135 Yes No No No No No 16.7
2.0 1.6 1.4 1.3 1.3 1.5 ns  Mitochondrion matrix {ECO 389 Yes Yes Yes No No No 50.0
1.5 1.4 1.4 1.8 1.5 1.5 ns  Nucleus {ECO Cytoplasm {ECO 353 Yes Yes Yes No Yes Yes 83.3
1.6 1.6 1.6 1.2 1.6 1.5 ns  Cytoplasm {ECO 139 Yes Yes Yes No Yes No 66.7
1.4 1.4 1.6 1.7 1.5 1.5 ns  Mitochondrion matrix. Peroxisome. 307 Yes Yes Yes No No No 50.0
1.5 1.5 1.5 1.5 1.5 1.5 ns  Nucleus. Cytoplasm. 61 Yes Yes Yes -- -- -- 100.0
1.4 1.6 1.3 1.5 1.6 1.5 ns Bad ID Error Error Error Error Error Error #DIV/0!
1.4 1.5 1.5 1.5 1.5 1.5 ns  Nucleus {ECO 16 Yes No -- -- -- -- 50.0
1.4 1.4 1.5 1.7 1.5 1.5 ns  Nucleus {ECO 180 Yes Yes -- -- -- -- 100.0
1.5 1.4 1.6 1.6 1.4 1.5 ns  Cytoplasm. Nucleus. Membrane {ECO 399 Yes Yes Yes Yes Yes Yes 100.0
1.7 1.2 1.4 1.6 1.5 1.5 ns 41 Yes Yes No No No No 33.3
1.4 1.5 1.4 1.6 1.5 1.5 ns  Mitochondrion matrix. 456 Yes Yes Yes -- -- Yes 100.0
1.0 1.7 1.4 1.7 1.6 1.5 ns  Cytoplasm, cytosol {ECO 306 Yes Yes -- -- -- -- 100.0
1.4 1.4 1.4 1.7 1.5 1.5 ns  Nucleus. Cytoplasm. Cell junction. Cell membrane. 364 Yes Yes -- -- -- -- 100.0
1.3 1.4 1.4 1.6 1.6 1.5 ns  Cytoplasm {ECO 42 Yes No No No No No 16.7
1.4 1.3 1.5 1.7 1.4 1.5 ns 13 Yes Yes Yes -- -- -- 100.0
192
252 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 DLAGC*IHGLSNVK 0.9 0.9 0.9
253 Q13636 RAB31 Ras-related protein Rab-31 RAB31 VC*LLGDTGVGK 0.8 1.0 0.9
254 Q00765 REEP5 Receptor expression-enhancing protein 5 REEP5 NC*MTDLLAK 1.1 1.0 1.0
255 P11498 PC Pyruvate carboxylase, mitochondrial PC FLYEC*PWR 1.2 1.1 1.1
256 Q02252
ALDH6A1 Methylmalonate-
semialdehyde dehydrogenase [acylating], 
mitochondrial
ALDH6A1 VC*NLIDSGTK 0.9 1.0 0.9
257 O15355 PPM1G Protein phosphatase 1G PPM1G C*SGDGVGAPR 1.0 0.9 1.0
258 P0CW22 RPS17L 40S ribosomal protein S17-like RPS17L VC*EEIAIIPSK 0.9 0.9 0.9
259 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 C*QTSMDELLK 0.9 1.0 1.0
260 P09429 HMGB1 High mobility group protein B1 HMGB1 MSSYAFFVQTC*R 1.0 0.8 0.9
261 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 ASYFQC*VQR 0.9 0.9 0.9
262 O00148 DDX39A ATP-dependent RNA helicase DDX39A DDX39A
AIVDC*GFEHPSEVQHEC*I
PQAILGMDVLC*QAK 0.9 1.5 1.2
263 P49327 FASN Fatty acid synthase FASN WVC*SSLR 1.0 0.9 0.9
264 Q00610 CLTC Clathrin heavy chain 1 CLTC IHEGC*EEPATHNALAK 0.9 1.1 1.0
265 Q9Y3A3 MOB4 MOB-like protein phocein MOB4 HTLDGAAC*LLNSNK 1.0 0.9 1.0
266 Q9UJU6 DBNL Drebrin-like protein DBNL AEEDVEPEC*IMEK 1.8 1.4 1.6
267 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 ADHQPLTEASYVNLPTIALC*NTDSPLR 0.9 0.9 0.9
268 Q9ULV4 CORO1C Coronin-1C CORO1C C*DLISIPK 0.9 1.0 1.0
269 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 HIIEDPC*TLR 1.1 0.9 1.0
270 P50552 VASP Vasodilator-stimulated phosphoprotein VASP
SSSSVTTSETQPC*TPSSSD
YSDLQR 0.7 1.4 1.1
271 P50991 CCT4 T-complex protein 1 subunit delta CCT4 TLSGMESYC*VR 0.8 1.0 0.9
272 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 PMC*VESFSDYPPLGR 1.0 1.0 1.0
273 Q15208 STK38 Serine/threonine-protein kinase 38 STK38 LSDFGLC*TGLK 1.1 1.0 1.1
274 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R HNRNPR SAFLC*GVMK 0.9 1.0 0.9
275 P63220 RPS21 40S ribosomal protein S21 RPS21 TYAIC*GAIR 1.4 1.0 1.2
276 Q8IUR0 TRAPPC5 Trafficking protein particle complex subunit 5 TRAPPC5
ENSTLNC*ASFTAGIVEAVL
THSGFPAK 0.9 1.0 1.0
277 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP NPVSQC*MR 0.9 1.1 1.0
278 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 QAVLGAGLPISTPC*TTINK 0.8 0.9 0.9
279 O15541 RNF113A RING finger protein 113A RNF113A AVDQVC*TFLFK 0.9 1.0 0.9
280 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
YC*SGTGWPSFSEAHGTSG
SDESHTGILR 1.0 0.9 0.9
281 Q15813 TBCE Tubulin-specific chaperone E TBCE NCAVSC*AGEK 1.4 1.1 1.2
282 Q96EB1 ELP4 Elongator complex protein 4 ELP4 VEPC*SLTPGYTK 0.9 0.9 0.9
283 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 TPC*NAGTFSQPEK 1.0 1.1 1.0
284 P30050 RPL12 60S ribosomal protein L12 RPL12 C*TGGEVGATSALAPK 0.9 0.9 0.9
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1.5 1.4 1.4 1.6 1.5 1.5 ns  Mitochondrion. 418 Yes Yes Yes No No Yes 66.7
1.6 1.3 1.5 1.5 1.4 1.5 ns  Golgi apparatus, trans-Golgi network {ECO 9 Yes Yes No No No No 33.3
1.5 1.5 1.3 1.7 1.4 1.5 ns  Membrane {ECO 18 Yes Yes -- -- -- No 66.7
1.5 1.5 1.4 1.4 1.6 1.5 ns  Mitochondrion matrix. 622 Yes Yes Yes No -- Yes 80.0
1.5 1.4 1.4 1.7 1.3 1.5 ns  Mitochondrion. 368 Yes Yes No No Yes No 50.0
1.3 1.5 1.5 1.5 1.5 1.4 ns  Cytoplasm {ECO 13 Yes Yes -- -- -- -- 100.0
1.5 1.4 1.4 1.5 1.5 1.4 ns 35 Yes Yes Yes Yes No Yes 83.3
1.4 1.0 2.0 1.2 1.6 1.4 ns  Cytoplasm {ECO 53 Yes Yes No No Yes Yes 66.7
1.4 1.7 1.4 1.4 1.4 1.4 ns  Nucleus {ECO 23 Yes Yes Yes -- No Yes 80.0
1.5 1.4 1.3 1.5 1.5 1.4 ns  Nucleus {ECO 47 Yes Yes No -- No No 40.0
1.5 1.3 1.3 1.7 1.5 1.4 ns  Nucleus {ECO 62 Yes Yes Yes Yes No Yes 83.3
74 Yes Yes Yes No Yes Yes 83.3
86 Yes Yes Yes Yes Yes Yes 100.0
1.5 1.2 1.5 1.4 1.5 1.4 ns  Cytoplasm {ECO 1548 Yes No -- -- -- No 33.3
1.6 1.1 1.4 1.6 1.5 1.4 ns  Cytoplasmic vesicle membrane {ECO 870 Yes Yes Yes No No No 50.0
1.4 1.4 1.4 1.5 1.4 1.4 ns  Cytoplasm, perinuclear region {ECO 134 Yes Yes Yes No No No 50.0
1.1 1.1 1.5 1.7 1.6 1.4 ns  Cytoplasm, cytoskeleton {ECO 127 Yes Yes No -- -- No 50.0
1.4 1.3 1.5 1.7 1.3 1.4 ns Bad ID Error Error Error Error Error Error #DIV/0!
1.3 1.3 1.5 1.6 1.4 1.4 ns  Cell membrane {ECO 420 Yes No No -- -- -- 33.3
1.6 1.2 1.3 1.6 1.4 1.4 ns  Cytoplasm {ECO 1832 Yes Yes -- -- -- -- 100.0
1.4 1.4 1.3 1.4 1.6 1.4 ns
 Cytoplasm. Cytoplasm, 
cytoskeleton. Cell junction, 
focal adhesion. Cell 
junction, tight junction 
{ECO
334 Yes No -- -- -- -- 50.0
1.3 1.4 1.4 1.6 1.3 1.4 ns  Cytoplasm {ECO 450 Yes Yes Yes No Yes Yes 83.3
1.5 1.3 1.4 1.5 1.4 1.4 ns  Cytoplasm. Nucleus. Nucleus, nucleolus. 411 Yes Yes Yes Yes No Yes 83.3
1.6 1.6 1.3 1.2 1.3 1.4 ns  Nucleus. Cytoplasm. 234 Yes Yes Yes No Yes Yes 83.3
2.1 1.1 1.3 1.3 1.2 1.4 ns  Nucleus {ECO 99 Yes Yes Yes -- -- No 75.0
1.2 1.7 1.2 1.4 1.5 1.4 ns 56 Yes Yes Yes No Yes Yes 83.3
1.4 1.4 1.3 1.3 1.6 1.4 ns  Golgi apparatus, cis-Golgi network {ECO 139 Yes Yes Yes Yes Yes Yes 100.0
1.5 1.3 1.3 1.5 1.4 1.4 ns  Nucleus {ECO 50 Yes Yes No -- -- No 50.0
1.3 1.4 1.4 1.4 1.4 1.4 ns  Mitochondrion. 119 Yes Yes Yes No Yes No 66.7
1.4 1.2 1.4 1.5 1.5 1.4 ns 15 Yes Yes -- -- Yes -- 100.0
1.7 1.3 1.1 1.4 1.4 1.4 ns  Mitochondrion {ECO 105 Yes Yes No No No No 33.3
1.2 1.4 1.5 1.1 1.7 1.4 ns  Cytoplasm {ECO 141 Yes No No No No No 16.7
1.1 1.3 1.4 1.6 1.5 1.4 ns  Cytoplasm. Nucleus. 218 Yes Yes -- No Yes No 60.0
1.2 1.5 1.3 1.6 1.2 1.4 ns
 Nucleus. Chromosome, 
centromere, kinetochore 
{ECO
129 Yes Yes No No No No 33.3
1.5 1.0 1.5 1.6 1.3 1.4 ns 17 Yes Yes Yes No No Yes 66.7
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285 Q9BXJ9 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit NAA15 LFNTAVC*ESK 1.0 0.9 1.0
286 P18085 ARF4 ADP-ribosylation factor 4 ARF4 NIC*FTVWDVGGQDR 0.9 1.0 0.9
287 P62633 CNBP Cellular nucleic acid-binding protein CNBP TSEVNC*YR 0.8 1.0 0.9
288 Q5T4S7 UBR4 E3 ubiquitin-protein ligase UBR4 UBR4 AVQC*LNTSSK 1.0 1.0 1.0
289 P49915 GMPS GMP synthase GMPS VICAEEPYIC*K 0.9 1.1 1.0
290 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 SQETEC*TYFSTPLLLGK 0.9 1.0 1.0
291 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 YVDIAIPC*NNK 0.9 1.0 0.9
292 Q9GZZ9 UBA5 Ubiquitin-like modifier-activating enzyme 5 UBA5
EGVC*AASLPTTMGVVAGI
LVQNVLK 1.1 1.1 1.1
293 P20073 ANXA7 Annexin A7 ANXA7 LGTDESC*FNMILATR 0.9 0.9 0.9
294 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 C*IPALDSLTPANEDQK 1.0 1.0 1.0
295 O14545 TRAFD1 TRAF-type zinc finger domain-containing protein 1 TRAFD1 AVC*EADQSHGGPR 1.0 1.0 1.0
296 Q9NP73 ALG13 UDP-N-acetylglucosamine transferase subunit ALG13 ALG13
ADLVISHAGAGSC*LETLE
K 1.0 1.0 1.0
297 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 FFSDC*K 1.0 1.1 1.0
298 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 IHMGSC*AENTAK 0.9 0.9 0.9
299 P60709 ACTB Actin, cytoplasmic 1 ACTB C*PEALFQPSFLGMESC*GIHETTFNSIMK 0.9 0.9 0.9
300 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O C*YNEMALIR 0.9 1.0 1.0
301 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 NMITGTSQADC*AVLIVAAGVGEFEAGISK 0.9 1.0 1.0
302 P49327 FASN Fatty acid synthase FASN ADEASELAC*PTPK 1.0 1.0 1.0
303 P60866 RPS20 40S ribosomal protein S20 RPS20 TPC*GEGSK 1.1 1.0 1.0
304 P84085 ARF5 ADP-ribosylation factor 5 ARF5 NIC*FTVWDVGGQDK 0.9 1.1 1.0
305 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 LTFSC*LGGSDNFK 0.9 1.0 1.0
306 Q9NUU7
DDX19A ATP-dependent RNA helicase 
DDX19A DDX19A VLVTTNVC*AR 0.9 1.0 0.9
307 P15924 DSP Desmoplakin DSP NQC*TQVVQER 1.0 0.9 0.9
308 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 VDENFDC*VEADDVEGK 1.0 0.9 1.0
309 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP ISASC*QHPTAFEEAIPK 0.9 0.9 0.9
310 P49327 FASN Fatty acid synthase FASN AINC*ATSGVVGLVNC*LR 1.0 1.0 1.0
311 P13639 EEF2 Elongation factor 2 EEF2 VTDGALVVVDC*VSGVC*VQTETVLR 1.7 1.1 1.4
312 E7EQ34 GOSR2 Golgi SNAP receptor complex member 2 GOSR2 QVHEIQSC*MGR 1.0 1.0 1.0
313 P61247 RPS3A 40S ribosomal protein S3a RPS3A MC*SMVK 0.8 0.9 0.9
314 P13639 EEF2 Elongation factor 2 EEF2 IWC*FGPDGTGPNILTDITK 1.0 1.1 1.0
315 Q04637 EIF4G1 Eukaryotic translation initiation factor 4 gamma 1 EIF4G1 LQGINC*GPDFTPSFANLGR 1.0 1.0 1.0
316 Q9UHD8 SEPT9 Septin-9 9-Sep
SQEATEAAPSC*VGDMAD
TPR 1.2 1.0 1.1
317 P61247 RPS3A 40S ribosomal protein S3a RPS3A AC*QSIYPLHDVFVR 1.0 0.7 0.8
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1.3 1.7 1.2 1.3 1.3 1.4 ns  Cytoplasm. Nucleus. 721 Yes Yes No -- No No 40.0
1.4 1.2 1.3 1.5 1.5 1.4 ns  Golgi apparatus. Membrane {ECO 62 Yes Yes Yes No No No 50.0
1.4 1.3 1.5 1.4 1.2 1.4 ns  Cytoplasm {ECO 158 Yes Yes Yes Yes Yes -- 100.0
2.0 1.2 1.3 0.9 1.3 1.4 ns  Membrane {ECO 2554 Yes Yes No -- -- -- 66.7
1.3 1.3 1.4 1.4 1.4 1.4 ns  Cytoplasm. 456 Yes Yes No No No No 33.3
1.3 1.3 1.4 1.4 1.4 1.4 ns  Mitochondrion matrix. 285 Yes Yes No No No No 33.3
1.4 1.2 1.4 1.5 1.3 1.3 ns Bad ID Error Error Error Error Error Error #DIV/0!
1.4 1.3 1.3 1.3 1.4 1.3 ns  Cytoplasm {ECO 250 Yes Yes Yes -- Yes Yes 100.0
1.5 1.3 1.2 1.4 1.4 1.3 ns 363 Yes Yes No -- No No 40.0
1.3 1.2 1.4 1.4 1.4 1.3 ns  Mitochondrion matrix. 447 Yes Yes Yes No No No 50.0
1.2 1.2 1.3 1.5 1.6 1.3 ns 267 Yes No -- -- -- -- 50.0
1.3 1.3 1.3 1.5 1.3 1.3 ns  Endoplasmic reticulum {ECO 86 Yes Yes -- No No Yes 60.0
1.4 1.2 1.5 1.3 1.3 1.3 ns  Nucleus, nucleoplasm. 34 Yes Yes No -- No No 40.0
1.4 1.2 1.3 1.4 1.4 1.3 ns  Mitochondrion. 196 Yes Yes Yes No Yes Yes 83.3
1.3 1.5 1.4 1.1 1.4 1.3 ns  Cytoplasm, cytoskeleton {ECO 257 Yes Yes Yes No Yes Yes 83.3
272 Yes Yes Yes No No No 50.0
1.2 1.3 1.2 1.5 1.5 1.3 ns  Cytoplasm {ECO 1099 Yes Yes No -- No No 40.0
1.3 1.4 1.4 1.4 1.3 1.3 ns  Cytoplasm. Nucleus. 111 Yes Yes Yes Yes Yes Yes 100.0
1.3 1.3 1.3 1.4 1.4 1.3 ns  Cytoplasm {ECO 2202 Yes No -- -- -- No 33.3
1.5 1.5 1.2 1.2 1.3 1.3 ns  Cytoplasm {ECO 70 Yes Yes Yes No Yes Yes 83.3
1.5 1.2 1.3 1.4 1.3 1.3 ns  Golgi apparatus {ECO 62 Yes Yes Yes No No No 50.0
0.7 1.2 1.9 1.9 0.8 1.3 ns  Cytoplasm. 40 Yes Yes No No No No 33.3
1.3 1.2 1.3 1.4 1.3 1.3 ns  Cytoplasm {ECO 392 Yes Yes No No No No 33.3
1.1 1.4 1.3 1.3 1.4 1.3 ns  Cell junction, desmosome {ECO 1805 Yes Yes -- -- -- -- 100.0
1.3 1.0 1.4 1.5 1.4 1.3 ns
 Nucleus matrix. 
Cytoplasm. Nucleus. 
Nucleus matrix. Nucleus, 
nucleoplasm. 
101 Yes Yes No No No No 33.3
1.3 1.3 1.3 1.4 1.4 1.3 ns  Cytoplasm {ECO 327 Yes No -- No No No 20.0
1.3 1.4 1.3 1.5 1.1 1.3 ns  Cytoplasm {ECO 1448/1459 Yes Yes -- -- -- Yes 100.0
1.3 1.3 1.0 1.0 2.0 1.3 ns  Cytoplasm. Nucleus {ECO 131 Yes Yes Yes No Yes Yes 83.3
136 Yes Yes Yes Yes Yes Yes 100.0
1.2 1.4 1.3 1.3 1.4 1.3 ns 18 Yes No No -- -- No 25.0
1.4 1.3 1.3 1.4 1.3 1.3 ns  Cytoplasm {ECO 111 Yes Yes No No No Yes 50.0
2.3 1.1 1.1 1.0 1.1 1.3 ns  Cytoplasm. Nucleus {ECO 651 Yes Yes Yes Yes No Yes 83.3
1.6 1.2 1.2 1.2 1.3 1.3 ns 662 Yes Yes No -- No No 40.0
1.2 1.3 1.3 1.6 1.2 1.3 ns  Cytoplasm, cytoskeleton {ECO 248 Yes Yes -- -- -- -- 100.0
1.2 1.6 1.3 1.4 1.1 1.3 ns  Cytoplasm {ECO 201 Yes Yes Yes No No Yes 66.7
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318 P21964 COMT Catechol O-methyltransferase COMT GSSC*FECTHYQSFLEYR 1.0 1.0 1.0
319 P13639 EEF2 Elongation factor 2 EEF2 STLTDSLVC*K 0.9 1.0 1.0
320 Q96CP2 FLYWCH2 FLYWCH family member 2 FLYWCH2 TEDSGLAAGPPEAAGENFAPC*SVAPGK 0.9 1.2 1.0
321 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 SSGGFVWAC*K 1.0 1.0 1.0
322 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 LLDLVQQSC*NYK 0.9 0.9 0.9
323 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 AAVEEGIVLGGGC*ALLR 0.9 1.0 1.0
324 P40222 TXLNA Alpha-taxilin TXLNA VTEAPC*YPGAPSTEASGQTGPQEPTSAR 0.9 1.4 1.1
325 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 EDLC*TK 0.9 1.1 1.0
326 Q9P1F3 ABRACL Costars family protein ABRACL ABRACL C*ANLFEALVGTLK 1.0 1.0 1.0
327 Q9HCC0 MCCC2 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial MCCC2
AATGEEVSAEDLGGADLH
C*R 0.9 0.9 0.9
328 O15075 DCLK1 Serine/threonine-protein kinase DCLK1 DCLK1 YQDDFLLDESEC*R 1.0 1.1 1.1
329 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 DAC*DTVR 1.0 1.0 1.0
330 Q9NQC3 RTN4 Reticulon-4 RTN4 YSNSALGHVNC*TIK 1.1 1.1 1.1
331 Q7L1Q6 BZW1 Basic leucine zipper and W2 domain-containing protein 1 BZW1
FDPTQFQDC*IIQGLTETGT
DLEAVAK 1.0 1.0 1.0
332 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 IIDINYYPVPEAC*LSNK 1.1 0.9 1.0
333 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM C*C*SGAIIVLTK 0.9 0.9 0.9
334 Q9P258 RCC2 Protein RCC2 RCC2 AVQDLC*GWR 1.1 1.2 1.1
335 Q13045 FLII Protein flightless-1 homolog FLII TGLC*YLPEELAALQK 0.8 1.1 1.0
336 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 C*VVVGDGAVGK 0.9 0.9 0.9
337 Q7Z4W1 DCXR L-xylulose reductase DCXR AVTNHSVYC*STK 0.9 0.8 0.9
338 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 IGNC*PFSQR 1.0 1.0 1.0
339 O43865 AHCYL1 Putative adenosylhomocysteinase 2 AHCYL1 LC*VPAMNVNDSVTK 0.9 1.0 0.9
340 Q9UPM8 AP4E1 AP-4 complex subunit epsilon-1 AP4E1 SSC*STLPDYLLYQCQK 0.7 0.7 0.7
341 P08238 HSP90AB1 Heat shock protein HSP 90-beta HSP90AB1 VFIMDSC*DELIPEYLNFIR 1.0 1.2 1.1
342 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 NLADC*LR 0.9 1.1 1.0
343 Q8NBF2 NHLRC2 NHL repeat-containing protein 2 NHLRC2
AILFSQPLQITDTQQGC*IA
PVELR 0.9 1.0 1.0
344 Q1KMD3
HNRNPUL2 Heterogeneous nuclear 
ribonucleoprotein U-like pro
HNRNPUL
2 EGC*TEVSLLR 1.0 1.0 1.0
345 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 IC*PVETLVEEAIQC*AEK 1.0 1.0 1.0
346 Q6IA69 NADSYN1 Glutamine-dependent NAD(+) synthetase NADSYN1 NSSQETC*TR 1.3 1.3 1.3
347 P30042 C21orf33 ES1 protein homolog, mitochondrial C21orf33 DC*K 0.9 1.0 0.9
348 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2 DLGGIVLANAC*GPC*IGQWDR 1.1 0.9 1.0
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1.4 1.2 1.2 1.3 1.3 1.3 ns
 Cytoplasm. Cell 
membrane; Single-pass 
type II membrane protein; 
Extracellular side {ECO
238 Yes No -- -- -- -- 50.0
1.3 1.1 1.2 1.3 1.5 1.3 ns  Cytoplasm. Nucleus {ECO 41 Yes Yes No No No No 33.3
1.2 1.3 1.4 1.4 1.2 1.3 ns 132 Yes -- -- -- -- -- 100.0
1.4 1.3 1.1 1.3 1.4 1.3 ns  Mitochondrion. 308 Yes Yes Yes No Yes Yes 83.3
1.3 1.3 1.2 1.3 1.3 1.3 ns  Nucleus, nucleolus {ECO 30 Yes Yes No No No No 33.3
1.3 1.2 1.3 1.3 1.3 1.3 ns  Mitochondrion matrix. 442 Yes Yes No No No No 33.3
1.1 1.5 1.2 1.3 1.4 1.3 ns 523 Yes Yes -- -- -- -- 100.0
1.2 1.2 1.3 1.5 1.3 1.3 ns 22 Yes Yes No -- -- No 50.0
1.1 1.3 1.3 1.4 1.3 1.3 ns 39 Yes Yes -- -- Yes -- 100.0
1.4 1.3 1.1 1.3 1.4 1.3 ns  Mitochondrion matrix {ECO 267 Yes Yes Yes -- Yes Yes 100.0
1.3 1.2 1.3 1.4 1.3 1.3 ns 276 Yes Yes No -- -- No 50.0
1.2 1.2 1.4 1.3 1.3 1.3 ns 204 Yes Yes No No No -- 40.0
1.1 1.5 1.0 1.3 1.5 1.3 ns
 Endoplasmic reticulum 
membrane; Multi-pass 
membrane protein. 
1101 Yes No No No No Yes 33.3
1.4 1.2 1.3 1.3 1.2 1.3 ns 35 Yes Yes No -- No -- 50.0
1.4 1.2 1.2 1.3 1.3 1.3 ns  Cytoplasm. 492 Yes No No No No No 16.7
1.2 1.3 1.3 1.3 1.2 1.3 ns  Cytoplasm. Nucleus. 423 Yes Yes No No No Yes 50.0
424 Yes Yes No No No No 33.3
1.3 1.1 1.3 1.4 1.3 1.3 ns




428 Yes Yes No -- No No 40.0
1.2 1.1 1.3 1.4 1.3 1.3 ns  Nucleus {ECO 46 Yes Yes No No -- No 40.0
1.2 1.3 1.5 1.1 1.3 1.3 ns  Cytoplasm. 6 Yes Yes Yes Yes Yes Yes 100.0
1.3 1.5 1.3 1.2 1.1 1.3 ns  Membrane {ECO 150 Yes Yes No No No Yes 50.0
1.3 1.2 1.2 1.3 1.4 1.3 ns  Nucleus. Nucleus membrane {ECO 24 Yes Yes Yes -- Yes No 80.0
1.2 1.0 1.4 1.2 1.4 1.3 ns  Endoplasmic reticulum {ECO 272 Yes Yes No No No No 33.3
1.3 1.1 1.3 1.4 1.3 1.3 ns
 Golgi apparatus, trans-
Golgi network. Membrane, 
coated pit {ECO
1119 Yes No -- -- -- -- 50.0
1.2 1.4 1.2 1.1 1.3 1.3 ns  Cytoplasm. Melanosome. 366 Yes Yes Yes No Yes Yes 83.3
1.3 1.3 1.2 1.2 1.3 1.3 ns  Cytoplasm. Nucleus. 91 Yes Yes No No No No 33.3
1.3 1.2 1.3 1.3 1.2 1.3 ns 716 Yes Yes -- -- -- -- 100.0
1.3 1.2 1.2 1.2 1.4 1.3 ns  Nucleus {ECO 308 Yes Yes -- -- No No 50.0
1.2 1.2 1.3 1.4 1.2 1.2 ns  Mitochondrion matrix. 213 Yes No No No No No 16.7
1.1 1.1 1.0 1.8 1.1 1.2 ns 428 Yes No No No No No 16.7
1.3 1.2 1.2 1.5 1.1 1.2 ns  Mitochondrion {ECO 153 Yes Yes -- -- -- -- 100.0
1.0 1.3 1.1 1.4 1.4 1.2 ns  Mitochondrion {ECO 448/451 Yes Yes Yes Yes Yes Yes 100.0
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349 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR
EQFSQGSPSNC*LETSLAEI
FPLGK 0.9 1.0 1.0
350 Q15233 NONO Non-POU domain-containing octamer-binding protein NONO C*SEGSFLLTTFPR 0.9 1.1 1.0
351 Q8IXH7 TH1L Negative elongation factor C/D TH1L AC*QALGAMLSK 1.1 0.9 1.0
352 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9 GIGMNEPLVDC*EGYPR 1.0 1.3 1.2
353 Q9UK41 VPS28 Vacuolar protein sorting-associated protein 28 homolog VPS28 LDC*PLAMER 1.1 1.3 1.2
354 P49327 FASN Fatty acid synthase FASN LTPGC*EAEAETEAICFFVQQFTDMEHNR 1.2 1.0 1.1
355 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 YEAAFPFLSPC*GR 1.2 1.0 1.1
356 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 DLNYC*FSGMSDHR 1.0 1.0 1.0
357 Q7L2H7 EIF3M Eukaryotic translation initiation factor 3 subunit EIF3M
VAASC*GAIQYIPTELDQV
R 0.9 1.0 0.9
358 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2 IENLELMSQHGC*NAWK 1.0 1.0 1.0
359 O43765
SGTA Small glutamine-rich 
tetratricopeptide repeat-containing protein 
alpha
SGTA AIC*IDPAYSK 1.0 1.0 1.0
360 P78406 RAE1 mRNA export factor RAE1 VFTASC*DK 0.9 1.0 1.0
361 Q8IWX8 CHERP Calcium homeostasis endoplasmic reticulum protein CHERP LALEQQQLIC*K 0.8 1.1 0.9
362 Q7Z4W1 DCXR L-xylulose reductase DCXR GVPGAIVNVSSQC*SQR 0.9 0.9 0.9
363 O00267 SUPT5H Transcription elongation factor SPT5 SUPT5H VELHSTC*QTISVDR 1.3 1.1 1.2
364 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10
TPSYSISSTLNPQAPEFILGC
*TASK 1.1 1.0 1.0
365 P55263 ADK Adenosine kinase ADK SLIANLAAANC*YK 1.0 1.0 1.0
366 P19367 HK1 Hexokinase-1 HK1 AAQLC*GAGMAAVVDK 0.9 0.6 0.8
367 Q14181 POLA2 DNA polymerase alpha subunit B POLA2 VLGC*PEALTGSYK 0.9 0.9 0.9
368 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 GTLTLC*PYHSDR 0.8 1.0 0.9
369 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK GSDFDC*ELR 0.9 0.9 0.9
370 P49327 FASN Fatty acid synthase FASN DGLLENQTPEFFQDVC*K 0.9 0.9 0.9
371 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 VGLGIC*YDMR 1.0 1.1 1.0
372 Q15004 KIAA0101 PCNA-associated factor KIAA0101 AC*PLQPDHTNDEK 1.1 1.0 1.0
373 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
LEGDLTGPSVDVEVPDVEL
EC*PDAK 1.1 1.1 1.1
374 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2 NDITAWQEC*VNNSMAQLEHQAVR 1.0 1.0 1.0
375 O95336 PGLS 6-phosphogluconolactonase PGLS AAC*CLAGAR 1.0 1.0 1.0
376 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5 NIDINDVTPNC*R 0.7 0.9 0.8
377 O75153 KIAA0664 Clustered mitochondria protein homolog KIAA0664 C*LTQQAVALQR 0.9 1.0 1.0
378 Q9BX63 BRIP1 Fanconi anemia group J protein BRIP1 LANNSDC*ILAK 0.9 1.0 0.9
379 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 SC*AHDWVYE 1.2 1.2 1.2
380 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 ENQWC*EEK 1.0 0.9 1.0
381 P15924 DSP Desmoplakin DSP AC*GSEIMQK 0.9 0.9 0.9
382 P20810 CAST Calpastatin CAST SEC*K 1.1 1.1 1.1
383 Q13185 CBX3 Chromobox protein homolog 3 CBX3 LTWHSC*PEDEAQ 0.9 1.0 1.0
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1.3 1.4 1.2 1.0 1.2 1.2 ns  Cytoplasm {ECO 161 Yes No No -- -- -- 33.3
1.1 1.0 1.4 1.4 1.4 1.2 ns  Nucleus. Nucleus, nucleolus. Nucleus speckle. 208 Yes Yes Yes -- No No 60.0
0.6 1.4 1.3 1.3 1.7 1.2 ns  Nucleus {ECO 293 Yes Yes Yes -- -- -- 100.0
1.3 1.2 1.2 1.3 1.1 1.2 ns 59 Yes Yes No No No No 33.3
1.2 1.2 1.3 1.3 1.2 1.2 ns  Cell membrane {ECO 103 Yes Yes Yes No Yes Yes 83.3
1.2 1.2 1.1 1.4 1.3 1.2 ns  Cytoplasm {ECO 2359 Yes Yes -- -- -- No 66.7
1.3 1.1 1.2 1.3 1.2 1.2 ns 98 Yes Yes Yes -- -- Yes 100.0
1.3 1.2 1.2 1.3 1.3 1.2 ns  Nucleus, nucleoplasm. 267 Yes Yes -- -- -- No 66.7
1.4 1.1 1.2 1.3 1.2 1.2 ns  Cytoplasm {ECO 134 Yes Yes Yes -- No No 60.0
1.3 1.0 1.2 1.4 1.2 1.2 ns  Nucleus, nucleolus {ECO 132 Yes Yes No -- No No 40.0
1.5 1.3 1.1 1.2 1.1 1.2 ns 153 Yes No No No No No 16.7
0.7 0.9 1.2 2.2 1.1 1.2 ns  Cytoplasm {ECO 106 Yes Yes Yes Yes Yes No 83.3
1.1 1.3 1.1 1.2 1.4 1.2 ns  Cytoplasm {ECO 69 Yes Yes -- -- No -- 66.7
1.3 1.2 1.1 1.2 1.3 1.2 ns  Membrane {ECO 138 Yes No No No No No 16.7
1.3 1.1 1.3 1.4 1.0 1.2 ns  Nucleus {ECO 740 Yes Yes Yes No No Yes 66.7
1.2 1.1 1.2 1.3 1.2 1.2 ns  Cytoplasm {ECO 94 Yes Yes -- -- -- -- 100.0
1.0 1.4 1.2 1.3 1.1 1.2 ns  Nucleus {ECO Cytoplasm {ECO 160 Yes Yes No No Yes No 50.0
2.0 1.2 1.0 0.9 1.1 1.2 ns  Mitochondrion outer membrane. 834 Yes Yes No No No -- 40.0
1.3 0.9 1.6 1.3 1.0 1.2 ns  Nucleus. 198 Yes No No No -- No 20.0
1.0 0.9 1.1 0.8 2.2 1.2 ns 779 Yes Yes No No No -- 40.0
1.1 1.3 1.3 1.2 1.3 1.2 ns  Cytoplasm {ECO 145 Yes Yes No No No No 33.3
1.3 1.0 1.1 1.5 1.1 1.2 ns  Cytoplasm {ECO 1992 Yes No -- -- -- No 33.3
1.4 1.1 1.0 1.2 1.3 1.2 ns  Cytoplasm {ECO 153 Yes Yes Yes Yes Yes Yes 100.0
1.3 1.0 1.2 1.4 1.1 1.2 ns  Nucleus {ECO 99 Yes Yes -- -- -- -- 100.0
1.1 1.1 1.1 1.4 1.2 1.2 ns  Nucleus. 2162 Yes No -- -- -- -- 50.0
0.8 1.3 1.2 1.5 1.3 1.2 ns  Nucleus, nucleolus {ECO 106 Yes Yes No -- No No 40.0
1.2 1.2 1.1 1.3 1.3 1.2 ns  Cytoplasm {ECO 32 Yes No No No No No 16.7
1.0 1.0 1.4 1.4 1.2 1.2 ns  Cytoplasm {ECO 112 Yes Yes Yes No No No 50.0
1.2 1.2 1.2 1.1 1.3 1.2 ns  Cytoplasm {ECO 1196 Yes Yes No -- No No 40.0
1.1 1.1 1.3 1.3 1.2 1.2 ns  Nucleus {ECO 1164 Yes Yes -- -- -- -- 100.0
1.4 1.4 1.0 1.0 1.2 1.2 ns 130 Yes Yes No No No No 33.3
1.2 1.2 1.2 1.2 1.2 1.2 ns 160 Yes Yes Yes No No Yes 66.7
1.2 1.2 1.2 1.2 1.1 1.2 ns  Cell junction, desmosome {ECO 1280 Yes Yes -- -- -- -- 100.0
1.0 1.1 1.5 1.3 1.1 1.2 ns 381 Yes No -- -- -- -- 50.0
1.2 1.1 1.1 1.3 1.2 1.2 ns  Nucleus {ECO 177 Yes Yes -- -- -- -- 100.0
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384 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1 IIC*SAGLSLLAEER 1.0 1.1 1.0
385 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
LEGDLTGPSVGVEVPDVEL
EC*PDAK 1.0 1.0 1.0
386 O15355 PPM1G Protein phosphatase 1G PPM1G GTEAGQVGEPGIPTGEAGPSC*SSASDK 1.0 1.0 1.0
387 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK LFQEC*C*PHSTDR 0.8 0.9 0.9
388 O15371 EIF3D Eukaryotic translation initiation factor 3 subunit EIF3D
FMTPVIQDNPSGWGPC*AV
PEQFR 1.0 1.0 1.0
389 O15382 BCAT2 Branched-chain-amino-acid aminotransferase, mitochondrial BCAT2 EVFGSGTAC*QVCPVHR 0.9 1.0 0.9
390 P17844 DDX5 Probable ATP-dependent RNA helicase DDX5 DDX5 LIDFLEC*GK 1.1 1.0 1.1
391 Q9Y3F4 STRAP Serine-threonine kinase receptor-associated protein STRAP
IGFPETTEEELEEIASENSD
C*IFPSAPDVK 1.0 1.1 1.0
392 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4 AGSDGESIGNC*PFSQR 1.0 1.0 1.0
393 Q2TAA2 IAH1 Isoamyl acetate-hydrolyzing esterase 1 homolog IAH1
VILITPTPLC*ETAWEEQCII
QGCK 0.9 0.9 0.9
394 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS YAGLSTC*FR 1.0 0.9 1.0
395 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 LC*VQNSPQEAR 1.0 1.0 1.0
396 Q9BSU1 C16orf70 UPF0183 protein C16orf70 C16orf70 LLAAGC*GPGLLADAK 0.9 0.9 0.9
397 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB HSMNPFC*EIAVEEAVR 1.2 1.1 1.2
398 Q9UNE7 STUB1 E3 ubiquitin-protein ligase CHIP STUB1 AQQAC*IEAK 1.0 1.1 1.1
399 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 C*EFQDAYVLLSEK 0.9 1.0 1.0
400 Q9UBF6 RNF7 RING-box protein 2 RNF7 VQVMDAC*LR 0.9 0.9 0.9
401 Q6YN16 HSDL2 Hydroxysteroid dehydrogenase-like protein 2 HSDL2
TAIHTAAMDMLGGPGIESQ
C*R 1.0 0.9 0.9
402 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 PIN1
SGEEDFESLASQFSDC*SSA
K 1.0 0.9 1.0
403 O14980 XPO1 Exportin-1 XPO1 LDINLLDNVVNC*LYHGEGAQQR 1.0 1.0 1.0
404 Q9UQ35 SRRM2 Serine/arginine repetitive matrix protein 2 SRRM2 SVSPC*SNVESR 1.0 0.9 1.0
405 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH ASVGFGGSC*FQK 0.9 1.0 1.0
406 Q9BRA2 TXNDC17 Thioredoxin domain-containing protein 17 TXNDC17 SWC*PDCVQAEPVVR 1.0 1.0 1.0
407 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS TIC*AILENYQTEK 0.9 1.0 1.0
408 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 HLNEIDLFHC*IDPNDSK 1.1 1.0 1.0
409 E9PPU0 EPPK1 Epiplakin EPPK1 TGGQALSTLEC*VK 0.9 1.0 0.9
410 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF C*NNVLYIR 1.0 1.0 1.0
411 P38646 HSPA9 Stress-70 protein, mitochondrial HSPA9 C*ELSSSVQTDINLPYLTMDSSGPK 0.9 1.0 0.9
412 P07900 HSP90AA1 Heat shock protein HSP 90-alpha HSP90AA1 VFIMDNC*EELIPEYLNFIR 1.1 1.0 1.0
413 Q15796 SMAD2 Mothers against decapentaplegic homolog 2 SMAD2 AITTQNC*NTK 0.9 1.1 1.0
414 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 LVVPATQC*GSLIGK 0.9 1.0 0.9
415 Q96RS6 NUDCD1 NudC domain-containing protein 1 NUDCD1 DSAQC*AAIAER 0.8 0.8 0.8
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1.3 1.2 1.1 1.2 1.1 1.2 ns  Nucleus {ECO 195 Yes No No No No No 16.7
1.1 1.1 1.2 1.5 1.1 1.2 ns  Nucleus. 1900 Yes No -- -- -- -- 50.0
1.2 1.1 1.2 1.3 1.2 1.2 ns  Cytoplasm {ECO 241 Yes Yes -- -- -- -- 100.0
1.2 1.1 1.3 1.3 1.2 1.2 ns  Cytoplasm {ECO 184 Yes Yes No No No No 33.3
185 Yes Yes No No Yes No 50.0
1.3 1.1 1.1 1.3 1.2 1.2 ns  Cytoplasm {ECO 19 Yes Yes Yes -- No No 60.0
1.1 1.2 1.1 1.1 1.4 1.2 ns  Mitochondrion. Cytoplasm. 342 Yes Yes Yes No No Yes 66.7
1.2 1.1 1.2 1.2 1.1 1.2 ns  Nucleus, nucleolus {ECO 234 Yes Yes No No No No 33.3
1.0 1.1 1.3 1.4 1.2 1.2 ns  Cytoplasm. Nucleus. 340 Yes No -- -- -- -- 50.0
1.1 1.3 1.0 1.3 1.1 1.2 ns





35 Yes Yes Yes -- Yes No 80.0
1.2 1.1 1.1 1.2 1.2 1.2 ns 137 Yes Yes -- No No -- 50.0
1.2 1.1 1.1 1.3 1.2 1.2 ns  Cytoplasm. 300 Yes Yes Yes Yes Yes Yes 100.0
1.3 1.1 1.2 1.2 1.2 1.2 ns  Nucleus {ECO 150 Yes Yes Yes -- No No 60.0
1.3 1.2 1.0 1.1 1.3 1.2 ns 222 Yes Yes No -- No No 40.0
1.1 1.0 1.3 1.3 1.2 1.2 ns  Mitochondrion matrix {ECO 42 Yes Yes No No Yes No 50.0
1.1 1.3 1.0 1.4 1.0 1.2 ns  Cytoplasm {ECO 199 Yes Yes No -- No No 40.0
1.1 1.2 1.1 1.2 1.2 1.2 ns  Mitochondrion matrix. 237 Yes Yes No No Yes No 50.0
1.1 1.4 1.1 1.1 1.1 1.2 ns  Cytoplasm {ECO 61 Yes Yes Yes Yes Yes Yes 100.0
0.9 1.2 1.1 1.5 1.1 1.2 ns  Peroxisome {ECO 218 Yes Yes No -- -- No 50.0
1.1 1.1 1.1 1.3 1.2 1.2 ns  Nucleus {ECO 113 Yes Yes Yes Yes Yes Yes 100.0
1.2 1.1 1.2 1.2 1.2 1.2 ns
 Cytoplasm. Nucleus, 
nucleoplasm. Nucleus, 
Cajal body. Nucleus, 
nucleolus
34 Yes Yes No No No No 33.3
1.1 1.1 1.1 1.5 1.1 1.2 ns  Nucleus speckle. 956 Yes Yes -- -- -- -- 100.0
1.2 1.0 1.6 1.0 1.1 1.2 ns 276 Yes Yes Yes -- Yes Yes 100.0
1.2 1.1 1.1 1.3 1.2 1.2 ns  Cytoplasm {ECO 43 Yes Yes Yes -- Yes Yes 100.0
1.2 1.2 1.1 1.2 1.2 1.2 ns  Cytoplasm. 438 Yes Yes Yes Yes Yes Yes 100.0
1.2 1.1 1.1 1.2 1.2 1.2 ns  Cytoplasm. 58 Yes Yes No No No No 33.3
1.2 1.2 1.0 1.4 1.1 1.2 ns Bad ID Error Error Error Error Error Error #DIV/0!
1.2 1.1 1.1 1.2 1.2 1.2 ns  Cytoplasm, cytosol {ECO 66 Yes Yes Yes Yes Yes Yes 100.0
1.1 1.0 1.1 1.4 1.1 1.2 ns  Mitochondrion {ECO 317 Yes Yes Yes No No Yes 66.7
1.2 1.1 1.2 1.3 1.1 1.2 ns  Cytoplasm. Melanosome. Cell membrane. 374 Yes Yes Yes No Yes Yes 83.3
1.3 0.4 1.4 1.4 1.3 1.2 ns  Cytoplasm {ECO 70 Yes Yes No -- -- No 50.0
1.2 1.1 1.2 1.2 1.2 1.2 ns  Nucleus. Cytoplasm. 109 Yes Yes Yes No Yes Yes 83.3
1.2 1.4 1.1 1.0 1.1 1.2 ns
 Cytoplasm. Nucleus. 
Cytoplasm. Cytoplasm. 
Nucleus.
376 Yes Yes No -- -- No 50.0
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416 Q16854 DGUOK Deoxyguanosine kinase, mitochondrial DGUOK AC*TAQSLGNLLDMMYR 1.0 1.2 1.1
417 P28838 LAP3 Cytosol aminopeptidase LAP3 SAGAC*TAAAFLK 0.9 1.0 1.0
418 P37802 TAGLN2 Transgelin-2 TAGLN2 QYDADLEQILIQWITTQC*R 1.0 1.0 1.0
419 P07741 APRT Adenine phosphoribosyltransferase APRT VVVVDDLLATGGTMNAAC*ELLGR 1.1 1.1 1.1
420 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5
GTPEQPQC*GFSNAVVQIL
R 1.0 1.0 1.0
421 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS PTEVDFLQGDC*TK 0.9 1.0 0.9
422 P53990 IST1 IST1 homolog IST1 IVADQLC*AK 1.0 1.0 1.0
423 Q5MNZ6
WDR45L WD repeat domain 
phosphoinositide-interacting protein 3 WDR45L C*NYLALVGGGK 1.0 1.0 1.0
424 Q9BV79 MECR Trans-2-enoyl-CoA reductase, mitochondrial MECR LALNC*VGGK 1.0 0.9 1.0
425 O75940 SMNDC1 Survival of motor neuron-related-splicing factor 3 SMNDC1 VGVGTC*GIADK 0.9 1.0 1.0
426 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/threonine phosphatase 2C ILKAP FILLAC*DGLFK 0.9 1.0 0.9
427 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 GFGFVC*FSSPEEATK 1.0 1.2 1.1
428 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 IAAYLQSDQFC*K 0.9 1.0 0.9
429 P78347 GTF2I General transcription factor II-I GTF2I SILSPGGSC*GPIK 0.9 0.9 0.9
430 P53602 MVD Diphosphomevalonate decarboxylase MVD DGDPLPSSLSC*K 1.0 1.3 1.1
431 P26641 EEF1G Elongation factor 1-gamma EEF1G AAAPAPEEEMDEC*EQALAAEPK 1.0 1.0 1.0
432 P49915 GMPS GMP synthase GMPS TVGVQGDC*R 0.5 1.1 0.8
433 P21964 COMT Catechol O-methyltransferase COMT IVDAVIQEHQPSVLLELGAYC*GYSAVR 0.9 1.0 1.0
434 P53396 ACLY ATP-citrate synthase ACLY FIC*TTSAIQNR 0.9 1.0 0.9
435 Q9UI30 TRMT112 tRNA methyltransferase 112 homolog TRMT112 IC*PVEFNPNFVAR 1.0 1.0 1.0
436 Q9UNH7 SNX6 Sorting nexin-6 SNX6 IGSSLYALGTQDSTDIC*K 0.9 0.9 0.9
437 P49841 GSK3B Glycogen synthase kinase-3 beta GSK3B LC*DFGSAK 1.0 1.0 1.0
438 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 HFLSDTGMAC*R 1.0 1.1 1.0
439 Q9Y224 C14orf166 UPF0568 protein C14orf166 C14orf166 LTALDYHNPAGFNC*K 1.0 1.0 1.0
440 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 QEPLGSDSEGVNC*LAYDEAIMAQQDR 1.0 1.0 1.0
441 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 INISEGNC*PER 1.0 1.0 1.0
442 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1 VIGIEC*SSISDYAVK 0.9 1.0 0.9
443 Q15181 PPA1 Inorganic pyrophosphatase PPA1 GISC*MNTTLSESPFK 1.0 1.3 1.2
444 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M HNRNPM AC*QIFVR 1.0 1.0 1.0
445 P00338 LDHA L-lactate dehydrogenase A chain LDHA VIGSGC*NLDSAR 1.0 1.0 1.0
446 Q14151 SAFB2 Scaffold attachment factor B2 SAFB2 ILDILGETC*K 1.0 0.7 0.8
447 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 GLLDVTC*K 1.0 0.9 1.0
448 Q9Y2Q3 GSTK1 Glutathione S-transferase kappa 1 GSTK1 ETTEAAC*R 1.0 1.0 1.0
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1.1 1.0 1.1 1.4 1.2 1.2 ns  Mitochondrion. 87 Yes No No -- No -- 25.0
1.1 0.9 1.2 1.4 1.1 1.2 ns  Cytoplasm. 462 Yes Yes Yes -- No No 60.0
0.8 1.8 1.2 1.0 0.9 1.2 ns 38 Yes Yes No No -- Yes 60.0
1.0 1.3 1.1 1.2 1.1 1.1 ns  Cytoplasm. 140 Yes Yes No No No No 33.3
1.2 1.1 1.1 1.2 1.2 1.1 ns  Mitochondrion matrix {ECO 67 Yes Yes Yes Yes Yes Yes 100.0
1.2 1.1 1.1 1.3 1.1 1.1 ns 336 Yes Yes No -- No No 40.0
1.1 1.1 1.3 1.2 1.0 1.1 ns  Cytoplasmic vesicle {ECO 125 Yes Yes No No No No 33.3
1.1 1.2 1.0 1.1 1.2 1.1 ns 63 Yes Yes Yes No Yes No 66.7
1.3 1.0 1.0 1.1 1.3 1.1 ns  Mitochondrion {ECO Cytoplasm {ECO 263 Yes Yes Yes No Yes Yes 83.3
1.0 1.4 1.0 1.2 1.1 1.1 ns  Nucleus speckle. Nucleus, Cajal body. 214 Yes Yes Yes -- No -- 75.0
1.0 1.1 1.4 1.2 0.9 1.1 ns  Cytoplasm {ECO 325 Yes Yes Yes Yes Yes Yes 100.0
1.0 1.2 1.3 1.2 1.0 1.1 ns  Cytoplasm. Nucleus. 339 Yes Yes Yes Yes No Yes 83.3
1.2 1.1 1.1 1.2 1.2 1.1 ns  Cytoplasm. 208 Yes No -- -- -- No 33.3
1.1 1.0 1.1 1.2 1.2 1.1 ns  Cytoplasm {ECO 215 Yes Yes -- -- -- -- 100.0
1.1 1.1 1.1 1.2 1.1 1.1 ns 108 Yes No No No No No 16.7
1.1 1.1 1.2 1.1 1.1 1.1 ns 266 Yes Yes No No No No 33.3
1.3 0.7 1.1 1.3 1.4 1.1 ns  Cytoplasm. 523 Yes Yes No No No No 33.3
1.1 1.1 1.2 1.1 1.2 1.1 ns
 Cytoplasm. Cell 
membrane; Single-pass 
type II membrane protein; 
Extracellular side {ECO
119 Yes Yes -- -- No -- 66.7
1.3 1.0 1.0 1.2 1.2 1.1 ns  Cytoplasm. 20 Yes Yes No -- -- No 50.0
0.9 1.2 1.2 1.2 1.2 1.1 ns 33 Yes No No No No No 16.7
1.1 1.0 1.1 1.2 1.2 1.1 ns  Early endosome {ECO 264 Yes Yes No -- No No 40.0
1.0 1.2 1.0 1.2 1.2 1.1 ns  Cytoplasm. Nucleus. Cell membrane. 199 Yes Yes Yes Yes Yes Yes 100.0
1.1 1.2 1.0 1.2 1.1 1.1 ns 119 Yes Yes No -- No No 40.0
1.1 1.1 1.1 1.2 1.1 1.1 ns






19 Yes Yes -- -- -- No 66.7
1.1 1.1 1.2 1.1 1.1 1.1 ns  Cytoplasm {ECO 23 Yes Yes -- -- Yes No 75.0
1.1 1.1 1.1 1.2 1.1 1.1 ns  Cytoplasm {ECO 86 Yes Yes Yes No No Yes 66.7
1.1 1.1 1.0 1.2 1.2 1.1 ns  Nucleus {ECO 109 Yes Yes Yes No Yes No 66.7
1.2 1.0 1.2 1.1 1.1 1.1 ns  Cytoplasm {ECO 242 Yes Yes No No -- No 40.0
1.2 1.1 1.1 1.0 1.2 1.1 ns  Nucleus, nucleolus {ECO 653 Yes Yes -- -- -- -- 100.0
1.1 1.1 1.2 1.1 1.1 1.1 ns  Cytoplasm. 163 Yes Yes No No No No 33.3
0.9 1.3 1.2 1.2 0.9 1.1 ns  Cytoplasm. Nucleus. 224 Yes Yes -- -- -- -- 100.0
1.1 1.1 1.1 1.1 1.1 1.1 ns 120 Yes Yes Yes Yes Yes Yes 100.0
1.1 1.1 1.2 1.1 1.1 1.1 ns  Peroxisome {ECO 176 Yes Yes -- -- -- No 66.7
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449 P53041 PPP5C Serine/threonine-protein phosphatase 5 PPP5C TEC*AEPPR 0.9 1.0 1.0
450 P36969 GPX4 Phospholipid hydroperoxide glutathione peroxidase, mitochondrial GPX4 YAEC*GLR 1.0 0.9 0.9
451 Q86YH6 PDSS2 Decaprenyl-diphosphate synthase subunit 2 PDSS2 C*LLSDELSNIAMQVR 0.8 1.0 0.9
452 Q9NYL2 MLTK Mitogen-activated protein kinase kinase kinase MLT MLTK IC*DFGASR 0.8 0.8 0.8
453 P42704 LRPPRC Leucine-rich PPR motif-containing protein, mitochondrial LRPPRC IHDVLC*K 1.0 1.2 1.1
454 Q96HE7 ERO1L ERO1-like protein alpha ERO1L HDDSSDNFC*EADDIQSPEAEYVDLLLNPER 0.9 1.1 1.0
455 P60981 DSTN Destrin DSTN C*STPEEIK 1.0 1.0 1.0
456 P29401 TKT Transketolase TKT MAAISESNINLCGSHC*GVSIGEDGPSQMALEDLAMFR 1.1 1.0 1.1
457 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 LVVPASQC*GSLIGK 0.9 1.0 0.9
458 Q15149 PLEC Plectin PLEC AFC*GFEDPR 1.0 1.0 1.0
459 Q8WTW3
COG1 Conserved oligomeric Golgi 
complex subunit 1 COG1 C*AVGLVDAVK 0.9 1.2 1.1
460 P62258 YWHAE 14-3-3 protein epsilon YWHAE LIC*C*DILDVLDK 1.0 1.0 1.0
461 Q969T9 WBP2 WW domain-binding protein 2 WBP2 DC*EIK 0.9 0.9 0.9
462 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK
IIPTLEEGLQLPSPTATSQLP
LESDAVEC*LNYQHYK 0.9 1.0 1.0
463 Q14247 CTTN Src substrate cortactin CTTN C*ALGWDHQEK 1.0 0.9 0.9
464 Q8TB45 DEPTOR DEP domain-containing mTOR-interacting protein DEPTOR SPSSQETHDSPFC*LR 0.7 1.0 0.9
465 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 LDFVC*SFLQK 1.0 0.8 0.9
466 Q9H773 DCTPP1 dCTP pyrophosphatase 1 DCTPP1 YTELPHGAISEDQAVGPADIPC*DSTGQTST 1.2 1.0 1.1
467 Q9BY32 ITPA Inosine triphosphate pyrophosphatase ITPA
GC*QDFGWDPCFQPDGYE
QTYAEMPK 1.0 1.0 1.0
468 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 YLEC*SALTQR 1.0 1.1 1.0
469 P62826 RAN GTP-binding nuclear protein Ran RAN VC*ENIPIVLC*GNK 0.9 1.0 1.0
470 Q9BW61 DDA1 DET1- and DDB1-associated protein 1 DDA1 FHADSVC*K 1.0 1.2 1.1
471 P36507 MAP2K2 Dual specificity mitogen-activated protein kinase kinase 2 MAP2K2
LC*DFGVSGQLIDSMANSF
VGTR 1.1 1.0 1.1
472 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 VTDDLVC*LVYK 0.8 0.9 0.8
473 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
GQAGGGGPGTGPGLGEAG
SLATC*ELPLAK 1.1 1.0 1.0
474 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS DGVC*VR 0.9 0.8 0.9
475 P50990 CCT8 T-complex protein 1 subunit theta CCT8 IAVYSC*PFDGMITETK 1.1 0.9 1.0
476 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
GPFVEAEVPDVDLEC*PDA
K 0.9 1.0 1.0
477 P51659 HSD17B4 Peroxisomal multifunctional enzyme type 2 HSD17B4 IC*DFENASK 1.1 1.1 1.1
478 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 AITIAGVPQSVTEC*VK 1.0 1.0 1.0
479 P62857 RPS28 40S ribosomal protein S28 RPS28 TGSQGQC*TQVR 0.9 0.9 0.9
480 Q8N987 NECAB1 N-terminal EF-hand calcium-binding protein 1 NECAB1
ETLNQLQSLQNSLEC*AME
TTEEQTR 1.0 0.9 0.9
481 P37802 TAGLN2 Transgelin-2 TAGLN2 NMAC*VQR 1.0 1.0 1.0
205
1.0 0.8 1.2 1.3 1.1 1.1 ns  Nucleus {ECO 11 Yes Yes -- -- -- -- 100.0
1.1 1.0 1.1 1.2 1.2 1.1 ns  Mitochondrion. Cytoplasm. 93 Yes Yes No No No No 33.3
0.7 1.1 1.2 1.3 1.2 1.1 ns  Mitochondrion {ECO 71 Yes Yes No -- -- -- 66.7
1.0 1.2 0.9 1.2 1.2 1.1 ns  Cytoplasm {ECO 150 Yes Yes No No Yes Yes 66.7
1.1 0.9 1.1 0.9 1.5 1.1 ns
 Mitochondrion. Nucleus, 
nucleoplasm. Nucleus inner 
membrane. Nucleus outer 
membrane. 
863 Yes Yes -- -- -- -- 100.0
1.0 1.2 1.0 1.2 1.2 1.1 ns  Endoplasmic reticulum membrane {ECO 166 Yes Yes Yes Yes No Yes 83.3
1.1 1.0 1.1 1.2 1.1 1.1 ns 23 Yes Yes No No No No 33.3
1.0 1.1 1.1 1.2 1.2 1.1 ns 417 Yes Yes Yes No No No 50.0
1.1 1.1 1.1 1.2 1.1 1.1 ns  Cytoplasm {ECO 141 Yes Yes Yes No Yes Yes 83.3
1.1 1.1 1.0 1.2 1.1 1.1 ns  Cytoplasm, cytoskeleton {ECO 4494 Yes Yes -- -- -- -- 100.0
1.1 1.0 1.0 1.4 1.0 1.1 ns  Golgi apparatus membrane {ECO 72 Yes Yes No -- No -- 50.0
1.2 1.0 1.1 1.1 1.1 1.1 ns  Cytoplasm {ECO 97 Yes Yes Yes No Yes Yes 83.3
98 Yes Yes No No No No 33.3
1.0 1.1 1.2 1.1 1.1 1.1 ns 80 Yes Yes No -- -- No 50.0
1.1 1.0 1.0 1.1 1.1 1.1 ns  Cytoplasm {ECO 132 Yes Yes No No No No 33.3
1.1 1.1 1.1 1.1 1.1 1.1 ns  Cytoplasm, cytoskeleton {ECO 246 Yes Yes No -- -- -- 66.7
1.0 1.2 1.2 1.0 1.0 1.1 ns 247 Yes Yes -- No -- -- 66.7
1.2 1.1 1.0 1.1 1.1 1.1 ns
 Nucleus matrix {ECO 
Cytoplasm, cytosol {ECO 
Cytoplasm, cytosol {ECO
65 Yes Yes -- -- -- -- 100.0
1.1 1.1 1.1 1.1 1.1 1.1 ns  Cytoplasm {ECO 162 Yes No -- -- -- -- 50.0
1.3 1.0 0.9 1.2 1.1 1.1 ns  Cytoplasm {ECO 146 Yes No No No No No 16.7
0.8 1.8 1.0 0.9 0.9 1.1 ns  Cytoplasm. 157 Yes Yes Yes Yes Yes Yes 100.0
1.1 1.0 1.2 1.0 1.1 1.1 ns




0 Yes Yes Yes Yes Yes Yes 100.0
1.0 1.2 1.0 1.0 1.1 1.1 ns 25 Yes Yes No -- No -- 50.0
1.1 1.0 1.0 1.1 1.2 1.1 ns  Cytoplasm {ECO 211 Yes Yes Yes Yes No Yes 83.3
1.1 1.0 1.1 1.1 1.1 1.1 ns  Cytoplasm. 48 Yes Yes Yes -- Yes Yes 100.0
1.1 1.0 0.9 1.2 1.1 1.1 ns  Mitochondrion {ECO 45 Yes No -- -- -- -- 50.0
1.2 0.9 1.2 1.1 1.0 1.1 ns  Cytoplasm, cytosol {ECO 265 Yes Yes No No No No 33.3
1.1 1.0 1.0 1.2 1.1 1.1 ns  Cytoplasm {ECO 244 Yes Yes Yes Yes No Yes 83.3
1.0 1.1 1.1 1.1 1.0 1.1 ns  Nucleus. 1833 Yes No -- -- -- -- 50.0
0.9 1.0 1.3 1.1 1.1 1.1 ns  Peroxisome. 277 Yes Yes No No -- No 40.0
1.0 1.2 1.1 0.9 1.1 1.1 ns  Nucleus. Cytoplasm. 158 Yes Yes Yes No No Yes 66.7
1.0 1.1 1.1 1.1 1.1 1.1 ns 27 Yes Yes Yes No No Yes 66.7
1.1 0.9 1.0 1.2 1.2 1.1 ns  Cytoplasm {ECO 152 Yes Yes -- -- -- -- 100.0
1.3 1.0 0.9 1.0 1.1 1.1 ns 124 Yes Yes No No -- No 40.0
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482 Q9NZZ3 CHMP5 Charged multivesicular body protein 5 CHMP5 APPPSLTDC*IGTVDSR 1.0 0.9 0.9
483 P30153
PPP2R1A Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform
PPP2R1A LNIISNLDC*VNEVIGIR 0.8 1.0 0.9
484 P55735 SEC13 Protein SEC13 homolog SEC13 FASGGC*DNLIK 1.0 1.0 1.0
485 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
EEFASTC*PDDEEIELAYEQ
VAK 1.3 1.3 1.3
486 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 FIC*EQDHQNFLR 1.1 1.2 1.1
487 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 LNEC*VDHTPK 1.0 0.9 1.0
488 Q96Q11 TRNT1 CCA tRNA nucleotidyltransferase 1, mitochondrial TRNT1 YQGEHC*LLK 0.9 0.9 0.9
489 P13639 EEF2 Elongation factor 2 EEF2 YVEPIEDVPC*GNIVGLVGVDQFLVK 1.0 1.0 1.0
490 P35270 SPR Sepiapterin reductase SPR TVVNISSLC*ALQPFK 0.9 0.8 0.9
491 P60981 DSTN Destrin DSTN LGGSLIVAFEGC*PV 0.9 0.9 0.9
492 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 YTC*GEAPDYDR 0.9 0.9 0.9
493 P08238 HSP90AB1 Heat shock protein HSP 90-beta HSP90AB1
LVSSPC*C*IVTSTYGWTAN
MER 0.8 1.0 0.9
494 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 MACROD1
LEVDAIVNAANSSLLGGG
GVDGC*IHR 0.9 1.0 1.0
495 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 FC*PFAER 1.0 1.0 1.0
496 P31947 SFN 14-3-3 protein sigma SFN GEELSC*EER 0.9 0.9 0.9
497 P52943 CRIP2 Cysteine-rich protein 2 CRIP2 ASSVTTFTGEPNTC*PR 1.0 0.9 0.9
498 Q6KB66 KRT80 Keratin, type II cytoskeletal 80 KRT80 C*HIDLSGIVEEVK 0.9 1.0 1.0
499 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F HNRNPF GLPFGC*TK 1.0 0.9 0.9
500 Q9Y5P6 GMPPB Mannose-1-phosphate guanyltransferase beta GMPPB LC*SGPGIVGNVLVDPSAR 0.9 1.1 1.0
501 Q14247 CTTN Src substrate cortactin CTTN HC*SQVDSVR 0.9 0.9 0.9
502 P13639 EEF2 Elongation factor 2 EEF2 TFC*QLILDPIFK 0.8 0.9 0.9
503 P33316 DUT Deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial DUT TDIQIALPSGC*YGR 1.0 1.0 1.0
504 P27348 YWHAQ 14-3-3 protein theta YWHAQ YLAEVAC*GDDR 0.9 1.0 0.9
505 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS C*LSVMEAK 0.9 0.9 0.9
506 Q9Y365 STARD10 PCTP-like protein STARD10 MEC*C*DVPAETLYDVLHDIEYR 1.0 1.1 1.1
507 P23434 GCSH Glycine cleavage system H protein, mitochondrial GCSH SC*YEDGWLIK 1.3 0.8 1.1
508 Q01518 CAP1 Adenylyl cyclase-associated protein 1 CAP1 ALLVTASQC*QQPAENK 0.9 1.0 1.0
509 P13639 EEF2 Elongation factor 2 EEF2 C*LYASVLTAQPR 1.0 0.8 0.9
510 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL LTAC*QVATAFNLSR 1.0 1.1 1.0
511 O00204 SULT2B1 Sulfotransferase family cytosolic 2B member 1 SULT2B1
APWC*ETIVGAFSLPDQYS
PR 0.9 1.0 1.0
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1.0 1.1 1.1 1.1 1.0 1.1 ns
 Cytoplasm, cytosol. 
Endosome membrane 
{ECO
20 Yes Yes Yes No No No 50.0
1.0 1.1 0.9 1.2 1.1 1.1 ns  Cytoplasm {ECO 390 Yes Yes Yes No No No 50.0
1.1 1.0 1.0 1.1 1.1 1.1 ns








Cytoplasmic side. Nucleus, 
nuclear pore complex. 
187 Yes Yes Yes No Yes No 66.7
0.9 1.0 1.3 1.1 1.1 1.1 ns  Nucleus. Nucleus membrane {ECO 223 Yes Yes Yes -- No Yes 80.0
0.8 1.0 1.1 1.2 1.2 1.1 ns  Cytoplasm {ECO 658 Yes Yes -- No No No 40.0
1.0 1.3 1.0 1.0 1.0 1.1 ns  Cytoplasm, cytosol {ECO 192 Yes Yes No No -- No 40.0
1.3 1.0 1.1 1.1 0.9 1.1 ns  Mitochondrion {ECO 373 Yes No No -- -- No 25.0
0.9 1.1 1.1 0.9 1.1 1.0 ns  Cytoplasm. Nucleus {ECO 466 Yes Yes No No Yes No 50.0
1.1 1.0 1.1 1.0 1.1 1.0 ns  Cytoplasm. 159 Yes Yes No No No No 33.3
1.1 1.0 1.0 1.1 1.0 1.0 ns 163 Yes No -- -- -- -- 50.0
1.0 1.0 1.2 1.1 0.9 1.0 ns  Cytoplasm. 39 Yes Yes No -- -- No 50.0
1.2 1.1 0.9 1.0 1.0 1.0 ns  Cytoplasm. Melanosome. 589 Yes Yes Yes No Yes Yes 83.3
590 Yes Yes Yes No Yes Yes 83.3
1.1 1.0 1.0 1.0 1.2 1.0 ns  Nucleus {ECO 186 Yes Yes No -- No No 40.0
1.1 1.0 1.1 1.1 1.1 1.0 ns  Cytoplasm, cytosol {ECO 32 Yes Yes Yes No No Yes 66.7
1.0 1.1 1.1 1.1 1.0 1.0 ns  Cytoplasm. Nucleus {ECO 38 Yes Yes No No No No 33.3
1.1 0.9 1.1 1.2 1.0 1.0 ns 126 Yes Yes Yes -- Yes Yes 100.0
1.0 1.0 1.0 1.1 1.1 1.0 ns 244 Yes Yes No -- -- No 50.0
1.0 1.1 1.1 1.0 1.0 1.0 ns  Nucleus, nucleoplasm. 122 Yes Yes No -- No Yes 60.0
1.0 1.0 1.0 1.0 1.1 1.0 ns  Cytoplasm {ECO 245 Yes No No No No No 16.7
1.1 0.9 1.1 1.1 1.0 1.0 ns  Cytoplasm, cytoskeleton {ECO 112 Yes Yes No -- -- -- 66.7
1.0 1.1 1.0 1.1 1.0 1.0 ns  Cytoplasm. Nucleus {ECO 290 Yes Yes Yes No No Yes 66.7
1.0 1.4 0.9 0.9 1.0 1.0 ns  Nucleus {ECO Mitochondrion {ECO 166 Yes Yes No No No No 33.3
0.9 1.1 1.1 1.0 1.1 1.0 ns  Cytoplasm. 134 Yes Yes No No No No 33.3
1.2 1.0 0.9 1.0 1.1 1.0 ns  Cytoplasm {ECO 773 Yes No No No No No 16.7
1.0 1.0 1.1 1.0 1.0 1.0 ns  Cell projection, cilium, flagellum {ECO 74/75 Yes Yes No -- No No 40.0
0.9 1.2 0.6 1.0 1.4 1.0 ns  Mitochondrion. 138 Yes Yes Yes No No No 50.0
0.9 1.1 1.0 0.9 1.2 1.0 ns  Cell membrane {ECO 93 Yes Yes No No No No 33.3
1.1 1.2 1.2 1.0 0.8 1.0 ns  Cytoplasm. Nucleus {ECO 728 Yes Yes Yes No No No 50.0
1.1 0.9 1.0 1.0 1.0 1.0 ns 441 Yes No -- -- No -- 33.3
1.3 1.0 1.1 0.8 0.9 1.0 ns  Cytoplasm. Microsome. Nucleus. 104 Yes Yes No -- No No 40.0
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512 P51610 HCFC1 Host cell factor 1 HCFC1 LVIYGGMSGC*R 0.9 0.9 0.9
513 P47756 CAPZB F-actin-capping protein subunit beta CAPZB DETVSDC*SPHIANIGR 1.1 1.0 1.0
514 Q12765 SCRN1 Secernin-1 SCRN1 TQSPC*FGDDDPAK 0.9 1.0 1.0
515 Q8TAQ2 SMARCC2 SWI/SNF complex subunit SMARCC2 SMARCC2 NLAGDVC*AIMR 1.2 1.1 1.2
516 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH ISSINSISALC*EATGADVEEVATAIGMDQR 1.0 1.0 1.0
517 P00492 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1 SYC*NDQSTGDIK 1.0 0.8 0.9
518 P30086 PEBP1 Phosphatidylethanolamine-binding protein 1 PEBP1
APVAGTC*YQAEWDDYVP
K 1.0 1.1 1.0
519 P35270 SPR Sepiapterin reductase SPR AVC*LLTGASR 1.0 1.0 1.0
520 Q96EY8 MMAB Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial MMAB
IQCTLQDVGSALATPC*SS
AR 0.9 1.1 1.0
521 O75131 CPNE3 Copine-3 CPNE3 NC*LNPQFSK 0.9 1.0 1.0
522 Q9HAV7 GRPEL1 GrpE protein homolog 1, mitochondrial GRPEL1 LYGIQAFC*K 1.0 0.8 0.9
523 Q8NDH3
NPEPL1 Probable aminopeptidase 
NPEPL1 NPEPL1
IVDTPC*NEMNTDTFLEEIN
K 0.9 1.1 1.0
524 Q9H8M7 FAM188A Protein FAM188A FAM188A SSPGLSDTIFC*R 1.5 0.9 1.2
525 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1 LSLDGQNIYNAC*C*TLR 0.9 1.1 1.0
526 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS
NVGC*LQEALQLATSFAQL
R 1.1 1.1 1.1
527 P14649 MYL6B Myosin light chain 6B MYL6B ILYSQC*GDVMR 1.0 0.9 1.0
528 P21964 COMT Catechol O-methyltransferase COMT LITIEINPDC*AAITQR 0.9 0.9 0.9
529 P30626 SRI Sorcin SRI DTAQQGVVNFPYDDFIQC*VMSV 1.0 0.9 0.9
530 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 ILSC*GEVIHVK 1.0 1.5 1.2
531 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 C*LDEFPNLK 1.0 1.1 1.1
532 P49753 ACOT2 Acyl-coenzyme A thioesterase 2, mitochondrial ACOT2 SEFYANEAC*K 1.0 1.0 1.0
533 P12004 PCNA Proliferating cell nuclear antigen PCNA C*AGNEDIITLR 1.2 0.9 1.1
534 Q9NRF9 POLE3 DNA polymerase epsilon subunit 3 POLE3
AASVFVLYATSC*ANNFAM
K 0.9 1.1 1.0
535 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 GDFC*IQVGR 1.0 0.9 0.9
536 Q7LG56 RRM2B Ribonucleoside-diphosphate reductase subunit M2 B RRM2B
IEQEFLTEALPVGLIGMNC*
ILMK 0.8 1.1 1.0
537 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 AITIAGIPQSIIEC*VK 1.1 1.0 1.1
538 Q9BSH4 TACO1 Translational activator of cytochrome c oxidase 1 TACO1
LDSLGLCSVSC*ALEFIPNS
K 0.8 1.1 1.0
539 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP NDTPC*GTTIGPILASR 1.0 1.0 1.0
540 Q96EY5 FAM125A Multivesicular body subunit 12A FAM125A GFSAISC*TVEGAPASFGK 0.9 1.0 0.9
541 P63167 DYNLL1 Dynein light chain 1, cytoplasmic DYNLL1
NADMSEEMQQDSVEC*AT
QALEK 1.0 0.9 0.9
542 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE IGPSILNSDLANLGAEC*LR 1.0 1.0 1.0
543 P51858 HDGF Hepatoma-derived growth factor HDGF C*GDLVFAK 1.0 1.0 1.0
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1.1 1.0 1.2 1.0 0.9 1.0 ns  Cytoplasm. Nucleus. 227 Yes Yes Yes No No No 50.0
1.0 1.0 1.2 1.0 0.9 1.0 ns  Cytoplasm, cytoskeleton {ECO 206 Yes Yes No No No No 33.3
1.1 0.9 1.0 1.0 1.2 1.0 ns  Cytoplasm {ECO 324 Yes Yes No -- -- -- 66.7
1.0 0.9 1.0 1.1 1.0 1.0 ns  Nucleus. 495 Yes Yes Yes No No Yes 66.7
1.0 1.1 1.0 0.9 1.1 1.0 ns 241 Yes Yes Yes -- Yes Yes 100.0
1.0 1.1 0.9 1.0 1.0 1.0 ns  Cytoplasm. 106 Yes Yes -- -- No No 50.0
0.9 1.1 1.1 1.0 1.1 1.0 ns  Cytoplasm {ECO 168 Yes Yes No -- No No 40.0
1.0 1.1 1.1 0.9 0.9 1.0 ns  Cytoplasm. 10 Yes Yes No No No -- 40.0
1.1 0.9 0.9 1.1 1.1 1.0 ns  Mitochondrion {ECO 132 Yes No -- -- -- No 33.3
1.0 1.0 1.0 1.0 1.0 1.0 ns  Nucleus {ECO 54 Yes No No -- No No 20.0
0.8 1.0 1.1 1.0 1.1 1.0 ns  Mitochondrion matrix. 108 Yes Yes Yes No No Yes 66.7
1.1 1.0 0.9 1.0 1.0 1.0 ns 189 Yes Yes Yes -- No No 60.0
0.5 1.2 1.0 1.0 1.4 1.0 ns  Nucleus {ECO 27 Yes Yes No -- No -- 50.0
1.0 0.7 1.2 1.0 1.1 1.0 ns  Nucleus. 250/251 Yes Yes Yes -- Yes Yes 100.0
0.9 0.9 0.6 1.6 1.0 1.0 ns  Cytoplasm {ECO 947 Yes Yes No -- No No 40.0
0.9 1.0 1.1 1.0 1.0 1.0 ns 89 Yes Yes No No No No 33.3
1.1 1.0 0.9 1.0 1.0 1.0 ns
 Cytoplasm. Cell 
membrane; Single-pass 
type II membrane protein; 
Extracellular side {ECO
145 Yes No -- -- No -- 33.3
1.2 0.9 1.0 0.8 1.0 1.0 ns
 Cytoplasm. Sarcoplasmic 
reticulum membrane; 
Peripheral membrane 
protein; Cytoplasmic side. 
194 Yes Yes No No No No 33.3
0.9 1.0 0.8 1.2 1.1 1.0 ns  Mitochondrion {ECO 180 Yes No No No No No 16.7
0.9 1.0 1.1 1.0 1.0 1.0 ns  Cytoplasm. 178 Yes Yes No -- -- No 50.0
1.0 1.0 0.8 0.9 1.2 1.0 ns  Mitochondrion {ECO 401 Yes No -- -- -- No 33.3
0.9 1.0 1.0 1.0 1.0 1.0 ns  Nucleus {ECO 81 Yes Yes Yes Yes Yes Yes 100.0
0.9 0.9 1.0 1.1 0.9 1.0 ns  Nucleus {ECO 51 Yes Yes No No No No 33.3
1.1 1.1 0.9 0.9 0.9 1.0 ns 94 Yes Yes Yes No No Yes 66.7
1.0 1.1 1.0 1.1 0.7 1.0 ns  Cytoplasm. Nucleus. 279 Yes Yes Yes No No Yes 66.7
1.0 1.1 1.0 0.9 1.0 1.0 ns  Nucleus {ECO 158 Yes Yes Yes No No Yes 66.7
0.7 1.0 1.0 1.1 1.0 1.0 ns  Mitochondrion {ECO 256 Yes Yes No No No No 33.3
0.9 0.9 1.0 1.0 0.9 1.0 ns  Cytoplasm {ECO 413 Yes Yes -- Yes Yes Yes 100.0
0.9 1.0 0.9 1.0 0.9 1.0 ns




centrosome. Late endosome 
membrane {ECO
33 Yes Yes No -- -- Yes 75.0
0.9 1.0 0.9 0.9 1.0 1.0 ns  Cytoplasm, cytoskeleton. 24 Yes Yes Yes No No Yes 66.7
0.8 1.0 1.4 0.8 0.9 1.0 ns 23 Yes Yes No Yes No Yes 66.7
0.8 1.1 1.0 1.1 0.9 1.0 ns  Cytoplasm. Nucleus. 12 Yes Yes No -- No No 40.0
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544 O43681 ASNA1 ATPase ASNA1 ASNA1 PC*K 1.0 1.2 1.1
545 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1 YADLTEDQLPSC*ESLK 0.9 0.9 0.9
546 Q04917 YWHAH 14-3-3 protein eta YWHAH NC*NDFQYESK 1.1 1.0 1.0
547 P11766 ADH5 Alcohol dehydrogenase class-3 ADH5 VC*LLGC*GISTGYGAAVNTAK 1.1 0.9 1.0
548 P40925 MDH1 Malate dehydrogenase, cytoplasmic MDH1 AIC*DHVR 1.0 1.0 1.0
549 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B FEELC*SDLFR 1.4 1.1 1.2
550 P61981 YWHAG 14-3-3 protein gamma YWHAG NC*SETQYESK 0.6 0.5 0.6
551 P30626 SRI Sorcin SRI PFNLETC*R 0.9 0.8 0.9
552 P62993 GRB2 Growth factor receptor-bound protein 2 GRB2 VLNEEC*DQNWYK 1.0 1.0 1.0
553 P23528 CFL1 Cofilin-1 CFL1 AVLFC*LSEDK 1.0 1.0 1.0
554 P52209 PGD 6-phosphogluconate dehydrogenase, decarboxylating PGD C*LSSLK 0.9 1.0 1.0
555 P10768 ESD S-formylglutathione hydrolase ESD CPALYWLSGLTC*TEQNFISK 1.2 1.0 1.1
556 Q1KMD3





AGPGGAC*K 1.1 1.1 1.1
557 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 YLLQYQEPIPC*EQLVTALC*DIK 1.1 1.1 1.1
558 P31947 SFN 14-3-3 protein sigma SFN VETELQGVC*DTVLGLLDSHLIK 1.2 0.9 1.1
559 O14964 HGS Hepatocyte growth factor-regulated tyrosine kinase HGS AC*GQIFC*GK 0.8 0.8 0.8
560 P60174 TPI1 Triosephosphate isomerase TPI1 IIYGGSVTGATC*K 1.1 1.0 1.1
561 P37802 TAGLN2 Transgelin-2 TAGLN2 DGTVLC*ELINALYPEGQAPVK 1.1 1.0 1.0
562 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 SC*FLC*MVC*K 1.0 1.0 1.0
563 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 GNGIVEC*LGPK 1.0 1.0 1.0
564 P22234 PAICS Multifunctional protein ADE2 PAICS ITSC*IFQLLQEAGIK 1.0 1.0 1.0
565 P52788 SMS Spermine synthase SMS LYC*PVEFSK 1.1 1.0 1.1
566 O75874 IDH1 Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 SEGGFIWAC*K 0.9 1.0 1.0
567 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 YSDESGNMDFDNFISC*LVR 1.1 1.3 1.2
568 P23528 CFL1 Cofilin-1 CFL1 HELQANC*YEEVK 1.0 1.0 1.0
569 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransferase PCMT1 ALDVGSGSGILTAC*FAR 1.0 1.0 1.0
570 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 LAAQSC*ALSLVR 0.8 0.7 0.8
571 Q96EI5 TCEAL4 Transcription elongation factor A protein-like 4 TCEAL4 PEVTC*TLEDK 0.9 0.5 0.7
572 P61970 NUTF2 Nuclear transport factor 2 NUTF2 NINDAWVC*TNDMFR 1.0 0.9 0.9
573 Q96FJ2 DYNLL2 Dynein light chain 2, cytoplasmic DYNLL2
NADMSEDMQQDAVDC*AT
QAMEK 1.1 0.9 1.0
574 P60174 TPI1 Triosephosphate isomerase TPI1 VPADTEVVC*APPTAYIDFAR 1.1 1.0 1.1
575 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 IC*PVETLVEEAIQC*AEK 0.9 0.9 0.9
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1.0 1.3 0.7 0.8 0.9 1.0 ns
 Cytoplasm. Endoplasmic 
reticulum. Nucleus, 
nucleolus.
289 Yes Yes Yes Yes No Yes 83.3
1.0 0.9 1.1 0.9 0.8 1.0 ns 153 Yes Yes No No No -- 40.0
0.9 1.1 0.9 0.9 1.0 0.9 ns 112 Yes Yes No No No No 33.3
1.1 0.8 1.0 1.0 0.9 0.9 ns  Cytoplasm. 170 Yes Yes Yes Yes Yes No 83.3
174 Yes Yes Yes Yes Yes Yes 100.0
0.9 1.1 1.0 0.8 1.0 0.9 ns  Cytoplasm. 251 Yes No Yes No Yes Yes 66.7
0.9 1.0 1.0 0.9 1.0 0.9 ns Bad ID Error Error Error Error Error Error #DIV/0!
0.9 0.9 1.0 0.9 1.0 0.9 ns  Cytoplasm {ECO 112 Yes Yes No No No No 33.3
1.0 0.8 1.0 0.9 1.0 0.9 ns




75 Yes Yes No No No Yes 50.0
0.9 0.8 1.0 0.9 1.0 0.9 ns  Nucleus {ECO 32 Yes Yes No -- -- No 50.0
0.8 1.0 1.1 0.8 0.9 0.9 ns  Nucleus matrix {ECO 39 Yes Yes No No No No 33.3
0.9 1.0 0.9 0.9 1.0 0.9 ns  Cytoplasm {ECO 289 Yes Yes Yes Yes No Yes 83.3
1.0 0.9 0.9 1.0 0.9 0.9 ns  Cytoplasm. Cytoplasmic vesicle. 56 Yes Yes Yes Yes Yes Yes 100.0
0.8 0.9 1.0 1.0 1.0 0.9 ns  Nucleus {ECO 57 Yes Yes -- -- -- -- 100.0
0.8 1.0 1.0 0.9 0.9 0.9 ns  Cytoplasm. Nucleus. Cytoplasm, P-body {ECO 107 Yes Yes Yes No No No 50.0
115 Yes Yes Yes No Yes Yes 83.3
0.8 1.0 1.1 0.9 0.9 0.9 ns  Cytoplasm. Nucleus {ECO 96 Yes Yes Yes No Yes Yes 83.3
1.0 0.7 0.9 1.2 0.9 0.9 ns
 Cytoplasm. Early 
endosome membrane; 
Peripheral membrane 




0 Yes Yes Yes Yes -- Yes 100.0
0.7 1.1 0.9 1.0 1.0 0.9 ns 255 Yes Yes No No No No 33.3
0.9 1.0 1.0 0.8 0.9 0.9 ns 63 Yes Yes Yes Yes -- Yes 100.0
0.9 0.8 0.9 1.0 1.0 0.9 ns  Nucleus. 34/37/40 Yes Yes Yes -- Yes Yes 100.0
0.6 1.5 0.7 1.1 0.6 0.9 ns  Nucleus {ECO 342 Yes Yes No -- No No 40.0
1.0 0.8 0.9 0.9 0.9 0.9 ns 63 Yes Yes No No -- No 40.0
0.9 0.8 1.0 0.9 0.9 0.9 ns 337 Yes Yes No -- No No 40.0
0.9 0.9 0.8 0.9 1.0 0.9 ns  Cytoplasm {ECO 269 Yes Yes Yes No Yes Yes 83.3
0.9 1.0 0.9 0.9 0.9 0.9 ns  Cytoplasm {ECO 232 Yes Yes Yes -- Yes No 80.0
0.9 0.9 0.9 0.9 1.0 0.9 ns  Nucleus matrix {ECO 139 Yes Yes -- No -- No 50.0
0.9 0.9 0.9 0.8 0.9 0.9 ns  Cytoplasm. 95 Yes Yes Yes -- Yes Yes 100.0
0.9 0.7 1.0 1.0 0.9 0.9 ns  Nucleus, nucleolus. Cytoplasm. 242 Yes Yes Yes -- -- Yes 100.0
0.8 0.8 1.0 0.9 0.9 0.9 ns  Nucleus {ECO 34 Yes No -- -- -- -- 50.0
0.9 0.9 0.9 0.9 0.9 0.9 ns  Cytoplasm. 114 Yes Yes No No No No 33.3
0.8 0.8 1.2 0.8 0.9 0.9 ns  Cytoplasm, cytoskeleton {ECO 24 Yes Yes Yes No No Yes 66.7
0.8 1.0 1.0 0.8 0.9 0.9 ns 79 Yes Yes No No No No 33.3
0.8 0.9 1.0 0.9 0.8 0.9 ns  Mitochondrion matrix. 213 Yes No No No No No 16.7
212
576 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 ATC*IGNNSAAAVSMLK 0.9 0.9 0.9
577 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM NTGIIC*TIGPASR 0.8 1.0 0.9
578 P00491 PNP Purine nucleoside phosphorylase PNP AC*VMMQGR 1.2 1.2 1.2
579 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 VVFC*PVK 1.0 0.9 1.0
580 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 C*GFLPGNEK 1.0 0.9 1.0
581 P60981 DSTN Destrin DSTN AVIFC*LSADK 0.8 0.9 0.8
582 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA
YASIC*QQNGIVPIVEPEILP
DGDHDLK 1.0 1.0 1.0
583 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 LNEDMAC*SVAGITSDANVLTNELR 0.9 0.9 0.9
584 Q9UHX1
PUF60 Poly(U)-binding-splicing factor 
PUF60 PUF60 ALAIMC*R 1.0 1.0 1.0
585 P27348 YWHAQ 14-3-3 protein theta YWHAQ SIC*TTVLELLDK 1.1 1.0 1.0
586 P07737 PFN1 Profilin-1 PFN1 C*YEMASHLR 1.0 0.9 1.0
587 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 FLDGNELTLADC*NLLPK 1.0 0.8 0.9
588 P00390 GSR Glutathione reductase, mitochondrial GSR LGGTC*VNVGCVPK 0.9 0.9 0.9
589 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA ALANSLAC*QGK 1.0 1.0 1.0
590 P14174 MIF Macrophage migration inhibitory factor MIF LLC*GLLAER 1.0 1.0 1.0
591 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ DIC*NDVLSLLEK 1.1 0.9 1.0
592 P60174 TPI1 Triosephosphate isomerase TPI1 IAVAAQNC*YK 0.9 1.0 1.0
593 P31949 S100A11 Protein S100-A11 S100A11 C*IESLIAVFQK 1.0 0.9 1.0
594 F5H284 PPIAL4D Peptidyl-prolyl cis-trans isomerase A-like 4D PPIAL4D IIPGFMC*QGGDFTR 1.0 1.0 1.0
595 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1 GTGELTQLLNSLC*TAVK 0.9 1.2 1.0
596 P61158 ACTR3 Actin-related protein 3 ACTR3 LPACVVDC*GTGYTK 1.1 1.0 1.0
597 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 MACROD1 SC*YLSSLDLLLEHR 1.0 1.0 1.0
598 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1 DC*LIPMGITSENVAER 0.9 0.9 0.9
599 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA ITIADC*GQLE 0.8 1.0 0.9
600 P21964 COMT Catechol O-methyltransferase COMT YLPDTLLLEEC*GLLR 0.9 1.0 0.9
601 P31150 GDI1 Rab GDP dissociation inhibitor alpha GDI1 TDDYLDQPC*LETVNR 0.9 1.1 1.0
602 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5 ALNVEPDGTGLTC*SLAPNIISQL 1.0 1.0 1.0
603 P13489 RNH1 Ribonuclease inhibitor RNH1 LSLQNC*C*LTGAGC*GVLSSTLR 0.9 1.0 0.9
604 Q15369 TCEB1 Transcription elongation factor B polypeptide 1 TCEB1 VC*MYFTYK 1.2 0.8 1.0
605 Q9Y3D0 FAM96B Mitotic spindle-associated MMXD complex subunit MIP18 FAM96B
VAAALENTHLLEVVNQC*
LSAR 1.0 1.0 1.0
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225 Yes Yes No -- No No 40.0
0.8 0.8 0.9 0.9 0.9 0.9 ns  Cytoplasm. Nucleus. Cytoplasm, P-body {ECO 163 Yes Yes Yes No No Yes 66.7
0.9 0.9 0.9 0.9 0.8 0.9 ns  Cytoplasm. Nucleus. 49 Yes Yes Yes No Yes Yes 83.3
0.7 1.1 1.0 0.7 0.8 0.9 ns  Cytoplasm, cytoskeleton {ECO 78 Yes Yes No No -- No 40.0
1.0 0.8 0.8 1.0 0.8 0.9 ns  Nucleus {ECO 214 Yes Yes No No No No 33.3
0.9 0.8 0.9 1.0 0.9 0.9 ns 91 Yes Yes No -- -- No 50.0
0.7 1.0 0.9 0.8 0.9 0.9 ns 39 Yes Yes No No No No 33.3
0.8 0.9 0.9 0.8 0.9 0.9 ns
 Cytoplasm, myofibril, 
sarcomere, I band. 
Cytoplasm, myofibril, 
sarcomere, M line. sides of 
the Z line in the absence of 
Ca(2+). {ECO
178 Yes Yes Yes -- Yes Yes 100.0
0.7 0.9 0.9 1.0 0.8 0.9 ns  Cytoplasm. Nucleus. Cytoplasm, P-body {ECO 74 Yes Yes Yes No Yes Yes 83.3
0.8 1.1 0.8 0.8 0.8 0.9 ns  Nucleus {ECO 129 Yes Yes Yes -- -- No 75.0
0.8 1.0 0.9 0.8 0.8 0.9 ns  Cytoplasm. 94 Yes Yes Yes No Yes Yes 83.3
0.9 0.9 0.8 0.8 0.9 0.9 ns  Cytoplasm, cytoskeleton. 128 Yes Yes -- No -- -- 66.7
0.9 0.8 1.0 0.7 0.9 0.9 ns  Nucleus. Nucleus membrane {ECO 178 Yes Yes Yes -- No Yes 80.0
0.8 0.9 0.8 0.9 0.9 0.9 ns  Mitochondrion. Cytoplasm. 102 Yes Yes Yes Yes Yes Yes 100.0
0.8 0.9 1.0 0.8 0.9 0.9 ns
 Cytoplasm, myofibril, 
sarcomere, I band. 
Cytoplasm, myofibril, 
sarcomere, M line.
339 Yes Yes No -- No No 40.0
0.9 0.9 0.9 0.8 0.9 0.9 ns  Secreted {ECO 81 Yes Yes -- -- No No 50.0
0.7 1.0 1.0 0.8 0.8 0.8 ns  Cytoplasm {ECO 94 Yes Yes Yes No Yes Yes 83.3
0.8 0.9 0.9 0.7 0.9 0.8 ns 104 Yes Yes No No No Yes 50.0
0.6 1.0 0.9 0.9 0.8 0.8 ns  Cytoplasm {ECO 13 Yes Yes -- -- -- -- 100.0
0.8 0.9 0.9 0.8 0.8 0.8 ns  Cytoplasm {ECO 62 Yes Yes Yes No Yes No 66.7
0.8 0.9 0.8 0.8 0.8 0.8 ns 39 Yes Yes No No No No 33.3
1.0 0.6 0.9 0.9 0.9 0.8 ns  Cytoplasm, cytoskeleton {ECO 12 Yes Yes No No No No 33.3
0.8 0.9 0.8 0.8 0.9 0.8 ns  Nucleus {ECO 246 Yes Yes Yes -- Yes Yes 100.0
0.8 0.9 0.8 0.9 0.8 0.8 ns  Peroxisome. 177 Yes Yes No Yes Yes No 66.7
0.8 1.0 0.8 0.8 0.8 0.8 ns  Cytoplasm {ECO 161 Yes Yes No No Yes Yes 66.7
0.8 0.9 0.8 0.7 0.8 0.8 ns
 Cytoplasm. Cell 
membrane; Single-pass 
type II membrane protein; 
Extracellular side {ECO
207 Yes Yes -- -- No -- 66.7
0.8 0.8 0.9 0.7 0.8 0.8 ns  Cytoplasm {ECO 202 Yes Yes No No No No 33.3
0.7 0.8 0.9 0.8 0.8 0.8 ns  Mitochondrion. Cytoplasm. Peroxisome. 204 Yes Yes Yes No No -- 60.0
1.1 0.4 0.8 0.8 0.8 0.8 ns  Cytoplasm. 95 Yes Yes Yes -- No No 60.0
96 Yes No No -- No No 20.0
102 Yes Yes No -- No No 40.0
0.9 0.6 0.9 0.8 0.7 0.8 ns  Nucleus {ECO 74 Yes Yes Yes No Yes Yes 83.3
0.6 0.8 0.6 0.6 0.7 0.7 ns  Nucleus {ECO 158 Yes Yes Yes No Yes Yes 83.3
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606 P25398 RPS12 40S ribosomal protein S12 RPS12 QAHLC*VLASNC*DEPMYVK 1.1 1.0 1.0
607 P25398 RPS12 40S ribosomal protein S12 RPS12 LVEALC*AEHQINLIK 1.0 1.0 1.0
608 Q14847 LASP1 LIM and SH3 domain protein 1 LASP1 ACFHC*ETC*K 1.0 1.0 1.0
609 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 C*SQAVYAAEK 1.0 1.0 1.0
610 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH VPTANVSVVDLTC*R 0.9 1.0 0.9
215
0.6 0.6 0.6 0.7 0.7 0.6 ns  Cytoplasm. 50 Yes Yes Yes No Yes Yes 83.3
56 Yes Yes No No Yes Yes 66.7
0.6 0.6 0.6 0.6 0.6 0.6 ns  Cytoplasm. 69 Yes Yes Yes No Yes Yes 83.3
0.6 0.5 0.7 0.6 0.7 0.6 ns  Cytoplasm, cell cortex {ECO 32/35 Yes Yes Yes -- Yes Yes 100.0
0.5 0.4 0.5 0.6 0.5 0.5 ns  Nucleus. 122 Yes Yes Yes -- Yes -- 100.0
0.4 0.5 0.5 0.5 0.4 0.5 ns  Cytoplasm, cytosol {ECO 247 Yes Yes No No Yes No 50.0
(2) "Conservation Ratio  (%)" = (number of "Yes" / number of "Yes+No") × 100%
(1) "--": cysteine is not found.
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1 ACO2 Aconitate hydratase, mitochondrial VGLIGSC*TNSSYEDMGR Y* in vitro
2 GAPDH Glyceraldehyde-3-phosphate dehydrogenase IISNASC*TTNCLAPLAK Y in vivo
3 P4HA1 Prolyl 4-hydroxylase subunit alpha-1 PC*TLSELE N
4 PAFAH1B1 Platelet-activating factor acetylhydrolase IB subunit alpha PNQDGTLIASC*SNDQTVR Y* in vitro
5 FN3K Fructosamine-3-kinase AFGGPGAGC*ISEGR N
6 NTPCR Cancer-related nucleoside-triphosphatase NADC*SSGPGQR N
7 CTSD Cathepsin D AIGAVPLIQGEYMIPC*EK Y* in vivo
8 PFKP 6-phosphofructokinase type C LPLMEC*VQMTQDVQK N
9 TUBB Tubulin beta chain LTTPTYGDLNHLVSATMSGVTTC*LR Y in vivo
10 GFPT1 Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 C*QNALQQVVAR N
11 PCBP1 Poly(rC)-binding protein 1 VMTIPYQPMPASSPVIC*AGGQDR N
12 TCP1 T-complex protein 1 subunit alpha IAC*LDFSLQK Y in vivo
13 TLE3 Transducin-like enhancer protein 3 SPISQLDC*LNR N
14 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial C*MALSTAVLVGEAK N
15 PCK2 Phosphoenolpyruvate carboxykinase QC*PIMDPAWEAPEGVPIDAIIFGGR N
16 GNB2L1 Guanine nucleotide-binding protein subunit beta-2-like 1 VWNLANC*K Y in vivo
17 TUBA4A Tubulin alpha-4A chain AYHEQLSVAEITNAC*FEPANQMVK Y in vivo
18 ATOX1 Copper transport protein ATOX1 VC*IESEHSMDTLLATLK Y* in vitro
19 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 TSAPITC*ELLNK Y in vitro
20 RPL34 60S ribosomal protein L34 AYGGSMC*AK N
21 AKT1 RAC-alpha serine/threonine-protein kinase TFC*GTPEYLAPEVLEDNDYGR Y
22 DLD Dihydrolipoyl dehydrogenase, mitochondrial NETLGGTC*LNVGC*IPSK Y* in vivo
23 TK1 Thymidine kinase, cytosolic NTMEALPAC*LLR N
24 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GYGC*AGVSSVAYGLLAR Y* in vivo
25 TUBA4A Tubulin alpha-4A chain AVC*MLSNTTAIAEAWAR Y in vivo
26 PPP1CB Serine/threonine-protein phosphatase PP1-beta catalytic subunit IC*GDIHGQYTDLLR N
27 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 LGNNC*VFAPADVTSEK N





Table 2A-2. Evaluation of the data obtained by the current cysteine-profiling
platform within the context of previously identified sites of S-nitrosation. The top 27
cysteine residues (R >3; Appendix I, Table 2A-1 in gray) was compaed to cysteines
previously identified as S-nitrosated in the dbSNO database, and are denoted with Y
(yes) and N (no), where Y* denotes presence of mouse homolog in dbSNO database.
In vitro reflects an entry in dbSNO where GSNO treatment was performed in vitro
and in vivo is a dbSNO entry where no exogenous treatment was applied.
Sequence yes/no 
(Y/Y*(1)/N)
in vitro(2) /in 
vivo
Identified in dbSNO database
(1) “Y*”: SNO was identified in mouse.
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0 50 100 200 500
1 P54136 RARS Arginine--tRNA ligase, cytoplasmic RARS
NC*GC*LGASPNLEQLQEE
NLK 1.1 1.3 1.3 9.0 9.4
2 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH IISNASC*TTNCLAPLAK 1.1 1.7 2.7 6.5 9.3
3 P31749 AKT1 RAC-alpha serine/threonine-protein kinase AKT1
TFC*GTPEYLAPEVLEDND
YGR 0.9 1.1 1.4 5.2 7.2
4 P07339 CTSD Cathepsin D CTSD AIGAVPLIQGEYMIPC*EK 1.1 1.5 1.5 4.0 6.6
5 Q9NXJ5 PGPEP1 Pyroglutamyl-peptidase 1 PGPEP1 YLC*DFTYYTSLYQSHGR 1.0 1.2 1.2 4.6 6.3
6 Q9UEW8 STK39 STE20/SPS1-related proline-alanine-rich protein kinase STK39
DAYELQEVIGSGATAVVQ





GFPT1 VDSTTC*LFPVEEK 0.8 1.0 1.6 2.1 4.8
8 Q9NUU7 DDX19A ATP-dependent RNA helicase DDX19A DDX19A VLVTTNVC*AR 1.1 1.0 1.1 1.3 4.6
9 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1 VCLC*QGSAGSGAIGPVEAAIR 1.2 1.4 2.0 1.7 4.4
10 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U HNRNPU MC*LFAGFQR 1.0 1.3 1.4 2.8 4.0
11 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 VGILDVDLC*GPSIPR 1.0 1.3 1.3 2.5 3.5
12 P62888 RPL30 60S ribosomal protein L30 RPL30 VC*TLAIIDPGDSDIIR 1.0 0.8 1.2 3.3 3.5
13 P07858 CTSB Cathepsin B CTSB GQDHC*GIESEVVAGIPR 0.9 1.3 1.3 3.0 3.5
14 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 
HSD17B1
0 LGNNC*VFAPADVTSEK 1.0 1.4 1.5 3.2 3.4
15 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A AVC*MLSNTTAIAEAWAR 1.0 1.3 1.8 2.8 3.4
16 P56192 MARS Methionine--tRNA ligase, cytoplasmic MARS
LFVSDGVPGC*LPVLAAA
GR 1.0 1.4 1.5 2.4 3.3
17 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 C*MTNTPVVVR 1.1 1.5 1.5 2.6 3.3
18 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A AYHEQLSVAEITNAC*FEPANQMVK 1.1 1.4 1.5 3.1 3.2
19 Q5JTZ9 AARS2 Alanine--tRNA ligase, mitochondrial AARS2
HSTYDTDLFSPLLNAIQQG
C*R 1.1 1.4 2.2 3.0 3.2




1.1 1.4 1.4 2.2 3.2
21 P50213 IDH3A Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial IDH3A C*SDFTEEICR 1.1 1.5 1.5 2.0 3.1
22 P51610 HCFC1 Host cell factor 1 HCFC1 VAGINAC*GR 1.1 0.9 1.2 2.1 3.1
23 Q6NXE6 ARMC6 Armadillo repeat-containing protein 6 ARMC6 AFLDNPGILSELC*GTLSR 1.0 1.5 1.3 2.5 3.1
24 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD AC*DEGHC*TAK 1.1 3.6 1.3 2.2 3.0
25 Q14318 FKBP8 Peptidyl-prolyl cis-trans isomerase FKBP8 FKBP8 C*LNNLAASQLK 1.0 1.1 1.8 2.1 3.0
26 Q01813 PFKP 6-phosphofructokinase type C PFKP AAC*NLLQR 1.0 1.3 1.4 3.0 3.0





PREX1 LC*VLNEILGTER 1.1 1.3 1.2 2.0 2.9
Table 2A-3. R-values from transnitrosation experiment at 0, 50, 100, 200 and 500
µM GSNO. A list of all identified peptides (* denotes labeled cysteine) is presented
at each GSNO concentration together with calculated Heavy:Light Ratios (R).
Heavy : Light Ratio
 GSNO concentration (µM)Peptide #
Uniprot 
# Description Symbol Sequence
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29 P61247 RPS3A 40S ribosomal protein S3a RPS3A LFC*VGFTK 1.4 1.3 1.2 2.1 2.9
30 Q9BVA1 TUBB2B Tubulin beta-2B chain TUBB2B ESESC*DCLQGFQLTHSLGGGTGSGMGTLLISK 1.0 1.5 1.6 2.4 2.9
31 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A YMACC*LLYR 1.0 1.2 1.3 2.4 2.9
32 P62879
GNB2 Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) subunit beta-
2
GNB2 AC*GDSTLTQITAGLDPVGR 1.0 1.2 1.3 3.3 2.8
33 P53621 COPA Coatomer subunit alpha COPA VQVPNC*DEIFYAGTGNLLLR 1.4 1.3 1.1 2.0 2.8
34 P29401 TKT Transketolase TKT QAFTDVATGSLGQGLGAAC*GMAYTGK 1.1 1.4 1.3 2.6 2.7
35 P07437 TUBB Tubulin beta chain TUBB TAVC*DIPPR 1.0 1.3 1.4 2.4 2.7
36 P17858 PFKL 6-phosphofructokinase, liver type PFKL VFANAPDSAC*VIGLK 1.1 1.4 1.5 2.3 2.7
37 O60568 PLOD3 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 PLOD3 GLDYEGGGC*R 1.2 1.0 1.5 2.2 2.7
38 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL AEAGEAGQATAEAEC*HR 0.9 0.8 0.9 1.2 2.7
39 P51553
IDH3G Isocitrate dehydrogenase 
[NAD] subunit gamma, 
mitochondrial
IDH3G TSLDLYANVIHC*K 1.2 1.5 1.5 2.4 2.7
40 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10
TPSYSISSTLNPQAPEFILG
C*TASK 0.8 1.1 0.9 1.6 2.7
41 Q92947 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GCDH GYGC*AGVSSVAYGLLAR 1.1 1.2 1.5 2.8 2.7
42 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 NVVAEC*LGK 1.0 1.3 0.8 2.6 2.7
43 P61247 RPS3A 40S ribosomal protein S3a RPS3A AC*QSIYPLHDVFVR 1.1 1.1 1.2 2.2 2.7
44 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 GASC*QGC*PNQR 0.9 1.0 1.0 1.7 2.7
45 Q13748 TUBA3D Tubulin alpha-3C/D chain TUBA3D TIQFVDWC*PTGFK 1.0 1.4 1.4 2.2 2.7
46 P49327 FASN Fatty acid synthase FASN AFDTAGNGYC*R 0.9 1.1 1.1 1.8 2.7
47 Q01813 PFKP 6-phosphofructokinase type C PFKP NESC*SENYTTDFIYQLYSEEGK 1.1 1.1 1.1 2.9 2.7
48 P35250 RFC2 Replication factor C subunit 2 RFC2 TTSILC*LAR 1.2 1.3 1.2 3.2 2.7
49 P07437 TUBB Tubulin beta chain TUBB NMMAAC*DPR 1.3 1.3 1.5 2.8 2.7
50 P07437 TUBB Tubulin beta chain TUBB LTTPTYGDLNHLVSATMSGVTTC*LR 1.1 1.4 1.5 2.6 2.7
51 P61163 ACTR1A Alpha-centractin ACTR1A AC*YLSINPQK 1.0 1.0 1.2 2.2 2.7
52 P62280 RPS11 40S ribosomal protein S11 RPS11 DVQIGDIVTVGEC*R 1.0 1.2 1.1 2.5 2.6
53 P49411 TUFM Elongation factor Tu, mitochondrial TUFM GEETPVIVGSALC*ALEGR 1.2 1.2 1.3 2.4 2.6
54 P62249 RPS16 40S ribosomal protein S16 RPS16 TATAVAHC*K 1.0 1.1 1.2 2.2 2.6
55 P42677 RPS27 40S ribosomal protein S27 RPS27 LTEGC*SFR 1.0 1.2 1.4 2.2 2.6
56 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 PEC*VLDK 1.1 1.3 1.4 3.3 2.6
57 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 AVHQC*DR 1.1 1.2 1.3 2.2 2.6
58 P56192 MARS Methionine--tRNA ligase, cytoplasmic MARS
AEVLISTVGPEDC*VVPFL
TR 1.1 1.2 1.5 2.0 2.6
59 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 GC*LLYGPPGTGK 1.0 1.0 1.3 1.3 2.6
60 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A SIQFVDWC*PTGFK 1.1 1.2 1.3 2.4 2.6
61 Q6ISB3 GRHL2 Grainyhead-like protein 2 homolog GRHL2 GQASQTQC*NSSSDGK 1.1 1.1 1.0 1.5 2.6
62 Q96RN5
MED15 Mediator of RNA 
polymerase II transcription subunit 
15
MED15 QQYLC*QPLLDAVLANIR 0.9 1.1 1.4 1.7 2.5
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63 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2-like 1 GNB2L1
HLYTLDGGDIINALC*FSP
NR 1.2 1.3 1.5 2.5 2.5
64 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U HNRNPU AVVVC*PK 1.0 1.1 1.2 2.4 2.5
65 Q8NBF2 NHLRC2 NHL repeat-containing protein 2 NHLRC2
AILFSQPLQITDTQQGC*IA
PVELR 1.1 1.0 1.1 2.1 2.5
66 P50213 IDH3A Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial IDH3A PC*VSIEGYK 1.0 1.3 1.1 1.8 2.5
67 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 QAVLGAGLPISTPC*TTINK 0.9 0.9 1.0 1.8 2.5
68 P12268 IMPDH2 Inosine-5-monophosphate dehydrogenase 2 IMPDH2 HGFC*GIPITDTGR 1.2 1.2 0.9 1.7 2.5
69 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 SLLINAVEASC*IR 1.0 1.2 1.3 2.3 2.5
70 P49327 FASN Fatty acid synthase FASN SFYGSTLFLC*R 1.3 1.2 1.1 2.1 2.5
71 P53597
SUCLG1 Succinyl-CoA ligase 
[ADP/GDP-forming] subunit alpha, 
mitochondrial
SUCLG1 IIC*QGFTGK 1.1 1.2 1.9 2.3 2.5
72 P50914 RPL14 60S ribosomal protein L14 RPL14 ALVDGPC*TQVR 1.0 1.2 1.4 2.8 2.4
73 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1
QGEYGLASIC*NGGGGAS
AMLIQK 1.0 0.9 1.3 1.9 2.4
74 P15880 RPS2 40S ribosomal protein S2 RPS2 GC*TATLGNFAK 1.0 1.2 1.3 1.9 2.4
75 P46734 MAP2K3 Dual specificity mitogen-activated protein kinase kinase 3 MAP2K3 FSPEFVDFTAQC*LR 1.0 1.4 1.4 2.4 2.4
76 Q7Z7H8 MRPL10 39S ribosomal protein L10, mitochondrial MRPL10 TVPFLPLLGGC*IDDTILSR 1.0 1.2 1.3 2.4 2.4
77 Q99460 PSMD1 26S proteasome non-ATPase regulatory subunit 1 PSMD1
TPEQC*PSVVSLLSESYNP
HVR 1.2 1.3 1.1 2.4 2.4
78 Q8IU81 IRF2BP1 Interferon regulatory factor 2-binding protein 1 IRF2BP1
LFTEYPC*GSGNVYAGVL
AVAR 1.0 0.9 0.8 1.4 2.4
79 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X EC*LPLIIFLR 0.9 1.2 1.2 2.4 2.4
80 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 VLGPAAC*R 1.0 1.5 1.4 2.2 2.4






1.1 1.3 1.0 2.0 2.4
82 P62829 RPL23 60S ribosomal protein L23 RPL23 ISLGLPVGAVINC*ADNTGAK 1.0 1.1 1.3 2.1 2.4
83 P49327 FASN Fatty acid synthase FASN DGLLENQTPEFFQDVC*K 1.0 1.1 1.3 2.0 2.4
84 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 NMITGTSQADC*AVLIVAAGVGEFEAGISK 1.2 1.3 1.4 1.8 2.4
85 Q14258 TRIM25 E3 ubiquitin/ISG15 ligase TRIM25 TRIM25
NTVLC*NVVEQFLQADLA






1 C*MALSTAVLVGEAK 0.8 1.1 0.9 2.4 2.4
87 P51570 GALK1 Galactokinase GALK1 GHALLIDC*R 0.9 1.1 0.9 2.3 2.4
88 O43264 ZW10 Centromere/kinetochore protein zw10 homolog ZW10
LAPILC*DGTATFVDLVPG
FR 1.9 1.1 1.3 2.1 2.4
89 P26641 EEF1G Elongation factor 1-gamma EEF1G FPEELTQTFMSC*NLITGMFQR 1.0 1.1 1.2 1.4 2.4
90 P46109 CRKL Crk-like protein CRKL VPC*AYDK 1.2 0.8 1.1 1.3 2.4
91 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 YNFFTGC*PK 1.4 1.1 1.2 1.8 2.3
92 P49411 TUFM Elongation factor Tu, mitochondrial TUFM GDEC*ELLGHSK 1.0 1.2 1.3 2.0 2.3
93 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 IC*DDELILIK 1.1 1.1 1.1 1.8 2.3
94 P22102 GART Trifunctional purine biosynthetic protein adenosine-3 GART FGDPEC*QVILPLLK 1.1 1.3 1.1 2.2 2.3
95 P46782 RPS5 40S ribosomal protein S5 RPS5 TIAEC*LADELINAAK 1.1 1.0 1.1 1.6 2.3
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96 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 LSTLC*PSAVLQR 1.0 1.2 1.3 2.0 2.3
97 O75362 ZNF217 Zinc finger protein 217 ZNF217 C*IPQLDPFTTFQAWQLATK 0.9 0.9 1.0 1.0 2.3
98 P13804 ETFA Electron transfer flavoprotein subunit alpha, mitochondrial ETFA TIYAGNALC*TVK 1.1 1.2 1.4 1.9 2.3
99 P49327 FASN Fatty acid synthase FASN DPETLVGYSMVGC*QR 1.1 0.9 0.9 1.5 2.3
100 O43837 IDH3B Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial IDH3B
LGDGLFLQC*C*EEVAELY
PK 1.4 1.3 1.7 1.7 2.2
101 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase 
ALDH18
A1 CEYPAAC*NALETLLIHR 1.1 1.1 1.3 2.0 2.2
102 P60981 DSTN Destrin DSTN HEC*QANGPEDLNR 0.8 1.0 1.2 1.6 2.2
103 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 LC*PNSTGAEIR 1.2 1.2 1.2 2.1 2.2
104 Q96I99 SUCLG2 Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial SUCLG2
IDATQVEVNPFGETPEGQV
VC*FDAK 1.1 0.9 1.2 2.2 2.2
105 Q9UBS0 RPS6KB2 Ribosomal protein S6 kinase beta-2 RPS6KB2 PC*LQSEEDVSQFDTR 1.2 1.3 1.3 1.9 2.2
106 Q9ULV4 CORO1C Coronin-1C CORO1C C*DLISIPK 1.2 0.6 1.0 1.6 2.2
107 Q07020 RPL18 60S ribosomal protein L18 RPL18 GC*GTVLLSGPR 1.1 1.1 1.2 2.1 2.2
108 P63220 RPS21 40S ribosomal protein S21 RPS21 TYAIC*GAIR 1.0 1.0 1.1 1.7 2.2
109 Q9UPN9 TRIM33 E3 ubiquitin-protein ligase TRIM33 TRIM33 C*DPVPAANGAIR 1.0 1.0 1.0 1.0 2.2
110 P62241 RPS8 40S ribosomal protein S8 RPS8 NC*IVLIDSTPYR 1.2 1.4 1.2 3.2 2.2
111 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2
NEC*DPALALLSDYVLHN
SNTMR 1.1 1.0 0.7 1.4 2.2
112 P60709 ACTB Actin, cytoplasmic 1 ACTB C*DVDIR 1.0 1.2 1.5 2.2 2.2
113 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 AC*ALQVLSAILEGSK 1.0 1.2 1.4 1.7 2.2
114 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 GNVC*GDSK 1.0 1.1 1.1 1.8 2.2
115 P23610 F8A3 Factor VIII intron 22 protein F8A3 LVC*PAAYGEPLQAAASALGAAVR 0.8 1.1 1.0 1.9 2.1
116 Q9BTZ2 DHRS4 Dehydrogenase/reductase SDR family member 4 DHRS4 VNC*LAPGLIK 1.1 1.2 1.3 1.9 2.1
117 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 C*FIVGADNVGSK 1.1 1.1 1.1 1.8 2.1
118 P51858 HDGF Hepatoma-derived growth factor HDGF C*GDLVFAK 1.0 0.9 1.3 1.6 2.1
119 Q9UL15 BAG5 BAG family molecular chaperone regulator 5 BAG5 NPC*IR 1.1 0.9 0.9 1.4 2.1
120 Q6P2I3
FAHD2B Fumarylacetoacetate 
hydrolase domain-containing protein 
2B
FAHD2B TFDTFC*PLGPALVTK 1.0 1.2 1.2 1.2 2.1
121 P13804 ETFA Electron transfer flavoprotein subunit alpha, mitochondrial ETFA LGGEVSC*LVAGTK 1.0 1.1 1.3 2.0 2.1
122 Q7L0Y3 TRMT10C Mitochondrial ribonuclease P protein 1 
TRMT10
C NVDPFHIYFC*NLK 1.4 1.3 1.2 1.7 2.1
123 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 VVLLGEGC*VGK 1.1 1.1 1.2 1.4 2.1
124 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 AVASQLDC*NFLK 1.0 1.0 1.2 1.8 2.1
125 Q96T76 MMS19 MMS19 nucleotide excision repair protein homolog MMS19
AC*DSVTSNVLPLLLEQFH
K 1.0 1.4 1.5 2.1 2.1
126 P30042 C21orf33 ES1 protein homolog, mitochondrial C21orf33 DC*K 1.0 0.9 0.9 1.8 2.1
127 Q8TEX9 IPO4 Importin-4 IPO4 AC*YALENFVENLGPK 0.9 1.0 1.3 2.1 2.1
128 P60763 RAC3 Ras-related C3 botulinum toxin substrate 3 RAC3 AVLC*PPPVK 1.0 1.0 1.1 1.3 2.1
129 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP C*PTSGR 1.0 1.1 1.2 1.8 2.1
130 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0
AGAIAPC*EVTVPAQNTGL
GPEK 0.9 1.0 1.2 1.8 2.1
221
131 Q9H773 DCTPP1 dCTP pyrophosphatase 1 DCTPP1 YTELPHGAISEDQAVGPADIPC*DSTGQTST 1.1 1.6 1.3 1.5 2.1
132 P21964 COMT Catechol O-methyltransferase COMT
IVDAVIQEHQPSVLLELGA
YC*GYSAVR 1.0 1.1 1.1 1.4 2.0
133 Q15393 SF3B3 Splicing factor 3B subunit 3 SF3B3 SEHPPLC*GR 1.1 1.0 1.1 1.3 2.0
134 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 EMQNLSFQDC*YSSK 1.2 1.1 1.1 2.0 2.0
135 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 C*ATITPDEAR 0.9 0.9 1.2 1.5 2.0
136 P35237 SERPINB6 Serpin B6 SERPINB6 SC*DFLSSFR 0.8 1.0 1.0 1.3 2.0
137 E9PPU0 EPPK1 Epiplakin EPPK1 YLQGTGC*IAGLLLPGSQER 1.0 1.2 1.0 1.8 2.0
138 Q9P1F3 ABRACL Costars family protein ABRACL ABRACL C*ANLFEALVGTLK 1.2 1.0 1.2 1.3 2.0




QR 1.1 1.1 1.1 1.5 2.0
140 P24468 NR2F2 COUP transcription factor 2 NR2F2 AIVLFTSDAC*GLSDVAHVESLQEK 1.1 1.0 1.2 1.3 2.0
141 P62280 RPS11 40S ribosomal protein S11 RPS11 C*PFTGNVSIR 1.0 1.2 1.2 1.9 2.0
142 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 IHMGSC*AENTAK 0.9 1.0 1.0 1.7 2.0
143 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 PMC*VESFSDYPPLGR 1.0 1.1 1.2 2.0 2.0
144 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1 ENSQLDTSPPC*LGGNK 0.9 0.9 1.1 1.5 2.0
145 Q9Y3D0 FAM96B Mitotic spindle-associated MMXD complex subunit MIP28 FAM96B
VAAALENTHLLEVVNQC*
LSAR 1.0 0.8 1.1 0.9 2.0
146 P08243 ASNS Asparagine synthetase ASNS IGC*LLSGGLDSSLVAATLLK 1.1 1.2 1.2 1.8 1.9
147 P25398 RPS12 40S ribosomal protein S12 RPS12 LVEALC*AEHQINLIK 1.0 1.3 1.1 1.6 1.9
148 P48643 CCT5 T-complex protein 1 subunit epsilon CCT5 VVNSC*HR 1.0 1.0 1.0 1.5 1.9
149 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 PVTDC*VISVPSFFTDAER 0.9 1.1 1.2 2.7 1.9
150 P60709 ACTB Actin, cytoplasmic 1 ACTB LC*YVALDFEQEMATAASSSSLEK 1.2 1.3 1.3 1.9 1.9
151 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 NC*IGDFLK 1.0 1.1 1.3 1.6 1.9
152 Q13636 RAB31 Ras-related protein Rab-31 RAB31 VC*LLGDTGVGK 1.1 1.1 1.4 1.3 1.9
153 P62879
GNB2 Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) subunit beta-
2
GNB2 TFVSGAC*DASIK 1.0 1.3 1.3 2.3 1.9
154 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase 
ALDH18
A1 GDEC*GLALGR 1.0 1.2 1.1 1.6 1.9
155 P82912 MRPS11 28S ribosomal protein S11, mitochondrial MRPS11
ASHNNTQIQVVSASNEPL
AFASC*GTEGFR 1.0 1.0 1.3 1.6 1.9
156 P62753 RPS6 40S ribosomal protein S6 RPS6 LNISFPATGC*QK 1.0 1.1 1.2 1.9 1.9
157 P22314 UBA1 Ubiquitin-like modifier-activating enzyme 1 UBA1 SIPIC*TLK 1.0 1.1 1.3 1.5 1.9
158 P41240 CSK Tyrosine-protein kinase CSK CSK SVLGGDC*LLK 1.1 1.1 1.0 1.4 1.9
159 P60866 RPS20 40S ribosomal protein S20 RPS20 TPC*GEGSK 1.0 1.1 1.0 1.6 1.9
160 B0LM41 RBM14/RBM4 fusion Transcriptional coactivator CoAZ 
RBM14/R
BM4 IFVGNVSAAC*TSQELR 1.0 1.1 1.3 1.6 1.9
161 Q8NEC7 GSTCD Glutathione S-transferase C-terminal domain-containing protein GSTCD LC*ELTIPLAIENFLR 1.2 0.9 1.0 1.5 1.9
162 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 GQPC*SQNYR 1.4 1.0 1.1 1.1 1.9
163 P83731 RPL24 60S ribosomal protein L24 RPL24 VELC*SFSGYK 1.6 0.8 1.8 2.2 1.9
164 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 ADHQPLTEASYVNLPTIALC*NTDSPLR 1.2 1.2 1.2 1.8 1.9
165 P01111 NRAS GTPase NRas NRAS TGEGFLC*VFAINNSK 1.1 1.0 1.1 1.3 1.9
222
166 P49321 NASP Nuclear autoantigenic sperm protein NASP
PTDGASSSNC*VTDISHLV
R 1.1 2.4 0.9 1.2 1.9
167 P05141 SLC25A5 ADP/ATP translocase 2 SLC25A5 GLGDC*LVK 1.0 0.9 1.2 1.7 1.9
168 P23396 RPS3 40S ribosomal protein S3 RPS3 GLC*AIAQAESLR 1.1 1.1 1.2 1.7 1.9
169 Q7L0Y3 TRMT10C Mitochondrial ribonuclease P protein 1 
TRMT10
C SSVQEEC*VSTISSSK 1.5 1.3 1.0 1.6 1.9
170 Q13418 ILK Integrin-linked protein kinase ILK FSFQC*PGR 1.0 0.9 1.0 1.5 1.9
171 Q7Z2W4 ZC3HAV1 Zinc finger CCCH-type antiviral protein 1 
ZC3HAV
1 NSNVDSSYLESLYQSC*PR 1.0 1.0 0.9 1.2 1.9
172 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 YVLC*TAPR 1.1 1.1 0.5 1.4 1.8




APC*SVAPGK 1.0 1.1 1.3 1.1 1.8
174 P07900 HSP90AA1 Heat shock protein HSP 90-alpha 
HSP90AA
1 VFIMDNC*EELIPEYLNFIR 1.1 1.0 1.0 1.1 1.8
175 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 SLHDALC*VVK 1.1 1.2 1.2 1.8 1.8
176 P50991 CCT4 T-complex protein 1 subunit delta CCT4 TGC*NVLLIQK 1.0 1.1 1.1 1.9 1.8
177 Q96CM8 ACSF2 Acyl-CoA synthetase family member 2, mitochondrial ACSF2 MVSTPIGGLSYVQGC*TK 1.0 1.2 1.1 1.6 1.8
178 P49327 FASN Fatty acid synthase FASN LGMLSPEGTC*K 0.9 1.2 1.7 2.5 1.8
179 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPU
L2 NFILDQC*NVYNSGQR 1.0 1.1 1.1 1.7 1.8
180 P15924 DSP Desmoplakin DSP YC*YLQNEVFGLFQK 1.1 1.0 1.2 1.6 1.8
181 Q9NP73 ALG13 UDP-N-acetylglucosamine transferase subunit ALG13 ALG13
ADLVISHAGAGSC*LETLE
K 1.0 0.9 0.9 1.4 1.8
182 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS LHYGDLTDSTC*LVK 0.9 0.9 1.2 1.4 1.8
183 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 GC*AFVTFTTR 1.1 0.9 1.3 1.3 1.8
184 Q9H1B7 IRF2BPL Interferon regulatory factor 2-binding protein-like IRF2BPL AHGC*FQDGR 0.9 0.9 0.9 1.3 1.8
185 P50991 CCT4 T-complex protein 1 subunit delta CCT4 ITGC*ASPGK 1.1 1.2 1.7 1.6 1.8
186 Q16576 RBBP7 Histone-binding protein RBBP7 RBBP7
VHIPNDDAQFDASHC*DS
DK 0.9 1.0 0.9 1.5 1.8
187 Q15723 ELF2 ETS-related transcription factor Elf-2 ELF2 IITIPATQLAQC*QLQTK 1.1 1.1 1.2 1.4 1.8
188 Q7RTV0 PHF5A PHD finger-like domain-containing protein 5A PHF5A PC*TLVR 1.0 1.1 1.0 1.4 1.8
189 Q9Y3F4 STRAP Serine-threonine kinase receptor-associated protein STRAP
IGFPETTEEELEEIASENSD
C*IFPSAPDVK 1.0 0.9 1.0 1.3 1.8
190 P50570 DNM2 Dynamin-2 DNM2 LQDAFSSIGQSC*HLDLPQIAVVGGQSAGK 1.0 1.0 1.1 1.3 1.8
191 Q15370 TCEB2 Transcription elongation factor B polypeptide 2 TCEB2
ADDTFEALC*IEPFSSPPEL
PDVMK 1.3 1.0 1.4 1.2 1.8
192 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O
GEVPC*TVTSASPLEEATL
SELK 1.0 1.3 1.3 1.6 1.8
193 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 LLDLVQQSC*NYK 1.0 1.0 1.0 1.6 1.8
194 O43175 PHGDH D-3-phosphoglycerate dehydrogenase PHGDH NAGNC*LSPAVIVGLLK 1.0 1.0 1.1 1.4 1.8
195 P49327 FASN Fatty acid synthase FASN ADEASELAC*PTPK 1.0 1.0 1.0 1.2 1.8
196 O15355 PPM1G Protein phosphatase 1G PPM1G C*SGDGVGAPR 1.0 1.1 1.1 1.3 1.7
197 Q9BQ61 C19orf43 Uncharacterized protein C19orf43 C19orf43 AHQC*GDDDK 1.1 1.0 1.0 0.8 1.7
198 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 LQISHEAAAC*ITGLR 1.1 1.0 1.0 1.5 1.7
199 P51553
IDH3G Isocitrate dehydrogenase 
[NAD] subunit gamma, 
mitochondrial
IDH3G LGDGLFLQC*CR 1.1 1.4 1.3 1.9 1.7
200 Q15631 TSN Translin TSN ETAAAC*VEK 0.9 1.1 1.0 1.6 1.7
223
201 P09429 HMGB1 High mobility group protein B1 HMGB1 MSSYAFFVQTC*R 1.0 1.0 1.1 2.0 1.7
202 Q8TEX9 IPO4 Importin-4 IPO4 APAALPALC*DLLASAADPQIR 1.1 1.2 1.3 1.6 1.7
203 P13639 EEF2 Elongation factor 2 EEF2 STLTDSLVC*K 1.0 1.0 1.0 1.4 1.7
204 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 SVLDAAQIVGLNC*LR 1.2 1.2 1.2 1.6 1.7
205 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 EDLC*TK 1.2 1.0 1.2 1.6 1.7
206 P28838 LAP3 Cytosol aminopeptidase LAP3 SAGAC*TAAAFLK 0.9 0.9 0.9 1.5 1.7
207 Q93052 LPP Lipoma-preferred partner LPP TYITDPVSAPC*APPLQPK 0.9 0.9 1.1 1.4 1.7
208 Q16186 ADRM1 Proteasomal ubiquitin receptor ADRM1 ADRM1 VPQC*PSGR 8.1 0.1 1.0 3.2 1.7
209 Q7Z4W1 DCXR L-xylulose reductase DCXR GVPGAIVNVSSQC*SQR 1.0 1.3 1.4 1.8 1.7
210 P36873
PPP1CC Serine/threonine-protein 
phosphatase PP1-gamma catalytic 
subunit
PPP1CC GNHEC*ASINR 1.0 1.0 1.1 1.7 1.7
211 P62316 SNRPD2 Small nuclear ribonucleoprotein Sm D2 SNRPD2 NNTQVLINC*R 1.0 1.2 1.3 10.4 1.7
212 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 YVDIAIPC*NNK 1.2 1.1 1.3 1.9 1.7
213 P00966 ASS1 Argininosuccinate synthase ASS1 FELSC*YSLAPQIK 0.9 1.1 1.3 1.3 1.7
214 Q969Z0 TBRG4 Protein TBRG4 TBRG4 LATDLLSLMPSLTSGEVAHC*AK 1.1 1.2 0.2 1.6 1.7
215 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 IIDINYYPVPEAC*LSNK 1.1 0.9 1.5 1.4 1.6
216 Q04637 EIF4G1 Eukaryotic translation initiation factor 4 gamma 1 EIF4G1
LQGINC*GPDFTPSFANLG
R 0.9 1.0 1.1 1.3 1.6
217 Q96JB2 COG3 Conserved oligomeric Golgi complex subunit 3 COG3
ELLLGPSIAC*TVAELTSQN
NR 1.0 1.0 1.0 1.2 1.6
218 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL LNVC*VSK 1.0 1.0 1.0 1.3 1.6
219 P17676 CEBPB CCAAT/enhancer-binding protein beta CEBPB APPTAC*YAGAAPAPSQVK 1.0 1.1 1.0 1.2 1.6
220 Q8NDH3 NPEPL1 Probable aminopeptidase NPEPL1 NPEPL1
IVDTPC*NEMNTDTFLEEI
NK 1.4 1.0 0.9 0.9 1.6
221 P21964 COMT Catechol O-methyltransferase COMT LITIEINPDC*AAITQR 1.0 1.2 1.1 1.2 1.6
222 P40227 CCT6A T-complex protein 1 subunit zeta CCT6A
NAIDDGC*VVPGAGAVEV
AMAEALIK 1.1 1.0 0.9 0.9 1.6
223 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 YVAAAFPSAC*GK 2.5 1.3 1.4 2.0 1.6
224 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F HNRNPF DLSYC*LSGMYDHR 1.2 1.1 0.9 1.6 1.6
225 Q99832 CCT7 T-complex protein 1 subunit eta CCT7
INALTAASEAAC*LIVSVD
ETIK 1.1 1.1 1.0 1.6 1.6
226 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 PDGNC*FYR 1.1 1.1 1.1 1.5 1.6
227 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNPH
1 DLNYC*FSGMSDHR 1.0 1.1 1.0 1.5 1.6
228 O60716 CTNND1 Catenin delta-1 CTNND1 TPAILEASAGAIQNLC*AGR 1.1 1.2 1.4 1.7 1.6
229 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 DC*LINAAK 1.0 1.1 1.1 1.4 1.6
230 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 YEAAFPFLSPC*GR 1.0 1.0 1.1 1.3 1.6
231 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS DGVC*VR 1.1 1.1 1.1 1.2 1.6
232 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 DLAGC*IHGLSNVK 1.0 1.1 1.2 1.6 1.6
233 P30153
PPP2R1A Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform
PPP2R1A LNIISNLDC*VNEVIGIR 0.9 1.0 1.1 1.3 1.6
234 O15355 PPM1G Protein phosphatase 1G PPM1G GTEAGQVGEPGIPTGEAGPSC*SSASDK 1.1 1.1 1.0 1.5 1.6
224
235 P25205 MCM3 DNA replication licensing factor MCM3 MCM3
TLTSC*FLSCVVCVEGIVT
K 1.1 1.1 1.2 1.4 1.6
236 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransferase PCMT1 MVGC*TGK 0.9 0.9 0.9 1.4 1.6
237Reverse_Q9NZV1CRIM1 Cysteine-rich motor neuron 1 protein CRIM1 SCSLEPC*K 1.1 1.2 1.3 1.5 1.5
238 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM
AEGSDVANAVLDGADC*I
MLSGETAK 0.8 1.0 1.2 1.2 1.5
239 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD LQFHDVAGDIFHQQC*K 1.3 1.1 1.1 1.3 1.5
240 Q9Y4L1 HYOU1 Hypoxia up-regulated protein 1 HYOU1 VEFEELC*ADLFER 1.2 0.9 1.1 1.1 1.5
241 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
EEFASTC*PDDEEIELAYEQ
VAK 1.6 1.6 1.5 1.4 1.5
242 P78346 RPP30 Ribonuclease P protein subunit p30 RPP30 LTIIVSDPSHC*NVLR 0.9 1.0 1.0 1.1 1.5
243 P53396 ACLY ATP-citrate synthase ACLY FIC*TTSAIQNR 1.0 0.7 0.9 1.1 1.5
244 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 FC*PFAER 1.1 1.0 1.1 1.0 1.5
245 Q9BXJ9 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit NAA15 LFNTAVC*ESK 1.1 1.0 1.1 1.4 1.5
246 Q9GZZ9 UBA5 Ubiquitin-like modifier-activating enzyme 5 UBA5
EGVC*AASLPTTMGVVAG
ILVQNVLK 0.9 1.2 0.9 1.2 1.5
247 P10599 TXN Thioredoxin TXN C*MPTFQFFK 1.1 1.0 1.0 1.2 1.5
248 Q15149 PLEC Plectin PLEC LC*FEGLR 0.9 0.9 1.1 1.1 1.5
249 P31949 S100A11 Protein S100-A11 S100A11 C*IESLIAVFQK 1.4 0.9 1.3 1.0 1.5
250 Q96RQ3
MCCC1 Methylcrotonoyl-CoA 
carboxylase subunit alpha, 
mitochondrial





PDXDC1 HAC*QLSQR 1.1 1.2 1.3 1.5 1.5
252 Q9HB40 SCPEP1 Retinoid-inducible serine carboxypeptidase SCPEP1 TFFSC*HK 1.0 1.0 1.5 1.4 1.5
253 Q04760 GLO1 Lactoylglutathione lyase GLO1 C*DFPIMK 1.2 0.8 0.9 1.3 1.5
254 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9 GIGMNEPLVDC*EGYPR 0.9 1.1 1.3 1.2 1.5
255 Q8WU76 SCFD2 Sec1 family domain-containing protein 2 SCFD2 AVFVLSC*LLK 1.2 1.1 1.0 1.2 1.5
256 Q96EY5 FAM125A Multivesicular body subunit 12A 
FAM125
A SC*SPLAFSAFGDLTIK 1.0 0.9 1.0 0.9 1.5
257 Q9UKV8 EIF2C2 Protein argonaute-2 EIF2C2 SFFTASEGC*SNPLGGGR 1.2 0.9 0.9 0.9 1.5
258 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS IYLGQLEC*FSLGNLDAK 1.1 1.0 1.0 1.8 1.5
259 P49915 GMPS GMP synthase GMPS TVGVQGDC*R 0.9 1.1 1.0 1.1 1.5
260 P46782 RPS5 40S ribosomal protein S5 RPS5 AQC*PIVER 1.0 1.1 1.1 1.4 1.5
261 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM C*CSGAIIVLTK 1.0 1.0 1.1 1.3 1.5
262 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
LEGDLTGPSVGVEVPDVE
LEC*PDAK 1.1 1.0 1.0 1.1 1.5
263 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 LVVPATQC*GSLIGK 1.0 0.9 1.0 1.1 1.5
264 P30040 ERP29 Endoplasmic reticulum resident protein 29 ERP29
GQGVYLGMPGC*LPVYD
ALAGEFIR 1.0 1.0 2.7 0.6 1.5
265 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 GC*DVVVIPAGVPR 1.0 1.2 1.3 1.4 1.5
266 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1 VEDLTFTSPFC*LQVK 1.0 1.2 1.1 1.0 1.5
267 Q9H8M7 FAM188A Protein FAM188A FAM188A SSPGLSDTIFC*R 1.9 2.6 1.6 3.5 1.5
268 Q16555 DPYSL2 Dihydropyrimidinase-related protein 2 DPYSL2 FQLTDC*QIYEVLSVIR 0.9 1.1 0.9 2.6 1.5
269 O75083 WDR1 WD repeat-containing protein 1 WDR1 SIQC*LTVHK 1.0 1.2 1.3 1.6 1.5
270 O00515 LAD1 Ladinin-1 LAD1 GLPC*TELFVAPVGVASK 1.2 1.0 1.6 1.3 1.5
225




LTHSGFPAK 1.0 1.0 1.0 1.3 1.5
272 Q8TEX9 IPO4 Importin-4 IPO4 DNIC*GALAR 1.0 1.3 1.3 1.3 1.5
273 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1
QEPLGSDSEGVNC*LAYD
EAIMAQQDR 1.0 1.0 1.1 1.2 1.5
274 P45974 USP5 Ubiquitin carboxyl-terminal hydrolase 5 USP5 VC*ASEK 1.0 1.0 1.0 1.2 1.5
275 P62244 RPS15A 40S ribosomal protein S15a RPS15A C*GVISPR 0.9 1.1 1.2 1.3 1.4
276 Q96EY5 FAM125A Multivesicular body subunit 12A 
FAM125
A GFSAISC*TVEGAPASFGK 1.0 0.8 0.9 0.9 1.4
277 P31153 MAT2A S-adenosylmethionine synthase isoform type-2 MAT2A
TC*NVLVALEQQSPDIAQG
VHLDR 1.0 1.1 1.1 1.3 1.4
278 P67936 TPM4 Tropomyosin alpha-4 chain TPM4 EENVGLHQTLDQTLNELNC*I 1.1 1.0 1.0 1.2 1.4
279 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
GPFVEAEVPDVDLEC*PD
AK 1.2 0.9 1.0 1.2 1.4
280 Q96IR7 HPDL 4-hydroxyphenylpyruvate dioxygenase-like protein HPDL
HAVPSATNLC*FDVADAG
AATR 1.2 1.1 0.9 2.2 1.4
281 P53597
SUCLG1 Succinyl-CoA ligase 
[ADP/GDP-forming] subunit alpha, 
mitochondrial
SUCLG1 LIGPNCPGVINPGEC*K 1.0 1.1 1.1 1.6 1.4
282 P38606 ATP6V1A V-type proton ATPase catalytic subunit A ATP6V1A
VLDALFPCVQGGTTAIPG
AFGC*GK 1.0 1.1 1.2 1.3 1.4
283 Q9Y3A3 MOB4 MOB-like protein phocein MOB4 HTLDGAAC*LLNSNK 0.9 1.0 1.0 1.2 1.4
284 P49327 FASN Fatty acid synthase FASN AINC*ATSGVVGLVNCLR 1.1 1.1 1.0 1.4 1.4
285 P24298 GPT Alanine aminotransferase 1 GPT LLEETGIC*VVPGSGFGQR 1.0 1.2 1.1 1.4 1.4
286 Q9HA64 FN3KRP Ketosamine-3-kinase FN3KRP ATGHSGGGC*ISQGR 1.0 1.2 1.0 1.4 1.4
287 P45985 MAP2K4 Dual specificity mitogen-activated protein kinase kinase 4 MAP2K4 LC*DFGISGQLVDSIAK 1.1 0.8 0.7 1.4 1.4
288 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS PTEVDFLQGDC*TK 1.0 0.9 1.1 1.2 1.4
289 E9PPU0 EPPK1 Epiplakin EPPK1 YLC*GLGAVGGVR 1.1 1.0 1.1 1.2 1.4
290 P36969
GPX4 Phospholipid hydroperoxide 
glutathione peroxidase, 
mitochondrial
GPX4 YAEC*GLR 1.0 1.0 1.0 1.1 1.4
291 P61158 ACTR3 Actin-related protein 3 ACTR3 LGYAGNTEPQFIIPSC*IAIK 1.1 1.1 1.1 1.5 1.4
292 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 SSGGFVWAC*K 1.4 1.0 1.1 1.5 1.4
293 P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT
VVC*SSGAVGNYSGGLAV
K 1.0 1.1 1.1 1.5 1.4





ILKAP FILLAC*DGLFK 1.0 0.9 1.1 1.3 1.4
296 P57081 WDR4 tRNA (guanine-N(7)-)-methyltransferase subunit WDR4 WDR4 SGDVYSFSVLEPHGC*GR 1.5 1.0 0.9 1.2 1.4
297 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1 YADLTEDQLPSC*ESLK 0.9 1.0 1.1 1.1 1.4
298 P30041 PRDX6 Peroxiredoxin-6 PRDX6 DFTPVC*TTELGR 1.0 0.8 1.0 0.9 1.4
299 A6NDG6 PGP Phosphoglycolate phosphatase PGP NNQESDC*VSK 1.0 0.9 1.1 1.3 1.4
300 O15382 BCAT2 Branched-chain-amino-acid aminotransferase, mitochondrial BCAT2 EVFGSGTAC*QVCPVHR 1.1 1.0 1.1 1.1 1.4
301 Q08J23 NSUN2 tRNA (cytosine(34)-C(5))-methyltransferase NSUN2
MVYSTC*SLNPIEDEAVIA
SLLEK 1.1 1.1 1.2 1.2 1.4
302 Q9Y508 RNF114 RING finger protein 114 RNF114 DC*GGAAQLAGPAAEADPLGR 1.0 1.0 1.1 1.2 1.4
303 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2
QC*PIMDPAWEAPEGVPID
AIIFGGR 1.0 1.1 1.3 1.5 1.4
304 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 SVHYC*PATK 0.9 1.0 1.0 1.5 1.4
226
305 P00338 LDHA L-lactate dehydrogenase A chain LDHA VIGSGC*NLDSAR 1.0 1.1 1.0 1.4 1.4
306 P13489 RNH1 Ribonuclease inhibitor RNH1 LDDC*GLTEAR 2.1 1.7 1.4 1.4 1.4
307 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
ALNALC*DGLIDELNQAL
K 1.0 1.0 1.0 1.3 1.4
308 P41250 GARS Glycine--tRNA ligase GARS SCYDLSC*HAR 1.1 1.1 1.3 1.3 1.4
309 Q7Z5L9 IRF2BP2 Interferon regulatory factor 2-binding protein 2 IRF2BP2 AHGC*FPEGR 0.9 0.9 0.9 1.2 1.4
310 Q86YH6 PDSS2 Decaprenyl-diphosphate synthase subunit 2 PDSS2 C*LLSDELSNIAMQVR 0.9 1.0 1.1 1.1 1.4
311 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondrial IDH2 VC*VETVESGAMTK 1.1 0.9 1.0 1.8 1.3
312 P50991 CCT4 T-complex protein 1 subunit delta CCT4
LGGTIDDC*ELVEGLVLTQ
K 0.9 1.1 1.1 1.4 1.3
313 O15144 ARPC2 Actin-related protein 2/3 complex subunit 2 ARPC2 NC*FASVFEK 0.9 1.0 1.1 1.4 1.3
314 Q99832 CCT7 T-complex protein 1 subunit eta CCT7
EGTDSSQGIPQLVSNISAC*
QVIAEAVR 0.9 1.1 1.0 1.4 1.3
315 P13489 RNH1 Ribonuclease inhibitor RNH1 ELDLSNNC*LGDAGILQLVESVR 1.0 1.0 1.1 1.4 1.3
316 P60709 ACTB Actin, cytoplasmic 1 ACTB CPEALFQPSFLGMESC*GIHETTFNSIMK 1.0 1.1 1.2 1.3 1.3
317 Q9HCC0
MCCC2 Methylcrotonoyl-CoA 
carboxylase beta chain, 
mitochondrial
MCCC2 AATGEEVSAEDLGGADLHC*R 0.9 1.0 1.1 1.2 1.3
318 Q9UI30 TRMT112 tRNA methyltransferase 112 homolog TRMT112 IC*PVEFNPNFVAR 1.1 1.0 1.0 1.2 1.3
319 Q9NZZ3 CHMP5 Charged multivesicular body protein 5 CHMP5 APPPSLTDC*IGTVDSR 1.2 1.0 1.2 1.1 1.3
320 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 VTDDLVC*LVYK 1.0 1.0 1.1 1.1 1.3
321 Q9P0W2
HMG20B SWI/SNF-related matrix-
associated actin-dependent regulator 
of chromatin subfamily E member 1-
related
HMG20B GGDC*DGFSTFDVPIFTEEFLDQNK 1.0 0.9 0.9 1.9 1.3
322 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2 VLVVGAGGIGC*ELLK 1.1 1.0 1.1 1.3 1.3
323 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP
VTEDENDEPIEIPSEDDGT
VLLSTVTAQFPGAC*GLR 1.3 0.9 1.2 1.3 1.3
324 Q8N806 UBR7 Putative E3 ubiquitin-protein ligase UBR7 UBR7
VEQNSEPC*AGSSSESDLQ
TVFK 1.1 1.1 1.1 1.2 1.3
325 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 GLLDVTC*K 1.1 0.9 1.0 1.0 1.3
326 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 AAVEEGIVLGGGC*ALLR 1.0 1.0 1.0 1.1 1.3
327 Q14247 CTTN Src substrate cortactin CTTN HC*SQVDSVR 1.0 0.9 1.0 1.1 1.3
328 Q96EP5 DAZAP1 DAZ-associated protein 1 DAZAP1 PC*TPR 1.0 0.9 1.2 1.0 1.3
329 O75223 GGCT Gamma-glutamylcyclotransferase GGCT NPSAAFFC*VAR 1.0 0.9 1.0 0.9 1.3
330 P36405 ARL3 ADP-ribosylation factor-like protein 3 ARL3 LSC*VPVLIFANK 1.0 0.9 1.0 1.1 1.3
331 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 AC*ANPAAGSVILLENLR 1.8 1.0 1.2 0.9 1.3
332 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP
AFAFVTFADDQIAQSLC*G
EDLIIK 1.7 1.3 0.8 1.7 1.3
333 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM GIFPVLC*K 1.1 1.0 1.1 1.3 1.3
334 P27348 YWHAQ 14-3-3 protein theta YWHAQ YLAEVAC*GDDR 0.8 0.8 0.8 1.0 1.3
335 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1
YCFSEMAPVC*AVVGGIL
AQEIVK 1.1 1.0 1.0 1.2 1.3
336 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 GCITIIGGGDTATC*CAK 0.9 0.9 0.6 1.0 1.3
337 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC ISAFGYLEC*SAK 0.9 0.7 0.8 1.0 1.3
338 Q9BQ52 ELAC2 Zinc phosphodiesterase ELAC protein 2 ELAC2
GPSGC*SGGPNTVYLQVV
AAGSR 0.9 1.2 1.5 1.7 1.3
227
339 P13639 EEF2 Elongation factor 2 EEF2 TFC*QLILDPIFK 1.0 1.0 1.0 1.2 1.3
340 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 LDFVC*SFLQK 1.1 0.8 1.0 1.1 1.3
341 P60981 DSTN Destrin DSTN LGGSLIVAFEGC*PV 1.0 1.0 1.0 1.0 1.3




QR 1.1 1.2 1.0 0.7 1.3
343 Q9Y263 PLAA Phospholipase A-2-activating protein PLAA AINC*PEDIVFPALDILR 1.0 1.0 1.1 1.2 1.3
344 O14980 XPO1 Exportin-1 XPO1 LDINLLDNVVNC*LYHGEGAQQR 1.1 1.0 1.0 1.2 1.3
345 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 
HSD17B1
0 VC*NFLASQVPFPSR 1.1 1.0 0.9 1.1 1.3
346 P26641 EEF1G Elongation factor 1-gamma EEF1G AAAPAPEEEMDEC*EQALAAEPK 1.0 1.0 1.0 1.1 1.3
347 P60981 DSTN Destrin DSTN C*STPEEIK 1.0 1.0 1.0 1.1 1.3
348 P49840 GSK3A Glycogen synthase kinase-3 alpha GSK3A LC*DFGSAK 1.0 0.8 0.9 1.3 1.3
349 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 VDENFDC*VEADDVEGK 1.0 0.9 0.9 1.2 1.3
350 Q96RS6 NUDCD1 NudC domain-containing protein 1 NUDCD1 DSAQC*AAIAER 1.0 0.9 1.0 1.2 1.3
351 P26639 TARS Threonine--tRNA ligase, cytoplasmic TARS
DQELYFFHELSPGSC*FFLP
K 1.0 1.0 1.0 1.2 1.3
352 P78371 CCT2 T-complex protein 1 subunit beta CCT2 SLHDALC*VLAQTVK 1.1 0.9 1.0 1.1 1.3
353 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF C*NNVLYIR 1.1 1.0 1.0 1.1 1.3
354 P35914 HMGCL Hydroxymethylglutaryl-CoA lyase, mitochondrial HMGCL VAQATC*K 0.9 0.9 1.0 1.1 1.2
355 P61158 ACTR3 Actin-related protein 3 ACTR3 TLTGTVIDSGDGVTHVIPVAEGYVIGSC*IK 1.0 1.3 1.1 1.4 1.2
356 P08238 HSP90AB1 Heat shock protein HSP 90-beta 
HSP90AB
1 VFIMDSC*DELIPEYLNFIR 1.2 1.1 1.0 1.3 1.2
357 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1 IIC*SAGLSLLAEER 1.0 1.0 1.0 1.2 1.2
358 P48431 SOX2 Transcription factor SOX-2 SOX2 APC*QAGDLR 1.0 0.9 0.9 1.2 1.2
359 P42704 LRPPRC Leucine-rich PPR motif-containing protein, mitochondrial LRPPRC SC*GSLLPELK 1.0 1.1 1.2 1.2 1.2
360 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 HLNEIDLFHC*IDPNDSK 1.0 1.0 1.0 1.1 1.2
361 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM NTGIIC*TIGPASR 1.0 1.1 1.1 1.1 1.2
362 P53602 MVD Diphosphomevalonate decarboxylase MVD DGDPLPSSLSC*K 1.0 0.9 1.0 1.1 1.2
363 Q96HE7 ERO1L ERO1-like protein alpha ERO1L HDDSSDNFC*EADDIQSPEAEYVDLLLNPER 1.1 1.1 1.0 1.1 1.2
364 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 QLC*DNAGFDATNILNK 0.9 0.9 0.9 1.1 1.2




GVDGC*IHR 1.0 1.0 1.0 1.1 1.2
366 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 C*IPALDSLTPANEDQK 1.2 1.0 1.0 1.0 1.2
367 Q7L1Q6 BZW1 Basic leucine zipper and W2 domain-containing protein 1 BZW1
FDPTQFQDC*IIQGLTETGT
DLEAVAK 1.0 1.0 1.0 1.1 1.2
368 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 LC*VQNSPQEAR 1.1 1.0 1.0 1.0 1.2
369 Q9Y5R8 TRAPPC1 Trafficking protein particle complex subunit 1 
TRAPPC
1 NPLC*PLGQTVQSELFR 0.9 1.1 1.1 1.3 1.2
370 Q9Y296 TRAPPC4 Trafficking protein particle complex subunit 4 
TRAPPC
4 C*ELFDQNLK 1.0 1.0 1.1 1.2 1.2
371 Q8IVH4 MMAA Methylmalonic aciduria type A protein, mitochondrial MMAA AC*LAEAITLVESTHSR 0.8 1.0 1.0 1.1 1.2
372 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD TQVC*GILR 1.0 1.0 0.9 1.1 1.2
373 O75131 CPNE3 Copine-3 CPNE3 NC*LNPQFSK 1.2 1.0 0.9 1.1 1.2
374 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 LVVPASQC*GSLIGK 1.0 0.9 0.9 1.0 1.2
228
375 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 AITIAGVPQSVTEC*VK 1.2 1.1 1.0 0.9 1.2
376 P12004 PCNA Proliferating cell nuclear antigen PCNA C*AGNEDIITLR 1.0 1.0 1.0 0.9 1.2
377 P21333 FLNA Filamin-A FLNA VGTEC*GNQK 1.0 0.9 1.0 1.1 1.2
378 Q09666 AHNAK Neuroblast differentiation-associated protein AHNAK AHNAK
LEGDLTGPSVDVEVPDVE
LEC*PDAK 1.1 1.0 1.0 1.1 1.2
379 P62258 YWHAE 14-3-3 protein epsilon YWHAE LIC*C*DILDVLDK 1.3 1.0 1.1 1.1 1.2
380 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1
APVPSTC*SSTFPEELSPPS
HQAK 1.0 0.9 1.0 1.0 1.2
381 Q9NS86 LANCL2 LanC-like protein 2 LANCL2 AFVNPFPDYEAAAGALLASGAAEETGC*VR 1.1 0.9 0.8 0.9 1.2
382 Q8WVV9HNRPLL Heterogeneous nuclear ribonucleoprotein L-like HNRPLL GLC*ESVVEADLVEALEK 1.4 1.1 1.1 1.8 1.2
383 Q9NYL2 MLTK Mitogen-activated protein kinase kinase kinase MLT MLTK
FDDLQFFENC*GGGSFGSV
YR 1.0 1.0 1.3 1.4 1.2
384 P49327 FASN Fatty acid synthase FASN LSIPTYGLQC*TR 1.0 1.0 1.0 1.3 1.2
385 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR
EQFSQGSPSNC*LETSLAEI
FPLGK 0.9 1.2 1.0 1.2 1.2
386 Q9Y2Q3 GSTK1 Glutathione S-transferase kappa 1 GSTK1 ETTEAAC*R 1.0 0.9 1.0 1.1 1.2
387 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL LC*FSTAQHAS 1.1 1.0 1.1 1.0 1.2
388 Q6IA69 NADSYN1 Glutamine-dependent NAD(+) synthetase 
NADSYN
1 NSSQETC*TR 1.0 1.0 0.9 1.2 1.2
389 Q15149 PLEC Plectin PLEC AFC*GFEDPR 1.0 0.9 1.0 1.1 1.2
390 P78347 GTF2I General transcription factor II-I GTF2I SILSPGGSC*GPIK 1.0 0.9 1.0 1.1 1.2
391 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 EYLPIGGLAEFC*K 0.9 1.1 1.1 1.3 1.2
392 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 TIIPLISQC*TPK 1.2 1.1 1.0 1.1 1.2
393 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 INISEGNC*PER 1.0 1.0 1.0 1.0 1.2
394 Q9Y224 C14orf166 UPF0568 protein C14orf166 
C14orf16
6 LTALDYHNPAGFNC*K 1.1 0.9 1.1 1.0 1.2
395 Q7Z4W1 DCXR L-xylulose reductase DCXR AVTNHSVYC*STK 1.1 1.2 1.2 1.2 1.2
396 P13639 EEF2 Elongation factor 2 EEF2 YVEPIEDVPC*GNIVGLVGVDQFLVK 1.2 1.3 0.9 1.1 1.2
397 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 VGLGIC*YDMR 1.1 1.0 0.9 1.1 1.2
398 P21333 FLNA Filamin-A FLNA AHVVPC*FDASK 1.1 1.0 1.0 1.1 1.2
399 P49915 GMPS GMP synthase GMPS AC*TTEEDQEK 1.2 0.9 1.0 1.0 1.2
400 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 IC*PVETLVEEAIQCAEK 1.1 1.0 1.0 1.0 1.2
401 O60610 DIAPH1 Protein diaphanous homolog 1 DIAPH1 AGC*AVTSLLASELTK 0.9 0.9 2.3 1.0 1.2
402 P14678
SNRPB Small nuclear 
ribonucleoprotein-associated protein 
B and B'
SNRPB C*ILQDGR 1.2 1.1 1.1 1.3 1.2
403 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 NLADC*LR 1.2 1.1 1.1 1.3 1.2
404 Q9NVS9 PNPO Pyridoxine-5-phosphate oxidase PNPO LPEEEAEC*YFHSR 1.2 1.1 1.3 1.2 1.2
405 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP NDTPC*GTTIGPILASR 1.3 1.2 1.3 1.1 1.2
406 Q00796 SORD Sorbitol dehydrogenase SORD YNLSPSIFFCATPPDDGNLC*R 1.0 1.0 0.9 1.1 1.2
407 Q5TC12
ATPAF1 ATP synthase 
mitochondrial F1 complex assembly 
factor 1
ATPAF1 C*AQNQNK 0.9 0.9 1.6 1.1 1.1
408 P47756 CAPZB F-actin-capping protein subunit beta CAPZB DETVSDC*SPHIANIGR 1.0 1.0 1.0 1.0 1.1
409 P53582 METAP1 Methionine aminopeptidase 1 METAP1 LGIQGSYFCSQEC*FK 1.0 1.0 1.1 1.0 1.1
229
410 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK
IIPTLEEGLQLPSPTATSQLP
LESDAVEC*LNYQHYK 1.0 1.0 1.0 1.1 1.1
411 O95861 BPNT1 3(2),5-bisphosphate nucleotidase 1 BPNT1 TC*ATDLQTK 1.0 1.0 1.0 1.0 1.1
412 Q9Y365 STARD10 PCTP-like protein STARD10 MECC*DVPAETLYDVLHDIEYR 1.1 1.0 1.0 1.0 1.1
413 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 GTLTLC*PYHSDR 1.0 1.1 1.0 1.0 1.1
414 Q9NTK5 OLA1 Obg-like ATPase 1 OLA1 STFFNVLTNSQASAENFPFC*TIDPNESR 1.0 0.9 0.9 1.0 1.1
415 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS
NVGC*LQEALQLATSFAQ
LR 0.9 0.9 1.0 1.0 1.1
416 P21964 COMT Catechol O-methyltransferase COMT GSSC*FEC*THYQSFLEYR 1.1 1.0 1.0 1.4 1.1
417 P20810 CAST Calpastatin CAST SEC*K 1.1 1.0 1.1 1.2 1.1
418 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 ALFAISC*LVR 1.3 1.1 1.1 1.0 1.1
419 Q96Q11
TRNT1 CCA tRNA 
nucleotidyltransferase 1, 
mitochondrial 
TRNT1 YQGEHC*LLK 1.0 1.0 1.0 1.0 1.1
420 Q96EY8
MMAB Cob(I)yrinic acid a,c-
diamide adenosyltransferase, 
mitochondrial
MMAB IQCTLQDVGSALATPC*SSAR 1.1 1.0 0.9 1.0 1.1
421 O14561 NDUFAB1 Acyl carrier protein, mitochondrial 
NDUFAB
1 LMC*PQEIVDYIADK 1.1 1.0 1.1 0.9 1.1
422 Q53T59 HS1BP3 HCLS1-binding protein 3 HS1BP3 LFDDPDLGGAIPLGDSLLLPAAC*ESGGPTPSLSHR 0.9 0.8 0.9 0.8 1.1
423 P43897 TSFM Elongation factor Ts, mitochondrial TSFM FEC*GEGEEAAETE 1.3 1.1 1.1 1.2 1.1
424 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 DAC*DTVR 1.0 0.8 1.0 1.2 1.1
425 O95336 PGLS 6-phosphogluconolactonase PGLS AAC*CLAGAR 1.1 1.0 1.0 1.2 1.1
426 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL LTAC*QVATAFNLSR 1.0 0.9 0.8 1.0 1.1
427 Q14566 MCM6 DNA replication licensing factor MCM6 MCM6 LGFSEYC*R 1.1 1.0 0.9 1.0 1.1
428 Q9BSH4 TACO1 Translational activator of cytochrome c oxidase 1 TACO1
LDSLGLCSVSC*ALEFIPNS
K 1.0 0.9 0.9 1.0 1.1
429 Q9UJ70 NAGK N-acetyl-D-glucosamine kinase NAGK FAGFC*R 1.2 1.2 1.0 1.3 1.1
430 Q9BT78 COPS4 COP9 signalosome complex subunit 4 COPS4 QIQSLC*FQVNNLLEK 1.4 1.1 1.1 1.1 1.1
431 P62826 RAN GTP-binding nuclear protein Ran RAN VC*ENIPIVLC*GNK 1.0 1.1 1.2 1.1 1.1
432 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB HSMNPFC*EIAVEEAVR 1.0 1.0 1.0 1.1 1.1
433 P00492 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1 SYC*NDQSTGDIK 1.4 1.1 1.1 1.1 1.1
434 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 C*EFQDAYVLLSEK 1.1 0.9 1.0 1.0 1.1
435 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M HNRNPM AC*QIFVR 1.0 1.0 0.9 1.0 1.1
436 P61981 YWHAG 14-3-3 protein gamma YWHAG NC*SETQYESK 1.2 1.2 1.3 0.9 1.1
437 P55036 PSMD4 26S proteasome non-ATPase regulatory subunit 4 PSMD4
SNPENNVGLITLANDC*EV
LTTLTPDTGR 1.1 0.9 1.0 0.6 1.1
438 Q06587 RING1 E3 ubiquitin-protein ligase RING1 RING1 FC*SDCIVTALR 1.1 1.3 0.9 1.3 1.1
439 P49327 FASN Fatty acid synthase FASN LTPGC*EAEAETEAICFFVQQFTDMEHNR 1.0 1.0 1.2 1.2 1.1
440 Q9NXG2 THUMPD1 THUMP domain-containing protein 1 
THUMPD
1 C*DAGGPR 1.1 1.0 1.0 1.1 1.1
441 Q9BV79 MECR Trans-2-enoyl-CoA reductase, mitochondrial MECR LALNC*VGGK 1.1 1.1 1.0 1.0 1.1
442 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR EEC*PVFTPPGGETLDQVK 1.0 1.2 0.9 1.2 1.1






SHMT2 AALEALGSC*LNNK 1.1 0.9 0.9 1.2 1.1
445 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 FLDGNELTLADC*NLLPK 1.3 1.1 0.9 1.0 1.1
446 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 SVC*TEAGMFAIR 1.2 1.3 1.1 0.9 1.1
447 P14649 MYL6B Myosin light chain 6B MYL6B ILYSQC*GDVMR 0.9 1.3 0.9 0.9 1.1
448 Q9HCC0
MCCC2 Methylcrotonoyl-CoA 
carboxylase beta chain, 
mitochondrial
MCCC2 LPC*IYLVDSGGAYLPR 1.0 1.1 1.1 1.3 1.1
449 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK GSDFDC*ELR 1.2 1.1 1.0 1.1 1.1
450 Q9Y5P6 GMPPB Mannose-1-phosphate guanyltransferase beta GMPPB LC*SGPGIVGNVLVDPSAR 1.1 0.9 0.9 1.1 1.1
451 Q969H4 CNKSR1 Connector enhancer of kinase suppressor of ras 1 CNKSR1 NLLQLC*PQSLEALAVR 1.0 1.0 1.0 1.4 1.1
452 Q15019 SEPT2 Septin-2 2-Sep LTVVDTPGYGDAINC*R 1.0 1.0 1.0 1.2 1.1
453 Q6PI48 DARS2 Aspartate--tRNA ligase, mitochondrial DARS2 LIC*LVTGSPSIR 1.2 1.0 1.0 1.1 1.1
454 O75390 CS Citrate synthase, mitochondrial CS LPC*VAAK 1.2 1.0 1.1 1.1 1.1
455 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 PIN1
SGEEDFESLASQFSDC*SS
AK 0.9 1.0 1.0 1.1 1.1
456 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 GFGFVC*FSSPEEATK 1.4 0.9 0.9 1.0 1.1
457 P55210 CASP7 Caspase-7 CASP7 LFFIQAC*R 1.0 0.8 0.8 0.9 1.1
458 Q9P2R7 SUCLA2 Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial SUCLA2 ILAC*DDLDEAAR 1.2 1.2 1.0 1.2 1.1
459 P36507 MAP2K2 Dual specificity mitogen-activated protein kinase kinase 2 MAP2K2
LC*DFGVSGQLIDSMANSF
VGTR 1.0 0.8 1.0 1.1 1.1
460 P31947 SFN 14-3-3 protein sigma SFN GEELSC*EER 1.1 1.0 1.0 1.0 1.1
461 P00338 LDHA L-lactate dehydrogenase A chain LDHA
DDVFLSVPC*ILGQNGISD
LVK 0.9 1.1 1.2 1.3 1.0
462 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 TDFQQGC*AK 1.0 1.1 1.1 1.3 1.0
463 P13639 EEF2 Elongation factor 2 EEF2 C*LYASVLTAQPR 1.1 1.0 1.1 1.0 1.0
464 P37802 TAGLN2 Transgelin-2 TAGLN2 NMAC*VQR 1.0 0.9 1.0 1.0 1.0
465 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE
IGPSILNSDLANLGAEC*L
R 1.2 1.0 1.0 0.8 1.0
466 Q02543 RPL18A 60S ribosomal protein L18a RPL18A DLTTAGAVTQC*YR 1.1 0.9 2.1 3.7 1.0
467 Q9HAV7 GRPEL1 GrpE protein homolog 1, mitochondrial GRPEL1 ATQC*VPK 1.0 0.9 0.9 1.0 1.0
468 O00268 TAF4 Transcription initiation factor TFIID subunit 4 TAF4 SC*K 1.0 1.2 0.9 0.8 1.0
469 Q04917 YWHAH 14-3-3 protein eta YWHAH NC*NDFQYESK 1.0 0.9 1.1 0.7 1.0
470 Q9UNH7 SNX6 Sorting nexin-6 SNX6 IGSSLYALGTQDSTDIC*K 0.9 1.0 0.9 1.2 1.0
471 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS YAGLSTC*FR 1.0 1.1 1.0 1.1 1.0
472 Q9Y530 C6orf130 O-acetyl-ADP-ribose deacetylase C6orf130 C6orf130 IGC*GLDR 0.9 0.9 0.9 1.1 1.0
473 P61158 ACTR3 Actin-related protein 3 ACTR3 YSYVC*PDLVK 0.8 1.0 1.0 1.0 1.0
474 P55735 SEC13 Protein SEC13 homolog SEC13 FASGGC*DNLIK 1.0 1.0 1.0 1.0 1.0
475 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 AITIAGIPQSIIEC*VK 1.2 1.0 1.0 1.0 1.0
476 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS
LSSC*DSFTSTINELNHCLS
LR 1.1 0.9 0.9 1.0 1.0
477 Q9BW61 DDA1 DET1- and DDB1-associated protein 1 DDA1 FHADSVC*K 1.1 1.0 1.0 1.0 1.0
478 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 SQETEC*TYFSTPLLLGK 1.4 1.0 1.1 0.9 1.0
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479 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD GSNTCELIFEDC*K 1.0 1.1 0.9 1.6 1.0
480 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 FIC*EQDHQNFLR 1.0 1.1 0.9 1.0 1.0
481 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS C*LSVMEAK 0.9 1.0 1.0 1.0 1.0
482 P24941 CDK2 Cyclin-dependent kinase 2 CDK2 APEILLGC*K 1.0 1.0 0.9 1.0 1.0
483 P51659 HSD17B4 Peroxisomal multifunctional enzyme type 2 HSD17B4 IC*DFENASK 0.9 1.0 1.0 1.0 1.0
484 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 C*GFLPGNEK 0.9 0.8 0.9 0.9 1.0
485 Q14738
PPP2R5D Serine/threonine-protein 
phosphatase 2A 56 kDa regulatory 
subunit delta isoform
PPP2R5D C*TAK 1.0 1.0 1.4 1.0 1.0
486 P23528 CFL1 Cofilin-1 CFL1 AVLFC*LSEDK 4.5 0.9 0.8 0.8 1.0
487 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 IGNC*PFSQR 1.0 1.0 1.0 1.1 1.0
488 P13489 RNH1 Ribonuclease inhibitor RNH1 LSLQNC*C*LTGAGC*GVLSSTLR 1.2 0.9 0.7 0.9 1.0
489 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F HNRNPF GLPFGC*TK 1.3 1.0 1.0 1.1 1.0
490 P50990 CCT8 T-complex protein 1 subunit theta CCT8 IAVYSC*PFDGMITETK 1.0 1.0 0.9 0.9 1.0
491 P37837 TALDO1 Transaldolase TALDO1 ALAGC*DFLTISPK 1.3 1.0 1.0 0.9 1.0
492 P37802 TAGLN2 Transgelin-2 TAGLN2 DGTVLC*ELINALYPEGQAPVK 1.5 1.1 1.0 0.9 1.0
493 P28838 LAP3 Cytosol aminopeptidase LAP3 QVVDC*QLADVNNIGK 0.9 1.0 0.9 0.8 1.0
494 P31942 HNRNPH3 Heterogeneous nuclear ribonucleoprotein H3 
HNRNPH
3 GLPFGC*SK 1.2 1.1 1.0 1.1 1.0
495 Q12765 SCRN1 Secernin-1 SCRN1 TQSPC*FGDDDPAK 1.1 1.1 0.9 0.9 1.0
496 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 YTC*GEAPDYDR 1.0 1.2 1.1 1.1 0.9
497 P49327 FASN Fatty acid synthase FASN AAPLDSIHSLAAYYIDC*IR 1.3 1.0 1.1 1.1 0.9
498 Q9HAV7 GRPEL1 GrpE protein homolog 1, mitochondrial GRPEL1 LYGIQAFC*K 1.1 0.7 1.0 1.0 0.9
499 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5
GTPEQPQC*GFSNAVVQIL
R 1.0 0.9 1.0 1.0 0.9
500 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 EGVVEC*SFVK 1.3 1.0 1.0 0.9 0.9
501 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5
ALNVEPDGTGLTC*SLAPN
IISQL 1.1 0.9 0.9 0.8 0.9
502 Q96EK6 GNPNAT1 Glucosamine 6-phosphate N-acetyltransferase 
GNPNAT
1 ITLEC*LPQNVGFYK 1.1 0.9 0.7 0.9 0.9
503 Q9NS86 LANCL2 LanC-like protein 2 LANCL2 SVVC*QESDLPDELLYGR 1.1 0.9 0.9 0.9 0.9
504 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS TIC*AILENYQTEK 1.1 1.0 1.0 1.0 0.9
505 P52209 PGD 6-phosphogluconate dehydrogenase, decarboxylating PGD
AVSTGVQAGIPMPC*FTTA
LSFYDGYR 1.4 1.0 0.9 1.0 0.9
506 P35270 SPR Sepiapterin reductase SPR TVVNISSLC*ALQPFK 1.0 0.9 1.0 1.0 0.9
507 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 HFLSDTGMAC*R 0.9 1.0 0.9 1.0 0.9
508 Q04917 YWHAH 14-3-3 protein eta YWHAH ELETVC*NDVLSLLDK 1.4 1.0 1.2 1.0 0.9
509 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ DIC*NDVLSLLEK 1.4 1.0 1.0 0.8 0.9
510 P60174 TPI1 Triosephosphate isomerase TPI1 IIYGGSVTGATC*K 1.4 1.0 1.0 0.8 0.9
511 P39687 ANP32A Acidic leucine-rich nuclear phosphoprotein 32 family member A ANP32A SLDLFNC*EVTNLNDYR 1.3 1.0 1.3 0.8 0.9
512 Q7L8W6 ATPBD4 ATP-binding domain-containing protein 4 ATPBD4 C*EGDEVEDLYELLK 1.4 0.6 0.9 0.8 0.9
513 P31948 STIP1 Stress-induced-phosphoprotein 1 STIP1
ALSVGNIDDALQC*YSEAI
K 1.2 1.1 1.1 1.2 0.9
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514 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC LVIVGDGAC*GK 1.0 1.4 1.1 1.1 0.9
515 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 ALYDTFSAFGNILSC*K 1.1 0.7 0.8 0.9 0.9
516 P15927 RPA2 Replication protein A 32 kDa subunit RPA2 AC*PR 1.1 0.8 1.0 0.8 0.9
517 P60174 TPI1 Triosephosphate isomerase TPI1 VAHALAEGLGVIAC*IGEK 1.4 0.9 1.0 0.8 0.9
518 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4 AGSDGESIGNC*PFSQR 1.0 1.0 1.0 1.1 0.9
519 Q9NUQ9 FAM49B Protein FAM49B FAM49B VLTC*TDLEQGPNFFLDFENAQPTESEK 0.9 0.6 1.2 1.0 0.9
520 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
GQAGGGGPGTGPGLGEA
GSLATC*ELPLAK 1.0 0.8 0.8 0.9 0.9
521 P60174 TPI1 Triosephosphate isomerase TPI1 IAVAAQNC*YK 1.3 0.9 1.0 0.8 0.9
522 Q92945 KHSRP Far upstream element-binding protein 2 KHSRP C*EHAAR 1.0 0.9 0.8 0.9 0.9
523 P21964 COMT Catechol O-methyltransferase COMT YLPDTLLLEEC*GLLR 1.3 1.0 1.0 0.9 0.9
524 P13489 RNH1 Ribonuclease inhibitor RNH1 SNELGDVGVHCVLQGLQTPSC*K 1.0 0.8 0.9 0.7 0.9
525 Q9NRF9 POLE3 DNA polymerase epsilon subunit 3 POLE3
AASVFVLYATSC*ANNFA
MK 1.1 1.0 0.9 0.9 0.9
526 P27348 YWHAQ 14-3-3 protein theta YWHAQ SIC*TTVLELLDK 1.4 0.9 1.1 0.9 0.9
527 Q9BWD1 ACAT2 Acetyl-CoA acetyltransferase, cytosolic ACAT2
ATVAPEDVSEVIFGHVLAA
GC*GQNPVR 1.0 0.8 0.8 0.8 0.9
528 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH YIEAC*AR 1.2 0.8 1.0 1.3 0.9
529 Q96S19 C16orf13 UPF0585 protein C16orf13 C16orf13 C*TEGLFR 1.1 0.8 1.0 1.3 0.9
530 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 GDFC*IQVGR 1.1 0.9 0.9 0.9 0.9
531 P52907 CAPZA1 F-actin-capping protein subunit alpha-1 CAPZA1
TIDGQQTIIAC*IESHQFQP
K 1.5 1.0 1.0 0.9 0.9
532 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH
ISSINSISALC*EATGADVE
EVATAIGMDQR 1.1 1.1 1.1 0.9 0.9
533 P23528 CFL1 Cofilin-1 CFL1 HELQANC*YEEVK 1.0 0.9 0.9 0.9 0.9
534 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA
YASIC*QQNGIVPIVEPEILP
DGDHDLK 1.3 1.0 1.0 0.9 0.9
535 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 FC*LDNGAK 0.9 1.1 1.4 0.8 0.9
536 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH ASVGFGGSC*FQK 1.0 1.0 1.0 0.8 0.9
537 P31948 STIP1 Stress-induced-phosphoprotein 1 STIP1 ALDLDSSC*K 1.0 0.9 1.0 1.0 0.9
538 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA ALANSLAC*QGK 1.1 0.9 1.0 0.9 0.9
539 P34896 SHMT1 Serine hydroxymethyltransferase, cytosolic SHMT1 NTC*PGDR 1.0 0.7 0.7 0.9 0.9
540 P11142 HSPA8 Heat shock cognate 71 kDa protein HSPA8 VC*NPIITK 1.5 1.1 1.1 0.9 0.9
541 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 GNGIVEC*LGPK 1.0 0.9 0.7 0.7 0.9
542 Q9NZA1 CLIC5 Chloride intracellular channel protein 5 CLIC5 AGIDGESIGNC*PFSQR 1.0 1.0 0.9 0.9 0.8
543 Q12849 GRSF1 G-rich sequence factor 1 GRSF1 YIELFLNSC*PK 0.8 1.0 0.9 0.9 0.8
544 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1 GTGELTQLLNSLC*TAVK 1.4 1.0 1.0 0.9 0.8
545 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 LTFSC*LGGSDNFK 1.3 0.9 0.9 1.0 0.8
546 P07237 P4HB Protein disulfide-isomerase P4HB ITEFC*HR 1.4 1.0 1.0 0.8 0.8
547 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNPH
1 FFSDC*K 1.2 0.9 1.0 1.1 0.8
548 P60174 TPI1 Triosephosphate isomerase TPI1 VPADTEVVC*APPTAYIDFAR 1.3 1.0 1.0 0.9 0.8
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549 F5H284 PPIAL4D Peptidyl-prolyl cis-trans isomerase A-like 4D PPIAL4D IIPGFMC*QGGDFTR 1.0 1.0 0.9 0.9 0.8
550 O75874 IDH1 Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 DLAAC*IK 1.3 0.9 1.0 0.8 0.8
551 P61158 ACTR3 Actin-related protein 3 ACTR3 LPACVVDC*GTGYTK 0.8 1.0 0.8 1.0 0.8
552 P22234 PAICS Multifunctional protein ADE2 PAICS ITSC*IFQLLQEAGIK 1.3 1.0 1.0 0.9 0.8
553 P24534 EEF1B2 Elongation factor 1-beta EEF1B2 SYIEGYVPSQADVAVFEAVSSPPPADLC*HALR 1.1 1.0 1.1 0.9 0.8
554 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA ITIADC*GQLE 1.4 0.9 1.0 0.9 0.8
555 P14174 MIF Macrophage migration inhibitory factor MIF LLC*GLLAER 1.4 1.0 1.0 0.9 0.8
556 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransferase PCMT1 ALDVGSGSGILTAC*FAR 1.4 1.0 1.1 0.8 0.8
557 P50395 GDI2 Rab GDP dissociation inhibitor beta GDI2 TDDYLDQPC*YETINR 1.6 1.2 1.2 0.9 0.8
558 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 QMFEPVSC*TFTYLLGDR 1.0 1.0 0.8 0.9 0.8
559 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
YLLQYQEPIPC*EQLVTAL
CDIK 1.2 0.7 1.2 1.1 0.8
560 Q9BS40 LXN Latexin LXN VNC*TAEVLYPSTGQETAPEVNFTFEGETGK 1.4 1.2 1.1 1.0 0.8
561 P55212 CASP6 Caspase-6 CASP6 GTC*ADR 1.0 0.9 1.0 0.8 0.8
562 P52788 SMS Spermine synthase SMS YFTQGNC*VNLTEALSLYEEQLGR 1.3 0.8 0.9 0.6 0.8
563 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 TDGFGIDTC*R 1.2 1.5 1.2 4.7 0.7
564 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 ILSC*GEVIHVK 1.3 1.0 1.0 0.9 0.7
565 P29373 CRABP2 Cellular retinoic acid-binding protein 2 CRABP2 PC*K 1.4 0.8 0.9 0.9 0.7




GGAFGGEK 1.1 1.1 0.9 0.9 0.7
567 P07737 PFN1 Profilin-1 PFN1 C*YEMASHLR 1.3 0.9 1.0 0.9 0.7
568 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 YSDESGNMDFDNFISC*LVR 2.2 1.4 1.1 1.0 0.7
569 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH
DVLNLVYLC*EALNLPEV
AR 1.3 1.1 0.9 0.9 0.7
570 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 LC*YSSDHEK 0.8 0.8 1.2 0.6 0.7
571 P26641 EEF1G Elongation factor 1-gamma EEF1G VPAFEGDDGFC*VFESNAIAYYVSNEELR 1.0 1.2 0.9 0.6 0.7
572 Q7Z5L9 IRF2BP2 Interferon regulatory factor 2-binding protein 2 IRF2BP2 LEDTHFVQC*PSVPSHK 1.0 1.2 1.1 1.1 0.7
573 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 
MACRO
D1 SC*YLSSLDLLLEHR 1.2 1.0 0.9 0.8 0.6
574 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH VPTANVSVVDLTC*R 1.1 0.7 0.6 0.5 0.6
575 P34896 SHMT1 Serine hydroxymethyltransferase, cytosolic SHMT1 AVLEALGSC*LNNK 1.0 0.4 0.4 1.1 0.3
576 P23443 RPS6KB1 Ribosomal protein S6 kinase beta-1 RPS6KB1 PEC*FELLR 1.4 1.0 1.1 1.1 0.3
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K 0.9 2.1 2.9 4.5 7.9 9.0
2 Q9NUU7
DDX19A ATP-dependent RNA 
helicase DDX19A DDX19A VLVTTNVC*AR 0.9 1.8 0.8 1.9 2.6 4.6







K 0.9 4.4 3.1 2.5 4.8 3.7
5 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A
AVC*MLSNTTAIAEAW
AR 0.9 2.5 2.1 3.2 3.1 3.4
6 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A YMACC*LLYR 0.9 2.1 1.7 2.1 2.2 3.0
7 P49327 FASN Fatty acid synthase FASN AFDTAGNGYC*R 1.0 3.3 2.7 3.1 3.4 2.9
8 O14561
NDUFAB1 Acyl carrier protein, 
mitochondrial 
NDUFAB
1 LMC*PQEIVDYIADK 0.9 1.7 1.0 1.1 1.5 2.8
9 P07437 TUBB Tubulin beta chain TUBB NMMAAC*DPR 0.9 3.7 2.6 3.2 3.5 2.8
10 P07437 TUBB Tubulin beta chain TUBB TAVC*DIPPR 0.9 3.1 2.7 3.7 3.5 2.8
11 P29401 TKT Transketolase TKT
QAFTDVATGSLGQGLG
AAC*GMAYTGK 0.9 3.2 2.7 4.4 3.1 2.7
12 P62333
PSMC6 26S protease regulatory 
subunit 10B PSMC6 GC*LLYGPPGTGK 0.9 3.7 2.2 20.0 2.8 2.6
13 P62249 RPS16 40S ribosomal protein S16 RPS16 TATAVAHC*K 0.9 3.2 3.1 3.5 4.1 2.6
14 P53621 COPA Coatomer subunit alpha COPA
TTYQALPC*LPSMYGY
PNR 0.8 11.2 2.2 1.7 4.1 2.6
15 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A SIQFVDWC*PTGFK 0.9 2.3 2.1 2.6 2.7 2.5
16 Q71U36 TUBA1A Tubulin alpha-1A chain TUBA1A TIQFVDWC*PTGFK 0.9 2.4 2.1 2.5 2.8 2.5
17 P60709 ACTB Actin, cytoplasmic 1 ACTB C*DVDIR 1.0 1.5 1.9 2.1 1.6 2.5
18 P62701
RPS4X 40S ribosomal protein S4, 
X isoform RPS4X EC*LPLIIFLR 0.9 0.8 2.3 2.5 3.8 2.5
19 P50914 RPL14 60S ribosomal protein L14 RPL14 ALVDGPC*TQVR 0.9 2.9 2.1 2.8 2.6 2.4
20 P15153
RAC2 Ras-related C3 botulinum 
toxin substrate 2 RAC2 YLEC*SALTQR 1.0 0.6 1.0 6.0 0.8 2.4
21 Q02252
ALDH6A1 Methylmalonate-
semialdehyde dehydrogenase ALDH6A1 C*MALSTAVLVGEAK 0.9 1.3 2.0 2.9 5.2 2.4
22 O95757
HSPA4L Heat shock 70 kDa 
protein 4L HSPA4L GC*ALQCAILSPAFK 0.9 2.2 2.0 2.1 2.8 2.3
23 Q86VP6
CAND1 Cullin-associated NEDD8-
dissociated protein 1 CAND1 LSTLC*PSAVLQR 1.0 1.9 1.7 1.9 1.9 2.3
24 P46782 RPS5 40S ribosomal protein S5 RPS5 TIAEC*LADELINAAK 0.9 2.6 2.5 3.4 6.5 2.3
25 P62333
PSMC6 26S protease regulatory 
subunit 10B PSMC6 AVASQLDC*NFLK 0.9 2.8 2.0 2.4 2.8 2.1
26 P60763
RAC3 Ras-related C3 botulinum 
toxin substrate 3 RAC3 AVLC*PPPVK 1.0 1.9 2.6 3.5 3.2 2.1
27 Q05639
EEF1A2 Elongation factor 1-alpha 
2 EEF1A2 PMC*VESFSQYPPLGR 1.0 2.3 2.1 2.4 2.3 2.0
28 P60709 ACTB Actin, cytoplasmic 1 ACTB
LC*YVALDFEQEMATA
ASSSSLEK 0.9 1.3 1.3 1.2 1.6 2.0
29 P30084
ECHS1 Enoyl-CoA hydratase, 
mitochondrial ECHS1 EMQNLSFQDC*YSSK 0.9 2.8 2.3 3.6 4.5 1.9
 GSNO (500 µM) 
transnitrosation time (min)
Table 2A-4. R-values from time-dependent transnitrosation experiment at 500 µM
GSNO ( 0, 5, 10, 20, 30 and 60 mins treatment). 0 µM GSNO with 60 mins treatment
was performed as a control. A list of all identified peptides (* denotes labeled
cysteine) is presented at GSNO treatment time together with calculated Heavy:Light
Ratios (R). 
Sequence
Heavy : Light Ratio
Pepti





ABRACL Costars family protein 





1 GDEC*GLALGR 1.0 2.2 2.1 2.9 3.2 1.9
32 Q9H2U2
PPA2 Inorganic pyrophosphatase 
2, mitochondrial PPA2 GQPC*SQNYR 1.5 1.4 1.5 1.9 2.2 1.9
33 P23396 RPS3 40S ribosomal protein S3 RPS3 GLC*AIAQAESLR 0.9 2.3 2.2 2.6 2.9 1.8
34 Q9BRA2
TXNDC17 Thioredoxin domain-
containing protein 17 TXNDC17 SWCPDC*VQAEPVVR 1.0 5.6 2.5 2.6 2.2 1.8
35 P63220 RPS21 40S ribosomal protein S21 RPS21 TYAIC*GAIR 1.4 3.1 2.6 3.5 3.8 1.8
36 Q96CM8
ACSF2 Acyl-CoA synthetase 
family member 2, mitochondrial ACSF2
MVSTPIGGLSYVQGC*
TK 1.4 1.6 1.8 2.1 2.6 1.8
37 P50991
CCT4 T-complex protein 1 subunit 





K 1.0 2.4 2.3 2.8 4.4 1.7
39 O15355 PPM1G Protein phosphatase 1G PPM1G C*SGDGVGAPR 1.0 2.3 2.6 2.8 3.1 1.7
40 P50570 DNM2 Dynamin-2 DNM2
LQDAFSSIGQSC*HLD
LPQIAVVGGQSAGK 1.0 2.2 2.0 2.6 2.6 1.7
41
O43765
SGTA Small glutamine-rich 
tetratricopeptide repeat-containing 
protein alpha
SGTA AIC*IDPAYSK 1.0 0.7 0.8 0.8 3.8 1.7
42 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 LLDLVQQSC*NYK 0.9 1.5 1.6 2.2 2.9 1.7
43 P13639 EEF2 Elongation factor 2 EEF2 STLTDSLVC*K 0.9 7.9 4.8 7.3 6.8 1.7
44 Q15370
TCEB2 Transcription elongation 
factor B polypeptide 2 TCEB2
ADDTFEALC*IEPFSSP




phosphatase PP1-gamma catalytic 
subunit
PPP1CC GNHEC*ASINR 0.9 1.1 1.1 1.4 1.3 1.7
46 Q6YN16
HSDL2 Hydroxysteroid 
dehydrogenase-like protein 2 HSDL2
TAIHTAAMDMLGGPGI
ESQC*R 1.0 3.0 2.5 2.0 3.2 1.7
47 Q8TEX9 IPO4 Importin-4 IPO4
APAALPAL*CDLLASA
ADPQIR 1.0 1.6 1.5 1.7 1.7 1.6
48 P28838 LAP3 Cytosol aminopeptidase LAP3 SAGAC*TAAAFLK 0.9 2.0 1.7 2.5 2.1 1.6
49 P31943
HNRNPH1 Heterogeneous nuclear 
ribonucleoprotein H 
HNRNPH
1 DLNYC*FSGMSDHR 1.0 3.5 2.6 2.8 3.2 1.6
50 Q96FW1
OTUB1 Ubiquitin thioesterase 
OTUB1 OTUB1 PDGNC*FYR 0.9 1.8 1.7 2.7 2.1 1.6
51 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 YEAAFPFLSPC*GR 1.2 2.8 2.7 3.4 3.1 1.6
52 P14618
PKM Pyruvate kinase isozymes 
M1/M2 PKM
AEGSDVANAVLDGAD
C*IMLSGETAK 0.9 0.8 1.0 1.2 1.0 1.5
53 P10599 TXN Thioredoxin TXN C*MPTFQFFK 1.0 4.0 4.5 4.5 4.2 1.5
54 Q96I99 SUCLG2 Succinyl-CoA ligase SUCLG2
SC*NGPVLVGSPQGGV
DIEEVAASNPELIFK 0.8 3.5 3.2 4.0 3.3 1.5
55 P48735 IDH2 Isocitrate dehydrogenase IDH2 DLAGC*IHGLSNVK 0.9 2.2 2.0 2.7 2.6 1.5
56 P53396 ACLY ATP-citrate synthase ACLY FIC*TTSAIQNR 0.9 1.7 1.7 1.8 2.1 1.5
57
Q9BXJ9 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit NAA15 LFNTAVC*ESK 1.0 2.5 2.0 2.2 2.6 1.5
58 P31949 S100A11 Protein S100-A11 S100A11 C*IESLIAVFQK 1.0 0.8 1.3 1.3 1.0 1.5






AHNAK GPFVEAEVPDVDLEC*PDAK 0.9 3.6 6.4 4.6 3.7 1.5
61 P49915 GMPS GMP synthase GMPS TVGVQGDC*R 0.5 1.8 2.4 3.6 3.5 1.5
62 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 LVVPATQC*GSLIGK 0.9 2.7 2.9 3.6 3.4 1.5
63 P11766
ADH5 Alcohol dehydrogenase 
class-3 ADH5
VCLLGC*GISTGYGAA
VNTAK 1.1 2.0 2.0 20.0 2.6 1.5




activating enzyme 5 UBA5
EGVC*AASLPTTMGVV
AGILVQNVLK 1.1 2.1 2.7 0.9 1.5 1.4
66 O00299
CLIC1 Chloride intracellular 
channel protein 1 CLIC1
EEFASTC*PDDEEIELA
YEQVAK 1.3 0.8 0.9 0.6 0.9 1.4
67 P00505
GOT2 Aspartate aminotransferase, 
mitochondrial GOT2 TC*GFDFTGAVEDISK 1.1 3.3 3.0 3.0 3.9 1.4
68 P49327 FASN Fatty acid synthase FASN
AINC*ATSGVVGLVNC
LR 1.0 1.4 1.5 1.6 2.5 1.4
69 P40925
MDH1 Malate dehydrogenase, 
cytoplasmic MDH1 AIC*DHVR 1.0 1.2 1.3 1.3 1.4 1.4
70 P14618
PKM Pyruvate kinase isozymes 






AHNAK LEGDLTGPSVGVEVPDVELEC*PDAK 1.0 4.2 4.4 5.4 4.9 1.4
72
P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT
VVC*SSGAVGNYSGGL
AVK 1.0 1.9 1.5 1.9 1.9 1.4
73 P18669
PGAM1 Phosphoglycerate mutase 
1 PGAM1
YADLTEDQLPSC*ESL
K 0.9 1.3 1.3 1.5 1.5 1.4
74 O00233
PSMD9 26S proteasome non-
ATPase regulatory subunit 9 PSMD9
GIGMNEPLVDC*EGYP
R 1.0 2.2 2.0 2.5 2.2 1.4
75 Q9NZZ3
CHMP5 Charged multivesicular 
body protein 5 CHMP5 APPPSLTDC*IGTVDSR 1.0 2.3 2.8 3.0 3.0 1.3
76 P30084
ECHS1 Enoyl-CoA hydratase, 
mitochondrial ECHS1
ALNALC*DGLIDELNQ
ALK 0.9 2.0 2.0 2.4 2.9 1.3
77 Q99832
CCT7 T-complex protein 1 subunit 
eta CCT7
EGTDSSQGIPQLVSNIS
AC*QVIAEAVR 1.0 2.5 2.3 2.8 2.8 1.3
78 P60709 ACTB Actin, cytoplasmic 1 ACTB
CPEALFQPSFLGMESC
*GIHETTFNSIMK 0.9 1.5 1.3 1.5 1.6 1.3
79 P12532
CKMT1B Creatine kinase U-type, 
mitochondrial CKMT1B LGYILTC*PSNLGTGLR 0.9 1.6 1.4 1.5 1.6 1.3
80 Q9UBT2
UBA2 SUMO-activating enzyme 
subunit 2 UBA2 VLVVGAGGIGC*ELLK 0.9 1.8 1.7 2.1 2.2 1.3
81 P63208
SKP1 S-phase kinase-associated 
protein 1 SKP1 GLLDVTC*K 1.0 1.7 1.5 1.8 2.0 1.3
82 P49721
PSMB2 Proteasome subunit beta 
type-2 PSMB2 NLADC*LR 0.9 1.5 0.8 0.7 1.1 1.3
83 P00558 PGK1 Phosphoglycerate kinase 1 PGK1
GCITIIGGGDTATC*CA
K 1.0 0.9 0.8 1.0 0.8 1.3
84 P60981 DSTN Destrin DSTN LGGSLIVAFEGC*PV 0.9 3.1 2.8 0.8 3.1 1.3







GGGVDGC*IHR 0.9 1.7 1.8 2.0 2.1 1.3
87 Q2TAA2
IAH1 Isoamyl acetate-hydrolyzing 
esterase 1 homolog IAH1
VILITPTPLC*ETAWEE
QCIIQGCK 0.9 2.0 1.9 2.5 2.3 1.3
88 P13639 EEF2 Elongation factor 2 EEF2 TFC*QLILDPIFK 0.8 0.8 1.2 1.0 1.2 1.3
89 P07900





FIR 0.9 0.8 0.8 0.9 1.0 1.3
90 O14980 XPO1 Exportin-1 XPO1
LDINLLDNVVNC*LYH
GEGAQQR 1.0 1.4 1.5 1.9 2.3 1.3
91 Q9NQC3 RTN4 Reticulon-4 RTN4 YSNSALGHVNC*TIK 1.1 1.2 1.5 2.3 2.2 1.3
92 Q12849 GRSF1 G-rich sequence factor 1 GRSF1 YIELFLNSC*PK 0.9 2.2 2.0 3.1 3.7 1.2
93 P60981 DSTN Destrin DSTN C*STPEEIK 1.0 2.4 2.5 2.9 2.6 1.2
94 P63208
SKP1 S-phase kinase-associated 
protein 1 SKP1 ENQWC*EEK 1.0 1.7 1.6 2.6 2.3 1.2
95 P42704
LRPPRC Leucine-rich PPR motif-
containing protein, mitochondrial LRPPRC SC*GSLLPELK 0.9 0.7 1.8 1.3 1.2 1.2
96 P26641
EEF1G Elongation factor 1-
gamma EEF1G
AAAPAPEEEMDEC*EQ
ALAAEPK 1.0 2.3 2.2 2.8 2.8 1.2
97 Q15185
PTGES3 Prostaglandin E synthase 
3 PTGES3
HLNEIDLFHC*IDPNDS
K 1.0 1.9 1.8 2.3 2.2 1.2
98 P49458
SRP9 Signal recognition particle 9 
kDa protein SRP9 VTDDLVC*LVYK 0.8 1.8 1.8 1.9 2.2 1.2
99 Q7L1Q6
BZW1 Basic leucine zipper and 
W2 domain-containing protein 1 BZW1
FDPTQFQDC*IIQGLTE
TGTDLEAVAK 1.0 1.6 1.5 1.8 1.8 1.2
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100 Q9Y5R8
TRAPPC1 Trafficking protein 
particle complex subunit 1 TRAPPC1
NPLC*PLGQTVQSELF
R 0.9 0.5 1.9 1.6 1.7 1.2
101 Q8NDH3
NPEPL1 Probable aminopeptidase 
NPEPL1 NPEPL1
IVDTPC*NEMNTDTFL
EEINK 1.1 1.4 1.4 1.6 1.7 1.2
102 P51812
RPS6KA3 Ribosomal protein S6 
kinase alpha-3 RPS6KA3
AENGLLMTPC*YTANF
VAPEVLK 0.9 2.1 1.7 2.5 3.1 1.2
103 P12004
PCNA Proliferating cell nuclear 
antigen PCNA C*AGNEDIITLR 1.2 1.1 1.1 1.1 1.2 1.2





QVK 0.9 2.5 2.1 2.8 3.4 1.2
106 P14618
PKM Pyruvate kinase isozymes 
M1/M2 PKM NTGIIC*TIGPASR 0.8 0.6 0.7 0.5 0.7 1.2
107 O14929
HAT1 Histone acetyltransferase 
type B catalytic subunit HAT1
VDENFDC*VEADDVE
GK 1.0 2.0 3.5 2.6 5.5 1.2
108 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 INISEGNC*PER 1.0 2.1 2.4 1.9 2.4 1.2
109 P60842
EIF4A1 Eukaryotic initiation 
factor 4A-I EIF4A1
VVMALGDYMGASCH
AC*IGGTNVR 1.0 1.0 1.0 1.4 1.4 1.2
110 P13639 EEF2 Elongation factor 2 EEF2
YVEPIEDVPC*GNIVGL
VGVDQFLVK 1.0 0.8 1.1 1.0 1.1 1.2
111 Q7Z4W1 DCXR L-xylulose reductase DCXR AVTNHSVYC*STK 0.9 1.0 0.9 0.8 1.0 1.2
112 P00505
GOT2 Aspartate aminotransferase, 
mitochondrial GOT2 EYLPIGGLAEFC*K 0.9 2.7 2.7 3.1 3.6 1.2
113
P14678
SNRPB Small nuclear 
ribonucleoprotein-associated 
protein
SNRPB C*ILQDGR 1.0 2.3 2.4 0.7 2.6 1.2
114 P21333 FLNA Filamin-A FLNA AHVVPC*FDASK 1.0 1.5 1.5 1.8 2.0 1.2
115 O95861
BPNT1 3(2),5-bisphosphate 
nucleotidase 1 BPNT1 TC*ATDLQTK 0.8 1.8 2.3 2.4 2.7 1.1
116




1.0 2.0 2.1 2.6 2.6 1.1
117 P30084
ECHS1 Enoyl-CoA hydratase, 
mitochondrial ECHS1
IC*PVETLVEEAIQCAE
K 0.9 1.0 1.2 2.3 1.3 1.1
118
Q96EY8
MMAB Cob(I)yrinic acid a,c-
diamide adenosyltransferase, 
mitochondrial
MMAB IQCTLQDVGSALATPC*SSAR 0.9 2.0 2.0 3.5 2.6 1.1
119 O95671
ASMTL N-acetylserotonin O-
methyltransferase-like protein ASMTL LTAC*QVATAFNLSR 1.0 2.3 2.1 2.7 2.8 1.1
120 P38117
ETFB Electron transfer 
flavoprotein subunit beta ETFB
HSMNPFC*EIAVEEAV
R 1.2 2.3 2.5 2.7 2.6 1.1
121 O95336 PGLS 6-phosphogluconolactonase PGLS AAC*CLAGAR 1.0 1.6 1.9 2.8 2.2 1.1




carboxylase beta chain, 
mitochondrial
MCCC2 LPC*IYLVDSGGAYLPR 0.9 0.8 0.8 0.9 0.9 1.1
124 P00492
HPRT1 Hypoxanthine-guanine 
phosphoribosyltransferase HPRT1 SYC*NDQSTGDIK 1.0 2.5 2.8 3.6 2.5 1.1
125 P31947 SFN 14-3-3 protein sigma SFN GEELSC*EER 0.9 1.7 1.5 2.9 1.9 1.1
126 Q99873
PRMT1 Protein arginine N-
methyltransferase 1 PRMT1 VIGIEC*SSISDYAVK 0.9 1.2 1.0 1.2 1.2 1.1
127 P23528 CFL1 Cofilin-1 CFL1 MLPDKDC*R 1.0 1.1 1.2 1.4 1.1 1.1
128 P14649 MYL6B Myosin light chain 6B MYL6B ILYSQC*GDVMR 1.0 0.8 0.9 1.0 0.9 1.1
129 Q9Y365 STARD10 PCTP-like protein STARD10
MECC*DVPAETLYDVL






SHMT2 AALEALGSC*LNNK 0.7 0.9 1.0 1.3 1.2 1.1
131 O00299
CLIC1 Chloride intracellular 
channel protein 1 CLIC1
FLDGNELTLADC*NLL





CLSLR 1.0 1.9 2.4 3.4 2.0 1.1
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133 Q6PI48
DARS2 Aspartate--tRNA ligase, 
mitochondrial DARS2 LIC*LVTGSPSIR 0.9 1.1 1.1 1.3 1.2 1.1
134 Q13526
PIN1 Peptidyl-prolyl cis-trans 
isomerase NIMA-interacting 1 PIN1
SGEEDFESLASQFSDC*
SSAK 1.0 1.1 0.9 1.1 1.1 1.1
135 P37802 TAGLN2 Transgelin-2 TAGLN2 NMAC*VQR 1.0 1.2 1.4 1.5 1.4 1.0
136 Q9UNH7 SNX6 Sorting nexin-6 SNX6
IGSSLYALGTQDSTDIC
*K 0.9 1.2 1.4 1.3 1.2 1.0
137 P62826
RAN GTP-binding nuclear protein 
Ran RAN VC*ENIPIVLC*GNK 1.0 1.0 1.0 1.1 1.2 1.0
138 P40926
MDH2 Malate dehydrogenase, 
mitochondrial MDH2
SQETEC*TYFSTPLLLG
K 1.0 0.8 1.1 0.9 0.9 1.0
139 P55735 SEC13 Protein SEC13 homolog SEC13 FASGGC*DNLIK 1.0 1.0 1.0 1.1 1.2 1.0
140 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 AITIAGIPQSIIEC*VK 1.1 1.0 1.3 1.1 1.1 1.0
141 P07237 P4HB Protein disulfide-isomerase P4HB EEC*PAVR 1.1 0.7 1.1 1.1 0.7 1.0
142 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 VGLGIC*YDMR 1.0 1.0 0.8 0.9 1.0 1.0
143 P60953
CDC42 Cell division control 
protein 42 homolog CDC42 YVEC*SALTQK 0.8 0.7 0.7 0.7 0.7 1.0
144 P21266
GSTM3 Glutathione S-transferase 
Mu 3 GSTM3 IAAYLQSDQFC*K 0.9 2.8 1.4 2.6 2.5 1.0
145 P50990
CCT8 T-complex protein 1 subunit 
theta CCT8 IAVYSC*PFDGMITETK 1.1 1.0 1.1 1.5 1.2 1.0
146 P17931 LGALS3 Galectin-3 LGALS3 VIVC*NTK 1.1 0.9 1.0 1.1 0.9 1.0
147 O00299
CLIC1 Chloride intracellular 
channel protein 1 CLIC1 IGNC*PFSQR 1.0 0.9 0.8 0.9 1.0 1.0
148 P08107
HSPA1B Heat shock 70 kDa 
protein 1A/1B HSPA1B FEELC*SDLFR 1.4 0.8 1.0 0.8 1.0 1.0
149
P36507 MAP2K2 Dual specificity mitogen-activated protein kinase kinase 2 MAP2K2
LC*DFGVSGQLIDSMA
NSFVGTR 1.2 1.1 1.0 1.2 1.3 1.0
150 P49591
SARS Serine--tRNA ligase, 
cytoplasmic SARS TIC*AILENYQTEK 0.9 0.9 0.8 1.1 1.2 1.0
151 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ DIC*NDVLSLLEK 1.1 0.6 0.9 1.3 0.8 1.0
152 P51610 HCFC1 Host cell factor 1 HCFC1 LVIYGGMSGC*R 0.9 1.4 1.3 1.1 1.4 0.9
153 Q86SX6
GLRX5 Glutaredoxin-related 
protein 5, mitochondrial GLRX5
GTPEQPQC*GFSNAVV





APNIISQL 1.0 0.9 0.9 0.9 0.8 0.9
155 P37802 TAGLN2 Transgelin-2 TAGLN2
DGTVLC*ELINALYPE
GQAPVK 1.1 0.7 0.9 0.7 0.7 0.9
156 P60174 TPI1 Triosephosphate isomerase TPI1
VPADTEVVC*APPTAYI
DFAR 1.1 0.7 0.8 0.7 0.7 0.9
157 P61158 ACTR3 Actin-related protein 3 ACTR3 YSYVC*PDLVK 0.9 1.4 1.4 1.6 1.6 0.9
158 P35270 SPR Sepiapterin reductase SPR TVVNISSLC*ALQPFK 0.9 0.8 0.8 0.8 0.8 0.9
159 P23528 CFL1 Cofilin-1 CFL1 AVLFC*LSEDK 1.2 0.8 1.1 0.9 0.8 0.9
160 P60174 TPI1 Triosephosphate isomerase TPI1 IIYGGSVTGATC*K 1.1 0.7 0.9 0.7 0.8 0.9
161 Q00610 CLTC Clathrin heavy chain 1 CLTC
IHEGC*EEPATHNALA
K 0.9 1.1 0.8 1.2 1.5 0.9
162 P21266
GSTM3 Glutathione S-transferase 
Mu 3 GSTM3 YTC*GEAPDYDR 0.9 1.4 1.1 1.1 1.2 0.9
163 P60174 TPI1 Triosephosphate isomerase TPI1 IAVAAQNC*YK 1.0 0.7 0.8 0.7 0.7 0.9
164 Q9Y696
CLIC4 Chloride intracellular 
channel protein 4 CLIC4
AGSDGESIGNC*PFSQ











LAAGC*GQNPVR 0.8 3.4 2.0 5.2 3.8 0.9
167 P23528 CFL1 Cofilin-1 CFL1 HELQANC*YEEVK 1.0 1.2 1.2 1.5 1.5 0.9
168 P62937
PPIA Peptidyl-prolyl cis-trans 
isomerase A PPIA ITIADC*GQLE 1.0 0.9 1.0 1.0 0.9 0.9
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169 O60361
NME2P1 Putative nucleoside 
diphosphate kinase NME2P1 SC*AHDWVYE 1.2 1.0 1.0 1.2 1.0 0.9
170 P52907
CAPZA1 F-actin-capping protein 
subunit alpha-1 CAPZA1
TIDGQQTIIAC*IESHQF
QPK 0.9 0.8 1.0 0.8 0.9 0.9
171 P04632 CAPNS1 Calpain small subunit 1 CAPNS1
YSDESGNMDFDNFISC





VEEVATAIGMDQR 1.0 0.7 0.7 0.6 0.8 0.9
173 P04075
ALDOA Fructose-bisphosphate 
aldolase A ALDOA ALANSLAC*QGK 1.0 0.7 0.8 0.7 0.8 0.9
174 P31948
STIP1 Stress-induced-
phosphoprotein 1 STIP1 ALDLDSSC*K 0.8 1.3 1.1 1.3 10.9 0.9
175 O60701
UGDH UDP-glucose 6-





EILPDGDHDLK 1.0 0.7 0.7 0.7 0.8 0.9
177 P78417
GSTO1 Glutathione S-transferase 





VK 0.9 0.7 0.8 0.5 0.8 0.8
179
P36969
GPX4 Phospholipid hydroperoxide 
glutathione peroxidase, 
mitochondrial
GPX4 ILAFPC*NQFGK 0.8 0.7 0.8 0.8 0.8 0.8
180 B4DXR9 ZNF732 Zinc finger protein 732 ZNF732 C*LDPAQQNLYR 1.0 0.9 1.0 1.0 1.0 0.8
181 P22234
PAICS Multifunctional protein 
ADE2 PAICS ITSC*IFQLLQEAGIK 0.9 0.7 0.7 0.6 0.9 0.8
182 P14174
MIF Macrophage migration 





R 1.0 0.8 0.8 0.8 0.8 0.8
184 P32322
PYCR1 Pyrroline-5-carboxylate 
reductase 1, mitochondrial PYCR1 SLLINAVEASC*IR 0.9 3.0 2.6 3.4 3.3 0.7
185 P07737 PFN1 Profilin-1 PFN1 C*YEMASHLR 1.0 0.7 0.9 0.8 0.8 0.7
186 Q99798
ACO2 Aconitate hydratase, 
mitochondrial ACO2
DLGGIVLANACGPC*I
GQWDR 1.1 1.8 2.6 3.5 2.9 0.7
187 P21266
GSTM3 Glutathione S-transferase 





AAC*ELLGR 1.0 0.7 0.9 0.8 0.8 0.6
189 P04406
GAPDH Glyceraldehyde-3-
phosphate dehydrogenase GAPDH VPTANVSVVDLTC*R 0.9 1.0 0.9 0.9 0.9 0.6
190 P30626 SRI Sorcin SRI
DTAQQGVVNFPYDDFI
QC*VMSV 1.2 1.6 1.1 0.9 1.0 0.5
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Constructs Vector
GSTO1-WT pcDNA3.1(+) forward 5’-TTACTCGAGATGTCCGGGGAGTCAGCCA-3’
reverse 5’-TTAGGTACCAGGCCTGTGACTATGGGCTC-3’
HADH2-WT pET23a forward 5’-TATGGATCCATGGCAGCAGCGTGTCG-3’
reverse 5’-TATCTCGAGAGGCTGCATACGAATGGCCC-3’
HADH2-C58S pET23a forward 5’-GTTAGGAAACAACTCCGTTTTCGCCCCAG-3’
reverse 5’-CTGGGGCGAAAACGGAGTTGTTTCCTAAC-3’
HADH2-C58A pET23a forward 5’-CAAGAAGTTAGGAAACAACGCCGTTTTCGCCCCAGCCGAC-3’
reverse 5’-GTCGGCTGGGGCGAAAACGGCGTTGTTTCCTAACTTCTTG-3’
CTSD-WT pcDNA3.1(+) forward 5’-TTACTCGAGATGCAGCCCTCCAGCCTTCTG-3’
reverse 5’-TTAAAGCTTGAGGCTGCCCGCCTC-3’
CTSD-C91A pcDNA3.1(+) forward 5’-GACGCCCCCCCAGGCCTTCACAGTCGTC-3’
reverse 5’-GACGACTGTGAAGGCCTGGGGGGGCGTC-3’
CTSD-C329A pcDNA3.1(+) forward 5’-GAGTACATGATCCAGAAGGTGTCCAC-3’
reverse 5’-GTGGACACCTTCTGGATCATGTACTC-3’
CTSD-C366A pcDNA3.1(+) forward 5’-GCCGGGAAGACCCTCGCCCTGAGCGGCTTCATG-3’
reverse 5’-CATGAAGCCGCTCAGGGCGAGGGTCTTCCCGGC-3’
Primers
Table 2A-5. Primers used for sub-cloning and mutagenesis of GSTO1, HADH2 and 
CTSD. 
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1 2 average 1 2 3 4 5
aver
age
1 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2
VGLIGSC*TNSSYE
DMGR 0.9 1.0 0.9 5.5 5.1 6.8
10.6 5.3 6.6 ***
2 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH
IISNASC*TTNCLAP
LAK 0.9 0.9 0.9 5.4 4.8 4.2 5.0 5.1 4.9 ***









DQTVR 1.0 0.9 0.9 4.9 4.4 3.4 3.8 4.2 4.1 ***
5 Q9H479 FN3K Fructosamine-3-kinase FN3K
AFGGPGAGC*ISEG
R 1.1 1.1 1.1 10.8 1.4 5.0 1.8 1.3 4.1 ***
6 Q9BSD7 NTPCR Cancer-related nucleoside-triphosphatase NTPCR NADC*SSGPGQR 0.9 0.9 0.9 3.6 3.5 3.9 4.7 4.1 3.9 ***
7 P07339 CTSD Cathepsin D CTSD AIGAVPLIQGEYMIPC*EK 0.8 0.9 0.9 3.4 3.2 4.0 4.7 3.7 3.8 ***
8 Q01813 PFKP 6-phosphofructokinase type C PFKP
LPLMEC*VQMTQD
VQK 0.9 1.0 0.9 3.9 3.5 3.4 4.0 3.7 3.7 ***






GFPT1 C*QNALQQVVAR 1.0 1.0 1.0 4.2 3.0 3.4 4.3 2.8 3.5 ***
11 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1
VMTIPYQPMPASSP
VIC*AGGQDR 1.0 1.0 1.0 3.2 3.2 3.4 3.9 3.4 3.4 ***
12 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 IAC*LDFSLQK 0.9 1.1 1.0 3.8 2.9 3.4 3.5 3.2 3.4 ***








AK 0.9 1.0 1.0 3.0 3.2 2.8 4.2 3.4 3.3 ***
15 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2
QC*PIMDPAWEAPE
GVPIDAIIFGGR 0.8 1.1 1.0 3.5 3.1 3.1 3.7 3.2 3.3 ***
16 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta-
2-like 1
GNB2L1 VWNLANC*K 1.0 1.1 1.0 3.0 4.1 2.6 3.3 3.5 3.3 ***




C*FEPANQMVK 1.0 1.0 1.0 3.3 3.0 3.1 3.5 3.3 3.2 ***
18 O00244 ATOX1 Copper transport protein ATOX1 ATOX1
VC*IESEHSMDTLL
ATLK 1.0 1.1 1.0 2.8 3.1 3.6 3.1 3.5 3.2 ***
19 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 TSAPITC*ELLNK 0.9 0.9 0.9 3.8 3.3 2.4 3.3 3.3 3.2 ***
20 P49207 RPL34 60S ribosomal protein L34 RPL34 AYGGSMC*AK 0.9 1.1 1.0 2.5 2.3 2.5 6.0 2.3 3.1 ***





0 µM GSNO 500 µM GSNO
Table 3A-1. R-values from transnitrosation experiment at 500 µM GSNO. A list of
all identified peptides (* denotes labeled cysteine) is presented together with
calculated Heavy:Light Ratios (R-values) in untreated (0 µM) (n=2) versus GSNO-
treated (500 µM) (n=5) MS analysis. Date were sorted by their average R-values of















DLD NETLGGTC*LNVGCIPSK 0.9 0.9 0.9 3.0 3.5 3.4 1.8 3.7 3.1 ***





GCDH GYGC*AGVSSVAYGLLAR 0.9 1.0 0.9 2.5 3.4 2.9 3.2 3.1 3.0 ***




AWAR 0.9 1.0 0.9 3.0 2.9 2.8 3.3 3.0 3.0 ***
26 P62140
PPP1CB Serine/threonine-
protein phosphatase PP1-beta 
catalytic subunit
PPP1CB IC*GDIHGQYTDLLR 1.1 1.0 1.0 3.2 1.5 3.0 3.6 3.5 3.0 ***









MDH2 GC*DVVVIPAGVPR 0.9 0.9 0.9 3.3 2.5 3.0 3.6 2.2 2.9 ***
29 P04183 TK1 Thymidine kinase, cytosolic TK1 YSSSFC*THDR 1.0 1.0 1.0 2.8 2.6 2.8 3.0 3.1 2.9 ***




SK 1.0 1.1 1.1 3.3 2.5 3.0 2.8 2.5 2.8 ***




0.9 1.0 1.0 2.7 2.7 2.5 3.0 3.2 2.8 ***
32 P63244
GNB2L1 Guanine nucleotide-






1.0 0.9 0.9 2.4 2.1 2.9 3.4 3.2 2.8 ***
33 P07437 TUBB Tubulin beta chain TUBB NMMAAC*DPR 0.9 1.0 0.9 2.9 2.6 2.6 3.0 2.8 2.8 ***
34 Q09028 RBBP4 Histone-binding protein RBBP4 RBBP4 YMPQNPC*IIATK 1.0 0.9 0.9 2.5 2.9 2.6 3.0 2.9 2.8 ***
35 P49327 FASN Fatty acid synthase FASN LGMLSPEGTC*K 0.9 1.0 1.0 2.7 2.8 2.6 3.3 2.4 2.8 ***
36 P60709 ACTB Actin, cytoplasmic 1 ACTB C*DVDIR 1.0 1.0 1.0 2.6 2.8 2.7 3.1 2.6 2.8 ***
37 P62280 RPS11 40S ribosomal protein S11 RPS11
DVQIGDIVTVGEC*
R 0.9 1.0 0.9 2.9 2.5 2.5 3.1 2.7 2.7 ***
38 Q9Y5M8 SRPRB Signal recognition particle receptor subunit beta SRPRB NTPSFLIAC*NK 1.0 1.1 1.1 2.6 1.4 2.7 3.4 3.3 2.7 ***




0.9 1.0 1.0 2.7 2.7 2.6 2.7 2.7 2.7 ***





PFKL VFANAPDSAC*VIGLK 0.9 1.0 0.9 3.0 2.5 2.6 3.0 2.4 2.7 ***
42 P07437 TUBB Tubulin beta chain TUBB TAVC*DIPPR 0.9 1.0 0.9 2.6 2.6 2.5 2.9 2.7 2.7 ***




0.9 1.1 1.0 3.2 2.5 2.5 2.6 2.4 2.6 ***
44 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta--
like 1
GNB2L1 LWNTLGVC*K 1.0 1.0 1.0 2.9 2.1 2.7 2.8 2.6 2.6 ***
45 P23396 RPS3 40S ribosomal protein S3 RPS3 GC*EVVVSGK 1.0 1.0 1.0 2.3 3.1 2.5 2.5 2.7 2.6 ***
46 P83731 RPL24 60S ribosomal protein L24 RPL24 VELC*SFSGYK 0.9 1.1 1.0 2.6 2.5 2.1 2.6 3.2 2.6 ***
47 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1
ALC*QITDSTMLQ
AIER 1.0 1.0 1.0 2.8 2.7 2.1 3.1 2.4 2.6 ***
48 P10644
PRKAR1A cAMP-dependent 
protein kinase type I-alpha 
regulatory subunit
PRKAR1
A EC*ELYVQK 0.9 1.0 1.0 2.2 3.1 2.4 2.5 2.8 2.6 ***
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49 Q01813 PFKP 6-phosphofructokinase type C PFKP
NESC*SENYTTDFI
YQLYSEEGK 1.0 1.0 1.0 2.7 2.3 2.3 2.9 2.8 2.6 ***
50 P32322
PYCR1 Pyrroline-5-
carboxylate reductase 1, 
mitochondrial PYCR1
SLLINAVEASC*IR 0.9 1.0 0.9 2.7 2.2 2.6 2.9 2.6 2.6 ***
51 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP C*PTSGR 0.9 0.9 0.9 2.6 2.5 2.5 2.6 2.8 2.6 ***
52 O95833 CLIC3 Chloride intracellular channel protein 3 CLIC3
ASEDGESVGHC*PS
CQR 0.9 1.0 1.0 2.4 1.8 4.2 2.3 2.3 2.6 ***
53 Q9BUF5 TUBB6 Tubulin beta-6 chain TUBB6 EIVHIQAGQC*GNQIGTK 0.8 1.0 0.9 3.1 1.7 2.0 4.7 1.3 2.6 ***
54 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta-
2-like 1
GNB2L1 FSPNSSNPIIVSC*GWDK 0.9 1.0 0.9 2.8 2.3 2.6 2.8 2.4 2.6 ***
55 P78527
PRKDC DNA-dependent 
protein kinase catalytic 
subunit 
PRKDC VEQLFQVMNGILAQDSAC*SQR 0.9 1.0 1.0 1.8 2.0 2.5 3.5 3.0 2.6 ***
56 P42677 RPS27 40S ribosomal protein S27 RPS27 LTEGC*SFR 0.9 1.0 0.9 2.5 2.5 2.4 2.8 2.5 2.5 ***
57 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1
VVVVQAISALC*Q
K 0.9 1.0 0.9 2.6 2.6 2.2 2.9 2.4 2.5 ***
58 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 C*GLALALNK 0.9 0.9 0.9 3.2 2.0 2.4 2.8 2.4 2.5 ***
59 P68366 TUBA4A Tubulin alpha-4A chain 
TUBA4
A SIQFVDWC*PTGFK 0.9 1.0 1.0 2.5 2.4 2.4 2.8 2.5 2.5 ***
60 P11498 PC Pyruvate carboxylase, mitochondrial PC
ADFAQAC*QDAGV
R 1.0 0.7 0.9 1.6 1.7 2.7 3.7 2.9 2.5 ***
61 P32322
PYCR1 Pyrroline-5-
carboxylate reductase 1, 
mitochondrial
PYCR1 C*MTNTPVVVR 1.0 1.0 1.0 2.7 2.4 2.5 2.7 2.3 2.5 ***











ELAC2 C*VLSGPPQLEK 0.8 0.9 0.9 2.6 2.1 2.4 2.4 2.9 2.5 ***
65 P17987 TCP1 T-complex protein 1 subunit alpha TCP1
GANDFMC*DEME
R 0.9 0.8 0.8 2.8 2.0 2.0 2.8 2.8 2.5 ***
66 P35250 RFC2 Replication factor C subunit 2 RFC2 VC*DEPHPLLVK 1.0 0.9 0.9 2.2 2.8 2.1 2.7 2.4 2.4 ***
67 Q71U36 TUBA1A Tubulin alpha-1A chain 
TUBA1
A TIQFVDWC*PTGFK 0.9 1.0 0.9 2.4 2.3 2.2 2.7 2.5 2.4 ***
68 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 YVAAAFPSAC*GK 1.0 0.9 0.9 2.8 2.1 2.3 2.6 2.4 2.4 ***






GNB2 AC*GDSTLTQITAGLDPVGR 1.0 0.9 0.9 2.6 2.2 2.2 2.7 2.3 2.4 ***
71 P68366 TUBA4A Tubulin alpha-4A chain 
TUBA4
A YMACC*LLYR 0.9 1.0 1.0 2.4 2.3 2.3 2.6 2.4 2.4 ***
72 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 SLHDALC*VVK 1.0 1.2 1.1 1.9 2.0 2.5 3.3 2.3 2.4 ***
73 P50914 RPL14 60S ribosomal protein L14 RPL14 C*MQLTDFILK 0.9 1.0 0.9 2.5 2.3 2.2 2.5 2.4 2.4 ***
74 Q16576 RBBP7 Histone-binding protein RBBP7 RBBP7
VHIPNDDAQFDAS
HC*DSDK 0.9 1.0 0.9 1.7 1.6 1.4 1.9 5.3 2.4 ***
75 P49327 FASN Fatty acid synthase FASN AFDTAGNGYC*R 1.0 1.0 1.0 2.5 1.9 2.2 2.9 2.3 2.4 ***











MDH2 GYLGPEQLPDC*LK 0.9 0.9 0.9 2.2 2.1 2.3 2.8 2.4 2.4 ***





PPP1CC GNHEC*ASINR 0.9 1.1 1.0 2.8 2.0 2.2 2.5 2.2 2.3 ***





MAT2A TC*NVLVALEQQSPDIAQGVHLDR 1.1 1.1 1.1 2.3 2.0 2.2 2.6 2.6 2.3 ***
83 P62280 RPS11 40S ribosomal protein S11 RPS11 C*PFTGNVSIR 1.0 1.0 1.0 2.3 2.2 1.9 2.4 2.8 2.3 ***
84 P50914 RPL14 60S ribosomal protein L14 RPL14 ALVDGPC*TQVR 0.9 1.0 1.0 2.5 2.1 2.1 2.7 2.3 2.3 ***
85 P40939
HADHA Trifunctional 
enzyme subunit alpha, 
mitochondrial 





DPYSL2 FQLTDC*QIYEVLSVIR 1.1 0.9 1.0 3.0 2.5 1.9 2.3 1.9 2.3 ***
87 P53384
NUBP1 Cytosolic Fe-S 
cluster assembly factor 
NUBP1 
NUBP1 GASC*QGC*PNQR 1.0 1.1 1.0 2.2 2.2 2.2 2.8 2.1 2.3 ***





GOT2 VGAFTMVC*K 0.9 1.0 1.0 3.0 2.8 1.3 3.1 1.2 2.3 ***











SUCLG2 IDATQVEVNPFGETPEGQVVC*FDAK 1.0 1.0 1.0 2.3 2.0 1.7 2.9 2.5 2.3 ***
93 P49411 TUFM Elongation factor Tu, mitochondrial TUFM
GEETPVIVGSALC*
ALEGR 1.0 0.9 1.0 2.2 2.1 2.2 2.5 2.3 2.3 ***
94 P33992 MCM5 DNA replication licensing factor MCM5 MCM5
C*SVLAAANSVFG
R 1.3 1.0 1.1 2.2 2.8 1.9 2.5 1.9 2.2 **





IVD GSNTCELIFEDC*K 1.0 0.9 1.0 2.2 2.1 2.2 2.5 2.0 2.2 **
97 P10589 NR2F1 COUP transcription factor 1 NR2F1 SQC*ALEEYVR 0.8 1.0 0.9 2.1 2.0 2.1 2.5 2.4 2.2 ***
98 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 YNFFTGC*PK 0.9 1.1 1.0 2.2 2.0 2.1 2.6 2.1 2.2 **
99 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9
TAC*TNFMMTPYV
VTR 2.7 1.0 1.9 4.6 1.4 1.6 1.6 1.7 2.2 ns
100 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 C*LQSGTLFR 0.8 1.0 0.9 2.3 2.2 1.9 2.4 2.1 2.2 ***
101 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 
KIAA19








LLIHR 0.9 1.1 1.0 2.3 2.1 2.0 2.0 2.5 2.2 **
103 P13804
ETFA Electron transfer 
flavoprotein subunit alpha, 
mitochondrial
ETFA LGGEVSC*LVAGTK 0.9 1.0 0.9 2.3 1.9 2.2 2.4 2.0 2.2 **
245
104 P46734






R 1.9 1.2 1.6 1.7 2.0 2.2 2.8 2.2 2.2 ns
105 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
ALNALC*DGLIDEL
NQALK 0.9 1.0 1.0 2.3 2.1 2.1 2.3 2.1 2.2 **
106 P13804
ETFA Electron transfer 
flavoprotein subunit alpha, 
mitochondrial
ETFA TIYAGNALC*TVK 1.0 1.0 1.0 1.9 2.1 2.3 2.5 2.0 2.2 **
107 O43719 HTATSF1 HIV Tat-specific factor 1 
HTATSF
1 GFEGSC*SQK 1.1 1.2 1.1 1.7 1.8 2.0 2.2 3.1 2.1 ns
108 Q9Y399 MRPS2 28S ribosomal protein S2, mitochondrial MRPS2 DC*GEYAHTR 0.8 0.9 0.9 1.0 1.7 2.9 2.7 2.4 2.1 ***
109 P42025 ACTR1B Beta-centractin ACTR1B AC*YLSINPQK 0.9 1.0 0.9 2.3 2.1 1.9 2.5 1.9 2.1 **
110 P62829 RPL23 60S ribosomal protein L23 RPL23
ISLGLPVGAVINC*
ADNTGAK 0.9 1.0 1.0 2.2 1.9 2.0 2.3 2.2 2.1 **








GSDSSR 1.0 1.1 1.0 2.3 1.7 2.0 2.5 2.0 2.1 *
113 Q9Y5Y2
NUBP2 Cytosolic Fe-S 
cluster assembly factor 
NUBP2 
NUBP2 VGILDVDLC*GPSIPR 1.0 1.0 1.0 2.1 1.7 2.0 2.7 1.9 2.1 **
114 P53618 COPB1 Coatomer subunit beta COPB1
ALSGYC*GFMAAN
LYAR 0.7 1.0 0.8 2.1 1.5 1.9 2.3 2.3 2.0 **
115 Q14152 EIF3A Eukaryotic translation initiation factor 3 subunit EIF3A NIC*QQVNIK 0.9 1.0 0.9 2.3 1.7 2.0 2.2 2.0 2.0 *
116 P62714
PPP2CB Serine/threonine-
protein phosphatase 2A 
catalytic subunit beta isoform 
PPP2CB NVVTIFSAPNYC*YR 0.9 1.0 1.0 2.3 1.8 2.2 2.0 1.9 2.0 *
117 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6
AC*ALQVLSAILEG





PPA2 GQPC*SQNYR 1.5 1.3 1.4 1.7 1.7 2.5 2.1 2.2 2.0 ns
119 P24468 NR2F2 COUP transcription factor 2 NR2F2
FGSQC*MQPNNIM
GIENICELAAR 1.2 1.0 1.1 2.2 2.1 2.2 1.7 1.9 2.0 ns
120 P21333 FLNA Filamin-A FLNA LQVEPAVDTSGVQC*YGPGIEGQGVFR 1.0 1.1 1.1 1.8 2.0 1.8 2.8 1.6 2.0 ns
121 P62888 RPL30 60S ribosomal protein L30 RPL30
VC*TLAIIDPGDSDI
IR 0.9 0.9 0.9 2.1 1.9 1.8 2.2 2.0 2.0 *
122 P62753 RPS6 40S ribosomal protein S6 RPS6 LNISFPATGC*QK 0.9 0.9 0.9 2.0 1.9 1.9 2.2 2.0 2.0 *
123 P53384
NUBP1 Cytosolic Fe-S 
cluster assembly factor 
NUBP1 








K 1.1 1.0 1.0 2.0 1.5 2.1 2.4 1.9 2.0 ns






1 GDLNDCFIPC*TPK 1.1 1.0 1.1 2.1 2.4 0.9 3.5 1.0 2.0 ns




QEALR 1.0 0.9 1.0 2.1 2.0 1.8 2.3 1.6 2.0 ns
128 P15924 DSP Desmoplakin DSP YC*YLQNEVFGLFQK 1.0 1.0 1.0 2.5 1.7 1.7 2.3 1.7 2.0 ns
129 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O NC*AQGEGSMAK 1.0 1.0 1.0 1.3 2.0 2.5 2.3 1.6 1.9 ns
130 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 C*FIVGADNVGSK 0.9 1.0 1.0 2.0 1.8 1.9 2.1 2.0 1.9 ns
131 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 YLLDSC*APLLR 0.8 1.3 1.0 1.9 1.8 2.3 1.9 1.9 1.9 ns
246
132 Q07020 RPL18 60S ribosomal protein L18 RPL18 GC*GTVLLSGPR 0.9 1.0 1.0 2.1 1.7 1.8 2.1 2.0 1.9 ns
133 P13639 EEF2 Elongation factor 2 EEF2 DLEEDHAC*IPIK 0.9 1.0 1.0 1.8 1.8 2.0 2.3 1.8 1.9 ns
134 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
EMQNLSFQDC*YS
SK 0.9 0.9 0.9 2.0 1.9 1.8 2.0 1.9 1.9 *
135 Q8TC07 TBC1D15 TBC1 domain family member 15 
TBC1D1
5 TLLVNC*QNK 1.1 1.0 1.1 1.9 1.4 1.9 2.2 2.1 1.9 ns
136 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X
FDTGNLC*MVTGG
ANLGR 0.9 0.9 0.9 2.0 1.7 2.1 2.2 1.7 1.9 *
137 P46776 RPL27A 60S ribosomal protein L27a RPL27A NQSFC*PTVNLDK 0.9 1.0 0.9 2.3 1.8 1.8 1.9 1.8 1.9 ns
138 P55060 CSE1L Exportin-2 CSE1L IC*AVGITK 0.9 1.0 0.9 1.9 2.1 1.7 2.0 1.9 1.9 ns
139 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1
TFVGTPC*WMAPE
VMEQVR 1.0 1.0 1.0 1.8 1.5 1.7 2.5 2.0 1.9 ns
140 Q68CP9 ARID2 AT-rich interactive domain-containing protein 2 ARID2 SC*SNAAFALK 0.8 1.0 0.9 2.2 1.6 1.4 1.9 2.5 1.9 ns
141 Q9Y5Y2
NUBP2 Cytosolic Fe-S 
cluster assembly factor 
NUBP2 
NUBP2 AVHQC*DR 1.0 1.1 1.1 2.0 1.8 1.8 2.2 1.7 1.9 ns





PPAT C*ELENCQPFVVETLHGK 0.8 1.1 1.0 1.6 1.3 1.4 1.7 3.5 1.9 ns
144 P27448 MARK3 MAP/microtubule affinity-regulating kinase 3 MARK3
LDTFC*GSPPYAAP
ELFQGK 0.9 1.0 1.0 1.5 1.6 1.6 3.1 1.7 1.9 ns
145 O95782 AP2A1 AP-2 complex subunit alpha-1 AP2A1
TVFEALQAPAC*H









SDR family member 4 
DHRS4 VNC*LAPGLIK 0.9 1.0 1.0 2.1 1.8 1.8 1.9 1.7 1.9 ns
148 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 LEIC*NLTPDALK 0.8 0.9 0.9 1.9 1.7 1.9 2.4 1.5 1.9 ns
149 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7 NC*EPMIGLVPILK 0.9 0.9 0.9 2.0 1.8 1.8 1.9 1.9 1.9 ns
150 Q04726 TLE3 Transducin-like enhancer protein 3 TLE3 FTVAESC*DR 0.9 1.0 1.0 2.5 1.1 2.0 1.6 2.0 1.8 ns
151 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 LC*ALR 0.6 1.0 0.8 2.0 1.5 1.8 2.0 1.9 1.8 *
152 Q9H1K1
ISCU Iron-sulfur cluster 
assembly enzyme ISCU, 
mitochondrial
ISCU NVGTGLVGAPAC*GDVMK 0.8 1.1 1.0 1.8 1.7 1.8 2.2 1.7 1.8 ns
153 P49411 TUFM Elongation factor Tu, mitochondrial TUFM GDEC*ELLGHSK 0.9 1.0 1.0 1.8 1.8 1.7 2.1 1.8 1.8 ns




0.9 0.9 0.9 2.1 1.6 1.9 1.9 1.6 1.8 ns
155 P51610 HCFC1 Host cell factor 1 HCFC1 AC*AAGTPAVIR 0.9 0.9 0.9 1.5 1.9 2.0 2.0 1.9 1.8 ns





MDH2 TIIPLISQC*TPK 0.9 1.0 0.9 1.7 1.8 1.9 1.9 1.8 1.8 ns
158 P02795 MT2A Metallothionein-2 MT2A SC*CSCCPVGC*AK 1.0 0.9 1.0 1.4 1.6 1.8 2.7 1.6 1.8 ns
159 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 FC*LDNGAK 1.1 1.0 1.0 0.8 2.6 2.4 0.8 2.5 1.8 ns
160 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 SFVQWLGC*R 1.1 0.9 1.0 1.7 1.6 1.8 1.8 2.1 1.8 ns
161 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O
GEVPC*TVTSASPL
EEATLSELK 1.0 1.0 1.0 3.3 1.5 1.3 1.5 1.5 1.8 ns
162 Q27J81 INF2 Inverted formin-2 INF2 AVLLASDAQEC*TLEEVVER 0.8 0.8 0.8 1.8 0.9 2.0 2.7 1.5 1.8 ns
247
163 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 AVASQLDC*NFLK 0.9 1.0 0.9 1.7 1.8 1.7 1.9 1.7 1.8 ns




0.8 0.9 0.9 2.0 1.3 1.8 2.2 1.5 1.8 ns








GQR 0.8 0.9 0.9 1.7 1.5 1.7 2.2 1.8 1.8 ns
167 Q9Y5Q8
GTF3C5 General 
transcription factor 3C 
polypeptide 5 
GTF3C5 VC*TNPVDR 0.9 1.1 1.0 1.6 1.1 1.7 2.0 2.4 1.8 ns
168 Q96CM8
ACSF2 Acyl-CoA synthetase 
family member 2, 
mitochondrial
ACSF2 MVSTPIGGLSYVQGC*TK 1.4 1.8 1.6 1.9 1.8 1.6 1.8 1.7 1.8 ns
169 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0
AGAIAPC*EVTVPA
QNTGLGPEK 0.9 1.0 0.9 1.8 1.6 1.7 2.0 1.8 1.8 ns
170 P00966 ASS1 Argininosuccinate synthase ASS1 FELSC*YSLAPQIK 1.1 1.0 1.0 2.1 1.7 1.6 1.6 1.8 1.8 ns
171 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 C*AMTALSSK 0.9 1.1 1.0 1.8 2.4 1.5 1.7 1.4 1.8 ns
172 P11802 CDK4 Cyclin-dependent kinase 4 CDK4 LMDVC*ATSR 1.0 1.0 1.0 1.7 2.0 1.6 2.0 1.5 1.8 ns
173 Q969Z0 TBRG4 Protein TBRG4 TBRG4 LATDLLSLMPSLTSGEVAHC*AK 1.0 1.1 1.0 1.7 1.8 1.7 2.0 1.6 1.7 ns
174 Q7Z406 MYH14 Myosin-14 MYH14 ADLLLEPC*SHYR 1.0 1.0 1.0 1.7 1.8 1.6 1.9 1.8 1.7 ns
175 Q15019 SEPT2 Septin-2 2-Sep LTVVDTPGYGDAINC*R 1.0 1.0 1.0 1.8 1.6 1.6 1.9 1.8 1.7 ns
176 P23396 RPS3 40S ribosomal protein S3 RPS3 GLC*AIAQAESLR 0.9 1.0 1.0 1.8 1.7 1.6 1.8 1.8 1.7 ns
177 P43246 MSH2 DNA mismatch repair protein Msh2 MSH2 HVIEC*AK 0.9 0.6 0.7 1.8 1.8 1.2 2.0 1.9 1.7 ns
178 P56377 AP1S2 AP-1 complex subunit sigma-2 AP1S2 MC*SFLEWR 1.0 0.9 1.0 2.0 1.5 1.5 2.2 1.5 1.7 ns
179 Q13155
AIMP2 Aminoacyl tRNA 
synthase complex-interacting 
multifunctional protein 2
AIMP2 FSIQTMC*PIEGEGNIAR 0.9 1.0 1.0 1.6 1.6 1.8 2.0 1.7 1.7 ns
180 Q99832 CCT7 T-complex protein 1 subunit eta CCT7
QLC*DNAGFDATNI
LNK 0.9 1.1 1.0 1.7 1.9 1.8 1.9 1.4 1.7 ns
181 P21333 FLNA Filamin-A FLNA THEAEIVEGENHTYC*IR 1.1 1.0 1.0 1.6 1.6 1.6 2.3 1.4 1.7 ns
182 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2
PMC*VESFSQYPPL
GR 0.9 1.0 0.9 1.6 1.6 1.8 1.9 1.6 1.7 ns
183 P62910 RPL32 60S ribosomal protein L32 RPL32 SYC*AEIAHNVSSK 0.8 1.0 0.9 1.6 1.7 1.7 1.7 1.8 1.7 ns
184 Q8WTW3COG1 Conserved oligomeric Golgi complex subunit 1 COG1
AQAISPC*VQNFCS
ALDSK 0.9 1.0 0.9 1.6 1.7 1.6 2.0 1.5 1.7 ns
185 Q13542
EIF4EBP2 Eukaryotic 







0.8 0.7 0.7 1.5 1.4 1.9 2.1 1.7 1.7 ns
186 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 C*SPIGVYTSGK 1.0 1.0 1.0 2.1 1.7 1.2 2.2 1.3 1.7 ns
187 A6NDG6 PGP Phosphoglycolate phosphatase PGP NNQESDC*VSK 1.0 1.0 1.0 1.7 1.7 1.6 1.8 1.8 1.7 ns
188 P62318 SNRPD3 Small nuclear ribonucleoprotein Sm D3 SNRPD3
VLHEAEGHIVTC*E










IDH2 C*ATITPDEAR 0.8 1.0 0.9 1.7 1.5 1.9 1.8 1.6 1.7 ns
191 P15880 RPS2 40S ribosomal protein S2 RPS2 GC*TATLGNFAK 1.0 1.0 1.0 1.8 1.7 1.6 1.7 1.7 1.7 ns
248
192 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 C*TPSVISFGSK 0.9 1.0 0.9 1.6 1.6 1.6 1.8 1.7 1.7 ns
193 P24385 CCND1 G1/S-specific cyclin-D1 CCND1 AEETC*APSVSYFK 0.8 1.1 1.0 1.8 1.5 2.4 1.8 0.9 1.7 ns
194 P46782 RPS5 40S ribosomal protein S5 RPS5
TIAEC*LADELINA
AK 0.9 1.0 0.9 1.7 1.6 1.6 1.8 1.7 1.7 ns
195 Q53H96 PYCRL Pyrroline-5-carboxylate reductase 3 PYCRL
SDVC*TPGGTTIYG





SUCLG1 LIGPNCPGVINPGEC*K 1.0 0.9 1.0 1.7 1.6 1.6 1.7 1.8 1.7 ns
197 P35125 USP6 Ubiquitin carboxyl-terminal hydrolase 6 USP6 SGTSC*PSSK 0.9 1.0 0.9 1.5 1.5 1.9 1.8 1.6 1.7 ns
198 O95685
PPP1R3D Protein 





R 0.9 1.4 1.1 1.0 3.1 1.1 0.8 2.2 1.6 ns
199 Q9Y508 RNF114 RING finger protein 114 RNF114
DC*GGAAQLAGPA
AEADPLGR 1.0 1.1 1.0 1.6 1.8 1.5 1.6 1.7 1.6 ns
200 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 LQGATC*NNNK 0.9 0.9 0.9 1.8 1.9 1.5 2.2 0.7 1.6 ns
201 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L
GC*ALQCAILSPAF
K 0.9 0.9 0.9 1.7 1.7 1.5 1.5 1.7 1.6 ns
202 Q9UHD8 SEPT9 Septin-9 9-Sep LTVIDTPGFGDHINNENC*WQPIMK 0.9 0.9 0.9 1.6 1.7 1.6 1.7 1.5 1.6 ns
203 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC ISAFGYLEC*SAK 0.7 0.7 0.7 1.9 1.2 1.8 1.8 1.5 1.6 ns
204 Q9H1K1
ISCU Iron-sulfur cluster 
assembly enzyme ISCU, 
mitochondrial
ISCU LHC*SMLAEDAIK 0.9 1.0 1.0 1.6 1.3 1.6 1.9 1.7 1.6 ns





MYD88 FITVCDYTNPC*TK 0.9 0.9 0.9 1.9 1.4 1.7 1.6 1.5 1.6 ns
207 P37198 NUP62 Nuclear pore glycoprotein p62 NUP62
DIIEHLNTSGAPAD
TSDPLQQIC*K 0.7 0.9 0.8 1.8 1.6 1.5 1.7 1.6 1.6 ns





MGMT VVC*SSGAVGNYSGGLAVK 1.0 1.0 1.0 1.7 1.6 1.4 1.6 1.7 1.6 ns
210 Q96RQ3
MCCC1 Methylcrotonoyl-
CoA carboxylase subunit 
alpha, mitochondrial
MCCC1 ESLC*QAALGLILK 1.0 0.9 1.0 1.4 2.0 1.4 1.6 1.6 1.6 ns
211 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2
VLVVGAGGIGC*E






A1 GDEC*GLALGR 1.0 1.0 1.0 1.7 1.5 1.5 1.7 1.6 1.6 ns
213 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 C*SFDVVK 0.8 0.9 0.8 1.7 1.3 1.5 1.8 1.7 1.6 ns
214 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 VVLLGEGC*VGK 1.1 1.0 1.1 1.8 1.4 1.5 1.6 1.6 1.6 ns
215 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 GNVC*GDSK 0.8 1.0 0.9 1.5 1.5 1.6 1.9 1.4 1.6 ns
216 Q66K14 TBC1D9B TBC1 domain family member 9B 
TBC1D9






A1 AEMDAAIASC*K 0.9 1.0 1.0 1.5 1.6 1.6 1.9 1.5 1.6 ns





PPCDC ASC*PAAAPLMER 1.0 1.2 1.1 1.4 1.5 1.7 1.8 1.6 1.6 ns
220 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 GC*AFVTFTTR 1.0 1.1 1.1 1.8 1.5 1.5 1.5 1.7 1.6 ns
249
221 P61758 VBP1 Prefoldin subunit 3 VBP1 DSC*GK 0.9 0.9 0.9 3.5 1.0 1.2 1.1 1.1 1.6 ns
222 A0MZ66 KIAA1598 Shootin-1 KIAA1598 VTFQPPSSIGC*R 1.0 1.1 1.0 1.5 1.7 1.7 1.5 1.5 1.6 ns
223 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 ANSSVVSVNC*K 0.9 1.0 1.0 1.7 1.4 1.4 1.8 1.7 1.6 ns





SUCLA2 ILAC*DDLDEAAR 0.7 1.0 0.9 1.2 1.7 1.4 2.1 1.5 1.6 ns
226 P20810 CAST Calpastatin CAST AAAPAPVSEAVC*R 1.0 0.9 0.9 1.6 1.5 1.6 1.6 1.5 1.6 ns
227 P62244 RPS15A 40S ribosomal protein S15a RPS15A C*GVISPR 0.9 0.9 0.9 1.6 1.7 1.5 1.4 1.6 1.6 ns
228 P46782 RPS5 40S ribosomal protein S5 RPS5 AQC*PIVER 0.9 0.9 0.9 1.6 1.6 1.3 1.7 1.6 1.6 ns
229 Q9NZA1 CLIC5 Chloride intracellular channel protein 5 CLIC5
AGIDGESIGNC*PF
SQR 1.0 1.0 1.0 1.6 1.5 1.5 1.7 1.5 1.6 ns













0.8 1.0 0.9 1.6 1.4 1.4 1.7 1.6 1.5 ns
232 Q6PKG0 LARP1 La-related protein 1 LARP1 TASISSSPSEGTPTVGSYGC*TPQSLPK 0.9 1.0 0.9 1.4 1.5 1.4 1.9 1.6 1.5 ns
233 Q7Z2W4
ZC3HAV1 Zinc finger 










IDH2 VC*VETVESGAMTK 0.9 0.9 0.9 1.4 1.4 1.4 2.0 1.5 1.5 ns
235 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA
VNLQMVYDSPLC*
R 0.9 0.9 0.9 1.1 1.5 1.6 2.0 1.6 1.5 ns
236 P60981 DSTN Destrin DSTN HEC*QANGPEDLNR 1.2 1.0 1.1 1.5 1.4 1.7 1.6 1.5 1.5 ns
237 O75439
PMPCB Mitochondrial-
processing peptidase subunit 
beta 
PMPCB LC*TSVTESEVAR 1.1 0.9 1.0 2.0 1.6 1.4 1.3 1.3 1.5 ns
238 P55263 ADK Adenosine kinase ADK TGC*TFPEK 1.0 1.0 1.0 1.5 1.4 1.4 1.8 1.5 1.5 ns





HMGCL LLEAGNFIC*QALNR 0.8 1.0 0.9 1.4 1.4 1.6 1.7 1.5 1.5 ns
241 P19838 NFKB1 Nuclear factor NF-kappa-B p105 subunit NFKB1
YVC*EGPSHGGLP
GASSEK 0.9 0.8 0.8 1.5 1.5 1.5 1.5 1.5 1.5 ns
242 E9PPU0 EPPK1 Epiplakin EPPK1 YLC*GLGAVGGVR 1.0 1.0 1.0 1.4 1.6 1.3 1.5 1.6 1.5 ns




1.1 1.0 1.0 1.4 1.5 1.5 1.5 1.5 1.5 ns
244 Q9BUH6 C9orf142 Uncharacterized protein C9orf142 C9orf142 C*PGESLINPGFK 1.0 1.0 1.0 1.4 1.4 1.5 1.7 1.5 1.5 ns
245 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1 AIC*TEAGLMALR 1.0 1.0 1.0 1.5 1.4 1.6 1.6 1.4 1.5 ns
246 P22102
GART Trifunctional purine 
biosynthetic protein 
adenosine-3
GART QVLVAPGNAGTAC*SEK 0.8 0.8 0.8 1.7 1.2 1.4 1.6 1.5 1.5 ns
247 P55809
OXCT1 Succinyl-CoA:3-
ketoacid coenzyme A 
transferase 1, mitochondrial
OXCT1 C*TLPLTGK 0.8 1.0 0.9 1.4 1.5 1.4 1.6 1.5 1.5 ns
248 Q13155
AIMP2 Aminoacyl tRNA 
synthase complex-interacting 
multifunctional protein 2
AIMP2 SC*ENLAPFNTALK 0.9 1.0 0.9 1.0 1.7 1.4 1.7 1.6 1.5 ns
250
249 Q93052 LPP Lipoma-preferred partner LPP
TYITDPVSAPC*AP
PLQPK 1.0 1.1 1.0 1.4 1.4 1.4 1.7 1.5 1.5 ns
250 Q8TEX9 IPO4 Importin-4 IPO4 APAALPALC*DLLASAADPQIR 1.0 1.1 1.0 1.3 1.4 1.4 1.6 1.6 1.5 ns





IDH2 DLAGC*IHGLSNVK 0.9 0.9 0.9 1.5 1.4 1.4 1.6 1.5 1.5 ns
253 Q13636 RAB31 Ras-related protein Rab-31 RAB31 VC*LLGDTGVGK 0.8 1.0 0.9 1.6 1.3 1.5 1.5 1.4 1.5 ns
254 Q00765 REEP5 Receptor expression-enhancing protein 5 REEP5 NC*MTDLLAK 1.1 1.0 1.0 1.5 1.5 1.3 1.7 1.4 1.5 ns






A1 VC*NLIDSGTK 0.9 1.0 0.9 1.5 1.4 1.4 1.7 1.3 1.5 ns
257 O15355 PPM1G Protein phosphatase 1G PPM1G C*SGDGVGAPR 1.0 0.9 1.0 1.3 1.5 1.5 1.5 1.5 1.4 ns
258 P0CW22 RPS17L 40S ribosomal protein S17-like RPS17L VC*EEIAIIPSK 0.9 0.9 0.9 1.5 1.4 1.4 1.5 1.5 1.4 ns
259 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 C*QTSMDELLK 0.9 1.0 1.0 1.4 1.0 2.0 1.2 1.6 1.4 ns
260 P09429 HMGB1 High mobility group protein B1 HMGB1 MSSYAFFVQTC*R 1.0 0.8 0.9 1.4 1.7 1.4 1.4 1.4 1.4 ns
261 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 ASYFQC*VQR 0.9 0.9 0.9 1.5 1.4 1.3 1.5 1.5 1.4 ns




0.9 1.5 1.2 1.5 1.3 1.3 1.7 1.5 1.4 ns
263 P49327 FASN Fatty acid synthase FASN WVC*SSLR 1.0 0.9 0.9 1.5 1.2 1.5 1.4 1.5 1.4 ns
264 Q00610 CLTC Clathrin heavy chain 1 CLTC IHEGC*EEPATHNALAK 0.9 1.1 1.0 1.6 1.1 1.4 1.6 1.5 1.4 ns
265 Q9Y3A3 MOB4 MOB-like protein phocein MOB4
HTLDGAAC*LLNS
NK 1.0 0.9 1.0 1.4 1.4 1.4 1.5 1.4 1.4 ns
266 Q9UJU6 DBNL Drebrin-like protein DBNL AEEDVEPEC*IMEK 1.8 1.4 1.6 1.1 1.1 1.5 1.7 1.6 1.4 ns




0.9 0.9 0.9 1.4 1.3 1.5 1.7 1.3 1.4 ns
268 Q9ULV4 CORO1C Coronin-1C CORO1C C*DLISIPK 0.9 1.0 1.0 1.3 1.3 1.5 1.6 1.4 1.4 ns
269 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 HIIEDPC*TLR 1.1 0.9 1.0 1.6 1.2 1.3 1.6 1.4 1.4 ns
270 P50552 VASP Vasodilator-stimulated phosphoprotein VASP
SSSSVTTSETQPC*
TPSSSDYSDLQR 0.7 1.4 1.1 1.4 1.4 1.3 1.4 1.6 1.4 ns
271 P50991 CCT4 T-complex protein 1 subunit delta CCT4 TLSGMESYC*VR 0.8 1.0 0.9 1.3 1.4 1.4 1.6 1.3 1.4 ns
272 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1
PMC*VESFSDYPPL
GR 1.0 1.0 1.0 1.5 1.3 1.4 1.5 1.4 1.4 ns
273 Q15208 STK38 Serine/threonine-protein kinase 38 STK38 LSDFGLC*TGLK 1.1 1.0 1.1 1.6 1.6 1.3 1.2 1.3 1.4 ns
274 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R 
HNRNP
R SAFLC*GVMK 0.9 1.0 0.9 2.1 1.1 1.3 1.3 1.2 1.4 ns
275 P63220 RPS21 40S ribosomal protein S21 RPS21 TYAIC*GAIR 1.4 1.0 1.2 1.2 1.7 1.2 1.4 1.5 1.4 ns
276 Q8IUR0
TRAPPC5 Trafficking 





IVEAVLTHSGFPAK 0.9 1.0 1.0 1.4 1.4 1.3 1.3 1.6 1.4 ns





ACAT1 QAVLGAGLPISTPC*TTINK 0.8 0.9 0.9 1.3 1.4 1.4 1.4 1.4 1.4 ns
251
279 O15541 RNF113A RING finger protein 113A 
RNF113
A AVDQVC*TFLFK 0.9 1.0 0.9 1.4 1.2 1.4 1.5 1.5 1.4 ns
280 Q9Y3D2
MSRB2 Methionine-R-






1.0 0.9 0.9 1.7 1.3 1.1 1.4 1.4 1.4 ns
281 Q15813 TBCE Tubulin-specific chaperone E TBCE NCAVSC*AGEK 1.4 1.1 1.2 1.2 1.4 1.5 1.1 1.7 1.4 ns
282 Q96EB1 ELP4 Elongator complex protein 4 ELP4 VEPC*SLTPGYTK 0.9 0.9 0.9 1.1 1.3 1.4 1.6 1.5 1.4 ns
283 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 TPC*NAGTFSQPEK 1.0 1.1 1.0 1.2 1.5 1.3 1.6 1.2 1.4 ns
284 P30050 RPL12 60S ribosomal protein L12 RPL12
C*TGGEVGATSAL
APK 0.9 0.9 0.9 1.5 1.0 1.5 1.6 1.3 1.4 ns
285 Q9BXJ9
NAA15 N-alpha-
acetyltransferase 15, NatA 
auxiliary subunit
NAA15 LFNTAVC*ESK 1.0 0.9 1.0 1.3 1.7 1.2 1.3 1.3 1.4 ns
286 P18085 ARF4 ADP-ribosylation factor 4 ARF4
NIC*FTVWDVGGQ
DR 0.9 1.0 0.9 1.4 1.2 1.3 1.5 1.5 1.4 ns
287 P62633 CNBP Cellular nucleic acid-binding protein CNBP TSEVNC*YR 0.8 1.0 0.9 1.4 1.3 1.5 1.4 1.2 1.4 ns
288 Q5T4S7 UBR4 E3 ubiquitin-protein ligase UBR4 UBR4 AVQC*LNTSSK 1.0 1.0 1.0 2.0 1.2 1.3 0.9 1.3 1.4 ns





MDH2 SQETEC*TYFSTPLLLGK 0.9 1.0 1.0 1.3 1.3 1.4 1.4 1.4 1.4 ns
291 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 YVDIAIPC*NNK 0.9 1.0 0.9 1.4 1.2 1.4 1.5 1.3 1.3 ns
292 Q9GZZ9 UBA5 Ubiquitin-like modifier-activating enzyme 5 UBA5
EGVC*AASLPTTM
GVVAGILVQNVLK 1.1 1.1 1.1 1.4 1.3 1.3 1.3 1.4 1.3 ns
293 P20073 ANXA7 Annexin A7 ANXA7 LGTDESC*FNMILATR 0.9 0.9 0.9 1.5 1.3 1.2 1.4 1.4 1.3 ns
294 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1
C*IPALDSLTPANED
QK 1.0 1.0 1.0 1.3 1.2 1.4 1.4 1.4 1.3 ns
295 O14545
TRAFD1 TRAF-type zinc 
finger domain-containing 
protein 1 




transferase subunit ALG13 
ALG13 ADLVISHAGAGSC*LETLEK 1.0 1.0 1.0 1.3 1.3 1.3 1.5 1.3 1.3 ns
297 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNP





ACAT1 IHMGSC*AENTAK 0.9 0.9 0.9 1.4 1.2 1.3 1.4 1.4 1.3 ns




0.9 0.9 0.9 1.3 1.5 1.4 1.1 1.4 1.3 ns
300 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O C*YNEMALIR 0.9 1.0 1.0 1.2 1.3 1.2 1.5 1.5 1.3 ns




0.9 1.0 1.0 1.3 1.4 1.4 1.4 1.3 1.3 ns
302 P49327 FASN Fatty acid synthase FASN ADEASELAC*PTPK 1.0 1.0 1.0 1.3 1.3 1.3 1.4 1.4 1.3 ns
303 P60866 RPS20 40S ribosomal protein S20 RPS20 TPC*GEGSK 1.1 1.0 1.0 1.5 1.5 1.2 1.2 1.3 1.3 ns
304 P84085 ARF5 ADP-ribosylation factor 5 ARF5
NIC*FTVWDVGGQ
DK 0.9 1.1 1.0 1.5 1.2 1.3 1.4 1.3 1.3 ns
305 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 LTFSC*LGGSDNFK 0.9 1.0 1.0 0.7 1.2 1.9 1.9 0.8 1.3 ns
306 Q9NUU7 DDX19A ATP-dependent RNA helicase DDX19A DDX19A VLVTTNVC*AR 0.9 1.0 0.9 1.3 1.2 1.3 1.4 1.3 1.3 ns




acetyltransferase type B 
catalytic subunit
HAT1 VDENFDC*VEADDVEGK 1.0 0.9 1.0 1.3 1.0 1.4 1.5 1.4 1.3 ns
309 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP
ISASC*QHPTAFEE
AIPK 0.9 0.9 0.9 1.3 1.3 1.3 1.4 1.4 1.3 ns
310 P49327 FASN Fatty acid synthase FASN AINC*ATSGVVGLVNCLR 1.0 1.0 1.0 1.3 1.4 1.3 1.5 1.1 1.3 ns
311 P13639 EEF2 Elongation factor 2 EEF2 VTDGALVVVDCVSGVC*VQTETVLR 1.7 1.1 1.4 1.3 1.3 1.0 1.0 2.0 1.3 ns
312 E7EQ34 GOSR2 Golgi SNAP receptor complex member 2 GOSR2 QVHEIQSC*MGR 1.0 1.0 1.0 1.2 1.4 1.3 1.3 1.4 1.3 ns
313 P61247 RPS3A 40S ribosomal protein S3a RPS3A MC*SMVK 0.8 0.9 0.9 1.4 1.3 1.3 1.4 1.3 1.3 ns
314 P13639 EEF2 Elongation factor 2 EEF2 IWC*FGPDGTGPNILTDITK 1.0 1.1 1.0 2.3 1.1 1.1 1.0 1.1 1.3 ns
315 Q04637
EIF4G1 Eukaryotic 
translation initiation factor 4 
gamma 1
EIF4G1 LQGINC*GPDFTPSFANLGR 1.0 1.0 1.0 1.6 1.2 1.2 1.2 1.3 1.3 ns
316 Q9UHD8 SEPT9 Septin-9 9-Sep SQEATEAAPSC*VGDMADTPR 1.2 1.0 1.1 1.2 1.3 1.3 1.6 1.2 1.3 ns
317 P61247 RPS3A 40S ribosomal protein S3a RPS3A
AC*QSIYPLHDVFV
R 1.0 0.7 0.8 1.2 1.6 1.3 1.4 1.1 1.3 ns
318 P21964 COMT Catechol O-methyltransferase COMT
GSSC*FECTHYQSF
LEYR 1.0 1.0 1.0 1.4 1.2 1.2 1.3 1.3 1.3 ns
319 P13639 EEF2 Elongation factor 2 EEF2 STLTDSLVC*K 0.9 1.0 1.0 1.3 1.1 1.2 1.3 1.5 1.3 ns











IDH2 SSGGFVWAC*K 1.0 1.0 1.0 1.4 1.3 1.1 1.3 1.4 1.3 ns
322 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 LLDLVQQSC*NYK 0.9 0.9 0.9 1.3 1.3 1.2 1.3 1.3 1.3 ns
323 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1
AAVEEGIVLGGGC
*ALLR 0.9 1.0 1.0 1.3 1.2 1.3 1.3 1.3 1.3 ns




0.9 1.4 1.1 1.1 1.5 1.2 1.3 1.4 1.3 ns
325 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 EDLC*TK 0.9 1.1 1.0 1.2 1.2 1.3 1.5 1.3 1.3 ns




K 1.0 1.0 1.0 1.1 1.3 1.3 1.4 1.3 1.3 ns
327 Q9HCC0
MCCC2 Methylcrotonoyl-
CoA carboxylase beta chain, 
mitochondrial
MCCC2 AATGEEVSAEDLGGADLHC*R 0.9 0.9 0.9 1.4 1.3 1.1 1.3 1.4 1.3 ns
328 O15075 DCLK1 Serine/threonine-protein kinase DCLK1 DCLK1
YQDDFLLDESEC*
R 1.0 1.1 1.1 1.3 1.2 1.3 1.4 1.3 1.3 ns
329 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 DAC*DTVR 1.0 1.0 1.0 1.2 1.2 1.4 1.3 1.3 1.3 ns
330 Q9NQC3 RTN4 Reticulon-4 RTN4 YSNSALGHVNC*TIK 1.1 1.1 1.1 1.1 1.5 1.0 1.3 1.5 1.3 ns
331 Q7L1Q6
BZW1 Basic leucine zipper 
and W2 domain-containing 
protein 1
BZW1 FDPTQFQDC*IIQGLTETGTDLEAVAK 1.0 1.0 1.0 1.4 1.2 1.3 1.3 1.2 1.3 ns
332 P23921
RRM1 Ribonucleoside-
diphosphate reductase large 
subunit
RRM1 IIDINYYPVPEAC*LSNK 1.1 0.9 1.0 1.4 1.2 1.2 1.3 1.3 1.3 ns
333 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM C*C*SGAIIVLTK 0.9 0.9 0.9 1.2 1.3 1.3 1.3 1.2 1.3 ns
334 Q9P258 RCC2 Protein RCC2 RCC2 AVQDLC*GWR 1.1 1.2 1.1 1.3 1.1 1.3 1.4 1.3 1.3 ns
335 Q13045 FLII Protein flightless-1 homolog FLII
TGLC*YLPEELAAL
QK 0.8 1.1 1.0 1.2 1.1 1.3 1.4 1.3 1.3 ns
336 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 C*VVVGDGAVGK 0.9 0.9 0.9 1.2 1.3 1.5 1.1 1.3 1.3 ns
337 Q7Z4W1 DCXR L-xylulose reductase DCXR AVTNHSVYC*STK 0.9 0.8 0.9 1.3 1.5 1.3 1.2 1.1 1.3 ns
253
338 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 IGNC*PFSQR 1.0 1.0 1.0 1.3 1.2 1.2 1.3 1.4 1.3 ns




TK 0.9 1.0 0.9 1.2 1.0 1.4 1.2 1.4 1.3 ns
340 Q9UPM8 AP4E1 AP-4 complex subunit epsilon-1 AP4E1
SSC*STLPDYLLYQ
CQK 0.7 0.7 0.7 1.3 1.1 1.3 1.4 1.3 1.3 ns




YLNFIR 1.0 1.2 1.1 1.2 1.4 1.2 1.1 1.3 1.3 ns
342 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 NLADC*LR 0.9 1.1 1.0 1.3 1.3 1.2 1.2 1.3 1.3 ns
















N1 NSSQETC*TR 1.3 1.3 1.3 1.1 1.1 1.0 1.8 1.1 1.2 ns
346 P30042 C21orf33 ES1 protein homolog, mitochondrial C21orf33 DC*K 0.9 1.0 0.9 1.3 1.2 1.2 1.5 1.1 1.2 ns
347 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2
DLGGIVLANACGP
C*IGQWDR 1.1 0.9 1.0 1.0 1.3 1.1 1.4 1.4 1.2 ns
348 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR
EQFSQGSPSNC*LE





NONO C*SEGSFLLTTFPR 0.9 1.1 1.0 1.1 1.0 1.4 1.4 1.4 1.2 ns
350 Q8IXH7 TH1L Negative elongation factor C/D TH1L AC*QALGAMLSK 1.1 0.9 1.0 0.6 1.4 1.3 1.3 1.7 1.2 ns
351 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9
GIGMNEPLVDC*E
GYPR 1.0 1.3 1.2 1.3 1.2 1.2 1.3 1.1 1.2 ns
352 Q9UK41
VPS28 Vacuolar protein 
sorting-associated protein 28 
homolog
VPS28 LDC*PLAMER 1.1 1.3 1.2 1.2 1.2 1.3 1.3 1.2 1.2 ns




1.2 1.0 1.1 1.2 1.2 1.1 1.4 1.3 1.2 ns
354 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 YEAAFPFLSPC*GR 1.2 1.0 1.1 1.3 1.1 1.2 1.3 1.2 1.2 ns




R 1.0 1.0 1.0 1.3 1.2 1.2 1.3 1.3 1.2 ns
356 Q7L2H7
EIF3M Eukaryotic 
translation initiation factor 3 
subunit
EIF3M VAASC*GAIQYIPTELDQVR 0.9 1.0 0.9 1.4 1.1 1.2 1.3 1.2 1.2 ns
357 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2
IENLELMSQHGC*
NAWK 1.0 1.0 1.0 1.3 1.0 1.2 1.4 1.2 1.2 ns
358 O43765
SGTA Small glutamine-rich 
tetratricopeptide repeat-
containing protein alpha
SGTA AIC*IDPAYSK 1.0 1.0 1.0 1.5 1.3 1.1 1.2 1.1 1.2 ns





CHERP LALEQQQLIC*K 0.8 1.1 0.9 1.1 1.3 1.1 1.2 1.4 1.2 ns
361 Q7Z4W1 DCXR L-xylulose reductase DCXR GVPGAIVNVSSQC*SQR 0.9 0.9 0.9 1.3 1.2 1.1 1.2 1.3 1.2 ns
362 O00267 SUPT5H Transcription elongation factor SPT5 SUPT5H
VELHSTC*QTISVD
R 1.3 1.1 1.2 1.3 1.1 1.3 1.4 1.0 1.2 ns
363 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10
TPSYSISSTLNPQAP
EFILGC*TASK 1.1 1.0 1.0 1.2 1.1 1.2 1.3 1.2 1.2 ns
364 P55263 ADK Adenosine kinase ADK SLIANLAAANC*YK 1.0 1.0 1.0 1.0 1.4 1.2 1.3 1.1 1.2 ns
365 P19367 HK1 Hexokinase-1 HK1 AAQLC*GAGMAAVVDK 0.9 0.6 0.8 2.0 1.2 1.0 0.9 1.1 1.2 ns
366 Q14181 POLA2 DNA polymerase alpha subunit B POLA2 VLGC*PEALTGSYK 0.9 0.9 0.9 1.3 0.9 1.6 1.3 1.0 1.2 ns
254
367 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 GTLTLC*PYHSDR 0.8 1.0 0.9 1.0 0.9 1.1 0.8 2.2 1.2 ns
368 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HNRNP
K GSDFDC*ELR 0.9 0.9 0.9 1.1 1.3 1.3 1.2 1.3 1.2 ns
369 P49327 FASN Fatty acid synthase FASN DGLLENQTPEFFQDVC*K 0.9 0.9 0.9 1.3 1.0 1.1 1.5 1.1 1.2 ns
370 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 VGLGIC*YDMR 1.0 1.1 1.0 1.4 1.1 1.0 1.2 1.3 1.2 ns









AHNAK LEGDLTGPSVDVEVPDVELEC*PDAK 1.1 1.1 1.1 1.1 1.1 1.1 1.4 1.2 1.2 ns
373 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2
NDITAWQEC*VNN
SMAQLEHQAVR 1.0 1.0 1.0 0.8 1.3 1.2 1.5 1.3 1.2 ns
374 O95336 PGLS 6-phosphogluconolactonase PGLS AAC*CLAGAR 1.0 1.0 1.0 1.2 1.2 1.1 1.3 1.3 1.2 ns






64 C*LTQQAVALQR 0.9 1.0 1.0 1.2 1.2 1.2 1.1 1.3 1.2 ns
377 Q9BX63 BRIP1 Fanconi anemia group J protein BRIP1 LANNSDC*ILAK 0.9 1.0 0.9 1.1 1.1 1.3 1.3 1.2 1.2 ns
378 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 SC*AHDWVYE 1.2 1.2 1.2 1.4 1.4 1.0 1.0 1.2 1.2 ns
379 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 ENQWC*EEK 1.0 0.9 1.0 1.2 1.2 1.2 1.2 1.2 1.2 ns
380 P15924 DSP Desmoplakin DSP AC*GSEIMQK 0.9 0.9 0.9 1.2 1.2 1.2 1.2 1.1 1.2 ns
381 P20810 CAST Calpastatin CAST SEC*K 1.1 1.1 1.1 1.0 1.1 1.5 1.3 1.1 1.2 ns
382 Q13185 CBX3 Chromobox protein homolog 3 CBX3 LTWHSC*PEDEAQ 0.9 1.0 1.0 1.2 1.1 1.1 1.3 1.2 1.2 ns





AHNAK LEGDLTGPSVGVEVPDVELEC*PDAK 1.0 1.0 1.0 1.1 1.1 1.2 1.5 1.1 1.2 ns
385 O15355 PPM1G Protein phosphatase 1G PPM1G
GTEAGQVGEPGIPT
GEAGPSC*SSASDK 1.0 1.0 1.0 1.2 1.1 1.2 1.3 1.2 1.2 ns
386 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HNRNP
K LFQECC*PHSTDR 0.8 0.9 0.9 1.2 1.1 1.3 1.3 1.2 1.2 ns
387 O15371 EIF3D Eukaryotic translation initiation factor 3 subunit EIF3D
FMTPVIQDNPSGW





BCAT2 EVFGSGTAC*QVCPVHR 0.9 1.0 0.9 1.1 1.2 1.1 1.1 1.4 1.2 ns
389 P17844
DDX5 Probable ATP-
dependent RNA helicase 
DDX5 









1.0 1.1 1.0 1.0 1.1 1.3 1.4 1.2 1.2 ns
391 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4
AGSDGESIGNC*PF
SQR 1.0 1.0 1.0 1.1 1.3 1.0 1.3 1.1 1.2 ns
392 Q2TAA2
IAH1 Isoamyl acetate-
hydrolyzing esterase 1 
homolog 
IAH1 VILITPTPLC*ETAWEEQCIIQGCK 0.9 0.9 0.9 1.2 1.1 1.1 1.2 1.2 1.2 ns
393 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS YAGLSTC*FR 1.0 0.9 1.0 1.2 1.1 1.1 1.3 1.2 1.2 ns
255
394 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 LC*VQNSPQEAR 1.0 1.0 1.0 1.3 1.1 1.2 1.2 1.2 1.2 ns
395 Q9BSU1 C16orf70 UPF0183 protein C16orf70 C16orf70
LLAAGC*GPGLLA
DAK 0.9 0.9 0.9 1.3 1.2 1.0 1.1 1.3 1.2 ns
396 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB
HSMNPFC*EIAVEE
AVR 1.2 1.1 1.2 1.1 1.0 1.3 1.3 1.2 1.2 ns
397 Q9UNE7 STUB1 E3 ubiquitin-protein ligase CHIP STUB1 AQQAC*IEAK 1.0 1.1 1.1 1.1 1.3 1.0 1.4 1.0 1.2 ns
398 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 C*EFQDAYVLLSEK 0.9 1.0 1.0 1.1 1.2 1.1 1.2 1.2 1.2 ns
399 Q9UBF6 RNF7 RING-box protein 2 RNF7 VQVMDAC*LR 0.9 0.9 0.9 1.1 1.4 1.1 1.1 1.1 1.2 ns
400 Q6YN16 HSDL2 Hydroxysteroid dehydrogenase-like protein 2 HSDL2
TAIHTAAMDMLGG





PIN1 SGEEDFESLASQFSDC*SSAK 1.0 0.9 1.0 1.1 1.1 1.1 1.3 1.2 1.2 ns
402 O14980 XPO1 Exportin-1 XPO1 LDINLLDNVVNC*LYHGEGAQQR 1.0 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.2 ns
403 Q9UQ35 SRRM2 Serine/arginine repetitive matrix protein 2 SRRM2 SVSPC*SNVESR 1.0 0.9 1.0 1.1 1.1 1.1 1.5 1.1 1.2 ns








VR 1.0 1.0 1.0 1.2 1.1 1.1 1.3 1.2 1.2 ns
406 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS TIC*AILENYQTEK 0.9 1.0 1.0 1.2 1.2 1.1 1.2 1.2 1.2 ns
407 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3
HLNEIDLFHC*IDP
NDSK 1.1 1.0 1.0 1.2 1.1 1.1 1.2 1.2 1.2 ns
408 E9PPU0 EPPK1 Epiplakin EPPK1 TGGQALSTLEC*VK 0.9 1.0 0.9 1.2 1.2 1.0 1.4 1.1 1.2 ns
409 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF C*NNVLYIR 1.0 1.0 1.0 1.2 1.1 1.1 1.2 1.2 1.2 ns
410 P38646 HSPA9 Stress-70 protein, mitochondrial HSPA9
C*ELSSSVQTDINL
PYLTMDSSGPK 0.9 1.0 0.9 1.1 1.0 1.1 1.4 1.1 1.2 ns




YLNFIR 1.1 1.0 1.0 1.2 1.1 1.2 1.3 1.1 1.2 ns
412 Q15796 SMAD2 Mothers against decapentaplegic homolog 2 SMAD2 AITTQNC*NTK 0.9 1.1 1.0 1.3 0.4 1.4 1.4 1.3 1.2 ns
413 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1
LVVPATQC*GSLIG
K 0.9 1.0 0.9 1.2 1.1 1.2 1.2 1.2 1.2 ns
414 Q96RS6 NUDCD1 NudC domain-containing protein 1 
NUDCD
1 DSAQC*AAIAER 0.8 0.8 0.8 1.2 1.4 1.1 1.0 1.1 1.2 ns
415 Q16854 DGUOK Deoxyguanosine kinase, mitochondrial DGUOK
AC*TAQSLGNLLD
MMYR 1.0 1.2 1.1 1.1 1.0 1.1 1.4 1.2 1.2 ns
416 P28838 LAP3 Cytosol aminopeptidase LAP3 SAGAC*TAAAFLK 0.9 1.0 1.0 1.1 0.9 1.2 1.4 1.1 1.2 ns
417 P37802 TAGLN2 Transgelin-2 TAGLN2 QYDADLEQILIQWITTQC*R 1.0 1.0 1.0 0.8 1.8 1.2 1.0 0.9 1.2 ns
418 P07741 APRT Adenine phosphoribosyltransferase APRT
VVVVDDLLATGGT
MNAAC*ELLGR 1.1 1.1 1.1 1.0 1.3 1.1 1.2 1.1 1.1 ns
419 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5
GTPEQPQC*GFSNA
VVQILR 1.0 1.0 1.0 1.2 1.1 1.1 1.2 1.2 1.1 ns
420 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS
PTEVDFLQGDC*T
K 0.9 1.0 0.9 1.2 1.1 1.1 1.3 1.1 1.1 ns
421 P53990 IST1 IST1 homolog IST1 IVADQLC*AK 1.0 1.0 1.0 1.1 1.1 1.3 1.2 1.0 1.1 ns
422 Q5MNZ6




L C*NYLALVGGGK 1.0 1.0 1.0 1.1 1.2 1.0 1.1 1.2 1.1 ns
423 Q9BV79 MECR Trans-2-enoyl-CoA reductase, mitochondrial MECR LALNC*VGGK 1.0 0.9 1.0 1.3 1.0 1.0 1.1 1.3 1.1 ns
424 O75940











ILKAP FILLAC*DGLFK 0.9 1.0 0.9 1.0 1.1 1.4 1.2 0.9 1.1 ns
426 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1
GFGFVC*FSSPEEA
TK 1.0 1.2 1.1 1.0 1.2 1.3 1.2 1.0 1.1 ns
427 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 IAAYLQSDQFC*K 0.9 1.0 0.9 1.2 1.1 1.1 1.2 1.2 1.1 ns
428 P78347 GTF2I General transcription factor II-I GTF2I SILSPGGSC*GPIK 0.9 0.9 0.9 1.1 1.0 1.1 1.2 1.2 1.1 ns
429 P53602 MVD Diphosphomevalonate decarboxylase MVD DGDPLPSSLSC*K 1.0 1.3 1.1 1.1 1.1 1.1 1.2 1.1 1.1 ns
430 P26641 EEF1G Elongation factor 1-gamma EEF1G
AAAPAPEEEMDEC
*EQALAAEPK 1.0 1.0 1.0 1.1 1.1 1.2 1.1 1.1 1.1 ns
431 P49915 GMPS GMP synthase GMPS TVGVQGDC*R 0.5 1.1 0.8 1.3 0.7 1.1 1.3 1.4 1.1 ns




0.9 1.0 1.0 1.1 1.1 1.2 1.1 1.2 1.1 ns






2 IC*PVEFNPNFVAR 1.0 1.0 1.0 0.9 1.2 1.2 1.2 1.2 1.1 ns
435 Q9UNH7 SNX6 Sorting nexin-6 SNX6 IGSSLYALGTQDSTDIC*K 0.9 0.9 0.9 1.1 1.0 1.1 1.2 1.2 1.1 ns
436 P49841 GSK3B Glycogen synthase kinase-3 beta GSK3B LC*DFGSAK 1.0 1.0 1.0 1.0 1.2 1.0 1.2 1.2 1.1 ns
437 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 HFLSDTGMAC*R 1.0 1.1 1.0 1.1 1.2 1.0 1.2 1.1 1.1 ns




C*K 1.0 1.0 1.0 1.1 1.1 1.1 1.2 1.1 1.1 ns




1.0 1.0 1.0 1.1 1.1 1.2 1.1 1.1 1.1 ns
440 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 INISEGNC*PER 1.0 1.0 1.0 1.1 1.1 1.1 1.2 1.1 1.1 ns
441 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1
VIGIEC*SSISDYAV
K 0.9 1.0 0.9 1.1 1.1 1.0 1.2 1.2 1.1 ns
442 Q15181 PPA1 Inorganic pyrophosphatase PPA1
GISC*MNTTLSESP
FK 1.0 1.3 1.2 1.2 1.0 1.2 1.1 1.1 1.1 ns
443 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M 
HNRNP
M AC*QIFVR 1.0 1.0 1.0 1.2 1.1 1.1 1.0 1.2 1.1 ns
444 P00338 LDHA L-lactate dehydrogenase A chain LDHA VIGSGC*NLDSAR 1.0 1.0 1.0 1.1 1.1 1.2 1.1 1.1 1.1 ns
445 Q14151 SAFB2 Scaffold attachment factor B2 SAFB2 ILDILGETC*K 1.0 0.7 0.8 0.9 1.3 1.2 1.2 0.9 1.1 ns
446 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 GLLDVTC*K 1.0 0.9 1.0 1.1 1.1 1.1 1.1 1.1 1.1 ns
447 Q9Y2Q3 GSTK1 Glutathione S-transferase kappa 1 GSTK1 ETTEAAC*R 1.0 1.0 1.0 1.1 1.1 1.2 1.1 1.1 1.1 ns





GPX4 YAEC*GLR 1.0 0.9 0.9 1.1 1.0 1.1 1.2 1.2 1.1 ns
450 Q86YH6
PDSS2 Decaprenyl-
diphosphate synthase subunit 
2 
PDSS2 C*LLSDELSNIAMQVR 0.8 1.0 0.9 0.7 1.1 1.2 1.3 1.2 1.1 ns
451 Q9NYL2
MLTK Mitogen-activated 
protein kinase kinase kinase 
MLT
MLTK IC*DFGASR 0.8 0.8 0.8 1.0 1.2 0.9 1.2 1.2 1.1 ns
452 P42704
LRPPRC Leucine-rich PPR 
motif-containing protein, 
mitochondrial
LRPPRC IHDVLC*K 1.0 1.2 1.1 1.1 0.9 1.1 0.9 1.5 1.1 ns
257




0.9 1.1 1.0 1.0 1.2 1.0 1.2 1.2 1.1 ns
454 P60981 DSTN Destrin DSTN C*STPEEIK 1.0 1.0 1.0 1.1 1.0 1.1 1.2 1.1 1.1 ns




1.1 1.0 1.1 1.0 1.1 1.1 1.2 1.2 1.1 ns
456 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3
LVVPASQC*GSLIG
K 0.9 1.0 0.9 1.1 1.1 1.1 1.2 1.1 1.1 ns
457 Q15149 PLEC Plectin PLEC AFC*GFEDPR 1.0 1.0 1.0 1.1 1.1 1.0 1.2 1.1 1.1 ns
458 Q8WTW3COG1 Conserved oligomeric Golgi complex subunit 1 COG1 C*AVGLVDAVK 0.9 1.2 1.1 1.1 1.0 1.0 1.4 1.0 1.1 ns
459 P62258 YWHAE 14-3-3 protein epsilon YWHAE LIC*C*DILDVLDK 1.0 1.0 1.0 1.2 1.0 1.1 1.1 1.1 1.1 ns
460 Q969T9 WBP2 WW domain-binding protein 2 WBP2 DC*EIK 0.9 0.9 0.9 1.0 1.1 1.2 1.1 1.1 1.1 ns






0.9 1.0 1.0 1.1 1.0 1.0 1.1 1.1 1.1 ns





DEPTOR SPSSQETHDSPFC*LR 0.7 1.0 0.9 1.0 1.2 1.2 1.0 1.0 1.1 ns
464 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 LDFVC*SFLQK 1.0 0.8 0.9 1.2 1.1 1.0 1.1 1.1 1.1 ns




1.2 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 ns
466 Q9BY32 ITPA Inosine triphosphate pyrophosphatase ITPA
GC*QDFGWDPCFQ
PDGYEQTYAEMPK 1.0 1.0 1.0 1.3 1.0 0.9 1.2 1.1 1.1 ns
467 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 YLEC*SALTQR 1.0 1.1 1.0 0.8 1.8 1.0 0.9 0.9 1.1 ns
468 P62826 RAN GTP-binding nuclear protein Ran RAN
VC*ENIPIVLC*GN
K 0.9 1.0 1.0 1.1 1.0 1.2 1.0 1.1 1.1 ns
469 Q9BW61 DDA1 DET1- and DDB1-associated protein 1 DDA1 FHADSVC*K 1.0 1.2 1.1 1.0 1.2 1.0 1.0 1.1 1.1 ns
470 P36507






MANSFVGTR 1.1 1.0 1.1 1.1 1.0 1.0 1.1 1.2 1.1 ns
471 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 VTDDLVC*LVYK 0.8 0.9 0.8 1.1 1.0 1.1 1.1 1.1 1.1 ns
472 Q9Y3D2
MSRB2 Methionine-R-






1.1 1.0 1.0 1.1 1.0 0.9 1.2 1.1 1.1 ns
473 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS DGVC*VR 0.9 0.8 0.9 1.2 0.9 1.2 1.1 1.0 1.1 ns
474 P50990 CCT8 T-complex protein 1 subunit theta CCT8
IAVYSC*PFDGMIT





AHNAK GPFVEAEVPDVDLEC*PDAK 0.9 1.0 1.0 1.0 1.1 1.1 1.1 1.0 1.1 ns
476 P51659
HSD17B4 Peroxisomal 
multifunctional enzyme type 
2 
HSD17B
4 IC*DFENASK 1.1 1.1 1.1 0.9 1.0 1.3 1.1 1.1 1.1 ns
477 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1
AITIAGVPQSVTEC
*VK 1.0 1.0 1.0 1.0 1.2 1.1 0.9 1.1 1.1 ns
478 P62857 RPS28 40S ribosomal protein S28 RPS28 TGSQGQC*TQVR 0.9 0.9 0.9 1.0 1.1 1.1 1.1 1.1 1.1 ns
479 Q8N987
NECAB1 N-terminal EF-





EC*AMETTEEQTR 1.0 0.9 0.9 1.1 0.9 1.0 1.2 1.2 1.1 ns
480 P37802 TAGLN2 Transgelin-2 TAGLN2 NMAC*VQR 1.0 1.0 1.0 1.3 1.0 0.9 1.0 1.1 1.1 ns
258
481 Q9NZZ3 CHMP5 Charged multivesicular body protein 5 CHMP5
APPPSLTDC*IGTV
DSR 1.0 0.9 0.9 1.0 1.1 1.1 1.1 1.0 1.1 ns
482 P30153
PPP2R1A Serine/threonine-
protein phosphatase 2A 65 





GIR 0.8 1.0 0.9 1.0 1.1 0.9 1.2 1.1 1.1 ns
483 P55735 SEC13 Protein SEC13 homolog SEC13 FASGGC*DNLIK 1.0 1.0 1.0 1.1 1.0 1.0 1.1 1.1 1.1 ns
484 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
EEFASTC*PDDEEIE
LAYEQVAK 1.3 1.3 1.3 0.9 1.0 1.3 1.1 1.1 1.1 ns
485 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 FIC*EQDHQNFLR 1.1 1.2 1.1 0.8 1.0 1.1 1.2 1.2 1.1 ns
486 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 LNEC*VDHTPK 1.0 0.9 1.0 1.0 1.3 1.0 1.0 1.0 1.1 ns
487 Q96Q11
TRNT1 CCA tRNA 
nucleotidyltransferase 1, 
mitochondrial 
TRNT1 YQGEHC*LLK 0.9 0.9 0.9 1.3 1.0 1.1 1.1 0.9 1.1 ns
488 P13639 EEF2 Elongation factor 2 EEF2 YVEPIEDVPC*GNIVGLVGVDQFLVK 1.0 1.0 1.0 0.9 1.1 1.1 0.9 1.1 1.0 ns
489 P35270 SPR Sepiapterin reductase SPR TVVNISSLC*ALQPFK 0.9 0.8 0.9 1.1 1.0 1.1 1.0 1.1 1.0 ns
490 P60981 DSTN Destrin DSTN LGGSLIVAFEGC*PV 0.9 0.9 0.9 1.1 1.0 1.0 1.1 1.0 1.0 ns
491 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 YTC*GEAPDYDR 0.9 0.9 0.9 1.0 1.0 1.2 1.1 0.9 1.0 ns














0.9 1.0 1.0 1.1 1.0 1.0 1.0 1.2 1.0 ns
494 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 FC*PFAER 1.0 1.0 1.0 1.1 1.0 1.1 1.1 1.1 1.0 ns
495 P31947 SFN 14-3-3 protein sigma SFN GEELSC*EER 0.9 0.9 0.9 1.0 1.1 1.1 1.1 1.0 1.0 ns
496 P52943 CRIP2 Cysteine-rich protein 2 CRIP2
ASSVTTFTGEPNTC
*PR 1.0 0.9 0.9 1.1 0.9 1.1 1.2 1.0 1.0 ns
497 Q6KB66 KRT80 Keratin, type II cytoskeletal 80 KRT80 C*HIDLSGIVEEVK 0.9 1.0 1.0 1.0 1.0 1.0 1.1 1.1 1.0 ns
498 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F 
HNRNP





GMPPB LC*SGPGIVGNVLVDPSAR 0.9 1.1 1.0 1.0 1.0 1.0 1.0 1.1 1.0 ns
500 Q14247 CTTN Src substrate cortactin CTTN HC*SQVDSVR 0.9 0.9 0.9 1.1 0.9 1.1 1.1 1.0 1.0 ns






DUT TDIQIALPSGC*YGR 1.0 1.0 1.0 1.0 1.4 0.9 0.9 1.0 1.0 ns
503 P27348 YWHAQ 14-3-3 protein theta YWHAQ YLAEVAC*GDDR 0.9 1.0 0.9 0.9 1.1 1.1 1.0 1.1 1.0 ns
504 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS C*LSVMEAK 0.9 0.9 0.9 1.2 1.0 0.9 1.0 1.1 1.0 ns
505 Q9Y365 STARD10 PCTP-like protein STARD10
MECC*DVPAETLY
DVLHDIEYR 1.0 1.1 1.1 1.0 1.0 1.1 1.0 1.0 1.0 ns
506 P23434
GCSH Glycine cleavage 
system H protein, 
mitochondrial 
GCSH SC*YEDGWLIK 1.3 0.8 1.1 0.9 1.2 0.6 1.0 1.4 1.0 ns
507 Q01518 CAP1 Adenylyl cyclase-associated protein 1 CAP1
ALLVTASQC*QQPA
ENK 0.9 1.0 1.0 0.9 1.1 1.0 0.9 1.2 1.0 ns














PDQYSPR 0.9 1.0 1.0 1.3 1.0 1.1 0.8 0.9 1.0 ns
511 P51610 HCFC1 Host cell factor 1 HCFC1 LVIYGGMSGC*R 0.9 0.9 0.9 1.1 1.0 1.2 1.0 0.9 1.0 ns
512 P47756 CAPZB F-actin-capping protein subunit beta CAPZB
DETVSDC*SPHIAN
IGR 1.1 1.0 1.0 1.0 1.0 1.2 1.0 0.9 1.0 ns
513 Q12765 SCRN1 Secernin-1 SCRN1 TQSPC*FGDDDPAK 0.9 1.0 1.0 1.1 0.9 1.0 1.0 1.2 1.0 ns
514 Q8TAQ2 SMARCC2 SWI/SNF complex subunit SMARCC2 
SMARC
C2 NLAGDVC*AIMR 1.2 1.1 1.2 1.0 0.9 1.0 1.1 1.0 1.0 ns













binding protein 1 
PEBP1 APVAGTC*YQAEWDDYVPK 1.0 1.1 1.0 0.9 1.1 1.1 1.0 1.1 1.0 ns
518 P35270 SPR Sepiapterin reductase SPR AVC*LLTGASR 1.0 1.0 1.0 1.0 1.1 1.1 0.9 0.9 1.0 ns
519 Q96EY8
MMAB Cob(I)yrinic acid a,c-
diamide adenosyltransferase, 
mitochondrial
MMAB IQCTLQDVGSALATPC*SSAR 0.9 1.1 1.0 1.1 0.9 0.9 1.1 1.1 1.0 ns
520 O75131 CPNE3 Copine-3 CPNE3 NC*LNPQFSK 0.9 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 ns
521 Q9HAV7 GRPEL1 GrpE protein homolog 1, mitochondrial GRPEL1 LYGIQAFC*K 1.0 0.8 0.9 0.8 1.0 1.1 1.0 1.1 1.0 ns
522 Q8NDH3 NPEPL1 Probable aminopeptidase NPEPL1 NPEPL1
IVDTPC*NEMNTD
TFLEEINK 0.9 1.1 1.0 1.1 1.0 0.9 1.0 1.0 1.0 ns
523 Q9H8M7 FAM188A Protein FAM188A 
FAM188
A SSPGLSDTIFC*R 1.5 0.9 1.2 0.5 1.2 1.0 1.0 1.4 1.0 ns
524 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1
LSLDGQNIYNAC*
CTLR 0.9 1.1 1.0 1.0 0.7 1.2 1.0 1.1 1.0 ns
525 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS
NVGC*LQEALQLA
TSFAQLR 1.1 1.1 1.1 0.9 0.9 0.6 1.6 1.0 1.0 ns
526 P14649 MYL6B Myosin light chain 6B MYL6B ILYSQC*GDVMR 1.0 0.9 1.0 0.9 1.0 1.1 1.0 1.0 1.0 ns
527 P21964 COMT Catechol O-methyltransferase COMT
LITIEINPDC*AAIT
QR 0.9 0.9 0.9 1.1 1.0 0.9 1.0 1.0 1.0 ns





PPA2 ILSC*GEVIHVK 1.0 1.5 1.2 0.9 1.0 0.8 1.2 1.1 1.0 ns
530 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 C*LDEFPNLK 1.0 1.1 1.1 0.9 1.0 1.1 1.0 1.0 1.0 ns
531 P49753 ACOT2 Acyl-coenzyme A thioesterase 2, mitochondrial ACOT2 SEFYANEAC*K 1.0 1.0 1.0 1.0 1.0 0.8 0.9 1.2 1.0 ns
532 P12004 PCNA Proliferating cell nuclear antigen PCNA C*AGNEDIITLR 1.2 0.9 1.1 0.9 1.0 1.0 1.0 1.0 1.0 ns
533 Q9NRF9 POLE3 DNA polymerase epsilon subunit 3 POLE3
AASVFVLYATSC*A
NNFAMK 0.9 1.1 1.0 0.9 0.9 1.0 1.1 0.9 1.0 ns




subunit M2 B 
RRM2B IEQEFLTEALPVGLIGMNC*ILMK 0.8 1.1 1.0 1.0 1.1 1.0 1.1 0.7 1.0 ns
536 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2
AITIAGIPQSIIEC*V
K 1.1 1.0 1.1 1.0 1.1 1.0 0.9 1.0 1.0 ns
537 Q9BSH4
TACO1 Translational 
activator of cytochrome c 
oxidase 1 
TACO1 LDSLGLCSVSC*ALEFIPNSK 0.8 1.1 1.0 0.7 1.0 1.0 1.1 1.0 1.0 ns
538 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP
NDTPC*GTTIGPIL
ASR 1.0 1.0 1.0 0.9 0.9 1.0 1.0 0.9 1.0 ns
260




ASFGK 0.9 1.0 0.9 0.9 1.0 0.9 1.0 0.9 1.0 ns




VEC*ATQALEK 1.0 0.9 0.9 0.9 1.0 0.9 0.9 1.0 1.0 ns
541 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE
IGPSILNSDLANLG
AEC*LR 1.0 1.0 1.0 0.8 1.0 1.4 0.8 0.9 1.0 ns
542 P51858 HDGF Hepatoma-derived growth factor HDGF C*GDLVFAK 1.0 1.0 1.0 0.8 1.1 1.0 1.1 0.9 1.0 ns
543 O43681 ASNA1 ATPase ASNA1 ASNA1 PC*K 1.0 1.2 1.1 1.0 1.3 0.7 0.8 0.9 1.0 ns
544 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1
YADLTEDQLPSC*E
SLK 0.9 0.9 0.9 1.0 0.9 1.1 0.9 0.8 1.0 ns
545 Q04917 YWHAH 14-3-3 protein eta YWHAH NC*NDFQYESK 1.1 1.0 1.0 0.9 1.1 0.9 0.9 1.0 0.9 ns
546 P11766 ADH5 Alcohol dehydrogenase class-3 ADH5
VCLLGC*GISTGYG
AAVNTAK 1.1 0.9 1.0 1.1 0.8 1.0 1.0 0.9 0.9 ns
547 P40925 MDH1 Malate dehydrogenase, cytoplasmic MDH1 AIC*DHVR 1.0 1.0 1.0 0.9 1.1 1.0 0.8 1.0 0.9 ns
548 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B FEELC*SDLFR 1.4 1.1 1.2 0.9 1.0 1.0 0.9 1.0 0.9 ns
549 P61981 YWHAG 14-3-3 protein gamma YWHAG NC*SETQYESK 0.6 0.5 0.6 0.9 0.9 1.0 0.9 1.0 0.9 ns
550 P30626 SRI Sorcin SRI PFNLETC*R 0.9 0.8 0.9 1.0 0.8 1.0 0.9 1.0 0.9 ns
551 P62993 GRB2 Growth factor receptor-bound protein 2 GRB2
VLNEEC*DQNWY
K 1.0 1.0 1.0 0.9 0.8 1.0 0.9 1.0 0.9 ns





PGD C*LSSLK 0.9 1.0 1.0 0.9 1.0 0.9 0.9 1.0 0.9 ns
554 P10768 ESD S-formylglutathione hydrolase ESD
CPALYWLSGLTC*T










1.1 1.1 1.1 0.8 0.9 1.0 1.0 1.0 0.9 ns
556 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
YLLQYQEPIPC*EQ
LVTALCDIK 1.1 1.1 1.1 0.8 1.0 1.0 0.9 0.9 0.9 ns
557 P31947 SFN 14-3-3 protein sigma SFN VETELQGVC*DTVLGLLDSHLIK 1.2 0.9 1.1 0.8 1.0 1.1 0.9 0.9 0.9 ns
558 O14964
HGS Hepatocyte growth 
factor-regulated tyrosine 
kinase
HGS AC*GQIFC*GK 0.8 0.8 0.8 1.0 0.7 0.9 1.2 0.9 0.9 ns
559 P60174 TPI1 Triosephosphate isomerase TPI1 IIYGGSVTGATC*K 1.1 1.0 1.1 0.7 1.1 0.9 1.0 1.0 0.9 ns
560 P37802 TAGLN2 Transgelin-2 TAGLN2 DGTVLC*ELINALYPEGQAPVK 1.1 1.0 1.0 0.9 1.0 1.0 0.8 0.9 0.9 ns
561 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 SCFLCMVC*K 1.0 1.0 1.0 0.9 0.8 0.9 1.0 1.0 0.9 ns
562 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 GNGIVEC*LGPK 1.0 1.0 1.0 0.6 1.5 0.7 1.1 0.6 0.9 ns
563 P22234 PAICS Multifunctional protein ADE2 PAICS
ITSC*IFQLLQEAGI
K 1.0 1.0 1.0 1.0 0.8 0.9 0.9 0.9 0.9 ns





IDH1 SEGGFIWAC*K 0.9 1.0 1.0 0.9 0.9 0.8 0.9 1.0 0.9 ns
566 P04632 CAPNS1 Calpain small subunit 1 CAPNS1
YSDESGNMDFDNF
ISC*LVR 1.1 1.3 1.2 0.9 1.0 0.9 0.9 0.9 0.9 ns





PCMT1 ALDVGSGSGILTAC*FAR 1.0 1.0 1.0 0.9 0.9 0.9 0.8 0.9 0.9 ns




elongation factor A protein-
like 4 
TCEAL4 PEVTC*TLEDK 0.9 0.5 0.7 0.8 0.8 1.0 0.9 0.9 0.9 ns
571 P61970 NUTF2 Nuclear transport factor 2 NUTF2
NINDAWVC*TNDM
FR 1.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 ns




VDC*ATQAMEK 1.1 0.9 1.0 0.8 0.8 1.2 0.8 0.9 0.9 ns
573 P60174 TPI1 Triosephosphate isomerase TPI1
VPADTEVVC*APPT
AYIDFAR 1.1 1.0 1.1 0.8 1.0 1.0 0.8 0.9 0.9 ns
574 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
IC*PVETLVEEAIQC
AEK 0.9 0.9 0.9 0.8 0.9 1.0 0.9 0.8 0.9 ns
575 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
ATC*IGNNSAAAVS
MLK 0.9 0.9 0.9 0.8 0.8 0.9 0.9 0.9 0.9 ns
576 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM NTGIIC*TIGPASR 0.8 1.0 0.9 0.9 0.9 0.9 0.9 0.8 0.9 ns
577 P00491 PNP Purine nucleoside phosphorylase PNP AC*VMMQGR 1.2 1.2 1.2 0.7 1.1 1.0 0.7 0.8 0.9 ns
578 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 VVFC*PVK 1.0 0.9 1.0 1.0 0.8 0.8 1.0 0.8 0.9 ns
579 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 C*GFLPGNEK 1.0 0.9 1.0 0.9 0.8 0.9 1.0 0.9 0.9 ns
580 P60981 DSTN Destrin DSTN AVIFC*LSADK 0.8 0.9 0.8 0.7 1.0 0.9 0.8 0.9 0.9 ns
581 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA
YASIC*QQNGIVPIV
EPEILPDGDHDLK 1.0 1.0 1.0 0.8 0.9 0.9 0.8 0.9 0.9 ns
582 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
LNEDMAC*SVAGI
TSDANVLTNELR 0.9 0.9 0.9 0.7 0.9 0.9 1.0 0.8 0.9 ns
583 Q9UHX1 PUF60 Poly(U)-binding-splicing factor PUF60 PUF60 ALAIMC*R 1.0 1.0 1.0 0.8 1.1 0.8 0.8 0.8 0.9 ns
584 P27348 YWHAQ 14-3-3 protein theta YWHAQ SIC*TTVLELLDK 1.1 1.0 1.0 0.8 1.0 0.9 0.8 0.8 0.9 ns
585 P07737 PFN1 Profilin-1 PFN1 C*YEMASHLR 1.0 0.9 1.0 0.9 0.9 0.8 0.8 0.9 0.9 ns
586 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
FLDGNELTLADC*
NLLPK 1.0 0.8 0.9 0.9 0.8 1.0 0.7 0.9 0.9 ns
587 P00390 GSR Glutathione reductase, mitochondrial GSR
LGGTC*VNVGCVP
K 0.9 0.9 0.9 0.8 0.9 0.8 0.9 0.9 0.9 ns
588 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA ALANSLAC*QGK 1.0 1.0 1.0 0.8 0.9 1.0 0.8 0.9 0.9 ns
589 P14174 MIF Macrophage migration inhibitory factor MIF LLC*GLLAER 1.0 1.0 1.0 0.9 0.9 0.9 0.8 0.9 0.9 ns
590 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ DIC*NDVLSLLEK 1.1 0.9 1.0 0.7 1.0 1.0 0.8 0.8 0.8 ns
591 P60174 TPI1 Triosephosphate isomerase TPI1 IAVAAQNC*YK 0.9 1.0 1.0 0.8 0.9 0.9 0.7 0.9 0.8 ns
592 P31949 S100A11 Protein S100-A11 S100A11 C*IESLIAVFQK 1.0 0.9 1.0 0.6 1.0 0.9 0.9 0.8 0.8 ns




R 1.0 1.0 1.0 0.8 0.9 0.9 0.8 0.8 0.8 ns
594 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1
GTGELTQLLNSLC*
TAVK 0.9 1.2 1.0 0.8 0.9 0.8 0.8 0.8 0.8 ns
595 P61158 ACTR3 Actin-related protein 3 ACTR3
LPACVVDC*GTGY








R 1.0 1.0 1.0 0.8 0.9 0.8 0.8 0.9 0.8 ns
597 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1
DC*LIPMGITSENV
AER 0.9 0.9 0.9 0.8 0.9 0.8 0.9 0.8 0.8 ns
598 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA ITIADC*GQLE 0.8 1.0 0.9 0.8 1.0 0.8 0.8 0.8 0.8 ns
599 P21964 COMT Catechol O-methyltransferase COMT
YLPDTLLLEEC*GL
LR 0.9 1.0 0.9 0.8 0.9 0.8 0.7 0.8 0.8 ns
600 P31150 GDI1 Rab GDP dissociation inhibitor alpha GDI1
TDDYLDQPC*LET
VNR 0.9 1.1 1.0 0.8 0.8 0.9 0.7 0.8 0.8 ns
601 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5
ALNVEPDGTGLTC
*SLAPNIISQL 1.0 1.0 1.0 0.7 0.8 0.9 0.8 0.8 0.8 ns
262
602 P13489 RNH1 Ribonuclease inhibitor RNH1
LSLQNC*C*LTGAG
C*GVLSSTLR 0.9 1.0 0.9 1.1 0.4 0.8 0.8 0.8 0.8 ns
603 Q15369
TCEB1 Transcription 
elongation factor B 
polypeptide 1 
TCEB1 VC*MYFTYK 1.2 0.8 1.0 0.9 0.6 0.9 0.8 0.7 0.8 ns
604 Q9Y3D0
FAM96B Mitotic spindle-
associated MMXD complex 
subunit MIP18
FAM96B VAAALENTHLLEVVNQC*LSAR 1.0 1.0 1.0 0.6 0.8 0.6 0.6 0.7 0.7 ns
605 P25398 RPS12 40S ribosomal protein S12 RPS12
QAHLCVLASNC*D
EPMYVK 1.1 1.0 1.0 0.6 0.6 0.6 0.7 0.7 0.6 ns
606 P25398 RPS12 40S ribosomal protein S12 RPS12
LVEALC*AEHQINL
IK 1.0 1.0 1.0 0.6 0.6 0.6 0.6 0.6 0.6 ns
607 Q14847 LASP1 LIM and SH3 domain protein 1 LASP1 ACFHC*ETC*K 1.0 1.0 1.0 0.6 0.5 0.7 0.6 0.7 0.6 ns
608 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 C*SQAVYAAEK 1.0 1.0 1.0 0.5 0.4 0.5 0.6 0.5 0.5 ns
609 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH
VPTANVSVVDLTC
*R 0.9 1.0 0.9 0.4 0.5 0.5 0.5 0.4 0.5 ns































GCDH K.GYGC*AGVSSVAYGLLAR.E 0.9 0.8 0.9 7.9 13.0 12.9 13.2 5.3 10.5
***
5 P25398 RPS12 40S ribosomal protein S12 RPS12
K.KLGEWVGLC*K.
I 0.7 0.9 0.8 11.5 10.6 9.3 12.1 6.4 10.0
***
6 Q01813 PFKP 6-phosphofructokinase type C PFKP
R.LPLMEC*VQMT






GNB2 K.AC*GDSTLTQITAGLDPVGR.I 0.9 0.9 0.9 4.9 20.0 9.1 6.4 5.9 9.2
***
8 P62888 RPL30 60S ribosomal protein L30 RPL30
R.VC*TLAIIDPGDS
DIIR.S 0.8 0.8 0.8 11.1 8.2 8.4 8.7 9.6 9.2
***









PREX1 R.LC*VLNEILGTER.D 0.9 0.8 0.8 9.0 20.0 4.0 5.5 4.4 8.6
***




0.9 0.9 0.9 9.3 8.3 8.1 10.0 7.1 8.5 ***
12 P04183 TK1 Thymidine kinase, cytosolic TK1
R.NTMEALPAC*LL
R.D 0.9 0.8 0.8 3.7 14.6 8.5 7.0 7.5 8.3
***
Table 3A-2. R-values from transnitrosation experiment at 500 µM CoA-SNO. A list
of all identified peptides (* denotes labeled cysteine) is presented together with
calculated Heavy:LightRatios (R-values) in untreated (0 µM) (n=2) versus CoA-
SNO-treated (500 µM) (n=5) MS analysis. Date were sorted by their average R-
values of CoA-SNO-treated experiments and numbered as "Peptide #".




# Description Symbol Sequence






SNO 500 µM CoA-SNO
263
13 P13674 P4HA1 Prolyl 4-hydroxylase subunit alpha-1 P4HA1 R.RPC*TLSELE.- 0.9 0.8 0.9 9.9 8.2 7.5 7.2 8.3 8.2
***
14 P15924 DSP Desmoplakin DSP R.DANSENC*NK.N 1.0 0.9 0.9 19.6 6.8 5.4 4.4 4.4 8.1 ***
15 Q01813 PFKP 6-phosphofructokinase type C PFKP
R.NESC*SENYTTD
FIYQLYSEEGK.G 1.0 0.9 0.9 7.2 13.9 6.5 6.4 5.9 8.0
***
16 P53384
NUBP1 Cytosolic Fe-S 
cluster assembly factor 
NUBP1 
NUBP1 R.GASC*QGCPNQR.L 0.8 0.8 0.8 6.9 7.2 7.1 7.4 8.9 7.5
***




GIAVASK.T 0.8 0.8 0.8 4.7 5.5 8.8 4.7 13.4 7.4
***
18 P46734






LR.K 1.0 0.8 0.9 6.3 6.8 5.0 6.4 12.5 7.4
***
19 Q9Y5Y2
NUBP2 Cytosolic Fe-S 
cluster assembly factor 
NUBP2 
NUBP2 K.VGILDVDLC*GPSIPR.M 0.9 0.8 0.9 9.3 8.0 6.0 5.9 6.1 7.0
***
20 Q9Y5M8
SRPRB Signal recognition 
particle receptor subunit beta SRPRB
K.NTPSFLIAC*NK.
Q 0.8 1.0 0.9 5.8 5.7 5.0 13.6 5.0 7.0
***
21 P35270 SPR Sepiapterin reductase SPR R.TVVNISSLC*ALQPFK.G 0.8 0.9 0.8 12.1 7.3 4.0 6.0 5.0 6.9
***
22 Q9Y3A3
MOB4 MOB-like protein 
phocein MOB4
R.HTLDGAAC*LLN
SNK.Y 0.9 0.9 0.9 6.5 7.6 6.4 7.8 6.0 6.9
***
23 P17987 TCP1 T-complex protein 1 subunit alpha TCP1
R.SLHDALC*VVK.
R 0.7 0.9 0.8 5.5 7.5 6.3 6.2 8.9 6.9
***




DVTSEK.D 0.9 0.8 0.9 3.6 8.0 7.3 7.9 7.3 6.8
***
25 Q14203 DCTN1 Dynactin subunit 1 DCTN1 K.VTFSC*AAGFGQR.H 1.2 1.1 1.2 2.0 9.0 2.4 17.6 3.0 6.8
***
26 P15924 DSP Desmoplakin DSP K.YQAEC*SQFK.A 0.9 0.9 0.9 7.4 9.9 6.7 4.6 5.1 6.7 ***
27 P21281
ATP6V1B2 V-type proton 





.T 0.9 0.9 0.9 2.7 4.1 15.3 7.0 2.2 6.3
***
28 P07339 CTSD Cathepsin D CTSD K.AIGAVPLIQGEYMIPC*EK.V 0.9 0.8 0.8 9.1 5.0 5.7 6.0 4.5 6.1
***
29 P49327 FASN Fatty acid synthase FASN R.LGMLSPEGTC*K.A 0.9 0.8 0.8 3.7 5.9 12.5 5.2 2.9 6.1
***
30 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH
K.IISNASC*TTNCL
APLAK.V 0.9 0.9 0.9 6.1 4.3 6.5 7.2 5.7 6.0
***
31 O15371 EIF3D Eukaryotic translation initiation factor 3 subunit EIF3D
R.NLAMEATYINHN
FSQQC*LR.M 0.9 0.9 0.9 2.7 2.5 2.0 20.0 1.9 5.8
***






0.9 0.9 0.9 6.5 5.7 5.6 5.7 5.2 5.7 ***
33 Q86Y56 HEATR2 HEAT repeat-containing protein 2 HEATR2
R.C*SLLDPFAAVR.
R 0.9 0.9 0.9 7.4 6.8 3.5 7.1 3.6 5.7
***
34 P54136 RARS Arginine--tRNA ligase, cytoplasmic RARS
K.NC*GCLGASPNL
EQLQEENLK.L 1.2 0.7 1.0 5.9 6.6 4.9 6.0 4.7 5.6
***
35 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
K.ALNALC*DGLID






PFKL R.VFANAPDSAC*VIGLK.K 0.9 0.8 0.8 5.6 5.9 5.6 5.5 5.2 5.5
***
37 Q09028 RBBP4 Histone-binding protein RBBP4 RBBP4
R.YMPQNPC*IIATK
.T 0.8 0.8 0.8 4.6 5.8 5.9 6.0 5.2 5.5
***
38 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2
R.YVAAAFPSAC*G
K.T 0.8 0.8 0.8 5.6 6.3 5.3 4.4 5.6 5.4
***




0.9 0.9 0.9 5.5 4.8 5.4 5.5 5.3 5.3 ***
40 P42677 RPS27 40S ribosomal protein S27 RPS27 K.ARLTEGC*SFR.R 0.8 0.9 0.8 5.6 5.8 5.0 5.3 4.8 5.3
***
264












SC*SNDQTVR.V 0.7 0.7 0.7 5.1 5.7 4.6 5.6 5.3 5.3
***




0.9 0.9 0.9 5.3 5.5 5.2 5.3 4.8 5.2 ***
44 P07437 TUBB Tubulin beta chain TUBB K.TAVC*DIPPR.G 0.9 0.8 0.9 5.3 5.1 5.0 5.7 5.0 5.2 ***
45 P15924 DSP Desmoplakin DSP K.YC*YLQNEVFGLFQK.L 1.0 0.9 1.0 5.7 5.6 5.2 5.5 3.7 5.1 **
46 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 K.IIC*QGFTGK.Q 0.9 0.9 0.9 4.8 5.3 5.8 4.5 5.1 5.1 **
47 Q96CM8
ACSF2 Acyl-CoA synthetase 
family member 2, 
mitochondrial
ACSF2 R.MVSTPIGGLSYVQGC*TK.K 1.5 1.4 1.4 8.5 5.5 3.5 4.9 3.1 5.1 *
48 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U 
HNRNP
U K.AVVVC*PK.D 0.9 0.8 0.9 11.7 3.8 3.5 3.2 3.1 5.0 **
49 P49411 TUFM Elongation factor Tu, mitochondrial TUFM
K.GEETPVIVGSAL





MAT2A K.TC*NVLVALEQQSPDIAQGVHLDR.N 0.9 0.8 0.9 6.0 5.5 4.8 4.9 3.6 5.0 **
51 P60709 ACTB Actin, cytoplasmic 1 ACTB K.C*DVDIRK.D 0.9 0.8 0.8 3.8 5.3 5.3 4.9 5.4 4.9 **
52 P32322
PYCR1 Pyrroline-5-
carboxylate reductase 1, 
mitochondrial
PYCR1 R.C*MTNTPVVVR.E 0.8 0.8 0.8 5.6 4.9 4.5 4.7 4.1 4.8 **
53 P33992 MCM5 DNA replication licensing factor MCM5 MCM5
R.C*SVLAAANSVF
GR.W 1.1 0.9 1.0 4.7 6.5 4.1 5.1 3.4 4.7 *
54 P13804
ETFA Electron transfer 
flavoprotein subunit alpha, 
mito
ETFA R.TIYAGNALC*TVK.C 1.0 0.9 0.9 5.1 4.6 4.4 5.2 4.1 4.7 *
55 P62280 RPS11 40S ribosomal protein S11 RPS11
R.DVQIGDIVTVGE
C*RPLSK.T 0.8 0.8 0.8 4.9 4.8 4.4 5.1 4.2 4.7 **
56 P36578 RPL4 60S ribosomal protein L4 RPL4
R.SGQGAFGNMC*
R.G 0.9 0.8 0.8 5.0 5.2 4.9 4.2 4.0 4.6 *
57 P13804
ETFA Electron transfer 
flavoprotein subunit alpha, 
mito
ETFA R.LGGEVSC*LVAGTK.C 0.9 0.8 0.8 3.8 4.9 4.5 5.4 4.6 4.6 *
58 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1
R.AGGIETIANEFSD
RC*TPSVISFGSK.N 0.9 0.8 0.9 3.8 5.3 4.7 5.5 3.9 4.6 *
59 P07437 TUBB Tubulin beta chain TUBB K.NMMAAC*DPR.H 0.9 0.8 0.8 5.1 4.8 4.5 4.6 4.2 4.6 *
60 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2
R.LC*PNSTGAEIR.
S 0.9 0.8 0.8 4.7 4.1 4.9 4.6 4.6 4.6 *




AEAWAR.L 0.9 0.9 0.9 4.8 4.8 4.6 4.6 4.3 4.6 *
62 P27635 RPL10 60S ribosomal protein L10 RPL10 K.MLSC*AGADR.L 0.9 0.8 0.9 5.6 4.8 4.4 4.2 4.1 4.6 *
63 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta-
2-





MGMT R.VVC*SSGAVGNYSGGLAVK.E 0.9 0.8 0.9 6.1 5.1 3.3 4.1 4.1 4.6 *
65 P62857 RPS28 40S ribosomal protein S28 RPS28
R.TGSQGQC*TQVR
.V 0.9 1.0 1.0 4.7 5.1 4.2 4.7 3.6 4.5 *
66 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2
R.SVC*TEAGMFAI
R.A 0.9 0.9 0.9 5.2 4.6 4.3 4.5 3.7 4.5 *
67 Q9UHD8 SEPT9 Septin-9 9-Sep
K.LTVIDTPGFGDHI
NNENC*WQPIMK.F 0.9 0.8 0.9 11.5 2.7 2.6 2.9 2.5 4.4 *
68 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1
R.LIGPNC*PGVINP
GECK.I 0.9 0.8 0.8 6.2 4.8 3.5 3.8 3.8 4.4 *
265
69 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 R.C*GLALALNK.L 0.8 0.7 0.8 4.1 5.0 4.9 3.9 4.2 4.4 *
70 P62241 RPS8 40S ribosomal protein S8 RPS8
K.NC*IVLIDSTPYR.
Q 0.9 0.9 0.9 4.2 4.5 4.5 4.8 4.0 4.4 *
71 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta-
2-
GNB2L1 R.FSPNSSNPIIVSC*GWDK.L 0.9 0.8 0.8 3.5 5.1 4.5 4.9 3.9 4.4 *
72 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L
R.GC*ALQCAILSPA
FK.V 0.8 0.8 0.8 4.4 4.2 4.4 4.5 4.4 4.4 *




K.E 0.9 0.8 0.9 3.4 5.2 3.9 5.5 3.9 4.4 *
74 P46734











ACAT1 R.QAVLGAGLPISTPC*TTINK.V 0.9 0.9 0.9 3.9 4.9 3.7 6.0 3.0 4.3 ns
76 Q5MNZ6






K.K 1.0 0.9 1.0 4.0 6.1 3.0 4.9 3.1 4.2 ns
77 Q13509 TUBB3 Tubulin beta-3 chain TUBB3 K.VAVC*DIPPR.G 0.9 0.8 0.8 3.8 4.0 4.3 4.5 4.4 4.2 ns
78 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1
K.ELAPAVSVLQLF
C*SSPK.A 0.9 0.9 0.9 3.5 4.0 4.2 4.0 5.1 4.2 ns
79 P23396 RPS3 40S ribosomal protein S3 RPS3 K.GC*EVVVSGK.L 0.9 1.0 0.9 3.9 4.8 3.5 4.3 4.2 4.2 ns
80 P49411 TUFM Elongation factor Tu, mitochondrial TUFM
K.KGDEC*ELLGHS
K.N 1.0 0.9 0.9 3.7 5.0 3.9 4.3 3.8 4.1 ns
81 P61163 ACTR1A Alpha-centractin ACTR1A R.AC*YLSINPQK.D 0.7 0.8 0.8 4.1 5.0 3.7 4.3 3.6 4.1 ns
82 P32322
PYCR1 Pyrroline-5-
carboxylate reductase 1, 
mitochondrial
PYCR1 R.SLLINAVEASC*IR.T 0.8 0.9 0.8 4.4 4.8 3.7 4.1 3.6 4.1 ns
83 P40939
HADHA Trifunctional 
enzyme subunit alpha, 
mitochondrial 
HADHA R.C*LAPMMSEVIR.I 0.8 0.7 0.8 3.3 4.3 4.4 3.8 4.4 4.0 ns
84 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10
R.TPSYSISSTLNPQ





DLD K.NETLGGTC*LNVGCIPSK.A 0.9 0.9 0.9 1.9 2.4 2.8 10.6 2.6 4.0 ns
86 Q9BYG5
PARD6B Partitioning 
defective 6 homolog beta PARD6B
R.HGAGSGC*LGT
MEVK.S 0.9 0.9 0.9 3.5 1.9 1.9 11.1 1.6 4.0 ns
87 Q14152 EIF3A Eukaryotic translation initiation factor 3 subunit EIF3A K.NIC*QQVNIK.S 0.8 0.9 0.9 3.0 3.3 3.2 7.6 2.7 4.0 ns
88 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1
K.ARDC*LIPMGITS
ENVAER.F 0.9 0.9 0.9 4.7 5.0 3.3 3.6 3.1 3.9 ns




GFK.V 0.9 0.8 0.9 4.3 4.1 3.8 3.9 3.5 3.9 ns





MDH2 K.GYLGPEQLPDC*LK.G 0.8 0.8 0.8 3.5 4.1 4.3 3.8 3.5 3.8 ns
92 Q8NBF2
NHLRC2 NHL repeat-




QQGC*IAPVELR.Y 1.2 0.9 1.1 4.0 4.4 3.1 4.8 2.9 3.8 ns
93 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 R.GNVC*GDSK.S 0.7 0.9 0.8 3.5 3.5 4.6 2.7 4.7 3.8 ns
94 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1
K.TFVGTPC*WMA
PEVMEQVR.G 0.9 0.8 0.9 2.7 4.6 4.0 3.8 3.8 3.8 ns
95 Q9ULV4 CORO1C Coronin-1C 
CORO1






MDH2 K.GC*DVVVIPAGVPR.K 0.8 0.7 0.7 3.8 2.3 3.5 3.9 5.3 3.8 ns

















0.8 1.0 0.9 10.8 2.2 1.8 2.0 1.9 3.7 ns
100 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.IC*DDELILIK.N 0.9 0.9 0.9 3.6 4.0 3.7 2.9 4.4 3.7 ns




FK.V 0.8 0.8 0.8 4.2 3.8 3.4 3.7 3.4 3.7 ns




0.7 0.8 0.8 2.2 3.8 4.2 4.7 3.2 3.6 ns




0.9 0.8 0.9 3.0 3.6 3.8 3.8 3.7 3.6 ns




.R 0.9 0.8 0.9 2.8 4.0 3.9 3.7 3.5 3.6 ns
105 Q9Y265 RUVBL1 RuvB-like 1 RUVBL1
K.VPFC*PMVGSEV
YSTEIK.K 0.9 0.8 0.8 2.0 5.8 3.6 2.4 4.1 3.6 ns
106 Q13185 CBX3 Chromobox protein homolog 3 CBX3
R.LTWHSC*PEDEA
Q.- 1.0 1.0 1.0 3.9 5.0 2.4 3.2 3.0 3.5 ns
107 P62829 RPL23 60S ribosomal protein L23 RPL23
R.ISLGLPVGAVINC
*ADNTGAK.N 0.9 0.8 0.8 3.9 3.6 3.3 3.3 3.3 3.5 ns
108 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6
R.AC*ALQVLSAIL
EGSK.Q 0.9 0.9 0.9 4.3 3.3 3.8 3.1 3.1 3.5 ns
109 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1
R.AAVEEGIVLGGG
C*ALLR.C 0.8 0.9 0.8 4.1 3.6 3.2 3.8 2.6 3.5 ns




VVK.M 0.8 0.8 0.8 4.5 3.2 3.3 2.8 3.4 3.5 ns
111 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2
K.NDITAWQEC*VN
NSMAQLEHQAVR.I 0.9 0.9 0.9 3.9 3.6 3.4 3.4 2.8 3.4 ns
112 P60866 RPS20 40S ribosomal protein S20 RPS20 R.KTPC*GEGSK.T 1.0 0.8 0.9 3.9 3.6 3.2 3.3 3.0 3.4 ns
113 P50914 RPL14 60S ribosomal protein L14 RPL14 K.C*MQLTDFILK.F 0.9 0.8 0.9 3.3 3.7 3.2 3.4 3.2 3.4 ns








L 0.9 0.9 0.9 2.8 3.6 3.3 3.7 3.2 3.3 ns




M 0.8 1.0 0.9 3.9 3.6 2.8 3.1 3.1 3.3 ns
117 P49327 FASN Fatty acid synthase FASN K.AFDTAGNGYC*R.S 0.8 0.9 0.9 3.6 4.1 2.7 2.9 3.1 3.3 ns
118 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1
K.VVVVQAISALC*
QK.Y 0.9 0.9 0.9 2.9 3.2 3.7 3.2 3.3 3.3 ns
119 P53618 COPB1 Coatomer subunit beta COPB1
K.ALSGYC*GFMA
ANLYAR.S 0.7 0.7 0.7 3.1 3.7 3.7 2.9 3.0 3.3 ns
120 P51553 IDH3G Isocitrate dehydrogenase IDH3G
K.LGDGLFLQC*CR








*LSK.L 1.1 0.7 0.9 3.7 3.3 3.7 2.9 2.7 3.3 ns
122 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 
KIAA19
67 R.VVTQNIC*QYR.S 0.8 0.8 0.8 3.6 3.4 3.6 3.0 2.7 3.2 ns
123 Q02543 RPL18A 60S ribosomal protein L18a RPL18A
R.DLTTAGAVTQC*









SGQR.R 0.9 0.9 0.9 3.3 3.8 2.8 3.4 2.8 3.2 ns
125 Q8TC07 TBC1D15 TBC1 domain family member 15 
TBC1D1
5 R.TLLVNC*QNK.S 1.0 0.8 0.9 3.4 4.6 3.2 2.1 2.8 3.2 ns
126 P68366 TUBA4A Tubulin alpha-4A chain 
TUBA4
A K.YMAC*CLLYR.G 0.9 0.9 0.9 3.4 3.2 3.3 3.2 3.0 3.2 ns
127 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1
R.SVLDAAQIVGLN
C*LR.L 0.8 0.8 0.8 2.2 3.4 4.2 3.2 3.2 3.2 ns
128 P50914 RPL14 60S ribosomal protein L14 RPL14
R.ALVDGPC*TQVR
.R 0.9 0.8 0.9 3.2 3.5 3.1 3.2 3.1 3.2 ns
129 P62280 RPS11 40S ribosomal protein S11 RPS11 K.C*PFTGNVSIR.G 0.9 0.9 0.9 3.2 3.5 3.2 3.2 2.9 3.2 ns
130 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC
R.ISAFGYLEC*SAK
.T 0.8 0.8 0.8 3.0 3.1 3.0 3.8 3.0 3.2 ns
131 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1
R.QFC*STQAALQA
MER.E 0.8 0.9 0.9 3.5 3.2 2.7 3.7 2.6 3.1 ns
132 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0
R.AGAIAPC*EVTV





ACAT1 K.DGLTDVYNKIHMGSC*AENTAK.K 0.9 0.9 0.9 3.3 3.4 2.7 3.2 3.0 3.1 ns
134 P28838 LAP3 Cytosol aminopeptidase LAP3
R.SAGAC*TAAAFL
K.E 0.8 0.9 0.8 2.8 3.7 3.0 3.1 3.0 3.1 ns
135 Q13636 RAB31 Ras-related protein Rab-31 RAB31
K.VC*LLGDTGVG
K.S 0.9 0.8 0.9 5.9 2.7 2.2 2.3 2.1 3.0 ns
136 P62753 RPS6 40S ribosomal protein S6 RPS6
K.LNISFPATGC*QK
.L 0.9 0.8 0.8 3.0 3.0 2.7 2.8 3.7 3.0 ns
137 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9
R.TAC*TNFMMTPY
VVTR.Y 0.9 0.9 0.9 3.0 3.6 2.9 2.8 2.8 3.0 ns
138 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0
K.C*FIVGADNVGS
K.Q 0.8 0.9 0.9 3.6 3.0 2.8 3.0 2.6 3.0 ns





PIN1 K.IKSGEEDFESLASQFSDC*SSAK.A 0.9 0.9 0.9 3.7 2.9 2.4 3.7 2.3 3.0 ns
141 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6
R.LC*ALRPDDSSS
AR.T 0.8 0.9 0.8 3.4 3.4 2.7 3.2 2.3 3.0 ns
142 O00743
PPP6C Serine/threonine-
protein phosphatase 6 
catalytic s




protein zw10 homolog 





SHMT2 R.AALEALGSC*LNNK.Y 0.7 0.9 0.8 1.3 4.3 3.7 2.2 3.2 3.0 ns
145 Q8TAQ2
SMARCC2 SWI/SNF 




.V 1.1 0.9 1.0 2.0 3.9 2.6 3.2 3.0 2.9 ns
146 Q07020 RPL18 60S ribosomal protein L18 RPL18
K.GC*GTVLLSGPR.
K 0.9 0.8 0.9 3.0 3.3 2.7 2.8 3.0 2.9 ns




0.6 0.8 0.7 0.8 3.2 3.7 4.2 2.8 2.9 ns
148 P55060 CSE1L Exportin-2 CSE1L K.IC*AVGITK.L 0.8 0.9 0.8 3.1 3.4 3.4 1.9 2.8 2.9 ns
149 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1
R.C*IPALDSLTPAN





MDH2 K.TIIPLISQC*TPK.V 0.7 0.8 0.8 2.7 3.0 3.2 3.1 2.6 2.9 ns
151 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82
R.YEAAFPFLSPC*
GR.E 0.9 0.9 0.9 2.8 3.2 2.8 3.1 2.6 2.9 ns
152 Q9BX63 BRIP1 Fanconi anemia group J protein BRIP1
R.LANNSDC*ILAK.
D 0.8 0.8 0.8 3.4 2.8 3.7 1.7 2.8 2.9 ns
268
153 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6
R.AVASQLDC*NFL
K.V 0.8 0.9 0.9 2.9 3.2 2.8 2.7 2.6 2.8 ns
154 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC
K.KLVIVGDGAC*G
K.T 0.9 0.9 0.9 2.5 3.1 3.1 3.0 2.5 2.8 ns
155 P62910 RPL32 60S ribosomal protein L32 RPL32
K.SYC*AEIAHNVS





GOT2 R.VGAFTMVC*K.D 0.8 0.8 0.8 3.2 2.9 1.7 3.0 3.5 2.8 ns
157 P62244 RPS15A 40S ribosomal protein S15a RPS15A K.C*GVISPR.F 0.7 0.8 0.7 3.8 2.9 2.7 2.4 2.3 2.8 ns
158 P63220 RPS21 40S ribosomal protein S21 RPS21 K.TYAIC*GAIR.R 0.9 1.0 0.9 3.6 3.1 2.8 2.4 2.3 2.8 ns
159 P67936 TPM4 Tropomyosin alpha-4 chain TPM4
K.EENVGLHQTLD
QTLNELNC*I.- 1.0 1.0 1.0 5.1 2.2 2.2 2.7 1.8 2.8 ns




1.0 0.8 0.9 1.8 3.1 2.9 2.9 3.2 2.8 ns
161 P55769 NHP2L1 NHP2-like protein 1 NHP2L1
K.KLLDLVQQSC*N
YK.Q 0.9 0.8 0.9 3.2 3.2 2.5 2.9 2.2 2.8 ns
162 Q7Z4W1 DCXR L-xylulose reductase DCXR
R.GVPGAIVNVSSQ
C*SQR.A 1.0 0.8 0.9 2.5 3.2 2.7 2.9 2.6 2.8 ns
163 Q93052 LPP Lipoma-preferred partner LPP
K.TYITDPVSAPC*
APPLQPK.G 0.9 1.0 1.0 3.6 3.4 2.5 2.7 1.8 2.8 ns




0.9 0.8 0.9 2.8 2.8 2.9 2.7 2.7 2.8 ns
165 E9PPU0 EPPK1 Epiplakin EPPK1 R.LLDAQLATGGLVC*PAR.R 0.9 0.9 0.9 3.0 4.0 2.5 2.5 2.0 2.8 ns
166 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
K.IC*PVETLVEEAI
QCAEK.I 0.9 0.9 0.9 1.8 2.3 3.0 3.6 3.1 2.8 ns
167 Q7Z2W4
ZC3HAV1 Zinc finger 





YQSC*PR.G 1.0 1.2 1.1 3.8 2.5 2.3 2.9 2.3 2.8 ns
168 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP R.NPVSQC*MR.G 0.8 1.0 0.9 2.9 3.5 2.6 2.5 2.2 2.7 ns
169 P10599 TXN Thioredoxin TXN K.C*MPTFQFFK.K 1.2 0.9 1.1 3.8 3.6 1.6 3.0 1.7 2.7 ns
170 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5
K.GVC*TEAGMYA
LR.E 0.9 0.8 0.9 2.3 2.7 3.4 2.5 2.6 2.7 ns
171 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1
K.PMC*VESFSDYP
PLGR.F 0.8 0.9 0.8 3.0 2.8 2.5 3.0 2.2 2.7 ns




transferase subunit ALG13 
ALG13 K.ADLVISHAGAGSC*LETLEK.G 1.0 0.9 0.9 3.1 3.4 2.6 2.3 2.1 2.7 ns
174 P46782 RPS5 40S ribosomal protein S5 RPS5
K.TIAEC*LADELIN
AAK.G 0.9 0.9 0.9 3.3 2.8 2.5 2.5 2.3 2.7 ns
175 Q9UN37
VPS4A Vacuolar protein 
sorting-associated protein 4A VPS4A
K.LLEPVVC*MSD
MLR.S 1.2 1.1 1.1 2.9 3.2 2.8 2.4 2.1 2.7 ns




1.0 0.9 0.9 1.8 2.7 3.0 3.2 2.7 2.7 ns
177 P49327 FASN Fatty acid synthase FASN R.LLSAAC*R.L 0.8 0.7 0.8 1.9 3.0 3.0 2.9 2.7 2.7 ns




0.9 0.9 0.9 3.2 3.0 2.6 2.5 2.0 2.7 ns
179 O14980 XPO1 Exportin-1 XPO1 K.DLLGLC*EQKR.G 0.8 0.9 0.8 3.2 2.4 2.2 3.0 2.5 2.7 ns
180 P15880 RPS2 40S ribosomal protein S2 RPS2
R.GC*TATLGNFAK.
A 0.9 0.9 0.9 3.1 2.8 2.4 2.7 2.3 2.7 ns
181 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I 1.0 1.1 1.0 3.9 2.6 1.8 3.3 1.6 2.6 ns




dependent RNA helicase 
DDX59 
DDX59 K.NLPC*ANVR.Q 0.8 0.5 0.6 3.0 1.7 1.5 1.7 5.4 2.6 ns
184 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.GIFPVLC*K.D 0.6 0.9 0.7 1.2 2.6 3.3 3.6 2.5 2.6 ns





PPP1CC R.GNHEC*ASINR.I 0.9 0.9 0.9 3.2 2.6 2.6 2.5 2.3 2.6 ns









0.9 0.9 0.9 2.9 2.8 2.4 2.5 2.5 2.6 ns
189 P50991 CCT4 T-complex protein 1 subunit delta CCT4 K.ITGC*ASPGK.T 0.9 0.9 0.9 3.0 3.1 2.2 2.3 2.5 2.6 ns
190 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 R.GDFC*IQVGR.N 0.8 0.9 0.8 1.0 3.1 3.2 3.2 2.5 2.6 ns
191 Q9Y508 RNF114 RING finger protein 114 RNF114
R.DC*GGAAQLAGP
AAEADPLGR.F 0.8 0.9 0.9 3.9 2.3 2.1 2.8 1.9 2.6 ns
192 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58
R.YVDIAIPC*NNK.
G 1.0 0.8 0.9 1.8 3.0 2.7 2.7 2.7 2.6 ns
193 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7
K.NC*EPMIGLVPIL
K.G 0.9 0.8 0.9 2.6 2.6 2.7 2.5 2.5 2.6 ns
194 P49327 FASN Fatty acid synthase FASN R.LSIPTYGLQC*TR.A 0.7 0.8 0.7 2.4 3.0 2.5 2.6 2.3 2.6 ns
195 P22695
UQCRC2 Cytochrome b-c1 





YR.I 0.9 0.8 0.8 2.5 2.8 2.6 2.8 2.1 2.6 ns
196 Q15796 SMAD2 Mothers against decapentaplegic homolog 2 SMAD2 K.AITTQNC*NTK.C 1.2 0.7 1.0 3.9 2.1 1.8 3.0 2.0 2.6 ns
197 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA
K.VNLQMVYDSPL





HMGCL K.LLEAGNFIC*QALNR.K 0.8 0.8 0.8 2.4 2.5 2.6 2.7 2.5 2.5 ns
199 Q9NUU7
DDX19A ATP-dependent 
RNA helicase DDX19A DDX19A
K.VLVTTNVC*AR.
G 1.0 0.9 1.0 2.8 2.7 2.7 2.4 2.2 2.5 ns
200 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM
R.NTGIIC*TIGPASR
.S 0.6 0.8 0.7 0.9 2.8 3.2 3.4 2.4 2.5 ns
201 O43707 ACTN4 Alpha-actinin-4 ACTN4 K.EGLLLWC*QR.K 0.9 0.9 0.9 1.8 3.0 2.4 3.0 2.5 2.5 ns
202 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.C*ATITPDEAR.V 0.7 0.8 0.7 2.5 2.3 2.6 2.8 2.5 2.5 ns
203 P48735 IDH2 Isocitrate dehydrogenase IDH2
K.DLAGC*IHGLSN
VK.L 0.8 0.7 0.8 2.7 2.9 1.8 2.9 2.3 2.5 ns
204 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21
K.VVLLGEGC*VG
K.T 1.1 0.9 1.0 2.9 2.7 2.4 2.4 2.0 2.5 ns
205 P62316 SNRPD2 Small nuclear ribonucleoprotein Sm D2 SNRPD2 K.NNTQVLINC*R.N 0.6 0.6 0.6 1.8 2.8 2.8 2.9 2.0 2.5 ns
206 Q9UHD8 SEPT9 Septin-9 9-Sep
R.SQEATEAAPSC*















EPRS K.LGVENC*YFPMFVSQSALEK.E 1.0 0.9 0.9 2.6 2.8 2.4 2.3 2.2 2.4 ns
209 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6
K.GC*LLYGPPGTG
K.T 0.9 0.8 0.8 2.1 3.0 0.9 3.0 3.0 2.4 ns
210 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1
K.AIC*TEAGLMAL
R.E 0.9 0.9 0.9 2.3 2.5 2.5 2.5 2.1 2.4 ns











K 1.0 0.8 0.9 2.6 2.2 1.9 2.3 2.9 2.4 ns
270
213 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R 
HNRNP
R K.SAFLC*GVMK.T 0.9 0.8 0.9 2.7 2.8 1.7 1.2 3.5 2.4 ns
214 Q15019 SEPT2 Septin-2 2-Sep R.LTVVDTPGYGDAINC*R.D 0.9 0.8 0.8 2.4 2.5 2.2 2.6 2.1 2.4 ns
215 Q13155
AIMP2 Aminoacyl tRNA 
synthase complex-interacting 
multif
AIMP2 K.FSIQTMC*PIEGEGNIAR.F 0.8 0.9 0.9 2.3 2.0 2.6 2.9 1.9 2.3 ns
216 P0CW22
RPS17L 40S ribosomal 
protein S17-like RPS17L R.VC*EEIAIIPSK.K 1.0 0.8 0.9 2.4 2.5 2.1 2.7 2.0 2.3 ns
217 P46782 RPS5 40S ribosomal protein S5 RPS5
R.VNQAIWLLC*TG
AR.E 0.9 0.8 0.9 2.4 2.5 2.6 2.3 1.8 2.3 ns
218 Q13155
AIMP2 Aminoacyl tRNA 
synthase complex-interacting 
multif
AIMP2 R.SC*ENLAPFNTALK.L 0.7 0.7 0.7 2.4 2.2 2.4 2.5 2.1 2.3 ns
219 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 R.GC*AFVTFTTR.A 1.1 0.9 1.0 1.8 2.4 2.6 2.6 2.2 2.3 ns
220 P21964 COMT Catechol O-methyltransferase COMT
R.GSSC*FECTHYQ
SFLEYR.E 0.9 0.9 0.9 3.3 2.4 1.9 2.1 1.7 2.3 ns
221 P61158 ACTR3 Actin-related protein 3 ACTR3
K.LGYAGNTEPQFII





PPCDC K.ASC*PAAAPLMER.K 1.0 1.0 1.0 3.0 2.2 2.1 2.2 1.8 2.3 ns
223 P23921
RRM1 Ribonucleoside-
diphosphate reductase large 
subunit
RRM1 K.IIDINYYPVPEAC*LSNK.R 0.9 0.9 0.9 2.5 2.3 2.1 2.4 2.0 2.3 ns
224 O14929
HAT1 Histone 
acetyltransferase type B 
catalytic subunit
HAT1 K.VDENFDC*VEADDVEGK.I 0.9 1.0 0.9 3.5 2.0 1.8 1.9 2.1 2.2 ns
225 Q7L8W6
ATPBD4 ATP-binding 
domain-containing protein 4 ATPBD4
K.C*EGDEVEDLYE
LLK.L 1.0 0.8 0.9 1.8 2.6 1.8 2.7 2.3 2.2 ns
226 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3
R.TPC*NAGTFSQP
EK.V 0.9 0.8 0.8 1.0 2.5 2.9 2.9 2.0 2.2 ns
227 Q9UPN9
TRIM33 E3 ubiquitin-
protein ligase TRIM33 TRIM33
R.C*DPVPAANGAI
R.F 0.8 0.8 0.8 2.4 0.9 2.1 4.7 1.0 2.2 ns
228 O60502 MGEA5 Bifunctional protein NCOAT MGEA5
R.ANSSVVSVNC*K
.G 0.9 0.8 0.9 2.4 2.3 2.0 2.7 1.8 2.2 ns
229 P55060 CSE1L Exportin-2 CSE1L K.LSTAC*PGR.V 0.7 0.8 0.8 2.1 1.9 2.2 3.0 2.0 2.2 ns
230 P62714
PPP2CB Serine/threonine-
protein phosphatase 2A 
catalytic 
PPP2CB R.NVVTIFSAPNYC*YR.C 0.7 0.8 0.8 1.6 2.3 2.8 2.5 1.8 2.2 ns
231 P22314 UBA1 Ubiquitin-like modifier-activating enzyme 1 UBA1
K.YFLVGAGAIGC*
ELLK.N 0.6 0.8 0.7 1.0 1.7 5.2 1.7 1.4 2.2 ns
232 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1
K.C*EFQDAYVLLS
EK.K 0.9 0.9 0.9 2.3 2.2 2.3 2.3 1.8 2.2 ns
233 P51946 CCNH Cyclin-H CCNH R.TC*LSQLLDIMK.S 1.0 0.9 1.0 2.4 2.3 2.1 2.4 1.7 2.2 ns
234 P23396 RPS3 40S ribosomal protein S3 RPS3
R.GLC*AIAQAESL
R.Y 0.9 0.9 0.9 2.3 2.3 2.2 2.1 2.0 2.2 ns




TANFVAPEVLK.R 1.0 0.9 0.9 2.5 2.0 2.6 2.0 1.8 2.2 ns




HR.Y 0.9 0.9 0.9 2.1 2.2 2.1 2.4 2.0 2.2 ns
237 Q99832 CCT7 T-complex protein 1 subunit eta CCT7
R.QLC*DNAGFDAT
NILNK.L 0.9 0.7 0.8 2.6 1.9 2.5 2.2 1.5 2.1 ns
238 P57678 GEMIN4 Gem-associated protein 4 GEMIN4
R.SDPDAC*PTMPL
LAMLLR.G 0.5 0.6 0.5 2.4 2.2 2.3 2.1 1.7 2.1 ns




HR.Y 0.8 0.9 0.9 2.2 2.1 2.3 2.1 2.0 2.1 ns
240 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O
R.GEVPC*TVTSAS
PLEEATLSELK.T 0.9 0.7 0.8 2.5 1.9 2.1 2.2 2.0 2.1 ns
241 O15355 PPM1G Protein phosphatase 1G PPM1G
K.C*SGDGVGAPR.
L 0.6 0.8 0.7 2.1 2.1 2.2 2.2 2.0 2.1 ns
271




L 0.9 1.0 0.9 3.2 2.1 1.9 1.9 1.5 2.1 ns




0.9 0.8 0.9 2.3 2.5 1.9 2.1 1.8 2.1 ns
244 P48735 IDH2 Isocitrate dehydrogenase IDH2
K.VC*VETVESGA
MTK.D 0.8 0.8 0.8 2.1 2.2 2.1 2.4 1.7 2.1 ns
245 P49327 FASN Fatty acid synthase FASN R.DPETLVGYSMVGC*QR.A 0.9 0.9 0.9 2.1 2.4 2.0 1.9 2.1 2.1 ns
246 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2
R.DLGGIVLANAC*
GPCIGQWDR.K 0.9 0.9 0.9 2.3 2.0 1.7 2.5 1.8 2.1 ns
247 P49327 FASN Fatty acid synthase FASN K.ADEASELAC*PTPK.E 0.9 1.0 0.9 2.5 2.2 1.6 2.4 1.6 2.1 ns
248 Q04760 GLO1 Lactoylglutathione lyase GLO1 K.C*DFPIMK.F 0.9 0.8 0.8 1.8 2.0 2.2 2.1 2.0 2.0 ns















ASMTL K.VDASAC*GMER.L 0.9 0.9 0.9 1.1 1.6 2.7 2.6 2.0 2.0 ns
253 Q00765 REEP5 Receptor expression-enhancing protein 5 REEP5 K.NC*MTDLLAK.L 0.9 1.0 0.9 2.1 2.0 1.9 2.1 1.9 2.0 ns
254 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 R.NLADC*LR.S 0.9 0.9 0.9 1.3 1.9 1.9 3.1 1.8 2.0 ns
255 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB
K.HSMNPFC*EIAV









1.0 0.9 0.9 2.6 2.1 1.6 1.9 1.7 2.0 ns




0.6 0.8 0.7 1.3 2.2 2.2 2.6 1.6 2.0 ns
258 Q9UNE7
STUB1 E3 ubiquitin-protein 
ligase CHIP STUB1 R.AQQAC*IEAK.H 1.3 1.7 1.5 2.3 2.1 2.1 1.5 1.8 1.9 ns
259 P46782 RPS5 40S ribosomal protein S5 RPS5 K.AQC*PIVER.L 0.9 0.8 0.8 2.0 2.2 1.7 1.9 2.0 1.9 ns





PPA2 R.GQPC*SQNYR.L 1.2 1.2 1.2 1.9 2.2 1.9 2.3 1.5 1.9 ns
262 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1
R.LVVPATQC*GSLI
GK.G 0.9 0.8 0.9 2.3 2.0 1.9 1.9 1.6 1.9 ns
263 P33991 MCM4 DNA replication licensing factor MCM4 MCM4 K.AGIIC*QLNAR.T 1.0 0.9 0.9 1.2 2.0 2.4 2.3 1.7 1.9 ns
264 P78347 GTF2I General transcription factor II-I GTF2I
R.SILSPGGSC*GPI
K.V 0.9 0.9 0.9 2.3 2.2 1.6 1.9 1.6 1.9 ns
265 Q969T9 WBP2 WW domain-binding protein 2 WBP2
K.DC*EIKQPVFGA





AFR.A 0.6 0.7 0.7 1.2 1.9 2.2 2.7 1.6 1.9 ns
267 Q14247 CTTN Src substrate cortactin CTTN K.HC*SQVDSVR.G 0.8 0.7 0.8 2.5 2.1 1.7 1.9 1.4 1.9 ns
268 Q14247 CTTN Src substrate cortactin CTTN K.C*ALGWDHQEK.L 0.9 0.9 0.9 2.2 2.0 1.8 2.0 1.5 1.9 ns
269 P37235 HPCAL1 Hippocalcin-like protein 1 HPCAL1
R.LLQC*DPSSASQF
.- 0.9 0.9 0.9 2.3 1.9 1.7 1.9 1.6 1.9 ns
270 P14678
SNRPB Small nuclear 
ribonucleoprotein-associated 
protein
SNRPB R.C*ILQDGR.I 0.8 0.8 0.8 1.6 1.9 2.1 2.2 1.7 1.9 ns
271 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS
K.NVGC*LQEALQL
ATSFAQLR.L 0.8 0.7 0.7 1.9 1.9 1.9 1.9 1.9 1.9 ns
272




0.9 0.8 0.8 1.4 1.8 2.1 2.1 2.0 1.9 ns
273 P00966 ASS1 Argininosuccinate synthase ASS1
R.FELSC*YSLAPQI
K.V 0.8 0.9 0.8 1.5 2.2 1.9 2.0 1.8 1.9 ns
274 P60900 PSMA6 Proteasome subunit alpha type-6 PSMA6
K.C*DPAGYYCGFK
.A 0.8 0.7 0.7 1.0 2.0 2.2 2.3 1.9 1.9 ns
275 P11498 PC Pyruvate carboxylase, mitochondrial PC R.FLYEC*PWR.R 1.0 0.8 0.9 2.0 2.3 1.7 1.3 2.2 1.9 ns






1 R.C*IVSPAGR.H 0.7 0.9 0.8 2.1 1.6 1.8 1.9 1.8 1.8 ns
278 P15924 DSP Desmoplakin DSP K.AC*GSEIMQK.K 1.1 0.8 0.9 2.1 2.0 2.0 1.6 1.5 1.8 ns
279 P52895
AKR1C2 Aldo-keto 
reductase family 1 member 
C2 
AKR1C2 R.EEPWVDPNSPVLLEDPVLC*ALAK.K 0.9 0.9 0.9 1.8 2.0 1.9 2.0 1.4 1.8 ns
280 Q7L5D6 GET4 Golgi to ER traffic protein 4 homolog GET4 K.EQNYC*ESR.Y 0.8 0.7 0.8 2.4 1.9 1.9 1.6 1.5 1.8 ns









MDH2 K.SQETEC*TYFSTPLLLGK.K 0.7 0.8 0.8 1.8 1.8 2.0 1.8 1.7 1.8 ns









AHNAK K.GPFVEAEVPDVDLEC*PDAK.L 0.9 0.9 0.9 1.9 2.0 1.8 1.7 1.6 1.8 ns
285 P61158 ACTR3 Actin-related protein 3 ACTR3 R.YSYVC*PDLVK.E 0.9 0.8 0.8 0.9 2.4 1.8 2.0 1.8 1.8 ns








R.M 0.9 0.9 0.9 1.8 1.9 1.8 1.8 1.6 1.8 ns
288 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 R.TDFQQGC*AK.T 0.9 0.9 0.9 2.6 1.8 1.5 1.4 1.5 1.8 ns
289 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1
R.YADLTEDQLPSC





VDAC3 K.VC*NYGLTFTQK.W 0.9 0.9 0.9 1.9 1.9 1.8 1.5 1.6 1.7 ns
291 P15924 DSP Desmoplakin DSP K.NQC*TQVVQER.E 0.8 1.3 1.1 1.9 1.7 1.7 1.7 1.7 1.7 ns
292 Q9HCC0
MCCC2 Methylcrotonoyl-
CoA carboxylase beta chain, 
mitoch
MCCC2 K.MVAAVAC*AQVPK.I 0.9 0.8 0.8 1.2 1.6 1.9 2.4 1.5 1.7 ns
293 Q9Y2Q3
GSTK1 Glutathione S-
transferase kappa 1 GSTK1 K.ETTEAAC*R.Y 1.0 0.9 0.9 1.8 1.7 1.9 1.6 1.7 1.7 ns
294 P51659
HSD17B4 Peroxisomal 





IQESTGSIIEVLSK.I 1.0 1.0 1.0 2.1 1.7 1.6 1.8 1.3 1.7 ns
295 Q15181 PPA1 Inorganic pyrophosphatase PPA1
K.GISC*MNTTLSES
PFK.C 1.1 1.4 1.2 2.5 1.9 1.5 1.5 1.3 1.7 ns
296 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.INISEGNC*PER.I 1.0 0.9 1.0 2.0 1.7 1.5 1.9 1.4 1.7 ns




ADKK.D 0.8 0.8 0.8 1.9 0.8 3.8 1.0 0.9 1.7 ns
298 Q8WW01
TSEN15 tRNA-splicing 
endonuclease subunit Sen15 TSEN15
R.GDSEPTPGC*SG









protein phosphatase 4 
regulatory 
PPP4R2 K.EVC*PVLDQFLCHVAK.T 1.0 0.9 0.9 1.6 1.7 1.4 2.0 1.7 1.7 ns
301 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 K.SC*AHDWVYE.- 0.9 0.9 0.9 1.2 1.6 1.9 2.0 1.7 1.7 ns
302 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HNRNP
K K.GSDFDC*ELR.L 0.6 1.0 0.8 1.6 1.8 1.6 1.8 1.5 1.7 ns
303 Q2TAA2
IAH1 Isoamyl acetate-
hydrolyzing esterase 1 
homolog 
















0.9 1.0 0.9 2.1 1.6 1.7 1.6 1.4 1.7 ns













T 0.9 0.8 0.9 1.8 1.4 1.5 1.8 1.7 1.7 ns







0.8 0.8 0.8 1.3 1.8 1.6 1.9 1.5 1.6 ns
311 P13639 EEF2 Elongation factor 2 EEF2 R.TFC*QLILDPIFK.V 0.6 0.7 0.7 1.4 1.7 1.7 1.9 1.4 1.6 ns
312 Q7Z4W1 DCXR L-xylulose reductase DCXR
R.AVTNHSVYC*ST
K.G 0.9 0.8 0.8 2.0 1.6 1.5 1.6 1.4 1.6 ns




DLTIK.S 0.8 0.8 0.8 1.9 1.9 1.7 1.3 1.4 1.6 ns
314 Q15370
TCEB2 Transcription 






0.9 0.9 0.9 2.1 1.5 1.6 1.5 1.4 1.6 ns
315 Q86YH6
PDSS2 Decaprenyl-
diphosphate synthase subunit 
2 
PDSS2 R.C*LLSDELSNIAMQVR.K 1.0 0.9 0.9 1.6 1.7 1.5 1.8 1.6 1.6 ns
316 Q9UBT2
UBA2 SUMO-activating 
enzyme subunit 2 UBA2
R.VLVVGAGGIGC*
ELLK.N 0.9 0.8 0.8 1.1 1.8 1.8 1.8 1.6 1.6 ns
317 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM K.C*CSGAIIVLTK.S 0.9 0.9 0.9 1.6 1.9 1.5 1.7 1.3 1.6 ns




LK.A 1.0 0.8 0.9 1.8 1.6 1.7 1.5 1.5 1.6 ns
319 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH
R.VPTANVSVVDLT
C*R.L 0.6 0.8 0.7 0.7 1.6 2.1 2.2 1.4 1.6 ns
320 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3
R.LVVPASQC*GSLI
GK.G 0.9 0.9 0.9 1.9 1.6 1.6 1.5 1.4 1.6 ns
321 P49327 FASN Fatty acid synthase FASN K.AINC*ATSGVVGLVNCLR.R 0.9 0.9 0.9 2.3 1.5 1.4 1.5 1.3 1.6 ns
322 Q9NRF9
POLE3 DNA polymerase 
epsilon subunit 3 POLE3
R.AASVFVLYATSC
*ANNFAMK.G 0.9 0.9 0.9 2.9 1.4 1.3 1.4 1.0 1.6 ns
323 Q96EY8 MMAB Cob(I)yrinic acid a,c-diamide adenosyltransferase, MMAB
K.IQCTLQDVGSAL
ATPC*SSAR.E 1.0 0.9 0.9 2.0 1.5 1.3 1.6 1.4 1.6 ns
324 O75940






PMTQYQDTSK.Y 1.0 0.8 0.9 1.9 1.6 1.7 1.4 1.4 1.6 ns







UL2 K.EGC*TEVSLLR.V 1.0 0.9 0.9 1.8 1.5 1.4 1.6 1.5 1.6 ns




0.9 0.9 0.9 2.1 1.8 1.4 1.4 1.1 1.5 ns
328 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD R.TQVC*GILR.E 0.9 0.9 0.9 1.8 1.6 1.4 1.6 1.3 1.5 ns
329 Q9Y3D2
MSRB2 Methionine-R-






1.0 0.9 0.9 2.1 1.7 1.2 1.5 1.2 1.5 ns
330 Q96P48
ARAP1 Arf-GAP with Rho-
GAP domain, ANK repeat 
and PH dom
ARAP1 R.AVFPEGPC*EEPLQLR.K 0.9 0.7 0.8 1.9 1.8 1.2 1.3 1.5 1.5 ns
331 Q9NQC3 RTN4 Reticulon-4 RTN4
K.YSNSALGHVNC*
TIK.E 0.8 0.8 0.8 1.7 1.4 1.7 1.5 1.4 1.5 ns
332 O95336 PGLS 6-phosphogluconolactonase PGLS R.AAC*CLAGAR.A 1.0 0.8 0.9 1.3 1.5 1.6 1.7 1.6 1.5 ns
333 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9
K.GIGMNEPLVDC*
EGYPR.S 0.8 1.0 0.9 1.7 1.4 1.5 1.8 1.2 1.5 ns
334 Q7L2H7
EIF3M Eukaryotic 
translation initiation factor 3 
subunit
EIF3M K.VAASC*GAIQYIPTELDQVR.K 0.8 0.9 0.9 1.4 1.6 1.4 1.7 1.4 1.5 ns




R.V 0.9 0.7 0.8 1.7 1.4 1.5 1.6 1.4 1.5 ns
336 P21333 FLNA Filamin-A FLNA K.VGTEC*GNQK.V 0.8 0.7 0.8 1.4 1.6 1.5 1.5 1.5 1.5 ns
337 Q9NZZ3
CHMP5 Charged 
multivesicular body protein 5 CHMP5
K.APPPSLTDC*IGT
VDSR.A 0.9 1.0 1.0 1.7 1.5 1.5 1.4 1.3 1.5 ns
338 P00338 LDHA L-lactate dehydrogenase A chain LDHA
R.VIGSGC*NLDSA
R.F 0.9 0.9 0.9 1.0 1.9 1.4 1.8 1.4 1.5 ns
339 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1
R.IIC*SAGLSLLAE
ER.Q 1.0 0.9 0.9 1.9 1.4 1.4 1.4 1.3 1.5 ns






1.0 0.9 0.9 1.8 1.5 1.3 1.5 1.2 1.5 ns
341 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA
R.ALANSLAC*QGK
.Y 0.5 0.8 0.6 0.9 1.5 1.7 2.2 1.0 1.5 ns




EYLNFIR.G 0.9 0.9 0.9 1.5 1.5 1.4 1.5 1.3 1.5 ns
343 Q16854 DGUOK Deoxyguanosine kinase, mitochondrial DGUOK
K.AC*TAQSLGNLL
DMMYR.E 0.9 0.9 0.9 1.8 1.3 1.3 1.5 1.5 1.5 ns
344 P55795 HNRNPH2 Heterogeneous nuclear ribonucleoprotein H2 
HNRNP
H2 R.GLPFGC*SK.E 1.0 0.9 0.9 1.4 1.5 1.5 1.4 1.4 1.4 ns
345 Q9HAV7
GRPEL1 GrpE protein 
homolog 1, mitochondrial GRPEL1 K.LYGIQAFC*K.D 0.8 1.0 0.9 1.6 1.5 1.4 1.3 1.4 1.4 ns
346 Q93009 USP7 Ubiquitin carboxyl-terminal hydrolase 7 USP7 K.GTC*VEGTIPK.L 1.0 0.8 0.9 1.8 1.6 1.4 1.3 1.2 1.4 ns
347 P53602 MVD Diphosphomevalonate decarboxylase MVD
R.DGDPLPSSLSC*
K.V 0.9 1.0 0.9 1.6 1.5 1.2 1.4 1.5 1.4 ns




0.5 0.8 0.6 0.9 1.4 1.6 2.0 1.2 1.4 ns
349 P26641 EEF1G Elongation factor 1-gamma EEF1G
K.AAAPAPEEEMDE
C*EQALAAEPK.A 1.0 1.0 1.0 1.7 1.4 1.3 1.5 1.1 1.4 ns
350 P84085 ARF5 ADP-ribosylation factor 5 ARF5
K.NIC*FTVWDVGG
QDK.I 0.9 0.9 0.9 1.4 1.1 1.4 1.8 1.4 1.4 ns
351 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2
K.LC*VQNSPQEAR











1.1 0.8 0.9 1.4 1.3 1.5 1.4 1.5 1.4 ns




0.9 0.9 0.9 1.9 1.4 1.4 1.3 1.1 1.4 ns
354 Q7L1Q6
BZW1 Basic leucine zipper 






1.0 1.1 1.0 1.7 1.3 1.4 1.3 1.3 1.4 ns
355 P25398 RPS12 40S ribosomal protein S12 RPS12
K.LVEALC*AEHQI
NLIK.V 1.0 1.0 1.0 1.5 1.4 1.5 1.3 1.2 1.4 ns
356 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.C*LSVMEAK.V 0.8 0.9 0.8 1.6 1.3 1.5 1.4 1.2 1.4 ns
357 Q9UJW0 DCTN4 Dynactin subunit 4 DCTN4
R.LLQPDFQPVC*A





DTFLEEINK.V 0.8 0.9 0.8 2.0 1.3 1.3 1.1 1.3 1.4 ns
359 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.LDFVC*SFLQK.N 0.7 0.8 0.8 1.7 1.3 1.3 1.4 1.2 1.4 ns




NC*K.D 0.9 0.9 0.9 1.4 1.4 1.3 1.5 1.2 1.4 ns
361 P60981 DSTN Destrin DSTN K.LGGSLIVAFEGC*PV.- 0.9 0.8 0.8 1.7 1.3 1.4 1.4 1.1 1.4 ns
362 O00204
SULT2B1 Sulfotransferase 





SLPDQYSPR.L 0.9 1.0 1.0 1.3 1.3 1.5 1.3 1.4 1.4 ns
363 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T 1.0 0.8 0.9 1.6 1.4 1.4 1.4 1.1 1.4 ns
364 P14649 MYL6B Myosin light chain 6B MYL6B
K.ILYSQC*GDVMR




binding protein 1 





EPRS K.LSSC*DSFTSTINELNHCLSLR.T 1.0 0.8 0.9 1.5 1.2 1.5 1.5 1.1 1.3 ns
367 P62826 RAN GTP-binding nuclear protein Ran RAN
R.VC*ENIPIVLCGN
K.V 0.7 0.8 0.7 1.1 1.3 1.4 1.6 1.2 1.3 ns
368 P31939 ATIC Bifunctional purine biosynthesis protein PURH ATIC K.VC*MVYDLYK.T 0.7 0.8 0.7 0.7 0.9 1.8 2.3 0.9 1.3 ns
369 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F 0.9 0.9 0.9 1.6 1.3 1.2 1.2 1.2 1.3 ns
370 A0AVT1
UBA6 Ubiquitin-like 
modifier-activating enzyme 6 UBA6
R.KPNVGC*QQDSE
ELLK.L 0.9 0.8 0.8 1.4 1.2 1.3 1.3 1.2 1.3 ns
371 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9
K.VTDDLVC*LVYK
.T 0.9 0.8 0.8 1.5 1.3 1.2 1.3 1.2 1.3 ns
372 P31947 SFN 14-3-3 protein sigma SFN K.GAVEKGEELSC*EER.N 0.9 0.9 0.9 1.5 1.2 1.4 1.3 1.0 1.3 ns
373 P48735 IDH2 Isocitrate dehydrogenase IDH2
K.SSGGFVWAC*K.
N 0.8 0.8 0.8 1.8 1.5 1.1 1.2 0.9 1.3 ns
374 O14964
HGS Hepatocyte growth 
factor-regulated tyrosine 
kinase





ILKAP R.FILLAC*DGLFK.V 1.4 0.8 1.1 1.6 1.0 1.5 1.2 1.3 1.3 ns





HPRT1 K.SYC*NDQSTGDIK.V 0.9 0.8 0.9 1.6 1.1 1.2 1.4 1.2 1.3 ns
378 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3
K.HLNEIDLFHC*ID





MDH2 K.EGVVEC*SFVK.S 0.7 0.9 0.8 1.2 0.9 1.5 1.3 1.4 1.3 ns
276
380 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 K.C*GFLPGNEK.V 0.9 0.9 0.9 1.6 1.3 1.1 1.3 1.1 1.3 ns
381 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 K.YLEC*SALTQR.G 0.8 0.8 0.8 1.0 0.9 1.1 2.3 1.0 1.3 ns
382 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF R.C*NNVLYIR.G 0.9 0.9 0.9 1.4 1.2 1.3 1.3 1.1 1.3 ns
383 P62993 GRB2 Growth factor receptor-bound protein 2 GRB2
K.VLNEEC*DQNW
YK.A 0.8 0.7 0.8 1.4 1.3 1.1 1.3 1.2 1.3 ns




SVTK.Q 0.8 1.0 0.9 1.4 1.2 1.2 1.2 1.4 1.3 ns
385 P51610 HCFC1 Host cell factor 1 HCFC1 K.LVIYGGMSGC*R.L 0.7 1.0 0.8 1.4 1.3 1.2 1.3 1.1 1.3 ns
386 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH
K.ASVGFGGSC*FQ
K.D 0.8 0.8 0.8 1.6 1.0 1.3 1.5 0.9 1.3 ns
387 P13798 APEH Acylamino-acid-releasing enzyme APEH
R.QPALSAAC*LGP
EVTTQYGGQYR.T 0.9 1.0 0.9 1.2 1.0 1.3 1.5 1.1 1.2 ns









BCAT2 R.EVFGSGTAC*QVCPVHR.I 0.6 1.0 0.8 1.3 1.5 1.1 1.1 1.1 1.2 ns
390 O14980 XPO1 Exportin-1 XPO1 K.LDINLLDNVVNC*LYHGEGAQQR.M 1.0 0.9 0.9 1.5 1.1 1.2 1.3 1.1 1.2 ns









GPX4 R.YAEC*GLR.I 0.9 0.9 0.9 1.5 1.2 1.2 1.3 1.1 1.2 ns
393 Q9Y365 STARD10 PCTP-like protein STARD10
R.MEC*CDVPAETL
YDVLHDIEYR.K 0.9 1.0 0.9 1.6 1.0 1.3 1.2 1.1 1.2 ns
394 P36507






DSMANSFVGTR.S 0.8 0.7 0.7 1.4 1.0 1.2 1.3 1.1 1.2 ns
395 P21333 FLNA Filamin-A FLNA K.AHVVPC*FDASK.V 0.9 0.9 0.9 1.4 1.2 1.2 1.2 1.1 1.2 ns
396 Q9NYL2
MLTK Mitogen-activated 
protein kinase kinase kinase 
MLT
MLTK K.IC*DFGASR.F 0.7 0.8 0.7 1.5 1.2 1.1 1.1 1.1 1.2 ns
397 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1
K.VIGIEC*SSISDYA
VK.I 0.8 0.8 0.8 1.3 1.2 1.2 1.2 1.1 1.2 ns
398 O43795 MYO1B Unconventional myosin-Ib MYO1B
K.LVMSYVAAVC*G
K.G 1.0 0.8 0.9 1.5 1.1 1.2 1.1 1.1 1.2 ns
399 P27348 YWHAQ 14-3-3 protein theta YWHAQ
R.YLAEVAC*GDDR
.K 1.0 0.8 0.9 1.6 1.2 1.2 1.0 1.1 1.2 ns
400 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1
R.AITIAGVPQSVTE
C*VK.Q 0.9 0.9 0.9 1.3 1.1 1.3 1.2 1.0 1.2 ns
401 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE
K.IGPSILNSDLANL
GAEC*LR.M 0.7 0.7 0.7 2.2 0.7 1.0 1.1 0.9 1.2 ns
402 Q08211 DHX9 ATP-dependent RNA helicase A DHX9
K.LAAQSC*ALSLV
R.Q 0.7 0.6 0.7 1.3 1.2 1.4 1.0 1.1 1.2 ns
403 Q9BW61
DDA1 DET1- and DDB1-
associated protein 1 DDA1 R.FHADSVC*K.A 1.0 0.9 0.9 1.1 1.2 1.4 1.2 1.0 1.2 ns
404 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS K.YAGLSTC*FR.Q 1.0 0.9 0.9 1.3 1.0 1.2 1.3 1.1 1.2 ns
405 Q8N987
NECAB1 N-terminal EF-







1.3 1.1 1.2 1.4 1.0 1.0 1.4 1.1 1.2 ns
406 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5
K.GTPEQPQC*GFS
NAVVQILR.L 0.9 0.9 0.9 1.4 1.1 1.1 1.2 1.0 1.2 ns




0.6 0.8 0.7 0.8 1.0 1.1 1.9 1.0 1.2 ns
408 P14868 DARS Aspartate--tRNA ligase, cytoplasmic DARS
R.LEYC*EALAMLR






PGD R.C*LSSLKDER.I 0.5 0.8 0.7 1.1 0.9 1.3 1.2 1.1 1.1 ns
410 Q96EI5
TCEAL4 Transcription 
elongation factor A protein-
like 4 
TCEAL4 R.KPEVTC*TLEDK.K 1.1 0.8 1.0 1.2 1.1 1.1 1.0 1.3 1.1 ns
411 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 K.SC*FLCMVCK.K 0.9 0.9 0.9 1.2 1.0 1.0 1.5 1.0 1.1 ns
412 P30153
PPP2R1A Serine/threonine-





VIGIR.Q 0.8 0.8 0.8 1.5 1.1 1.1 1.3 0.6 1.1 ns
413 O95372 LYPLA2 Acyl-protein thioesterase 2 LYPLA2
K.TYPGVMHSSC*P
QEMAAVK.E 0.8 0.8 0.8 1.1 1.0 1.2 1.4 0.9 1.1 ns
414 P37802 TAGLN2 Transgelin-2 TAGLN2 K.NMAC*VQR.T 0.9 1.0 0.9 1.3 1.1 1.1 1.2 1.0 1.1 ns
415 P60174 TPI1 Triosephosphate isomerase TPI1
R.IIYGGSVTGATC*
K.E 0.7 0.8 0.8 0.9 1.0 1.2 1.4 1.0 1.1 ns
416 Q02790 FKBP4 Peptidyl-prolyl cis-trans isomerase FKBP4 FKBP4 K.TQLAVC*QQR.I 0.8 0.8 0.8 1.1 1.0 1.1 1.2 1.0 1.1 ns
417 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1
K.GFGFVC*FSSPEE
ATK.A 1.0 1.1 1.0 1.1 1.0 1.1 1.2 1.0 1.1 ns
418 P23528 CFL1 Cofilin-1 CFL1 K.HELQANC*YEEVK.D 0.9 0.9 0.9 1.3 1.0 1.0 1.1 1.0 1.1 ns
419 Q9NZA1
CLIC5 Chloride intracellular 
channel protein 5 CLIC5
K.AGIDGESIGNC*P
FSQR.L 0.9 0.8 0.8 1.1 0.9 1.3 1.0 1.1 1.1 ns
420 P23528 CFL1 Cofilin-1 CFL1 K.AVLFC*LSEDK.K 0.8 0.8 0.8 0.8 1.0 1.5 0.9 1.1 1.1 ns
421 P12004 PCNA Proliferating cell nuclear antigen PCNA
K.C*AGNEDIITLR.
A 0.6 0.8 0.7 1.2 1.0 1.1 1.2 0.9 1.1 ns
422 Q9BSH4
TACO1 Translational 
activator of cytochrome c 
oxidase 1 
TACO1 K.KLDSLGLCSVSC*ALEFIPNSK.V 1.0 0.8 0.9 1.4 0.9 1.0 1.0 1.0 1.1 ns
423 P11142 HSPA8 Heat shock cognate 71 kDa protein HSPA8 K.VC*NPIITK.L 1.0 0.9 1.0 0.8 0.9 1.1 1.5 1.0 1.1 ns




1.0 0.8 0.9 0.8 1.1 1.2 1.1 1.1 1.1 ns
425 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2
R.AITIAGIPQSIIEC
*VK.Q 0.9 0.9 0.9 1.2 1.0 1.2 0.9 1.0 1.1 ns
426 P61970 NUTF2 Nuclear transport factor 2 NUTF2
K.NINDAWVC*TN
DMFR.L 0.6 0.7 0.7 0.9 1.0 1.2 1.2 1.0 1.1 ns
427 P25398 RPS12 40S ribosomal protein S12 RPS12
R.QAHLC*VLASNC
DEPMYVK.L 0.9 1.0 1.0 1.3 1.1 1.0 0.9 1.0 1.1 ns
428 P50990 CCT8 T-complex protein 1 subunit theta CCT8
K.IAVYSC*PFDGMI
TETK.G 0.9 0.9 0.9 1.2 1.0 1.1 1.1 0.9 1.0 ns
429 P37802 TAGLN2 Transgelin-2 TAGLN2 K.DGTVLC*ELINALYPEGQAPVK.K 0.8 0.9 0.9 1.0 1.0 1.2 1.0 1.0 1.0 ns
430 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2
R.VGLGIC*YDMR.
F 0.9 0.9 0.9 1.2 1.0 1.0 1.0 1.0 1.0 ns
431 O75533 SF3B1 Splicing factor 3B subunit 1 SF3B1
K.VQENC*IDLVGR.
I 1.1 0.9 1.0 0.2 0.8 1.1 0.9 2.1 1.0 ns
432 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
K.ATC*IGNNSAAA
VSMLK.Q 0.8 0.8 0.8 0.7 1.0 1.3 1.2 0.8 1.0 ns
433 Q9BT78 COPS4 COP9 signalosome complex subunit 4 COPS4
K.QIQSLC*FQVNN
LLEK.I 0.7 0.9 0.8 1.1 0.6 1.4 1.2 0.8 1.0 ns
434 P52788 SMS Spermine synthase SMS R.LYC*PVEFSK.E 1.0 1.0 1.0 1.0 1.0 1.3 1.0 0.8 1.0 ns
435 P31949 S100A11 Protein S100-A11 S100A11 K.ISSPTETERC*IESLIAVFQK.Y 0.8 0.8 0.8 0.9 0.6 1.4 0.8 1.3 1.0 ns
436 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 R.FC*PFAER.T 0.9 0.8 0.9 1.1 1.1 0.9 1.0 1.0 1.0 ns
437 Q04917 YWHAH 14-3-3 protein eta YWHAH K.NC*NDFQYESK.V 0.7 1.0 0.9 1.2 0.9 1.0 1.0 0.9 1.0 ns
438 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
K.AGSDGAKIGNC*
PFSQR.L 0.9 0.9 0.9 1.0 0.9 1.0 1.0 1.0 1.0 ns
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439 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
R.EEFASTC*PDDEE
IELAYEQVAK.A 0.7 0.9 0.8 0.9 1.0 1.0 1.2 0.8 1.0 ns




YGWTANMER.I 1.0 0.8 0.9 1.0 0.8 1.0 1.1 0.9 1.0 ns
441 P50395 GDI2 Rab GDP dissociation inhibitor beta GDI2
R.TDDYLDQPC*YE





PCMT1 K.ALDVGSGSGILTAC*FAR.M 0.8 0.9 0.8 1.0 1.0 1.1 1.0 0.9 1.0 ns
443 P62258 YWHAE 14-3-3 protein epsilon YWHAE
K.LIC*CDILDVLDK
.H 0.9 0.8 0.9 1.0 0.9 1.1 1.0 1.0 1.0 ns
444 P41250 GARS Glycine--tRNA ligase GARS R.SC*YDLSCHAR.A 0.7 0.8 0.7 0.9 1.1 1.2 0.7 0.9 1.0 ns
445 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5
K.ALNVEPDGTGLT
C*SLAPNIISQL.- 1.0 1.0 1.0 1.1 0.9 0.9 0.9 0.9 1.0 ns
446 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4
K.AGSDGESIGNC*
PFSQR.L 1.0 0.8 0.9 1.0 0.9 1.0 0.9 0.9 1.0 ns
447 Q9UNH7 SNX6 Sorting nexin-6 SNX6
R.IGSSLYALGTQDS
TDIC*K.F 0.9 0.8 0.9 1.1 0.7 0.9 1.1 0.9 0.9 ns
448 P60174 TPI1 Triosephosphate isomerase TPI1
K.VPADTEVVC*AP
PTAYIDFAR.Q 0.6 0.8 0.7 0.8 0.8 1.0 1.3 0.8 0.9 ns
449 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4
R.YLLQYQEPIPC*E
QLVTALCDIK.Q 0.9 0.9 0.9 0.8 0.8 1.2 1.0 0.8 0.9 ns
450 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R 0.7 0.9 0.8 0.8 0.9 1.1 1.0 0.8 0.9 ns
451 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3
K.IAAYLQSDQFC*
K.M 0.8 0.8 0.8 1.0 1.0 0.8 1.0 0.7 0.9 ns
452 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1
K.FLDGNELTLADC
*NLLPK.L 0.6 0.8 0.7 0.8 0.9 1.1 1.0 0.8 0.9 ns
453 Q9UHX1
PUF60 Poly(U)-binding-
splicing factor PUF60 PUF60 R.ALAIMC*R.V 0.9 0.8 0.8 0.9 0.8 1.1 0.9 0.8 0.9 ns
454 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1
K.LNEC*VDHTPK.
L 0.8 0.8 0.8 1.0 0.8 1.0 0.8 0.9 0.9 ns
455 P22234 PAICS Multifunctional protein ADE2 PAICS
K.ITSC*IFQLLQEA
GIK.T 0.8 0.7 0.8 0.9 0.8 1.0 0.9 0.9 0.9 ns
456 P60174 TPI1 Triosephosphate isomerase TPI1 K.IAVAAQNC*YK.V 0.6 0.7 0.7 0.7 0.7 1.1 1.2 0.8 0.9 ns
457 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1
K.ALYDTFSAFGNI
LSC*K.V 0.9 1.2 1.0 0.9 0.8 1.1 0.8 0.9 0.9 ns
458 P00390 GSR Glutathione reductase, mitochondrial GSR
K.LGGTC*VNVGC





PPA2 K.ILSC*GEVIHVK.I 0.7 0.8 0.7 1.0 0.8 0.9 0.8 0.9 0.9 ns
460 Q12849 GRSF1 G-rich sequence factor 1 GRSF1
R.YIELFLNSC*PK.





SHMT1 R.AVLEALGSC*LNNK.Y 0.6 0.8 0.7 0.5 1.1 0.9 1.0 0.7 0.8 ns




0.9 0.9 0.9 0.9 0.8 0.8 0.8 0.9 0.8 ns
463 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2
K.GTLTLC*PYHSD
R.Q 0.8 0.8 0.8 0.7 0.9 0.8 0.9 0.8 0.8 ns
464 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ
K.IETELRDIC*NDV
LSLLEK.F 0.8 0.8 0.8 0.7 0.7 1.0 0.8 0.9 0.8 ns
465 O75874 IDH1 Isocitrate dehydrogenase IDH1 K.SEGGFIWAC*K.N 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 ns
466 P30041 PRDX6 Peroxiredoxin-6 PRDX6 R.DFTPVC*TTELGR.A 0.5 0.6 0.6 0.4 0.9 0.9 1.1 0.7 0.8 ns




TR.H 0.7 0.8 0.8 0.7 0.7 0.9 0.9 0.8 0.8 ns
468 P14174 MIF Macrophage migration inhibitory factor MIF K.LLC*GLLAER.L 0.8 0.9 0.9 0.8 0.7 0.9 0.7 0.8 0.8 ns
279
469 P27348 YWHAQ 14-3-3 protein theta YWHAQ
R.SIC*TTVLELLDK
.Y 0.9 0.9 0.9 0.8 0.7 0.9 0.8 0.7 0.8 ns
470 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3
K.LTFSC*LGGSDN
FK.H 0.8 0.7 0.8 0.7 0.8 0.9 0.7 0.8 0.8 ns
471 P52907 CAPZA1 F-actin-capping protein subunit alpha-1 CAPZA1
K.TIDGQQTIIAC*IE
SHQFQPK.N 0.8 0.9 0.8 0.8 0.6 1.0 0.7 0.8 0.8 ns
472 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA K.KITIADC*GQLE.- 0.7 0.8 0.8 0.7 0.6 0.9 0.8 0.7 0.7 ns
473 P19367 HK1 Hexokinase-1 HK1 R.AAQLC*GAGMAAVVDK.I 0.9 1.4 1.2 0.7 0.6 0.9 0.7 0.8 0.7 ns
474 P04632 CAPNS1 Calpain small subunit 1 CAPNS1
R.YSDESGNMDFD
NFISC*LVR.L 0.8 0.8 0.8 0.7 0.5 0.8 0.8 0.8 0.7 ns
475 P21964 COMT Catechol O-methyltransferase COMT
R.YLPDTLLLEEC*





RRM2 K.LIGMNC*TLMK.Q 0.8 0.9 0.8 0.7 0.4 0.8 0.8 0.8 0.7 ns
477 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1
R.GTGELTQLLNSL
C*TAVK.A 0.9 0.7 0.8 0.7 0.6 0.8 0.7 0.8 0.7 ns







AKT1 K.TFC*GTPEYLAPEVLEDNDYGR.A 1.0 1.0 1.0 19.2 20.0 20.0 18.7 20.0 19.6
***











PFKL K.C*HDYYTTEFLYNLYSSEGK.G 1.1 0.9 1.0 13.3 12.3 17.5 0.0 0.0 14.4
***
4 Q96BF6 NACC2 Nucleus accumbens-
associated protein 2 












GCDH K.GYGC*AGVSSVAYGLLAR.E 1.0 0.9 0.9 8.7 14.4 13.7 9.1 12.8 11.7
***
7 P07858 CTSB Cathepsin B CTSB
R.GQDHC*GIESEV
VAGIPR.T 1.0 1.0 1.0 9.7 10.0 13.9 12.5 11.5 11.5
***
8 E9PPU0 EPPK1 Epiplakin EPPK1
R.YLQGTGC*IAGL
LLPGSQER.L 0.9 0.9 0.9 8.3 9.6 9.3 10.6 13.4 10.2
***
9 Q15005 SPCS2 Signal peptidase 
complex subunit 2 






PFKL R.VFANAPDSAC*VIGLK.K 1.0 0.9 0.9 7.9 8.3 10.2 10.7 10.2 9.5
***
11 P27635
RPL10 60S ribosomal 
protein L10 RPL10 K.MLSC*AGADR.L 1.1 1.0 1.0 7.6 7.6 11.9 10.1 10.1 9.4 ***
Table 3A-3. R-values from transnitrosation experiment at 90 µM Trx-SNO. A list of
all identified peptides (* denotes labeled cysteine) is presented together with
calculated Heavy:Light Ratios (R-values) in untreated (0 µM) (n=2) versus Trx-SNO-
treated (90 µM) (n=5) MS analysis. Date were sorted by their average R-values of




# Description Symbol Sequence






SNO 90 µM Trx-SNO
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12 Q9Y5Y2
NUBP2 Cytosolic Fe-S 
cluster assembly factor 
NUBP2 
NUBP2 R.AVHQC*DR.G 1.0 1.0 1.0 9.1 9.3 10.4 8.4 0.0 9.3 ***







1.1 1.0 1.0 8.1 8.2 10.9 8.6 8.9 8.9 ***
14 P68104
EEF1A1 Elongation factor 1-
alpha 1 EEF1A1
K.PMC*VESFSDYP
PLGR.F 1.0 1.0 1.0 7.9 7.9 9.6 9.4 7.9 8.6
***
15 P13804
ETFA Electron transfer 
flavoprotein subunit alpha, 
mito












PPP1CC R.GNHEC*ASINR.I 0.9 1.0 1.0 7.0 7.9 8.8 8.0 8.7 8.1 ***
18 E9PPU0 EPPK1 Epiplakin EPPK1
R.YLC*GLGAVGGV




activator GCN1 GCN1L1 R.C*GLALALNK.L 0.9 0.9 0.9 7.0 8.4 8.0 7.2 8.1 7.7 ***
20 P49327 FASN Fatty acid synthase FASN
R.LGMLSPEGTC*K.
A 1.1 0.9 1.0 6.3 7.6 7.4 8.2 0.0 7.4
***
21 Q4ZG55 GREB1 Protein GREB1 GREB1 R.LINSSC*LVR.T 0.9 1.0 1.0 7.2 7.2 6.1 7.4 8.4 7.2 ***
22 P60709





1.0 0.9 1.0 6.7 5.9 8.4 7.5 6.9 7.1 ***
23 P35998
PSMC2 26S protease 
regulatory subunit 7 PSMC2
R.LC*PNSTGAEIR.
S 1.0 1.0 1.0 5.5 6.3 8.6 7.9 0.0 7.1
***
24 E9PPU0 EPPK1 Epiplakin EPPK1
R.LLDAQLATGGLV
C*PAR.R 1.0 0.9 1.0 6.3 6.0 8.3 7.2 6.6 6.9
***
25 P07339 CTSD Cathepsin D CTSD
K.AIGAVPLIQGEY








DVTSEK.D 1.0 0.9 1.0 5.6 5.9 7.8 6.1 7.6 6.6
***
27 Q16822 PCK2 Phosphoenolpyruvate 
carboxykinase 
PCK2 R.YVAAAFPSAC*GK.T 1.1 1.0 1.0 6.4 6.8 8.1 6.3 5.3 6.6
***
28 P68366





AEAWAR.L 1.0 1.0 1.0 6.9 6.6 7.2 6.2 6.0 6.6
***
29 O95757
HSPA4L Heat shock 70 kDa 
protein 4L HSPA4L
R.GC*ALQCAILSPA
FK.V 1.0 0.9 0.9 5.9 6.8 6.5 7.2 6.2 6.5
***
30 P36578
RPL4 60S ribosomal protein 
L4 RPL4
R.SGQGAFGNMC*
R.G 1.1 0.9 1.0 5.0 5.6 7.7 6.6 7.0 6.4
***
31 P62333
PSMC6 26S protease 
regulatory subunit 10B PSMC6
R.AVASQLDC*NFL



















H 1.0 1.0 1.0 5.5 5.9 7.6 6.5 6.2 6.3
***
35 P62280
RPS11 40S ribosomal 
protein S11 RPS11 K.C*PFTGNVSIR.G 1.1 0.8 0.9 5.8 5.7 7.3 6.3 6.2 6.3 ***
36 P62249
RPS16 40S ribosomal 
protein S16 RPS16 K.TATAVAHC*K.R 1.0 0.9 0.9 5.2 5.4 7.6 6.0 6.1 6.0 ***
37 P42677
RPS27 40S ribosomal 
protein S27 RPS27 K.ARLTEGC*SFR.R 1.0 1.0 1.0 5.2 5.9 6.3 6.6 0.0 6.0 ***
38 P62753
RPS6 40S ribosomal protein 
S6 RPS6
K.LNISFPATGC*QK
.L 1.0 0.9 1.0 4.8 5.2 6.7 5.6 5.6 5.6
***
39 P62829
RPL23 60S ribosomal 
protein L23 RPL23
R.ISLGLPVGAVINC





terized K.TAVC*DIPPR.G 1.1 1.0 1.0 4.9 4.9 6.5 5.5 5.4 5.5
***
281
41 Q8N163 KIAA1967 DBIRD complex 
subunit KIAA1967 
KIAA19
67 R.VVTQNIC*QYR.S 1.1 1.0 1.1 6.7 5.4 4.3 5.5 5.1 5.4
***
42 P23396
RPS3 40S ribosomal protein 







FK.V 1.0 1.0 1.0 4.7 4.9 6.4 5.7 5.3 5.4
***
44 P46782
RPS5 40S ribosomal protein 
S5 RPS5 K.AQC*PIVER.L 1.0 0.9 1.0 4.8 4.9 6.0 6.0 5.2 5.4 ***
45 O95747
OXSR1 Serine/threonine-
protein kinase OSR1 OXSR1
K.TFVGTPC*WMA






QDR.I 1.2 1.1 1.1 7.2 5.6 4.9 3.9 5.0 5.3
***
47 Q92598 HSPH1 Heat shock protein 
105 kDa 




RNA helicase DDX19A DDX19A
K.VLVTTNVC*AR.




containing protein 6 HEATR6
R.AC*ALQVLSAIL
EGSK.Q 1.0 1.0 1.0 4.4 4.8 6.2 5.2 5.5 5.2
***
50 P68366



















GIAVASK.T 1.0 1.1 1.0 3.3 6.6 3.6 5.5 6.7 5.1
***
53 P50914
RPL14 60S ribosomal 
protein L14 RPL14 K.C*MQLTDFILK.F 1.0 0.9 0.9 4.0 4.2 6.0 5.1 5.6 5.0 ***
54 O94979
SEC31A Protein transport 
protein Sec31A SEC31A K.SC*ATFSSSHR.Y 1.4 1.1 1.3 4.9 5.6 4.8 4.1 0.0 4.8 ***
55 P50914
RPL14 60S ribosomal 
protein L14 RPL14
R.ALVDGPC*TQVR
.R 1.0 1.0 1.0 4.1 4.7 5.6 4.7 5.0 4.8
***
56 P46782
RPS5 40S ribosomal protein 
S5 RPS5
K.TIAEC*LADELIN




containing protein 6 HEATR6
R.LC*ALRPDDSSS
AR.T 1.0 0.9 0.9 3.6 5.0 7.0 4.2 3.9 4.7
***
58 P50991
CCT4 T-complex protein 1 
subunit delta CCT4 K.ITGC*ASPGK.T 1.0 0.9 0.9 2.8 4.7 5.8 5.5 3.9 4.5 ***
59 P60866
RPS20 40S ribosomal 











EQLQEENLK.L 0.9 1.0 1.0 3.6 4.0 5.5 4.4 4.7 4.4
***
62 P07437





1.1 1.0 1.0 4.2 4.1 5.4 3.5 4.9 4.4 ***





.R 0.9 0.7 0.8 3.1 4.1 4.8 4.6 5.3 4.4
***
64 P15924 DSP Desmoplakin DSP R.DANSENC*NK.N 1.1 1.0 1.1 3.6 4.8 5.0 3.8 4.8 4.4 ***
65 P46782
RPS5 40S ribosomal protein 
S5 RPS5
R.VNQAIWLLC*TG




binding protein RhoC RHOC
K.KLVIVGDGAC*G






APLAK.V 1.0 1.0 1.0 3.5 3.7 4.9 5.1 4.3 4.3
***
68 P55060 CSE1L Exportin-2 CSE1L K.IC*AVGITK.L 1.0 1.0 1.0 3.5 4.1 5.7 4.0 4.3 4.3 ***
69 P82912 MRPS11 28S ribosomal 





0.9 0.8 0.9 3.7 3.9 4.9 4.3 4.2 4.2 ***
70 Q96CM8
ACSF2 Acyl-CoA synthetase 
family member 2, 
mitochondrial




TUBA4A Tubulin alpha-4A 
chain 
TUBA4
























L 1.0 0.9 1.0 3.3 3.4 4.6 4.1 3.9 3.9
***
75 O95833 CLIC3 Chloride intracellular 
channel protein 3 
CLIC3 K.ASEDGESVGHC*PSCQR.L 1.1 0.9 1.0 3.2 3.0 4.8 4.4 3.8 3.8
***
76 P62333
PSMC6 26S protease 
regulatory subunit 10B PSMC6
R.NVC*TEAGMFAI
R.A 1.0 0.9 0.9 2.7 4.1 3.9 4.3 3.9 3.8
***
77 P13639 EEF2 Elongation factor 2 EEF2
K.DLEEDHAC*IPIK




ligase SUCLG1 K.IIC*QGFTGK.Q 1.0 1.0 1.0 3.3 3.4 4.6 3.6 3.9 3.8 ***
79 Q15796
SMAD2 Mothers against 
decapentaplegic homolog 2 SMAD2 K.AITTQNC*NTK.C 0.9 1.0 0.9 3.3 4.5 3.2 4.0 0.0 3.7 ***
80 Q9UNH7 SNX6 Sorting nexin-6 SNX6
R.IGSSLYALGTQDS






VDAC2 R.PMC*IPPSYADLGK.A 1.4 1.1 1.3 2.8 4.0 4.1 4.1 3.5 3.7
***
82 Q9BV86 NTMT1 N-terminal Xaa-Pro-
Lys N-methyltransferase 1 
NTMT1 R.IIC*SAGLSLLAEER.Q 1.1 0.9 1.0 3.0 2.9 4.3 4.1 3.6 3.6
***
83 P31943 HNRNPH1 Heterogeneous 










K.E 1.0 0.9 1.0 3.5 3.3 3.9 3.5 3.1 3.4
***
85 P23396
RPS3 40S ribosomal protein 
S3 RPS3
R.GLC*AIAQAESL






MCMBP R.DASALLDPMEC*TDTAEEQR.V 1.1 0.8 1.0 2.2 4.7 4.0 3.4 2.6 3.4
***
87 Q13155
AIMP2 Aminoacyl tRNA 
synthase complex-interacting 
multif










1.0 1.0 1.0 3.3 3.1 3.9 3.2 3.2 3.3 ***
89 O14976
GAK Cyclin-G-associated 
kinase GAK R.AIIQEVC*FMK.K 1.0 0.9 1.0 2.7 3.0 3.8 3.4 3.7 3.3 ***
90 Q27J81 INF2 Inverted formin-2 INF2
R.AVLLASDAQEC*




ubiquitin receptor ADRM1 ADRM1 R.VPQC*PSGR.V 1.3 0.9 1.1 2.9 2.7 3.5 3.4 3.3 3.1 **
92 P05388
RPLP0 60S acidic ribosomal 
protein P0 RPLP0
K.C*FIVGADNVGS
K.Q 1.0 1.0 1.0 2.4 3.1 3.6 3.0 3.3 3.1 **
93 P15924 DSP Desmoplakin DSP
K.YC*YLQNEVFGL
FQK.L 1.0 1.1 1.1 2.9 2.8 3.6 3.1 2.9 3.1 **
94 Q13636
RAB31 Ras-related protein 
Rab-31 RAB31
K.VC*LLGDTGVG
K.S 1.0 0.7 0.9 1.9 2.7 4.5 2.5 3.7 3.1 **
95 O15075
DCLK1 Serine/threonine-
protein kinase DCLK1 DCLK1
R.YQDDFLLDESEC
*R.V 1.3 1.0 1.2 2.8 2.7 3.5 3.1 3.2 3.0 *
96 P55769
NHP2L1 NHP2-like protein 
1 NHP2L1
K.KLLDLVQQSC*N
YK.Q 1.1 0.9 1.0 2.4 2.9 3.8 3.2 2.9 3.0 **
97 P49207
RPL34 60S ribosomal 
protein L34 RPL34 R.AYGGSMC*AK.C 1.0 1.1 1.0 2.8 2.6 3.3 3.6 2.8 3.0 **
98 P62195
PSMC5 26S protease 
regulatory subunit 8 PSMC5
K.GVC*TEAGMYA






EPRS K.LGVENC*YFPMFVSQSALEK.E 1.1 0.9 1.0 2.6 2.6 3.5 3.1 3.2 3.0 **
100 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1
R.VC*LCQGSAGSG
AIGPVEAAIR.T 1.0 0.9 1.0 2.5 3.2 3.7 2.3 3.3 3.0 **
101 P21333 FLNA Filamin-A FLNA
R.VTYC*PTEPGNY





QDK.I 1.2 0.9 1.0 2.9 2.6 3.0 3.2 0.0 2.9 *
103 Q9HCC0
MCCC2 Methylcrotonoyl-
CoA carboxylase beta chain, 
mitoch
MCCC2 K.MVAAVAC*AQVPK.I 1.1 0.8 1.0 2.3 2.6 3.7 3.1 2.8 2.9 *
















YGETVATGPYR.A 1.2 0.9 1.0 3.2 2.5 2.6 2.9 3.0 2.8 ns
107 P53618
COPB1 Coatomer subunit 
beta COPB1
K.ALSGYC*GFMA





PDHA1 R.FAAAYC*R.S 1.0 0.8 0.9 2.1 2.4 2.9 3.2 3.5 2.8 *
109 P63244
GNB2L1 Guanine nucleotide-
binding protein subunit beta-
2-
GNB2L1 R.FSPNSSNPIIVSC*GWDK.L 1.0 0.9 0.9 2.6 2.5 3.1 2.9 2.9 2.8 *
110 Q9ULV4 CORO1C Coronin-1C 
CORO1
C K.C*DLISIPK.K 1.1 1.0 1.0 2.3 2.8 3.4 2.9 2.4 2.8 ns
111 Q7Z6Z7
HUWE1 E3 ubiquitin-
protein ligase HUWE1 HUWE1 R.HIIEDPC*TLR.H 1.0 1.0 1.0 1.9 2.7 3.4 2.4 3.4 2.8 ns
112 Q07020
RPL18 60S ribosomal 
protein L18 RPL18
K.GC*GTVLLSGPR.
K 1.0 1.1 1.0 2.1 2.3 3.6 2.8 2.9 2.7 ns
113 A6NE09











EGR.A 1.1 1.2 1.1 2.3 2.0 2.8 4.3 2.2 2.7 ns
115 Q14204
DYNC1H1 Cytoplasmic 




M 1.2 1.1 1.2 3.3 2.1 2.5 2.3 3.1 2.7 ns
116 Q8IXH7
TH1L Negative elongation 
factor C/D TH1L
R.AC*QALGAMLS
K.G 0.9 1.1 1.0 2.6 2.3 3.0 2.5 3.0 2.7 ns
117 P38117
ETFB Electron transfer 
flavoprotein subunit beta ETFB
K.HSMNPFC*EIAV
EEAVR.L 1.0 0.9 1.0 2.3 2.9 2.9 2.4 2.8 2.7 ns
118 O60502
MGEA5 Bifunctional protein 
NCOAT MGEA5
R.ANSSVVSVNC*K
.G 1.1 1.0 1.0 1.9 2.4 3.7 2.5 2.7 2.7 ns
119 Q9UBT2
UBA2 SUMO-activating 
enzyme subunit 2 UBA2
R.VLVVGAGGIGC*
ELLK.N 1.1 0.9 1.0 2.0 2.2 3.3 2.5 3.2 2.7 ns
120 P25205
MCM3 DNA replication 
licensing factor MCM3 MCM3 R.SVHYC*PATK.K 1.2 0.9 1.1 2.3 2.5 3.3 2.5 2.6 2.6 ns
121 P62244
RPS15A 40S ribosomal 
protein S15a RPS15A K.C*GVISPR.F 0.9 0.7 0.8 2.3 1.7 3.6 2.8 2.8 2.6 *
122 P38117
ETFB Electron transfer 
flavoprotein subunit beta ETFB
K.EVIAVSCGPAQC
*QETIR.T 1.0 0.9 1.0 2.3 2.2 3.1 2.9 2.5 2.6 ns
123 O60502
MGEA5 Bifunctional protein 





PPCDC K.ASC*PAAAPLMER.K 1.1 1.1 1.1 1.9 2.2 3.6 2.6 2.6 2.6 ns
125 Q08AM6
VAC14 Protein VAC14 
homolog VAC14
K.GLEC*SPSTPTM





ACAT1 K.IHMGSC*AENTAK.K 1.1 1.0 1.0 2.3 2.4 3.1 2.7 2.4 2.5 ns
127 Q9UPN9
TRIM33 E3 ubiquitin-
protein ligase TRIM33 TRIM33
R.C*DPVPAANGAI






DTFLEEINK.V 1.0 1.1 1.0 1.9 2.5 3.9 2.4 2.0 2.5 ns
129 Q5TFE4 NT5DC1 5-nucleotidase 
domain-containing protein 1 





ASMTL K.VDASAC*GMER.L 1.0 1.2 1.1 2.6 1.7 2.9 2.5 2.8 2.5 ns
131 Q15631 TSN Translin TSN K.ETAAAC*VEK.- 1.0 1.1 1.1 1.9 2.3 3.0 2.2 3.1 2.5 ns
132 P05388 RPLP0 60S acidic ribosomal 
protein P0 





G 1.0 0.8 0.9 2.1 2.2 2.7 2.5 2.8 2.5 ns
134 Q9NQT5
EXOSC3 Exosome complex 
component RRP40 
EXOSC3 K.LLAPDC*EIIQEVGK.L 1.1 0.8 1.0 2.0 2.3 3.2 2.3 2.5 2.4 ns
135 P08134
RHOC Rho-related GTP-
binding protein RhoC RHOC
R.ISAFGYLEC*SAK
.T 0.8 0.8 0.8 1.7 2.6 3.3 3.0 1.5 2.4 ns
136 P63220
RPS21 40S ribosomal 
protein S21 RPS21 K.TYAIC*GAIR.R 1.3 1.0 1.1 2.2 2.3 2.4 2.6 2.6 2.4 ns
137 P25205
MCM3 DNA replication 
licensing factor MCM3 MCM3 R.YVLC*TAPR.A 1.0 0.9 0.9 2.0 2.3 2.9 2.2 2.6 2.4 ns
138 P46379
BAG6 Large proline-rich 
protein BAG6 BAG6 R.C*NLACTPPR.H 0.8 1.0 0.9 2.1 1.6 2.5 3.1 2.6 2.4 ns
139 Q13185
CBX3 Chromobox protein 
homolog 3 CBX3
R.LTWHSC*PEDEA
Q.- 1.0 1.1 1.0 2.3 2.0 2.4 2.6 2.6 2.4 ns
140 P49327 FASN Fatty acid synthase FASN
R.LSIPTYGLQC*TR
.A 1.0 0.9 1.0 1.8 2.1 3.0 2.3 2.7 2.4 ns
141 Q7Z4W1 DCXR L-xylulose reductase DCXR
R.GVPGAIVNVSSQ
C*SQR.A 1.0 1.0 1.0 2.1 2.1 2.9 2.3 2.4 2.4 ns
142 Q7Z6Z7
HUWE1 E3 ubiquitin-
protein ligase HUWE1 HUWE1
R.AQC*ETLSPDGL
PEEQPQTTK.L 1.1 1.1 1.1 1.7 1.8 3.6 2.4 2.3 2.4 ns
143 O14929
HAT1 Histone 
acetyltransferase type B 
catalytic subunit





ENVAER.F 1.1 0.8 0.9 1.8 1.9 2.7 2.1 2.9 2.3 ns
145 P62857
RPS28 40S ribosomal 
protein S28 RPS28
R.TGSQGQC*TQVR
.V 1.1 1.0 1.1 1.9 2.3 2.9 2.0 2.3 2.3 ns
146 Q8NBF2
NHLRC2 NHL repeat-




QQGC*IAPVELR.Y 1.1 1.0 1.0 1.9 2.2 2.6 2.3 2.4 2.3 ns
147 P00338
LDHA L-lactate 
dehydrogenase A chain LDHA
R.VIGSGC*NLDSA
R.F 1.1 1.0 1.0 1.8 1.8 2.7 2.6 2.4 2.2 ns
148 Q13148
TARDBP TAR DNA-binding 





GK.G 0.9 0.9 0.9 2.0 2.2 2.5 2.3 2.2 2.2 ns
150 Q5MNZ6






K.K 1.0 1.0 1.0 1.9 2.2 2.4 2.4 2.2 2.2 ns
151 Q7Z2W4
ZC3HAV1 Zinc finger 













T 1.0 1.4 1.2 1.6 1.8 3.3 1.8 2.3 2.2 ns




SGQR.R 1.1 0.9 1.0 1.7 1.9 2.7 2.2 2.2 2.2 ns
154 Q7Z4W1 DCXR L-xylulose reductase DCXR
R.AVTNHSVYC*ST
K.G 1.0 0.9 0.9 1.9 2.1 2.4 1.9 2.4 2.1 ns
155 Q9NR33
POLE4 DNA polymerase 
epsilon subunit 4 POLE4
K.DAYC*CAQQGK.
R 0.8 0.9 0.8 3.6 1.8 1.6 1.4 2.2 2.1 ns
285
156 Q9BSU1
C16orf70 UPF0183 protein 
C16orf70 C16orf70
R.LLAAGC*GPGLL
ADAK.M 1.0 0.9 1.0 1.8 2.0 2.8 1.8 2.1 2.1 ns
157 Q15208
STK38 Serine/threonine-
protein kinase 38 STK38
K.LSDFGLC*TGLK.
K 1.1 0.8 1.0 2.0 2.1 2.5 1.9 1.9 2.1 ns
158 P55263 ADK Adenosine kinase ADK
R.SLIANLAAANC*
YK.K 1.0 0.9 0.9 1.8 1.7 3.0 2.1 1.7 2.1 ns
159 Q96SW2 CRBN Protein cereblon 
CRBN K.VQILPEC*VLPSTMSAVQLESLNK.C 0.9 1.2 1.0 2.0 1.8 2.6 1.9 2.1 2.1 ns
160 Q96P48
ARAP1 Arf-GAP with Rho-
GAP domain, ANK repeat 
and PH dom
ARAP1 R.AVFPEGPC*EEPLQLR.K 1.0 0.9 0.9 1.7 1.9 2.6 2.1 2.0 2.1 ns
161 Q8N2W9
PIAS4 E3 SUMO-protein 





OGT K.VMAEANHFIDLSQIPC*NGK.A 1.1 1.1 1.1 1.6 1.9 2.5 2.1 2.1 2.1 ns
163 P23528 CFL1 Cofilin-1 CFL1
K.HELQANC*YEEV
K.D 1.1 1.1 1.1 1.7 1.9 2.5 2.2 1.9 2.0 ns
164 P25205
MCM3 DNA replication 
licensing factor MCM3 MCM3
R.TLTSC*FLSCVVC
VEGIVTK.C 1.2 0.9 1.0 2.2 1.6 2.7 2.2 1.5 2.0 ns
165 B5ME19
EIF3CL Eukaryotic 
translation initiation factor 3 
subunit
EIF3CL R.GC*ILTLVER.M 1.0 1.0 1.0 2.0 2.1 2.8 2.3 1.0 2.0 ns
166 P30281
CCND3 G1/S-specific cyclin-
D3 CCND3 R.ASYFQC*VQR.E 1.1 1.0 1.0 1.8 1.9 2.4 2.2 1.9 2.0 ns
167 Q14318
FKBP8 Peptidyl-prolyl cis-
trans isomerase FKBP8 FKBP8
K.C*LNNLAASQLK










1.1 0.9 1.0 1.8 1.9 2.3 2.1 2.1 2.0 ns
169 P61247
RPS3A 40S ribosomal 
protein S3a RPS3A R.LFC*VGFTK.K 0.9 0.9 0.9 1.7 1.6 2.3 2.2 2.3 2.0 ns
170 P41250 GARS Glycine--tRNA ligase GARS
R.SC*YDLSCHAR.
A 1.1 0.9 1.0 1.8 2.3 2.9 1.5 1.6 2.0 ns
171 Q9Y6C9
MTCH2 Mitochondrial 
carrier homolog 2 MTCH2
K.YC*GLCDSIITIY
R.E 0.9 0.8 0.8 2.0 2.0 2.6 1.8 1.5 2.0 ns
172 Q86YH6
PDSS2 Decaprenyl-
diphosphate synthase subunit 
2 
PDSS2 R.C*LLSDELSNIAMQVR.K 1.2 1.1 1.2 2.1 1.9 2.1 2.0 1.8 2.0 ns
173 Q14204
DYNC1H1 Cytoplasmic 




L 1.0 0.9 0.9 1.4 2.3 2.3 1.1 2.8 2.0 ns
174 P45984
MAPK9 Mitogen-activated 
protein kinase 9 MAPK9
R.TAC*TNFMMTPY
VVTR.Y 1.1 1.0 1.0 1.9 1.8 2.3 1.9 2.0 2.0 ns
175 O00233 PSMD9 26S proteasome non-
ATPase regulatory subunit 9 





VDAC2 K.SC*SGVEFSTSGSSNTDTGK.V 1.0 1.0 1.0 1.9 2.1 1.8 1.9 2.0 1.9 ns











QGR.S 1.0 0.9 1.0 1.6 1.9 2.1 1.6 2.3 1.9 ns
179 Q99873
PRMT1 Protein arginine N-
methyltransferase 1 PRMT1
K.VIGIEC*SSISDYA
VK.I 1.0 0.9 1.0 1.7 1.7 2.3 1.8 1.9 1.9 ns
180 P26599
PTBP1 Polypyrimidine tract-
binding protein 1 PTBP1
K.LSLDGQNIYNAC
*CTLR.I 1.1 1.0 1.1 1.4 1.3 3.7 1.5 1.6 1.9 ns
181 Q9UHD8 SEPT9 Septin-9 40794
R.SQEATEAAPSC*





CAND1 R.LSTLC*PSAVLQR.L 1.0 0.9 1.0 1.7 1.6 3.0 0.9 2.4 1.9 ns
183 Q9NZZ3
CHMP5 Charged 
multivesicular body protein 5 




protein phosphatase 4 
regulatory 





MDH2 K.TIIPLISQC*TPK.V 0.9 0.9 0.9 1.8 1.7 2.2 1.6 2.0 1.9 ns
186 P60981 DSTN Destrin DSTN K.C*STPEEIKK.R 1.1 1.0 1.0 1.5 1.6 2.1 1.8 2.1 1.8 ns
187 P13639 EEF2 Elongation factor 2 EEF2 K.STLTDSLVC*K.A 1.2 1.0 1.1 1.5 1.5 2.5 1.7 1.9 1.8 ns
188 P57721
PCBP3 Poly(rC)-binding 





EAIPK.S 1.0 1.0 1.0 1.7 1.7 2.3 1.7 1.7 1.8 ns
190 P60981 DSTN Destrin DSTN
K.LGGSLIVAFEGC*





LASR.L 1.0 1.3 1.1 1.5 1.8 2.2 1.5 2.1 1.8 ns
192 P31943 HNRNPH1 Heterogeneous 
nuclear ribonucleoprotein H 
HNRNP





.- 1.1 1.0 1.0 1.5 1.6 1.7 2.3 1.7 1.8 ns
194 Q00610 CLTC Clathrin heavy chain 1 CLTC
R.IHEGC*EEPATHN
ALAK.I 1.0 1.2 1.1 1.6 1.7 1.8 1.9 1.8 1.8 ns
195 P49327















MDH2 K.SQETEC*TYFSTPLLLGK.K 0.9 1.1 1.0 1.6 1.5 2.2 1.6 1.9 1.8 ns
198 P61978 HNRNPK Heterogeneous 






1.1 1.0 1.1 1.6 1.6 2.0 1.8 1.8 1.8 ns
199 Q7L5D6
GET4 Golgi to ER traffic 
protein 4 homolog GET4 K.EQNYC*ESR.Y 1.1 1.0 1.0 1.5 1.7 2.0 1.7 1.8 1.8 ns
200 Q9H1B7
IRF2BPL Interferon 
regulatory factor 2-binding 
protein-lik





GK.G 1.0 1.0 1.0 1.5 1.7 2.1 1.8 1.7 1.7 ns
202 Q9Y296
TRAPPC4 Trafficking 
protein particle complex 
subunit 4 
TRAPPC
4 R.C*ELFDQNLK.L 1.2 0.9 1.1 1.6 1.8 2.0 1.8 1.4 1.7 ns
203 O94906
PRPF6 Pre-mRNA-
processing factor 6 PRPF6
R.AAQDLC*EEALR
.H 1.0 1.1 1.1 1.4 1.6 2.0 0.0 0.0 1.7 ns
204 Q68CP9 ARID2 AT-rich interactive 
domain-containing protein 2 








R.M 1.0 0.9 1.0 1.3 1.4 2.0 1.7 2.0 1.7 ns
206 Q9Y3D2
MSRB2 Methionine-R-











MGMT R.VVC*SSGAVGNYSGGLAVK.E 0.9 0.9 0.9 1.6 1.6 1.9 1.7 1.6 1.7 ns
208 O43684
BUB3 Mitotic checkpoint 
protein BUB3 BUB3
R.TPC*NAGTFSQP
EK.V 1.0 1.0 1.0 1.3 1.4 1.9 1.8 2.0 1.7 ns
209 P62826
RAN GTP-binding nuclear 
protein Ran RAN
R.VC*ENIPIVLCGN






EPRS K.LSSC*DSFTSTINELNHCLSLR.T 0.9 1.1 1.0 1.4 1.5 1.8 1.5 2.1 1.7 ns
211 P49721
PSMB2 Proteasome subunit 





VDAC3 K.VC*NYGLTFTQK.W 1.0 1.0 1.0 1.3 1.7 2.0 1.5 1.8 1.6 ns
213 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I 1.1 1.0 1.1 1.3 1.5 2.2 1.6 1.7 1.6 ns
214 P49327 FASN Fatty acid synthase FASN
K.ADEASELAC*PT
PK.E 1.0 1.1 1.1 1.3 1.8 2.0 1.8 1.4 1.6 ns
215 P36507






DSMANSFVGTR.S 0.9 0.9 0.9 1.5 1.5 2.0 1.5 1.8 1.6 ns
216 Q9Y3P9
RABGAP1 Rab GTPase-


















PPAT K.C*ELENCQPFVVETLHGK.I 1.1 0.9 1.0 1.4 1.5 1.9 1.7 1.6 1.6 ns






0.9 0.9 0.9 1.5 1.4 2.2 1.6 1.5 1.6 ns
220 Q15120 PDK3 PDK3
K.HIGSIDPTC*NVA
DVVK.D 0.9 0.9 0.9 1.5 1.5 1.9 1.5 1.6 1.6 ns
221 H3BQZ7 Uncharacterized protein 
Uncharac










*VK.Q 0.9 0.9 0.9 1.5 1.4 1.9 1.5 1.8 1.6 ns
224 P60604 UBE2G2 Ubiquitin-
conjugating enzyme E2 G2 




TIGAR K.AAREEC*PVFTPPGGETLDQVK.M 1.0 1.1 1.1 1.3 1.4 1.8 1.7 1.8 1.6 ns
226 P61978 HNRNPK Heterogeneous 




R.V 0.9 0.9 0.9 1.3 1.4 2.1 1.5 1.6 1.6 ns
227 P52272 HNRNPM Heterogeneous 
nuclear ribonucleoprotein M 
HNRNP
M R.GC*AVVEFK.M 1.1 1.0 1.0 1.4 1.3 2.2 1.5 1.6 1.6 ns
228 P49591
SARS Serine--tRNA ligase, 
cytoplasmic SARS K.YAGLSTC*FR.Q 1.6 1.0 1.3 1.3 1.9 1.9 1.4 1.5 1.6 ns
229 P62306
SNRPF Small nuclear 
ribonucleoprotein F SNRPF R.C*NNVLYIR.G 1.0 1.0 1.0 1.4 1.5 1.9 1.5 1.6 1.6 ns
230 P21291
CSRP1 Cysteine and glycine-
rich protein 1 CSRP1 K.SCFLCMVC*K.K 0.8 1.0 0.9 1.3 1.5 2.1 1.4 1.6 1.6 ns
231 P51858
HDGF Hepatoma-derived 
growth factor HDGF K.C*GDLVFAK.M 1.0 1.0 1.0 1.4 1.3 2.2 1.4 1.6 1.6 ns
232 P30519 HMOX2 Heme oxygenase 2 HMOX2
K.CPFYAAEQDKG
ALEGSSC*PFR.T 1.3 1.0 1.1 1.1 1.9 2.0 1.2 1.7 1.6 ns
233 Q96Q11
TRNT1 CCA tRNA 
nucleotidyltransferase 1, 
mitochondrial 
TRNT1 K.YQGEHC*LLK.E 1.0 1.0 1.0 1.3 1.4 1.9 1.4 1.9 1.6 ns
234 P49458
SRP9 Signal recognition 
particle 9 kDa protein SRP9
K.VTDDLVC*LVYK
.T 0.8 1.0 0.9 1.5 1.3 1.9 1.4 1.7 1.6 ns
235 Q6P1X6
C8orf82 UPF0598 protein 
C8orf82 C8orf82
R.YEAAFPFLSPC*





K 1.4 0.9 1.1 1.5 1.4 1.8 1.6 1.6 1.6 ns
288
237 Q15019 SEPT2 Septin-2 40787
R.LTVVDTPGYGD
AINC*R.D 1.0 1.0 1.0 1.3 1.4 2.1 1.6 1.4 1.6 ns
238 Q04760
GLO1 Lactoylglutathione 
lyase GLO1 K.C*DFPIMK.F 0.9 1.2 1.0 1.4 1.3 1.9 1.5 1.6 1.6 ns
239 O14980
XPO1 Exportin-1 









0.9 1.1 1.0 1.6 1.4 1.8 1.5 1.5 1.5 ns
241 Q6QNY0




3 R.GDLC*ALAER.L 0.7 0.9 0.8 1.6 1.1 1.8 1.4 1.8 1.5 ns
242 P51610 HCFC1 Host cell factor 1 HCFC1
K.LVIYGGMSGC*R












K.G 1.0 0.8 0.9 1.4 1.1 1.9 1.6 1.7 1.5 ns






0.8 0.9 0.8 1.4 1.4 1.4 1.9 1.7 1.5 ns
246 P49915 GMPS GMP synthase GMPS K.AC*TTEEDQEK.L 1.0 1.1 1.0 1.2 1.3 2.1 1.6 1.5 1.5 ns
247 P11413
G6PD Glucose-6-phosphate 
1-dehydrogenase G6PD R.TQVC*GILR.E 1.0 0.9 0.9 1.3 1.2 1.8 1.7 1.6 1.5 ns
248 P08238
HSP90AB1 Heat shock 




EYLNFIR.G 1.1 0.9 1.0 1.4 1.5 1.7 1.5 1.5 1.5 ns
249 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R 0.9 0.9 0.9 1.4 1.2 1.8 1.3 1.9 1.5 ns
250 P47756
CAPZB F-actin-capping 
protein subunit beta CAPZB
R.QMEKDETVSDC
*SPHIANIGR.L 1.1 1.1 1.1 1.3 1.2 2.0 1.5 1.6 1.5 ns
251 Q9C0C9
UBE2O Ubiquitin-
conjugating enzyme E2 O UBE2O R.C*YNEMALIR.V 1.1 1.1 1.1 1.5 1.2 1.8 1.6 1.5 1.5 ns
252 A0AVT1
UBA6 Ubiquitin-like 
modifier-activating enzyme 6 








QVC*CNGTR.V 1.0 0.8 0.9 1.6 1.4 1.8 1.2 1.5 1.5 ns
254 Q9ULA0
DNPEP Aspartyl 
aminopeptidase DNPEP K.C*PTSGR.L 1.0 0.9 1.0 1.3 1.4 1.8 1.4 1.5 1.5 ns
255 Q15185
PTGES3 Prostaglandin E 
synthase 3 PTGES3
K.HLNEIDLFHC*ID
PNDSK.H 1.1 1.0 1.0 1.3 1.4 1.8 1.6 1.5 1.5 ns
256 Q9UPM8
AP4E1 AP-4 complex 
subunit epsilon-1 AP4E1
R.SSC*STLPDYLLY
QCQK.V 0.9 0.6 0.8 1.4 1.5 1.8 1.3 1.5 1.5 ns
257 P35270 SPR Sepiapterin reductase SPR
R.TVVNISSLC*AL






N1 K.NSSQETC*TR.A 1.0 0.9 1.0 1.3 1.3 1.7 1.5 1.6 1.5 ns
259 O75874
IDH1 Isocitrate 
dehydrogenase IDH1 K.SEGGFIWAC*K.N 1.1 1.0 1.1 1.4 1.5 1.6 1.4 1.5 1.5 ns
260 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F 1.1 1.2 1.1 1.4 1.4 1.7 1.5 1.4 1.5 ns
261 P30153
PPP2R1A Serine/threonine-





VIGIR.Q 1.0 0.9 1.0 1.6 1.4 1.5 1.4 1.6 1.5 ns
262 P26641 EEF1G Elongation factor 1-
gamma 
EEF1G K.AAAPAPEEEMDEC*EQALAAEPK.A 1.2 1.1 1.1 1.4 1.3 1.8 1.5 1.5 1.5 ns
263 P49327 FASN Fatty acid synthase FASN
K.AINC*ATSGVVG
LVNCLR.R 1.0 0.9 0.9 1.3 1.4 1.8 1.5 1.5 1.5 ns
264 P60763
RAC3 Ras-related C3 
botulinum toxin substrate 3 RAC3 R.AVLC*PPPVK.K 1.1 1.0 1.0 1.3 1.3 1.9 1.5 1.4 1.5 ns
265 P13639 EEF2 Elongation factor 2 EEF2
K.IWC*FGPDGTGP






.V 1.1 0.9 1.0 1.3 1.2 2.0 1.5 1.4 1.5 ns
267 P14866
HNRNPL Heterogeneous 
nuclear ribonucleoprotein L 
HNRNP
L K.LC*FSTAQHAS.- 0.8 1.0 0.9 1.3 1.7 1.3 1.5 1.6 1.5 ns
268 Q9NQC3 RTN4 Reticulon-4 RTN4
K.YSNSALGHVNC*
TIK.E 1.1 1.1 1.1 1.3 1.5 1.9 1.3 1.4 1.5 ns
269 P04632
CAPNS1 Calpain small 
subunit 1 CAPNS1
R.YSDESGNMDFD





APPLQPK.G 1.1 1.0 1.1 1.2 1.4 1.7 1.5 1.5 1.5 ns
271 Q96RS6
NUDCD1 NudC domain-




L 1.2 0.9 1.0 1.2 1.4 1.9 1.4 1.5 1.5 ns
272 Q14980
NUMA1 Nuclear mitotic 
apparatus protein 1 NUMA1 R.LDFVC*SFLQK.N 1.0 0.8 0.9 1.2 1.2 1.7 1.6 1.7 1.5 ns
273 Q9H3U1
UNC45A Protein unc-45 
homolog A UNC45A
R.AIQTVSC*LLQG
PCDAGNR.A 0.9 1.1 1.0 1.4 1.3 1.7 1.3 1.6 1.5 ns
274 P13489 RNH1 Ribonuclease 
inhibitor 








SK.R 1.1 0.9 1.0 1.3 1.3 1.6 1.5 1.6 1.5 ns
276 P53602 MVD Diphosphomevalonate 
decarboxylase 
MVD R.DGDPLPSSLSC*K.V 1.2 1.1 1.2 1.7 1.2 1.6 1.4 1.4 1.5 ns
277 O14964
HGS Hepatocyte growth 
factor-regulated tyrosine 
kinase
HGS R.AC*GQIFCGK.C 1.1 1.0 1.1 1.6 1.2 1.8 1.5 1.2 1.5 ns
278 P78347
GTF2I General transcription 
factor II-I GTF2I
R.SILSPGGSC*GPI
K.V 1.0 1.0 1.0 1.3 1.6 1.7 1.4 1.4 1.5 ns
279 Q9NYL2
MLTK Mitogen-activated 
protein kinase kinase kinase 
MLT





PPA2 R.GQPC*SQNYR.L 1.1 1.1 1.1 1.2 1.2 1.7 1.5 1.6 1.4 ns
281 P52895
AKR1C2 Aldo-keto 
reductase family 1 member 
C2 
AKR1C2 R.EEPWVDPNSPVLLEDPVLC*ALAK.K 0.9 1.1 1.0 1.3 1.4 1.6 1.5 1.5 1.4 ns
282 Q15459
SF3A1 Splicing factor 3A 





SPTSSB K.IC*GYHSTISN.- 1.1 1.0 1.0 1.4 1.4 1.7 1.3 1.4 1.4 ns
284 P60981 DSTN Destrin DSTN
K.HEC*QANGPEDL
NR.A 0.9 0.9 0.9 1.3 1.2 1.5 1.4 1.8 1.4 ns
285 P04183
TK1 Thymidine kinase, 
cytosolic TK1
R.NTMEALPAC*LL





C*VK.Q 1.0 0.8 0.9 1.3 1.2 1.9 1.2 1.6 1.4 ns
287 O15355
PPM1G Protein phosphatase 
1G PPM1G
K.C*SGDGVGAPR.
L 0.9 0.9 0.9 1.2 1.3 1.8 1.5 1.5 1.4 ns
288 P21333 FLNA Filamin-A FLNA
K.AHVVPC*FDASK
.V 1.1 1.1 1.1 1.2 1.3 1.8 1.3 1.5 1.4 ns
289 Q7L2H7
EIF3M Eukaryotic 
translation initiation factor 3 
subunit
EIF3M K.VAASC*GAIQYIPTELDQVR.K 1.1 1.0 1.0 1.1 1.5 1.6 1.4 1.5 1.4 ns
290 O95861 BPNT1 3(2),5-bisphosphate 
nucleotidase 1 
BPNT1 K.TC*ATDLQTK.A 1.0 0.9 0.9 1.2 1.4 1.8 1.3 1.3 1.4 ns
291 Q96EY8 MMAB Cob(I)yrinic acid a,c-
diamide adenosyltransferase,
MMAB K.IQCTLQDVGSALATPC*SSAR.E 1.1 1.0 1.0 1.1 1.4 1.7 1.5 1.4 1.4 ns
292 P11940
PABPC1 Polyadenylate-
binding protein 1 PABPC1
K.GFGFVC*FSSPEE
ATK.A 1.1 1.0 1.0 1.2 1.3 1.7 1.2 1.6 1.4 ns
293 Q92879
CELF1 CUGBP Elav-like 
family member 1 CELF1 R.GC*AFVTFTTR.A 1.0 1.0 1.0 1.3 1.4 1.6 1.5 1.3 1.4 ns
290
294 P13639 EEF2 Elongation factor 2 EEF2
R.TFC*QLILDPIFK.
V 0.9 0.8 0.9 1.1 1.3 1.9 1.2 1.5 1.4 ns
295 O43765 SGTA Small glutamine-rich 
tetratricopeptide repeat-cont
SGTA R.AIC*IDPAYSK.A 0.9 1.1 1.0 1.4 1.3 1.4 1.5 1.3 1.4 ns






1.2 1.1 1.2 1.1 1.3 1.6 1.5 1.5 1.4 ns
297 Q9Y508
RNF114 RING finger protein 
114 RNF114
R.DC*GGAAQLAGP
AAEADPLGR.F 1.0 1.0 1.0 1.2 1.4 1.7 1.4 1.3 1.4 ns
298 P27348
YWHAQ 14-3-3 protein 
theta YWHAQ
R.YLAEVAC*GDDR





PCMT1 K.ALDVGSGSGILTAC*FAR.M 0.9 1.0 0.9 1.7 1.2 1.6 1.1 1.4 1.4 ns
300 Q7L1Q6
BZW1 Basic leucine zipper 






1.3 1.0 1.2 1.3 1.3 1.6 1.3 1.4 1.4 ns
301 P20073 ANXA7 Annexin A7 ANXA7
R.LGTDESC*FNMI
LATR.S 1.0 1.0 1.0 1.2 1.4 1.5 1.4 1.4 1.4 ns
302 P00390
GSR Glutathione reductase, 
mitochondrial GSR
K.LGGTC*VNVGC
VPK.K 1.0 1.0 1.0 1.2 1.3 1.5 1.4 1.4 1.4 ns
303 O43390
HNRNPR Heterogeneous 
nuclear ribonucleoprotein R 
HNRNP
R K.SAFLC*GVMK.T 1.0 0.8 0.9 1.2 1.2 1.4 1.4 1.6 1.4 ns






0.9 0.9 0.9 1.1 1.2 1.5 1.5 1.5 1.4 ns
305 Q92598
HSPH1 Heat shock protein 
105 kDa HSPH1
K.FIC*EQDHQNFL
R.L 1.1 0.9 1.0 1.2 1.2 1.5 1.5 1.4 1.4 ns
306 Q9Y3D0
FAM96B Mitotic spindle-
associated MMXD complex 
subunit MI
FAM96B R.VAAALENTHLLEVVNQC*LSAR.S 0.9 0.9 0.9 1.3 1.5 1.3 1.3 1.5 1.4 ns
307 P55212 CASP6 Caspase-6 CASP6
R.GTC*ADRDNLTR
.R 1.4 0.9 1.1 1.1 1.2 1.5 1.6 1.5 1.4 ns
308 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T 1.1 1.0 1.0 1.2 1.3 1.7 1.3 1.4 1.4 ns
309 P55735
SEC13 Protein SEC13 
homolog SEC13
R.FASGGC*DNLIK.
L 0.9 1.0 1.0 1.2 1.1 1.6 1.7 1.3 1.4 ns
310 P04075 ALDOA Fructose-





0.8 1.0 0.9 1.1 1.1 1.8 1.0 1.7 1.4 ns
311 P31947 SFN 14-3-3 protein sigma SFN
K.GAVEKGEELSC*
EER.N 1.1 1.0 1.0 1.1 1.2 1.5 1.4 1.4 1.3 ns
312 P62258
YWHAE 14-3-3 protein 
epsilon YWHAE
K.LIC*CDILDVLDK





L 1.0 1.2 1.1 1.3 1.1 1.7 1.3 1.3 1.3 ns
314 P31948
STIP1 Stress-induced-
phosphoprotein 1 STIP1 K.ALDLDSSC*K.E 0.9 1.1 1.0 1.0 1.3 1.8 1.6 1.0 1.3 ns
315 Q9NXG2
THUMPD1 THUMP domain-
containing protein 1 
THUMP
D1 R.C*DAGGPR.Q 1.0 1.1 1.1 1.1 1.3 1.6 1.4 1.3 1.3 ns




YDVLHDIEYR.K 1.1 1.1 1.1 1.1 1.2 1.7 1.2 1.4 1.3 ns
317 Q9Y3A3
MOB4 MOB-like protein 
phocein MOB4
R.HTLDGAAC*LLN
SNK.Y 1.0 0.9 0.9 1.2 1.3 1.5 1.4 1.3 1.3 ns
318 P22314 UBA1 Ubiquitin-like 
modifier-activating enzyme 1 




binding protein 1 
PEBP1 R.APVAGTC*YQAEWDDYVPK.L 0.8 0.7 0.7 1.1 1.1 1.5 1.1 1.7 1.3 ns
320 P35270 SPR Sepiapterin reductase SPR R.AVC*LLTGASR.G 1.0 0.8 0.9 1.2 1.2 1.5 1.3 1.4 1.3 ns
321 P55263 ADK Adenosine kinase ADK
R.TGC*TFPEKPDF
H.- 1.1 0.9 1.0 1.2 1.3 1.5 1.3 1.3 1.3 ns
291
322 Q86SX6 GLRX5 Glutaredoxin-related 
protein 5, mitochondrial 
GLRX5 K.GTPEQPQC*GFSNAVVQILR.L 1.1 1.0 1.0 1.2 1.3 1.5 1.3 1.3 1.3 ns
323 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2
R.VGLGIC*YDMR.
F 1.0 0.9 1.0 1.2 1.2 1.5 1.3 1.3 1.3 ns
324 P49588
AARS Alanine--tRNA ligase, 
cytoplasmic AARS K.C*LSVMEAK.V 1.1 1.9 1.5 1.2 1.3 1.7 1.1 1.3 1.3 ns
325 Q9Y490 TLN1 Talin-1 TLN1
K.VVAPTISSPVC*Q
EQLVEAGR.L 0.7 1.1 0.9 1.2 1.3 1.2 1.4 1.3 1.3 ns
326 Q9UL25
RAB21 Ras-related protein 
Rab-21 RAB21
K.VVLLGEGC*VG
K.T 1.0 1.1 1.0 1.1 1.3 1.5 1.2 1.4 1.3 ns
327 O14966
RAB7L1 Ras-related protein 
Rab-7L1 RAB7L1 K.C*DLSPWAVSR.D 1.1 1.1 1.1 1.1 1.5 1.3 1.2 0.0 1.3 ns
328 Q96EY5
FAM125A Multivesicular 




DLTIK.S 1.1 1.1 1.1 1.1 1.1 1.6 1.2 1.4 1.3 ns
329 P14618
PKM Pyruvate kinase 
isozymes M1/M2 PKM K.C*CSGAIIVLTK.S 1.1 1.0 1.0 1.1 1.1 1.6 1.2 1.3 1.3 ns
330 P14174
MIF Macrophage migration 





TCCAK.W 1.1 0.9 1.0 1.3 1.2 1.4 1.3 1.1 1.3 ns
332 Q12765 SCRN1 Secernin-1 SCRN1
K.TQSPC*FGDDDP















PIN1 K.IKSGEEDFESLASQFSDC*SSAK.A 1.1 1.0 1.1 1.2 1.2 1.4 1.3 1.3 1.3 ns
336 O95336
PGLS 6-
phosphogluconolactonase PGLS R.AAC*CLAGAR.A 1.0 0.9 1.0 1.2 1.2 1.4 1.2 1.2 1.2 ns
337 Q9BW61
DDA1 DET1- and DDB1-





K.E 0.9 1.0 0.9 1.2 1.2 1.4 1.2 1.3 1.2 ns
339 P61970
NUTF2 Nuclear transport 
factor 2 NUTF2
K.NINDAWVC*TN





HPRT1 K.SYC*NDQSTGDIK.V 1.0 1.1 1.1 1.2 1.2 1.4 1.1 1.3 1.2 ns
341 P49753 ACOT2 Acyl-coenzyme A 
thioesterase 2, mitochondrial 













*AIVR.G 1.0 0.9 0.9 1.0 1.3 1.4 1.1 1.3 1.2 ns
344 Q9Y696 CLIC4 Chloride intracellular 
channel protein 4 
CLIC4 K.AGSDGESIGNC*PFSQR.L 1.0 1.1 1.1 1.5 1.1 1.3 1.2 1.1 1.2 ns
345 Q04917 YWHAH 14-3-3 protein eta YWHAH
K.ELETVC*NDVLS
LLDK.F 1.2 0.6 0.9 1.1 0.9 2.0 1.1 1.1 1.2 ns
346 P11142
HSPA8 Heat shock cognate 





QCAEK.I 1.2 0.9 1.1 1.2 1.2 1.4 1.1 1.2 1.2 ns
348 P63104
YWHAZ 14-3-3 protein 
zeta/delta YWHAZ
K.IETELRDIC*NDV
LSLLEK.F 0.9 1.1 1.0 1.1 1.3 1.4 0.9 1.4 1.2 ns
349 P62937
PPIA Peptidyl-prolyl cis-
trans isomerase A PPIA K.KITIADC*GQLE.- 0.8 1.0 0.9 1.1 1.0 1.5 1.0 1.5 1.2 ns
350 P04075
ALDOA Fructose-
bisphosphate aldolase A ALDOA
R.ALANSLAC*QGK
.Y 0.9 1.0 1.0 1.0 1.0 1.4 1.2 1.4 1.2 ns






K.L 1.0 1.0 1.0 1.4 1.1 1.2 1.2 1.2 1.2 ns
353 P25398
RPS12 40S ribosomal 
protein S12 RPS12
R.QAHLC*VLASNC
DEPMYVK.L 1.0 1.2 1.1 1.0 1.2 1.4 1.2 1.2 1.2 ns
354 H3BU86 STX16-NPEPL1 Protein 
STX16-NPEPL1 
STX16-
NPEPL1 R.AC*SEQEGR.L 1.1 1.0 1.1 1.0 1.4 1.5 1.2 0.9 1.2 ns
355 P60174
TPI1 Triosephosphate 





C*TAVK.A 0.9 1.0 1.0 1.2 1.1 1.5 0.9 1.2 1.2 ns
357 P37802 TAGLN2 Transgelin-2 TAGLN2
K.DGTVLC*ELINA
LYPEGQAPVK.K 0.9 1.0 1.0 1.1 1.2 1.3 1.0 1.2 1.2 ns
358 Q01518
CAP1 Adenylyl cyclase-
associated protein 1 CAP1
R.ALLVTASQC*QQ
PAENK.L 0.8 1.1 0.9 1.1 1.1 1.4 1.1 1.1 1.2 ns
359 Q9Y224





NC*K.D 1.0 0.9 1.0 1.0 1.1 1.4 1.2 1.2 1.2 ns
360 P78417
GSTO1 Glutathione S-
transferase omega-1 GSTO1 R.FC*PFAER.T 1.0 0.9 1.0 1.1 1.1 1.3 1.2 1.1 1.2 ns
361 P08238
HSP90AB1 Heat shock 




YGWTANMER.I 1.0 1.0 1.0 1.0 1.1 1.5 1.1 1.1 1.2 ns
362 O00299 CLIC1 Chloride intracellular 
channel protein 1 
CLIC1 K.AGSDGAKIGNC*PFSQR.L 1.1 0.9 1.0 1.1 1.1 1.3 1.1 1.2 1.2 ns
363 Q02790
FKBP4 Peptidyl-prolyl cis-
trans isomerase FKBP4 FKBP4 K.TQLAVC*QQR.I 0.9 1.0 1.0 1.0 0.9 1.4 1.1 1.2 1.1 ns
364 P14618
PKM Pyruvate kinase 
isozymes M1/M2 PKM
R.NTGIIC*TIGPASR
.S 0.8 0.9 0.9 0.9 1.0 1.3 1.0 1.3 1.1 ns











PTAYIDFAR.Q 0.8 1.0 0.9 1.0 1.1 1.4 1.0 1.1 1.1 ns
367 Q04917 YWHAH 14-3-3 protein eta YWHAH
K.NC*NDFQYESK.
V 1.2 0.9 1.1 1.0 1.0 1.2 1.2 1.2 1.1 ns
368 Q9UL46
PSME2 Proteasome activator 
complex subunit 2 PSME2 K.C*GFLPGNEK.V 1.0 0.9 1.0 0.9 1.1 1.3 1.1 1.1 1.1 ns
369 P23528 CFL1 Cofilin-1 CFL1
K.AVLFC*LSEDKK.





C*FK.G 1.2 1.0 1.1 0.9 0.9 1.5 1.0 1.0 1.1 ns
371 P31949 S100A11 Protein S100-A11 S100A11
K.ISSPTETERC*IES
LIAVFQK.Y 0.7 0.9 0.8 0.9 1.1 1.4 0.9 0.9 1.0 ns
372 Q08211
DHX9 ATP-dependent RNA 
helicase A DHX9
K.LAAQSC*ALSLV
R.Q 0.8 1.1 0.9 1.0 1.2 1.0 1.1 0.9 1.0 ns
373 Q8TAQ2
SMARCC2 SWI/SNF 









C*SLAPNIISQL.- 1.1 1.1 1.1 0.8 0.9 1.2 0.9 1.0 1.0 ns
375 P33240
CSTF2 Cleavage stimulation 
factor subunit 2 CSTF2
K.LC*VQNSPQEAR





T 1.0 1.0 1.0 0.8 0.8 1.1 0.8 1.0 0.9 ns
377 Q15185
PTGES3 Prostaglandin E 
synthase 3 PTGES3
K.LTFSC*LGGSDN
FK.H 0.8 1.0 0.9 0.9 0.8 1.1 0.8 0.9 0.9 ns
378 P10599 TXN Thioredoxin TXN
K.LVVVDFSATWC*





C*R.L 0.9 1.0 1.0 0.4 0.4 0.6 0.4 0.5 0.5 ns
! 293!
Table 3A-4. R-values of cysteines (* denotes labeled cysteine) identified from 
transnitrosation experiments at 500 µM GSNO, 500 µM CoA-SNO, and 90 µM Trx-
SNO. 756 cysteine residues identified in all transnitrosation donor-treated samples are 
presented together with calculated Heavy:Light ratios (R-values). Five replicates of each 
donor-treated experiments were performed. Each cysteine’s sensitivity to GSNO, CoA-
SNO and Trx-SNO were ranked by their average R-values respectively and listed in the 









138 24 1 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH K.IISNASC*TTNCLAPLAK.V
468 358 2 O94906 PRPF6 Pre-mRNA-processing factor 6 PRPF6 R.AAQDLC*EEALR.H
57 25 3 P07339 CTSD Cathepsin D CTSD K.AIGAVPLIQGEYMIPC*EK.V
6 3 4 Q01813 PFKP 6-phosphofructokinase type C PFKP R.LPLMEC*VQMTQDVQK.A
7 4 5 Q92947 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GCDH K.GYGC*AGVSSVAYGLLAR.E
125 48 6 P07437 TUBB Tubulin beta chain TUBB K.LTTPTYGDLNHLVSATMSGVTTC*LR.F
349 32 7 P29590 PML Protein PML PML R.LQDLSSC*ITQGK.D
44 15 8 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.VMTIPYQPMPASSPVIC*AGGQDR.C
60 17 9 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 
HSD17B
10 K.KLGNNC*VFAPADVTSEK.D
12 34 10 P28290 SSFA2 Sperm-specific antigen 2 SSFA2 R.VC*SVNPPSAIEMQLR.R
2 22 11 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase 
ALDH6A
1 R.C*MALSTAVLVGEAK.K
361 56 12 Q04726 TLE3 Transducin-like enhancer protein 3 TLE3 K.SPISQLDC*LNR.D
254 107 13 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.QC*PIMDPAWEAPEGVPIDAIIFGGR.R
30 33 14 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.AYHEQLSVAEITNAC*FEPANQMVK.C
20 85 15 P62241 RPS8 40S ribosomal protein S8 RPS8 K.NC*IVLIDSTPYR.Q
250 275 16 Q02543 RPL18A 60S ribosomal protein L18a RPL18A R.DLTTAGAVTQC*YR.D
93 98 17 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 K.TSAPITC*ELLNK.Q
1 1 18 P31749 AKT1 RAC-alpha serine/threonine-protein kinase AKT1 K.TFC*GTPEYLAPEVLEDNDYGR.A
203 43 19 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1 R.VC*LCQGSAGSGAIGPVEAAIR.T
41 45 20 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD K.AC*DEGHCTAK.D
33 29 21 P36578 RPL4 60S ribosomal protein L4 RPL4 R.YAIC*SALAASALPALVMSK.G
62 71 22 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A R.AVC*MLSNTTAIAEAWAR.L
666 11 23 P04183 TK1 Thymidine kinase, cytosolic TK1 R.NTMEALPAC*LLR.D
34 113 24 Q9H9P8 L2HGDH L-2-hydroxyglutarate dehydrogenase, mitochondrial L2HGDH K.AC*FLGATVK.Y
264 106 25 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.GC*DVVVIPAGVPR.K
74 94 26 P50213 IDH3A Isocitrate dehydrogenase IDH3A R.IEAAC*FATIK.D
88 10 27 Q8TCU6
PREX1 Phosphatidylinositol 3,4,5-
trisphosphate-dependent PREX1 R.LC*VLNEILGTER.D
526 180 28 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 R.VGAFTMVC*K.D
55 28 29 P04183 TK1 Thymidine kinase, cytosolic TK1 R.YSSSFC*THDR.N
26 66 30 O14733 MAP2K7 Dual specificity mitogen-activated protein kinase MAP2K7 R.SAGC*AAYMAPER.I
265 263 31 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 K.YTVQDESHSEWVSC*VR.F




# Description Symbol Sequence
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1 2 3 4 5 average 1 2 3 4 5
avera
ge 1 2 3 4 5
avera
ge
5.4 4.4 4.2 5.2 5.1 4.9 6.3 5.3 6.7 7.3 6.4 6.4 3.7 3.7 4.8 4.6 4.3 4.2
4.0 5.3 3.0 4.7 4.4 4.3 5.5 1.5 1.1 0.4 1.5 2.0 1.4 0.0 0.0 1.4 2.0 1.6
3.7 3.2 4.2 4.7 3.7 3.9 8.1 6.2 5.7 7.0 4.5 6.3 5.3 7.2 7.8 6.3 7.7 6.9
4.0 3.5 3.4 4.0 3.7 3.7 11.4 10.6 9.4 10.7 9.2 10.3 13.6 12.3 12.6 13.2 12.9 12.9
4.0 3.5 3.4 4.0 3.7 3.7 11.4 10.6 9.4 10.7 9.2 10.3 13.6 12.3 12.6 13.2 12.9 12.9
3.8 3.5 3.5 4.0 3.6 3.7 5.3 5.5 5.2 5.2 4.8 5.2 4.2 4.1 5.4 4.7 4.6 4.6
1.6 3.3 3.9 0.0 5.2 3.5 3.6 4.6 0.0 9.4 0.0 5.9 1.6 0.0 0.0 1.4 2.8 1.9
3.2 3.2 3.4 4.0 3.4 3.4 0.0 7.1 7.3 8.6 6.4 7.4 6.5 7.8 9.4 0.0 7.9 7.9
3.6 3.4 3.2 3.8 3.1 3.4 5.1 7.7 7.5 7.7 7.6 7.1 5.6 5.9 7.8 6.1 7.6 6.6
0.0 3.4 3.1 3.0 3.8 3.4 5.1 5.9 5.9 6.3 5.3 5.7 12.1 11.8 0.0 11.0 0.0 11.6
3.0 3.2 2.8 4.2 3.4 3.3 7.2 6.2 7.1 6.9 5.5 6.6 14.7 17.4 0.0 13.0 15.0 15.0
4.6 3.1 2.2 3.3 3.5 3.3 5.3 0.0 4.5 6.1 4.1 5.0 1.8 1.6 2.2 2.0 1.9 1.9
3.5 3.1 3.1 3.7 3.2 3.3 4.7 3.7 3.7 3.8 3.8 4.0 2.2 2.5 2.7 2.9 2.4 2.6
3.4 3.0 3.2 3.6 3.3 3.3 6.4 5.9 5.6 6.3 5.1 5.9 8.1 8.2 10.9 8.6 8.9 8.9
2.7 3.2 3.2 3.7 3.5 3.3 4.2 4.5 4.5 4.7 4.0 4.4 7.7 10.7 11.2 9.8 9.7 9.8
3.8 3.5 2.4 4.0 2.1 3.2 2.8 2.3 3.2 2.8 1.4 2.5 1.7 0.0 2.9 2.8 3.1 2.6
3.5 3.3 2.4 3.3 3.3 3.1 5.1 4.2 5.3 1.3 5.3 4.2 4.0 4.3 0.0 5.2 8.8 5.6
3.6 2.9 2.9 3.2 2.9 3.1 8.8 11.6 14.6 11.7 8.0 10.9 18.5 18.5 18.7 19.3 18.7 18.7
2.5 3.1 3.2 3.4 3.1 3.1 5.6 5.6 4.8 5.6 4.9 5.3 2.5 3.2 3.7 2.3 3.6 3.1
3.6 2.5 2.9 2.9 3.3 3.1 0.0 5.2 4.7 0.0 5.9 5.3 7.1 8.9 0.0 8.0 0.0 8.0
0.0 2.9 2.7 3.1 3.5 3.0 7.5 6.4 5.5 5.7 5.8 6.2 6.9 0.0 9.3 0.0 9.9 8.7
3.0 2.9 2.8 3.3 3.1 3.0 4.8 4.8 4.7 4.6 4.3 4.6 5.9 6.5 7.6 6.7 6.2 6.6
3.0 2.4 3.1 3.7 2.8 3.0 7.0 8.5 8.5 7.0 8.2 7.9 1.5 1.1 1.9 0.6 1.2 1.3
2.9 4.0 2.5 2.9 2.6 3.0 3.7 3.7 3.8 4.8 3.4 3.9 7.2 7.7 0.0 7.7 11.9 8.6
3.3 2.3 3.3 3.6 2.6 3.0 3.8 4.3 3.1 3.9 5.0 4.0 1.9 2.1 4.0 0.0 2.1 2.5
4.0 2.3 2.6 2.8 2.9 2.9 4.2 4.5 4.6 4.9 3.2 4.3 6.3 9.3 2.4 7.4 0.0 6.4
2.8 2.4 2.4 3.2 3.8 2.9 9.0 8.3 4.9 8.1 9.8 8.0 5.1 4.3 7.5 6.1 0.0 5.7
3.0 2.8 2.8 3.1 2.8 2.9 3.2 2.8 2.7 3.0 3.5 3.0 1.2 1.9 1.4 1.4 1.6 1.5
2.8 2.6 2.8 3.0 3.1 2.9 0.0 7.9 6.4 5.4 5.2 6.2 5.2 7.1 8.3 8.5 6.9 7.2
2.9 2.8 2.1 2.3 4.2 2.9 4.5 3.4 3.0 7.6 4.7 4.7 4.7 0.0 0.0 14.1 9.7 9.5
2.8 2.8 2.8 3.3 2.4 2.8 3.1 2.8 2.8 1.8 2.2 2.5 2.1 2.4 2.7 2.6 2.8 2.5
2.7 2.7 2.5 3.0 3.2 2.8 5.5 4.6 5.3 5.5 5.3 5.3 6.7 7.8 9.3 6.8 7.9 7.7
Heavy : Light Ratio
500 µM GSNO 500 µM CoA-SNO 90 µM Trx-SNO
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3 18 33 P17858 PFKL 6-phosphofructokinase, liver type PFKL K.C*HDYYTTEFLYNLYSSEGK.G
76 73 34 P07437 TUBB Tubulin beta chain TUBB K.NMMAAC*DPR.H
9 61 35 P62280 RPS11 40S ribosomal protein S11 RPS11 R.DVQIGDIVTVGEC*RPLSK.T
23 37 36 P17858 PFKL 6-phosphofructokinase, liver type PFKL R.VFANAPDSAC*VIGLK.K
35 54 37 P49327 FASN Fatty acid synthase FASN R.LGMLSPEGTC*K.A
92 31 38 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 
HSD17B
10 K.FGRVDVAVNC*AGIAVASK.T
80 44 39 P42677 RPS27 40S ribosomal protein S27 RPS27 K.ARLTEGC*SFR.R
18 165 40 Q9Y5M8
SRPRB Signal recognition particle receptor 
subunit beta SRPRB K.NTPSFLIAC*NK.Q
8 16 41 P07858 CTSB Cathepsin B CTSB R.GQDHC*GIESEVVAGIPR.T
96 67 42 P07437 TUBB Tubulin beta chain TUBB K.TAVC*DIPPR.G
50 88 43 P60709 ACTB Actin, cytoplasmic 1 ACTB K.C*DVDIRK.D
4 52 44 P35250 RFC2 Replication factor C subunit 2 RFC2 K.TTSILC*LAR.A
11 104 45 P23396 RPS3 40S ribosomal protein S3 RPS3 K.GC*EVVVSGK.L
45 81 46 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 R.C*GLALALNK.L
116 105 47 Q92797 SYMPK Symplekin SYMPK K.AVAC*SGAAQVR.I
239 77 48 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 K.LWNTLGVC*K.Y
141 93 49 P83731 RPL24 60S ribosomal protein L24 RPL24 K.VELC*SFSGYK.I
240 151 50 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 K.VQYPQSQAC*K.M
514 290 51 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP K.C*PTSGR.L
37 210 52 P50213 IDH3A Isocitrate dehydrogenase IDH3A K.TFDLYANVRPC*VSIEGYK.T
106 30 53 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) GNB2 K.AC*GDSTLTQITAGLDPVGR.I
36 95 54 LLGL2 LLGL2 Lethal(2) giant larvae protein homolog 2 LLGL2 R.SLVPYGPFPC*K.A
110 110 55 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.RSIQFVDWC*PTGFK.V
227 84 56 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 R.FSPNSSNPIIVSC*GWDK.L
186 51 57 P22102 GART Trifunctional purine biosynthetic protein adenosin GART R.SAGVQC*FGPTAEAAQLESSK.R
208 129 58 P49207 RPL34 60S ribosomal protein L34 RPL34 R.AYGGSMC*AK.C
223 155 59 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 K.VVVVQAISALC*QK.Y
376 148 60 P31948 STIP1 Stress-induced-phosphoprotein 1 STIP1 K.ALDLDSSC*K.E
124 244 61 P49327 FASN Fatty acid synthase FASN R.LLSAAC*R.L
27 76 62 P27635 RPL10 60S ribosomal protein L10 RPL10 K.MLSC*AGADR.L
161 62 63 O95833 CLIC3 Chloride intracellular channel protein 3 CLIC3 K.ASEDGESVGHC*PSC*QR.L
10 39 64 P35250 RFC2 Replication factor C subunit 2 RFC2 R.FALAC*NASDK.I
205 350 65 Q13045 FLII Protein flightless-1 homolog FLII R.NQLTSLPSAIC*K.L
134 192 66 O43264 ZW10 Centromere/kinetochore protein zw10 homolog ZW10 R.LAPILC*DGTATFVDLVPGFR.R
297
3.0 2.7 2.5 3.0 2.8 2.8 7.7 7.8 5.9 6.7 6.6 6.9 13.3 12.3 17.5 0.0 0.0 14.4
3.0 2.6 2.6 3.0 2.8 2.8 5.1 4.8 4.5 4.5 4.2 4.6 5.5 5.9 7.6 6.5 6.2 6.3
2.9 2.5 2.6 3.1 2.7 2.8 4.9 4.8 4.4 5.1 4.2 4.7 10.9 12.7 0.0 11.4 12.9 12.0
2.8 2.6 2.8 3.2 2.4 2.8 5.6 5.9 5.6 5.5 5.2 5.6 8.3 9.6 10.2 9.8 10.3 9.6
2.7 2.6 2.7 3.0 2.7 2.7 3.9 5.8 5.1 5.4 5.1 5.0 7.3 7.7 8.4 10.1 9.0 8.5
3.3 2.4 2.7 2.8 2.5 2.7 4.7 5.5 5.7 6.8 7.1 5.9 3.6 6.6 5.5 6.7 5.6 5.6
2.8 2.6 2.6 3.2 2.4 2.7 5.8 5.8 5.0 5.0 4.8 5.3 5.2 5.9 6.3 6.6 6.0 6.0
2.6 1.4 2.7 3.4 3.3 2.7 3.7 3.5 3.5 2.0 3.1 3.2 10.3 8.6 12.2 9.9 8.8 10.0
2.9 3.1 2.4 2.5 2.5 2.7 5.4 6.7 8.1 7.8 8.6 7.3 0.0 9.9 16.0 12.5 11.5 12.5
2.7 2.6 2.5 2.9 2.7 2.7 5.0 4.7 4.3 5.2 4.1 4.7 4.9 5.0 6.5 5.4 5.4 5.4
2.5 2.6 2.6 2.9 2.6 2.7 3.8 3.9 5.0 4.9 4.2 4.4 6.1 7.4 8.8 7.3 8.0 7.5
2.5 3.4 2.2 2.6 2.5 2.6 5.1 5.8 4.4 0.0 4.9 5.1 14.8 15.4 0.0 12.6 0.0 14.3
2.3 3.1 2.9 2.2 2.7 2.6 3.9 4.8 3.0 4.3 4.6 4.1 11.8 11.4 0.0 9.6 14.2 11.8
3.2 2.1 2.3 3.1 2.5 2.6 4.1 5.2 4.9 3.9 4.2 4.4 7.0 8.4 8.0 7.2 8.1 7.7
0.0 2.5 3.1 0.0 2.3 2.6 0.0 5.3 4.5 0.0 2.5 4.1 3.1 4.8 0.0 6.6 0.0 4.8
2.9 2.1 2.7 2.8 2.6 2.6 3.7 4.8 4.8 5.2 4.4 4.6 2.2 2.3 3.1 3.0 2.8 2.7
2.7 2.5 2.1 2.6 3.2 2.6 5.2 4.2 4.0 0.0 3.8 4.3 4.2 0.0 4.5 4.1 3.8 4.1
1.9 2.3 2.7 3.6 2.6 2.6 3.9 3.6 2.8 3.1 3.1 3.3 3.3 2.1 2.5 2.3 3.1 2.7
2.6 2.5 2.5 2.6 2.8 2.6 2.2 2.6 2.5 2.4 2.3 2.4 1.3 1.4 1.8 1.4 1.5 1.5
2.7 2.1 2.4 3.0 2.8 2.6 3.9 2.8 2.8 2.4 2.4 2.9 6.2 8.4 9.3 9.8 8.7 8.5
2.6 2.2 2.7 2.8 2.6 2.6 5.0 6.7 5.7 6.7 5.9 6.0 4.4 5.9 0.0 5.3 0.0 5.2
3.0 2.4 1.8 3.0 2.5 2.5 5.1 0.0 4.7 3.4 3.7 4.3 7.6 0.0 9.5 8.8 8.1 8.5
2.5 2.4 2.4 2.9 2.5 2.5 4.4 4.1 3.8 3.9 3.5 3.9 4.6 4.8 5.2 5.2 5.3 5.0
2.6 2.3 2.5 2.8 2.4 2.5 3.5 5.1 4.5 4.9 3.9 4.4 2.6 2.5 3.1 2.9 3.0 2.8
2.6 1.5 3.0 2.6 2.9 2.5 5.3 0.0 0.0 4.6 5.4 5.1 3.8 4.6 2.8 2.1 3.3 3.3
2.5 2.3 2.5 2.9 2.3 2.5 4.1 3.4 3.2 4.1 3.2 3.6 2.8 2.6 3.3 3.6 2.8 3.0
2.6 2.6 2.1 2.9 2.4 2.5 2.9 3.2 3.7 3.2 3.3 3.3 2.3 2.6 3.9 2.5 3.1 2.9
3.2 1.9 2.5 2.4 2.4 2.5 3.8 3.1 4.2 2.8 2.9 3.3 3.8 1.3 1.8 1.3 1.0 1.8
2.6 0.0 2.5 2.6 2.3 2.5 1.9 3.0 3.0 2.9 2.7 2.7 4.1 0.0 5.3 4.4 4.7 4.6
2.4 2.2 2.5 2.9 2.5 2.5 5.6 4.8 4.4 4.2 4.1 4.6 7.6 7.6 11.9 10.1 10.1 9.4
2.4 1.8 3.6 2.4 2.2 2.5 6.3 5.3 1.8 5.4 4.6 4.7 3.2 3.0 4.8 4.2 3.6 3.7
2.7 2.8 0.0 2.8 1.7 2.5 6.9 5.2 5.7 4.7 4.8 5.5 8.2 15.4 0.0 10.6 13.4 11.9
2.2 2.4 2.4 2.9 2.5 2.5 1.9 2.5 0.0 2.0 1.8 2.0 2.2 0.0 3.5 3.3 3.2 3.0
2.5 3.7 2.1 2.1 1.9 2.5 2.8 3.6 3.0 2.8 2.5 3.0 4.1 3.5 5.9 3.9 4.5 4.4
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15 57 67 P35250 RFC2 Replication factor C subunit 2 RFC2 K.VC*DEPHPLLVK.E
86 118 68 Q13748 TUBA3D Tubulin alpha-3C/D chain TUBA3D R.TIQFVDWC*PTGFK.V
51 75 69 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 R.LC*PNSTGAEIR.S
63 40 70 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.YVAAAFPSAC*GK.T
71 69 71 P36578 RPL4 60S ribosomal protein L4 RPL4 R.SGQGAFGNMC*R.G
266 131 72 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.IC*DDELILIK.N
53 72 73 Q4ZG55 GREB1 Protein GREB1 GREB1 R.LINSSC*LVR.T
68 92 74 Q8N8R5 C2orf69 UPF0565 protein C2orf69 C2orf69 R.C*SLSAEVR.R
167 242 75 P11586 MTHFD1 C-1-tetrahydrofolate synthase, cytoplasmic MTHFD1 R.GDLNDCFIPC*TPK.G
146 158 76 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.YMAC*CLLYR.G
291 26 77 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.SLHDALC*VVK.R
109 144 78 P50914 RPL14 60S ribosomal protein L14 RPL14 K.C*MQLTDFILK.F
16 9 79 P25398 RPS12 40S ribosomal protein S12 RPS12 K.KLGEWVGLC*K.I
696 154 80 P53582 METAP1 Methionine aminopeptidase 1 METAP1 R.VCETDGC*SSEAK.L
159 50 81 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 K.IIC*QGFTGK.Q
143 178 82 P16278 GLB1 Beta-galactosidase GLB1 K.TVGAALDILC*PSGPIK.S
117 161 83 P50914 RPL14 60S ribosomal protein L14 RPL14 R.ALVDGPC*TQVR.R
49 214 84 P11586 MTHFD1 C-1-tetrahydrofolate synthase, cytoplasmic MTHFD1 K.C*THWAEGGK.G
215 211 85 Q7RTV0
PHF5A PHD finger-like domain-containing 
protein 5A PHF5A R.ICDEC*NYGSYQGR.C
153 207 86 Q96CW1 AP2M1 AP-2 complex subunit mu AP2M1 K.MC*DVMAAYFGK.I
24 41 87 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 R.C*SVLAAANSVFGR.W
77 222 88 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 K.SSVNC*PFSSQDMK.Y
29 271 89 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC K.TFTDC*FNC*LPIAAIVDEK.I
48 220 90 P58107 EPPK1 Epiplakin EPPK1 R.LLDAQLATGGLVC*PAR.R
718 8 91 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.FC*LDNGAK.S
66 163 92 P62280 RPS11 40S ribosomal protein S11 RPS11 K.C*PFTGNVSIR.G
427 53 93 Q68CP9 ARID2 AT-rich interactive domain-containing protein 2 ARID2 R.SC*SNAAFALK.Q
253 453 94 Q08AM6 VAC14 Protein VAC14 homolog VAC14 K.GLEC*SPSTPTMNSYFYK.F
164 101 95 P45880 VDAC2 Voltage-dependent anion-selective channel protein VDAC2 R.PMC*IPPSYADLGK.A
177 201 96 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 R.C*ALGVFR.K
17 171 97 P58107 EPPK1 Epiplakin EPPK1 R.YLQGTGC*IAGLLLPGSQER.L
52 123 98 P60709 ACTB Actin, cytoplasmic 1 ACTB K.EKLC*YVALDFEQEMATAASSSSLEK.S
226 153 99 P53618 COPB1 Coatomer subunit beta COPB1 K.ALSGYC*GFMAANLYAR.S
303 753 100 Q99439 CNN2 Calponin-2 CNN2 K.C*ASQVGMTAPGTR.R
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2.2 2.8 2.1 2.7 2.4 2.4 4.7 4.6 6.5 4.8 4.3 5.0 10.8 0.0 0.0 10.3 10.2 10.4
2.4 2.4 2.3 2.7 2.5 2.4 4.2 3.8 3.5 3.8 3.5 3.8 5.0 5.0 6.0 6.3 6.4 5.7
2.6 2.4 2.3 2.4 2.4 2.4 4.7 4.1 4.9 4.6 4.6 4.6 5.4 6.3 10.3 7.9 7.5 7.5
2.8 2.1 2.3 2.6 2.4 2.4 5.6 6.3 5.3 4.4 5.6 5.4 6.4 6.8 8.1 6.3 5.3 6.6
2.6 2.1 2.2 2.6 2.5 2.4 5.0 5.2 4.9 4.2 4.0 4.6 5.0 5.6 7.7 6.6 7.0 6.4
0.0 2.3 2.4 2.6 2.4 2.4 3.6 4.0 3.7 3.1 3.7 3.6 1.9 0.0 3.8 1.9 0.0 2.5
3.1 0.6 2.5 3.5 2.3 2.4 3.8 5.4 4.1 4.0 5.8 4.6 7.2 7.2 6.1 7.4 8.4 7.2
2.5 2.2 2.0 2.9 0.0 2.4 4.1 4.7 4.5 0.0 4.0 4.3 6.0 0.0 5.7 6.4 7.6 6.4
2.1 2.2 2.6 3.2 2.1 2.4 2.5 2.5 1.8 2.1 4.5 2.7 3.3 2.4 5.2 0.0 0.0 3.6
2.5 2.3 2.3 2.6 2.4 2.4 3.4 3.3 3.3 3.2 3.0 3.2 3.6 3.7 4.9 3.8 4.0 4.0
1.9 2.0 2.5 3.3 2.3 2.4 5.5 7.5 6.3 6.2 6.1 6.3 2.2 2.7 2.9 1.5 0.0 2.3
2.5 2.3 2.2 2.5 2.4 2.4 3.3 3.7 3.2 3.4 3.2 3.4 4.2 4.2 6.0 5.4 5.6 5.1
2.0 2.4 2.3 2.9 2.3 2.4 7.8 7.5 9.3 10.5 6.4 8.3 10.0 8.8 13.1 0.0 9.4 10.3
2.3 2.6 1.6 2.8 2.5 2.4 0.0 5.8 2.6 2.9 1.9 3.3 1.4 1.1 1.2 1.2 1.2 1.2
2.0 2.3 2.4 2.6 2.5 2.4 4.4 5.5 5.6 4.7 5.6 5.2 3.3 3.4 4.6 3.6 3.9 3.8
2.4 2.3 2.3 2.6 2.1 2.3 4.4 2.7 2.9 3.0 2.3 3.1 4.9 3.6 0.0 3.8 0.0 4.1
2.5 2.1 2.1 2.7 2.3 2.3 3.2 3.5 3.1 3.2 3.1 3.2 4.1 4.7 5.6 4.6 5.0 4.8
1.4 2.8 2.8 2.5 2.1 2.3 1.7 2.1 4.1 3.9 2.3 2.8 7.1 7.3 6.9 8.7 0.0 7.5
2.2 2.4 2.1 2.1 2.7 2.3 2.8 2.7 2.7 3.1 3.1 2.9 2.2 0.0 4.6 2.2 2.9 3.0
2.3 2.3 2.2 2.5 2.3 2.3 0.0 2.9 3.2 2.5 3.0 2.9 3.6 0.0 0.0 4.0 4.2 3.9
2.2 2.8 1.9 2.8 1.9 2.3 4.9 6.8 4.9 5.1 5.6 5.4 8.2 9.6 0.0 0.0 11.0 9.6
2.5 2.7 2.0 2.4 2.0 2.3 2.8 2.3 3.4 0.0 2.8 2.8 5.2 7.4 5.2 8.1 5.3 6.2
0.0 2.0 2.4 2.4 2.4 2.3 2.7 2.8 2.1 2.7 2.0 2.5 8.1 6.7 11.3 8.3 10.6 9.0
2.5 2.1 2.4 2.2 2.3 2.3 3.0 4.0 2.7 2.5 2.0 2.8 7.8 6.1 8.3 7.2 8.9 7.6
0.8 2.6 2.4 3.1 2.5 2.3 6.8 9.9 8.6 0.0 8.6 8.5 0.0 1.1 0.0 0.9 1.3 1.1
2.3 2.2 1.9 2.4 2.5 2.3 3.2 3.5 3.2 3.2 2.9 3.2 6.0 6.7 7.3 6.3 6.2 6.5
2.2 1.9 2.9 1.9 2.5 2.3 5.0 5.3 5.6 4.9 4.5 5.1 1.4 1.6 1.8 1.8 1.8 1.7
2.3 1.8 2.7 2.2 0.0 2.2 1.9 1.5 1.6 1.8 0.0 1.7 2.5 2.7 2.6 2.6 2.4 2.6
1.9 1.7 2.7 2.8 2.1 2.2 4.3 4.3 4.4 0.0 3.6 4.1 2.8 4.0 4.1 4.1 3.6 3.7
2.2 0.0 2.3 2.4 2.0 2.2 4.3 0.0 2.9 1.8 2.8 2.9 3.1 2.9 4.1 3.8 3.2 3.4
2.1 2.4 0.0 2.6 1.7 2.2 4.5 2.8 2.5 3.2 2.6 3.1 8.2 9.6 9.3 10.6 13.4 10.2
2.2 2.0 2.2 2.4 2.2 2.2 3.1 3.8 4.0 4.0 3.7 3.7 6.3 7.8 8.4 7.5 7.2 7.4
2.1 2.1 2.1 2.5 2.3 2.2 3.1 3.7 3.6 2.9 3.3 3.3 2.4 2.6 3.4 2.6 3.0 2.8
3.6 1.4 1.9 1.9 0.0 2.2 0.7 0.5 0.9 0.6 0.6 0.7 2.0 0.0 2.4 0.0 2.1 2.2
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40 251 101 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC R.GNHEC*ASINR.I
229 203 102 P08559 PDHA1 Pyruvate dehydrogenase E1 component subunit alpha, PDHA1 R.FAAAYC*R.S
19 13 103 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase 
ALDH18
A1 K.C*EYPAAC*NALETLLIHR.D
87 70 104 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.LGGEVSC*LVAGTK.C
69 141 105 P26641 EEF1G Elongation factor 1-gamma EEF1G R.FPEELTQTFMSC*NLITGMFQR.L
443 35 106 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.ALNALC*DGLIDELNQALK.T
13 74 107 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD
R.GSNTC*ELIFEDC*KIPAANILGHEN
K.G
155 177 108 Q5UIP0 RIF1 Telomere-associated protein RIF1 RIF1 K.SLIDNFALNPDILC*SAK.R
598 130 109 O43815 STRN Striatin STRN K.C*YIASAGADALAK.V
84 149 110 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 
KIAA196
7 R.VVTQNIC*QYR.S
196 36 111 P15924 DSP Desmoplakin DSP K.YC*YLQNEVFGLFQK.L
108 133 112 P62829 RPL23 60S ribosomal protein L23 RPL23 R.ISLGLPVGAVINC*ADNTGAK.N
94 5 113 Q9NZB2




56 65 114 P62249 RPS16 40S ribosomal protein S16 RPS16 K.TATAVAHC*K.R
31 63 115 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.TIYAGNALC*TVK.C
189 189 116 Q14152 EIF3A Eukaryotic translation initiation factor 3 subunit EIF3A K.NIC*QQVNIK.S
166 314 117 P62714 PPP2CB Serine/threonine-protein phosphatase 2A catalytic PPP2CB R.NVVTIFSAPNYC*YR.C
554 379 118 Q9H2U2
PPA2 Inorganic pyrophosphatase 2, 
mitochondrial PPA2 R.GQPC*SQNYR.L
32 111 119 P24468 NR2F2 COUP transcription factor 2 NR2F2 R.FGSQC*MQPNNIMGIENICELAAR.M
43 6 120 P62888 RPL30 60S ribosomal protein L30 RPL30 R.VC*TLAIIDPGDSDIIR.S
299 339 121 Q8WXH0 SYNE2 Nesprin-2 SYNE2 K.NLAGEC*QNINK.Q
73 181 122 P62753 RPS6 40S ribosomal protein S6 RPS6 K.LNISFPATGC*QK.L
100 115 123 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 K.TFVGTPC*WMAPEVMEQVR.G
113 14 124 P15924 DSP Desmoplakin DSP R.GVITDQNSDGYC*QTGTMSR.H
334 132 125 Q14318 FKBP8 Peptidyl-prolyl cis-trans isomerase FKBP8 FKBP8 K.C*LNNLAASQLK.L
22 143 126 P49327 FASN Fatty acid synthase FASN K.AFDTAGNGYC*R.S
89 307 127 O75150 RNF40 E3 ubiquitin-protein ligase BRE1B RNF40 R.LTCPC*CNTR.K
157 21 128 P13639 EEF2 Elongation factor 2 EEF2 K.DLEEDHAC*IPIK.K
190 157 129 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 R.MLSAVSQQVQC*IQEALR.E
90 108 130 Q86Y56 HEATR2 HEAT repeat-containing protein 2 HEATR2 R.RPPEAC*EELR.L
99 194 131 O60716 CTNND1 Catenin delta-1 CTNND1 K.TPAILEASAGAIQNLC*AGR.W
104 137 132 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.AC*ALQVLSAILEGSK.Q
200 184 133 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 K.C*FIVGADNVGSK.Q
144 229 134 P46776 RPL27A 60S ribosomal protein L27a RPL27A K.RNQSFC*PTVNLDK.L
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2.2 2.0 2.2 2.4 2.2 2.2 3.2 2.6 2.6 2.5 2.3 2.6 7.0 7.9 8.8 8.0 8.7 8.1
0.0 1.9 2.2 2.4 0.0 2.2 3.6 2.9 2.9 2.6 2.6 2.9 2.1 2.4 2.9 3.2 3.5 2.8
2.3 2.1 2.0 2.0 2.5 2.2 6.8 8.0 7.2 7.2 8.5 7.5 11.5 15.6 7.8 4.9 0.0 9.9
2.3 1.9 2.2 2.4 2.0 2.2 3.8 4.9 4.5 5.4 4.6 4.6 6.1 6.0 0.0 5.4 5.5 5.7
2.1 2.1 0.0 2.3 0.0 2.2 3.0 3.5 3.6 0.0 3.6 3.4 5.5 5.9 7.5 6.2 7.0 6.4
2.3 2.1 2.1 2.3 2.1 2.2 6.3 5.4 5.4 5.9 5.0 5.6 1.5 1.5 2.0 1.6 1.6 1.6
2.1 2.1 2.1 2.6 2.0 2.2 5.1 4.8 3.3 5.8 4.0 4.6 9.6 8.7 13.6 11.4 0.0 10.8
0.0 1.7 1.9 3.3 1.7 2.2 3.0 3.4 2.9 0.0 3.0 3.1 3.2 4.2 0.0 4.2 0.0 3.9
1.5 2.1 2.2 2.6 2.3 2.2 4.2 3.4 5.5 2.1 2.8 3.6 1.4 1.4 1.5 1.5 1.3 1.4
1.8 2.2 1.9 2.4 2.5 2.1 3.6 3.4 3.6 3.4 2.7 3.3 6.9 5.4 5.5 5.8 5.4 5.8
2.5 1.7 2.1 2.1 2.3 2.1 6.0 5.5 5.3 5.5 5.8 5.6 3.3 2.8 3.6 3.1 2.9 3.1
2.2 1.9 2.0 2.3 2.2 2.1 4.0 3.8 3.4 3.3 3.3 3.5 4.4 4.9 5.8 5.1 5.4 5.1
2.3 1.7 2.0 2.5 2.0 2.1 12.1 8.7 11.2 8.8 7.5 9.7 4.6 6.1 5.0 6.2 5.8 5.5
2.0 1.9 2.3 2.3 1.9 2.1 3.9 5.6 5.1 4.2 4.6 4.7 7.2 7.1 7.7 6.3 7.0 7.0
1.9 2.1 2.0 2.2 2.0 2.0 5.1 4.6 4.4 5.2 4.1 4.7 7.5 7.5 11.4 9.0 8.6 8.8
2.3 1.7 2.0 2.2 2.0 2.0 3.0 3.3 3.2 2.8 2.7 3.0 3.6 0.0 3.3 0.0 2.9 3.3
2.3 1.8 2.2 2.0 1.9 2.0 1.6 2.3 2.8 2.6 1.8 2.2 2.8 4.7 0.0 3.8 3.4 3.6
1.6 1.7 2.5 2.1 2.2 2.0 1.9 2.2 1.9 2.3 1.5 1.9 1.2 1.2 1.7 1.5 1.6 1.4
2.2 2.1 2.2 1.7 1.9 2.0 4.9 3.5 3.3 5.3 2.6 3.9 9.1 8.4 7.2 8.7 10.1 8.7
2.1 1.9 1.8 2.2 2.0 2.0 9.9 8.2 8.4 8.7 8.2 8.7 6.2 6.6 0.0 8.8 10.2 7.9
2.5 1.5 2.2 1.8 0.0 2.0 2.2 0.0 2.8 0.0 1.3 2.1 1.9 2.2 0.0 2.5 2.3 2.2
2.0 1.8 1.9 2.2 2.0 2.0 3.0 3.0 2.7 2.8 3.7 3.0 7.7 6.4 6.7 5.4 5.7 6.4
1.8 2.0 1.7 2.5 2.0 2.0 2.7 4.6 4.0 3.8 3.8 3.8 5.8 4.6 5.4 5.0 5.9 5.3
2.1 2.0 1.5 2.5 1.9 2.0 7.0 7.1 0.0 0.0 8.5 7.5 4.1 0.0 5.0 6.5 4.1 4.9
1.8 1.8 2.2 2.3 1.9 2.0 3.2 4.1 3.5 3.2 3.9 3.6 1.9 1.8 2.3 1.7 2.4 2.0
2.1 1.9 1.9 2.1 1.9 2.0 3.6 4.1 3.2 3.1 2.9 3.4 5.7 0.0 0.0 9.5 14.0 9.7
2.4 0.0 1.7 2.0 1.8 2.0 2.7 2.3 1.5 0.0 2.5 2.3 5.1 5.2 7.8 4.9 5.6 5.7
2.0 1.8 1.9 2.4 1.8 2.0 5.8 8.2 0.0 7.2 5.4 6.6 3.1 3.6 4.1 3.8 4.2 3.8
2.1 2.0 1.8 2.3 1.6 2.0 4.6 2.5 3.3 3.6 2.2 3.3 2.7 2.7 0.0 3.8 4.0 3.3
2.0 1.9 0.0 2.0 0.0 2.0 0.0 4.0 3.3 4.7 3.9 4.0 5.7 4.5 8.4 5.6 4.2 5.7
0.0 0.0 2.0 2.2 1.7 2.0 2.8 0.0 3.2 3.0 2.8 3.0 0.0 0.0 4.9 3.8 7.4 5.4
2.3 1.5 2.0 2.3 1.7 2.0 4.4 3.5 3.3 3.1 3.1 3.5 4.4 4.8 6.2 5.2 5.5 5.2
1.9 1.8 1.9 2.1 2.0 1.9 3.6 3.0 2.8 3.0 2.6 3.0 2.4 3.1 3.6 3.0 3.3 3.1
2.3 1.8 1.8 2.0 1.7 1.9 2.8 2.6 3.1 3.0 2.4 2.8 4.2 4.0 0.0 0.0 4.2 4.1
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256 7 135 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1
K.AFAAGADIKEMQNLSFQDC*YSSK.
F
581 343 136 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X K.FDTGNLC*MVTGGANLGR.I
130 202 137 P55060 CSE1L Exportin-2 CSE1L K.IC*AVGITK.L
224 119 138 B0LM41




28 49 139 Q9Y5Y2
NUBP2 Cytosolic Fe-S cluster assembly 
factor NUBP2 NUBP2 R.AVHQC*DR.G
353 384 140 Q9Y5L0 TNPO3 Transportin-3 TNPO3 K.GLC*EKPLASAAAK.A
230 200 141 Q07020 RPL18 60S ribosomal protein L18 RPL18 K.GC*GTVLLSGPR.K
14 239 142 P04183 TK1 Thymidine kinase, cytosolic TK1 K.LTAVC*MECFR.E
156 135 143 O95782 AP2A1 AP-2 complex subunit alpha-1 AP2A1 K.TVFEALQAPAC*HENMVK.V
58 198 144 Q9BTZ2 DHRS4 Dehydrogenase/reductase SDR family member 4 DHRS4 R.VNC*LAPGLIK.T
21 336 145 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 R.LEIC*NLTPDALK.S
38 257 146 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7 K.NC*EPMIGLVPILK.G
119 190 147 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.LC*ALRPDDSSSAR.T
233 89 148 Q16576 RBBP7 Histone-binding protein RBBP7 RBBP7 R.VHIPNDDAQFDASHC*DSDKGEFGGFGSVTGK.I
61 103 149 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.KGDEC*ELLGHSK.N
285 311 150 Q9NQT5
EXOSC3 Exosome complex component 
RRP40 EXOSC3 K.LLAPDC*EIIQEVGK.L
59 205 151 P62330 ARF6 ADP-ribosylation factor 6 ARF6 R.DRNWYVQPSC*ATSGDGLYEGLTWLTSNYK.S
421 152 152 Q9H1B7 IRF2BPL Interferon regulatory factor 2-binding protein-lik IRF2BPL R.AHGC*FQDGR.S
326 352 153 O15294 OGT UDP-N-acetylglucosamine--peptide N-acetylglucosami OGT K.VMAEANHFIDLSQIPC*NGK.A
219 140 154 P31689 DNAJA1 DnaJ homolog subfamily A member 1 DNAJA1 K.GAVEC*CPNCR.G
371 206 155 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.TIIPLISQC*TPK.V
231 276 156 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 K.SFVQWLGC*R.S
242 305 157 O76039 CDKL5 Cyclin-dependent kinase-like 5 CDKL5 K.LC*DFGFAR.N





KBTBD6 Kelch repeat and BTB domain-
containing protein 6 KBTBD6 R.RALFSAC*AER.V
139 120 160 P82912 MRPS11 28S ribosomal protein S11, mitochondrial MRPS11
K.ASHNNTQIQVVSASNEPLAFASC*G
TEGFR.N
129 182 161 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC K.KLVIVGDGAC*GK.T
222 20 162 P15924 DSP Desmoplakin DSP K.YQAEC*SQFK.A
311 160 163 Q1KMD3
HNRNPUL2 Heterogeneous nuclear 
ribonucleoprotein U-like pro 
HNRNP
UL2 R.NFILDQC*NVYNSGQR.R
105 405 164 P00966 ASS1 Argininosuccinate synthase ASS1 K.GNDQVRFELSC*YSLAPQIK.V
308 326 165 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 K.C*AMTALSSK.L
270 169 166 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 R.AGAIAPC*EVTVPAQNTGLGPEK.T
238 218 167 P62244 RPS15A 40S ribosomal protein S15a RPS15A K.C*GVISPR.F
322 382 168 Q9UL40 ZNF346 Zinc finger protein 346 ZNF346 K.NQC*LFTNTQCK.V
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2.0 1.8 1.7 2.2 1.7 1.9 0.0 6.0 5.1 4.9 4.8 5.2 9.1 9.3 10.4 8.4 0.0 9.3
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1.8 0.0 1.6 1.9 1.9 1.8 3.2 2.1 1.5 0.0 1.4 2.0 1.6 1.9 2.5 2.1 2.1 2.1
2.2 1.8 1.5 1.6 2.0 1.8 4.1 0.0 4.2 0.0 2.1 3.4 2.8 3.0 0.0 2.9 0.0 2.9
1.7 1.8 1.9 1.9 1.9 1.8 2.7 3.0 3.2 3.1 2.6 2.9 1.8 1.7 2.2 1.6 2.0 1.8
1.7 1.6 1.8 1.8 2.1 1.8 2.4 2.4 2.9 2.3 2.3 2.5 2.8 2.9 3.0 2.3 2.9 2.8
1.7 0.0 2.2 1.5 0.0 1.8 2.9 2.1 0.0 0.0 1.9 2.3 2.3 2.5 2.8 2.6 3.2 2.7
1.8 1.8 1.8 1.8 1.9 1.8 3.2 2.4 2.2 3.0 1.9 2.5 2.0 2.0 2.7 1.7 2.4 2.2
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1.6 1.5 1.7 2.2 1.8 1.8 3.4 3.8 2.8 3.4 2.8 3.2 1.7 1.9 2.7 2.2 2.2 2.2
2.1 1.7 1.6 1.6 1.8 1.8 1.5 2.2 1.9 2.0 1.8 1.9 5.5 4.7 5.7 4.6 5.5 5.2
1.8 2.4 1.5 1.7 1.4 1.8 2.2 2.0 2.6 2.4 1.7 2.2 1.9 2.2 2.6 1.8 2.3 2.2
1.7 1.6 1.7 2.0 1.8 1.8 3.3 3.3 3.0 3.5 2.6 3.1 2.1 2.4 2.9 2.6 2.5 2.5
1.7 1.8 1.7 1.8 1.7 1.8 3.6 2.8 2.7 2.6 2.5 2.8 2.3 1.7 3.6 3.3 2.7 2.7
2.0 0.0 1.3 1.3 2.4 1.8 1.9 2.3 1.6 0.0 2.1 1.9 1.7 1.6 3.5 2.1 1.4 2.1
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310 256 169 Q7Z406 MYH14 Myosin-14 MYH14 K.ADLLLEPC*SHYR.F
136 96 170 Q96CM8
ACSF2 Acyl-CoA synthetase family 
member 2, mitochondrial ACSF2 R.MVSTPIGGLSYVQGC*TK.K
491 293 171 Q15019 SEPT2 Septin-2 42249 R.LTVVDTPGYGDAINC*R.D
178 327 172 P23396 RPS3 40S ribosomal protein S3 RPS3 R.GLC*AIAQAESLR.Y
70 212 173 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 R.AVASQLDC*NFLK.V
236 60 174 Q9H479 FN3K Fructosamine-3-kinase FN3K R.AFGGPGAGC*ISEGR.A
172 297 175 Q13155 AIMP2 Aminoacyl tRNA synthase complex-interacting multif AIMP2 K.FSIQTMC*PIEGEGNIAR.F
132 252 176 P53618 COPB1 Coatomer subunit beta COPB1 K.VLSECSPLMNDIFNKEC*R.Q
486 319 177 P30519 HMOX2 Heme oxygenase 2 HMOX2 K.CPFYAAEQDKGALEGSSC*PFR.T
195 224 178 P23919 DTYMK Thymidylate kinase DTYMK K.LVEALC*AAGHR.A
171 168 179 Q6ZRV2 FAM83H Protein FAM83H FAM83H R.TVAGPTYYC*R.T
478 269 180 P49321 NASP Nuclear autoantigenic sperm protein NASP R.KPTDGASSSNC*VTDISHLVR.K
165 164 181 P55060 CSE1L Exportin-2 CSE1L K.NLFEDQNTLTSIC*EK.V
85 126 182 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 K.SGDAAIVEMVPGKPMC*VESFSQYPPLGR.F
374 273 183 P21333 FLNA Filamin-A FLNA K.THEAEIVEGENHTYC*IR.F
377 642 184 Q6IA86 ELP2 Elongator complex protein 2 ELP2 K.TLLASAC*K.A
280 215 185 P62910 RPL32 60S ribosomal protein L32 RPL32 K.SYC*AEIAHNVSSK.N
160 232 186 Q8WTW3
COG1 Conserved oligomeric Golgi 
complex subunit 1 COG1 K.AQAISPC*VQNFCSALDSK.L
490 291 187 A6NDG6 PGP Phosphoglycolate phosphatase PGP K.NNQESDC*VSK.K
359 577 188 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 K.C*SPIGVYTSGK.G
475 437 189 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 R.TDFQQGC*AK.T
115 270 190 Q8WXG6
MADD MAP kinase-activating death 
domain protein MADD K.LINMTYC*PK.T
126 79 191 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 R.LIGPNC*PGVINPGEC*K.I
678 179 192 P53621 COPA Coatomer subunit alpha COPA R.TTYQALPC*LPSMYGYPNR.N
188 236 193 P15880 RPS2 40S ribosomal protein S2 RPS2 R.GC*TATLGNFAK.A
626 315 194 P55060 CSE1L Exportin-2 CSE1L K.LSTAC*PGR.V
158 341 195 P57678 GEMIN4 Gem-associated protein 4 GEMIN4 R.SDPDAC*PTMPLLAMLLR.G
65 86 196 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L R.GC*ALQCAILSPAFK.V
112 240 197 P46782 RPS5 40S ribosomal protein S5 RPS5 K.TIAEC*LADELINAAK.G
162 351 198 Q15796 SMAD2 Mothers against decapentaplegic homolog 2 SMAD2 K.AITTQNC*NTK.C
95 68 199 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 R.AGGIETIANEFSDRC*TPSVISFGSK.N
179 145 200 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U 
HNRNP
U K.AVVVC*PK.D
198 246 201 Q969Z0 TBRG4 Protein TBRG4 TBRG4 R.LATDLLSLMPSLTSGEVAHC*AK.S
237 259 202 P53618 COPB1 Coatomer subunit beta COPB1 K.VLSEC*SPLMNDIFNK.E
305
1.7 1.8 1.6 1.9 1.8 1.7 2.7 2.4 3.1 0.0 2.2 2.6 1.9 2.3 2.6 2.1 1.9 2.2
1.8 1.8 1.6 1.8 1.7 1.7 4.3 5.6 3.5 4.9 3.1 4.2 3.6 3.5 5.4 3.9 4.8 4.3
1.8 1.6 1.6 1.9 1.8 1.7 2.4 2.5 2.2 2.6 2.1 2.4 1.3 1.4 2.1 1.6 1.4 1.6
1.8 1.7 1.6 1.8 1.8 1.7 2.3 2.3 2.2 2.1 2.0 2.2 3.0 3.2 4.1 3.3 3.4 3.4
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1.8 0.8 1.8 1.9 1.9 1.7 3.4 3.8 3.5 3.2 3.1 3.4 2.9 2.9 4.4 3.4 3.4 3.4
1.5 1.5 1.6 1.9 1.7 1.7 0.0 2.6 2.9 2.5 2.6 2.7 3.2 2.1 3.8 0.0 3.3 3.1
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375 386 203 P33991 MCM4 DNA replication licensing factor MCM4 MCM4 K.AGIIC*QLNAR.T
595 267 204 Q9Y508 RNF114 RING finger protein 114 RNF114 R.DC*GGAAQLAGPAAEADPLGR.F
217 548 205 P21333 FLNA Filamin-A FLNA R.VTYC*PTEPGNYIINIK.F
128 112 206 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase 
ALDH6A
1 K.AEMDAAIASC*K.R
756 172 207 P10599 TXN Thioredoxin TXN K.C*MPTFQFFK.K
409 185 208 P13639 EEF2 Elongation factor 2 EEF2 K.EGALC*EENMR.G
83 217 209 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.C*ATITPDEAR.V
210 237 210 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5 K.GVC*TEAGMYALR.E
131 47 211 P15924 DSP Desmoplakin DSP R.DANSENC*NK.N
493 396 212 Q0PNE2 ELP6 Elongator complex protein 6 ELP6 R.AEGLATGFC*R.D
67 134 213 Q99836 MYD88 Myeloid differentiation primary response protein M MYD88 R.FITVCDYTNPC*TK.S
260 174 214 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC R.ISAFGYLEC*SAK.T
98 335 215 P23396 RPS3 40S ribosomal protein S3 RPS3 R.AC*YGVLR.F
91 354 216 Q8TEW0 PARD3 Partitioning defective 3 homolog PARD3 K.VTVC*FGR.T
347 428 217 P45880 VDAC2 Voltage-dependent anion-selective channel protein VDAC2 K.SC*SGVEFSTSGSSNTDTGK.V
449 87 218 Q06203 PPAT Amidophosphoribosyltransferase PPAT K.C*ELENCQPFVVETLHGK.I
276 395 219 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.YVLC*TAPR.A
416 59 220 P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT R.VVC*SSGAVGNYSGGLAVK.E
244 454 221 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2 R.VLVVGAGGIGC*ELLK.N
151 150 222 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase 
ALDH18
A1 K.LGSAVVTRGDEC*GLALGR.L
357 159 223 Q9Y6D5




140 260 224 Q29RF7 PDS5A Sister chromatid cohesion protein PDS5 homolog A PDS5A R.ELLDLHKQPTSEANC*SAMFGK.L
318 221 225 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 
DYNC1
H1 K.LQGATC*NNNK.L
455 400 226 Q92797 SYMPK Symplekin SYMPK K.ATNLC*FAER.N
351 183 227 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9 R.TAC*TNFMMTPYVVTR.Y
133 300 228 P46782 RPS5 40S ribosomal protein S5 RPS5 R.VNQAIWLLC*TGAR.E
747 42 229 P10599 TXN Thioredoxin TXN K.LVVVDFSATWC*GPC*K.M
589 302 230 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 R.GC*AFVTFTTR.A
176 253 231 P50991 CCT4 T-complex protein 1 subunit delta CCT4 K.ITGC*ASPGK.T
175 156 232 Q9Y5Q8
GTF3C5 General transcription factor 3C 
polypeptide 5 GTF3C5 R.VC*TNPVDR.K
259 294 233 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 R.ANSSVVSVNC*K.G
262 287 234 Q96CD2 PPCDC Phosphopantothenoylcysteine decarboxylase PPCDC K.ASC*PAAAPLMER.K
331 439 235 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.TLTSC*FLSCVVCVEGIVTK.C
330 367 236 B5ME19
EIF3CL Eukaryotic translation initiation 
factor 3 subunit EIF3CL R.GC*ILTLVER.M
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1.7 1.7 1.5 1.7 1.6 1.6 0.0 1.9 2.3 2.1 1.9 2.0 4.4 0.0 6.9 5.2 6.1 5.6
1.8 1.4 1.6 0.0 0.0 1.6 1.5 1.6 0.0 0.0 2.3 1.8 1.9 2.1 1.8 1.9 2.0 1.9
1.6 1.3 1.4 1.7 2.1 1.6 4.7 3.9 5.1 3.5 4.7 4.4 1.4 1.5 1.9 1.7 1.6 1.6
1.6 1.5 1.6 1.6 1.6 1.6 2.0 2.0 2.1 0.0 1.6 1.9 2.0 2.3 2.9 2.2 2.6 2.4
1.7 1.6 1.4 1.6 1.7 1.6 6.1 5.2 3.3 4.1 5.0 4.7 1.6 1.7 1.9 1.8 1.7 1.7
1.6 1.5 1.6 1.7 1.5 1.6 1.4 1.8 1.7 1.8 1.8 1.7 2.0 2.2 3.3 2.5 3.2 2.7
1.7 1.5 1.5 1.7 1.6 1.6 2.8 3.6 3.3 3.7 3.2 3.3 3.7 3.4 4.6 4.1 3.9 3.9
0.0 0.0 1.7 1.6 1.6 1.6 4.6 3.3 2.8 3.2 2.2 3.2 1.5 1.9 2.2 2.0 2.0 1.9
1.3 1.5 1.4 1.5 2.3 1.6 2.9 2.3 3.0 2.6 1.9 2.6 3.7 3.8 4.9 3.8 4.6 4.2
1.8 1.9 1.5 1.5 1.2 1.6 1.9 3.6 3.0 3.4 2.2 2.8 1.4 2.1 2.3 2.0 2.8 2.1
0.0 1.5 1.5 1.8 1.6 1.6 2.1 1.5 1.9 1.9 2.1 1.9 2.0 1.3 1.9 1.2 1.8 1.6
1.6 1.4 1.6 1.6 1.7 1.6 3.0 3.6 2.9 2.8 2.8 3.0 1.8 1.8 2.3 1.9 2.0 1.9
1.6 1.5 0.0 0.0 1.6 1.6 2.4 2.5 2.6 2.3 1.8 2.3 3.8 3.7 5.3 3.5 5.6 4.4
1.5 1.2 2.1 1.7 1.4 1.6 6.0 7.7 3.3 5.2 4.4 5.3 0.6 0.6 0.9 0.9 0.8 0.8
1.8 1.5 1.5 1.5 1.7 1.6 1.8 2.4 2.6 2.6 2.2 2.3 1.2 1.4 1.6 1.5 1.3 1.4
1.6 1.4 1.7 1.7 1.5 1.6 3.0 3.1 2.2 2.3 2.5 2.6 2.1 4.7 3.9 3.5 2.8 3.4
1.6 1.1 1.7 2.0 1.5 1.6 4.0 0.0 3.4 3.1 2.6 3.3 2.6 3.9 0.0 3.9 3.2 3.4
1.7 1.4 1.6 1.8 1.5 1.6 2.4 2.3 2.2 2.7 2.2 2.4 2.0 2.4 3.0 2.5 2.7 2.5
1.4 1.5 1.7 1.8 1.6 1.6 3.0 2.2 2.1 2.2 2.5 2.4 1.9 2.5 3.0 2.6 2.6 2.5
2.4 1.4 1.1 1.6 1.4 1.6 0.0 1.9 1.7 2.0 1.6 1.8 2.2 1.6 2.7 2.2 1.5 2.0
1.6 0.0 1.7 1.1 2.0 1.6 2.0 1.9 2.0 0.0 2.0 2.0 2.0 2.1 2.8 2.3 1.0 2.0
308
120 128 237 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 K.HLC*QQLQAEQAAAEK.R
97 370 238 P46782 RPS5 40S ribosomal protein S5 RPS5 K.AQC*PIVER.L
639 366 239 Q00765 REEP5 Receptor expression-enhancing protein 5 REEP5 K.NC*MTDLLAK.L
452 401 240 P14678 SNRPB Small nuclear ribonucleoprotein-associated protein SNRPB R.C*ILQDGR.I
212 281 241 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.LGVENC*YFPMFVSQSALEK.E
501 204 242 Q96I99 SUCLG2 Succinyl-CoA ligase SUCLG2 R.SC*NGPVLVGSPQGGVDIEEVAASNPELIFK.E
302 230 243 Q7Z2W4




148 261 244 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA K.VNLQMVYDSPLC*R.L
123 284 245 P60866 RPS20 40S ribosomal protein S20 RPS20 K.TPC*GEGSK.T
122 344 246 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.VC*VETVESGAMTK.D
422 398 247 P41240 CSK Tyrosine-protein kinase CSK CSK R.SVLGGDC*LLK.F





569 321 249 P60981 DSTN Destrin DSTN K.HEC*QANGPEDLNR.A
570 324 250 Q6XZF7 DNMBP Dynamin-binding protein DNMBP R.SLDQTSPC*PLVLVR.I
135 109 251 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 R.GNVC*GDSK.S
369 416 252 O75439 PMPCB Mitochondrial-processing peptidase subunit beta PMPCB R.LC*TSVTESEVAR.A
642 325 253 P0CW22 RPS17L 40S ribosomal protein S17-like RPS17L R.VC*EEIAIIPSK.K
339 464 254 P61247 RPS3A 40S ribosomal protein S3a RPS3A R.LFC*VGFTK.K
635 317 255 P55263 ADK Adenosine kinase ADK R.TGC*TFPEKPDFH.-
647 478 256 Q96EY5 FAM125A Multivesicular body subunit 12A 
FAM125
A K.SC*SPLAFSAFGDLTIK.S
246 58 257 P19838 NFKB1 Nuclear factor NF-kappa-B p105 subunit NFKB1 R.YVC*EGPSHGGLPGASSEK.N
79 264 258 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 K.GC*LLYGPPGTGK.T
42 376 259 P58107 EPPK1 Epiplakin EPPK1 R.YLC*GLGAVGGVR.L
221 365 260 Q9P2R7 SUCLA2 Succinyl-CoA ligase SUCLA2 R.IC*NQVLVCER.K
111 262 261 P35914 HMGCL Hydroxymethylglutaryl-CoA lyase, mitochondrial HMGCL K.LLEAGNFIC*QALNR.K
372 166 262 Q9BUL9 RPP25 Ribonuclease P protein subunit p25 RPP25
R.SEEAPAGC*GAEGGGPGSGPFADLA
PGAVHMR.V
75 279 263 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.DLAGC*IHGLSNVK.L
211 286 264 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1 K.AIC*TEAGLMALR.E
107 147 265 Q13418 ILK Integrin-linked protein kinase ILK K.FSFQC*PGR.M
539 225 266 Q93052 LPP Lipoma-preferred partner LPP K.TYITDPVSAPC*APPLQPK.G
182 301 267 Q13155 AIMP2 Aminoacyl tRNA synthase complex-interacting multif AIMP2 R.SC*ENLAPFNTALK.L
333 357 268 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U 
HNRNP
U K.DC*EVVMMIGLPGAGK.T
396 504 269 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 R.LSTLC*PSAVLQR.L
652 489 270 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 K.C*QTSMDELLK.E
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1.7 0.9 1.6 1.6 1.9 1.6 0.0 4.1 3.7 2.8 3.9 3.6 4.0 5.0 5.4 0.0 4.5 4.7
1.6 1.6 1.3 1.7 1.6 1.6 2.0 2.3 1.7 2.0 1.9 2.0 5.1 5.1 6.0 5.9 5.1 5.4
0.0 1.5 1.3 2.1 1.4 1.6 2.1 2.0 1.9 2.1 1.9 2.0 1.2 1.3 0.0 1.3 1.4 1.3
1.6 0.0 1.4 1.7 1.5 1.6 1.6 1.9 2.1 2.2 1.7 1.9 1.3 2.0 1.6 1.7 0.0 1.6
0.0 1.3 1.3 1.8 1.8 1.5 2.6 2.8 2.4 2.3 2.2 2.4 2.6 2.6 3.5 3.1 3.2 3.0
1.6 1.4 1.4 1.7 1.6 1.5 3.0 2.9 2.8 3.0 2.9 2.9 1.4 1.4 1.4 1.9 1.7 1.5
1.2 1.3 1.6 1.9 1.7 1.5 3.8 2.5 2.3 2.9 2.3 2.8 2.1 2.5 2.7 1.8 1.9 2.2
1.1 1.5 1.6 2.0 1.6 1.5 2.9 3.0 2.5 2.4 2.0 2.5 4.6 3.0 4.4 0.0 3.9 4.0
1.6 1.5 1.5 1.7 1.5 1.5 2.6 2.6 2.4 2.3 2.2 2.4 3.9 4.0 5.7 4.7 4.7 4.6
1.4 1.4 1.4 2.0 1.5 1.5 2.1 2.1 2.1 2.4 1.7 2.1 3.5 5.0 4.4 5.2 5.3 4.7
0.0 1.4 1.4 1.6 1.7 1.5 2.5 1.8 1.8 0.0 1.5 1.9 1.6 1.7 0.0 1.8 1.7 1.7
1.6 1.5 1.4 1.6 1.6 1.5 2.2 2.9 2.4 2.4 2.0 2.4 1.7 1.9 2.3 0.0 2.1 2.0
1.5 1.4 1.7 1.6 1.5 1.5 1.9 2.3 2.4 2.6 1.9 2.2 1.3 1.2 1.5 1.4 1.8 1.4
1.2 2.0 1.4 1.5 1.5 1.5 0.0 2.6 1.2 2.9 2.0 2.2 1.6 1.2 0.0 1.6 1.4 1.4
1.5 1.6 1.4 1.8 1.3 1.5 0.0 3.5 4.2 3.5 4.6 4.0 3.8 4.0 5.2 4.1 4.3 4.3
2.0 1.6 1.4 1.3 1.3 1.5 1.5 2.1 1.9 0.0 0.0 1.8 1.7 0.0 0.0 2.1 1.7 1.9
1.5 1.4 1.6 1.7 1.5 1.5 2.3 2.3 2.3 2.1 2.0 2.2 1.2 1.4 1.3 1.3 1.4 1.3
1.6 1.6 1.6 1.2 1.6 1.5 1.9 1.8 1.7 1.4 1.5 1.7 1.7 1.6 2.3 2.2 2.3 2.0
1.4 1.4 1.4 1.8 1.5 1.5 0.0 2.1 2.6 2.3 1.8 2.2 1.2 1.3 1.5 1.3 1.3 1.3
1.1 1.5 1.5 2.1 1.4 1.5 1.9 1.9 1.7 1.3 1.4 1.6 1.1 1.1 1.6 1.2 1.4 1.3
1.5 1.5 1.5 1.6 1.5 1.5 5.1 5.1 3.5 0.0 5.2 4.7 2.5 2.4 3.2 2.7 2.4 2.6
1.5 1.8 0.7 1.8 1.7 1.5 2.1 3.0 0.9 3.0 3.6 2.5 7.1 5.5 5.2 0.0 6.6 6.1
1.4 1.6 1.3 1.5 1.6 1.5 1.9 2.1 1.8 2.0 2.0 2.0 6.9 6.8 11.4 7.5 7.4 8.0
1.7 1.1 1.8 0.0 1.4 1.5 2.2 1.8 2.1 1.9 1.9 2.0 0.0 3.9 3.3 2.4 1.9 2.9
1.4 1.3 1.6 1.7 1.5 1.5 2.4 2.5 2.6 2.7 2.5 2.5 5.0 4.3 0.0 0.0 5.7 5.0
1.4 1.5 1.5 1.5 1.5 1.5 3.5 3.3 3.2 3.6 2.3 3.2 1.6 0.0 2.2 1.8 1.9 1.8
1.5 1.4 1.5 1.7 1.5 1.5 2.7 2.8 1.8 2.7 2.3 2.5 5.2 5.9 7.3 6.3 7.1 6.3
1.5 1.4 1.6 1.6 1.4 1.5 2.3 2.5 2.6 2.5 2.1 2.4 0.0 2.5 3.2 2.9 3.5 3.0
1.5 1.3 1.5 1.5 1.6 1.5 4.5 3.6 2.8 3.5 2.4 3.4 4.8 5.3 0.0 4.3 6.3 5.2
1.4 1.4 1.4 1.7 1.5 1.5 3.6 3.4 2.5 2.7 1.8 2.8 1.2 1.4 1.7 1.5 1.5 1.5
1.0 1.7 1.4 1.7 1.6 1.5 2.4 2.2 2.4 2.5 2.1 2.3 2.8 2.7 3.7 3.5 4.0 3.3
2.1 1.6 1.3 1.3 1.1 1.5 2.8 1.8 1.9 1.8 1.7 2.0 1.6 2.5 2.0 1.8 2.2 2.0
1.0 1.8 2.0 1.3 1.2 1.5 1.9 1.1 1.4 2.5 0.8 1.5 1.7 1.6 2.4 0.9 2.4 1.8
1.4 1.0 2.0 1.3 1.6 1.5 1.2 2.4 1.0 1.0 2.5 1.6 1.1 0.0 1.4 1.3 1.4 1.3
310
384 508 271 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD R.TQVC*GILR.E
193 372 272 O00148 DDX39A ATP-dependent RNA helicase DDX39A DDX39A
R.AIVDC*GFEHPSEVQHECIPQAILGM
DVLCQAK.S
400 383 273 Q5T4S7 UBR4 E3 ubiquitin-protein ligase UBR4 UBR4 K.AVQC*LNTSSK.E
232 312 274 Q13636 RAB31 Ras-related protein Rab-31 RAB31 K.VC*LLGDTGVGK.S
101 406 275 P11498 PC Pyruvate carboxylase, mitochondrial PC R.FLYEC*PWR.R
81 91 276 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase 
ALDH6A
1 K.ERVC*NLIDSGTK.E
184 195 277 O14976 GAK Cyclin-G-associated kinase GAK R.AIIQEVC*FMK.K
645 268 278 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 K.VVLLGEGC*VGK.T
573 333 279 O15355 PPM1G Protein phosphatase 1G PPM1G K.C*SGDGVGAPR.L
436 424 280 Q9Y277 VDAC3 Voltage-dependent anion-selective channel protein VDAC3 K.VC*NYGLTFTQK.W
46 363 281 P09429 HMGB1 High mobility group protein B1 HMGB1 K.MSSYAFFVQTC*R.E
147 337 282 P62241 RPS8 40S ribosomal protein S8 RPS8 R.LDVGNFSWGSEC*CTR.K
332 175 283 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 R.ASYFQC*VQR.E
315 440 284 Q9NY27
PPP4R2 Serine/threonine-protein 
phosphatase 4 regulatory PPP4R2 K.EVC*PVLDQFLCHVAK.T
154 142 285 P51153 RAB13 Ras-related protein Rab-13 RAB13 R.LLLGNKC*DMEAK.R
373 255 286 Q06330 RBPJ Recombining binding protein suppressor of hairless RBPJ R.IIQFQATPC*PK.E
268 122 287 P46013 MKI67 Antigen KI-67 MKI67 R.KADVEGELLAC*R.N
185 254 288 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1
K.QGEYGLASIC*NGGGGASAMLIQK.
L
288 443 289 Q9Y2Q3 GSTK1 Glutathione S-transferase kappa 1 GSTK1 K.ETTEAAC*R.Y
397 450 290 Q00610 CLTC Clathrin heavy chain 1 CLTC R.IHEGC*EEPATHNALAK.I
417 407 291 P50570 DNM2 Dynamin-2 DNM2 K.LQDAFSSIGQSC*HLDLPQIAVVGGQSAGK.S
574 616 292 P21333 FLNA Filamin-A FLNA K.AHVVPC*FDASK.V
248 274 293 Q14C86 GAPVD1 GTPase-activating protein and VPS9 domain-containi GAPVD1 R.FSLC*SDNLEGISEGPSNR.S
616 473 294 Q9UJU6 DBNL Drebrin-like protein DBNL R.AEEDVEPEC*IMEK.V
142 377 295 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.TVLIAC*NVK.Q
631 19 296 Q9Y3A3 MOB4 MOB-like protein phocein MOB4 R.HTLDGAAC*LLNSNK.Y
287 622 297 Q969H4 CNKSR1 Connector enhancer of kinase suppressor of ras 1 CNKSR1 K.NLLQLC*PQSLEALAVR.S
234 313 298 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.HIIEDPC*TLR.H
194 162 299 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58
R.ADHQPLTEASYVNLPTIALC*NTDSP
LR.Y
442 360 300 P49327 FASN Fatty acid synthase FASN K.ADEASELAC*PTPK.E
329 409 301 Q6P996 PDXDC1 Pyridoxal-dependent decarboxylase domain-containin PDXDC1 R.HSC*DALNR.W
191 191 302 Q27J81 INF2 Inverted formin-2 INF2 R.AVLLASDAQEC*TLEEVVER.L
319 296 303 Q15208 STK38 Serine/threonine-protein kinase 38 STK38 K.LSDFGLC*TGLK.K
582 331 304 Q9H1B7 IRF2BPL Interferon regulatory factor 2-binding protein-lik IRF2BPL
K.EGVPGADMLPQPYLDASC*PMLPT
ALVSLSR.A
150 97 305 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 R.QAVLGAGLPISTPC*TTINK.V
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1.4 1.3 1.5 1.7 1.4 1.5 1.8 1.6 1.5 1.6 1.3 1.5 2.8 1.2 1.7 1.7 1.6 1.8
1.5 0.0 1.3 1.6 1.5 1.5 2.0 2.1 1.9 2.1 1.8 2.0 2.9 2.6 4.1 0.0 3.3 3.2
2.0 1.2 1.3 1.4 1.3 1.5 1.1 2.2 2.0 2.2 2.2 1.9 1.5 1.5 3.0 1.2 1.6 1.8
1.6 1.3 1.5 1.5 1.4 1.5 1.9 2.7 2.2 2.3 2.1 2.2 1.9 2.7 3.7 2.8 2.8 2.8
1.5 1.5 1.4 1.4 1.6 1.5 2.0 2.3 1.7 1.3 2.2 1.9 4.4 0.0 5.7 5.2 6.0 5.3
1.5 1.4 1.4 1.7 1.3 1.5 3.4 5.2 3.9 4.5 4.7 4.3 4.7 4.1 7.8 7.7 5.8 6.0
0.0 1.5 1.5 1.5 1.3 1.5 4.6 2.9 2.1 3.2 1.9 3.0 2.7 3.0 3.8 3.4 3.7 3.3
1.4 1.4 1.4 1.6 1.5 1.4 2.9 2.6 2.3 2.4 2.3 2.5 1.1 1.3 1.5 1.2 1.4 1.3
1.3 1.5 1.5 1.5 1.5 1.4 2.3 2.1 1.9 2.6 1.8 2.1 1.2 1.3 1.8 1.5 1.5 1.4
0.0 1.3 1.9 1.6 1.0 1.4 1.9 1.9 2.1 1.5 1.6 1.8 1.3 1.7 2.0 1.5 1.8 1.6
1.4 1.7 1.4 1.4 1.4 1.4 0.6 0.0 1.1 4.1 2.2 2.0 5.0 0.0 11.2 0.0 7.0 7.7
0.0 1.3 1.5 1.6 1.4 1.4 2.4 0.0 2.1 0.0 1.8 2.1 3.4 3.4 5.6 0.0 3.6 4.0
1.5 1.4 1.3 1.5 1.5 1.4 3.6 3.3 3.2 2.9 2.5 3.1 1.8 1.9 2.4 2.2 1.9 2.0
1.4 1.3 1.3 1.4 1.8 1.4 1.6 1.7 1.7 2.0 1.8 1.8 2.7 1.4 2.5 1.8 2.2 2.1
1.4 1.4 1.4 1.6 0.0 1.4 4.2 0.0 3.8 2.6 3.0 3.4 2.7 3.0 3.5 7.1 3.2 3.9
1.1 2.0 1.0 0.0 1.7 1.4 2.6 2.6 2.2 3.3 2.3 2.6 0.0 1.5 2.5 1.5 0.0 1.8
0.0 1.3 1.3 2.2 1.0 1.4 0.0 4.4 3.5 0.0 3.3 3.7 2.3 0.0 0.0 2.4 2.8 2.5
0.0 1.7 1.2 1.5 1.3 1.4 2.9 2.8 2.4 2.5 2.5 2.6 3.3 3.1 3.9 3.1 3.2 3.3
0.0 1.1 1.2 1.9 1.5 1.4 1.8 1.7 1.9 1.6 1.7 1.7 0.0 2.2 2.3 2.4 0.0 2.3
1.6 1.1 1.4 1.6 1.5 1.4 2.6 1.6 1.4 1.3 1.6 1.7 1.6 1.7 1.8 1.9 1.8 1.8
1.6 1.4 1.3 0.0 1.5 1.4 0.0 2.2 0.0 1.9 1.6 1.9 1.2 0.0 2.0 0.0 2.0 1.7
0.0 1.2 1.9 0.0 1.2 1.4 1.4 1.2 1.2 1.2 1.1 1.2 1.3 1.3 1.8 1.3 1.5 1.4
1.2 1.8 1.1 1.5 0.0 1.4 2.6 2.9 2.5 2.5 2.0 2.5 2.2 2.9 2.7 0.0 0.0 2.6
1.1 1.1 1.5 1.7 1.6 1.4 1.7 1.4 1.8 1.4 1.9 1.6 1.0 1.5 1.7 0.0 1.3 1.4
1.4 1.7 1.2 1.3 1.5 1.4 1.4 2.0 2.3 2.0 2.1 2.0 4.8 0.0 0.0 3.6 4.1 4.1
1.4 1.4 1.4 1.5 1.4 1.4 6.5 7.6 6.4 7.7 6.0 6.9 1.2 1.3 1.5 1.4 1.3 1.3
0.0 1.1 1.4 1.7 1.5 1.4 0.0 1.3 1.2 1.3 1.1 1.2 2.2 0.0 2.7 0.0 2.0 2.3
1.6 1.2 1.3 1.6 1.4 1.4 3.0 2.3 2.1 2.0 1.9 2.2 1.9 2.7 3.4 2.4 3.4 2.8
1.4 1.3 1.5 1.7 1.3 1.4 3.8 3.1 2.9 2.9 3.2 3.2 2.3 3.3 3.4 3.9 3.2 3.2
1.3 1.3 1.3 1.8 1.4 1.4 2.2 2.2 1.6 2.4 1.6 2.0 1.3 1.8 2.0 1.8 1.4 1.6
1.2 1.6 0.0 1.4 1.4 1.4 0.0 1.4 1.5 2.6 0.0 1.9 0.0 1.5 2.7 2.0 0.0 2.0
1.5 1.0 1.5 2.0 1.1 1.4 3.3 3.2 2.2 3.1 3.1 3.0 2.6 2.5 3.9 3.6 3.5 3.2
1.6 1.6 1.3 1.2 1.3 1.4 3.4 2.1 2.1 0.0 1.8 2.3 2.0 2.1 2.5 1.9 1.9 2.1
1.6 0.0 1.0 1.6 0.0 1.4 0.0 2.4 2.2 2.6 1.5 2.2 1.2 1.5 1.5 0.0 1.5 1.4
1.3 1.4 1.4 1.4 1.4 1.4 4.3 4.9 3.7 4.4 3.9 4.2 3.5 4.1 4.4 3.8 4.0 4.0
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296 231 306 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP R.NPVSQC*MR.G
403 322 307 Q05655 PRKCD Protein kinase C delta type PRKCD K.VLMSVQYFLEDVDC*K.Q
381 587 308 Q8N1F7 NUP93 Nuclear pore complex protein Nup93 NUP93 K.SSGQSAQLLSHEPGDPPC*LR.R
402 472 309 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 K.NC*IGDFLK.T
25 233 310 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.PMC*VESFSDYPPLGR.F
519 570 311 A0AVT1
UBA6 Ubiquitin-like modifier-activating 
enzyme 6 UBA6 R.KPNVGC*QQDSEELLK.L
218 538 312 P84085 ARF5 ADP-ribosylation factor 5 ARF5 K.NIC*FTVWDVGGQDK.I
214 272 313 P62316 SNRPD2 Small nuclear ribonucleoprotein Sm D2 SNRPD2 K.NNTQVLINC*R.N
152 332 314 P18085 ARF4 ADP-ribosylation factor 4 ARF4 K.NIC*FTVWDVGGQDR.I
365 492 315 Q6P2E9 EDC4 Enhancer of mRNA-decapping protein 4 EDC4 K.SC*QAMFQQINDSFR.L
354 389 316 Q96EB1 ELP4 Elongator complex protein 4 ELP4 K.VEPC*SLTPGYTK.L
673 288 317 P22102 GART Trifunctional purine biosynthetic protein adenosin GART K.QVLVAPGNAGTAC*SEK.I
432 299 318 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 R.TPC*NAGTFSQPEK.V
228 116 319 Q9ULV4 CORO1C Coronin-1C CORO1C K.C*DLISIPK.K
274 234 320 P63220 RPS21 40S ribosomal protein S21 RPS21 K.TYAIC*GAIR.R
360 578 321 Q9BXJ9 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subun NAA15 R.LFNTAVC*ESK.D
627 491 322 P22314 UBA1 Ubiquitin-like modifier-activating enzyme 1 UBA1 K.SIPIC*TLK.N
281 258 323 P49327 FASN Fatty acid synthase FASN R.LSIPTYGLQC*TR.A
257 241 324 Q9UN37
VPS4A Vacuolar protein sorting-associated 
protein 4A VPS4A K.LLEPVVC*MSDMLR.S
261 345 325 Q15813 TBCE Tubulin-specific chaperone E TBCE R.NCAVSC*AGEK.G
414 298 326 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.C*NTNTAIELK.L
448 420 327 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.SQETEC*TYFSTPLLLGK.K
395 369 328 P49368 CCT3 T-complex protein 1 subunit gamma CCT3 R.TLIQNC*GASTIR.L
54 99 329 P48556 PSMD8 26S proteasome non-ATPase regulatory subunit 8 PSMD8 K.C*GEELGR.L
202 280 330 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 R.YVDIAIPC*NNK.G
279 285 331 P67936 TPM4 Tropomyosin alpha-4 chain TPM4 K.EENVGLHQTLDQTLNELNC*I.-
286 385 332 P20073 ANXA7 Annexin A7 ANXA7 R.LGTDESC*FNMILATR.S
64 12 333 Q9GZZ9




458 399 334 Q9Y3D2




440 124 335 P12532 CKMT1B Creatine kinase U-type, mitochondrial 
CKMT1
B R.LGYILTC*PSNLGTGLR.A
102 243 336 Q9NP73 ALG13 UDP-N-acetylglucosamine transferase subunit ALG13 ALG13 K.ADLVISHAGAGSC*LETLEK.G
368 637 337 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNP
H1 R.FFSDC*K.I
460 482 338 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.DQSAQC*TASK.S
255 170 339 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 K.DGLTDVYNKIHMGSC*AENTAK.K
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513 417 340 P49189 ALDH9A1 4-trimethylaminobutyraldehyde dehydrogenase 
ALDH9A
1 K.GALMANFLTQGQVC*CNGTR.V
511 500 341 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O R.C*YNEMALIR.V
103 266 342 Q9NUU7
DDX19A ATP-dependent RNA helicase 
DDX19A DDX19A K.VLVTTNVC*AR.G
509 445 343 Q14139 UBE4A Ubiquitin conjugation factor E4 A UBE4A R.SQQEIC*EQLNINHMIQR.I
180 355 344 Q9BTE3 MCMBP Mini-chromosome maintenance complex-binding protei MCMBP R.DASALLDPMEC*TDTAEEQR.V
617 746 345 P19367 HK1 Hexokinase-1 HK1 R.AAQLC*GAGMAAVVDK.I
435 447 346 P15924 DSP Desmoplakin DSP K.NQC*TQVVQER.E
269 197 347 P34897 SHMT2 Serine hydroxymethyltransferase, mitochondrial SHMT2 R.AALEALGSC*LNNK.Y
401 304 348 E7EQ34 GOSR2 Golgi SNAP receptor complex member 2 GOSR2 K.QVHEIQSC*MGR.L
387 397 349 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP R.ISASC*QHPTAFEEAIPK.S
453 502 350 H3BQZ7 Uncharacterized protein 
Uncharac
terized K.EGC*TEVSLLR.V
549 497 351 P49327 FASN Fatty acid synthase FASN K.AINC*ATSGVVGLVNCLR.R
701 503 352 P49915 GMPS GMP synthase GMPS R.VICAEEPYIC*K.D
343 404 353 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.NMITGTSQADC*AVLIVAAGVGEFEAGISK.N
653 467 354 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM K.C*C*SGAIIVLTK.S
362 277 355 Q9UHD8 SEPT9 Septin-9 42256 R.SQEATEAAPSC*VGDMADTPR.D
292 348 356 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.VDENFDC*VEADDVEGK.I
82 573 357 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.SSGGFVWAC*K.N
352 374 358 P61247 RPS3A 40S ribosomal protein S3a RPS3A K.AC*QSIYPLHDVFVR.K
405 392 359 P15924 DSP Desmoplakin DSP K.AC*GSEIMQK.K
325 249 360 Q86XN7 PROSER1 Proline and serine-rich protein 1 
PROSER
1 K.DGEEC*TNEGK.G
411 393 361 P33316 DUT Deoxyuridine 5-triphosphate nucleotidohydrolase, DUT R.IAQLIC*ER.I
420 514 362 Q9Y296 TRAPPC4 Trafficking protein particle complex subunit 4 
TRAPPC
4 R.C*ELFDQNLK.L
385 121 363 P13639 EEF2 Elongation factor 2 EEF2 K.STLTDSLVC*K.A
169 318 364 P21964 COMT Catechol O-methyltransferase COMT R.GSSC*FECTHYQSFLEYR.E
267 364 365 P62633 CNBP Cellular nucleic acid-binding protein CNBP R.C*GESGHLAR.E
206 226 366 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 K.KLLDLVQQSC*NYK.Q
284 138 367 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 R.AAVEEGIVLGGGC*ALLR.C
201 167 368 Q9HCC0
MCCC2 Methylcrotonoyl-CoA carboxylase 
beta chain, mitoch MCCC2 K.AATGEEVSAEDLGGADLHC*R.K
447 419 369 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 K.VDVFREDLC*TK.T
464 488 370 Q9P1F3 ABRACL Costars family protein ABRACL ABRACL K.C*ANLFEALVGTLK.A
163 512 371 Q13330 MTA1 Metastasis-associated protein MTA1 MTA1 R.ALDC*SSSVR.Q
204 90 372 O15075 DCLK1 Serine/threonine-protein kinase DCLK1 DCLK1 R.YQDDFLLDESEC*R.V
532 493 373 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 R.LLDRDAC*DTVR.V
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525 495 374 Q9NQC3 RTN4 Reticulon-4 RTN4 K.YSNSALGHVNC*TIK.E
388 442 375 Q9NSD9
FARSB Phenylalanine--tRNA ligase beta 
subunit FARSB K.EYTAC*ELMNIYK.T
561 543 376 Q15459 SF3A1 Splicing factor 3A subunit 1 SF3A1 R.EVLDQVC*YR.V
290 127 377 Q86YS7 KIAA0528 Uncharacterized protein KIAA0528 
KIAA052
8 R.SAPPC*ANSTVGVVK.M
410 412 378 Q7L5D6 GET4 Golgi to ER traffic protein 4 homolog GET4 K.EQNYC*ESR.Y
197 308 379 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 K.IIDINYYPVPEAC*LSNK.R
390 483 380 Q13045 FLII Protein flightless-1 homolog FLII R.TGLC*YLPEELAALQK.L
355 38 381 Q9HA64 FN3KRP Ketosamine-3-kinase FN3KRP R.ATGHSGGGC*ISQGR.S
312 509 382 Q96P48 ARAP1 Arf-GAP with Rho-GAP domain, ANK repeat and PH dom ARAP1 R.AVFPEGPC*EEPLQLR.K
419 146 383 Q06587 RING1 E3 ubiquitin-protein ligase RING1 RING1 R.FC*SDCIVTALR.S
199 481 384 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 K.C*VVVGDGAVGK.T
313 477 385 Q7Z4W1 DCXR L-xylulose reductase DCXR R.AVTNHSVYC*STK.G
546 388 386 P60763 RAC3 Ras-related C3 botulinum toxin substrate 3 RAC3 R.AVLC*PPPVK.K
225 451 387 Q9Y2S7 POLDIP2 Polymerase delta-interacting protein 2 POLDIP2 R.DC*PHISQR.S
438 320 388 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I
366 527 389 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNP
H1 R.GLPFGC*SK.E
737 555 390 Q15257 PPP2R4 Serine/threonine-protein phosphatase 2A activator PPP2R4 R.IDYGTGHEAAFAAFLC*C*LC*K.I
566 342 391 Q8IWX8
CHERP Calcium homeostasis endoplasmic 
reticulum protein CHERP K.LALEQQQLIC*K.Q
121 589 392 O43865 AHCYL1 Putative adenosylhomocysteinase 2 AHCYL1 K.LC*VPAMNVNDSVTK.Q
610 209 393 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R 
HNRNP
R K.SAFLC*GVMK.T
294 114 394 Q8NBF2 NHLRC2 NHL repeat-containing protein 2 NHLRC2 K.AILFSQPLQITDTQQGC*IAPVELR.Y
412 353 395 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 R.NLADC*LR.S
516 534 396 Q9UPM8 AP4E1 AP-4 complex subunit epsilon-1 AP4E1 R.SSC*STLPDYLLYQCQK.V
700 690 397 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.AGSDGAKIGNC*PFSQR.L
346 468 398 O75153 KIAA0664 Clustered mitochondria protein homolog 
KIAA066
4 K.C*LTQQAVALQR.T
241 524 399 Q8IXH7 TH1L Negative elongation factor C/D TH1L R.AC*QALGAMLSK.G
406 469 400 Q9H0W8 SMG9 Protein SMG9 SMG9 R.REDFC*PR.K
545 595 401 P13489 RNH1 Ribonuclease inhibitor RNH1 R.ELDLSNNC*LGDAGILQLVESVR.Q
459 238 402 Q8NFG4 FLCN Folliculin FLCN K.VFEAEQFGC*PQR.A





534 519 404 Q6IA69 NADSYN1 Glutamine-dependent NAD(+) synthetase 
NADSY
N1 K.NSSQETC*TR.A
391 27 405 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.IC*PVETLVEEAIQC*AEK.I





423 425 407 P28074 PSMB5 Proteasome subunit beta type-5 PSMB5 K.KVIEINPYLLGTMAGGAADC*SFWER.L
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556 742 408 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 R.LC*YSSDHEK.L
273 329 409 Q9UL15 BAG5 BAG family molecular chaperone regulator 5 BAG5 K.TELQGLIGQLDEVSLEKNPC*IR.E
393 402 410 P37235 HPCAL1 Hippocalcin-like protein 1 HPCAL1 R.LLQC*DPSSASQF.-
503 347 411 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2 R.DLGGIVLANAC*GPCIGQWDR.K
607 517 412 Q7L2H7 EIF3M Eukaryotic translation initiation factor 3 subunit EIF3M K.VAASC*GAIQYIPTELDQVR.K
295 490 413 O14561 NDUFAB1 Acyl carrier protein, mitochondrial 
NDUFAB
1 K.LMC*PQEIVDYIADKK.D
277 125 414 Q13185 CBX3 Chromobox protein homolog 3 CBX3 R.LTWHSC*PEDEAQ.-
258 338 415 Q9BYG5
PARD6B Partitioning defective 6 homolog 
beta PARD6B R.HGAGSGC*LGTMEVK.S
479 528 416 Q96TA1 FAM129B Niban-like protein 1 FAM129B K.GPTKEELC*K.S
472 531 417 Q93009 USP7 Ubiquitin carboxyl-terminal hydrolase 7 USP7 K.GTC*VEGTIPK.L
498 536 418 P08238 HSP90AB1 Heat shock protein HSP 90-beta 
HSP90A
B1 R.VFIMDSC*DELIPEYLNFIR.G
492 208 419 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 R.YEAAFPFLSPC*GR.E
173 328 420 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H 
HNRNP
H1 R.DLNYC*FSGMSDHR.Y
307 436 421 P49840 GSK3A Glycogen synthase kinase-3 alpha GSK3A K.LC*DFGSAK.Q
398 501 422 P49327 FASN Fatty acid synthase FASN K.LTPGC*EAEAETEAICFFVQQFTDMEHNR.V
350 515 423 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9 K.GIGMNEPLVDC*EGYPR.S
340 187 424 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2 R.IENLELMSQHGC*NAWK.V
304 186 425 P63220 RPS21 40S ribosomal protein S21 RPS21 K.C*SASNR.I
278 223 426 Q7Z4W1 DCXR L-xylulose reductase DCXR R.GVPGAIVNVSSQC*SQR.A
114 323 427 P78406 RAE1 mRNA export factor RAE1 K.VFTASC*DK.T
392 295 428 Q15233 NONO Non-POU domain-containing octamer-binding protein NONO R.C*SEGSFLLTTFPR.P
174 394 429 Q9UPN9
TRIM33 E3 ubiquitin-protein ligase 
TRIM33 TRIM33 R.C*DPVPAANGAIR.F
713 705 430 Q9P107 GMIP GEM-interacting protein GMIP R.LC*QAFENGR.A
378 643 431 O95059 RPP14 Ribonuclease P protein subunit p14 RPP14 R.IC*SSGLVK.L
341 292 432 P55263 ADK Adenosine kinase ADK R.SLIANLAAANC*YK.K
540 340 433 Q96RS6 NUDCD1 NudC domain-containing protein 1 
NUDCD
1 R.DSAQC*AAIAER.L
456 434 434 O75390 CS Citrate synthase, mitochondrial CS K.LPC*VAAK.I
209 448 435 O94885 SASH1 SAM and SH3 domain-containing protein 1 SASH1 R.C*GIPEALVQR.Y
473 458 436 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HNRNP
K K.GSDFDC*ELR.L
578 516 437 Q9NYL2
MLTK Mitogen-activated protein kinase 
kinase kinase MLT MLTK K.FDDLQFFENC*GGGSFGSVYR.A
657 507 438 O95336 PGLS 6-phosphogluconolactonase PGLS R.AAC*CLAGAR.A
591 525 439 Q7L1Q6 BZW1 Basic leucine zipper and W2 domain-containing prot BZW1
R.FDPTQFQDC*IIQGLTETGTDLEAVA
K.F
457 547 440 Q9UJW0 DCTN4 Dynactin subunit 4 DCTN4 R.LLQPDFQPVC*ASQLYPR.H
480 627 441 O43795 MYO1B Unconventional myosin-Ib MYO1B K.LVMSYVAAVC*GK.G
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344 459 442 Q9NVU0
POLR3E DNA-directed RNA polymerase 
III subunit RPC5 POLR3E R.AAGTDSFNGHPPQGC*ASTPVAR.E
559 245 443 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5 K.FVVDVDKNIDINDVTPNC*R.V
597 479 444 Q15370 TCEB2 Transcription elongation factor B polypeptide 2 TCEB2
R.ADDTFEALC*IEPFSSPPELPDVMKP
QDSGSSANEQAVQ.-
632 661 445 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 R.VGLGIC*YDMR.F
271 188 446 Q15631 TSN Translin TSN K.ETAAAC*VEK.-
445 461 447 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVDVEVPDVELEC*PDA
K.L
450 470 448 Q2TAA2
IAH1 Isoamyl acetate-hydrolyzing esterase 
1 homolog IAH1 R.VILITPTPLC*ETAWEEQCIIQGCK.L
517 414 449 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 R.KENQWC*EEK.-
693 456 450 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 K.SC*AHDWVYE.-
643 695 451 O43765 SGTA Small glutamine-rich tetratricopeptide repeat-cont SGTA K.AIELNPANAVYFC*NR.A
213 330 452 P51812 RPS6KA3 Ribosomal protein S6 kinase alpha-3 
RPS6KA
3 R.AENGLLMTPC*YTANFVAPEVLK.R
497 373 453 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVGVEVPDVELEC*PDA
K.L
542 647 454 Q9H3U1 UNC45A Protein unc-45 homolog A UNC45A R.AIQTVSC*LLQGPCDAGNR.A
145 729 455 Q12849 GRSF1 G-rich sequence factor 1 GRSF1 R.YIELFLNSC*PK.G
321 247 456 O15355 PPM1G Protein phosphatase 1G PPM1G R.GTEAGQVGEPGIPTGEAGPSC*SSASDK.L
466 518 457 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HNRNP
K K.LFQEC*CPHSTDR.V
434 615 458 O15382 BCAT2 Branched-chain-amino-acid aminotransferase, mitoch BCAT2 R.EVFGSGTAC*QVCPVHR.I
487 632 459 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS K.YAGLSTC*FR.Q
425 452 460 Q8WW01
TSEN15 tRNA-splicing endonuclease 
subunit Sen15 TSEN15 R.GDSEPTPGC*SGLGPGGVR.G
628 545 461 Q16630 CPSF6 Cleavage and polyadenylation specificity factor su CPSF6 R.ELHGQNPVVTPC*NK.Q
289 432 462 P17844 DDX5 Probable ATP-dependent RNA helicase DDX5 DDX5 R.LIDFLEC*GK.T
243 371 463 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.HSMNPFC*EIAVEEAVR.L
275 23 464 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 
HSD17B
10 K.VC*NFLASQVPFPSR.L
638 444 465 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 K.TRPDGNC*FYR.A
746 540 466 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 K.LC*VQNSPQEAR.N
537 597 467 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.HLNEIDLFHC*IDPNDSK.H
78 139 468 Q6YN16
HSDL2 Hydroxysteroid dehydrogenase-
like protein 2 HSDL2 K.TAIHTAAMDMLGGPGIESQC*R.K
470 585 469 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.EGVVEC*SFVK.S
669 176 470 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacti PIN1 K.IKSGEEDFESLASQFSDC*SSAK.A
508 462 471 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1
K.QEPLGSDSEGVNC*LAYDEAIMAQQ
DR.I
118 544 472 O14966 RAB7L1 Ras-related protein Rab-7L1 RAB7L1 K.C*DLSPWAVSR.D
272 80 473 Q9UQ35
SRRM2 Serine/arginine repetitive matrix 
protein 2 SRRM2 R.SVSPC*SNVESR.L
611 346 474 P13639 EEF2 Elongation factor 2 EEF2 R.YVEPIEDVPC*GNIVGLVGVDQFLVK.T
496 605 475 O14980 XPO1 Exportin-1 XPO1 K.LDINLLDNVVNC*LYHGEGAQQR.M
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245 216 477 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB
K.QAIDDDC*NQTGQMTAGFLDWPQG
TFASQVTLEGDKLK.V
672 529 478 Q16854 DGUOK Deoxyguanosine kinase, mitochondrial DGUOK K.AC*TAQSLGNLLDMMYR.E
495 612 479 Q9UK41
VPS28 Vacuolar protein sorting-associated 
protein 28 hom VPS28 R.LDC*PLAMER.I
656 659 480 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS R.TIC*AILENYQTEK.G
187 173 481 P28838 LAP3 Cytosol aminopeptidase LAP3 R.SAGAC*TAAAFLK.E
382 381 482 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.LVVPATQC*GSLIGK.G
463 601 483 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF R.C*NNVLYIR.G
593 609 484 P38646 HSPA9 Stress-70 protein, mitochondrial HSPA9 K.AKC*ELSSSVQTDINLPYLTMDSSGPK.H
5 100 485 Q96BF6 NACC2 Nucleus accumbens-associated protein 2 NACC2 R.NTLANSC*GTGIR.S
655 610 486 P07900 HSP90AA1 Heat shock protein HSP 90-alpha 
HSP90A
A1 R.VFIMDNC*EELIPEYLNFIR.G
504 599 487 P49915 GMPS GMP synthase GMPS K.AC*TTEEDQEK.L
220 422 488 Q9HCC0
MCCC2 Methylcrotonoyl-CoA carboxylase 
beta chain, mitoch MCCC2 K.MVAAVAC*AQVPK.I
624 496 489 O43765 SGTA Small glutamine-rich tetratricopeptide repeat-cont SGTA R.AIC*IDPAYSK.A
485 410 490 Q52LJ0 FAM98B Protein FAM98B FAM98B R.EKTAC*AINK.V
309 368 491 P56381 ATP5E ATP synthase subunit epsilon, mitochondrial ATP5E R.YSQIC*AK.A
137 521 492 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1 R.IIC*SAGLSLLAEER.Q
216 415 493 Q9UNE7 STUB1 E3 ubiquitin-protein ligase CHIP STUB1 R.AQQAC*IEAK.H
444 607 494 P07741 APRT Adenine phosphoribosyltransferase APRT R.VVVVDDLLATGGTMNAAC*ELLGR.L
317 475 495 Q9BSU1 C16orf70 UPF0183 protein C16orf70 C16orf70 R.LLAAGC*GPGLLADAK.M
739 471 496 P43897 TSFM Elongation factor Ts, mitochondrial TSFM R.FEC*GEGEEAAETE.-
636 630 497 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5 K.GTPEQPQC*GFSNAVVQILR.L
324 375 498 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS K.YYRPTEVDFLQGDC*TK.A
594 513 499 O43747 AP1G1 AP-1 complex subunit gamma-1 AP1G1 R.FTC*TVNR.I
300 55 500 Q5MNZ6
WDR45L WD repeat domain 
phosphoinositide-interacting prot WDR45L R.C*NYLALVGGGK.K
394 136 501 Q9BV79 MECR Trans-2-enoyl-CoA reductase, mitochondrial MECR R.LALNC*VGGK.S
623 499 502 O75940 SMNDC1 Survival of motor neuron-related-splicing factor 3
SMNDC
1 K.VGVGTC*GIADKPMTQYQDTSK.Y
676 698 503 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4 K.AGSDGESIGNC*PFSQR.L
323 463 504 P60981 DSTN Destrin DSTN K.C*STPEEIK.K
170 614 505 Q9Y5X2 SNX8 Sorting nexin-8 SNX8 K.ESAQCVGDEFLNC*K.L
680 721 506 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 K.IAAYLQSDQFC*K.M
588 652 507 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 K.GFGFVC*FSSPEEATK.A
523 539 508 P26641 EEF1G Elongation factor 1-gamma EEF1G K.AAAPAPEEEMDEC*EQALAAEPK.A
599 535 509 Q8N6M0
OTUD6B OTU domain-containing protein 
6B OTUD6B K.DC*ALTVVALR.S
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1.2 1.1 1.1 1.3 1.2 1.2 10.6 14.0 7.2 11.6 11.0 10.9 3.4 3.1 4.8 4.4 4.0 4.0
0.0 1.0 1.1 1.3 1.2 1.2 2.4 2.8 3.3 2.9 0.0 2.8 2.0 0.0 3.1 2.6 2.9 2.6
1.1 1.1 1.1 1.4 1.2 1.2 1.8 1.3 1.3 1.5 1.5 1.5 1.2 1.3 1.6 1.1 1.1 1.2
1.1 1.2 1.1 1.3 1.2 1.2 0.0 1.1 1.4 0.0 1.1 1.2 1.5 1.6 0.0 1.4 1.7 1.5
1.2 1.2 1.1 1.2 1.2 1.2 1.2 0.9 1.2 0.0 1.0 1.1 1.1 1.3 0.0 1.3 1.3 1.3
1.1 1.0 1.2 1.4 1.2 1.2 2.8 3.7 3.0 3.1 3.0 3.1 3.0 3.3 3.6 3.7 2.9 3.3
1.2 1.1 1.2 1.2 1.2 1.2 2.3 2.0 1.9 1.9 1.6 1.9 1.9 1.9 2.1 1.8 1.6 1.8
1.2 1.1 1.1 1.2 1.2 1.2 1.4 1.2 1.3 1.3 1.1 1.3 1.4 1.5 2.0 1.5 1.6 1.6
1.1 1.0 1.1 1.4 1.1 1.2 1.4 1.2 1.4 1.1 1.1 1.2 1.1 1.3 1.6 1.5 1.5 1.4
1.2 1.6 0.7 0.0 1.2 1.2 5.1 1.5 4.8 4.7 4.7 4.1 10.2 0.0 19.2 0.0 12.0 13.8
1.2 1.1 1.2 1.3 1.1 1.2 1.4 1.2 1.3 1.2 1.0 1.2 1.2 0.0 0.0 1.3 1.4 1.3
1.3 1.0 1.1 1.2 0.0 1.2 0.0 1.4 1.3 1.1 1.2 1.3 1.2 1.3 2.1 1.6 1.5 1.5
1.2 1.1 1.2 1.2 1.1 1.2 1.2 2.0 1.9 2.4 1.5 1.8 2.3 2.6 3.7 3.1 2.8 2.9
1.5 0.9 1.1 1.2 1.1 1.2 2.1 1.5 1.4 0.0 1.4 1.6 1.2 1.3 1.4 1.5 1.3 1.3
0.0 0.0 1.1 1.1 1.2 1.2 2.8 1.7 1.5 0.0 1.4 1.9 1.4 1.6 0.0 1.6 1.7 1.6
0.0 1.1 1.2 1.3 1.1 1.2 2.3 2.1 1.8 1.8 1.9 2.0 1.8 0.0 2.4 0.0 2.3 2.2
1.2 1.2 1.0 1.2 1.1 1.2 1.9 1.4 1.4 1.4 1.3 1.5 3.9 4.0 4.0 4.5 4.7 4.2
1.1 1.3 1.0 1.2 1.0 1.1 1.9 2.1 2.1 1.5 1.6 1.8 2.2 2.6 3.7 3.3 2.8 2.9
1.0 1.3 1.1 1.2 1.1 1.1 1.1 1.2 1.4 1.3 1.1 1.2 1.5 1.4 2.2 1.6 1.5 1.6
1.1 1.2 1.0 1.1 1.3 1.1 2.2 1.5 1.5 1.7 1.3 1.6 1.8 2.0 2.8 1.8 2.1 2.1
0.8 0.0 1.2 1.3 1.3 1.1 0.7 1.5 2.1 0.0 2.3 1.6 0.8 0.0 1.1 0.0 1.1 1.0
1.2 1.1 1.1 1.2 1.2 1.1 1.4 1.1 1.1 1.2 1.0 1.2 1.2 1.3 1.5 1.3 1.3 1.3
1.2 1.1 1.1 1.3 1.1 1.1 2.3 2.0 1.7 2.1 1.7 2.0 1.5 2.1 2.5 2.1 0.0 2.1
1.2 0.0 1.1 1.2 1.2 1.1 1.8 1.5 1.4 0.0 1.4 1.5 1.3 1.3 0.0 1.4 1.6 1.4
1.1 1.2 1.0 1.1 1.2 1.1 4.5 5.0 4.6 6.3 4.7 5.0 1.9 2.2 2.4 2.4 2.2 2.2
1.3 1.0 1.0 1.1 1.3 1.1 3.1 4.2 3.7 0.0 3.0 3.5 1.5 1.5 0.0 1.7 2.4 1.8
1.0 1.4 1.0 1.2 1.1 1.1 1.9 1.6 1.7 1.4 1.4 1.6 0.0 1.3 1.3 1.4 0.0 1.3
1.1 1.2 1.0 1.2 1.1 1.1 1.0 0.9 1.0 0.9 0.9 1.0 1.5 1.2 1.3 1.1 1.1 1.2
1.1 1.2 1.0 1.2 1.2 1.1 1.5 1.7 1.5 2.3 1.4 1.7 1.5 1.8 2.7 1.8 2.5 2.1
1.0 0.0 1.3 1.1 1.1 1.1 1.3 1.2 1.0 0.0 1.3 1.2 2.5 3.0 3.9 3.7 4.8 3.6
1.2 1.1 1.1 1.2 1.2 1.1 1.0 1.2 0.8 0.5 0.7 0.9 1.1 1.1 1.5 1.2 1.2 1.2
1.0 1.2 1.3 1.2 1.0 1.1 1.1 1.1 1.1 1.2 1.0 1.1 1.2 1.3 1.7 1.2 1.6 1.4
1.2 1.1 1.2 1.1 1.1 1.1 1.7 1.4 1.3 1.5 1.1 1.4 1.4 1.4 1.8 1.5 1.5 1.5
1.1 1.1 1.0 1.2 1.2 1.1 2.0 1.3 1.2 0.0 1.3 1.4 1.3 0.0 0.0 1.6 1.2 1.4
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550 349 510 P78347 GTF2I General transcription factor II-I GTF2I R.SILSPGGSC*GPIK.V
584 532 511 P53602 MVD Diphosphomevalonate decarboxylase MVD R.DGDPLPSSLSC*K.V
736 431 512 P49915 GMPS GMP synthase GMPS K.TVGVQGDC*R.S
356 618 513 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1 K.VIGIEC*SSISDYAVK.I
755 303 514 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.AVYTQDC*PLAAAK.A
327 429 515 Q96SW2 CRBN Protein cereblon CRBN K.VQILPEC*VLPSTMSAVQLESLNK.C
565 460 516 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 R.GCITIIGGGDTATC*C*AK.W
663 117 517 Q9Y2S2 CRYL1 Lambda-crystallin homolog CRYL1 R.VILSSSTSC*LMPSK.L
428 433 518 Q9UI30 TRMT112 tRNA methyltransferase 112 homolog 
TRMT11
2 R.IC*PVEFNPNFVAR.M
183 611 519 Q9UNH7 SNX6 Sorting nexin-6 SNX6 R.IGSSLYALGTQDSTDIC*K.F
348 421 520 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M 
HNRNP
M K.AC*QIFVR.N
709 553 521 Q9Y224 C14orf166 UPF0568 protein C14orf166 C14orf166 K.LTALDYHNPAGFNC*K.D
536 568 522 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F
521 719 523 P34897 SHMT2 Serine hydroxymethyltransferase, mitochondrial SHMT2 R.GLELIASENFC*SR.A
614 679 524 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 K.FIC*EQDHQNFLR.L
380 283 525 P35270 SPR Sepiapterin reductase SPR K.GKLVDC*K.V
558 411 526 P52895 AKR1C2 Aldo-keto reductase family 1 member C2 AKR1C2
R.EEPWVDPNSPVLLEDPVLC*ALAK.
K
579 613 527 Q9Y365 STARD10 PCTP-like protein STARD10 R.MEC*CDVPAETLYDVLHDIEYR.K
469 361 528 Q8N335 GPD1L Glycerol-3-phosphate dehydrogenase 1-like protein GPD1L R.IC*DEITGR.V
413 590 529 P49327 FASN Fatty acid synthase FASN R.AAPLDSIHSLAAYYIDC*IR.Q
557 602 530 Q52LJ0 FAM98B Protein FAM98B FAM98B K.SLC*NLEESITSAGR.D
714 606 531 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/threonine phosphatase 2C ILKAP R.FILLAC*DGLFK.V
336 635 532 P14868 DARS Aspartate--tRNA ligase, cytoplasmic DARS R.LEYC*EALAMLR.E
477 664 533 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL K.LC*FSTAQHAS.-
192 83 534 P45985 MAP2K4 Dual specificity mitogen-activated protein kinase MAP2K4 K.LC*DFGISGQLVDSIAK.T
207 449 535 Q9HCC0
MCCC2 Methylcrotonoyl-CoA carboxylase 
beta chain, mitoch MCCC2
K.NIAQIAVVMGSC*TAGGAYVPAMA
DENIIVR.K
367 466 536 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.INISEGNC*PER.I
580 559 537 Q9BW61
DDA1 DET1- and DDB1-associated 
protein 1 DDA1 R.FHADSVC*K.A
698 571 538 Q9NTK5 OLA1 Obg-like ATPase 1 OLA1
K.STFFNVLTNSQASAENFPFC*TIDPN
ESR.V
754 423 539 Q15181 PPA1 Inorganic pyrophosphatase PPA1 K.GISC*MNTTLSESPFK.C
535 565 540 P36405 ARL3 ADP-ribosylation factor-like protein 3 ARL3 K.LSC*VPVLIFANK.Q
407 465 541 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 K.GLLDVTC*K.T
297 520 542 P00338 LDHA L-lactate dehydrogenase A chain LDHA R.VIGSGC*NLDSAR.F
717 658 543 Q02790 FKBP4 Peptidyl-prolyl cis-trans isomerase FKBP4 FKBP4 K.TQLAVC*QQR.I
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1.1 1.0 1.1 1.2 1.2 1.1 2.3 2.2 2.2 1.9 1.6 2.0 1.3 1.6 1.7 1.4 1.4 1.5
1.1 1.1 1.1 1.2 1.1 1.1 1.6 1.5 1.2 1.4 1.5 1.4 1.7 1.2 1.6 1.2 1.4 1.4
1.3 0.7 1.1 1.3 1.4 1.1 2.2 1.8 1.6 1.8 1.5 1.8 1.2 0.9 0.0 0.0 1.0 1.0
1.1 1.1 1.0 1.2 1.2 1.1 1.3 1.2 1.2 1.2 1.1 1.2 1.8 1.7 2.3 1.8 1.9 1.9
1.1 0.0 0.9 1.3 1.2 1.1 2.3 2.5 2.5 2.0 2.1 2.3 0.4 0.4 0.5 0.4 0.3 0.4
0.9 0.0 0.0 1.4 1.1 1.1 2.1 1.7 1.7 1.7 1.7 1.8 2.0 1.8 2.6 1.9 2.1 2.1
1.1 1.0 1.2 0.0 1.1 1.1 0.0 1.4 0.0 2.0 1.6 1.7 1.4 0.0 1.8 0.0 1.1 1.4
0.0 1.2 1.0 1.2 1.2 1.1 3.8 0.0 3.7 0.0 3.8 3.8 1.2 1.1 1.5 1.3 1.2 1.3
0.9 1.2 1.2 1.2 1.2 1.1 1.8 1.9 1.8 1.8 1.6 1.8 1.3 1.4 2.0 1.7 2.0 1.7
1.1 1.0 1.1 1.2 1.2 1.1 1.7 0.9 1.3 1.1 1.1 1.2 2.8 3.8 3.4 2.9 3.8 3.3
1.2 1.1 1.1 1.0 1.2 1.1 1.9 1.9 1.7 0.0 1.8 1.8 2.0 1.7 2.2 1.8 2.1 1.9
1.1 1.1 1.1 1.2 1.1 1.1 1.4 1.4 1.3 1.5 1.2 1.4 1.0 1.1 1.4 1.2 1.2 1.2
1.3 1.0 1.0 1.2 1.2 1.1 1.6 1.3 1.2 1.2 1.2 1.3 1.4 1.4 1.6 1.5 1.4 1.5
0.0 1.2 0.9 0.0 1.2 1.1 0.8 0.9 0.0 0.0 0.9 0.9 1.3 0.0 1.7 1.3 1.6 1.5
1.0 1.0 1.1 1.3 1.2 1.1 1.1 0.0 1.0 0.0 1.0 1.0 1.2 1.2 1.5 1.5 1.4 1.4
1.2 1.1 1.2 1.1 1.1 1.1 2.5 2.8 2.1 0.0 2.3 2.4 2.4 2.0 2.0 1.4 1.4 1.8
0.0 1.1 1.1 1.3 1.0 1.1 1.8 2.0 1.9 2.0 1.4 1.8 1.3 1.4 1.6 1.5 1.5 1.4
1.1 1.0 1.3 1.1 1.0 1.1 1.6 1.0 1.3 1.2 1.1 1.2 1.2 1.8 1.7 1.2 1.3 1.4
0.0 1.0 1.1 1.2 1.1 1.1 1.6 1.6 3.7 0.0 1.1 2.0 1.4 1.7 0.0 1.7 0.0 1.6
1.1 1.1 1.0 0.0 1.2 1.1 1.1 1.1 1.4 1.5 1.2 1.3 1.6 0.0 2.2 1.5 0.0 1.7
1.2 0.8 1.2 1.2 1.2 1.1 1.6 1.3 1.1 0.0 1.1 1.2 1.2 1.3 0.0 0.0 1.8 1.4
1.0 1.0 1.4 1.2 0.9 1.1 1.6 1.0 1.3 1.2 1.2 1.2 1.5 0.8 1.2 1.1 1.1 1.1
1.1 1.2 1.1 1.0 1.1 1.1 1.4 1.1 1.2 1.1 0.9 1.1 1.9 2.1 0.0 2.1 0.0 2.0
1.2 1.2 1.0 1.1 1.1 1.1 1.2 1.0 1.2 1.0 1.0 1.1 1.4 1.7 1.3 1.5 2.1 1.6
1.2 1.2 0.9 1.3 1.1 1.1 4.7 4.7 4.3 0.0 4.0 4.4 3.2 3.0 3.1 4.7 2.2 3.2
1.3 1.1 1.0 1.0 1.1 1.1 2.0 0.0 2.0 1.4 1.5 1.7 3.4 0.0 0.0 2.6 3.1 3.0
1.1 1.0 1.1 1.2 1.1 1.1 2.0 1.7 1.5 1.7 1.4 1.7 1.6 1.7 2.3 1.8 1.9 1.9
1.1 1.2 1.2 1.0 1.1 1.1 1.8 1.2 1.4 1.2 1.1 1.3 1.1 1.3 2.4 1.1 1.2 1.4
1.2 1.1 0.9 1.1 1.3 1.1 1.5 1.3 1.2 1.5 1.1 1.3 1.2 1.1 0.0 1.3 1.2 1.2
1.2 1.0 1.2 1.1 1.1 1.1 2.5 1.9 1.5 1.5 1.6 1.8 0.4 0.4 0.6 0.4 0.4 0.4
0.0 1.1 1.3 1.0 1.1 1.1 1.6 0.0 1.1 1.2 0.0 1.3 1.0 0.0 2.3 0.0 1.2 1.5
1.1 1.1 1.1 1.1 1.1 1.1 2.1 1.4 1.7 1.7 1.3 1.7 1.4 1.5 2.1 1.8 1.9 1.8
1.1 1.1 1.2 1.1 1.1 1.1 1.0 1.9 1.4 1.8 1.4 1.5 1.8 1.8 2.7 2.5 2.3 2.2
0.8 1.1 1.0 1.4 1.2 1.1 1.1 1.0 1.1 1.2 1.0 1.1 1.0 0.9 1.4 1.1 1.2 1.1
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252 334 544 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.EVIAVSC*GPAQCQETIR.T
316 608 545 P36969 GPX4 Phospholipid hydroperoxide glutathione peroxidase, GPX4 R.YAEC*GLR.I
691 600 546 Q99460 PSMD1 26S proteasome non-ATPase regulatory subunit 1 PSMD1 K.VLTMPETC*R.Y
551 617 547 Q9NYL2
MLTK Mitogen-activated protein kinase 
kinase kinase MLT MLTK K.IC*DFGASR.F
515 554 548 Q5JRX3 PITRM1 Presequence protease, mitochondrial PITRM1 R.SQQSKPQDASC*LPALK.V
251 505 549 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 K.HFLSDTGMAC*R.S
467 413 550 Q9NQ88
TIGAR Fructose-2,6-bisphosphatase 
TIGAR TIGAR K.AAREEC*PVFTPPGGETLDQVK.M
505 603 551 P78347 GTF2I General transcription factor II-I GTF2I K.ITINPGC*VVVDGMPPGVSFK.A
298 487 552 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.LVVPASQC*GSLIGK.G
282 430 553 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.AQC*ETLSPDGLPEEQPQTTK.L
429 561 554 P62826 RAN GTP-binding nuclear protein Ran RAN R.VC*ENIPIVLCGNK.V
681 588 555 Q15149 PLEC Plectin PLEC K.AFC*GFEDPR.T
441 657 556 Q9Y4P1 ATG4B Cysteine protease ATG4B ATG4B K.NFPAIGGTGPTSDTGWGC*MLR.C
547 575 557 Q9NVG8




650 696 558 P62258 YWHAE 14-3-3 protein epsilon YWHAE K.LIC*C*DILDVLDK.H
247 310 559 Q8TB45 DEPTOR DEP domain-containing mTOR-interacting protein DEPTOR K.SPSSQETHDSPFC*LR.K
358 408 560 Q8NDH3




541 552 561 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.LDFVC*SFLQK.N
424 619 562 P36507 MAP2K2 Dual specificity mitogen-activated protein kinase MAP2K2 K.LC*DFGVSGQLIDSMANSFVGTR.S
731 196 563 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.AEGSDVANAVLDGADC*IMLSGETAK.G





585 418 565 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK K.GPFVEAEVPDVDLEC*PDAK.L
533 380 566 P13639 EEF2 Elongation factor 2 EEF2 K.IWC*FGPDGTGPNILTDITK.G
489 566 567 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 K.VTDDLVC*LVYK.T
710 687 568 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 R.FC*PFAER.T
608 441 569 Q8N201 INTS1 Integrator complex subunit 1 INTS1 R.SQDGDTAAC*SLIQAR.L
476 665 570 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS R.SKDGVC*VR.V
738 591 571 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH K.ASVGFGGSC*FQK.D
646 674 572 P50990 CCT8 T-complex protein 1 subunit theta CCT8 K.IAVYSC*PFDGMITETK.G
418 702 573 P60900 PSMA6 Proteasome subunit alpha type-6 PSMA6 R.GKDC*AVIVTQK.K
649 677 574 P55735 SEC13 Protein SEC13 homolog SEC13 R.FASGGC*DNLIK.L





563 624 576 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.AITIAGVPQSVTEC*VK.Q
293 78 577 P62857 RPS28 40S ribosomal protein S28 RPS28 R.TGSQGQC*TQVR.V
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1.1 0.0 1.1 1.3 1.0 1.1 2.2 2.2 2.4 0.0 1.8 2.1 2.1 2.2 3.1 2.9 2.5 2.6
1.1 1.0 1.1 1.2 1.2 1.1 1.5 1.2 1.2 1.3 1.1 1.2 2.0 2.1 0.0 2.2 2.2 2.1
0.0 1.2 0.7 0.0 1.3 1.1 0.9 1.2 2.0 1.6 0.8 1.3 0.0 0.0 1.3 0.9 1.4 1.2
1.0 1.2 0.9 1.2 1.2 1.1 1.5 1.2 1.1 1.1 1.1 1.2 1.6 1.1 1.8 1.2 1.6 1.5
1.2 1.0 1.0 1.4 1.0 1.1 1.5 1.4 1.3 0.0 1.3 1.4 1.0 1.6 1.7 0.0 1.7 1.5
1.2 1.1 1.0 1.1 1.1 1.1 1.6 1.6 0.0 1.6 1.4 1.5 2.6 2.2 2.9 2.6 2.7 2.6
0.0 1.3 1.0 1.1 1.1 1.1 1.9 1.8 2.0 0.0 1.6 1.8 1.3 1.4 1.8 1.7 1.8 1.6
1.1 0.0 1.1 0.0 1.1 1.1 0.0 1.3 0.0 1.2 1.3 1.2 1.3 1.4 1.7 0.0 1.8 1.5
1.1 1.1 1.1 1.1 1.1 1.1 1.9 1.6 1.6 1.5 1.4 1.6 2.0 2.2 2.6 2.3 2.2 2.2
0.0 0.0 1.1 1.1 1.0 1.1 2.0 1.8 1.9 1.7 1.6 1.8 1.7 1.8 3.6 2.4 2.3 2.4
1.0 1.0 1.3 1.0 1.1 1.1 1.1 1.3 1.4 1.6 1.2 1.3 1.3 1.6 2.0 1.6 2.0 1.7
1.1 1.1 1.0 1.2 1.1 1.1 1.5 1.3 1.2 0.0 1.1 1.3 1.2 1.2 0.0 1.3 1.2 1.2
1.0 1.1 0.0 1.2 1.2 1.1 0.0 1.2 1.2 1.0 1.0 1.1 1.4 1.6 2.1 0.0 1.5 1.6
1.1 1.0 0.9 1.4 1.1 1.1 1.7 1.2 1.2 1.3 1.1 1.3 1.3 1.5 1.6 1.6 1.3 1.5
1.2 1.0 1.1 1.1 1.1 1.1 1.0 0.8 1.1 1.0 0.9 1.0 1.3 1.3 1.9 1.1 0.9 1.3
1.0 1.2 1.2 1.0 1.0 1.1 2.3 2.6 1.9 2.6 1.9 2.3 1.7 3.4 2.6 2.5 3.0 2.6
0.9 1.0 1.2 1.2 1.1 1.1 2.6 0.0 1.7 0.0 1.3 1.9 1.7 0.0 0.0 2.3 1.7 1.9
1.2 1.1 1.0 1.1 1.1 1.1 1.7 1.3 1.3 1.4 1.2 1.4 1.2 1.2 1.7 1.6 1.7 1.5
1.1 1.0 1.1 1.0 1.2 1.1 1.5 1.0 1.2 1.3 1.1 1.2 1.6 1.4 2.0 1.7 1.8 1.7
0.0 0.9 1.2 1.1 1.0 1.1 0.8 3.2 3.8 4.2 2.8 3.0 0.7 0.0 1.1 1.0 1.4 1.0
1.1 1.0 1.1 1.1 1.1 1.1 1.8 1.5 1.3 1.5 1.2 1.5 1.6 1.6 2.0 1.8 1.8 1.8
1.0 1.2 1.1 1.1 1.0 1.1 1.9 2.0 1.8 1.8 1.6 1.8 0.9 1.1 2.0 1.7 1.4 1.4
0.0 1.1 1.1 1.0 1.1 1.1 1.2 2.2 2.1 2.1 2.0 1.9 1.3 1.4 1.6 1.4 1.7 1.5
1.1 1.0 1.1 1.1 1.1 1.1 1.5 1.3 1.3 1.3 1.2 1.3 1.5 1.3 1.9 1.4 1.7 1.6
1.1 1.0 1.1 1.2 1.1 1.1 1.1 1.1 0.9 1.0 1.0 1.0 1.1 1.1 1.3 1.2 1.1 1.2
0.0 1.0 1.1 1.2 1.1 1.1 1.5 1.1 1.4 3.0 0.0 1.7 0.0 1.3 1.3 1.5 0.0 1.4
1.2 0.9 1.2 1.1 1.0 1.1 1.3 1.0 1.2 1.0 0.9 1.1 1.4 1.4 2.2 1.3 1.7 1.6
1.2 1.0 1.3 0.8 1.1 1.1 1.6 1.0 1.3 1.5 0.9 1.3 0.8 0.9 1.2 1.1 0.9 1.0
1.1 1.0 1.0 1.2 1.1 1.1 1.2 1.0 1.1 1.1 0.9 1.0 0.0 1.3 0.0 1.3 1.2 1.3
1.1 1.2 0.9 1.2 0.0 1.1 0.0 0.0 1.2 0.8 0.9 0.9 0.0 0.8 2.9 0.8 2.4 1.7
1.1 1.1 1.0 1.1 1.1 1.1 1.2 1.0 1.0 1.0 0.9 1.0 1.1 1.2 1.6 1.3 1.3 1.3
0.9 1.0 1.3 1.1 1.1 1.1 2.1 1.7 1.6 1.8 1.3 1.7 1.8 0.0 2.3 2.1 2.5 2.2
1.0 1.2 1.1 0.9 1.1 1.1 1.3 1.1 1.3 1.1 1.0 1.2 1.2 1.2 1.9 1.3 1.6 1.4
1.0 1.1 1.1 1.1 1.1 1.1 4.7 5.1 4.2 4.7 3.6 4.5 1.9 2.3 2.9 2.0 2.3 2.3
328
370 511 578 Q9NZZ3
CHMP5 Charged multivesicular body 
protein 5 CHMP5 K.APPPSLTDC*IGTVDSR.A
404 692 579 P57081 WDR4 tRNA (guanine-N(7)-)-methyltransferase subunit WDR WDR4 K.SGDVYSFSVLEPHGC*GR.L
675 387 580 Q969T9 WBP2 WW domain-binding protein 2 WBP2 K.DC*EIKQPVFGANYIK.G
433 510 581 Q9Y3D2




695 646 582 P37802 TAGLN2 Transgelin-2 TAGLN2 K.NMAC*VQR.T





606 494 584 Q9NX24
NHP2 H/ACA ribonucleoprotein complex 
subunit 2 NHP2 K.ADPDGPEAQAEAC*SGER.T
590 639 585 P30153 PPP2R1A Serine/threonine-protein phosphatase 2A 65 kDa reg PPP2R1A R.LNIISNLDC*VNEVIGIR.Q
481 596 586 Q96Q11 TRNT1 CCA tRNA nucleotidyltransferase 1, mitochondrial TRNT1 K.YQGEHC*LLK.E
439 681 587 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 R.EEFASTC*PDDEEIELAYEQVAK.A
625 707 588 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 K.LNEC*VDHTPK.L
345 480 589 Q86YH6
PDSS2 Decaprenyl-diphosphate synthase 
subunit 2 PDSS2 R.C*LLSDELSNIAMQVR.K
674 711 590 Q14103 HNRNPD Heterogeneous nuclear ribonucleoprotein D0 
HNRNP
D K.FGEVVDC*TLKLDPITGR.S
383 551 591 P60981 DSTN Destrin DSTN K.LGGSLIVAFEGC*PV.-
527 282 592 P37837 TALDO1 Transaldolase TALDO1 K.ALAGC*DFLTISPK.L
729 629 593 Q9BXV9






552 485 594 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 K.RYTC*GEAPDYDR.S
335 672 595 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.HLGYTLC*K.Q
572 526 596 Q6KB66 KRT80 Keratin, type II cytoskeletal 80 KRT80 R.C*HIDLSGIVEEVK.A
686 584 597 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F HNRNPF R.GLPFGC*TK.E
518 64 598 P35270 SPR Sepiapterin reductase SPR R.TVVNISSLC*ALQPFK.G
484 219 599 P13639 EEF2 Elongation factor 2 EEF2 R.ETVSEESNVLC*LSK.S
494 356 600 Q04760 GLO1 Lactoylglutathione lyase GLO1 K.C*DFPIMK.F
568 476 601 P13639 EEF2 Elongation factor 2 EEF2 R.TFC*QLILDPIFK.V
619 569 602 P31947 SFN 14-3-3 protein sigma SFN K.GAVEKGEELSC*EER.N
530 649 603 Q9Y5P6 GMPPB Mannose-1-phosphate guanyltransferase beta GMPPB R.LC*SGPGIVGNVLVDPSAR.I
640 522 604 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.C*LSVMEAK.V
524 579 605 P33316 DUT Deoxyuridine 5-triphosphate nucleotidohydrolase, DUT K.TDIQIALPSGC*YGR.V
603 620 606 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.YLAEVAC*GDDR.K
592 359 607 Q9P2T1 GMPR2 GMP reductase 2 GMPR2 K.VGIGPGSVC*TTR.K
431 250 608 P13639 EEF2 Elongation factor 2 EEF2 R.C*LYASVLTAQPR.L
721 686 609 Q01518 CAP1 Adenylyl cyclase-associated protein 1 CAP1 R.ALLVTASQC*QQPAENK.L
127 391 610 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL K.LTAC*QVATAFNLSR.F




1.0 1.1 1.1 1.1 1.0 1.1 1.7 1.5 1.5 1.5 1.3 1.5 1.7 1.6 2.2 1.9 1.9 1.9
1.5 0.8 1.2 0.9 1.0 1.1 1.1 1.2 0.9 1.0 0.7 1.0 1.3 1.5 2.6 1.6 0.0 1.8
1.0 1.1 1.2 1.1 1.0 1.1 2.0 2.0 2.1 1.8 1.8 1.9 0.9 1.1 1.9 1.1 0.0 1.2
1.1 1.0 0.9 1.1 1.1 1.1 2.1 1.7 1.2 1.5 1.2 1.5 1.5 1.5 2.0 1.8 1.6 1.7
1.3 1.0 0.9 1.0 1.1 1.1 1.3 1.1 1.1 1.2 1.0 1.1 1.1 1.2 1.5 1.2 1.1 1.2
1.1 1.0 1.0 1.0 1.1 1.1 3.2 3.0 2.2 2.2 1.7 2.5 1.8 1.9 2.3 2.1 2.1 2.0
0.9 1.0 1.0 1.3 0.0 1.1 1.9 1.9 1.3 1.5 1.4 1.6 1.4 1.2 1.5 1.3 1.5 1.4
1.0 1.1 0.9 1.2 1.1 1.1 1.5 1.1 1.1 1.3 0.6 1.1 1.6 0.9 1.5 1.5 1.6 1.4
1.3 1.0 1.1 1.1 0.9 1.1 1.2 1.3 1.4 1.2 1.2 1.3 1.3 1.4 1.9 1.5 1.9 1.6
0.9 1.0 1.3 1.1 1.1 1.1 0.9 1.0 1.1 1.2 0.9 1.0 1.3 1.4 0.0 1.7 2.2 1.6
1.0 1.3 1.0 1.0 1.0 1.1 1.0 0.8 1.0 0.8 0.9 0.9 1.3 1.1 1.7 1.3 1.3 1.3
0.7 1.1 1.2 1.3 1.0 1.1 1.6 1.7 1.5 1.8 1.6 1.6 2.1 1.9 2.1 2.0 1.8 2.0
0.0 1.1 1.0 0.9 1.1 1.1 0.8 0.9 1.0 0.0 0.8 0.9 1.3 1.1 0.0 1.3 0.0 1.2
1.1 1.0 1.0 1.1 1.0 1.0 1.7 1.3 1.4 1.4 1.1 1.4 1.5 1.7 2.3 1.7 1.9 1.8
0.0 1.1 0.0 0.9 1.2 1.0 2.0 0.0 3.0 2.4 0.0 2.4 1.5 1.5 1.7 1.1 1.6 1.5
0.0 1.2 1.1 1.1 0.8 1.0 1.5 1.3 0.3 1.5 1.3 1.2 1.3 0.0 1.0 0.8 1.1 1.1
1.0 1.0 1.2 1.1 0.9 1.0 1.8 1.6 1.6 1.7 1.4 1.6 1.5 1.1 0.0 1.3 1.9 1.5
0.9 0.0 1.2 1.0 1.0 1.0 0.9 0.8 1.1 0.0 1.4 1.0 1.8 1.6 2.6 0.0 0.0 2.0
1.0 1.0 1.0 1.1 1.1 1.0 1.8 1.3 1.4 1.6 1.2 1.5 0.0 1.3 1.7 1.3 0.0 1.4
1.0 1.1 1.1 1.0 1.0 1.0 1.5 1.3 1.3 0.0 1.0 1.3 1.1 1.1 1.5 0.9 1.4 1.2
1.1 0.9 1.1 1.0 1.1 1.0 4.1 5.0 3.3 6.0 5.0 4.7 1.3 1.3 1.9 1.6 1.5 1.5
0.0 1.0 1.1 1.0 1.1 1.0 0.9 2.6 3.8 3.9 3.0 2.8 1.5 1.5 0.0 1.8 0.0 1.6
1.0 0.9 1.2 1.2 0.9 1.0 1.8 2.0 2.2 2.1 2.0 2.0 1.4 1.3 1.9 1.5 1.6 1.6
1.0 1.1 1.0 1.1 1.0 1.0 1.4 1.7 1.7 1.9 1.4 1.6 1.1 1.5 1.9 1.2 1.5 1.4
1.0 1.0 1.1 1.1 1.0 1.0 1.5 1.2 1.4 1.3 1.1 1.3 1.1 1.2 1.5 1.4 1.4 1.3
1.0 1.0 1.0 1.0 1.1 1.0 0.0 1.2 1.0 1.2 1.0 1.1 1.3 1.4 1.9 0.0 1.4 1.5
1.2 1.0 0.9 1.0 1.1 1.0 1.5 1.9 1.5 1.4 1.2 1.5 1.2 1.3 1.7 1.1 1.3 1.3
1.0 1.4 0.9 0.9 1.0 1.0 1.4 1.0 1.5 0.0 1.2 1.3 1.3 1.8 0.0 1.4 0.0 1.5
0.9 1.1 1.1 1.0 1.1 1.0 1.6 1.2 1.2 1.0 1.1 1.2 1.3 1.0 1.4 1.6 1.7 1.4
1.6 0.6 0.9 1.0 1.1 1.0 2.3 2.0 2.0 0.0 1.8 2.0 1.3 1.5 0.0 1.4 0.0 1.4
1.1 1.2 1.2 1.0 0.8 1.0 1.0 3.0 2.8 3.1 3.2 2.6 1.2 1.5 2.1 1.5 2.1 1.7
0.9 1.1 1.0 0.9 1.2 1.0 1.1 1.0 0.9 0.0 1.0 1.0 1.1 1.1 0.0 1.1 1.1 1.1
1.1 0.9 1.0 1.0 1.0 1.0 2.5 2.1 2.1 1.4 1.5 1.9 0.0 0.0 4.8 4.5 4.2 4.5
1.3 1.0 1.1 0.8 0.9 1.0 1.3 1.3 1.5 1.3 1.4 1.4 2.0 2.1 2.4 0.0 2.3 2.2
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426 576 612 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL
K.QPAIMPGQSYGLEDGSC*SYKDFSE
SR.N
446 572 613 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.LSSC*DSFTSTINELNHCLSLR.T
500 594 614 P51610 HCFC1 Host cell factor 1 HCFC1 K.LVIYGGMSGC*R.L
510 546 615 P47756 CAPZB F-actin-capping protein subunit beta CAPZB K.DETVSDC*SPHIANIGR.L
633 537 616 Q9NXG2




712 670 617 P08238 HSP90AB1 Heat shock protein HSP 90-beta 
HSP90A
B1 R.LVSSPC*C*IVTSTYGWTANMER.I
660 653 618 Q12765 SCRN1 Secernin-1 SCRN1 K.TQSPC*FGDDDPAKKEPR.F
600 235 619 Q9H3P7 ACBD3 Golgi resident protein GCP60 ACBD3 K.QVLMGPYNPDTC*PEVGFFDVLGNDR.R
741 199 620 Q8TAQ2




671 583 621 P00492 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1 K.SYC*NDQSTGDIK.V
560 621 622 Q9BWJ5 SF3B5 Splicing factor 3B subunit 5 SF3B5 K.MLQPC*GPPADKPEEN.-
719 309 623 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 R.GDFC*IQVGR.N
587 498 624 Q96EY8 MMAB Cob(I)yrinic acid a,c-diamide adenosyltransferase, MMAB K.IQCTLQDVGSALATPC*SSAR.E
586 557 625 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T
634 564 626 P30086 PEBP1 Phosphatidylethanolamine-binding protein 1 PEBP1 R.APVAGTC*YQAEWDDYVPK.L
181 735 627 P30626 SRI Sorcin SRI R.CLTQSGIAGGYKPFNLETC*R.L
620 567 628 P31939 ATIC Bifunctional purine biosynthesis protein PURH ATIC K.VC*MVYDLYK.T
612 530 629 Q9HAV7
GRPEL1 GrpE protein homolog 1, 
mitochondrial GRPEL1 K.LYGIQAFC*K.D
740 644 630 Q14914 PTGR1 Prostaglandin reductase 1 PTGR1 R.IAIC*GAISTYNR.T
454 730 631 P07237 P4HB Protein disulfide-isomerase P4HB K.KEEC*PAVR.L
263 549 632 Q8NDH3
NPEPL1 Probable aminopeptidase 
NPEPL1 NPEPL1 R.IVDTPC*NEMNTDTFLEEINK.V
249 558 633 Q9GZQ3




629 710 634 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH R.ISSINSISALC*EATGADVEEVATAIGMDQR.I
728 403 635 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.NVGC*LQEALQLATSFAQLR.L
622 213 636 P35270 SPR Sepiapterin reductase SPR R.AVC*LLTGASR.G
283 628 637 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1 K.LSLDGQNIYNAC*CTLR.I
637 663 638 P60660 MYL6 Myosin light polypeptide 6 MYL6 K.ILYSQC*GDVMR.A
742 227 639 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.GIFPVLC*K.D
379 641 640 P21964 COMT Catechol O-methyltransferase COMT R.LITIEINPDC*AAITQR.M
575 727 641 Q9H2U2
PPA2 Inorganic pyrophosphatase 2, 
mitochondrial PPA2 K.ILSC*GEVIHVK.I
363 701 642 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 R.YLLQYQEPIPC*EQLVTALC*DIK.Q
605 640 643 O95372 LYPLA2 Acyl-protein thioesterase 2 LYPLA2 K.TYPGVMHSSC*PQEMAAVK.E
386 390 644 O75348 ATP6V1G1 V-type proton ATPase subunit G 1 
ATP6V1
G1 R.GSC*STEVEKETQEK.M
679 648 645 P49753 ACOT2 Acyl-coenzyme A thioesterase 2, mitochondrial ACOT2 K.SEFYANEAC*KR.L
331
1.1 0.9 1.0 1.1 1.1 1.0 1.6 1.4 1.1 0.0 1.1 1.3 1.5 1.7 0.0 0.0 1.9 1.7
0.9 1.2 1.0 1.1 1.0 1.0 1.5 1.2 1.3 1.5 1.1 1.3 1.3 1.5 1.8 1.5 2.1 1.6
1.1 1.0 1.2 1.0 0.9 1.0 1.4 1.3 1.2 1.3 1.1 1.3 1.3 1.4 2.0 1.5 1.5 1.5
1.0 1.0 1.2 1.0 0.9 1.0 1.5 1.4 1.4 1.4 1.2 1.4 1.3 1.2 2.0 1.5 1.6 1.5
0.8 1.0 1.1 1.1 1.3 1.0 1.5 1.4 1.4 1.4 1.4 1.4 1.1 1.3 1.6 1.4 1.3 1.3
1.2 0.9 0.9 1.0 1.0 1.0 1.0 0.8 1.3 1.3 0.9 1.1 1.0 1.1 1.5 1.1 1.1 1.2
1.1 0.9 1.0 1.0 1.2 1.0 1.2 1.2 1.0 1.0 1.1 1.1 1.0 1.2 1.5 1.3 1.3 1.3
0.0 1.0 1.1 1.1 1.0 1.0 3.9 1.8 2.7 2.9 2.3 2.7 1.3 0.0 1.7 1.3 1.2 1.4
1.0 0.9 1.0 1.1 1.0 1.0 2.0 3.9 2.6 3.2 3.0 2.9 0.9 0.9 1.2 0.9 1.0 1.0
1.0 1.1 0.9 1.0 1.0 1.0 1.6 1.1 1.2 1.4 1.2 1.3 1.2 1.3 1.4 1.2 1.2 1.3
1.2 0.9 1.1 1.3 0.5 1.0 1.9 0.7 0.9 1.7 0.8 1.2 1.1 1.4 1.7 0.0 1.6 1.4
1.1 1.2 0.9 0.9 1.0 1.0 1.3 3.3 3.2 2.3 1.3 2.3 1.1 1.0 0.0 1.1 1.3 1.1
1.1 0.9 0.9 1.1 1.1 1.0 2.0 1.5 1.3 1.6 1.4 1.6 1.1 1.4 1.7 1.5 1.4 1.4
1.0 1.0 1.0 1.0 1.0 1.0 1.7 1.4 1.3 1.4 1.1 1.4 1.2 1.6 1.7 1.3 1.4 1.4
0.9 1.1 1.1 1.0 1.1 1.0 1.3 1.4 1.5 1.3 1.1 1.3 1.1 1.1 1.5 1.1 1.7 1.3
1.1 1.1 1.1 1.0 0.8 1.0 0.8 0.7 0.9 0.8 0.8 0.8 2.5 0.0 2.7 3.9 4.3 3.4
0.0 1.3 0.9 1.0 0.8 1.0 0.7 0.9 1.8 2.3 0.9 1.3 1.1 1.5 1.3 1.5 0.0 1.3
0.8 1.0 1.1 1.0 1.1 1.0 1.6 1.5 1.4 1.3 1.4 1.4 1.2 0.0 1.7 1.3 1.3 1.4
0.8 1.4 0.9 0.8 0.0 1.0 1.1 1.0 1.2 0.0 1.2 1.1 0.8 0.8 1.1 1.1 1.0 1.0
0.0 1.2 0.9 0.8 1.1 1.0 0.9 0.0 0.0 0.9 0.8 0.8 0.0 1.5 2.0 1.3 0.0 1.6
1.1 1.0 0.9 1.0 1.0 1.0 2.0 1.3 1.3 1.1 1.3 1.4 1.9 3.0 3.4 2.4 2.0 2.5
0.8 1.2 1.0 1.0 1.0 1.0 1.7 1.2 1.2 0.0 0.0 1.3 1.3 0.0 0.0 4.8 1.7 2.6
0.9 1.1 1.0 0.9 1.1 1.0 1.1 0.6 0.9 0.0 0.9 0.9 1.4 1.1 1.7 0.0 1.2 1.3
0.9 0.9 0.6 1.6 1.0 1.0 1.9 1.9 1.9 1.9 1.9 1.9 0.7 0.0 0.9 1.8 0.9 1.1
0.9 1.1 1.0 1.0 0.9 1.0 2.9 2.8 3.2 2.9 2.4 2.8 1.2 1.2 1.6 1.3 1.4 1.3
1.0 0.7 1.2 1.0 1.1 1.0 1.2 1.0 1.3 0.0 1.2 1.2 1.4 2.2 3.7 1.5 3.0 2.3
0.9 1.0 1.1 1.0 1.0 1.0 1.1 1.0 1.2 1.0 1.1 1.1 1.1 1.1 1.6 1.4 1.3 1.3
0.8 1.0 1.2 1.0 1.0 1.0 2.3 2.6 2.9 3.6 2.5 2.8 0.7 0.8 1.4 1.0 0.0 1.0
1.1 1.0 0.9 1.0 1.0 1.0 1.3 1.2 1.2 0.0 0.9 1.1 0.0 1.8 0.0 2.0 1.7 1.8
0.9 1.0 0.8 1.2 1.1 1.0 0.9 0.7 1.0 0.8 0.8 0.8 1.4 0.0 1.8 1.2 1.3 1.4
0.8 1.3 1.0 0.9 0.9 1.0 0.8 0.8 1.2 1.0 0.8 0.9 1.7 2.3 2.4 1.6 1.4 1.9
1.1 1.0 0.9 1.0 0.9 1.0 1.1 1.0 1.2 1.4 0.9 1.1 1.3 0.0 1.6 1.4 1.3 1.4
1.0 0.0 0.9 1.0 0.0 1.0 0.0 1.9 2.2 2.0 1.7 1.9 1.3 1.7 2.5 0.0 0.0 1.8
1.0 1.0 0.8 0.9 1.2 1.0 1.4 1.0 1.0 1.0 1.1 1.1 1.2 1.2 1.3 1.1 1.4 1.2
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389 362 646 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP R.NDTPC*GTTIGPILASR.L
465 645 647 P60604 UBE2G2 Ubiquitin-conjugating enzyme E2 G2 UBE2G2 R.VC*ISILHAPGDDPMGYESSAER.W
488 740 648 P52907 CAPZA1 F-actin-capping protein subunit alpha-1 CAPZA1 K.TIDGQQTIIAC*IESHQFQPK.N
399 455 649 P42704 LRPPRC Leucine-rich PPR motif-containing protein, mitocho LRPPRC R.IHDVLC*K.L
644 306 650 P61158 ACTR3 Actin-related protein 3 ACTR3 K.LGYAGNTEPQFIIPSC*IAIK.E
544 634 651 O14818 PSMA7 Proteasome subunit alpha type-7 PSMA7 R.VEC*QSHR.L
621 666 652 P12004 PCNA Proliferating cell nuclear antigen PCNA K.C*AGNEDIITLR.A
562 723 653 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE K.IGPSILNSDLANLGAEC*LR.M
462 667 654 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 R.AITIAGIPQSIIEC*VK.Q
512 712 655 Q8IY67 RAVER1 Ribonucleoprotein PTB-binding 1 RAVER1 R.ALSAVHSPTFCQLAC*GQDGQLK.G
564 316 656 Q96EY5 FAM125A Multivesicular body subunit 12A 
FAM125
A R.GFSAISC*TVEGAPASFGK.S
685 581 657 P63167 DYNLL1 Dynein light chain 1, cytoplasmic DYNLL1 K.NADMSEEMQQDSVEC*ATQALEK.Y
502 592 658 P62993 GRB2 Growth factor receptor-bound protein 2 GRB2 K.VLNEEC*DQNWYK.A
727 671 659 P60981 DSTN Destrin DSTN K.AVIFC*LSADKK.C
667 714 660 Q96FX7 TRMT61A  tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit 
TRMT61
A R.FCSFSPC*IEQVQR.T
677 745 661 Q13404 UBE2V1 Ubiquitin-conjugating enzyme E2 variant 1 UBE2V1 K.LPQPPEGQC*YSN.-
730 562 662 Q96EL3 MRPL53 39S ribosomal protein L53, mitochondrial MRPL53 R.VQFC*PFEK.N
602 582 663 P58107 EPPK1 Epiplakin EPPK1 R.YLEGTSC*IAGVLVPAK.D
364 668 664 Q9BSH4
TACO1 Translational activator of 
cytochrome c oxidase 1 TACO1 K.KLDSLGLCSVSC*ALEFIPNSK.V
451 426 665 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M 
HNRNP
M R.GC*AVVEFK.M
483 427 666 P51858 HDGF Hepatoma-derived growth factor HDGF K.C*GDLVFAK.M
567 580 667 O14745 SLC9A3R1 Na(+)/H(+) exchange regulatory cofactor NHE-RF1 
SLC9A3
R1 R.IVEVNGVC*MEGK.Q
664 435 668 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1 R.YADLTEDQLPSC*ESLK.D
474 604 669 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 K.AMHQAQTMEGC*SSPMVVK.F
720 680 670 O43681 ASNA1 ATPase ASNA1 ASNA1 K.IDTHNIIVNQLVFPDPEKPC*K.M
723 662 671 Q04917 YWHAH 14-3-3 protein eta YWHAH K.NC*NDFQYESK.V
715 682 672 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B R.ARFEELC*SDLFR.S
613 732 673 P10768 ESD S-formylglutathione hydrolase ESD K.AETGKCPALYWLSGLTC*TEQNFISK.S
609 722 674 P40925 MDH1 Malate dehydrogenase, cytoplasmic MDH1 K.AIC*DHVR.D
543 248 675 P80404 ABAT 4-aminobutyrate aminotransferase, mitochondrial ABAT R.NKGVVLGGC*GDK.S
437 699 676 Q6NXG1
ESRP1 Epithelial splicing regulatory 
protein 1 ESRP1 R.VNYKFESGTC*SK.M
235 713 677 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 K.GTLTLC*PYHSDR.Q
555 542 678 P17931 LGALS3 Galectin-3 LGALS3 R.VIVC*NTK.L
577 636 679 P52209 PGD 6-phosphogluconate dehydrogenase, decarboxylating PGD R.C*LSSLKDER.I
415 708 680 P22234 PAICS Multifunctional protein ADE2 PAICS K.ITSC*IFQLLQEAGIK.T
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1.0 0.9 1.0 1.0 0.9 1.0 1.4 2.2 2.3 2.6 1.5 2.0 1.5 1.8 2.2 1.5 2.1 1.8
0.0 0.0 1.0 1.1 0.9 1.0 1.5 1.0 1.1 0.0 0.9 1.1 1.4 1.3 2.3 1.5 1.6 1.6
0.9 1.0 1.0 1.0 1.0 1.0 0.8 0.6 1.0 0.7 0.8 0.8 1.2 1.4 2.1 0.0 0.0 1.6
1.1 0.9 1.1 0.9 0.9 1.0 2.3 1.3 1.3 1.2 2.3 1.7 1.2 3.5 1.4 1.3 1.6 1.8
0.9 1.0 1.1 0.9 1.0 1.0 1.0 2.3 2.7 3.1 2.3 2.3 1.0 1.1 1.7 0.0 1.4 1.3
0.9 0.9 1.2 1.1 0.8 1.0 0.0 1.0 1.2 1.2 0.0 1.1 1.2 0.0 1.8 1.3 1.6 1.5
0.9 1.0 1.0 1.0 0.9 1.0 1.2 1.0 1.1 1.2 0.9 1.1 1.0 1.1 1.3 1.6 1.7 1.3
0.8 1.0 1.4 0.8 0.9 1.0 0.7 0.7 1.0 1.1 0.8 0.9 1.2 1.4 1.4 1.5 1.8 1.4
1.0 1.1 1.0 0.9 1.0 1.0 1.2 1.0 1.2 0.9 1.0 1.1 1.5 1.4 1.9 1.5 1.8 1.6
1.0 0.0 0.9 1.1 0.9 1.0 1.1 0.9 0.8 0.9 0.8 0.9 1.2 0.0 1.6 1.6 1.7 1.5
0.9 1.0 0.9 1.0 0.9 1.0 2.3 0.0 2.7 0.0 1.7 2.2 1.3 0.0 1.8 1.6 1.0 1.4
0.9 1.0 0.9 0.9 1.0 1.0 0.9 1.5 0.0 1.4 1.3 1.3 0.9 0.0 1.7 0.0 1.0 1.2
0.9 1.0 1.0 1.0 1.0 1.0 1.4 1.3 1.1 1.3 1.2 1.3 1.2 1.3 2.2 1.5 1.5 1.5
1.1 1.0 1.0 0.8 0.9 1.0 0.9 1.3 1.1 1.1 0.8 1.0 0.0 0.9 1.3 1.0 1.1 1.1
1.1 0.0 0.9 0.8 1.1 1.0 1.0 1.0 0.9 0.6 0.9 0.9 1.3 1.2 0.0 1.3 0.0 1.3
0.8 1.1 1.0 0.9 1.1 1.0 0.6 0.5 1.0 0.6 1.1 0.7 0.0 1.0 1.6 1.1 1.3 1.2
0.8 0.0 0.9 0.9 1.3 1.0 0.0 1.7 1.2 0.0 1.1 1.3 1.1 0.9 0.0 1.2 0.0 1.1
0.8 0.9 1.0 1.1 0.9 1.0 0.9 1.7 1.3 1.5 1.0 1.3 0.0 1.3 1.6 1.2 1.5 1.4
0.7 1.0 1.0 1.1 0.9 1.0 1.4 0.9 1.0 1.0 1.0 1.1 1.8 0.0 2.3 1.6 0.0 1.9
0.8 1.1 1.0 1.1 0.9 1.0 1.6 1.6 2.3 1.5 1.9 1.8 1.4 1.5 2.2 1.5 1.6 1.6
0.8 1.1 1.0 1.1 0.9 1.0 1.6 1.6 2.3 1.5 1.9 1.8 1.4 1.3 2.2 1.4 1.6 1.6
0.0 0.0 1.2 0.9 0.7 1.0 1.4 1.2 1.4 1.1 0.0 1.3 1.3 1.5 0.0 0.0 1.4 1.4
1.0 0.9 1.1 0.9 0.8 1.0 1.0 1.9 1.7 2.6 1.6 1.8 1.5 0.9 1.4 1.4 1.2 1.3
0.4 1.4 1.0 0.8 1.2 1.0 1.2 1.3 1.3 1.3 1.1 1.2 1.5 0.0 2.2 1.1 0.0 1.6
1.0 1.3 0.7 0.8 0.9 1.0 1.0 0.8 1.3 1.0 0.9 1.0 0.9 0.0 1.6 1.0 1.0 1.1
0.9 1.1 0.9 0.9 1.0 0.9 1.2 0.9 1.4 1.0 0.9 1.1 1.0 1.0 1.2 1.2 1.2 1.1
0.9 1.0 1.0 0.9 1.0 0.9 0.9 0.9 1.2 1.1 1.0 1.0 1.0 1.0 1.5 0.9 1.2 1.1
1.0 0.9 0.9 1.0 0.9 0.9 0.9 0.8 0.8 0.8 0.9 0.8 1.1 1.2 1.5 1.5 1.5 1.4
0.9 1.1 1.0 0.8 1.0 0.9 0.7 0.7 1.1 1.0 0.9 0.9 1.5 0.0 1.4 1.2 0.0 1.4
0.9 0.6 0.9 1.0 1.3 0.9 2.4 2.4 3.0 0.0 2.7 2.6 1.3 1.5 0.0 1.4 1.7 1.5
0.9 0.9 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.9 0.8 0.9 1.7 1.5 1.9 0.0 1.5 1.6
1.0 0.9 1.1 0.8 0.9 0.9 0.7 0.9 1.1 0.9 0.8 0.9 2.7 1.3 3.8 1.4 4.5 2.7
0.9 1.0 1.1 0.8 0.9 0.9 0.0 1.6 1.4 1.4 1.1 1.4 1.3 1.6 1.7 1.1 1.6 1.4
0.9 1.0 0.9 0.9 1.0 0.9 1.1 0.9 1.3 1.2 1.1 1.1 1.2 1.2 1.8 1.2 1.6 1.4
1.0 0.9 0.9 0.9 1.0 0.9 0.9 0.8 1.0 0.9 0.9 0.9 1.7 0.0 2.2 1.5 1.6 1.7
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665 541 681 Q1KMD3
HNRNPUL2 Heterogeneous nuclear 





687 598 682 P13798 APEH Acylamino-acid-releasing enzyme APEH R.QPALSAAC*LGPEVTTQYGGQYR.T
735 724 683 P61981 YWHAG 14-3-3 protein gamma YWHAG K.NC*SETQYESK.V
615 631 684 P28838 LAP3 Cytosol aminopeptidase LAP3 R.QVVDC*QLADVNNIGK.Y
682 688 685 O60664 PLIN3 Perilipin-3 PLIN3 R.DIAQQLQATC*TSLGSSIQGLPTNVK.D
553 623 686 O14964 HGS Hepatocyte growth factor-regulated tyrosine kinase HGS R.AC*GQIFCGK.C
722 675 687 P23528 CFL1 Cofilin-1 CFL1 K.AVLFC*LSEDK.K
748 563 688 Q9Y676 MRPS18B 28S ribosomal protein S18b, mitochondrial 
MRPS18
B K.VVGNPC*PIC*R.D
699 651 689 P60174 TPI1 Triosephosphate isomerase TPI1 R.IIYGGSVTGATC*K.E
703 678 690 P37802 TAGLN2 Transgelin-2 TAGLN2 K.DGTVLC*ELINALYPEGQAPVK.K
744 754 691 Q96BN8 FAM105B Protein FAM105B FAM105B R.VRGDNYC*ALR.A
482 638 692 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 K.SC*FLC*MVC*K.K
528 715 693 Q15369 TCEB1 Transcription elongation factor B polypeptide 1 TCEB1 K.VC*MYFTYK.V
726 633 694 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.TGQATVASGIPAGWMGLDC*GPESSK.K
522 733 695 O75874 IDH1 Isocitrate dehydrogenase IDH1 K.SEGGFIWAC*K.N
548 718 696 P22626 HNRNPA2B1 Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPA
2B1 K.LTDC*VVMRDPASK.R
661 752 697 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 R.GC*ITIIGGGDTATC*C*AK.W
328 660 698 P23528 CFL1 Cofilin-1 CFL1 K.HELQANC*YEEVK.D
538 747 699 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 R.YSDESGNMDFDNFISC*LVR.L
716 193 700 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.NTGIIC*TIGPASR.S
641 716 701 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.FLDGNELTLADC*NLLPK.L
734 626 702 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 K.LAAQSC*ALSLVR.Q
604 694 703 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransf PCMT1 K.ALDVGSGSGILTAC*FAR.M
683 673 704 P61970 NUTF2 Nuclear transport factor 2 NUTF2 K.NINDAWVC*TNDMFR.L
596 741 705 Q96FJ2 DYNLL2 Dynein light chain 2, cytoplasmic DYNLL2 K.NADMSEDMQQDAVDC*ATQAMEK.Y
749 486 706 P13489 RNH1 Ribonuclease inhibitor RNH1 R.SNELGDVGVHC*VLQGLQTPSC*K.I
499 656 707 Q6QNY0




583 684 708 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 K.ATC*IGNNSAAAVSMLK.Q
725 700 709 P60174 TPI1 Triosephosphate isomerase TPI1 K.VPADTEVVC*APPTAYIDFAR.Q
659 669 710 P11142 HSPA8 Heat shock cognate 71 kDa protein HSPA8 K.VC*NPIITK.L
684 689 711 Q04917 YWHAH 14-3-3 protein eta YWHAH K.ELETVC*NDVLSLLDK.F
658 726 712 P00491 PNP Purine nucleoside phosphorylase PNP R.AC*VMMQGR.F
724 586 713 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 K.C*GFLPGNEK.V
314 725 714 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 K.VVFC*PVK.E
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0.8 0.9 1.0 1.0 1.0 0.9 1.4 1.3 1.5 1.4 1.5 1.4 1.4 1.3 1.4 0.0 1.0 1.3
0.0 1.1 0.8 0.9 1.0 0.9 1.2 1.0 1.3 1.7 1.1 1.3 1.0 1.3 0.0 1.3 0.0 1.2
0.9 0.9 1.0 0.9 0.9 0.9 0.0 0.0 0.7 0.7 1.1 0.9 1.0 0.9 0.0 0.0 1.1 1.0
0.0 0.9 0.9 0.9 1.0 0.9 1.9 1.1 0.9 1.1 0.8 1.2 1.2 1.1 1.7 1.2 1.6 1.4
1.0 0.0 1.0 0.8 0.9 0.9 1.1 1.1 1.0 0.0 0.9 1.0 1.2 1.2 0.0 1.3 1.2 1.2
1.0 0.7 0.9 1.2 0.9 0.9 1.6 1.1 1.2 1.0 1.1 1.2 1.6 1.2 1.8 1.5 1.2 1.5
0.5 1.0 1.1 0.9 1.1 0.9 0.9 1.2 1.1 0.9 1.1 1.0 1.1 1.0 1.4 0.8 1.2 1.1
1.3 0.0 0.5 2.3 0.5 0.9 1.0 0.9 2.0 1.4 1.4 1.3 0.0 1.2 1.1 1.0 0.0 0.7
0.7 1.1 0.9 1.0 1.0 0.9 0.9 1.0 1.2 1.4 1.0 1.1 1.1 1.2 1.3 1.1 1.2 1.2
0.9 1.0 1.0 0.8 0.9 0.9 1.0 1.0 1.2 1.0 1.0 1.0 1.1 1.2 1.3 1.0 1.2 1.2
0.0 0.0 0.8 0.9 1.0 0.9 0.5 0.5 0.8 0.0 0.0 0.6 0.0 1.1 1.1 0.6 0.0 0.9
0.9 0.8 0.9 1.0 1.0 0.9 1.2 1.0 1.0 1.5 1.0 1.1 1.4 1.5 2.1 1.3 1.6 1.6
0.9 1.3 0.9 0.8 0.7 0.9 0.8 0.9 1.0 0.0 0.9 0.9 1.9 0.6 0.0 0.0 1.9 1.5
0.9 1.0 1.0 0.7 1.0 0.9 0.8 1.0 1.1 1.9 1.0 1.1 1.2 1.1 0.0 1.0 1.1 1.1
0.9 0.9 0.8 0.9 1.0 0.9 0.8 0.8 0.8 0.8 0.8 0.8 1.4 1.5 1.6 1.4 1.5 1.5
0.9 0.8 1.1 0.9 0.8 0.9 0.9 0.9 0.8 0.9 0.9 0.9 1.3 1.3 1.6 1.5 1.6 1.5
0.0 0.9 0.9 0.9 1.0 0.9 0.6 0.5 1.0 0.6 0.5 0.7 1.2 1.3 1.4 1.3 1.1 1.3
0.9 0.9 0.9 0.9 1.0 0.9 1.3 1.0 1.0 1.1 1.0 1.1 1.7 1.9 2.5 2.1 2.0 2.0
0.9 1.0 0.9 0.9 0.9 0.9 0.7 0.5 0.8 0.8 0.8 0.7 1.4 1.4 1.8 1.4 1.5 1.5
0.8 1.0 1.0 0.9 0.8 0.9 3.0 2.8 3.2 3.4 2.4 3.0 0.9 1.1 1.3 1.1 1.3 1.1
0.9 0.9 1.0 0.7 1.0 0.9 0.8 0.9 1.1 0.8 0.8 0.9 1.1 1.3 0.0 1.0 1.9 1.3
0.9 0.7 1.0 1.0 0.9 0.9 1.3 1.2 1.4 1.0 1.1 1.2 1.0 1.2 1.0 1.1 0.9 1.0
0.9 0.9 0.9 0.8 0.9 0.9 1.0 1.0 1.1 1.0 0.9 1.0 1.7 1.2 1.6 1.1 1.4 1.4
0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 1.1 1.2 1.0 1.0 1.0 1.4 1.4 1.2 1.2 1.2
0.8 0.8 1.2 0.8 0.9 0.9 0.7 0.7 0.9 0.8 0.7 0.8 1.2 0.0 0.0 1.4 1.6 1.4
1.0 0.8 0.9 0.9 0.9 0.9 1.4 1.6 1.6 2.0 1.4 1.6 0.0 0.6 0.8 0.7 0.6 0.6
0.0 0.9 0.8 0.9 0.9 0.9 1.1 1.6 0.8 1.1 0.9 1.1 1.6 1.1 1.8 1.4 1.8 1.5
0.8 0.8 0.9 0.9 0.9 0.9 0.7 1.0 1.3 1.2 0.8 1.0 0.0 1.3 1.6 1.3 1.4 1.4
0.8 1.0 1.0 0.8 0.9 0.9 0.8 0.8 1.0 1.3 0.8 0.9 1.0 1.1 1.4 1.0 1.1 1.1
0.8 0.9 1.0 0.9 0.9 0.9 0.8 0.9 1.1 1.5 1.0 1.1 1.0 0.0 1.6 0.9 1.4 1.3
0.0 1.0 0.9 0.8 0.9 0.9 1.1 0.8 1.1 1.1 0.9 1.0 1.1 0.9 2.0 1.1 1.1 1.2
0.7 1.1 1.0 0.7 0.8 0.9 0.6 0.7 1.0 1.0 0.9 0.8 1.1 0.0 0.0 0.9 1.8 1.3
0.9 0.8 0.9 1.0 0.9 0.9 1.6 1.2 1.2 1.3 1.1 1.3 0.8 1.1 1.3 1.2 1.1 1.1
1.0 0.8 0.8 1.0 0.8 0.9 0.7 1.0 0.9 0.0 0.9 0.9 1.9 2.0 2.2 2.3 2.4 2.1
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654 693 715 P50395 GDI2 Rab GDP dissociation inhibitor beta GDI2 R.TDDYLDQPC*YETINR.I
618 533 716 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA R.YASIC*QQNGIVPIVEPEILPDGDHDLK.R
694 574 717 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA R.ALANSLAC*QGK.Y
507 704 718 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R
576 703 719 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ R.YDDMAAC*MK.S
529 709 720 Q9UHX1
PUF60 Poly(U)-binding-splicing factor 
PUF60 PUF60 R.ALAIMC*R.V
688 737 721 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.SIC*TTVLELLDK.Y
520 744 722 P55212 CASP6 Caspase-6 CASP6 R.GTC*ADRDNLTR.R
648 736 723 P14174 MIF Macrophage migration inhibitory factor MIF K.LLC*GLLAER.L
662 731 724 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ K.IETELRDIC*NDVLSLLEK.F
732 685 725 P31949 S100A11 Protein S100-A11 S100A11 K.ISSPTETERC*IESLIAVFQK.Y
690 720 726 P60174 TPI1 Triosephosphate isomerase TPI1 K.IAVAAQNC*YK.V
745 738 727 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.LTFSC*LGGSDNFK.H
689 228 728 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.IC*PVETLVEEAIQC*AEK.I
531 474 729 O75663 TIPRL TIP41-like protein TIPRL K.VAC*AEEWQESR.T
471 625 730 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 K.YLEC*SALTQR.G
630 706 731 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B K.ELEQVC*NPIISGLYQGAGGPGPGGFGAQGPK.G
704 750 732 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1 R.GTGELTQLLNSLC*TAVK.A
708 691 733 P61158 ACTR3 Actin-related protein 3 ACTR3 R.LPAC*VVDC*GTGYTK.L
706 734 734 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA R.IIPGFMC*QGGDFTR.H
668 650 735 P14625 HSP90B1 Endoplasmin HSP90B1 R.LTESPC*ALVASQYGWSGNMER.I
430 655 736 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 
MACRO
D1 R.SC*YLSSLDLLLEHR.L
571 717 737 P00390 GSR Glutathione reductase, mitochondrial GSR K.LGGTC*VNVGCVPK.K
692 743 738 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA K.KITIADC*GQLE.-
702 748 739 P21964 COMT Catechol O-methyltransferase COMT R.YLPDTLLLEEC*GLLR.K
506 593 740 Q9BWD1




670 484 741 Q9Y3D0
FAM96B Mitotic spindle-associated 
MMXD complex subunit MI FAM96B R.VAAALENTHLLEVVNQC*LSAR.S
707 676 742 P31150 GDI1 Rab GDP dissociation inhibitor alpha GDI1 R.TDDYLDQPC*LETVNR.I
743 697 743 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5 K.ALNVEPDGTGLTC*SLAPNIISQL.-
751 755 744 P13489 RNH1 Ribonuclease inhibitor RNH1 K.LSLQNC*C*LTGAGC*GVLSSTLR.T
320 82 745 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1 K.ARDC*LIPMGITSENVAER.F
342 683 746 P41250 GARS Glycine--tRNA ligase GARS R.SC*YDLSC*HAR.A
72 751 747 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 K.GNGIVEC*LGPK.-
697 739 748 U2AF2 U2AF2 Splicing factor U2AF 65 kDa subunit U2AF2 K.SIEIPRPVDGVEVPGC*GK.I
733 749 749 P60174 TPI1 Triosephosphate isomerase TPI1 K.DC*GATWVVLGHSER.R
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0.8 1.0 0.9 0.8 1.0 0.9 1.0 1.0 1.0 1.0 0.9 1.0 1.1 1.1 2.0 0.9 1.3 1.3
0.8 0.9 0.9 0.8 0.9 0.9 0.9 1.4 1.6 2.0 1.2 1.4 1.1 1.1 1.8 1.0 1.7 1.4
0.8 0.9 1.0 0.7 0.9 0.9 0.9 1.5 1.5 1.5 1.0 1.3 1.0 1.0 1.4 1.2 1.4 1.2
0.9 0.9 0.8 0.8 0.9 0.9 0.8 0.9 1.1 1.0 0.8 0.9 1.4 1.2 1.8 1.3 1.9 1.5
0.9 0.0 1.1 0.7 0.7 0.9 0.7 0.7 1.1 1.0 1.0 0.9 1.1 0.0 1.6 0.9 2.0 1.4
0.8 1.1 0.8 0.8 0.8 0.9 0.9 0.8 1.1 0.9 0.8 0.9 1.3 0.0 1.7 0.0 1.5 1.5
0.8 1.0 0.9 0.8 0.8 0.9 0.8 0.7 0.9 0.8 0.7 0.8 1.2 1.1 0.0 1.0 1.6 1.2
0.0 0.8 0.9 1.0 0.8 0.9 0.0 0.8 0.6 1.0 0.6 0.7 1.3 1.2 1.5 1.5 2.0 1.5
0.9 0.9 0.9 0.8 0.9 0.9 0.8 0.7 0.9 0.7 0.8 0.8 1.2 1.2 1.4 1.2 1.4 1.3
0.7 1.0 1.0 0.8 0.8 0.8 0.8 0.7 1.0 0.8 0.9 0.8 1.1 1.3 1.4 0.9 1.7 1.3
0.6 1.0 0.9 0.9 0.8 0.8 0.9 0.7 1.4 0.8 1.3 1.0 0.9 1.1 1.4 0.9 0.9 1.0
0.8 0.9 0.9 0.7 0.9 0.8 0.6 0.7 1.1 1.2 0.8 0.9 1.0 1.1 1.4 1.2 1.3 1.2
0.8 1.0 0.8 0.8 0.8 0.8 0.7 0.8 0.9 0.7 0.8 0.8 0.9 0.8 1.1 0.9 0.9 0.9
0.7 0.9 0.9 0.9 0.7 0.8 2.6 2.7 2.9 3.2 2.5 2.8 1.2 1.2 1.4 1.1 1.2 1.2
1.0 0.8 0.8 0.8 0.0 0.8 2.0 0.0 0.0 1.6 1.4 1.6 1.7 0.0 1.6 1.5 1.2 1.5
0.9 0.6 1.0 0.9 0.9 0.8 1.0 1.2 1.1 1.6 1.0 1.2 1.7 1.6 1.8 1.3 0.0 1.6
0.7 0.9 0.9 0.7 0.9 0.8 0.0 1.0 0.9 0.8 0.9 0.9 1.2 0.0 1.5 0.0 1.3 1.3
0.8 0.9 0.8 0.8 0.8 0.8 0.7 0.6 0.7 0.7 0.8 0.7 1.2 1.1 1.5 0.9 1.2 1.2
1.0 0.6 0.9 0.9 0.9 0.8 0.9 0.9 1.1 1.1 0.9 1.0 1.0 1.1 0.0 0.0 1.3 1.2
0.8 0.9 0.9 0.7 0.8 0.8 0.7 0.7 0.9 0.9 0.8 0.8 1.0 1.1 1.4 1.1 1.3 1.2
0.0 0.0 0.8 0.8 0.9 0.8 1.0 0.0 1.1 1.0 1.3 1.1 0.0 1.2 0.0 1.2 1.4 1.3
0.8 0.9 0.8 0.8 0.9 0.8 0.8 1.1 1.1 1.4 1.1 1.1 1.2 2.1 1.8 0.0 0.0 1.7
0.7 0.8 0.8 0.8 0.9 0.8 1.0 0.8 0.9 0.9 0.8 0.9 1.3 1.3 1.7 1.5 1.4 1.4
0.7 1.0 0.8 0.8 0.8 0.8 0.7 0.6 0.9 0.8 0.7 0.7 1.1 1.0 1.5 1.0 1.5 1.2
0.8 0.9 0.8 0.7 0.8 0.8 0.6 0.6 0.9 0.7 0.8 0.7 1.2 0.0 1.5 0.8 1.2 1.2
1.1 0.8 0.6 0.7 0.9 0.8 1.1 1.3 1.3 1.4 1.2 1.3 1.4 1.4 1.9 0.0 1.5 1.5
0.7 0.8 1.0 0.9 0.7 0.8 1.5 1.6 0.0 1.6 1.8 1.6 0.9 1.5 1.3 1.1 1.5 1.3
0.8 0.8 0.9 0.7 0.8 0.8 0.8 0.9 1.2 1.4 0.9 1.0 1.2 0.9 1.6 0.9 1.3 1.2
0.7 0.8 0.9 0.8 0.8 0.8 1.1 0.9 0.9 0.9 0.9 1.0 0.8 0.9 1.2 0.9 1.0 1.0
1.1 0.4 0.8 0.8 0.8 0.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.3 0.0 0.5
0.8 0.7 0.7 0.8 0.8 0.8 4.7 5.0 4.4 4.5 3.6 4.4 1.8 1.9 2.7 2.1 2.1 2.1
0.8 0.7 0.8 0.8 0.8 0.8 0.9 1.1 1.2 1.0 0.9 1.0 1.8 2.3 2.8 1.5 1.6 2.0
0.6 0.7 0.7 1.1 0.6 0.8 0.7 0.8 0.6 0.8 0.5 0.7 6.5 0.0 0.0 6.4 6.2 6.4
0.7 0.0 0.7 0.7 0.8 0.7 1.2 0.5 0.0 0.9 0.5 0.8 1.0 1.0 1.4 1.3 1.3 1.2
0.6 0.0 0.7 0.7 0.9 0.7 0.5 0.7 0.9 0.0 0.8 0.7 1.1 1.0 0.0 1.0 0.0 1.0
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711 560 750 P25398 RPS12 40S ribosomal protein S12 RPS12 K.VVGC*SCVVVK.D
461 438 751 O43290 SART1 U4/U6.U5 tri-snRNP-associated protein 1 SART1 K.SLPSAVYC*IEDK.M
705 654 752 P25398 RPS12 40S ribosomal protein S12 RPS12 R.QAHLC*VLASNCDEPMYVK.L
651 550 753 P25398 RPS12 40S ribosomal protein S12 RPS12 K.LVEALC*AEHQINLIK.V
752 728 754 P30041 PRDX6 Peroxiredoxin-6 PRDX6 R.DFTPVC*TTELGR.A
753 457 755 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH R.VPTANVSVVDLTC*R.L
750 756 756 P41250 GARS Glycine--tRNA ligase GARS K.C*SVLPLSQNQEFMPFVK.E
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0.0 0.7 0.7 0.7 0.7 0.7 1.5 0.0 0.7 1.7 1.6 1.3 1.0 1.0 1.3 1.3 1.2 1.2
0.0 0.0 0.7 0.6 0.7 0.6 2.2 0.0 1.8 0.0 1.3 1.8 1.4 1.2 0.0 0.0 2.2 1.6
0.6 0.6 0.6 0.6 0.7 0.6 1.3 1.1 1.0 1.0 1.0 1.1 1.0 1.2 1.4 1.1 1.2 1.2
0.6 0.6 0.6 0.6 0.6 0.6 1.5 1.4 1.5 1.3 1.2 1.4 1.3 1.2 1.3 1.4 1.2 1.3
1.0 0.5 0.5 0.5 0.5 0.6 0.4 0.9 0.9 1.2 0.8 0.8 0.5 0.6 0.5 0.4 0.0 0.5
0.4 0.5 0.4 0.4 0.4 0.4 0.7 2.0 2.1 2.2 1.4 1.7 0.4 0.4 0.5 0.4 0.5 0.5
0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.6 0.4 0.4 0.4 0.0 0.6 0.0 0.6 0.5
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Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 P04406 GAPDH ISNASCTTNCL 1U8F 18.712 11.18
2 P07339 CTSD EYMIPCEKVST 1LYW 5.256 −
3 Q01813 PFKP LPLMECVQMTQ 4U1R 5.754 11.03
4 Q92947 GCDH IKGYGCAGVSS 1SIQ 0.000 11.23
5 Q99714 HSD17B10 KLGNNCVFAPA 2O23 0.000 11.26
6 P31749 AKT1 TMKTFCGTPEY 4EJN 2.253 −
7 P26440 IVD NVAKACDEGHC 1IVH 0.000 −
8 P36578 RPL4 KRYAICSALAA 4UG0 0.000 11.00
9 P04183 TK1 EALPACLLRDV 2ORV 26.727 9.37
10 P40926 MDH2 DCLKGCDVVVI 4WLV 0.000 10.61
11 Q8TCU6 PREX1 LRLRLCVLNEI 4YON 45.320 9.30
12 P04183 TK1 YSSSFCTHDRN 2ORV 64.257 8.97
13 O14733 MAP2K7 TRSAGCAAYMA 3WZU 14.636 10.59
14 P63244 GNB2L1 SEWVSCVRFSP 4AOW 3.802 9.82
15 P49327 FASN SPEGTCKAFDT 3HHD 0.000 12.76
16 Q99714 HSD17B10 DVAVNCAGIAV 2O23 0.000 10.69
17 P07858 CTSB RGQDHCGIESE 3PBH 3.319 11.79
18 P60709 ACTB NSIMKCDVDIR 3J82 0.068 10.53
19 P63244 GNB2L1 NTLGVCKYTVQ 4AOW 6.423 8.80
Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 Q9UHX1 PUF60 ALAIMCRVYVG 3UWT 12.219 11.45
2 P27348 YWHAQ ELRSICTTVLE 2BTP 0 12.52
3 P55212 CASP6 ERRGTCADRDN 4HVA 33.628 10.28
4 P14174 MIF YSKLLCGLLAE 1MIF 13.173 10.08
5 P63104 YWHAZ ELRDICNDVLS 2O02 0 12.47
6 P31949 S100A11 TETERCIESLI 2LUC 33.66 9.37
7 P60174 TPI1 VAAQNCYKVTN 4POD 0 11.94
8 Q15185 PTGES3 KLTFSCLGGSD 1EJF 0 10.81
9 P30084 ECHS1 LVSKICPVETL 2HW5 0.204 11.63
10 P30084 ECHS1 EEAIQCAEKIA 2HW5 16.643 9.18
11 P15153 RAC2 VKYLECSALTQ 1DS6 0.222 12.14
12 P0DMV9 (P0DMV8) HSPA1B ELEQVCNPIIS 4PO2 0 7.44
13 P09467 FBP1 LLNSLCTAVKA 2Y5K 9.271 11.05
14 P62937 PPIA IPGFMCQGGDF 4YUO 0 12.47
15 Q9BQ69 MACROD1 AELRSCYLSSL 2X47 0 11.23
16 P00390 GSR KLGGTCVNVGC 3DK8 8.24 13.94
17 P62937 PPIA ITIADCGQLE* 4YUO 1.267 11.43
18 P21964 COMT LLLEECGLLRK 4PYK 12.471 9.93
19 Q9BWD1 ACAT2 VLAAGCGQNPV 1WL5 9.421 8.59
Table 3A-5. PDB codes, solvent-accessible surface area (SASA) and pKa values for
19 of the most-sensitive and insensitive cysteines to GSNO, CoA-SNO and Trx-
SNO transnitrosation respectively. Data from this table are plotted in Figure 3-7.
19 GSNO-sensitive cysteines with PDB entries
19 GSNO-insensitive cysteines with PDB entries
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Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 P31749 AKT1 TMKTFCGTPEY 4EJN 2.253 −
2 Q9BRA2 TXNDC17 GGKSWCPDCVQ 1WOU 4.919 −
3 Q01813 PFKP LPLMECVQMTQ 4U1R 5.754 11.03
4 Q92947 GCDH IKGYGCAGVSS 1SIQ 0.000 11.23
5 P30084 ECHS1 LSFQDCYSSKF 2HW5 20.113 9.64
6 P00558 PGK1 PSIKFCLDNGA 3ZOZ 0.000 12.22
7 Q8TCU6 PREX1 LRLRLCVLNEI 4YON 45.320 9.30
8 P04183 TK1 EALPACLLRDV 2ORV 26.727 9.37
9 Q9GZZ9 UBA5 KREGVCAASLP 3H8V 1.748 9.76
10 P54886 ALDH18A1 VRDSKCEYPAA 2H5G 0.529 10.94
11 P54886 ALDH18A1 EYPAACNALET 2H5G 21.058 3.40
12 P07858 CTSB RGQDHCGIESE 3PBH 3.319 11.79
13 Q99714 HSD17B10 KLGNNCVFAPA 2O23 0.000 11.26
14 Q99714 HSD17B10 LPEKVCNFLAS 2O23 62.971 8.78
15 P04406 GAPDH ISNASCTTNCL 1U8F 18.712 11.18
16 P07339 CTSD EYMIPCEKVST 1LYW 5.256 −
17 P30084 ECHS1 LVSKICPVETL 2HW5 0.204 11.63
18 P30084 ECHS1 EEAIQCAEKIA 2HW5 16.643 9.18
19 P04183 TK1 YSSSFCTHDRN 2ORV 64.257 8.97
Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 Q96FX7 TRMT61A CSFSPCIEQVQ 5CCB 58.964 9.5
2 Q15369 TCEB1 VLSKVCMYFTY 1VCB 0 11.44
3 O00299 CLIC1 LTLADCNLLPK 1K0M 0 13.71
4 P00390 GSR KLGGTCVNVGC 3DK8 8.24 13.94
5 P22626 HNRNPA2B1 GKLTDCVVMRD 1X4B 13.342 10.32
6 P34897 SHMT2 ASENFCSRAAL 3OU5 0.402 11
7 P60174 TPI1 VAAQNCYKVTN 4POD 0 11.94
8 P21266 GSTM3 QSDQFCKMPIN 3GTU 29.912 9.34
9 Q96AT9 RPE NLGAECLRMLD 3OVP 0 11.71
10 P61981 YWHAG YLIKNCSETQY 3UZD 4.38 10.35
11 Q9UBE0 SAE1 KKVVFCPVKEA 3KYC 0.243 10.96
12 P00491 PNP LNGRACVMMQG 3K8Q 0 12.14
13 P30041 PRDX6 DFTPVCTTELG 1PRX 1.054 10.22
14 Q12849 GRSF1 LFLNSCPKGK* 4QU7 29.36 9.13
15 P07237 P4HB LKKEECPAVRL 4EKZ 0 10.53
16 P63104 YWHAZ ELRDICNDVLS 2O02 0 12.47
17 P10768 ESD LSGLTCTEQNF 3FCX 2.991 9.98
18 O75874 IDH1 GFIWACKNYDG 1T09 6.815 11.39
19 P62937 PPIA IPGFMCQGGDF 4YUO 0 12.47
Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 P31749 AKT1 TMKTFCGTPEY 4EJN 2.253 −
2 Q01813 PFKP LPLMECVQMTQ 4U1R 5.754 11.03
19 CoA-SNO-sensitive cysteines with PDB entries
19 CoA-SNO-insensitive cysteines with PDB entries
19 Trx-SNO-sensitive cysteines with PDB entries
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3 Q92947 GCDH IKGYGCAGVSS 1SIQ 0.000 11.23
4 P07858 CTSB RGQDHCGIESE 3PBH 3.319 11.79
5 P26440 IVD RGSNTCELIFE 1IVH 0.000 11.39
6 P26440 IVD LIFEDCKIPAA 1IVH 0.092 11.09
7 P04183 TK1 KLTAVCMECFR 2ORV 0.000 5.89
8 P54886 ALDH18A1 VRDSKCEYPAA 2H5G 0.529 10.94
9 P54886 ALDH18A1 EYPAACNALET 2H5G 21.058 3.40
10 P07384 CAPN1 TRLEICNLTPD 2ARY 11.349 11.92
11 P49327 FASN AGNGYCRSEGV 3HHD 0.000 11.51
12 O14733 MAP2K7 TRSAGCAAYMA 3WZU 14.636 10.59
13 P36873 PPP1CC KTFTDCFNCLP 1JK7 0.075 8.12
14 P36873 PPP1CC TDCFNCLPIAA 1JK7 0.000 10.65
15 P13804 ETFA AGNALCTVKCD 2A1U 27.706 9.22
16 P24468 NR2F2 RFGSQCMQPNN 3CJW 46.835 9.56
17 P36578 RPL4 KRYAICSALAA 4UG0 0.000 11.00
18 P49327 FASN SPEGTCKAFDT 3HHD 0.000 12.76
19 P36873 PPP1CC RGNHECASINR 1JK7 0.616 11.23
Peptide # Uniprot # Symbol Sequence PDB  SASA (Å2) pKa
1 Q04917 YWHAH FLIKNCNDFQY 2C63 3.458 10.7
2 P60174 TPI1 DTEVVCAPPTA 4POD 0 12.29
3 P00558 PGK1 WMGLDCGPESS 3ZOZ 0 12.43
4 P60981 DSTN KAVIFCLSADK 1AK7 0 16.74
5 P14618 PKM LDGADCIMLSG 3BJT 0 12.84
6 P31949 S100A11 TETERCIESLI 2LUC 33.66 9.37
7 P60174 TPI1 GMIKDCGATWV 4POD 35.078 10.11
8 Q08211 DHX9 LAAQSCALSLV 3VYX 0 11.38
9 P61981 YWHAG YLIKNCSETQY 3UZD 4.38 10.35
10 P49915 GMPS GVQGDCRSYSY 2VXO 68.393 9.17
11 Q15257 PPP2R4 FAAFLCCLCKI 2HV6 3.653 13.15
12 Q15257 PPP2R4 AAFLCCLCKIG 2HV6 0 14.32
13 Q15257 PPP2R4 FLCCLCKIGVL 2HV6 6.782 11.86
14 O60701 UGDH GFGGSCFQKDV 4QEJ 33.156 10.59
15 Q14914 PTGR1 GRIAICGAIST 2Y05 4.735 12.4
16 P14618 PKM IFPVLCKDPVQ 3BJT 0 10.68
17 P30044 PRDX5 GTGLTCSLAPN 1OC3 8.158 10.03
18 Q96BN8 FAM105B RGDNYCALRAT 3ZNV 1.18 11.03
19 Q15185 PTGES3 KLTFSCLGGSD 1EJF 0 10.81

















1 P78417 GSTO1 Glutathione transferase omega-1 GSTO1 R.FC*PFAER.T 0.8 1.1 1.0 1.2
2 P49189 ALDH9A1 aldehyde dehydrogenase 9A1 ALDH9A1
K.GALMANFLTQGQVC*C
NGTR.V 0.9 1.3 1.8 1.5




PVVR.E 1.0 1.2 10.9 4.0
4 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase
ALDH6
A1 R.C*MALSTAVLVGEAK.K 1.1 3.3 6.6 15.0




A 1.1 1.3 3.7 1.6
6 P16455 MGMT Methylated-DNA--protein-cysteine methyltransf MGMT
R.VVC*SSGAVGNYSGGLA
VK.E 1.2 1.6 4.7 1.7
7 O75874 IDH1 Isocitrate dehydrogenase [NADP] cytoplasmic E IDH1 K.SEGGFIWAC*K.N 1.4 0.9 0.8 1.5
8 Q9Y696 CLIC4 Chloride intracellular channel protein 4 ENS CLIC4
K.AGSDGESIGNC*PFSQR.
L 1.5 1.1 1.0 1.2
9 O95336 PGLS 6-phosphogluconolactonase PGLS R.AAC*CLAGAR.A 1.5 1.2 1.5 1.3
10 Q9H0W8 C19orf61 59 kDa protein C19orf61 R.REDFC*PR.K 1.5 1.2 1.6 1.8
11 P46782 RPS5 40S ribosomal protein S5 RPS5 K.AQC*PIVER.L 1.6 1.6 2.0 5.4
12 Q9BW61 C19orf58 Uncharacterized protein C19orf58 C19orf58 R.FHADSVC*K.A 1.7 1.1 1.3 1.4
13 Q8N1F7 NUP93 Nuclear pore complex protein Nup93 NUP93
K.SSGQSAQLLSHEPGDPP
C*LR.R 1.8 1.4 1.3 1.8
14 Q99873 PRMT1 HMT1 hnRNP methyltransferase-like 2 isoform PRMT1 K.VIGIEC*SSISDYAVK.I 1.9 1.1 1.2 1.9
15 O00299 DDAH2 CLIC1 Chloride intracellular channel protein DDAH2
K.AGSDGAKIGNC*PFSQR.
L 2.0 1.3 1.0 1.2
16 A0AVT1 UBE1L2 Isoform 1 of Ubiquitin-activating enzyme E1 UBE1L2
R.KPNVGC*QQDSEELLK.
L 2.0 1.4 1.3 1.5
17 P07339 CTSD Cathepsin D precursor CTSD K.AIGAVPLIQGEYMIPC*EK.V 2.1 3.9 6.3 6.9
18 P23396 RPS3 40S ribosomal protein S3 RPS3 R.GLC*AIAQAESLR.Y 2.2 1.7 2.2 3.4
19 P07437 TUBB Tubulin beta chain TUBB K.LTTPTYGDLNHLVSATMSGVTTC*LR.F 2.3 3.7 5.2 4.6
20 Q9NQR4 NIT2 Nitrilase family member 2 NIT2 R.VGLGIC*YDMR.F 2.4 1.2 1.1 1.3




EQR.V 2.5 1.3 2.0 3.4
22 Q9NYL2 ZAK Isoform 1 of Mitogen-activated protein kinase ZAK
K.FDDLQFFENC*GGGSFG
SVYR.A 2.6 1.2 1.5 1.4
23 Q9HA64 FN3KRP Ketosamine-3-kinase FN3KRP R.ATGHSGGGC*ISQGR.S 2.6 1.3 5.6 1.9
24 Q13418 ILK Integrin-linked protein kinase ILK K.FSFQC*PGR.M 2.6 1.5 3.4 5.2
25 Q9NQC3 RTN4 Isoform 1 of Reticulon-4 RTN4 K.YSNSALGHVNC*TIK.E 2.8 1.3 1.6 1.5
Table 3A-6. Comparison of cysteine transnitrosatio sensitivity to cysteine reactivity.
A list of all peptides (* denotes labeled cysteine) identified in the GSNO (500 µM),
CoA-SNO (500 µM), Trx-C73-SNO (90 µM) analysis and a previous study of
cysteine reactivity (reactivity ratio) is presented together with calculated heavy:light
ratios (R-values). In the reactivity data, the ratios are presented as light:heavy, where
labeling at 100 µM IA (light) was compared to 10 µM IA (heavy). A lower ratio
value in the reactivity ratio column signifies increased reactivity of a cysteine.
Pepti
de # Uniprot # Description Symbol Sequence
Ratio 
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2.8 1.1 1.9 1.9
27 P62249 RPS16 RPS16 protein RPS16 K.TATAVAHC*K.R 2.8 2.1 4.7 7.0
28 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 K.HFLSDTGMAC*R.S 3.0 1.1 1.5 2.6
29 P62280 RPS11 40S ribosomal protein S11 RPS11 K.C*PFTGNVSIR.G 3.0 2.3 3.2 6.5
30 O15294 OGT Isoform 3 of UDP-N-acetylglucosamine--peptide OGT
K.VMAEANHFIDLSQIPC*
NGK.A 3.0 1.8 2.0 2.1




K.D 3.1 3.4 7.1 6.6
32 P45984 MAPK9 Isoform Alpha-2 of Mitogen-activated protein MAPK9
R.TAC*TNFMMTPYVVTR.
Y 3.2 1.6 3.0 1.9
33 P28838 LAP3 Isoform 1 of Cytosol aminopeptidase LAP3 R.SAGAC*TAAAFLK.E 3.3 1.2 3.1 3.3
34 P38117 ETFB Isoform 2 of Electron transfer flavoprotein s ETFB
K.HSMNPFC*EIAVEEAVR.
L 3.5 1.2 2.0 2.7
35 Q9ULA0 DNPEP aspartyl aminopeptidase DNPEP K.C*PTSGR.L 3.5 2.6 2.4 1.5
36 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.YMAC*CLLYR.G 3.6 2.4 3.2 4.0
37 Q7L1Q6 BZW1 similar to basic leucine zipper and W2 domain BZW1
R.FDPTQFQDC*IIQGLTET
GTDLEAVAK.F 3.6 1.2 1.5 1.4
38 P55735 SEC13 41 kDa protein SEC13 R.FASGGC*DNLIK.L 3.7 1.1 1.0 1.3
39 Q7L5D6 C7orf20 Protein of unknown function DUF410 family C7orf20 K.EQNYC*ESR.Y 3.7 1.3 1.8 1.8




K.K 3.8 1.7 4.2 4.3
41 P30044 PRDX5 Isoform Mitochondrial of Peroxiredoxin-5, mi PRDX5
K.ALNVEPDGTGLTC*SLA
PNIISQL.- 3.8 0.8 1.0 1.0
42 O95571 ETHE1 ETHE1 protein, mitochondrial precursor ETHE1 R.TDFQQGC*AK.T 3.8 1.7 1.8 1.6
43 Q9NQ88 C12orf5 Uncharacterized protein C12orf5 C12orf5
K.EADQKEQFSQGSPSNC*
LETSLAEIFPLGK.N 3.8 1.2 1.5 1.4
44 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondria IDH2 K.SSGGFVWAC*K.N 3.9 1.3 1.3 5.9
45 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1 R.VC*LCQGSAGSGAIGPVEAAIR.T 3.9 3.1 5.3 3.1
46 P25205 MCM3 DNA replication licensing factor MCM3 MCM3
R.TLTSC*FLSCVVCVEGIV
TK.C 4.0 1.6 1.8 2.0
47 Q5MNZ6
WDR45L WD repeat domain 
phosphoinositide-interacti
WDR45
L R.C*NYLALVGGGK.K 4.0 1.1 5.0 2.2
48 Q2TAA2 IAH1 Isoamyl acetate-hydrolyzing esterase 1 homolo IAH1
R.VILITPTPLC*ETAWEEQ
CIIQGCK.L 4.0 1.2 1.6 1.6
49 P14618 PKM2 Uncharacterized protein PKM2 PKM2 R.AEGSDVANAVLDGADC*IMLSGETAK.G 4.0 1.1 3.0 1.0
50 O43795 MYO1B Isoform 1 of Myosin-Ib MYO1B K.LVMSYVAAVC*GK.G 4.1 1.2 1.2 1.6
51 P04632 CAPNS1 34 kDa protein CAPNS1 R.YSDESGNMDFDNFISC*LVR.L 4.1 0.9 0.7 1.5
52 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit PSMD2 K.GTLTLC*PYHSDR.Q 4.2 0.9 0.9 2.7
53 A6NDG6
LOC283871 hypothetical protein 
LOC283871
LOC283
871 K.NNQESDC*VSK.K 4.2 1.7 2.4 1.6
54 P42677 _ Uncharacterized protein ENSP00000301828 _ K.ARLTEGC*SFR.R 4.2 2.7 5.3 6.0
55 Q9BSH4 CCDC44 Coiled-coil domain-containing protein 44 EN CCDC44
K.KLDSLGLCSVSC*ALEFI
PNSK.V 4.3 1.0 1.1 1.9
56 P31749 AKT1 RAC-alpha serine/threonine-protein kinase ENS AKT1
K.TFC*GTPEYLAPEVLED
NDYGR.A 4.3 3.1 10.9 18.7
57 Q16822 PCK2 mitochondrial phosphoenolpyruvate carboxykina PCK2 R.YVAAAFPSAC*GK.T 4.4 2.4 5.4 6.6
58 Q15813 TBCE Tubulin-specific chaperone E TBCE R.NCAVSC*AGEK.G 4.4 1.4 2.1 2.5
59 Q8NDH3 STX16 56 kDa protein STX16
R.IVDTPC*NEMNTDTFLE
EINK.V 4.4 1.0 1.4 2.5
60 O15355 PPM1G Protein phosphatase 1G PPM1G K.C*SGDGVGAPR.L 4.4 1.4 2.1 1.4
345
61 P52895 AKR1C2 Aldo-keto reductase family 1 member C2 ENSG AKR1C2
R.EEPWVDPNSPVLLEDPV
LC*ALAK.K 4.4 1.1 1.8 1.4
62 P10599 TXN Thioredoxin TXN K.LVVVDFSATWC*GPC*K.M 4.4 1.6 5.3 0.8
63 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A
K.AYHEQLSVAEITNAC*FE
PANQMVK.C 4.5 3.3 5.9 8.9
64 Q96EY8 MMAB Cob MMAB K.IQCTLQDVGSALATPC*SSAR.E 4.5 1.0 1.6 1.4
65 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.RSIQFVDWC*PTGFK.V 4.5 2.5 3.9 5.0
66 Q6KB66 KRT80 Keratin-80 KRT80 R.C*HIDLSGIVEEVK.A 4.5 1.0 1.5 1.4
67 P55060 CSE1L Isoform 1 of Exportin-2 CSE1L K.IC*AVGITK.L 4.5 1.9 2.9 4.4
68 P15880 RPS2 40S ribosomal protein S2 RPS2 R.GC*TATLGNFAK.A 4.6 1.7 2.7 3.3
69 P31949 S100A11 Protein S100-A11 S100A11 K.ISSPTETERC*IESLIAVFQK.Y 4.6 0.8 1.0 1.0
70 P11498 PC Pyruvate carboxylase, mitochondrial precursor E PC R.FLYEC*PWR.R 4.6 1.5 1.9 5.3
71 Q7Z4W1 DCXR L-xylulose reductase DCXR R.GVPGAIVNVSSQC*SQR.A 4.6 1.2 2.8 2.4
72 Q06330 RBPJ Isoform APCR-2 of Recombining binding protein RBPJ R.IIQFQATPC*PK.E 4.6 1.4 2.6 1.8
73 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 K.KLLDLVQQSC*NYK.Q 4.6 1.3 2.8 3.0
74 P22314 UBE1 Ubiquitin-activating enzyme E1 UBE1 K.SIPIC*TLK.N 4.6 1.4 1.6 1.3
75 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-inte PIN1
K.IKSGEEDFESLASQFSDC
*SSAK.A 4.6 1.2 3.1 1.3
76 Q13748 TUBA1A Tubulin alpha-1A chain TUBA1A R.TIQFVDWC*PTGFK.V 4.6 2.4 3.8 5.7
77 P49327 FASN Fatty acid synthase FASN K.LTPGC*EAEAETEAICFFVQQFTDMEHNR.V 4.7 1.2 1.6 1.8
78 Q9Y5Y2 NUBP2 Nucleotide-binding protein 2 NUBP2 R.AVHQC*DR.G 4.7 1.9 5.2 9.3




GGVDGC*IHR.A 4.7 1.1 2.5 2.0
80 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 K.SGDAAIVEMVPGKPMC*VESFSQYPPLGR.F 4.7 1.7 3.7 5.8
81 Q14139 UBE4A Isoform 2 of Ubiquitin conjugation factor E4 UBE4A
R.SQQEIC*EQLNINHMIQR
.I 4.7 1.3 1.7 1.5
82 O75390 CS Citrate synthase, mitochondrial precursor CS K.LPC*VAAK.I 4.8 1.2 1.8 1.6
83 O95747 STK39 STE20/SPS1-related proline-alanine-rich prot STK39
K.TFVGTPC*WMAPEVME
QVR.G 4.8 2.0 3.8 5.3
84 P07437 TUBB Tubulin beta chain TUBB K.NMMAAC*DPR.H 4.8 2.8 4.6 6.3




YQDTSK.Y 4.8 1.1 1.6 1.3
86 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ R.YDDMAAC*MK.S 4.8 0.9 0.9 1.4
87 P33240 CSTF2 Uncharacterized protein CSTF2 CSTF2 K.LC*VQNSPQEAR.N 4.8 1.2 1.4 0.9




PR.G 4.8 1.5 2.8 2.2
89 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T 4.9 1.0 1.4 1.4
90 Q96Q11 TRNT1 Isoform 1 of tRNA-nucleotidyltransferase 1, TRNT1 K.YQGEHC*LLK.E 4.9 1.1 1.3 1.6
91 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/ GNB2
K.AC*GDSTLTQITAGLDP
VGR.I 4.9 2.6 6.0 5.2
92 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/thr ILKAP R.FILLAC*DGLFK.V 4.9 1.1 1.2 1.1
93 P14174 MIF Macrophage migration inhibitory factor MIF K.LLC*GLLAER.L 4.9 0.9 0.8 1.3
94 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.IC*DDELILIK.N 4.9 2.4 3.6 2.5
95 Q00765 REEP5 Receptor expression-enhancing protein 5 ENSG REEP5 K.NC*MTDLLAK.L 4.9 1.6 2.0 1.3
96 Q9NQT5 EXOSC3 Exosome complex exonuclease RRP40 EXOSC3 K.LLAPDC*EIIQEVGK.L 5.0 1.8 2.2 2.3
346
97 P10809 HSPD1 61 kDa protein HSPD1 R.AAVEEGIVLGGGC*ALLR.C 5.0 1.3 3.4 2.3
98 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.NMITGTSQADC*AVLIVAAGVGEFEAGISK.N 5.0 1.3 1.9 2.0
99 Q9NXG2
THUMPD1 Putative uncharacterized 
protein DKFZp686C
THUMP
D1 R.C*DAGGPR.Q 5.0 1.0 1.4 1.3
100 O15355 PPM1G Protein phosphatase 1G PPM1G R.GTEAGQVGEPGIPTGEAGPSC*SSASDK.L 5.0 1.2 2.6 2.1
101 P26641 EEF1G Elongation factor 1-gamma EEF1G R.FPEELTQTFMSC*NLITGMFQR.L 5.0 2.2 3.4 6.4
102 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ K.IETELRDIC*NDVLSLLEK.F 5.1 0.8 0.8 1.3
103 Q27J81 C14orf173 inverted formin 2 isoform 1 C14orf173
R.AVLLASDAQEC*TLEEV
VER.L 5.1 1.4 3.0 3.2
104 O14980 XPO1 Exportin-1 XPO1 K.LDINLLDNVVNC*LYHGEGAQQR.M 5.1 1.2 1.2 1.5
105 P13639 EEF2 Elongation factor 2 EEF2 K.IWC*FGPDGTGPNILTDITK.G 5.1 1.1 1.9 1.5
106 Q99714 HSD17B10 Isoform 1 of 3-hydroxyacyl-CoA dehydrogen
HSD17B
10 K.VC*NFLASQVPFPSR.L 5.1 1.2 6.4 2.4
107 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2 MSRB2
K.YC*SGTGWPSFSEAHGT
SGSDESHTGILR.R 5.1 1.3 1.9 1.6
108 P49327 FASN Fatty acid synthase FASN K.AINC*ATSGVVGLVNCLR.R 5.2 1.3 1.6 1.5
109 P13639 EEF2 Elongation factor 2 EEF2 K.STLTDSLVC*K.A 5.2 1.3 3.7 1.8
110 P15924 DSP Isoform DPI of Desmoplakin DSP K.YC*YLQNEVFGLFQK.L 5.2 2.1 5.6 3.1
111 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH K.ASVGFGGSC*FQK.D 5.2 1.1 1.3 1.0




C*MLR.C 5.2 1.1 1.1 1.6
113 Q16822 PCK2 mitochondrial phosphoenolpyruvate carboxykina PCK2
R.QC*PIMDPAWEAPEGVPI
DAIIFGGR.R 5.2 3.3 4.0 2.6
114 Q9H2U2 PPA2 Isoform 2 of Inorganic pyrophosphatase 2, mit PPA2 R.GQPC*SQNYR.L 5.2 2.0 1.9 1.4
115 P60174 TPI1 Isoform 1 of Triosephosphate isomerase TPI1 K.IAVAAQNC*YK.V 5.2 0.8 0.9 1.2
116 P62888 RPL30 60S ribosomal protein L30 RPL30 R.VC*TLAIIDPGDSDIIR.S 5.3 2.0 8.7 7.9
117 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1
K.QGEYGLASIC*NGGGGA
SAMLIQK.L 5.3 1.4 2.6 3.3
118 P04075 ALDOA 45 kDa protein ALDOA R.ALANSLAC*QGK.Y 5.3 0.9 1.3 1.2
119 P48735 IDH2 Isocitrate dehydrogenase [NADP], mitochondria IDH2 K.DLAGC*IHGLSNVK.L 5.3 1.5 2.5 6.3
120 P57721 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.INISEGNC*PER.I 5.3 1.1 1.7 1.9
121 P62753 RPS6 40S ribosomal protein S6 RPS6 K.LNISFPATGC*QK.L 5.3 2.0 3.0 6.4
122 P62316 SNRPD2 Small nuclear ribonucleoprotein Sm D2 SNRPD2 K.NNTQVLINC*R.N 5.3 1.4 2.5 3.0
123 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R 5.3 0.9 0.9 1.5
124 P28074 PSMB5 Putative uncharacterized protein DKFZp686I01 PSMB5
K.KVIEINPYLLGTMAGGA
ADC*SFWER.L 5.3 1.2 1.8 1.7
125 P63220 RPS21 8.2 kDa differentiation factor RPS21 K.C*SASNR.I 5.3 1.2 3.0 2.2
126 O00299 DDAH2 CLIC1 Chloride intracellular channel protein DDAH2
R.EEFASTC*PDDEEIELAY
EQVAK.A 5.3 1.1 1.0 1.6
127 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1
K.DGLTDVYNKIHMGSC*
AENTAK.K 5.3 1.3 3.1 2.6
128 Q52LJ0 FAM98B family with sequence similarity 98, member FAM98B R.EKTAC*AINK.V 5.3 1.2 1.9 1.6




5.4 1.1 1.5 1.8
130 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF R.C*NNVLYIR.G 5.4 1.2 1.3 1.6
131 P08238 HSP90AB1 85 kDa protein HSP90AB1
R.VFIMDSC*DELIPEYLNF
IR.G 5.4 1.2 1.4 1.5
132 P00390 GSR Isoform Mitochondrial of Glutathione reductase GSR K.LGGTC*VNVGCVPK.K 5.4 0.8 0.9 1.4
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133 Q6YN16 HSDL2 Hydroxysteroid dehydrogenase-like protein 2 HSDL2
K.TAIHTAAMDMLGGPGIE
SQC*R.K 5.4 1.2 3.4 6.2
134 Q52LJ0 FAM98B family with sequence similarity 98, member FAM98B K.SLC*NLEESITSAGR.D 5.4 1.1 1.2 1.4
135 Q00610 CLTC Isoform 1 of Clathrin heavy chain 1 CLTC R.IHEGC*EEPATHNALAK.I 5.4 1.4 1.7 1.8
136 P00338 LDHA Isoform 1 of L-lactate dehydrogenase A chain LDHA R.VIGSGC*NLDSAR.F 5.4 1.1 1.5 2.2
137 P49591 SARS Uncharacterized protein SARS SARS K.YAGLSTC*FR.Q 5.4 1.2 1.2 1.6
138 P10599 TXN Thioredoxin TXN K.C*MPTFQFFK.K 5.4 1.6 3.1 0.2
139 P49321 NASP nuclear autoantigenic sperm protein isoform 1 NASP
R.KPTDGASSSNC*VTDISH
LVR.K 5.5 1.7 2.5 1.6
140 P07437 TUBB Tubulin beta chain TUBB K.TAVC*DIPPR.G 5.5 2.7 4.7 5.4
141 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal precurs ACAA1
K.ARDC*LIPMGITSENVAE
R.F 5.5 0.8 4.4 2.1
142 P14618 PKM2 Uncharacterized protein PKM2 PKM2 R.GIFPVLC*K.D 5.5 1.0 2.8 1.0
143 P07741 APRT 20 kDa protein APRT R.VVVVDDLLATGGTMNAAC*ELLGR.L 5.5 1.1 1.2 1.6
144 P60866 _ Uncharacterized protein ENSP00000348430 _ K.TPC*GEGSK.T 5.5 1.5 2.4 4.6
145 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS R.SKDGVC*VR.V 5.5 1.1 1.1 1.6
146 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.VMTIPYQPMPASSPVIC*AGGQDR.C 5.5 3.4 7.4 7.9
147 P60981 DSTN Destrin DSTN K.HEC*QANGPEDLNR.A 5.6 1.5 2.2 1.4
148 P04183 TK1 thymidine kinase 1, soluble TK1 R.YSSSFC*THDR.N 5.6 2.9 6.2 7.2
149 P31947 SFN Isoform 1 of 14-3-3 protein sigma SFN K.GAVEKGEELSC*EER.N 5.6 1.0 1.3 1.3
150 P04406 GAPDH 39 kDa protein GAPDH K.IISNASC*TTNCLAPLAK.V 5.6 4.9 6.4 4.2
151 Q9UHD8 SEPT9 Isoform 1 of Septin-9 9-Sep
R.SQEATEAAPSC*VGDMA
DTPR.D 5.6 1.3 2.5 1.9
152 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I 5.6 1.3 2.2 1.6
153 P60174 TPI1 Isoform 1 of Triosephosphate isomerase TPI1
K.VPADTEVVC*APPTAYID
FAR.Q 5.6 0.9 0.9 1.1
154 Q9Y224 C14orf166 Protein C14orf166 C14orf166
K.LTALDYHNPAGFNC*K.
D 5.6 1.1 1.4 1.2
155 Q9NZL4 HSPBP1 Isoform 1 of Hsp70-binding protein 1 HSPBP1 R.LLDRDAC*DTVR.V 5.6 1.3 1.6 1.5
156 P47756 CAPZB Capping protein CAPZB K.DETVSDC*SPHIANIGR.L 5.7 1.0 1.4 1.5
157 Q09666 AHNAK AHNAK nucleoprotein isoform 1 AHNAK
K.LEGDLTGPSVGVEVPDV
ELEC*PDAK.L 5.7 1.2 2.0 1.5
158 P52272 HNRPM Isoform 1 of Heterogeneous nuclear ribonucle HNRPM K.AC*QIFVR.N 5.7 1.1 1.8 1.9
159 O43264 ZW10 Centromere/kinetochore protein zw10 homolog E ZW10
R.LAPILC*DGTATFVDLVP
GFR.R 5.7 2.5 3.0 4.4
160 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.PMC*VESFSDYPPLGR.F 5.7 1.4 2.7 9.6
161 O75663 TIPRL Uncharacterized protein TIPRL TIPRL K.VAC*AEEWQESR.T 5.7 0.8 1.6 1.5
162 P49840 GSK3B Isoform 2 of Glycogen synthase kinase-3 beta GSK3B K.LC*DFGSAK.Q 5.8 1.2 1.8 2.2
163 Q86YS7 KIAA0528 KIAA0528 protein KIAA0528 R.SAPPC*ANSTVGVVK.M 5.8 1.3 3.6 2.3
164 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F 5.8 1.1 1.3 1.5
165 P22234 PAICS Multifunctional protein ADE2 PAICS K.ITSC*IFQLLQEAGIK.T 5.8 0.9 0.9 1.7
166 P11413 G6PD Isoform Long of Glucose-6-phosphate 1-dehydro G6PD R.TQVC*GILR.E 5.8 1.5 1.5 1.8
167 P23528 CFL1 Uncharacterized protein CFL1 CFL1 K.HELQANC*YEEVK.D 5.8 0.9 1.1 2.0




SFVGTR.S 5.8 1.1 1.2 1.7
169 P62993 GRB2 Isoform 1 of Growth factor receptor-bound pro GRB2 K.VLNEEC*DQNWYK.A 5.8 1.0 1.3 1.5
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170 P67936 TPM4 Isoform 2 of Tropomyosin alpha-4 chain TPM4
K.EENVGLHQTLDQTLNE
LNC*I.- 5.8 1.3 2.4 2.4
171 Q9Y5P6 GMPPB AMIGO3 GDP-mannose pyrophosphorylase B isofo GMPPB
R.LC*SGPGIVGNVLVDPS
AR.I 5.9 1.0 1.1 1.5
172 Q13185 CBX3 LOC653972 Chromobox protein homolog 3 CBX3 R.LTWHSC*PEDEAQ.- 5.9 1.2 3.7 2.4
173 P78417 GSTO1 Glutathione transferase omega-1 GSTO1 K.LNEC*VDHTPK.L 5.9 1.1 0.9 1.3
174 Q86SX6 GLRX5 Glutaredoxin-related protein 5 GLRX5 K.GTPEQPQC*GFSNAVVQILR.L 5.9 1.1 1.2 1.3
175 Q9UJW0  DCTN4 Dynactin subunit 4 DCTN4 R.LLQPDFQPVC*ASQLYPR.H 5.9 1.2 1.4 1.6
176 P40926 MDH2 Malate dehydrogenase, mitochondrial precursor MDH2 K.EGVVEC*SFVK.S 5.9 1.2 1.3 1.6
177 P49721 PSMB2 Proteasome beta 2 subunit variant (Fragment) PSMB2 R.NLADC*LR.S 5.9 1.3 2.0 1.7
178 Q96RS6 NUDCD1 NudC domain-containing protein 1
NUDCD
1 R.DSAQC*AAIAER.L 5.9 1.2 2.1 1.5
179 Q92879 CUGBP1 Isoform 4 of CUG-BP- and ETR-3-like factor CUGBP1 R.GC*AFVTFTTR.A 5.9 1.6 2.3 1.4
180 Q9H3U1 UNC45A Isoform 1 of UNC45 homolog A UNC45A
R.AIQTVSC*LLQGPCDAG
NR.A 5.9 1.2 1.1 1.5
181 Q96EY5 FAM125A Isoform 1 of Protein FAM125A
FAM125
A K.SC*SPLAFSAFGDLTIK.S 6.0 1.5 1.6 1.3
182 P49588 AARS Uncharacterized protein AARS AARS K.C*LSVMEAK.V 6.0 1.0 1.5 1.3
183 Q9BV86 C9orf32 Protein of unknown function DUF858, methyl C9orf32 R.IIC*SAGLSLLAEER.Q 6.0 1.2 1.5 4.2
184 Q9BXJ9 NARG1 Isoform 1 of NMDA receptor-regulated protein NARG1 R.LFNTAVC*ESK.D 6.0 1.4 1.3 1.9
185 Q96BF6 BTBD14B BTB/POZ domain-containing protein 14B ENSG
BTBD14
B R.NTLANSC*GTGIR.S 6.0 1.2 4.1 13.8
186 P21333 FLNA Filamin-A FLNA K.AHVVPC*FDASK.V 6.0 1.4 1.2 1.4
187 O43681 CRABP2 Cellular retinoic acid-binding protein 2 EN CRABP2
K.IDTHNIIVNQLVFPDPEK
PC*K.M 6.1 1.0 1.0 1.1
188 P52272 HNRPM Isoform 1 of Heterogeneous nuclear ribonucle HNRPM R.GC*AVVEFK.M 6.1 1.0 1.8 1.6
189 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.SLHDALC*VVK.R 6.1 2.4 6.3 2.3
190 P50570 DNM2 98 kDa protein DNM2 K.LQDAFSSIGQSC*HLDLPQIAVVGGQSAGK.S 6.1 1.4 1.9 1.7
191 P55263 ADK Isoform Long of Adenosine kinase ADK R.TGC*TFPEKPDFH.- 6.1 1.5 2.2 1.3
192 Q9C0C9 UBE2O Uncharacterized protein UBE2O UBE2O R.C*YNEMALIR.V 6.1 1.3 1.6 1.5




GILVQNVLK.F 6.1 1.3 7.7 6.5
194 P50990 CCT8 Uncharacterized protein CCT8 CCT8 K.IAVYSC*PFDGMITETK.G 6.1 1.1 1.0 1.3
195 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 K.VVFC*PVK.E 6.1 0.9 0.9 2.1
196 P09429 HMG1L1 High-mobility group protein 1-like 1
HMG1L
1 K.MSSYAFFVQTC*R.E 6.1 1.4 2.0 7.7




IR.G 6.2 1.2 1.2 1.3
198 P60709 ACTB Actin, cytoplasmic 2 ACTB K.EKLC*YVALDFEQEMATAASSSSLEK.S 6.2 2.2 3.7 7.4




GR.L 6.2 1.6 3.3 3.9
200 P84085 ARF5 ADP-ribosylation factor 5 ARF5 K.NIC*FTVWDVGGQDK.I 6.2 1.4 1.4 2.9
201 Q09666 AHNAK AHNAK nucleoprotein isoform 1 AHNAK
K.LEGDLTGPSVDVEVPDV
ELEC*PDAK.L 6.3 1.2 1.7 1.6
202 P49458 SRP9 hCG_1781062 Signal recognition particle 9 kDa SRP9 K.VTDDLVC*LVYK.T 6.3 1.1 1.3 1.6
203 P13639 EEF2 Elongation factor 2 EEF2 R.YVEPIEDVPC*GNIVGLVGVDQFLVK.T 6.3 1.2 2.1 1.4
204 Q92598 HSPH1 Isoform Alpha of Heat shock protein 105 kDa HSPH1
R.AGGIETIANEFSDRC*TP
SVISFGSK.N 6.3 1.7 4.7 5.5
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205 Q9UL46 _ Uncharacterized protein ENSP00000310225 _ K.C*GFLPGNEK.V 6.4 0.9 1.3 1.1
206 P57721 PCBP3 Poly(RC) binding protein 3 PCBP3 R.LVVPASQC*GSLIGK.G 6.4 1.1 1.6 2.2
207 Q15366 PCBP2 poly(rC)-binding protein 2 isoform a PCBP2 R.AITIAGIPQSIIEC*VK.Q 6.4 1.0 1.1 1.6
208 P60174 TPI1 Isoform 1 of Triosephosphate isomerase TPI1 R.IIYGGSVTGATC*K.E 6.4 0.9 1.1 1.2
209 P13489 RNH1 Ribonuclease inhibitor RNH1 R.ELDLSNNC*LGDAGILQLVESVR.Q 6.5 1.2 1.3 1.5
210 O75348 FLJ25715 ATP6V1G1 Vacuolar ATP synthase subunit G
FLJ2571
5 R.GSC*STEVEKETQEK.M 6.5 1.0 1.9 1.8
211 Q9NTK5 OLA1 Isoform 1 of Putative GTP-binding protein 9 E OLA1
K.STFFNVLTNSQASAENF
PFC*TIDPNESR.V 6.5 1.1 1.3 1.2
212 P62937 _ Uncharacterized protein ENSP00000369516 _ R.IIPGFMC*QGGDFTR.H 6.6 0.8 0.8 1.2




IAPVELR.Y 6.6 1.3 3.8 2.3
214 Q16630 CPSF6 Isoform 2 of Cleavage and polyadenylation sp CPSF6 R.ELHGQNPVVTPC*NK.Q 6.6 1.2 1.4 1.3
215 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.SIC*TTVLELLDK.Y 6.6 0.9 0.8 1.2
216 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial precursor ECHS1
K.ALNALC*DGLIDELNQA
LK.T 6.6 2.2 5.6 1.6




Q 6.6 1.1 1.1 1.4
218 O15075 DCLK1 Isoform 2 of Serine/threonine-protein kinase DCLK1 R.YQDDFLLDESEC*R.V 6.6 1.3 4.3 3.0
219 Q15185 PTGES3 19 kDa protein PTGES3 K.HLNEIDLFHC*IDPNDSK.H 6.6 1.2 1.3 1.5




APEVLK.R 6.7 1.2 2.2 3.0
221 P18085 ARF4 similar to ADP-ribosylation factor 4 ARF4 K.NIC*FTVWDVGGQDR.I 6.7 1.4 2.1 3.9
222 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 R.TPC*NAGTFSQPEK.V 6.7 1.4 2.3 1.7
223 Q93052 LPP Lipoma-preferred partner LPP K.TYITDPVSAPC*APPLQPK.G 6.7 1.5 2.8 1.5
224 P10768 ESD S-formylglutathione hydrolase ESD K.AETGKCPALYWLSGLTC*TEQNFISK.S 6.7 0.9 0.8 1.4
225 O14929 HAT1 Histone acetyltransferase type B catalytic su HAT1
K.VDENFDC*VEADDVEG
K.I 6.7 1.3 2.0 2.3
226 P00492 HPRT1 Uncharacterized protein HPRT1 HPRT1 K.SYC*NDQSTGDIK.V 6.7 1.0 1.3 1.3
227 P26641 EEF1G Elongation factor 1-gamma EEF1G K.AAAPAPEEEMDEC*EQALAAEPK.A 6.7 1.1 1.4 1.5
228 P12004 PCNA Proliferating cell nuclear antigen PCNA K.C*AGNEDIITLR.A 6.8 1.0 1.1 1.3
229 Q9UI30 HSPC152 TRM112-like protein HSPC152 R.IC*PVEFNPNFVAR.M 6.8 1.1 1.8 1.7
230 P18669 PGAM1 hCG_2015138 Phosphoglycerate mutase 1 PGAM1
R.YADLTEDQLPSC*ESLK.
D 6.8 1.0 1.8 1.3
231 P23921 RRM1 Ribonucleoside-diphosphate reductase large su RRM1
K.IIDINYYPVPEAC*LSNK.
R 6.8 1.3 2.3 3.1
232 Q15019 SEPT2 Septin-2 2-Sep R.LTVVDTPGYGDAINC*R.D 6.8 1.7 2.4 1.6
233 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.YLAEVAC*GDDR.K 6.9 1.0 1.2 1.4
234 Q09666 AHNAK AHNAK nucleoprotein isoform 1 AHNAK
K.GPFVEAEVPDVDLEC*P
DAK.L 6.9 1.1 1.8 1.4
235 P60763 RAC3 Ras-related C3 botulinum toxin substrate 3 pr RAC3 R.AVLC*PPPVK.K 6.9 1.3 1.9 1.5
236 P22102 GART Isoform Long of Trifunctional purine biosynth GART
K.QVLVAPGNAGTAC*SEK
.I 7.0 1.4 2.4 1.2
237 P49327 FASN Fatty acid synthase FASN K.ADEASELAC*PTPK.E 7.0 1.4 2.0 1.6
238 P40926 MDH2 Malate dehydrogenase, mitochondrial precursor MDH2 K.TIIPLISQC*TPK.V 7.0 1.8 2.9 1.8
239 P49915 GMPS GMP synthase GMPS K.TVGVQGDC*R.S 7.1 1.1 1.8 1.0
240 Q9NVG8





A 7.1 1.1 1.3 1.5
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241 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 R.AGAIAPC*EVTVPAQNTGLGPEK.T 7.1 1.8 3.1 2.5
242 Q15796 SMAD2 Isoform Long of Mothers against decapentaple SMAD2 K.AITTQNC*NTK.C 7.1 1.7 2.0 3.7
243 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.LVVPATQC*GSLIGK.G 7.1 1.2 1.9 1.8
244 Q12849 GRSF1 G-rich RNA sequence binding factor 1 isoform GRSF1 R.YIELFLNSC*PK.G 7.2 1.2 0.8 4.0
245 Q99439 CNN2 Calponin-2 CNN2 K.C*ASQVGMTAPGTR.R 7.3 2.2 0.7 2.2
246 P62829 RPL23 60S ribosomal protein L23 RPL23 R.ISLGLPVGAVINC*ADNTGAK.N 7.3 2.1 3.5 5.1
247 P60981 DSTN Destrin DSTN K.LGGSLIVAFEGC*PV.- 7.3 1.0 1.4 1.8
248 P52907 CAPZA1 F-actin-capping protein subunit alpha-1 ENS CAPZA1
K.TIDGQQTIIAC*IESHQFQ
PK.N 7.4 1.0 0.8 1.6
249 P55212 CASP6 Isoform Alpha of Caspase-6 precursor CASP6 R.GTC*ADRDNLTR.R 7.4 0.9 0.7 1.5
250 Q02790 FKBP4 FK506-binding protein 4 FKBP4 K.TQLAVC*QQR.I 7.4 1.1 1.1 1.1
251 P62826 RAN 26 kDa protein RAN R.VC*ENIPIVLCGNK.V 7.5 1.1 1.3 1.7
252 O15382 BCAT2 Branched chain aminotransferase 2, mitochond BCAT2
R.EVFGSGTAC*QVCPVHR
.I 7.5 1.2 1.2 1.7
253 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1
R.QAVLGAGLPISTPC*TTI
NK.V 7.5 1.4 4.2 4.0
254 Q15631 TSN Translin TSN K.ETAAAC*VEK.- 7.5 1.2 3.0 2.5
255 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 R.ASYFQC*VQR.E 7.6 1.4 3.1 2.0
256 P14618 PKM2 Uncharacterized protein PKM2 PKM2 R.NTGIIC*TIGPASR.S 7.6 0.9 3.0 1.1
257 P78347 GTF2I Isoform 1 of General transcription factor II GTF2I R.SILSPGGSC*GPIK.V 7.6 1.1 2.0 1.5
258 P36405 ARL3 ADP-ribosylation factor-like protein 3 ARL3 K.LSC*VPVLIFANK.Q 7.6 1.1 1.3 1.5
259 Q9UHX1 PUF60 Isoform 1 of Poly PUF60 R.ALAIMC*R.V 7.6 0.9 0.9 1.5
260 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.YVLC*TAPR.A 7.7 1.6 1.9 2.4
261 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.TGQATVASGIPAGWMGLDC*GPESSK.K 7.7 0.9 1.1 1.1
262 P29590 PML Isoform PML-1 of Probable transcription factor PML R.LQDLSSC*ITQGK.D 7.7 3.5 5.9 1.9
263 Q15185 PTGES3 19 kDa protein PTGES3 K.LTFSC*LGGSDNFK.H 7.9 0.8 0.8 0.9
264 Q9NUU7
DDX19B Isoform 1 of ATP-dependent 
RNA helicase DDX DDX19B K.VLVTTNVC*AR.G 8.0 1.3 2.5 5.2
265 P33316 DUT Isoform DUT-M of Deoxyuridine 5-triphosphate DUT R.IAQLIC*ER.I 8.1 1.3 1.9 1.8
266 P31948 STIP1 STIP1 protein STIP1 K.ALDLDSSC*K.E 8.1 2.5 3.3 1.8
267 Q04917 YWHAH 14-3-3 protein eta YWHAH K.ELETVC*NDVLSLLDK.F 8.1 0.9 1.0 1.2
268 P49915 GMPS GMP synthase GMPS K.AC*TTEEDQEK.L 8.1 1.2 1.3 1.5
269 P49915 GMPS GMP synthase GMPS R.VICAEEPYIC*K.D 8.3 1.3 1.5 1.2
270 Q01518 CAP1 Adenylyl cyclase-associated protein 1 CAP1
R.ALLVTASQC*QQPAENK.
L 8.7 1.0 1.0 1.1
271 Q00839 HNRNPU heterogeneous nuclear ribonucleoprotein U i
HNRNP
U K.AVVVC*PK.D 8.8 1.7 3.4 3.4
272 Q7RTV0 PHF5A PHD finger-like domain-containing protein 5A PHF5A R.ICDEC*NYGSYQGR.C 9.7 2.3 2.9 3.0
273 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit PSMD2 R.C*ALGVFR.K 10.0 2.2 2.9 3.4
274 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.AITIAGVPQSVTEC*VK.Q 10.7 1.1 1.2 1.4
275 P04406 GAPDH 39 kDa protein GAPDH R.VPTANVSVVDLTC*R.L 11.2 0.4 1.7 0.5
276 P14868 DARS Aspartyl-tRNA synthetase, cytoplasmic DARS R.LEYC*EALAMLR.E 11.5 1.1 1.1 2.0
277 P45880 VDAC2 LOC729317 similar to voltage-dependent anion VDAC2 R.PMC*IPPSYADLGK.A 12.7 2.2 4.1 3.7
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278 O95833 CLIC3 Chloride intracellular channel protein 3 ENS CLIC3
K.ASEDGESVGHC*PSC*Q
R.L 14.8 2.5 4.7 3.7
Table 3A-7. R-values from 1 mM MeGSH competitive transnitrosation experiment at 
500 µM GSNO. A list of all identified peptides (* denotes labeled cysteine) is
presented together with calculated Heavy:Light Ratios (R-values) in pre-treated with
1 mM MeGSH (light, n=3), or left untreated as a control (heavy, n=5), then
transnitrosated by 500 µM GSNO and taken through the quantitative mass
spectrometry workflow. Date were sorted by ΔR (R of control minus R of pre-treated
sample)  and numbered as "Peptide #".        
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1 O94906 PRPF6 Pre-mRNA-processing factor 6 PRPF6 R.AAQDLC*EEALR.H
2 P34896 SHMT1 Serine hydroxymethyltransferase, cytosolic SHMT1 R.AVLEALGSC*LNNK.Y
3 P02795 MT2A Metallothionein-2 MT2A K.C*AQGCICK.G
4 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 R.VGAFTMVC*K.D
5 Q13347 EIF3I Eukaryotic translation initiation factor 3 subunit EIF3I K.HVLTGSADNSC*R.L
6 P50995 ANXA11 Annexin A11 ANXA11 K.FNAVLC*SR.S
7 P31948 STIP1 Stress-induced-phosphoprotein 1 STIP1 K.ALDLDSSC*K.E
8 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 K.C*LQNPSSDIR.L
9 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.QC*PIMDPAWEAPEGVPIDAIIFGGR.R
10 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.ALNALC*DGLIDELNQALK.T
11 Q04724 TLE1 Transducin-like enhancer protein 1 TLE1 K.SPVSQLDC*LNR.D
12 P07437 TUBB Tubulin beta chain TUBB K.LTTPTYGDLNHLVSATMSGVTTC*LR.F
13 P34932 HSPA4 Heat shock 70 kDa protein 4 HSPA4 R.AGGIETIANEYSDRC*TPACISFGPK.N
14 P50213 IDH3A Isocitrate dehydrogenase IDH3A R.IEAAC*FATIK.D
15 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 K.KLGNNC*VFAPADVTSEK.D
16 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.SLHDALC*VVK.R
17 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP K.C*PTSGR.L
18 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 R.GQPC*SQNYR.L
19 Q7L5Y1 ENOSF1 Mitochondrial enolase superfamily member 1 ENOSF1 K.ALQFLQIDSC*R.L
20 P83731 RPL24 60S ribosomal protein L24 RPL24 K.VELC*SFSGYK.I
21 P30519 HMOX2 Heme oxygenase 2 HMOX2 K.GALEGSSC*PFR.T
22 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 R.C*SVLAAANSVFGR.W
23 Q68CP9 ARID2 AT-rich interactive domain-containing protein 2 ARID2 R.SC*SNAAFALK.Q
24 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2 R.DLGGIVLANAC*GPCIGQWDR.K
25 Q96CD2 PPCDC Phosphopantothenoylcysteine decarboxylase PPCDC K.KLVC*GDEGLGAMAEVGTIVDK.V
26 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 K.C*QTSMDELLK.E
27 Q7Z406 MYH14 Myosin-14 MYH14 K.AEDMAELTC*LNEASVLHNLR.E
28 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.YVAAAFPSAC*GK.T
29 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 R.LC*PNSTGAEIR.S
30 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.LTFSC*LGGSDNFK.H
31 P10599 TXN Thioredoxin TXN K.C*MPTFQFFK.K
32 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A R.AVC*MLSNTTAIAEAWAR.L
33 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPUL
2 R.NFILDQC*NVYNSGQR.R
34 P31948 STIP1 Stress-induced-phosphoprotein 1 STIP1 K.ALSVGNIDDALQC*YSEAIK.L
35 P07437 TUBB Tubulin beta chain TUBB K.TAVC*DIPPR.G
36 Q9H479 FN3K Fructosamine-3-kinase FN3K R.AFGGPGAGC*ISEGR.A
37 Q9Y3L5 RAP2C Ras-related protein Rap-2c RAP2C R.ALAQEWGC*PFMETSAK.S
38 Q9Y3E2 BOLA1 BolA-like protein 1 BOLA1 R.VC*LCQGSAGSGAIGPVEAAIR.T
39 Q27J81 INF2 Inverted formin-2 INF2 R.AVLLASDAQEC*TLEEVVER.L
Pepti
de # Uniprot # Description Symbol Sequence
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ΔR
1 2 3 4 5 average 1 2 3 average
4.0 5.3 3.0 4.7 4.4 4.3 1.2 1.3 0.9 1.1 3.1
0.0 2.5 0.0 1.8 2.9 2.4 0.2 0.2 0.2 0.2 2.2
1.1 2.1 2.9 3.9 3.2 2.6 1.3 0.5 0.7 0.8 1.8
3.0 2.8 2.8 3.1 2.8 2.9 1.2 1.2 1.2 1.2 1.7
3.6 2.4 4.9 4.7 0.0 3.9 2.6 2.0 2.2 2.3 1.6
3.4 1.7 3.4 3.5 3.5 3.1 1.0 2.3 1.5 1.6 1.5
3.2 1.9 2.5 2.4 2.4 2.5 0.9 1.4 0.9 1.1 1.4
2.5 0.0 1.7 3.2 0.0 2.5 0.9 2.1 1.6 1.5 1.0
3.5 3.1 3.1 3.7 3.2 3.3 2.0 2.3 2.8 2.4 0.9
2.2 2.1 2.1 2.3 2.1 2.2 1.3 1.4 1.4 1.4 0.8
1.4 0.0 1.9 2.3 2.1 1.9 1.3 1.0 1.3 1.2 0.7
3.8 3.5 3.5 4.0 3.6 3.7 2.8 2.9 3.1 2.9 0.7
1.9 1.3 1.7 3.2 2.0 2.0 1.4 1.3 1.2 1.3 0.7
0.0 2.4 2.6 2.8 2.9 2.7 2.4 2.5 1.1 2.0 0.7
2.9 2.7 3.0 3.8 2.8 3.0 2.2 2.4 2.5 2.4 0.7
1.9 2.0 2.5 3.3 2.3 2.4 1.8 1.7 1.6 1.7 0.7
2.6 2.5 2.5 2.6 2.8 2.6 1.9 2.0 2.0 2.0 0.6
1.7 1.7 2.5 2.1 2.2 2.0 1.2 1.5 1.5 1.4 0.6
0.0 1.6 2.8 2.3 1.5 2.1 1.2 1.8 1.3 1.4 0.6
2.6 2.5 2.1 2.6 3.2 2.6 2.0 2.5 1.6 2.0 0.6
1.7 1.7 1.6 1.8 1.9 1.7 1.3 0.8 1.2 1.1 0.6
2.2 2.8 1.9 2.5 1.9 2.3 1.5 1.6 2.0 1.7 0.6
2.2 1.6 1.4 1.9 2.5 1.9 1.4 1.3 1.4 1.3 0.6
1.0 1.3 1.1 1.4 1.4 1.2 0.7 0.8 0.7 0.7 0.5
0.0 1.8 1.8 2.0 0.0 1.8 1.3 1.2 1.5 1.3 0.5
1.6 1.0 2.0 1.3 2.0 1.6 1.1 1.2 1.0 1.1 0.5
2.4 2.3 2.5 2.8 2.3 2.5 2.2 1.8 1.9 2.0 0.5
2.8 2.1 2.3 2.6 2.4 2.4 1.7 2.0 2.1 1.9 0.5
2.6 2.4 2.3 2.4 2.4 2.4 1.7 2.1 2.0 2.0 0.5
0.7 1.2 1.9 1.9 0.8 1.3 0.7 1.0 0.9 0.9 0.5
1.4 1.2 2.4 1.7 1.5 1.6 1.0 1.4 1.1 1.2 0.5
3.0 2.9 2.8 3.3 3.1 3.0 2.4 2.6 2.7 2.6 0.5
1.6 1.5 1.7 2.2 1.8 1.8 1.3 1.3 1.4 1.3 0.4
1.1 0.9 1.4 1.7 0.8 1.2 1.0 0.3 0.9 0.7 0.4
2.6 2.5 2.5 2.9 2.7 2.7 2.1 2.0 2.6 2.2 0.4
1.6 1.4 2.0 1.8 1.8 1.7 1.2 1.5 1.3 1.3 0.4
0.0 1.7 2.0 2.1 2.1 2.0 1.4 1.4 1.9 1.6 0.4
2.5 0.0 3.2 3.4 3.1 3.1 3.0 2.5 2.6 2.7 0.4
1.8 0.9 2.0 2.7 1.5 1.8 1.1 1.5 1.7 1.4 0.4
Ctrl - 
Sample
Heavy : Light Ratio R
500 µM GSNO (control) 1 mM MEGSH + 500 µM GSNO (sample)
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40 P62888 RPL30 60S ribosomal protein L30 RPL30 R.VC*TLAIIDPGDSDIIR.S
41 O43815 STRN Striatin STRN K.C*YIASAGADALAK.V
42 Q15019 SEPT2 Septin-2 2-Sep R.LTVVDTPGYGDAINC*R.D
43 Q14318 FKBP8 Peptidyl-prolyl cis-trans isomerase FKBP8 FKBP8 K.C*LNNLAASQLK.L
44 P46013 MKI67 Antigen KI-67 MKI67 R.KADVEGELLAC*R.N
45 P23396 RPS3 40S ribosomal protein S3 RPS3 K.GC*EVVVSGK.L
46 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 R.NLADC*LR.S
47 P52943 CRIP2 Cysteine-rich protein 2 CRIP2 R.ASSVTTFTGEPNTC*PR.C
48 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
R.GQAGGGGPGTGPGLGEAGSLATC*E
LPLAK.S
49 P25398 RPS12 40S ribosomal protein S12 RPS12 K.LGEWVGLC*K.I
50 P04183 TK1 Thymidine kinase, cytosolic TK1 R.NTMEALPAC*LLR.D
51 P51946 CCNH Cyclin-H CCNH R.TC*LSQLLDIMK.S
52 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 K.C*AMTALSSK.L
53 P13489 RNH1 Ribonuclease inhibitor RNH1 R.SNELGDVGVHC*VLQGLQTPSCK.I
54 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.GEETPVIVGSALC*ALEGR.D
55 Q9BUL9 RPP25 Ribonuclease P protein subunit p25 RPP25 R.SEEAPAGC*GAEGGGPGSGPFADLAPGAVHMR.V
56 P14678 SNRPB Small nuclear ribonucleoprotein-associated protein SNRPB R.C*ILQDGR.I
57 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 R.GC*AFVTFTTR.A
58 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 R.SVLDAAQIVGLNC*LR.L
59 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 K.VVLLGEGC*VGK.T
60 Q969Z0 TBRG4 Protein TBRG4 TBRG4 R.LATDLLSLMPSLTSGEVAHC*AK.S
61 P62280 RPS11 40S ribosomal protein S11 RPS11 K.C*PFTGNVSIR.G
62 Q5T4S7 UBR4 E3 ubiquitin-protein ligase UBR4 UBR4 K.AVQC*LNTSSK.E
63 Q9Y399 MRPS2 28S ribosomal protein S2, mitochondrial MRPS2 R.DC*GEYAHTR.Y
64 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2 R.VLVVGAGGIGC*ELLK.N
65 Q9ULV4 CORO1C Coronin-1C CORO1C K.C*DLISIPK.K
66 Q15459 SF3A1 Splicing factor 3A subunit 1 SF3A1 R.EVLDQVC*YR.V
67 P13639 EEF2 Elongation factor 2 EEF2 K.IWC*FGPDGTGPNILTDITK.G
68 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 K.TRPDGNC*FYR.A
69 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.GIFPVLC*K.D
70 P02795 MT2A Metallothionein-2 MT2A K.KSC*CSCCPVGCAK.C
71 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.AFAAGADIKEMQNLSFQDC*YSSK.F
72 P62873 GNB1 Guanine nucleotide-binding protein G(I)/G(S)/G(T) GNB1 R.VSC*LGVTDDGMAVATGSWDSFLK.I
73 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O R.C*YNEMALIR.V
74 Q6P2I3 FAHD2B Fumarylacetoacetate hydrolase domain-containing pr FAHD2B K.TFDTFC*PLGPALVTK.D
75 P50991 CCT4 T-complex protein 1 subunit delta CCT4 R.TLSGMESYC*VR.A
76 Q86YS7 KIAA0528 Uncharacterized protein KIAA0528 KIAA0528 R.SAPPC*ANSTVGVVK.M
77 P07437 TUBB Tubulin beta chain TUBB K.NMMAAC*DPR.H
78 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 R.ANSSVVSVNC*K.G
79 Q86XN7 PROSER1 Proline and serine-rich protein 1 PROSER1 K.DGEEC*TNEGK.G
80 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.YVLC*TAPR.A
81 P57678 GEMIN4 Gem-associated protein 4 GEMIN4 R.SDPDAC*PTMPLLAMLLR.G
82 P23528 CFL1 Cofilin-1 CFL1 K.AVLFC*LSEDK.K
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2.1 1.9 1.8 2.2 2.0 2.0 1.5 1.6 1.7 1.6 0.4
1.5 1.5 0.0 0.0 2.3 1.8 1.7 1.4 1.1 1.4 0.4
1.8 1.6 1.6 1.9 1.8 1.7 1.4 1.4 1.4 1.4 0.4
1.8 1.8 2.2 2.3 1.9 2.0 1.6 1.6 1.7 1.6 0.4
0.0 1.3 1.3 2.2 1.0 1.4 1.3 1.2 0.8 1.1 0.4
2.3 3.1 2.6 2.5 2.7 2.6 2.2 2.4 2.2 2.3 0.4
1.8 1.3 1.2 1.2 1.3 1.4 1.1 1.0 1.0 1.0 0.3
1.1 0.9 1.1 1.2 1.0 1.0 0.8 0.6 0.7 0.7 0.3
1.1 1.0 0.9 1.2 1.1 1.1 0.7 0.8 0.7 0.7 0.3
2.5 2.5 2.5 3.2 2.4 2.6 2.1 2.0 2.6 2.2 0.3
3.0 2.4 3.1 3.7 3.1 3.1 1.9 3.2 3.0 2.7 0.3
1.5 0.0 1.2 1.3 1.3 1.3 0.8 1.0 1.0 1.0 0.3
1.8 2.4 1.5 1.7 1.4 1.8 1.4 1.6 1.3 1.4 0.3
1.0 0.7 1.0 0.9 0.9 0.9 0.6 0.6 0.5 0.6 0.3
2.3 2.1 2.2 2.5 2.4 2.3 1.1 2.9 1.8 1.9 0.3
1.4 1.5 1.5 1.5 1.5 1.5 1.1 1.2 1.2 1.2 0.3
1.3 0.0 1.2 1.6 1.5 1.4 1.1 1.1 1.1 1.1 0.3
1.8 1.5 1.5 1.5 1.7 1.6 1.2 1.3 1.3 1.3 0.3
2.0 1.5 3.0 3.0 3.0 2.5 2.1 2.2 2.3 2.2 0.3
1.4 1.4 1.4 1.6 1.5 1.4 1.1 1.1 1.2 1.1 0.3
1.7 1.8 1.7 2.0 1.6 1.8 1.3 1.4 1.6 1.4 0.3
2.3 2.2 1.9 2.4 2.8 2.3 1.9 2.0 2.2 2.0 0.3
2.0 1.2 1.3 0.9 1.3 1.4 1.5 0.9 0.8 1.1 0.3
1.4 1.7 2.9 2.7 2.4 2.2 1.5 2.1 2.2 1.9 0.3
1.6 1.5 1.6 1.7 1.5 1.6 1.2 1.3 1.4 1.3 0.3
1.3 1.4 1.5 1.6 1.4 1.4 1.1 1.3 0.9 1.1 0.3
0.0 1.2 0.9 1.6 1.5 1.3 1.0 1.0 0.9 1.0 0.3
2.3 1.1 1.1 1.0 1.1 1.3 1.1 1.2 0.8 1.0 0.3
1.3 1.2 0.0 0.0 1.0 1.2 0.8 1.0 0.9 0.9 0.3
0.8 1.0 1.2 1.0 1.0 1.0 0.9 0.5 0.7 0.7 0.3
1.4 1.6 1.8 2.7 1.6 1.8 1.6 1.1 1.9 1.5 0.3
2.0 1.9 1.8 2.0 1.9 1.9 1.5 1.9 1.6 1.6 0.3
3.0 1.6 1.7 0.0 1.2 1.9 1.9 1.6 1.4 1.6 0.3
1.2 1.3 1.2 1.5 1.5 1.3 1.1 0.9 1.2 1.1 0.3
2.1 0.0 2.0 2.5 2.1 2.2 1.9 1.6 2.4 1.9 0.3
1.3 1.4 1.4 1.6 1.3 1.4 1.7 1.5 0.3 1.2 0.3
1.1 0.0 1.1 1.6 1.4 1.3 0.9 1.0 1.3 1.0 0.3
2.9 2.6 2.6 3.0 2.8 2.8 2.4 2.5 2.7 2.5 0.3
1.7 1.9 1.4 1.8 1.9 1.7 1.4 1.6 1.5 1.5 0.2
1.4 1.2 1.2 0.0 0.0 1.3 0.9 1.2 1.1 1.0 0.2
1.6 1.5 1.6 1.6 1.6 1.6 1.2 1.4 1.5 1.4 0.2
1.8 0.0 1.4 1.8 0.0 1.7 1.6 1.3 1.4 1.4 0.2
0.8 1.0 1.1 0.8 0.9 0.9 0.8 0.7 0.6 0.7 0.2
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83 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 R.ASYFQC*VQR.E
84 P19838 NFKB1 Nuclear factor NF-kappa-B p105 subunit NFKB1 R.YVC*EGPSHGGLPGASSEK.N
85 Q9H3P7 ACBD3 Golgi resident protein GCP60 ACBD3 K.QVLMGPYNPDTC*PEVGFFDVLGNDR.R
86 P33991 MCM4 DNA replication licensing factor MCM4 MCM4 K.AGIIC*QLNAR.T
87 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 K.NC*DKGQSFFIDAPDSPATLAYR.S
88 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10 R.SSVELPPYSGTVLC*GTQAVDKLPDGQEYQR.I
89 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.YMAC*CLLYR.G
90 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.AEGSDVANAVLDGADC*IMLSGETAK.G
91 Q9Y277 VDAC3 Voltage-dependent anion-selective channel protein VDAC3 K.VC*NYGLTFTQK.W
92 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 R.LLDRDAC*DTVR.V
93 O43765 SGTA Small glutamine-rich tetratricopeptide repeat-cont SGTA R.AIC*IDPAYSK.A
94 Q8NBF2 NHLRC2 NHL repeat-containing protein 2 NHLRC2 K.AILFSQPLQITDTQQGC*IAPVELR.Y
95 Q15020 SART3 Squamous cell carcinoma antigen recognized by T-ce SART3 K.C*AAVDVEPPSK.Q
96 P34897 SHMT2 Serine hydroxymethyltransferase, mitochondrial SHMT2 R.AALEALGSC*LNNK.Y
97 Q9Y3A3 MOB4 MOB-like protein phocein MOB4 R.HTLDGAAC*LLNSNK.Y
98 P55263 ADK Adenosine kinase ADK R.TGC*TFPEKPDFH.-
99 Q96RQ3 MCCC1 Methylcrotonoyl-CoA carboxylase subunit alpha, mit MCCC1 K.ESLC*QAALGLILK.E
100 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 K.VVFC*PVK.E
101 Q8NDH3 NPEPL1 Probable aminopeptidase NPEPL1 NPEPL1 R.IVDTPC*NEMNTDTFLEEINK.V
102 P63167 DYNLL1 Dynein light chain 1, cytoplasmic DYNLL1 K.NADMSEEMQQDSVEC*ATQALEK.Y
103 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1 R.YADLTEDQLPSC*ESLK.D
104 P51553 IDH3G Isocitrate dehydrogenase IDH3G K.LGDGLFLQC*CR.E
105 Q02790 FKBP4 Peptidyl-prolyl cis-trans isomerase FKBP4 FKBP4 K.TQLAVC*QQR.I
106 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 R.LSTLC*PSAVLQR.L
107 P49327 FASN Fatty acid synthase FASN K.ADEASELAC*PTPK.E
108 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP R.ISASC*QHPTAFEEAIPK.S
109 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R HNRNPR K.SAFLC*GVMK.T
110 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.HIIEDPC*TLR.H
111 Q06330 RBPJ Recombining binding protein suppressor of hairless RBPJ R.IIQFQATPC*PK.E
112 P15924 DSP Desmoplakin DSP K.AC*GSEIMQK.K
113 Q8TAQ2 SMARCC2 SWI/SNF complex subunit SMARCC2 SMARCC2 R.NLAGDVC*AIMR.V
114 Q04760 GLO1 Lactoylglutathione lyase GLO1 K.C*DFPIMK.F
115 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 K.SC*AHDWVYE.-
116 Q96CD2 PPCDC Phosphopantothenoylcysteine decarboxylase PPCDC K.ASC*PAAAPLMER.K
117 Q9H9P8 L2HGDH L-2-hydroxyglutarate dehydrogenase, mitochondrial L2HGDH R.GLMAIDC*PHTGIVDYR.Q
118 Q9NZB2 FAM120A Constitutive coactivator of PPAR-gamma-like protei FAM120A R.VAAASGHC*GAFSGSDSSR.T
119 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.GC*DVVVIPAGVPR.K
120 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 KIAA1967 R.VVTQNIC*QYR.S
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1.5 1.5 1.3 1.5 1.5 1.4 1.3 1.1 1.3 1.2 0.2
1.5 1.5 1.5 1.6 1.5 1.5 1.1 1.2 1.5 1.3 0.2
0.0 1.0 1.2 1.2 1.0 1.1 0.7 1.0 0.9 0.9 0.2
2.1 1.2 0.0 0.0 1.7 1.6 1.6 1.4 1.3 1.4 0.2
2.0 2.1 1.6 2.5 1.7 2.0 2.0 1.1 2.2 1.8 0.2
1.1 1.2 1.2 1.4 1.1 1.2 1.0 1.2 0.6 1.0 0.2
2.5 2.3 2.3 2.6 2.4 2.4 2.1 2.1 2.3 2.2 0.2
0.0 0.9 1.2 1.1 1.0 1.1 0.8 0.9 0.9 0.8 0.2
0.0 1.3 1.9 1.6 1.0 1.4 1.3 1.2 1.3 1.2 0.2
1.2 1.2 1.4 1.3 1.3 1.3 1.1 1.0 1.1 1.1 0.2
1.5 1.1 1.1 1.2 1.1 1.2 1.1 1.2 0.6 1.0 0.2
1.3 1.1 1.3 1.3 1.4 1.3 0.9 1.2 1.0 1.0 0.2
1.1 0.8 1.3 1.2 1.6 1.2 0.6 1.3 1.0 1.0 0.2
0.0 1.3 1.3 1.6 1.1 1.3 1.1 1.2 1.0 1.1 0.2
1.4 1.4 1.4 1.5 1.4 1.4 1.2 1.1 1.2 1.2 0.2
1.4 1.4 1.4 1.8 1.5 1.5 1.3 1.4 1.2 1.3 0.2
1.4 2.0 1.4 1.6 1.6 1.6 1.4 1.4 1.3 1.4 0.2
1.0 0.8 0.8 1.0 0.8 0.9 0.6 0.7 0.7 0.7 0.2
1.1 1.0 0.9 1.1 1.1 1.0 0.8 0.9 0.8 0.8 0.2
0.9 1.0 0.9 0.9 1.0 1.0 0.6 0.9 0.7 0.7 0.2
1.0 0.9 1.1 0.9 0.8 1.0 0.8 0.9 0.5 0.7 0.2
2.2 2.2 2.0 2.4 2.3 2.2 1.2 2.2 2.6 2.0 0.2
0.8 1.1 1.0 1.4 1.2 1.1 0.9 1.1 0.8 0.9 0.2
0.7 1.8 2.0 1.3 1.2 1.4 1.4 0.8 1.4 1.2 0.2
1.3 1.3 1.3 1.4 1.4 1.3 0.9 1.3 1.1 1.1 0.2
1.3 1.3 1.3 1.4 1.4 1.3 1.0 1.2 1.1 1.1 0.2
2.1 1.1 1.3 1.3 1.2 1.4 1.1 1.2 1.2 1.2 0.2
1.6 1.2 1.3 1.6 1.4 1.4 1.4 1.1 1.2 1.2 0.2
1.1 2.0 1.0 0.0 1.7 1.4 1.5 0.9 1.3 1.2 0.2
1.5 1.3 1.2 1.2 1.2 1.3 1.2 1.2 0.9 1.1 0.2
1.0 0.9 1.0 1.1 1.0 1.0 0.9 0.8 0.8 0.8 0.2
1.0 0.9 1.2 1.3 0.9 1.1 0.8 0.9 0.9 0.9 0.2
1.4 1.4 1.0 1.0 1.2 1.2 1.1 1.1 0.8 1.0 0.2
1.4 1.5 1.7 1.8 1.6 1.6 1.1 1.5 1.6 1.4 0.2
0.0 3.8 4.0 4.8 0.0 4.2 4.3 3.6 4.2 4.0 0.2
2.3 1.7 2.0 2.5 2.0 2.1 1.6 2.0 2.2 1.9 0.2
3.3 2.5 3.0 3.6 2.2 2.9 2.4 3.6 2.2 2.7 0.2
1.8 2.4 1.9 2.0 2.5 2.1 1.9 2.1 1.8 1.9 0.2
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121 Q7L2H7 EIF3M Eukaryotic translation initiation factor 3 subunit EIF3M K.VAASC*GAIQYIPTELDQVR.K
122 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK K.LFQEC*CPHSTDR.V
123 Q7L1Q6 BZW1 Basic leucine zipper and W2 domain-containing prot BZW1
R.FDPTQFQDC*IIQGLTETGTDLEAVAK
.F
124 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVDVEVPDVELEC*PDA
K.L
125 P46782 RPS5 40S ribosomal protein S5 RPS5 K.TIAEC*LADELINAAK.G
126 O43865 AHCYL1 Putative adenosylhomocysteinase 2 AHCYL1 K.LC*VPAMNVNDSVTK.Q
127 P61981 YWHAG 14-3-3 protein gamma YWHAG K.NC*SETQYESK.V
128 P78347 GTF2I General transcription factor II-I GTF2I R.SILSPGGSC*GPIK.V
129 P15924 DSP Desmoplakin DSP R.DANSENC*NK.N
130 Q13542 EIF4EBP2 Eukaryotic translation initiation factor 4E-bindin EIF4EBP2
R.TVAISDAAQLPHDYC*TTPGGTLFST
TPGGTR.I
131 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 R.EEFASTC*PDDEEIELAYEQVAK.A
132 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A R.SIQFVDWC*PTGFK.V
133 Q9BX63 BRIP1 Fanconi anemia group J protein BRIP1 R.LANNSDC*ILAK.D
134 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP R.NPVSQC*MR.G
135 Q9NQC3 RTN4 Reticulon-4 RTN4 K.YSNSALGHVNC*TIK.E
136 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) GNB2 K.AC*GDSTLTQITAGLDPVGR.I
137 Q05655 PRKCD Protein kinase C delta type PRKCD K.VLMSVQYFLEDVDC*K.Q
138 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH K.ASVGFGGSC*FQK.D
139 P36578 RPL4 60S ribosomal protein L4 RPL4 R.GPC*IIYNEDNGIIK.A
140 Q93052 LPP Lipoma-preferred partner LPP K.TYITDPVSAPC*APPLQPK.G
141 P11413 G6PD Glucose-6-phosphate 1-dehydrogenase G6PD R.TQVC*GILR.E
142 Q14847 LASP1 LIM and SH3 domain protein 1 LASP1 K.ACFHC*ETCK.M
143 O14964 HGS Hepatocyte growth factor-regulated tyrosine kinase HGS R.AC*GQIFCGK.C
144 P62241 RPS8 40S ribosomal protein S8 RPS8 K.NC*IVLIDSTPYR.Q
145 Q71U36 TUBA1A Tubulin alpha-1A chain TUBA1A R.TIQFVDWC*PTGFK.V
146 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 K.GLLDVTC*K.T
147 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ALDH18A1 K.LGSAVVTRGDEC*GLALGR.L
148 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9 R.TAC*TNFMMTPYVVTR.Y
149 P07858 CTSB Cathepsin B CTSB R.GQDHC*GIESEVVAGIPR.T
150 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL K.LC*FSTAQHAS.-
151 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 K.FIC*EQDHQNFLR.L
152 P13639 EEF2 Elongation factor 2 EEF2 K.STLTDSLVC*K.A
153 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 R.TPC*NAGTFSQPEK.V
154 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 R.SLLINAVEASC*IR.T
155 P46782 RPS5 40S ribosomal protein S5 RPS5 K.AQC*PIVER.L
156 P50990 CCT8 T-complex protein 1 subunit theta CCT8 K.IAVYSC*PFDGMITETK.G
157 Q9Y3F4 STRAP Serine-threonine kinase receptor-associated protei STRAP
K.IGFPETTEEELEEIASENSDC*IFPSAP
DVK.A
158 P47756 CAPZB F-actin-capping protein subunit beta CAPZB K.DETVSDC*SPHIANIGR.L
159 P09429 HMGB1 High mobility group protein B1 HMGB1 K.MSSYAFFVQTC*R.E
160 O75153 KIAA0664 Clustered mitochondria protein homolog KIAA0664 K.C*LTQQAVALQR.T
161 Q9UNH7 SNX6 Sorting nexin-6 SNX6 R.IGSSLYALGTQDSTDIC*K.F
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1.4 1.1 1.2 1.3 1.2 1.2 0.9 1.1 1.2 1.1 0.2
1.2 1.1 1.3 1.3 1.2 1.2 1.1 1.0 1.0 1.0 0.2
1.4 1.1 1.2 1.2 1.2 1.2 1.0 1.1 1.1 1.0 0.2
0.0 1.1 1.1 1.4 1.2 1.2 0.9 1.3 1.0 1.1 0.2
1.7 1.6 1.6 1.8 1.7 1.7 1.4 1.5 1.6 1.5 0.2
1.2 1.0 1.4 1.2 1.4 1.3 1.2 0.9 1.2 1.1 0.2
0.9 0.9 1.0 0.9 0.9 0.9 0.6 1.0 0.8 0.8 0.2
1.1 1.0 1.1 1.2 1.2 1.1 0.9 1.1 0.9 1.0 0.2
1.2 1.6 1.8 2.1 1.4 1.6 1.4 1.3 1.7 1.5 0.2
1.5 1.4 1.9 2.1 1.7 1.7 1.2 1.8 1.7 1.5 0.2
0.9 1.0 1.3 1.1 1.1 1.1 0.9 1.1 0.7 0.9 0.2
2.5 2.4 2.4 2.8 2.5 2.5 2.3 2.3 2.5 2.4 0.2
1.1 1.1 1.3 1.3 1.2 1.2 1.0 1.2 1.0 1.0 0.2
1.5 1.3 1.3 1.5 1.4 1.4 1.1 1.3 1.3 1.2 0.2
1.1 1.5 1.0 1.3 1.5 1.3 1.2 1.1 1.1 1.1 0.2
2.8 2.2 2.5 2.8 2.6 2.6 2.7 2.1 2.5 2.4 0.2
0.0 1.2 1.5 0.0 1.5 1.4 1.3 1.2 1.3 1.2 0.2
1.2 1.0 1.9 1.0 1.1 1.2 1.0 1.2 1.0 1.1 0.2
0.0 3.1 2.2 0.0 2.5 2.6 2.4 2.3 2.7 2.5 0.2
1.4 1.4 1.4 1.7 1.5 1.5 1.2 1.4 1.3 1.3 0.2
1.4 1.3 1.5 1.7 1.4 1.5 1.3 1.4 1.3 1.3 0.2
0.6 0.5 0.7 0.6 0.7 0.6 0.4 0.6 0.4 0.5 0.2
1.0 0.7 0.9 1.2 0.9 0.9 0.6 0.8 0.9 0.8 0.2
2.6 3.2 3.2 3.7 3.5 3.2 2.8 2.5 3.9 3.1 0.2
2.4 2.4 2.3 2.7 2.5 2.4 2.2 2.3 2.4 2.3 0.2
1.1 1.1 1.1 1.1 1.1 1.1 0.9 1.0 0.9 1.0 0.2
1.7 1.5 1.5 1.7 1.6 1.6 1.3 1.5 1.5 1.4 0.2
1.6 1.4 1.6 1.6 1.7 1.6 1.5 1.4 1.4 1.4 0.2
4.1 3.0 3.1 2.5 2.5 3.0 2.7 2.8 3.2 2.9 0.2
1.3 1.2 1.1 1.1 1.1 1.2 1.1 1.2 0.8 1.0 0.1
1.0 1.0 1.1 1.3 1.2 1.1 0.8 1.1 1.1 1.0 0.1
1.3 1.1 1.2 1.3 1.5 1.3 1.1 1.1 1.2 1.1 0.1
1.2 1.5 1.3 1.6 1.2 1.4 1.0 1.6 1.1 1.2 0.1
2.7 2.2 2.6 2.9 2.6 2.6 2.4 2.5 2.5 2.4 0.1
1.6 1.6 1.3 1.7 1.6 1.6 1.4 1.4 1.5 1.4 0.1
1.1 1.0 1.0 1.2 1.1 1.1 0.9 1.0 0.9 0.9 0.1
1.0 1.1 1.3 1.4 1.2 1.2 0.9 1.1 1.1 1.0 0.1
1.0 1.0 1.2 1.0 0.9 1.0 0.9 1.0 0.9 0.9 0.1
1.4 1.7 1.4 1.4 1.4 1.4 1.0 1.6 1.3 1.3 0.1
1.3 1.2 1.2 1.3 1.3 1.3 0.9 1.3 1.1 1.1 0.1
1.1 1.0 1.1 1.2 1.2 1.1 1.0 0.9 1.1 1.0 0.1
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162 Q4ZG55 GREB1 Protein GREB1 GREB1 R.LINSSC*LVR.T
163 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4 K.AGSDGESIGNC*PFSQR.L
164 P42677 RPS27 40S ribosomal protein S27 RPS27 R.LTEGC*SFR.R
165 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 R.KENQWC*EEK.-
166 Q9UM54 MYO6 Unconventional myosin-VI MYO6 R.C*GGIQYLQNAIESR.Q
167 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 K.GKEDKENRDQSAQC*TASK.S
168 P60709 ACTB Actin, cytoplasmic 1 ACTB K.C*DVDIRKDLYANTVLSGGTTMYPGIADR.M
169 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 R.VDVAVNC*AGIAVASK.T
170 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5 K.ALNVEPDGTGLTC*SLAPNIISQL.-
171 Q99497 PARK7 Protein DJ-1 PARK7 K.VTVAGLAGKDPVQC*SR.D
172 Q6IA69 NADSYN1 Glutamine-dependent NAD(+) synthetase NADSYN1 K.NSSQETC*TR.A
173 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.LVVPATQC*GSLIGK.G
174 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/threonine ILKAP R.FILLAC*DGLFK.V
175 O43681 ASNA1 ATPase ASNA1 ASNA1 K.IDTHNIIVNQLVFPDPEKPC*K.M
176 P12004 PCNA Proliferating cell nuclear antigen PCNA K.C*AGNEDIITLR.A
177 Q15181 PPA1 Inorganic pyrophosphatase PPA1 K.GISC*MNTTLSESPFK.C
178 Q9BY32 ITPA Inosine triphosphate pyrophosphatase ITPA R.GC*QDFGWDPCFQPDGYEQTYAEMPK.A
179 Q9Y224 C14orf166 UPF0568 protein C14orf166 C14orf166 K.LTALDYHNPAGFNC*K.D
180 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 K.IHMGSC*AENTAK.K
181 P28838 LAP3 Cytosol aminopeptidase LAP3 R.SAGAC*TAAAFLK.E
182 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.TIIPLISQC*TPK.V
183 P46782 RPS5 40S ribosomal protein S5 RPS5 R.VNQAIWLLC*TGAR.E
184 Q7L5D6 GET4 Golgi to ER traffic protein 4 homolog GET4 K.EQNYC*ESR.Y
185 Q9H3U1 UNC45A Protein unc-45 homolog A UNC45A R.AIQTVSCLLQGPC*DAGNR.A
186 P17858 PFKL 6-phosphofructokinase, liver type PFKL R.VFANAPDSAC*VIGLK.K
187 P30042 C21orf33 ES1 protein homolog, mitochondrial C21orf33 K.NLSTFAVDGKDC*K.V
188 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 K.LAAQSC*ALSLVR.Q
189 P10620 MGST1 Microsomal glutathione S-transferase 1 MGST1 K.VFANPEDC*VAFGK.G
190 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5 K.GTPEQPQC*GFSNAVVQILR.L
191 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.IGNC*PFSQR.L
192 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 K.LC*VQNSPQEAR.N
193 Q9UNE7 STUB1 E3 ubiquitin-protein ligase CHIP STUB1 R.AQQAC*IEAK.H
194 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.YLAEVAC*GDDR.K
195 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH R.VPTANVSVVDLTC*R.L
196 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.VDENFDC*VEADDVEGK.I
197 Q8TC07 TBC1D15 TBC1 domain family member 15 TBC1D15 R.TLLVNC*QNK.S
198 P10768 ESD S-formylglutathione hydrolase ESD K.AETGKCPALYWLSGLTC*TEQNFISK.S
199 Q12765 SCRN1 Secernin-1 SCRN1 K.TQSPC*FGDDDPAKKEPR.F
200 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 R.TDFQQGC*AK.T
201 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.NTGIIC*TIGPASR.S
202 P23528 CFL1 Cofilin-1 CFL1 K.HELQANC*YEEVK.D
203 P62241 RPS8 40S ribosomal protein S8 RPS8 K.LLAC*IASR.P
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3.1 0.6 2.5 3.5 2.3 2.4 2.1 2.3 2.5 2.3 0.1
1.1 1.3 1.0 1.3 1.1 1.2 1.0 1.1 1.0 1.1 0.1
2.4 2.6 2.5 2.8 2.4 2.6 2.2 2.4 2.7 2.4 0.1
1.2 1.2 1.2 1.2 1.2 1.2 1.0 1.1 1.2 1.1 0.1
0.0 0.0 0.7 0.7 1.1 0.9 0.7 0.7 0.7 0.7 0.1
1.1 1.6 1.3 1.3 1.3 1.3 1.4 1.4 0.9 1.2 0.1
2.7 2.8 2.8 3.1 2.6 2.8 2.6 2.6 2.9 2.7 0.1
3.3 2.5 3.0 2.8 2.5 2.8 2.4 2.6 3.1 2.7 0.1
0.7 0.8 0.9 0.8 0.8 0.8 0.7 0.8 0.6 0.7 0.1
0.5 0.5 0.6 0.5 0.6 0.6 0.5 0.5 0.4 0.4 0.1
1.1 1.1 1.0 1.8 1.1 1.2 1.1 1.1 1.2 1.1 0.1
1.2 1.1 1.2 1.2 1.2 1.2 1.0 1.1 1.1 1.0 0.1
1.0 1.1 1.4 1.2 0.9 1.1 1.0 1.0 1.1 1.0 0.1
1.0 1.3 0.7 0.8 0.9 1.0 1.0 0.9 0.7 0.8 0.1
0.9 1.0 1.0 1.0 0.9 1.0 0.8 1.0 0.8 0.9 0.1
1.2 1.0 1.2 1.1 1.1 1.1 0.9 1.0 1.1 1.0 0.1
1.3 1.0 0.9 1.2 1.1 1.1 1.0 0.7 1.2 1.0 0.1
1.1 1.1 1.1 1.2 1.1 1.1 1.0 1.0 1.0 1.0 0.1
1.4 1.2 1.3 1.4 1.4 1.3 0.7 1.4 1.5 1.2 0.1
1.1 0.9 1.2 1.4 1.1 1.2 0.9 1.2 1.0 1.0 0.1
1.7 1.8 1.9 1.9 1.8 1.8 1.7 1.8 1.6 1.7 0.1
1.6 1.5 0.0 0.0 1.6 1.6 1.4 1.5 1.6 1.5 0.1
0.0 0.0 1.3 1.1 1.4 1.3 1.3 1.1 1.2 1.2 0.1
1.3 0.0 1.2 1.1 0.0 1.2 1.2 1.1 0.9 1.1 0.1
3.0 2.5 2.6 3.0 2.4 2.7 2.4 2.6 2.7 2.6 0.1
1.3 1.2 1.2 1.5 1.1 1.3 1.2 1.1 1.2 1.1 0.1
0.9 0.7 1.0 1.0 0.9 0.9 1.0 0.9 0.5 0.8 0.1
1.6 1.5 1.5 1.4 1.2 1.4 1.5 1.3 1.2 1.3 0.1
1.2 1.1 1.1 1.2 1.2 1.1 1.0 1.1 1.1 1.0 0.1
1.3 1.2 1.2 1.3 1.3 1.3 1.1 1.1 1.2 1.2 0.1
1.3 1.1 1.2 1.2 1.2 1.2 1.0 1.2 1.0 1.1 0.1
1.1 1.3 1.0 1.4 1.0 1.2 0.9 1.2 1.1 1.1 0.1
0.9 1.1 1.1 1.0 1.1 1.0 0.9 1.1 0.9 0.9 0.1
0.4 0.5 0.4 0.5 0.4 0.5 0.4 0.4 0.3 0.4 0.1
1.3 1.0 1.4 1.5 1.4 1.3 0.9 1.5 1.3 1.2 0.1
1.9 1.4 1.9 2.2 2.1 1.9 1.6 1.9 2.0 1.8 0.1
1.0 0.9 0.9 1.0 0.9 0.9 0.9 0.7 1.0 0.9 0.1
1.1 0.9 1.0 1.0 1.2 1.0 0.9 0.9 0.9 0.9 0.1
0.0 1.6 1.7 1.6 1.9 1.7 1.5 1.8 1.5 1.6 0.1
0.9 0.9 0.9 0.9 0.8 0.9 0.8 0.9 0.6 0.8 0.1
0.9 0.9 0.9 0.9 1.0 0.9 0.8 0.8 0.8 0.8 0.1
4.0 3.5 3.8 4.1 0.0 3.9 4.1 3.5 3.7 3.8 0.1
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204 Q9UJW0 DCTN4 Dynactin subunit 4 DCTN4 R.LLQPDFQPVC*ASQLYPR.H
205 Q9HA64 FN3KRP Ketosamine-3-kinase FN3KRP R.ATGHSGGGC*ISQGR.S
206 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 R.VGLGIC*YDMR.F
207 P30626 SRI Sorcin SRI R.CLTQSGIAGGYKPFNLETC*R.L
208 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK K.GSDFDC*ELR.L
209 P50914 RPL14 60S ribosomal protein L14 RPL14 R.ALVDGPC*TQVR.R
210 P20073 ANXA7 Annexin A7 ANXA7 R.LGTDESC*FNMILATR.S
211 P14649 MYL6B Myosin light chain 6B MYL6B K.ILYSQC*GDVMR.A
212 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 K.C*GFLPGNEK.V
213 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 R.C*GLALALNK.L
214 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVGVEVPDVELEC*PDA
K.L
215 P50213 IDH3A Isocitrate dehydrogenase IDH3A K.TFDLYANVRPC*VSIEGYK.T
216 Q9UI30 TRMT112 tRNA methyltransferase 112 homolog TRMT112 R.IC*PVEFNPNFVAR.M
217 P53618 COPB1 Coatomer subunit beta COPB1 K.ALSGYC*GFMAANLYAR.S
218 P46776 RPL27A 60S ribosomal protein L27a RPL27A R.NQSFC*PTVNLDK.L
219 Q9UQ35 SRRM2 Serine/arginine repetitive matrix protein 2 SRRM2 R.SVSPC*SNVESR.L
220 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS K.YAGLSTC*FR.Q
221 P00338 LDHA L-lactate dehydrogenase A chain LDHA R.VIGSGC*NLDSAR.F
222 P30041 PRDX6 Peroxiredoxin-6 PRDX6 R.DFTPVC*TTELGR.A
223 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.HLNEIDLFHC*IDPNDSK.H
224 P37235 HPCAL1 Hippocalcin-like protein 1 HPCAL1 R.LLQC*DPSSASQF.-
225 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 K.EGTDSSQGIPQLVSNISAC*QVIAEAVR.T
226 P29401 TKT Transketolase TKT K.QAFTDVATGSLGQGLGAAC*GMAYTGK.Y
227 P49207 RPL34 60S ribosomal protein L34 RPL34 R.AYGGSMC*AK.C
228 Q7Z406 MYH14 Myosin-14 MYH14 K.ADLLLEPC*SHYR.F
229 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF R.C*NNVLYIR.G
230 P49327 FASN Fatty acid synthase FASN K.AINC*ATSGVVGLVNCLR.R
231 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.C*LSVMEAK.V
232 O95336 PGLS 6-phosphogluconolactonase PGLS R.AAC*CLAGAR.A
233 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.AITIAGVPQSVTEC*VK.Q
234 Q9BWJ5 SF3B5 Splicing factor 3B subunit 5 SF3B5 K.MLQPC*GPPADKPEEN.-
235 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I
236 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC R.ISAFGYLEC*SAK.T
237 P62829 RPL23 60S ribosomal protein L23 RPL23 R.ISLGLPVGAVINC*ADNTGAK.N
238 P62820 RAB1A Ras-related protein Rab-1A RAB1A K.LLVGNKC*DLTTK.K
239 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 R.FC*PFAER.T
240 Q9P2T1 GMPR2 GMP reductase 2 GMPR2 K.VGIGPGSVC*TTR.K
241 O75874 IDH1 Isocitrate dehydrogenase IDH1 K.SEGGFIWAC*K.N
242 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 K.ILSC*GEVIHVK.I
243 P62857 RPS28 40S ribosomal protein S28 RPS28 R.TGSQGQC*TQVR.V
244 Q5MNZ6 WDR45L WD repeat domain phosphoinositide-interacting prot WDR45L R.C*NYLALVGGGK.K
245 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE K.IGPSILNSDLANLGAEC*LR.M
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1.3 1.4 1.0 1.0 1.3 1.2 1.2 0.9 1.2 1.1 0.1
1.2 1.4 1.2 0.0 1.4 1.3 1.1 1.2 1.2 1.2 0.1
1.4 1.1 1.0 1.2 1.3 1.2 1.0 1.2 1.1 1.1 0.1
1.1 0.0 1.0 1.0 1.1 1.0 0.9 1.1 0.8 0.9 0.1
1.1 1.3 1.3 1.2 1.3 1.2 1.1 1.2 1.1 1.1 0.1
2.5 2.1 2.1 2.7 2.3 2.3 2.2 2.2 2.3 2.2 0.1
1.5 1.3 1.2 1.4 1.4 1.3 1.2 1.4 1.2 1.3 0.1
0.9 1.0 1.1 1.0 1.0 1.0 0.9 1.0 0.9 0.9 0.1
0.9 0.8 0.9 1.0 0.9 0.9 0.8 0.9 0.7 0.8 0.1
3.2 2.1 2.3 3.1 2.5 2.6 2.2 3.1 2.4 2.5 0.1
1.1 1.1 1.2 1.5 1.1 1.2 1.2 1.2 0.9 1.1 0.1
2.7 0.0 1.5 3.0 1.5 2.2 1.8 2.3 2.2 2.1 0.1
0.9 1.2 1.2 1.2 1.2 1.1 1.1 1.2 0.8 1.0 0.1
2.1 1.5 1.9 2.3 2.3 2.0 1.7 2.3 1.9 2.0 0.1
2.3 1.8 1.8 2.0 1.7 1.9 1.8 1.7 2.1 1.9 0.1
1.1 1.5 1.1 1.2 1.1 1.2 1.1 1.0 1.2 1.1 0.1
1.2 1.1 1.1 1.2 1.2 1.1 1.0 1.1 1.1 1.1 0.1
1.1 1.1 1.2 1.1 1.1 1.1 0.9 1.1 1.1 1.0 0.1
1.0 0.5 0.5 0.5 0.5 0.6 0.4 0.6 0.6 0.5 0.1
1.2 1.1 1.1 1.2 1.2 1.2 1.1 1.1 1.1 1.1 0.1
0.0 1.2 1.3 1.3 1.3 1.2 1.1 1.2 1.2 1.2 0.1
0.0 1.4 1.4 1.5 1.5 1.4 1.4 1.5 1.3 1.4 0.1
3.2 2.5 2.5 2.6 2.4 2.6 2.5 2.6 2.6 2.6 0.1
2.5 2.3 2.5 2.9 2.3 2.5 2.6 2.2 2.5 2.5 0.1
1.7 1.8 1.6 1.9 1.8 1.7 1.9 1.4 1.8 1.7 0.1
1.2 1.1 1.1 1.2 1.2 1.2 1.1 1.1 1.1 1.1 0.1
1.3 1.4 1.3 1.5 1.1 1.3 1.2 1.3 1.3 1.2 0.1
1.2 1.0 0.9 1.0 1.1 1.0 1.0 1.0 0.9 1.0 0.1
1.2 1.2 1.1 1.3 1.3 1.2 1.2 1.1 1.1 1.1 0.1
1.0 1.2 1.1 0.9 1.1 1.1 1.1 1.1 0.8 1.0 0.1
1.0 0.7 1.0 1.3 0.0 1.0 0.9 0.9 1.1 0.9 0.1
1.3 1.1 1.2 1.3 1.3 1.2 1.0 1.2 1.4 1.2 0.1
1.9 1.2 1.8 1.8 1.5 1.6 1.4 1.7 1.6 1.6 0.1
2.2 1.9 2.0 2.3 2.2 2.1 2.0 2.1 2.1 2.0 0.1
1.0 0.0 1.0 1.2 0.0 1.1 1.1 1.0 0.9 1.0 0.1
1.1 1.0 1.1 1.1 1.1 1.0 0.9 1.1 1.0 1.0 0.1
1.6 0.0 1.0 1.0 1.3 1.2 1.2 1.2 1.2 1.2 0.1
0.9 0.9 0.8 0.9 1.0 0.9 1.0 0.9 0.8 0.9 0.1
0.9 1.0 0.8 1.2 1.1 1.0 1.0 1.0 0.8 0.9 0.1
1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.0 1.0 0.1
1.1 1.2 1.0 1.1 1.2 1.1 1.1 1.0 1.2 1.1 0.1
0.8 1.0 1.4 0.8 0.9 1.0 0.8 1.3 0.7 0.9 0.0
364
246 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.INISEGNC*PER.I
247 Q9UBF6 RNF7 RING-box protein 2 RNF7 R.VQVMDAC*LR.C
248 Q66K14 TBC1D9B TBC1 domain family member 9B TBC1D9B R.AKNEC*YR.A
249 P15924 DSP Desmoplakin DSP R.GVITDQNSDGYC*QTGTMSR.H
250 O75223 GGCT Gamma-glutamylcyclotransferase GGCT R.NPSAAFFC*VAR.L
251 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 R.YEAAFPFLSPC*GR.E
252 Q52LJ0 FAM98B Protein FAM98B FAM98B R.EKTAC*AINK.V
253 Q2TAA2 IAH1 Isoamyl acetate-hydrolyzing esterase 1 homolog IAH1 R.VILITPTPLC*ETAWEEQCIIQGCK.L
254 Q96I99 SUCLG2 Succinyl-CoA ligase SUCLG2 R.SC*NGPVLVGSPQGGVDIEEVAASNPELIFK.E
255 P26641 EEF1G Elongation factor 1-gamma EEF1G K.AAAPAPEEEMDEC*EQALAAEPK.A
256 Q8TB45 DEPTOR DEP domain-containing mTOR-interacting protein DEPTOR K.SPSSQETHDSPFC*LR.K
257 Q9BWD1 ACAT2 Acetyl-CoA acetyltransferase, cytosolic ACAT2 R.ATVAPEDVSEVIFGHVLAAGC*GQNPVR.Q
258 Q96RS6 NUDCD1 NudC domain-containing protein 1 NUDCD1 R.DSAQC*AAIAER.L
259 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacti PIN1 K.IKSGEEDFESLASQFSDC*SSAK.A
260 P36969 GPX4 Phospholipid hydroperoxide glutathione peroxidase, GPX4 R.YAEC*GLR.I
261 O15355 PPM1G Protein phosphatase 1G PPM1G K.C*SGDGVGAPR.L
262 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPUL
2 K.EGC*TEVSLLR.V
263 P42025 ACTR1B Beta-centractin ACTR1B R.AC*YLSINPQKDEALETEK.V
264 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA K.VNLQMVYDSPLC*R.L
265 Q15149 PLEC Plectin PLEC K.AFC*GFEDPR.T
266 Q9NYL2 MLTK Mitogen-activated protein kinase kinase kinase MLT MLTK K.FDDLQFFENC*GGGSFGSVYR.A
267 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.HSMNPFC*EIAVEEAVR.L
268 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 R.C*MTNTPVVVR.E
269 P08238 HSP90AB1 Heat shock protein HSP 90-beta HSP90AB1 R.VFIMDSC*DELIPEYLNFIR.G
270 P31947 SFN 14-3-3 protein sigma SFN K.GAVEKGEELSC*EER.N
271 P37802 TAGLN2 Transgelin-2 TAGLN2 K.NMAC*VQR.T
272 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 K.VDVFREDLC*TK.T
273 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 K.C*FIVGADNVGSK.Q
274 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR K.EADQKEQFSQGSPSNC*LETSLAEIFPLGK.N
275 Q9BW61 DDA1 DET1- and DDB1-associated protein 1 DDA1 R.FHADSVC*K.A
276 O43837 IDH3B Isocitrate dehydrogenase IDH3B K.LGDGLFLQC*CEEVAELYPK.I
277 P13639 EEF2 Elongation factor 2 EEF2 R.TFC*QLILDPIFK.V
278 Q9Y5P6 GMPPB Mannose-1-phosphate guanyltransferase beta GMPPB R.LC*SGPGIVGNVLVDPSAR.I
279 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK K.GPFVEAEVPDVDLEC*PDAK.L
280 Q9BYG5 PARD6B Partitioning defective 6 homolog beta PARD6B R.HGAGSGC*LGTMEVK.S
281 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.AQC*ETLSPDGLPEEQPQTTK.L
282 P00491 PNP Purine nucleoside phosphorylase PNP R.AC*VMMQGR.F
283 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T
284 P35270 SPR Sepiapterin reductase SPR R.TVVNISSLC*ALQPFK.G
285 Q9UHD8 SEPT9 Septin-9 9-Sep R.SQEATEAAPSC*VGDMADTPR.D
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1.1 1.1 1.1 1.2 1.1 1.1 1.0 1.1 1.1 1.1 0.0
1.1 1.4 1.1 1.1 1.1 1.2 1.3 1.0 1.0 1.1 0.0
1.4 1.6 1.4 1.7 1.8 1.6 1.3 1.7 1.6 1.5 0.0
0.0 2.0 1.5 2.5 1.6 1.9 1.7 1.7 2.1 1.8 0.0
0.8 0.0 1.0 0.9 0.9 0.9 0.9 1.0 0.5 0.8 0.0
1.3 1.1 1.2 1.3 1.2 1.2 1.1 1.3 1.1 1.2 0.0
0.0 0.0 1.1 1.1 1.2 1.2 1.1 1.0 1.2 1.1 0.0
1.2 1.1 1.1 1.3 1.3 1.2 1.2 1.0 1.2 1.2 0.0
1.6 1.4 1.4 1.7 1.6 1.5 1.6 1.5 1.4 1.5 0.0
1.1 1.1 1.2 1.1 1.1 1.1 1.0 1.1 1.1 1.1 0.0
1.0 1.2 1.2 1.0 1.0 1.1 0.8 1.3 1.0 1.0 0.0
0.0 0.7 0.7 0.8 0.6 0.7 0.5 0.7 0.7 0.6 0.0
1.2 1.4 1.1 1.0 1.1 1.2 1.0 1.2 1.1 1.1 0.0
1.1 1.1 1.1 1.3 1.2 1.2 1.2 1.1 1.1 1.1 0.0
1.1 1.0 1.1 1.2 1.2 1.1 0.9 1.0 1.3 1.1 0.0
1.3 1.5 1.5 1.5 1.5 1.4 1.3 1.5 1.5 1.4 0.0
1.3 1.2 1.2 1.3 1.3 1.3 1.1 1.4 1.2 1.2 0.0
2.1 2.0 1.9 2.4 1.9 2.1 1.8 2.1 2.2 2.0 0.0
1.1 1.5 1.6 2.0 1.6 1.5 1.5 1.5 1.5 1.5 0.0
1.1 1.1 1.0 1.2 1.1 1.1 1.0 1.1 1.1 1.1 0.0
1.2 1.0 1.1 1.5 1.4 1.2 1.1 1.2 1.2 1.2 0.0
1.1 1.0 1.3 1.3 1.2 1.2 1.1 1.2 1.1 1.1 0.0
2.7 2.4 2.5 2.7 2.3 2.5 2.2 2.5 2.7 2.5 0.0
1.1 1.3 1.2 1.2 1.3 1.2 1.1 1.3 1.2 1.2 0.0
1.0 1.0 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 0.0
1.3 1.0 0.9 1.0 1.1 1.1 1.0 1.1 1.0 1.0 0.0
1.2 1.2 1.3 1.5 1.3 1.3 1.2 1.4 1.2 1.3 0.0
2.0 1.8 1.9 2.1 2.0 1.9 1.8 1.9 2.1 1.9 0.0
1.3 1.4 1.2 1.0 1.2 1.2 1.4 1.0 1.3 1.2 0.0
1.1 1.2 1.1 1.0 1.1 1.1 0.9 1.3 1.0 1.1 0.0
0.0 2.6 2.3 2.2 2.0 2.3 2.0 2.4 2.4 2.2 0.0
1.0 1.1 1.0 1.1 1.0 1.0 1.1 1.0 1.0 1.0 0.0
1.0 1.0 1.0 1.0 1.1 1.0 1.0 1.0 1.1 1.0 0.0
1.0 1.1 1.1 1.1 1.0 1.1 1.0 1.1 1.0 1.0 0.0
0.0 0.0 1.2 1.4 1.1 1.2 1.1 1.1 1.4 1.2 0.0
0.0 0.0 1.1 1.1 1.0 1.1 1.1 1.1 1.0 1.1 0.0
0.7 1.1 1.0 0.7 0.8 0.9 0.8 1.1 0.8 0.9 0.0
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.0
1.1 0.9 1.1 1.0 1.1 1.0 1.0 1.0 1.1 1.0 0.0
1.2 1.3 1.3 1.6 1.2 1.3 1.3 1.3 1.3 1.3 0.0
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286 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.EVIAVSC*GPAQCQETIR.T
287 O14980 XPO1 Exportin-1 XPO1 K.LDINLLDNVVNC*LYHGEGAQQR.M
288 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.FLDGNELTLADC*NLLPK.L
289 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 K.VTDDLVC*LVYK.T
290 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2 R.IENLELMSQHGC*NAWK.V
291 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA K.KITIADC*GQLE.-
292 P61513 RPL37A 60S ribosomal protein L37a RPL37A K.YTCSFC*GK.T
293 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ K.IETELRDIC*NDVLSLLEK.F
294 P60981 DSTN Destrin DSTN K.LGGSLIVAFEGC*PV.-
295 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK
K.IIPTLEEGLQLPSPTATSQLPLESDAVE
C*LNYQHYK.G
296 P60174 TPI1 Triosephosphate isomerase TPI1 R.IIYGGSVTGATC*K.E
297 P51610 HCFC1 Host cell factor 1 HCFC1 K.LVIYGGMSGC*R.L
298 Q86Y56 HEATR2 HEAT repeat-containing protein 2 HEATR2 R.RPPEAC*EELR.L
299 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 R.YLLQYQEPIPC*EQLVTALCDIK.Q
300 P67936 TPM4 Tropomyosin alpha-4 chain TPM4 K.EENVGLHQTLDQTLNELNC*I.-
301 Q99829 CPNE1 Copine-1 CPNE1 R.NC*SSPEFSK.T
302 P23396 RPS3 40S ribosomal protein S3 RPS3 R.GLC*AIAQAESLR.Y
303 P26368 U2AF2 Splicing factor U2AF 65 kDa subunit U2AF2 K.SIEIPRPVDGVEVPGC*GK.I
304 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM K.C*CSGAIIVLTK.S
305 Q9Y5Q8 GTF3C5 General transcription factor 3C polypeptide 5 GTF3C5 R.VC*TNPVDR.K
306 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 K.IIC*QGFTGK.Q
307 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.LVVPASQC*GSLIGK.G
308 O15355 PPM1G Protein phosphatase 1G PPM1G R.C*VVSEAGK.A
309 P62258 YWHAE 14-3-3 protein epsilon YWHAE K.LIC*CDILDVLDK.H
310 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 R.GLPFGC*SK.E
311 P30086 PEBP1 Phosphatidylethanolamine-binding protein 1 PEBP1 R.APVAGTC*YQAEWDDYVPK.L
312 Q9P1F3 ABRACL Costars family protein ABRACL ABRACL K.C*ANLFEALVGTLK.A
313 P60981 DSTN Destrin DSTN K.C*STPEEIKKR.K
314 P60174 TPI1 Triosephosphate isomerase TPI1 K.VPADTEVVC*APPTAYIDFAR.Q
315 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR K.AAREEC*PVFTPPGGETLDQVK.M
316 P63220 RPS21 40S ribosomal protein S21 RPS21 K.C*SASNR.I
317 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7 K.NC*EPMIGLVPILK.G
318 F5H284 PPIAL4D Peptidyl-prolyl cis-trans isomerase PPIAL4D R.IIPGFMC*QGGDFTR.H
319 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA R.ALANSLAC*QGK.Y
320 P0CW22 RPS17L 40S ribosomal protein S17-like RPS17L R.VC*EEIAIIPSK.K
321 Q14247 CTTN Src substrate cortactin CTTN K.C*ALGWDHQEK.L
322 P51659 HSD17B4 Peroxisomal multifunctional enzyme type 2 HSD17B4 K.IC*DFENASKPQSIQESTGSIIEVLSK.I
323 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 R.GNVC*GDSK.S
324 Q7Z4W1 DCXR L-xylulose reductase DCXR R.GVPGAIVNVSSQC*SQR.A
325 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.AC*ALQVLSAILEGSK.Q
326 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.KGDEC*ELLGHSK.N
327 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransf PCMT1 K.ALDVGSGSGILTAC*FAR.M
328 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.SQETEC*TYFSTPLLLGK.K
367
1.1 0.0 1.1 1.3 1.0 1.1 1.1 1.1 1.1 1.1 0.0
1.2 1.1 1.2 1.2 1.2 1.2 1.2 1.1 1.1 1.1 0.0
0.9 0.8 1.0 0.7 0.9 0.9 0.9 1.1 0.6 0.8 0.0
1.1 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.1 0.0
1.3 1.0 1.2 1.4 1.2 1.2 1.1 1.2 1.4 1.2 0.0
0.8 1.0 0.8 0.7 0.8 0.8 0.8 1.0 0.6 0.8 0.0
1.5 0.9 1.1 1.1 0.9 1.1 1.1 1.0 1.2 1.1 0.0
0.7 1.0 1.0 0.8 0.8 0.8 0.9 1.0 0.7 0.8 0.0
1.1 1.0 1.0 1.1 1.0 1.0 1.0 1.0 1.1 1.0 0.0
1.1 1.0 1.0 1.1 1.1 1.1 1.0 1.1 1.1 1.1 0.0
0.7 1.1 0.9 1.0 1.0 0.9 1.0 1.1 0.6 0.9 0.0
1.1 1.0 1.2 1.0 0.9 1.0 0.8 1.1 1.2 1.0 0.0
2.0 1.9 0.0 2.0 0.0 2.0 2.1 1.7 2.1 2.0 0.0
0.8 1.0 1.0 0.9 0.9 0.9 0.9 1.2 0.6 0.9 0.0
0.0 1.2 1.4 1.6 1.3 1.4 1.2 1.4 1.4 1.4 0.0
0.7 1.2 2.1 0.7 0.0 1.2 1.2 1.4 0.8 1.2 0.0
1.8 1.7 1.6 1.8 1.8 1.7 1.7 1.7 1.9 1.7 0.0
0.7 0.0 0.7 0.7 0.8 0.7 0.7 0.9 0.7 0.7 0.0
1.2 1.3 1.3 1.3 1.2 1.3 1.3 1.2 1.2 1.3 0.0
1.6 1.1 1.7 2.0 2.4 1.8 2.1 1.2 2.1 1.8 0.0
2.0 2.3 2.4 2.6 2.5 2.4 2.1 2.5 2.5 2.4 0.0
1.1 1.1 1.1 1.2 1.1 1.1 1.0 1.2 1.1 1.1 0.0
0.0 1.0 1.2 1.7 1.4 1.3 1.2 1.5 1.4 1.3 0.0
1.2 1.0 1.1 1.1 1.1 1.1 1.0 1.1 1.2 1.1 0.0
1.2 1.2 1.2 1.2 1.1 1.2 1.1 1.2 1.2 1.2 0.0
0.9 1.1 1.1 1.0 1.1 1.0 1.0 1.3 0.8 1.0 0.0
1.1 1.3 1.3 1.4 1.3 1.3 1.2 1.4 1.3 1.3 0.0
1.1 1.0 1.1 1.2 1.1 1.1 1.0 1.1 1.1 1.1 0.0
0.8 1.0 1.0 0.8 0.9 0.9 0.9 1.2 0.7 0.9 0.0
0.0 1.3 1.0 1.1 1.1 1.1 0.9 1.4 1.0 1.1 0.0
1.2 0.0 1.2 1.3 1.2 1.2 1.2 1.5 1.0 1.2 0.0
2.0 1.8 1.8 1.9 1.9 1.9 1.8 1.8 2.0 1.9 0.0
0.8 0.9 0.9 0.8 0.7 0.8 0.8 1.0 0.6 0.8 0.0
0.8 0.9 1.0 0.8 0.9 0.9 0.9 1.1 0.7 0.9 0.0
1.5 1.6 1.4 1.7 1.4 1.5 1.4 1.5 1.6 1.5 0.0
1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.2 1.1 1.1 0.0
0.9 1.0 1.3 1.1 1.1 1.1 1.0 1.3 1.0 1.1 0.0
1.5 1.6 1.4 1.8 1.3 1.5 1.2 1.7 1.8 1.5 0.0
1.3 1.2 1.1 1.3 1.3 1.2 1.1 1.3 1.4 1.2 0.0
2.1 1.6 2.0 2.3 2.2 2.0 2.0 2.0 2.2 2.1 0.0
1.8 1.8 1.7 2.1 1.8 1.8 1.8 1.9 1.9 1.9 0.0
0.9 0.9 0.9 0.8 0.9 0.9 1.0 1.1 0.7 0.9 0.0
1.3 1.3 1.4 1.4 1.4 1.4 1.4 1.6 1.0 1.4 0.0
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329 Q9NZZ3 CHMP5 Charged multivesicular body protein 5 CHMP5 K.APPPSLTDC*IGTVDSR.A
330 Q9UHD8 SEPT9 Septin-9 9-Sep K.LTVIDTPGFGDHINNENC*WQPIMK.F
331 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.IC*PVETLVEEAIQCAEK.I
332 P25398 RPS12 40S ribosomal protein S12 RPS12 R.QAHLC*VLASNCDEPMYVK.L
333 Q9NX24 NHP2 H/ACA ribonucleoprotein complex subunit 2 NHP2 K.ADPDGPEAQAEAC*SGER.T
334 P31939 ATIC Bifunctional purine biosynthesis protein PURH ATIC R.VVAC*NLYPFVK.T
335 Q04917 YWHAH 14-3-3 protein eta YWHAH K.NC*NDFQYESK.V
336 O95295 SNAPIN SNARE-associated protein Snapin SNAPIN R.EQIDNLATELC*R.I
337 O15355 PPM1G Protein phosphatase 1G PPM1G R.GTEAGQVGEPGIPTGEAGPSC*SSASDK.L
338 P35250 RFC2 Replication factor C subunit 2 RFC2 K.VC*DEPHPLLVK.E
339 Q9NVS2 MRPS18A 28S ribosomal protein S18a, mitochondrial MRPS18A R.DNVC*YSR.T
340 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 R.AITIAGIPQSIIEC*VK.Q
341 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R
342 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O R.GEVPC*TVTSASPLEEATLSELK.T
343 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.TGQATVASGIPAGWMGLDC*GPESSKK.Y
344 P49327 FASN Fatty acid synthase FASN R.LGMLSPEGTC*K.A
345 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH R.ISSINSISALC*EATGADVEEVATAIGMDQR.I
346 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC K.KLVIVGDGAC*GK.T
347 Q96Q11 TRNT1 CCA tRNA nucleotidyltransferase 1, mitochondrial TRNT1 K.YQGEHC*LLK.E
348 O15382 BCAT2 Branched-chain-amino-acid aminotransferase, mitoch BCAT2 R.EVFGSGTAC*QVCPVHR.I
349 P22626 HNRNPA2B1 Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPA2
B1 K.LTDC*VVMRDPASK.R
350 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 R.QLC*DNAGFDATNILNK.L
351 O75874 IDH1 Isocitrate dehydrogenase IDH1 K.DLAAC*IK.G
352 P62249 RPS16 40S ribosomal protein S16 RPS16 K.TATAVAHC*K.R
353 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9 K.GIGMNEPLVDC*EGYPR.S
354 Q15370 TCEB2 Transcription elongation factor B polypeptide 2 TCEB2
R.ADDTFEALC*IEPFSSPPELPDVMKPQ
DSGSSANEQAVQ.-
355 Q9NP73 ALG13 UDP-N-acetylglucosamine transferase subunit ALG13 ALG13 K.ADLVISHAGAGSC*LETLEK.G
356 Q86YH6 PDSS2 Decaprenyl-diphosphate synthase subunit 2 PDSS2 R.C*LLSDELSNIAMQVR.K
357 P61158 ACTR3 Actin-related protein 3 ACTR3 R.YSYVC*PDLVK.E
358 P49327 FASN Fatty acid synthase FASN R.AAPLDSIHSLAAYYIDC*IR.Q
359 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F
360 P00390 GSR Glutathione reductase, mitochondrial GSR K.LGGTC*VNVGCVPK.K
361 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.NMITGTAPLDGC*ILVVAANDGPMPQTR.E
362 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL
K.QPAIMPGQSYGLEDGSC*SYKDFSES
R.N
363 O00204 SULT2B1 Sulfotransferase family cytosolic 2B member 1 SULT2B1 R.APWC*ETIVGAFSLPDQYSPR.L
364 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 R.AVASQLDC*NFLK.V
365 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 K.LQGATC*NNNK.L
366 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 K.QGEYGLASIC*NGGGGASAMLIQK.L
367 P60174 TPI1 Triosephosphate isomerase TPI1 K.IAVAAQNC*YK.V
369
1.0 1.1 1.1 1.1 1.0 1.1 1.1 1.1 1.1 1.1 0.0
1.6 1.7 1.6 1.7 1.5 1.6 1.6 1.5 1.8 1.7 0.0
0.8 0.9 0.9 0.9 0.8 0.8 0.8 0.9 0.8 0.9 0.0
0.6 0.6 0.6 0.7 0.7 0.6 0.7 0.6 0.7 0.7 0.0
0.9 1.0 1.0 1.3 0.0 1.1 1.2 1.1 1.0 1.1 0.0
0.8 0.8 1.0 0.7 0.0 0.8 0.8 1.0 0.8 0.9 0.0
0.9 1.1 0.9 0.9 1.0 0.9 0.8 1.4 0.8 1.0 0.0
0.0 1.4 1.0 1.2 1.1 1.2 1.2 1.3 1.1 1.2 0.0
1.2 1.1 1.2 1.3 1.2 1.2 1.1 1.1 1.4 1.2 0.0
2.2 2.4 2.3 2.9 2.4 2.4 2.2 2.4 2.8 2.5 0.0
1.6 1.1 0.0 1.4 1.2 1.3 1.3 1.3 1.4 1.3 0.0
1.0 1.0 1.0 0.9 1.0 1.0 1.1 1.1 0.7 1.0 0.0
0.9 0.9 0.8 0.8 0.9 0.9 1.0 1.0 0.7 0.9 0.0
1.5 1.5 1.3 1.5 1.5 1.4 1.7 1.4 1.3 1.5 0.0
0.9 1.0 1.0 0.7 1.0 0.9 1.0 1.1 0.7 0.9 0.0
2.7 2.8 2.6 3.3 2.4 2.8 2.7 2.7 3.0 2.8 0.0
0.9 1.1 1.0 0.9 1.1 1.0 1.0 1.2 1.0 1.0 0.0
1.9 1.5 1.4 1.8 1.6 1.6 1.7 1.7 1.7 1.7 0.0
1.3 1.0 1.1 1.1 0.9 1.1 1.1 1.1 1.1 1.1 0.0
1.1 1.2 1.1 1.1 1.4 1.2 1.1 1.2 1.4 1.2 0.0
0.9 0.8 1.1 0.9 0.8 0.9 1.1 1.0 0.8 1.0 0.0
2.0 1.6 1.6 1.7 1.2 1.6 1.4 1.6 2.0 1.7 0.0
0.0 1.0 1.1 0.9 1.2 1.0 1.0 1.2 1.1 1.1 0.0
2.0 1.9 2.3 2.3 1.9 2.1 1.8 2.5 2.1 2.1 0.0
1.3 1.2 1.2 1.3 1.1 1.2 1.0 1.3 1.5 1.3 -0.1
0.0 1.2 1.1 1.4 1.1 1.2 1.3 1.2 1.3 1.3 -0.1
1.3 1.3 1.3 1.5 1.3 1.3 1.3 1.3 1.6 1.4 -0.1
0.7 1.1 1.2 1.3 1.0 1.1 1.1 1.2 1.1 1.1 -0.1
0.9 1.0 1.0 0.9 1.1 1.0 1.0 1.1 1.0 1.0 -0.1
1.1 1.1 1.0 0.0 1.2 1.1 1.4 1.0 1.1 1.2 -0.1
1.3 1.0 1.0 1.2 1.7 1.2 1.5 1.3 1.1 1.3 -0.1
0.8 0.9 0.8 0.9 0.9 0.9 0.9 0.9 1.0 0.9 -0.1
2.7 2.7 2.5 3.0 3.2 2.8 2.7 3.0 2.9 2.9 -0.1
1.1 1.0 1.0 1.1 1.1 1.1 1.0 1.1 1.3 1.1 -0.1
1.3 1.0 1.1 0.8 0.9 1.0 1.3 1.0 0.9 1.1 -0.1
1.7 1.8 1.7 1.8 1.7 1.7 1.6 1.7 2.1 1.8 -0.1
1.8 1.9 1.5 2.2 0.7 1.6 1.7 1.9 1.5 1.7 -0.1
0.0 1.7 1.2 1.5 1.3 1.4 1.3 1.6 1.6 1.5 -0.1
0.8 0.9 0.9 0.7 0.9 0.8 0.9 1.2 0.6 0.9 -0.1
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368 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1 K.AIC*TEAGLMALR.E
369 P22234 PAICS Multifunctional protein ADE2 PAICS K.ITSC*IFQLLQEAGIK.T
370 P37802 TAGLN2 Transgelin-2 TAGLN2 K.DGTVLC*ELINALYPEGQAPVK.K
371 P36507 MAP2K2 Dual specificity mitogen-activated protein kinase MAP2K2 K.LC*DFGVSGQLIDSMANSFVGTR.S
372 P25398 RPS12 40S ribosomal protein S12 RPS12 K.LVEALC*AEHQINLIK.V
373 P62753 RPS6 40S ribosomal protein S6 RPS6 K.LNISFPATGC*QK.L
374 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 R.DLNYC*FSGMSDHR.Y
375 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 K.VGILDVDLC*GPSIPR.M
376 P61158 ACTR3 Actin-related protein 3 ACTR3 K.LGYAGNTEPQFIIPSC*IAIK.E
377 P10644 PRKAR1A cAMP-dependent protein kinase type I-alpha regulat PRKAR1A R.SLREC*ELYVQK.H
378 P15880 RPS2 40S ribosomal protein S2 RPS2 R.GC*TATLGNFAK.A
379 E9PPU0 EPPK1 Epiplakin EPPK1 R.YLC*GLGAVGGVR.L
380 Q92947 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GCDH K.GYGC*AGVSSVAYGLLAR.E
381 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC R.IYGFYDEC*K.R
382 P14174 MIF Macrophage migration inhibitory factor MIF K.LLC*GLLAER.L
383 P53602 MVD Diphosphomevalonate decarboxylase MVD R.DGDPLPSSLSC*K.V
384 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1 K.VIGIEC*SSISDYAVK.I
385 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 R.LIGPNC*PGVINPGECK.I
386 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 R.FSPNSSNPIIVSC*GWDK.L





388 P51812 RPS6KA3 Ribosomal protein S6 kinase alpha-3 RPS6KA3 R.AENGLLMTPC*YTANFVAPEVLK.R
389 O14561 NDUFAB1 Acyl carrier protein, mitochondrial NDUFAB1 K.LMC*PQEIVDYIADKK.D
390 P60866 RPS20 40S ribosomal protein S20 RPS20 K.TPC*GEGSK.T
391 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5 K.GVC*TEAGMYALR.E
392 P27635 RPL10 60S ribosomal protein L10 RPL10 K.MLSC*AGADR.L
393 Q9BTZ2 DHRS4 Dehydrogenase/reductase SDR family member 4 DHRS4 R.VNC*LAPGLIK.T
394 Q9Y2Q5 LAMTOR2 Ragulator complex protein LAMTOR2 LAMTOR2 K.FILMDC*MEGR.V
395 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 K.LNEC*VDHTPK.L
396 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.LGVENC*YFPMFVSQSALEK.E
397 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC R.GNHEC*ASINR.I
398 Q7Z2W4 ZC3HAV1 Zinc finger CCCH-type antiviral protein 1 ZC3HAV1 K.NSNVDSSYLESLYQSC*PR.G
399 Q14247 CTTN Src substrate cortactin CTTN K.HC*SQVDSVR.G
400 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1 R.GTGELTQLLNSLC*TAVK.A
401 Q9BXV9 C14orf142 Uncharacterized protein C14orf142 C14orf142 R.VSC*EAPGDGDPFQGLLSGVAQMK.D
402 P21964 COMT Catechol O-methyltransferase COMT R.YLPDTLLLEEC*GLLR.K
403 Q8IY67 RAVER1 Ribonucleoprotein PTB-binding 1 RAVER1 R.ALSAVHSPTFCQLAC*GQDGQLK.G
404 P55786 NPEPPS Puromycin-sensitive aminopeptidase NPEPPS R.SKDGVC*VR.V
405 P62280 RPS11 40S ribosomal protein S11 RPS11 R.DVQIGDIVTVGEC*RPLSK.T
406 P50914 RPL14 60S ribosomal protein L14 RPL14 K.C*MQLTDFILK.F
407 Q86UU0 BCL9L B-cell CLL/lymphoma 9-like protein BCL9L K.TGNGGAQSQHQNVNQGPTC*NVGSK.G
408 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 R.AGAIAPC*EVTVPAQNTGLGPEK.T
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1.5 1.4 1.6 1.6 1.4 1.5 1.3 1.6 1.8 1.6 -0.1
1.0 0.9 0.9 0.9 1.0 0.9 1.0 1.1 0.9 1.0 -0.1
0.9 1.0 1.0 0.9 0.9 0.9 1.0 1.1 0.8 1.0 -0.1
1.1 1.0 1.0 1.1 1.2 1.1 1.2 1.2 1.1 1.1 -0.1
0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.8 0.6 0.7 -0.1
2.0 1.8 1.9 2.2 2.0 2.0 1.9 2.1 2.2 2.1 -0.1
1.3 1.2 1.2 1.3 1.3 1.2 1.2 1.4 1.3 1.3 -0.1
2.1 1.7 2.0 2.7 1.9 2.1 2.0 2.0 2.5 2.2 -0.1
0.9 1.0 1.1 0.9 1.0 1.0 0.9 1.3 1.0 1.1 -0.1
2.2 3.1 2.4 2.5 2.8 2.6 2.7 2.4 2.9 2.7 -0.1
1.8 1.7 1.6 1.7 1.7 1.7 1.6 1.8 1.9 1.8 -0.1
1.4 1.6 1.3 1.5 1.6 1.5 1.6 1.4 1.8 1.6 -0.1
2.5 3.4 2.9 3.2 3.1 3.0 2.8 2.7 3.8 3.1 -0.1
2.9 1.8 0.0 0.0 2.4 2.4 2.2 2.6 2.6 2.5 -0.1
0.9 0.9 0.9 0.8 0.9 0.9 0.9 1.1 0.8 0.9 -0.1
1.1 1.1 1.1 1.2 1.1 1.1 1.0 1.3 1.2 1.2 -0.1
1.2 1.1 1.0 1.2 1.2 1.1 1.2 1.2 1.3 1.2 -0.1
1.7 1.6 1.6 1.7 1.8 1.7 1.5 2.1 1.7 1.7 -0.1
2.8 2.3 2.6 2.8 2.4 2.6 2.3 2.3 3.4 2.7 -0.1
0.8 0.9 1.0 1.0 1.0 0.9 0.9 1.1 1.1 1.0 -0.1
0.0 1.1 1.3 1.1 1.2 1.2 1.3 1.3 1.2 1.3 -0.1
0.9 0.0 1.3 0.9 1.2 1.1 1.3 1.1 1.0 1.1 -0.1
1.4 1.4 1.3 1.4 1.4 1.4 1.4 1.5 1.5 1.5 -0.1
1.6 1.6 1.5 1.9 1.6 1.6 1.6 1.7 1.8 1.7 -0.1
2.4 2.2 2.5 2.9 2.5 2.5 2.5 2.6 2.7 2.6 -0.1
2.1 1.7 1.8 1.9 1.7 1.9 1.8 2.0 2.0 1.9 -0.1
0.0 0.9 1.3 0.8 0.0 1.0 1.2 1.0 1.0 1.1 -0.1
1.0 1.3 1.0 1.0 1.0 1.1 1.4 1.1 0.9 1.1 -0.1
0.0 1.3 1.3 1.8 1.8 1.5 1.6 1.7 1.7 1.6 -0.1
2.2 2.0 2.2 2.4 2.2 2.2 2.2 2.2 2.5 2.3 -0.1
1.2 1.3 1.6 1.9 1.7 1.5 1.2 1.9 1.8 1.6 -0.1
1.1 0.9 1.1 1.1 1.0 1.0 0.8 1.6 1.0 1.1 -0.1
0.8 0.9 0.8 0.8 0.8 0.8 1.0 1.1 0.7 0.9 -0.1
0.0 1.2 1.1 1.1 0.8 1.0 0.8 1.7 1.0 1.2 -0.1
0.8 0.9 0.8 0.7 0.8 0.8 1.0 1.0 0.7 0.9 -0.1
1.0 0.0 0.9 1.1 0.9 1.0 0.7 1.0 1.6 1.1 -0.1
1.2 0.9 1.2 1.1 1.0 1.1 1.2 1.2 1.2 1.2 -0.1
2.9 2.5 2.5 3.1 2.7 2.7 2.8 2.7 3.1 2.8 -0.1
2.5 2.3 2.2 2.5 2.4 2.4 2.4 2.4 2.8 2.5 -0.1
1.0 1.6 0.0 0.0 1.6 1.4 1.1 1.7 1.8 1.5 -0.1
1.7 1.6 1.7 2.0 1.8 1.8 1.8 1.9 1.9 1.9 -0.1
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409 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 R.YSDESGNMDFDNFISC*LVR.L
410 P62633 CNBP Cellular nucleic acid-binding protein CNBP R.C*GESGHLAR.E
411 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 K.ATC*IGNNSAAAVSMLK.Q
412 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 R.YVDIAIPC*NNK.G
413 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.SIC*TTVLELLDK.Y
414 P50395 GDI2 Rab GDP dissociation inhibitor beta GDI2 R.TDDYLDQPC*YETINR.I
415 P62633 CNBP Cellular nucleic acid-binding protein CNBP R.GFQFVSSSLPDIC*YR.C
416 Q01813 PFKP 6-phosphofructokinase type C PFKP R.NESC*SENYTTDFIYQLYSEEGK.G
417 P18085 ARF4 ADP-ribosylation factor 4 ARF4 K.NIC*FTVWDVGGQDR.I
418 P36578 RPL4 60S ribosomal protein L4 RPL4 R.SGQGAFGNMC*R.G
419 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 R.AVHQC*DR.G
420 O14976 GAK Cyclin-G-associated kinase GAK R.AIIQEVC*FMK.K
421 P82912 MRPS11 28S ribosomal protein S11, mitochondrial MRPS11 K.ASHNNTQIQVVSASNEPLAFASC*GTEGFR.N
422 P10768 ESD S-formylglutathione hydrolase ESD K.C*FGGLQK.V
423 P49790 NUP153 Nuclear pore complex protein Nup153 NUP153 K.CVACETPKPGTC*VK.R
424 P51570 GALK1 Galactokinase GALK1 R.RQC*EEVAR.A
425 Q9UHX1 PUF60 Poly(U)-binding-splicing factor PUF60 PUF60 R.ALAIMC*R.V
426 P35125 USP6 Ubiquitin carboxyl-terminal hydrolase 6 USP6 K.SGTSC*PSSK.N
427 P40925 MDH1 Malate dehydrogenase, cytoplasmic MDH1 K.AIC*DHVR.D
428 Reverse_Q9H5V8 CDCP1 CUB domain-containing protein 1 CDCP1 R.SELCVFC*GPVFKR.S
429 Q9Y5M8 SRPRB Signal recognition particle receptor subunit beta SRPRB K.NTPSFLIAC*NK.Q
430 P37837 TALDO1 Transaldolase TALDO1 K.ALAGC*DFLTISPK.L
431 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL R.VFNVFC*LYGNVEK.V
432 Q9Y3D0 FAM96B Mitotic spindle-associated MMXD complex subunit MI FAM96B R.VAAALENTHLLEVVNQC*LSAR.S
433 P28331 NDUFS1 NADH-ubiquinone oxidoreductase 75 kDa subunit, mit NDUFS1 K.VVAAC*AMPVMK.G
434 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 MACROD1
K.LEVDAIVNAANSSLLGGGGVDGC*I
HR.A
435 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/threonine ILKAP R.C*GVTSVPDIR.R
436 P62633 CNBP Cellular nucleic acid-binding protein CNBP R.DC*DHADEQK.C
437 P35270 SPR Sepiapterin reductase SPR R.AVC*LLTGASR.G
438 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.GANDFMC*DEMER.S
439 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.NMITGTSQADC*AVLIVAAGVGEFEAGISK.N
440 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 K.KLLDLVQQSC*NYK.Q
441 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 R.ADHQPLTEASYVNLPTIALC*NTDSPLR.Y
442 Q07020 RPL18 60S ribosomal protein L18 RPL18 K.GC*GTVLLSGPR.K
443 P62826 RAN GTP-binding nuclear protein Ran RAN R.VC*ENIPIVLCGNK.V
444 P00492 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1 K.SYC*NDQSTGDIK.V
445 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 K.LNEDMAC*SVAGITSDANVLTNELR.L
446 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1 K.LSLDGQNIYNAC*CTLR.I
447 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 K.LWNTLGVC*K.Y
448 E9PPU0 EPPK1 Epiplakin EPPK1 R.LLDAQLATGGLVC*PAR.R
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0.9 1.0 0.9 0.9 0.9 0.9 1.2 1.1 0.8 1.0 -0.1
1.1 1.2 1.4 1.4 1.4 1.3 1.4 1.4 1.4 1.4 -0.1
0.8 0.8 0.9 0.9 0.9 0.9 1.0 1.2 0.9 1.0 -0.1
1.4 1.2 1.4 1.5 1.3 1.3 1.4 1.5 1.6 1.5 -0.1
0.8 1.0 1.0 0.8 0.8 0.9 0.9 1.3 0.8 1.0 -0.1
0.9 1.0 1.0 0.8 1.0 0.9 0.9 1.4 0.8 1.1 -0.1
0.0 0.7 0.8 0.7 0.7 0.7 0.9 0.7 0.9 0.8 -0.1
2.7 2.3 2.3 2.9 2.8 2.6 2.6 2.6 2.9 2.7 -0.1
1.4 1.2 1.3 1.5 1.5 1.4 1.7 1.6 1.2 1.5 -0.1
1.9 2.1 2.2 2.6 2.5 2.3 2.2 2.3 2.8 2.4 -0.1
2.0 1.8 1.7 2.2 1.7 1.9 1.9 2.0 2.2 2.0 -0.1
0.0 1.5 1.4 1.5 1.3 1.4 1.4 1.4 1.9 1.6 -0.1
2.0 1.3 1.8 2.2 1.5 1.8 1.9 1.8 2.1 1.9 -0.1
0.0 0.9 1.0 0.8 0.9 0.9 1.0 1.3 0.7 1.0 -0.1
1.2 1.0 0.0 1.4 1.2 1.2 0.8 1.7 1.5 1.3 -0.1
1.7 0.0 1.4 1.6 1.3 1.5 1.8 1.4 1.8 1.7 -0.1
0.8 1.1 0.8 0.8 0.8 0.9 0.9 1.3 0.8 1.0 -0.1
1.5 1.5 1.9 1.8 1.6 1.7 1.7 1.7 2.0 1.8 -0.1
0.9 1.1 1.0 0.8 1.0 0.9 1.3 1.2 0.7 1.1 -0.1
0.0 2.3 2.2 3.3 0.0 2.6 2.2 3.6 2.4 2.7 -0.1
1.9 1.4 2.2 2.4 3.3 2.3 2.9 2.1 2.3 2.4 -0.1
0.0 1.0 0.0 0.9 1.2 1.0 1.2 1.4 0.8 1.2 -0.1
0.0 0.0 1.0 0.8 1.0 0.9 0.9 1.5 0.8 1.0 -0.1
0.7 0.8 0.6 0.6 0.7 0.7 0.9 0.8 0.8 0.8 -0.1
2.6 2.2 2.3 0.0 0.0 2.4 2.1 2.6 2.9 2.5 -0.2
1.1 1.0 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.2 -0.2
1.4 1.2 1.6 2.1 1.5 1.5 1.2 2.4 1.5 1.7 -0.2
0.0 0.7 0.8 0.9 0.0 0.8 0.8 1.0 1.0 0.9 -0.2
0.9 1.1 1.0 1.0 0.9 1.0 1.3 1.2 1.0 1.2 -0.2
2.8 2.0 2.0 2.8 2.8 2.5 3.1 2.5 2.2 2.6 -0.2
1.3 1.4 1.4 1.4 1.3 1.3 1.5 1.6 1.4 1.5 -0.2
1.3 1.3 1.2 1.3 1.3 1.3 1.4 1.4 1.5 1.4 -0.2
1.4 1.3 1.5 1.7 1.3 1.4 1.5 1.6 1.6 1.6 -0.2
1.9 1.7 1.8 2.0 2.0 1.9 2.1 2.0 2.0 2.0 -0.2
1.0 1.0 1.2 1.0 1.1 1.1 1.2 1.3 1.2 1.2 -0.2
1.0 1.1 0.9 1.0 1.0 1.0 1.5 1.0 1.1 1.2 -0.2
0.7 0.9 0.9 1.0 0.8 0.9 1.0 1.2 0.8 1.0 -0.2
1.0 0.7 1.2 1.0 1.1 1.0 1.2 0.9 1.4 1.2 -0.2
2.9 2.1 2.7 2.8 2.6 2.6 2.7 2.5 3.2 2.8 -0.2
2.5 2.1 2.4 2.2 2.3 2.3 2.2 2.8 2.4 2.5 -0.2
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449 P63220 RPS21 40S ribosomal protein S21 RPS21 K.TYAIC*GAIR.R
450 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.TIYAGNALC*TVK.C
451 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 R.QAVLGAGLPISTPC*TTINK.V
452 Q15054 POLD3 DNA polymerase delta subunit 3 POLD3 K.FSAIQC*AAAVPR.A
453 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.LDFVC*SFLQK.N
454 O43795 MYO1B Unconventional myosin-Ib MYO1B K.LVMSYVAAVC*GK.G
455 Q9Y6D5 ARFGEF2 Brefeldin A-inhibited guanine nucleotide-exchange ARFGEF2 K.ANFIEADKYFLPFELAC*QSK.S
456 Q13418 ILK Integrin-linked protein kinase ILK K.FSFQC*PGR.M
457 O14545 TRAFD1 TRAF-type zinc finger domain-containing protein 1 TRAFD1 R.AVC*EADQSHGGPR.S
458 Q9H7X7 RABL5 Rab-like protein 5 RABL5 K.ILFVGPC*ESGK.T
459 P31949 S100A11 Protein S100-A11 S100A11 K.ISSPTETERC*IESLIAVFQK.Y
460 O75348 ATP6V1G1 V-type proton ATPase subunit G 1 ATP6V1G1 R.GSC*STEVEKETQEK.M
461 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 R.YNFFTGC*PK.A
462 P62266 RPS23 40S ribosomal protein S23 RPS23 K.ITAFVPNDGC*LNFIEENDEVLVAGFGR.K
463 Q7Z4W1 DCXR L-xylulose reductase DCXR R.AVTNHSVYC*STK.G
464 O15075 DCLK1 Serine/threonine-protein kinase DCLK1 DCLK1 R.YQDDFLLDESEC*R.V
465 Q7L2J0 MEPCE 7SK snRNA methylphosphate capping enzyme MEPCE R.C*APSAGSPAAAVGR.E
466 Q9Y508 RNF114 RING finger protein 114 RNF114 K.SVVC*PICASMPWGDPNYR.S
467 Q96FJ2 DYNLL2 Dynein light chain 2, cytoplasmic DYNLL2 K.NADMSEDMQQDAVDC*ATQAMEK.Y
468 P49327 FASN Fatty acid synthase FASN K.AFDTAGNGYC*R.S
469 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L R.GC*ALQCAILSPAFK.V
470 P51858 HDGF Hepatoma-derived growth factor HDGF K.C*GDLVFAK.M
471 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 K.C*EFQDAYVLLSEK.K
472 Q8TCU6 PREX1 Phosphatidylinositol 3,4,5-trisphosphate-dependent PREX1 R.LC*VLNEILGTER.D
473 Q9BRA2 TXNDC17 Thioredoxin domain-containing protein 17 TXNDC17 K.DAGGKSWC*PDCVQAEPVVR.E
474 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 K.TFVGTPC*WMAPEVMEQVR.G
475 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1 R.IIC*SAGLSLLAEER.Q
476 P49327 FASN Fatty acid synthase FASN K.FC*FTPHTEEGCLSER.A
477 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 R.LEIC*NLTPDALK.S
478 P28676 GCA Grancalcin GCA R.C*LTQSGINGTYSPFSLETCR.I
479 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.AYHEQLSVAEITNAC*FEPANQMVK.C
480 P36578 RPL4 60S ribosomal protein L4 RPL4 R.YAIC*SALAASALPALVMSK.G
481 B0LM41 RBM14/RBM4 fusion Transcriptional coactivator CoAZ 
RBM14/RB
M4 R.TAPGMGDQSGC*YR.C
482 P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT R.VVC*SSGAVGNYSGGLAVK.E
483 P25398 RPS12 40S ribosomal protein S12 RPS12 K.VVGC*SCVVVK.D
484 Q15813 TBCE Tubulin-specific chaperone E TBCE R.NCAVSC*AGEK.G
485 Q12849 GRSF1 G-rich sequence factor 1 GRSF1 R.YIELFLNSC*PK.G
486 B0LM41 RBM14/RBM4 fusion Transcriptional coactivator CoAZ 
RBM14/RB
M4 K.IFVGNVSAAC*TSQELR.S
487 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 K.YLEC*SALTQR.G
488 Q53H96 PYCRL Pyrroline-5-carboxylate reductase 3 PYCRL R.SDVC*TPGGTTIYGLHALEQGGLR.A
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1.2 1.7 1.2 1.4 1.5 1.4 1.6 1.6 1.5 1.6 -0.2
1.9 2.1 2.3 2.5 2.0 2.2 2.1 2.3 2.6 2.3 -0.2
1.3 1.4 1.4 1.4 1.4 1.4 1.4 1.8 1.5 1.6 -0.2
0.0 1.9 1.4 1.9 1.7 1.7 1.7 1.3 2.7 1.9 -0.2
1.2 1.1 1.0 1.1 1.1 1.1 0.9 1.0 1.8 1.3 -0.2
1.4 1.1 1.1 1.2 1.2 1.2 1.3 1.4 1.4 1.4 -0.2
0.0 0.0 1.7 1.6 1.6 1.6 1.3 2.3 1.8 1.8 -0.2
1.5 1.3 1.5 1.5 1.6 1.5 1.5 1.6 1.8 1.7 -0.2
1.2 1.2 1.3 1.5 1.6 1.3 1.4 1.5 1.6 1.5 -0.2
1.8 0.0 1.4 1.7 1.6 1.6 1.7 2.1 1.6 1.8 -0.2
0.6 1.0 0.9 0.9 0.8 0.8 1.3 1.1 0.7 1.0 -0.2
1.0 0.0 0.9 1.0 0.0 1.0 1.1 1.3 1.2 1.2 -0.2
2.2 2.0 2.1 2.6 2.1 2.2 2.3 2.3 2.6 2.4 -0.2
0.0 2.0 1.9 2.2 1.2 1.8 2.5 1.2 2.5 2.0 -0.2
1.3 1.5 1.3 1.2 1.1 1.3 1.4 1.6 1.5 1.5 -0.2
1.3 1.2 1.3 1.4 1.3 1.3 1.3 1.7 1.4 1.5 -0.2
1.2 0.0 1.1 1.1 1.0 1.1 1.4 1.3 1.4 1.3 -0.2
0.0 0.4 0.7 0.6 0.7 0.6 0.8 0.9 0.8 0.8 -0.2
0.8 0.8 1.2 0.8 0.9 0.9 1.1 1.3 1.0 1.1 -0.2
2.5 1.9 2.2 2.9 2.3 2.4 2.5 2.4 2.9 2.6 -0.2
1.6 1.7 1.5 1.5 1.7 1.6 2.1 1.4 2.1 1.8 -0.2
0.8 1.1 1.0 1.1 0.9 1.0 1.2 1.2 1.1 1.2 -0.2
1.1 1.2 1.1 1.2 1.2 1.2 1.5 1.6 1.1 1.4 -0.2
0.0 2.4 1.8 2.2 2.3 2.2 2.3 2.5 2.4 2.4 -0.2
1.2 1.1 1.1 1.2 1.2 1.1 1.3 1.4 1.5 1.4 -0.2
1.8 1.5 1.7 2.5 2.0 1.9 2.1 2.1 2.3 2.1 -0.2
1.3 1.2 1.1 1.2 1.1 1.2 1.4 1.5 1.4 1.4 -0.2
0.7 1.0 0.9 0.9 0.9 0.9 1.0 1.2 1.2 1.1 -0.3
1.9 1.7 1.9 2.4 1.5 1.9 1.9 2.3 2.1 2.1 -0.3
0.9 1.0 0.8 1.0 0.9 0.9 1.5 1.3 0.7 1.2 -0.3
3.3 3.0 3.1 3.5 3.3 3.2 3.2 3.5 3.9 3.5 -0.3
0.0 2.9 2.7 3.1 3.5 3.0 2.8 3.3 3.9 3.3 -0.3
0.0 0.8 0.8 1.2 0.0 0.9 1.0 1.4 1.1 1.2 -0.3
1.7 1.6 1.4 1.6 1.7 1.6 1.7 2.0 1.9 1.9 -0.3
0.0 0.6 0.7 0.7 0.7 0.7 0.8 1.3 0.8 1.0 -0.3
1.3 1.1 1.5 1.1 1.8 1.4 2.5 1.3 1.3 1.7 -0.3
1.1 0.0 0.9 1.0 0.0 1.0 0.8 1.2 1.9 1.3 -0.3
0.0 1.8 2.0 2.0 1.8 1.9 2.2 2.2 2.2 2.2 -0.3
0.8 1.3 1.0 0.9 0.9 1.0 1.6 1.4 0.9 1.3 -0.3
1.6 1.6 1.7 1.8 1.7 1.7 2.0 2.2 1.8 2.0 -0.3
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489 P49327 FASN Fatty acid synthase FASN R.LLSAAC*R.L
490 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL K.LTAC*QVATAFNLSR.F
491 P49327 FASN Fatty acid synthase FASN K.AC*LDTAVENMPSLK.M
492 P51153 RAB13 Ras-related protein Rab-13 RAB13 R.LLLGNKC*DMEAK.R
493 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.LC*ALRPDDSSSAR.T
494 P08559 PDHA1 Pyruvate dehydrogenase E1 component subunit alpha, PDHA1 R.FAAAYC*R.S
495 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 R.SVC*TEAGMFAIR.A
496 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 K.GC*LLYGPPGTGK.T
497 P62910 RPL32 60S ribosomal protein L32 RPL32 K.SYC*AEIAHNVSSK.N
498 P62714 PPP2CB Serine/threonine-protein phosphatase 2A catalytic PPP2CB R.NVVTIFSAPNYC*YR.C
499 P60709 ACTB Actin, cytoplasmic 1 ACTB K.EKLC*YVALDFEQEMATAASSSSLEK.S
500 P49327 FASN Fatty acid synthase FASN K.SFYGSTLFLC*R.R
501 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 R.FFSDC*K.I
502 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 K.QEPLGSDSEGVNC*LAYDEAIMAQQDR.I
503 P31749 AKT1 RAC-alpha serine/threonine-protein kinase AKT1 K.TFC*GTPEYLAPEVLEDNDYGR.A
504 Q9Y676 MRPS18B 28S ribosomal protein S18b, mitochondrial MRPS18B K.VVGNPC*PICR.D
505 P27448 MARK3 MAP/microtubule affinity-regulating kinase 3 MARK3 K.LDTFC*GSPPYAAPELFQGK.K
506 P36578 RPL4 60S ribosomal protein L4 RPL4 R.FC*IWTESAFR.K
507 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 R.MLSAVSQQVQC*IQEALR.E
508 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.DLAGC*IHGLSNVK.L
509 P61247 RPS3A 40S ribosomal protein S3a RPS3A R.LFC*VGFTK.K
510 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD R.GSNTC*ELIFEDCKIPAANILGHENK.G
511 E9PPU0 EPPK1 Epiplakin EPPK1 R.YLQGTGC*IAGLLLPGSQER.L
512 Q9NRF9 POLE3 DNA polymerase epsilon subunit 3 POLE3 R.AASVFVLYATSC*ANNFAMK.G
513 P11498 PC Pyruvate carboxylase, mitochondrial PC R.FLYEC*PWR.R
514 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X K.FDTGNLC*MVTGGANLGR.I
515 Q7L8W6 ATPBD4 ATP-binding domain-containing protein 4 ATPBD4 K.C*EGDEVEDLYELLK.L
516 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.VC*VETVESGAMTK.D
517 P49327 FASN Fatty acid synthase FASN R.WVC*SSLR.H
518 P24468 NR2F2 COUP transcription factor 2 NR2F2 R.FGSQC*MQPNNIMGIENICELAAR.M
519 P07437 TUBB Tubulin beta chain TUBB K.VSDTVVEPYNATLSVHQLVENTDETYC*IDNEALYDICFR.T
520 P49327 FASN Fatty acid synthase FASN R.DPETLVGYSMVGC*QR.A
521 Q96BF6 NACC2 Nucleus accumbens-associated protein 2 NACC2 R.NTLANSC*GTGIR.S
522 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.LGGEVSC*LVAGTK.C
523 P62244 RPS15A 40S ribosomal protein S15a RPS15A K.C*GVISPR.F
524 P43897 TSFM Elongation factor Ts, mitochondrial TSFM R.FEC*GEGEEAAETE.-
525 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC K.IC*GDIHGQYYDLLR.L
526 O43290 SART1 U4/U6.U5 tri-snRNP-associated protein 1 SART1 K.SLPSAVYC*IEDK.M
527 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 K.IVSLPEC*FNSPYGAK.Y
528 P40429 RPL13A 60S ribosomal protein L13a RPL13A R.C*EGINISGNFYR.N
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2.6 0.0 2.5 2.6 2.3 2.5 2.6 2.7 3.1 2.8 -0.3
1.1 0.9 1.0 1.0 1.0 1.0 1.4 1.4 1.3 1.3 -0.3
0.8 0.9 0.8 1.2 0.8 0.9 1.2 1.3 1.1 1.2 -0.3
1.4 0.0 1.4 1.6 0.0 1.4 1.8 2.0 1.4 1.7 -0.3
2.0 1.5 1.8 2.0 1.9 1.8 2.1 2.1 2.3 2.2 -0.3
0.0 1.7 2.2 2.4 0.0 2.1 2.5 2.7 2.1 2.4 -0.3
0.0 1.5 2.0 2.3 2.1 2.0 2.4 2.2 2.2 2.3 -0.3
0.0 1.8 0.7 0.0 1.7 1.4 1.9 1.4 2.0 1.7 -0.3
1.6 1.7 1.7 1.7 1.8 1.7 1.9 1.9 2.4 2.0 -0.3
2.3 1.8 2.2 2.0 1.9 2.0 2.1 2.4 2.7 2.4 -0.4
2.2 2.1 2.2 2.4 2.1 2.2 2.5 2.4 2.7 2.6 -0.4
1.1 1.1 1.3 1.7 2.0 1.5 1.8 1.9 1.8 1.8 -0.4
1.4 1.2 1.5 1.3 1.3 1.3 1.6 1.8 1.8 1.7 -0.4
1.1 1.1 1.2 1.1 1.1 1.1 1.1 1.9 1.6 1.5 -0.4
3.6 2.9 2.9 3.2 2.9 3.1 2.8 2.8 4.9 3.5 -0.4
0.9 0.0 0.5 0.0 0.5 0.6 1.0 1.4 0.7 1.0 -0.4
1.5 1.6 1.6 3.1 1.7 1.9 2.1 2.1 2.6 2.3 -0.4
0.0 2.4 1.8 2.7 0.0 2.3 2.0 3.8 2.4 2.7 -0.4
2.1 2.0 1.8 2.3 1.6 2.0 2.1 2.6 2.4 2.4 -0.4
1.5 1.4 1.5 1.7 1.5 1.5 2.0 2.0 1.7 1.9 -0.4
1.6 1.6 1.7 1.7 1.1 1.5 1.9 2.0 2.0 2.0 -0.4
2.2 2.1 2.2 2.5 2.0 2.2 2.1 2.8 3.1 2.6 -0.4
2.1 2.4 0.0 0.0 1.7 2.1 2.7 2.6 2.3 2.5 -0.5
0.9 0.9 1.0 1.1 0.9 1.0 1.3 1.6 1.5 1.4 -0.5
1.5 1.5 1.4 1.4 1.6 1.5 2.1 1.4 2.2 1.9 -0.5
2.0 1.7 2.1 2.2 1.7 1.9 2.2 2.4 2.4 2.4 -0.5
0.0 0.0 1.4 2.0 1.7 1.7 1.5 2.3 2.7 2.2 -0.5
1.4 1.4 1.4 2.0 1.5 1.5 1.8 2.1 2.1 2.0 -0.5
1.5 1.2 1.5 1.4 1.5 1.4 1.9 1.8 2.1 1.9 -0.5
2.2 2.1 2.2 1.7 1.9 2.0 2.2 2.5 2.9 2.5 -0.5
2.7 2.7 2.4 2.4 2.7 2.6 3.4 2.6 3.2 3.1 -0.5
1.8 1.8 1.6 2.0 1.8 1.8 2.1 2.2 2.7 2.3 -0.5
1.3 1.6 0.7 0.0 1.4 1.2 1.5 1.8 2.0 1.8 -0.5
2.3 1.9 2.2 2.4 2.0 2.2 2.5 2.6 3.1 2.7 -0.5
1.4 1.7 1.7 1.9 1.5 1.6 2.4 1.8 2.2 2.2 -0.5
0.8 0.0 1.2 1.3 1.3 1.1 1.3 1.5 2.3 1.7 -0.5
2.8 0.0 3.1 3.4 2.4 2.9 3.4 3.6 3.5 3.5 -0.6
0.0 0.0 0.7 0.6 0.7 0.6 1.2 1.3 1.2 1.2 -0.6
1.5 0.0 1.4 1.3 1.5 1.4 1.8 2.4 1.9 2.0 -0.6
1.5 0.0 0.9 1.0 0.0 1.1 1.7 1.6 1.8 1.7 -0.6
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529 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.SSGGFVWAC*K.N
530 P61247 RPS3A 40S ribosomal protein S3a RPS3A R.DKMC*SMVK.K
531 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase ALDH6A1 K.AEMDAAIASC*K.R
532 P07741 APRT Adenine phosphoribosyltransferase APRT R.VVVVDDLLATGGTMNAAC*ELLGR.L
533 P49327 FASN Fatty acid synthase FASN R.DGLLENQTPEFFQDVC*KPK.Y
534 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 K.SGDAAIVEMVPGKPMC*VESFSQYPPLGR.F
535 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase ALDH6A1 K.ERVC*NLIDSGTK.E
536 P16278 GLB1 Beta-galactosidase GLB1 K.TVGAALDILC*PSGPIK.S
537 Q96HY7 DHTKD1 Probable 2-oxoglutarate dehydrogenase E1 component DHTKD1 R.VEELC*PFPLDSLQQEMSK.Y
538 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC K.TFTDC*FNCLPIAAIVDEK.I
539 Q02543 RPL18A 60S ribosomal protein L18a RPL18A R.DLTTAGAVTQC*YR.D
540 P26440 IVD Isovaleryl-CoA dehydrogenase, mitochondrial IVD K.ACDEGHC*TAK.D
541 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.PMC*VESFSDYPPLGR.F
542 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.C*ATITPDEAR.V
543 Q6P2C8 MED27 Mediator of RNA polymerase II transcription subuni MED27 K.LFQAPC*QR.C
544 P48556 PSMD8 26S proteasome non-ATPase regulatory subunit 8 PSMD8 K.C*GEELGR.L
545 Q9Y508 RNF114 RING finger protein 114 RNF114 R.DC*GGAAQLAGPAAEADPLGR.F
546 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 R.AGGIETIANEFSDRC*TPSVISFGSK.N
547 Q9GZZ9 UBA5 Ubiquitin-like modifier-activating enzyme 5 UBA5 R.EGVC*AASLPTTMGVVAGILVQNVLK.F
548 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 R.C*LQSGTLFR.D
549 P78406 RAE1 mRNA export factor RAE1 K.VFTASC*DK.T
550 P13674 P4HA1 Prolyl 4-hydroxylase subunit alpha-1 P4HA1 R.RPC*TLSELE.-
551 Q01813 PFKP 6-phosphofructokinase type C PFKP R.LPLMEC*VQMTQDVQK.A
552 Q96CM8 ACSF2 Acyl-CoA synthetase family member 2, mitochondrial ACSF2 R.MVSTPIGGLSYVQGC*TK.K
553 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH K.IISNASC*TTNCLAPLAK.V
554 P07339 CTSD Cathepsin D CTSD K.AIGAVPLIQGEYMIPC*EK.V
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1.4 1.3 1.1 1.3 1.4 1.3 1.8 1.8 2.0 1.9 -0.6
1.4 1.3 1.3 1.4 1.3 1.3 1.8 1.9 2.1 1.9 -0.6
1.7 1.6 1.6 1.9 1.5 1.6 2.2 2.0 2.5 2.3 -0.6
1.0 1.1 1.1 1.1 1.1 1.1 1.8 2.0 1.4 1.7 -0.6
1.3 1.0 1.1 1.5 1.1 1.2 1.9 1.9 1.9 1.9 -0.7
1.6 1.6 1.8 1.9 1.6 1.7 2.3 2.7 2.2 2.4 -0.7
1.5 1.4 1.4 1.7 1.3 1.5 2.2 2.0 2.3 2.2 -0.7
2.4 2.3 2.3 2.6 2.1 2.3 3.3 3.1 2.8 3.0 -0.7
1.7 1.4 1.9 0.0 1.3 1.6 1.6 2.2 3.0 2.3 -0.7
0.0 1.7 2.6 2.4 2.4 2.3 3.3 2.5 3.3 3.0 -0.7
3.8 3.5 2.4 4.0 2.1 3.2 3.3 4.2 4.3 3.9 -0.7
3.6 2.5 2.9 2.9 3.3 3.1 4.0 3.3 4.2 3.8 -0.8
1.4 1.3 1.4 1.5 1.4 1.4 1.9 2.2 2.4 2.2 -0.8
1.7 1.5 1.9 1.8 1.6 1.7 2.4 2.2 2.9 2.5 -0.8
0.0 1.8 0.0 1.7 1.6 1.7 1.9 2.3 3.4 2.5 -0.8
2.3 1.4 1.0 0.0 0.0 1.5 2.0 2.8 2.5 2.4 -0.9
1.6 1.8 1.5 1.6 1.7 1.6 2.4 2.8 2.4 2.6 -0.9
1.6 1.6 1.6 0.9 1.6 1.5 2.2 2.4 2.6 2.4 -0.9
1.4 1.3 1.3 1.3 1.4 1.3 1.9 2.7 2.2 2.3 -0.9
2.3 2.2 1.9 2.4 2.5 2.3 2.8 3.4 3.6 3.3 -1.0
0.7 0.9 1.2 2.2 1.1 1.2 1.9 2.2 2.5 2.2 -1.0
5.0 4.0 4.4 5.9 4.2 4.7 5.2 5.4 6.9 5.8 -1.1
4.1 3.5 3.4 4.0 3.7 3.7 4.5 5.1 5.0 4.8 -1.1
1.9 1.8 1.6 1.8 1.7 1.8 2.4 3.4 3.1 2.9 -1.2
5.4 4.8 4.2 5.0 5.1 4.9 6.1 5.8 7.0 6.3 -1.4
3.4 3.2 4.0 4.7 3.7 3.8 7.8 7.3 8.9 8.0 -4.2
Table 3A-8. R-values from 1 mM ATP competitive transnitrosation experiment at
500 µM CoA-SNO. A list of all identified peptides (* denotes labeled cysteine) is
presented together with calculated heavy:light ratios (R-values) in pre-treated with
1 mM ATP (light, n=2), or left untreated as a control (heavy, n=5), then
transnitrosated by 500 µM CoA-SNO and taken through the quantitative mass
spectrometry workflow. Date were sorted by ΔR (R of control minus R of pre-
treated sample)  and numbered as ‘Peptide #”.        
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1 Q01813 PFKP 6-phosphofructokinase type C PFKP R.LPLMEC*VQMTQDVQK.A
2 Q92947 GCDH Glutaryl-CoA dehydrogenase, mitochondrial GCDH K.GYGC*AGVSSVAYGLLAR.E
3 P21333 FLNA Filamin-A FLNA K.AHVVPC*FDASK.V
4 Q68CP9 ARID2 AT-rich interactive domain-containing protein 2 ARID2 R.SC*SNAAFALK.Q
5 P31749 AKT1 RAC-alpha serine/threonine-protein kinase AKT1 K.TFC*GTPEYLAPEVLEDNDYGR.A
6 Q8TCU6 PREX1 Phosphatidylinositol 3,4,5-trisphosphate-dependent PREX1 R.LC*VLNEILGTER.D
7 P27708 CAD CAD protein CAD K.VHVDC*MTSQK.L
8 P10599 TXN Thioredoxin TXN K.LVVVDFSATWC*GPCK.M
9 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 R.LC*ASGAGATPDTAIEEIKEK.M
10 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 K.KLMSSNSTDLPLNIEC*FMNDKDVSGK.M
11 P35914 HMGCL Hydroxymethylglutaryl-CoA lyase, mitochondrial HMGCL R.GYVSCALGC*PYEGK.I
12 Q13418 ILK Integrin-linked protein kinase ILK K.FSFQC*PGR.M
13 Q9NP61 ARFGAP3 ADP-ribosylation factor GTPase-activating protein ARFGAP3 K.LANTC*FNEIEK.Q
14 Q01813 PFKP 6-phosphofructokinase type C PFKP R.NESC*SENYTTDFIYQLYSEEGK.G
15 Q9Y3A3 MOB4 MOB-like protein phocein MOB4 R.HTLDGAAC*LLNSNK.Y
16 Q9BSD7 NTPCR Cancer-related nucleoside-triphosphatase NTPCR R.NADC*SSGPGQR.V
17 P15924 DSP Desmoplakin DSP K.YQAEC*SQFK.A
18 P04183 TK1 Thymidine kinase, cytosolic TK1 R.YSSSFC*THDR.N
19 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 K.HLC*QQLQAEQAAAEK.R
20 P55263 ADK Adenosine kinase ADK R.TGC*TFPEKPDFH.-
21 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1 K.ARDC*LIPMGITSENVAER.F
22 Q9UPN9 TRIM33 E3 ubiquitin-protein ligase TRIM33 TRIM33 R.C*DPVPAANGAIR.F
23 Q5MNZ6 WDR45L WD repeat domain phosphoinositide-interacting prot WDR45L R.C*NYLALVGGGK.K
24 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 R.MLSAVSQQVQC*IQEALR.E
25 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.YVAAAFPSAC*GK.T
26 O95833 CLIC3 Chloride intracellular channel protein 3 CLIC3 K.ASEDGESVGHC*PSCQR.L
27 P12532 CKMT1B Creatine kinase U-type, mitochondrial CKMT1B R.LGYILTC*PSNLGTGLR.A
28 P30519 HMOX2 Heme oxygenase 2 HMOX2 K.GALEGSSC*PFR.T
29 P61289 PSME3 Proteasome activator complex subunit 3 PSME3 R.LDEC*EEAFQGTK.V
30 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 K.VC*NFLASQVPFPSR.L
31 Q5VV41 ARHGEF16 Rho guanine nucleotide exchange factor 16 ARHGEF16 R.LPLLMDTLC*LK.T
32 P15924 DSP Desmoplakin DSP K.YC*YLQNEVFGLFQK.L
33 P13674 P4HA1 Prolyl 4-hydroxylase subunit alpha-1 P4HA1 R.RPC*TLSELE.-
34 P36578 RPL4 60S ribosomal protein L4 RPL4 R.YAIC*SALAASALPALVMSK.G
35 O00244 ATOX1 Copper transport protein ATOX1 ATOX1 K.VC*IESEHSMDTLLATLK.K
36 P49321 NASP Nuclear autoantigenic sperm protein NASP R.KPTDGASSSNC*VTDISHLVR.K
37 Q06203 PPAT Amidophosphoribosyltransferase PPAT K.C*ELENCQPFVVETLHGK.I
Pepti
de # Uniprot # Description Symbol Sequence
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ΔR
1 2 3 4 5 average 1 2 average
8.7 10.6 9.4 10.7 9.2 9.7 4.8 5.1 4.9 4.8
11.4 10.6 9.4 10.7 9.2 10.3 5.6 5.4 5.5 4.7
9.5 0.0 4.7 4.1 4.7 5.8 1.3 1.3 1.3 4.4
5.0 5.3 4.9 0.0 4.5 4.9 1.1 1.8 1.5 3.5
8.8 11.6 14.6 11.7 8.0 10.9 6.6 8.7 7.7 3.3
9.0 8.3 4.9 8.1 9.8 8.0 4.6 5.8 5.2 2.8
5.7 4.4 7.0 2.1 0.0 4.8 2.2 2.2 2.2 2.6
6.0 7.7 3.3 5.2 4.4 5.3 2.3 3.8 3.0 2.3
2.4 3.9 0.0 0.0 3.4 3.2 1.0 1.0 1.0 2.3
6.7 4.0 4.1 4.1 3.8 4.5 3.3 1.5 2.4 2.1
2.5 4.4 6.3 0.0 0.0 4.4 2.9 2.1 2.5 1.9
4.5 3.6 2.8 0.0 2.6 3.4 1.6 1.7 1.6 1.8
0.0 0.0 4.1 3.2 1.2 2.9 1.4 0.8 1.1 1.8
7.2 7.8 6.5 6.4 5.9 6.8 5.2 4.9 5.1 1.7
6.5 7.6 6.4 7.7 6.0 6.9 5.2 5.4 5.3 1.6
9.0 7.9 8.3 0.0 8.2 8.3 6.9 6.7 6.8 1.6
7.4 9.9 6.7 4.6 5.1 6.7 5.4 5.3 5.4 1.4
0.0 7.9 6.4 5.4 5.2 6.2 4.3 5.6 5.0 1.3
0.0 4.1 3.7 2.8 3.9 3.6 3.0 1.9 2.4 1.2
0.0 2.1 2.6 2.3 1.8 2.2 1.0 1.1 1.1 1.2
4.7 5.0 4.4 4.5 3.6 4.4 2.7 3.9 3.3 1.2
3.9 0.0 3.2 0.0 1.0 2.7 1.8 1.5 1.6 1.1
4.5 5.0 4.6 6.3 4.7 5.0 3.3 4.6 3.9 1.1
4.6 2.5 3.3 0.0 2.2 3.2 1.2 2.9 2.1 1.1
5.6 6.3 5.3 4.2 5.6 5.4 3.5 5.3 4.4 1.0
6.3 5.3 1.8 5.4 4.6 4.7 2.8 4.6 3.7 1.0
0.0 4.3 3.2 3.8 3.5 3.7 2.5 2.9 2.7 1.0
2.6 3.1 2.4 0.0 2.4 2.6 1.7 1.7 1.7 0.9
7.4 0.0 6.0 0.0 3.6 5.7 3.9 5.6 4.8 0.9
0.0 5.9 6.6 6.8 0.0 6.4 5.0 6.1 5.5 0.9
3.2 4.8 4.2 0.0 6.5 4.7 4.2 3.3 3.7 0.9
6.0 5.5 5.3 5.5 5.8 5.6 4.9 4.5 4.7 0.9
9.9 8.2 7.5 7.2 8.3 8.2 7.9 6.8 7.3 0.9
7.5 6.4 5.5 5.7 5.8 6.2 5.3 5.4 5.3 0.9
3.9 0.0 0.0 3.6 3.0 3.5 3.6 1.6 2.6 0.9
0.0 4.8 0.0 3.5 3.7 4.0 3.3 3.0 3.2 0.8
4.7 3.9 5.1 3.5 4.7 4.4 3.7 3.4 3.6 0.8
Ctrl - 
Sample
Heavy : Light Ratio R
500 µM CoA-SNO (control) 1 mM ATP + 500 µM CoA-SNO (sample)
382
38 Q9NZB2 FAM120A Constitutive coactivator of PPAR-gamma-like protei FAM120A R.VAAASGHC*GAFSGSDSSR.T
39 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC R.ISAFGYLEC*SAK.T
40 P13639 EEF2 Elongation factor 2 EEF2 K.DLEEDHAC*IPIK.K
41 Q9BRA2 TXNDC17 Thioredoxin domain-containing protein 17 TXNDC17 K.DAGGKSWC*PDCVQAEPVVR.E
42 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 R.C*MTNTPVVVR.E
43 P31153 MAT2A S-adenosylmethionine synthase isoform type-2 MAT2A K.VAC*ETVAK.T
44 P62316 SNRPD2 Small nuclear ribonucleoprotein Sm D2 SNRPD2 K.NNTQVLINC*R.N
45 P78527 PRKDC DNA-dependent protein kinase catalytic subunit PRKDC R.VEQLFQVMNGILAQDSAC*SQR.A
46 P13639 EEF2 Elongation factor 2 EEF2 K.STLTDSLVC*K.A
47 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.NMITGTAPLDGC*ILVVAANDGPMPQTR.E
48 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 K.ELAPAVSVLQLFC*SSPK.A
49 P18085 ARF4 ADP-ribosylation factor 4 ARF4 K.NIC*FTVWDVGGQDR.I
50 Q96CM8 ACSF2 Acyl-CoA synthetase family member 2, mitochondrial ACSF2 R.MVSTPIGGLSYVQGC*TK.K
51 Q9NUU7 DDX19A ATP-dependent RNA helicase DDX19A DDX19A K.VLVTTNVC*AR.G
52 P83436 COG7 Conserved oligomeric Golgi complex subunit 7 COG7 K.YLSDSC*SPR.S
53 Q86Y56 HEATR2 HEAT repeat-containing protein 2 HEATR2 R.C*SLLDPFAAVR.R
54 Q00610 CLTC Clathrin heavy chain 1 CLTC K.VIQC*FAETGQVQK.I
55 Q8NBF2 NHLRC2 NHL repeat-containing protein 2 NHLRC2 K.AILFSQPLQITDTQQGC*IAPVELR.Y
56 O14561 NDUFAB1 Acyl carrier protein, mitochondrial NDUFAB1 K.LMC*PQEIVDYIADKK.D
57 Q8NFF5 FLAD1 FAD synthase FLAD1 R.LHYGTDPC*TGQPFR.F
58 P45985 MAP2K4 Dual specificity mitogen-activated protein kinase MAP2K4 K.LC*DFGISGQLVDSIAK.T
59 P07437 TUBB Tubulin beta chain TUBB K.TAVC*DIPPR.G
60 E9PPU0 EPPK1 Epiplakin EPPK1 R.LLDAQLATGGLVC*PAR.R
61 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 R.QAVLGAGLPISTPC*TTINK.V
62 P53621 COPA Coatomer subunit alpha COPA R.TTYQALPC*LPSMYGYPNR.N
63 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 MACROD1
K.LEVDAIVNAANSSLLGGGGVDGC*I
HR.A
64 Q9BTE3 MCMBP Mini-chromosome maintenance complex-binding protei MCMBP R.DASALLDPMEC*TDTAEEQR.V
65 Q96EY5 FAM125A Multivesicular body subunit 12A FAM125A R.GFSAISC*TVEGAPASFGK.S
66 P10599 TXN Thioredoxin TXN K.C*MPTFQFFK.K
67 P30042 C21orf33 ES1 protein homolog, mitochondrial C21orf33 K.NLSTFAVDGKDC*K.V
68 P51812 RPS6KA3 Ribosomal protein S6 kinase alpha-3 RPS6KA3 R.AENGLLMTPC*YTANFVAPEVLK.R
69 P49903 SEPHS1 Selenide, water dikinase 1 SEPHS1 R.LGIGMDTC*VIPLR.H
70 O00148 DDX39A ATP-dependent RNA helicase DDX39A DDX39A R.AIVDC*GFEHPSEVQHECIPQAILGMDVLCQAK.S
71 P49327 FASN Fatty acid synthase FASN K.FC*FTPHTEEGCLSER.A
72 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ALDH18A1 K.C*EYPAACNALETLLIHR.D
73 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.HSMNPFC*EIAVEEAVR.L
74 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 R.AAEC*NIVVTQPR.R
75 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 R.YWLC*AATGPSIK.I
76 Q9UL15 BAG5 BAG family molecular chaperone regulator 5 BAG5 K.TELQGLIGQLDEVSLEKNPC*IR.E
77 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 R.AVHQC*DR.G
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12.1 8.7 11.2 8.8 7.5 9.7 7.5 10.2 8.9 0.8
3.0 3.1 3.0 3.8 3.0 3.2 1.9 2.8 2.4 0.8
5.8 8.2 0.0 7.2 5.4 6.6 5.9 5.8 5.8 0.8
10.6 14.0 7.2 11.6 11.0 10.9 8.6 11.6 10.1 0.8
5.6 4.9 4.5 4.7 4.1 4.8 3.5 4.6 4.0 0.7
0.0 7.4 7.0 5.3 4.7 6.1 5.6 5.1 5.4 0.7
1.8 2.8 2.8 2.9 2.0 2.5 1.8 1.8 1.8 0.7
3.6 6.4 4.2 0.0 5.8 5.0 3.3 5.3 4.3 0.7
4.4 3.9 3.6 3.4 3.4 3.7 2.8 3.3 3.1 0.7
5.5 4.8 5.3 5.5 5.3 5.3 4.6 4.8 4.7 0.7
3.5 4.0 4.2 0.0 5.1 4.2 3.3 3.9 3.6 0.7
2.5 1.9 2.2 2.4 1.6 2.1 1.5 1.5 1.5 0.6
4.3 5.5 3.5 5.2 3.1 4.3 3.1 4.3 3.7 0.6
2.8 2.7 2.7 2.4 2.2 2.5 2.0 1.9 1.9 0.6
3.0 0.0 2.6 0.0 3.1 2.9 2.0 2.7 2.3 0.6
7.4 6.8 5.0 7.1 4.7 6.2 5.7 5.5 5.6 0.6
3.3 2.6 0.0 1.5 2.0 2.3 2.5 0.9 1.7 0.6
4.0 4.4 3.1 4.8 2.9 3.8 3.2 3.3 3.2 0.6
1.9 0.8 2.8 1.0 1.4 1.6 1.0 1.0 1.0 0.6
2.0 3.9 0.0 0.0 1.7 2.5 1.9 2.1 2.0 0.6
4.7 4.7 4.3 0.0 4.0 4.4 4.3 3.4 3.8 0.6
5.3 5.1 5.0 6.7 5.0 5.4 4.9 4.8 4.9 0.6
3.0 4.0 2.7 2.5 2.0 2.8 2.1 2.4 2.3 0.6
4.3 4.9 3.7 4.4 3.9 4.2 3.7 3.7 3.7 0.5
0.0 3.5 3.2 3.6 2.0 3.1 2.8 2.2 2.5 0.5
3.2 3.0 2.2 2.2 1.7 2.5 1.8 2.1 2.0 0.5
2.0 2.0 3.4 0.0 1.8 2.3 1.6 2.0 1.8 0.5
2.3 0.0 2.7 0.0 1.7 2.2 1.7 1.7 1.7 0.5
3.8 3.6 3.1 3.0 2.2 3.1 2.3 3.0 2.6 0.5
3.1 4.0 5.9 3.5 0.0 4.1 4.1 3.2 3.7 0.5
2.5 2.0 2.6 2.0 1.8 2.2 1.7 1.7 1.7 0.5
0.9 0.7 2.9 0.0 0.9 1.3 0.8 0.9 0.9 0.4
1.9 2.1 2.0 2.1 2.4 2.1 1.7 1.6 1.7 0.4
0.0 2.7 3.2 3.6 2.3 3.0 2.5 2.6 2.5 0.4
6.8 8.0 7.2 7.2 8.5 7.5 7.8 6.5 7.1 0.4
2.0 2.1 2.0 2.0 1.8 2.0 1.5 1.6 1.5 0.4
4.6 4.5 6.2 0.0 6.3 5.4 6.4 3.6 5.0 0.4
0.0 0.0 4.5 6.9 4.0 5.1 4.7 4.7 4.7 0.4
3.0 1.9 1.8 2.2 2.0 2.2 1.7 1.8 1.7 0.4
0.0 6.0 0.0 4.9 4.8 5.2 4.9 4.8 4.8 0.4
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78 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase ALDH6A1 K.ERVC*NLIDSGTK.E
79 Q9Y3D0 FAM96B Mitotic spindle-associated MMXD complex subunit MI FAM96B R.VAAALENTHLLEVVNQC*LSAR.S
80 P22102 GART Trifunctional purine biosynthetic protein adenosin GART K.QVLVAPGNAGTAC*SEK.I
81 Q15019 SEPT2 Septin-2 2-Sep R.LTVVDTPGYGDAINC*R.D
82 Q9HA64 FN3KRP Ketosamine-3-kinase FN3KRP R.ATGHSGGGC*ISQGR.S
83 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.VDENFDC*VEADDVEGK.I
84 Q86Y56 HEATR2 HEAT repeat-containing protein 2 HEATR2 R.RPPEAC*EELR.L
85 P09110 ACAA1 3-ketoacyl-CoA thiolase, peroxisomal ACAA1 R.QC*SSGLQAVASIAGGIR.N
86 P62306 SNRPF Small nuclear ribonucleoprotein F SNRPF R.C*NNVLYIR.G
87 Q27J81 INF2 Inverted formin-2 INF2 R.AVLLASDAQEC*TLEEVVER.L
88 Q6P2E9 EDC4 Enhancer of mRNA-decapping protein 4 EDC4 R.LC*TQLEGLQSTVTGHVER.A
89 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.QAIDDDC*NQTGQMTAGFLDWPQGTFASQVTLEGDKLK.V
90 P17858 PFKL 6-phosphofructokinase, liver type PFKL K.C*HDYYTTEFLYNLYSSEGK.G
91 Q92616 GCN1L1 Translational activator GCN1 GCN1L1 R.C*GLALALNK.L
92 P46734 MAP2K3 Dual specificity mitogen-activated protein kinase MAP2K3 K.TMDAGC*KPYMAPER.I
93 Q5T9C2 FAM102A Protein FAM102A FAM102A K.VTIGMFLLSGDPC*FK.T
94 A6NDU8 C5orf51 UPF0600 protein C5orf51 C5orf51 R.C*PIQLNEGVSFQDLDTAK.L
95 Q9Y508 RNF114 RING finger protein 114 RNF114 R.DC*GGAAQLAGPAAEADPLGR.F
96 P09622 DLD Dihydrolipoyl dehydrogenase, mitochondrial DLD K.NETLGGTC*LNVGCIPSK.A
97 Q9HCC0 MCCC2 Methylcrotonoyl-CoA carboxylase beta chain, mitoch MCCC2 K.AATGEEVSAEDLGGADLHC*R.K
98 Q00765 REEP5 Receptor expression-enhancing protein 5 REEP5 K.NC*MTDLLAK.L
99 P16455 MGMT Methylated-DNA--protein-cysteine methyltransferase MGMT R.VVC*SSGAVGNYSGGLAVK.E
100 P55769 NHP2L1 NHP2-like protein 1 NHP2L1 K.KLLDLVQQSC*NYK.Q
101 P13639 EEF2 Elongation factor 2 EEF2 R.ETVSEESNVLC*LSK.S
102 P62879 GNB2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) GNB2 K.AC*GDSTLTQITAGLDPVGR.I
103 P41240 CSK Tyrosine-protein kinase CSK CSK R.SVLGGDC*LLK.F
104 Q2TAY7 SMU1 WD40 repeat-containing protein SMU1 SMU1 K.SHVEC*AR.F
105 P45984 MAPK9 Mitogen-activated protein kinase 9 MAPK9 R.TAC*TNFMMTPYVVTR.Y
106 Q99829 CPNE1 Copine-1 CPNE1 R.NC*SSPEFSK.T
107 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 R.LIGPNC*PGVINPGECK.I
108 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK K.SSGC*DVNLPGVNVK.L
109 Q12849 GRSF1 G-rich sequence factor 1 GRSF1 R.YIELFLNSC*PK.G
110 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.IC*PVETLVEEAIQCAEK.I
111 Q7L8W6 ATPBD4 ATP-binding domain-containing protein 4 ATPBD4 K.C*EGDEVEDLYELLK.L
112 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.GC*DVVVIPAGVPR.K
113 P51610 HCFC1 Host cell factor 1 HCFC1 R.AC*AAGTPAVIR.I
114 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 R.NEC*DPALALLSDYVLHNSNTMR.L
115 Q5T0W9 FAM83B Protein FAM83B FAM83B R.LC*SSSDTLVSEGEENQKPK.K
116 O94760 DDAH1 N(G),N(G)-dimethylarginine dimethylaminohydrolase DDAH1 K.SFC*SMAGPNLIAIGSSESAQK.A
117 Q8N335 GPD1L Glycerol-3-phosphate dehydrogenase 1-like protein GPD1L R.IC*DEITGR.V
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3.4 5.2 3.9 4.5 3.9 4.2 3.5 4.0 3.8 0.4
1.5 1.6 0.0 1.6 1.8 1.6 1.0 1.4 1.2 0.4
2.9 0.0 2.3 2.6 1.9 2.4 2.4 1.6 2.0 0.4
2.4 2.5 2.2 2.6 2.1 2.4 1.7 2.2 2.0 0.4
0.0 5.0 6.9 6.3 4.0 5.6 4.8 5.6 5.2 0.4
3.5 2.0 1.8 1.9 2.1 2.2 1.8 1.9 1.9 0.4
0.0 4.0 3.3 4.7 3.9 4.0 3.7 3.5 3.6 0.4
3.0 2.1 2.1 2.1 1.9 2.2 1.9 1.9 1.9 0.4
1.7 1.3 1.3 1.4 1.1 1.3 1.0 0.9 1.0 0.4
3.3 3.2 2.2 3.1 3.1 3.0 2.9 2.3 2.6 0.4
3.0 1.8 1.3 0.0 1.4 1.9 1.3 1.7 1.5 0.4
2.4 2.8 3.3 2.9 0.0 2.8 2.5 2.5 2.5 0.3
6.8 0.0 5.9 6.7 5.8 6.3 5.9 6.0 5.9 0.3
4.1 5.2 4.9 3.9 4.2 4.4 3.9 4.3 4.1 0.3
3.0 3.2 2.7 0.0 2.2 2.8 1.8 3.1 2.4 0.3
0.0 3.5 0.0 2.1 1.4 2.3 1.8 2.2 2.0 0.3
2.6 2.4 1.7 0.0 1.6 2.1 1.9 1.6 1.7 0.3
3.9 2.3 2.1 2.8 1.9 2.6 2.1 2.4 2.3 0.3
1.9 2.4 2.8 0.0 2.6 2.4 2.1 2.1 2.1 0.3
4.0 0.0 2.6 2.8 3.3 3.2 2.6 3.1 2.9 0.3
2.1 3.8 1.9 2.1 3.8 2.7 2.4 2.5 2.4 0.3
6.1 5.2 3.3 4.1 5.0 4.7 4.0 4.9 4.4 0.3
3.2 3.2 2.5 2.9 2.2 2.8 2.4 2.6 2.5 0.3
0.0 2.9 3.6 4.5 3.4 3.6 3.3 3.4 3.3 0.3
5.0 6.7 5.7 6.7 5.9 6.0 5.6 5.8 5.7 0.3
2.5 1.8 1.8 0.0 1.5 1.9 1.5 1.7 1.6 0.3
3.6 2.9 2.9 2.5 3.3 3.0 2.2 3.4 2.8 0.3
3.0 3.6 2.9 2.8 2.8 3.0 2.7 2.8 2.8 0.3
0.0 1.9 1.6 1.0 0.0 1.5 1.4 1.1 1.2 0.3
6.2 4.8 3.5 3.7 3.8 4.4 3.9 4.4 4.1 0.2
2.0 1.7 1.7 0.0 0.0 1.8 1.4 1.6 1.5 0.2
1.1 0.8 0.8 1.9 0.7 1.1 0.8 0.9 0.8 0.2
1.8 2.3 3.0 3.6 2.5 2.6 2.7 2.2 2.4 0.2
1.8 2.6 1.8 2.7 2.3 2.2 1.6 2.5 2.0 0.2
3.8 4.3 3.1 3.9 5.0 4.0 3.7 3.9 3.8 0.2
4.9 5.7 3.4 0.0 0.0 4.6 4.1 4.7 4.4 0.2
1.9 0.0 1.7 1.5 0.0 1.7 1.4 1.5 1.5 0.2
2.9 1.8 2.0 2.3 1.6 2.1 2.0 1.8 1.9 0.2
0.0 3.8 3.8 0.0 4.2 3.9 4.3 3.2 3.7 0.2
1.6 1.6 3.7 0.0 1.1 2.0 1.8 1.8 1.8 0.2
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118 P46109 CRKL Crk-like protein CRKL K.RVPC*AYDK.T
119 P07339 CTSD Cathepsin D CTSD K.AIGAVPLIQGEYMIPC*EK.V
120 O95671 ASMTL N-acetylserotonin O-methyltransferase-like protein ASMTL K.LTAC*QVATAFNLSR.F
121 Q9UN37 VPS4A Vacuolar protein sorting-associated protein 4A VPS4A K.LLEPVVC*MSDMLR.S
122 Q96AT9 RPE Ribulose-phosphate 3-epimerase RPE K.IGPSILNSDLANLGAEC*LR.M
123 P60981 DSTN Destrin DSTN K.C*STPEEIK.K
124 Q9UHD8 SEPT9 Septin-9 9-Sep R.SQEATEAAPSC*VGDMADTPR.D
125 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR K.EADQKEQFSQGSPSNC*LETSLAEIFPLGK.N
126 Q15796 SMAD2 Mothers against decapentaplegic homolog 2 SMAD2 K.AITTQNC*NTK.C
127 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.VMTIPYQPMPASSPVIC*AGGQDR.C
128 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.HIIEDPC*TLR.H
129 Q06210 GFPT1 Glucosamine--fructose-6-phosphate aminotransferase GFPT1 K.C*QNALQQVVAR.Q
130 P23528 CFL1 Cofilin-1 CFL1 K.HELQANC*YEEVK.D
131 Q15813 TBCE Tubulin-specific chaperone E TBCE R.NCAVSC*AGEK.G
132 Q16630 CPSF6 Cleavage and polyadenylation specificity factor su CPSF6 R.ELHGQNPVVTPC*NK.Q
133 Q8WTW3 COG1 Conserved oligomeric Golgi complex subunit 1 COG1 K.AQAISPC*VQNFCSALDSK.L
134 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 K.TSAPITC*ELLNK.Q
135 P62195 PSMC5 26S protease regulatory subunit 8 PSMC5 K.FVVDVDKNIDINDVTPNC*R.V
136 Q15208 STK38 Serine/threonine-protein kinase 38 STK38 K.LSDFGLC*TGLK.K
137 P49773 HINT1 Histidine triad nucleotide-binding protein 1 HINT1 K.C*AADLGLNK.G
138 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 K.EGTDSSQGIPQLVSNISAC*QVIAEAVR.T
139 P15924 DSP Desmoplakin DSP K.AC*GSEIMQK.K
140 Q00610 CLTC Clathrin heavy chain 1 CLTC R.IHEGC*EEPATHNALAK.I
141 O75832 PSMD10 26S proteasome non-ATPase regulatory subunit 10 PSMD10 K.GAQVNAVNQNGC*TPLHYAASK.N
142 Q8WW01 TSEN15 tRNA-splicing endonuclease subunit Sen15 TSEN15 R.GDSEPTPGC*SGLGPGGVR.G
143 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP R.ISASC*QHPTAFEEAIPK.S
144 P51649 ALDH5A1 Succinate-semialdehyde dehydrogenase, mitochondria ALDH5A1
R.WLPAAATFPVQDPASGAALGMVADC
*GVR.E
145 P19367 HK1 Hexokinase-1 HK1 R.AILQQLGLNSTC*DDSILVK.T
146 P62873 GNB1 Guanine nucleotide-binding protein G(I)/G(S)/G(T) GNB1 K.AC*ADATLSQITNNIDPVGR.I
147 A6NDG6 PGP Phosphoglycolate phosphatase PGP K.NNQESDC*VSK.K
148 P49327 FASN Fatty acid synthase FASN K.TGGAYGEDLGADYNLSQVC*DGK.V
149 O00233 PSMD9 26S proteasome non-ATPase regulatory subunit 9 PSMD9 K.GIGMNEPLVDC*EGYPR.S
150 O95782 AP2A1 AP-2 complex subunit alpha-1 AP2A1 K.TVFEALQAPAC*HENMVK.V
151 P18669 PGAM1 Phosphoglycerate mutase 1 PGAM1 R.YADLTEDQLPSC*ESLK.D
152 Q13158 FADD Protein FADD FADD R.SC*QMNLVADLVQEVQQAR.D
153 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 K.LWNTLGVC*K.Y
154 Q9GZQ3 COMMD5 COMM domain-containing protein 5 COMMD5 K.FVVSSLQGEDC*R.E
155 Q6P996 PDXDC1 Pyridoxal-dependent decarboxylase domain-containin PDXDC1 R.HSC*DALNR.W
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3.2 0.0 1.5 2.2 0.0 2.3 2.0 2.1 2.1 0.2
8.1 6.2 5.7 7.0 4.5 6.3 6.2 6.0 6.1 0.2
0.0 2.1 2.1 1.4 1.5 1.8 1.8 1.4 1.6 0.2
2.9 3.2 2.8 2.4 2.1 2.7 2.2 2.7 2.5 0.2
2.2 0.7 1.0 1.1 0.9 1.2 1.1 0.8 1.0 0.2
2.5 1.7 1.7 2.0 1.4 1.8 1.8 1.5 1.7 0.2
3.3 2.4 1.9 2.5 2.1 2.5 2.1 2.5 2.3 0.2
1.8 0.0 1.4 1.5 0.0 1.5 1.3 1.4 1.4 0.2
3.9 2.1 1.8 3.0 2.0 2.6 2.6 2.2 2.4 0.2
0.0 7.1 7.3 8.6 6.4 7.4 6.5 7.9 7.2 0.2
3.0 2.3 2.1 2.0 1.9 2.2 2.0 2.1 2.1 0.2
7.7 7.5 7.4 7.6 5.4 7.1 5.8 8.1 6.9 0.2
1.3 1.0 1.0 1.1 1.0 1.1 0.9 1.0 0.9 0.2
0.0 0.9 1.7 0.0 1.5 1.4 1.2 1.3 1.2 0.2
1.7 1.2 1.4 1.3 1.6 1.4 1.1 1.5 1.3 0.2
3.2 0.0 2.6 0.0 2.6 2.8 2.1 3.2 2.7 0.2
5.1 7.0 5.3 0.0 5.3 5.7 5.3 5.7 5.5 0.1
2.6 2.9 2.5 2.1 2.5 2.5 1.9 2.8 2.4 0.1
3.5 1.7 2.1 0.0 1.8 2.3 2.0 2.2 2.1 0.1
0.9 3.1 1.3 0.0 2.2 1.9 1.2 2.3 1.7 0.1
2.3 2.5 1.9 2.1 1.8 2.1 1.8 2.1 2.0 0.1
2.1 2.0 2.0 1.6 1.5 1.8 2.0 1.4 1.7 0.1
2.6 1.6 1.4 1.3 1.6 1.7 1.5 1.6 1.6 0.1
0.0 1.0 0.0 1.2 1.0 1.0 1.0 0.8 0.9 0.1
1.9 1.6 1.8 1.8 1.5 1.7 1.6 1.6 1.6 0.1
2.4 2.2 2.2 1.7 1.5 2.0 1.9 1.8 1.9 0.1
0.0 0.0 4.6 5.6 4.7 4.9 4.6 5.0 4.8 0.1
1.3 1.4 1.4 1.5 1.1 1.3 1.5 0.9 1.2 0.1
3.1 5.4 6.2 5.1 4.7 4.9 5.1 4.5 4.8 0.1
2.6 2.2 1.9 2.3 2.9 2.4 2.3 2.2 2.2 0.1
0.0 0.0 3.4 2.9 1.9 2.7 3.5 1.6 2.6 0.1
1.7 1.4 1.5 1.8 1.2 1.5 1.3 1.5 1.4 0.1
0.0 3.6 0.0 3.1 3.8 3.5 3.4 3.4 3.4 0.1
1.0 1.9 1.7 2.6 1.6 1.7 2.0 1.3 1.6 0.1
0.9 0.7 2.4 0.8 0.7 1.1 1.0 1.0 1.0 0.1
3.7 4.8 4.8 5.2 4.4 4.6 4.4 4.6 4.5 0.1
1.7 1.2 1.2 0.0 0.0 1.3 1.0 1.5 1.2 0.1
0.0 1.4 1.5 2.6 0.0 1.9 1.7 1.8 1.8 0.1
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156 Q29RF7 PDS5A Sister chromatid cohesion protein PDS5 homolog A PDS5A R.ELLDLHKQPTSEANC*SAMFGK.L
157 Q13630 TSTA3 GDP-L-fucose synthase TSTA3 R.KVVSCLSTC*IFPDK.T
158 Q5VYK3 ECM29 Proteasome-associated protein ECM29 homolog ECM29 R.TIAALLPC*LLDK.G
159 P49588 AARS Alanine--tRNA ligase, cytoplasmic AARS K.C*LSVMEAK.V
160 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 R.C*ALGVFR.K
161 Q52LJ0 FAM98B Protein FAM98B FAM98B R.EKTAC*AINK.V
162 Q9H3U1 UNC45A Protein unc-45 homolog A UNC45A R.AIQTVSCLLQGPC*DAGNR.A
163 Q9P2R7 SUCLA2 Succinyl-CoA ligase SUCLA2 K.ILAC*DDLDEAAR.M
164 O15541 RNF113A RING finger protein 113A RNF113A K.AVDQVC*TFLFK.K
165 P35237 SERPINB6 Serpin B6 SERPINB6 K.SC*DFLSSFR.D
166 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 K.IAAYLQSDQFC*K.M
167 P07437 TUBB Tubulin beta chain TUBB K.LTTPTYGDLNHLVSATMSGVTTC*LR.F
168 Q99836 MYD88 Myeloid differentiation primary response protein M MYD88 R.FITVCDYTNPC*TK.S
169 Q8NFG4 FLCN Folliculin FLCN K.VFEAEQFGC*PQR.A
170 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.TGQATVASGIPAGWMGLDC*GPESSK.K
171 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.AYHEQLSVAEITNAC*FEPANQMVK.C
172 P49327 FASN Fatty acid synthase FASN K.AINC*ATSGVVGLVNCLR.R
173 P53618 COPB1 Coatomer subunit beta COPB1 K.ALSGYC*GFMAANLYAR.S
174 O14980 XPO1 Exportin-1 XPO1 K.DLLGLC*EQKR.G
175 O75934 BCAS2 Pre-mRNA-splicing factor SPF27 BCAS2 K.NDITAWQEC*VNNSMAQLEHQAVR.I
176 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.SSGGFVWAC*K.N
177 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 K.QEPLGSDSEGVNC*LAYDEAIMAQQDR.I
178 P53990 IST1 IST1 homolog IST1 K.IVADQLC*AK.Y
179 Q9BXV9 C14orf142 Uncharacterized protein C14orf142 C14orf142 R.VSC*EAPGDGDPFQGLLSGVAQMK.D
180 P51610 HCFC1 Host cell factor 1 HCFC1 K.LVIYGGMSGC*R.L
181 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 K.LAAQSC*ALSLVR.Q
182 P38117 ETFB Electron transfer flavoprotein subunit beta ETFB K.EVIAVSC*GPAQCQETIR.T
183 P30281 CCND3 G1/S-specific cyclin-D3 CCND3 R.ASYFQC*VQR.E
184 O00204 SULT2B1 Sulfotransferase family cytosolic 2B member 1 SULT2B1 R.APWC*ETIVGAFSLPDQYSPR.L
185 Q7Z4W1 DCXR L-xylulose reductase DCXR R.GVPGAIVNVSSQC*SQR.A
186 O14964 HGS Hepatocyte growth factor-regulated tyrosine kinase HGS R.ACGQIFC*GK.C
187 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.ADIDVSGPKVDVEC*PDVNIEGPEGK
.W
188 Q9NXG2 THUMPD1 THUMP domain-containing protein 1 THUMPD1 R.RC*DAGGPR.Q
189 Q13308 PTK7 Inactive tyrosine-protein kinase 7 PTK7 R.LPQPEGC*PSK.L
190 Q96TA1 FAM129B Niban-like protein 1 FAM129B K.GPTKEELC*K.S
191 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 R.DLNYC*FSGMSDHR.Y
192 P49458 SRP9 Signal recognition particle 9 kDa protein SRP9 K.VTDDLVC*LVYK.T
193 O60547 GMDS GDP-mannose 4,6 dehydratase GMDS K.YYRPTEVDFLQGDC*TK.A
194 P36969 GPX4 Phospholipid hydroperoxide glutathione peroxidase, GPX4 R.ILAFPC*NQFGK.Q
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2.9 2.3 0.0 2.6 1.9 2.4 2.5 2.2 2.3 0.1
0.0 4.4 0.0 4.3 3.8 4.2 3.9 4.2 4.1 0.1
0.0 0.0 2.0 2.9 2.4 2.4 2.5 2.2 2.3 0.1
1.6 1.3 1.5 1.4 1.2 1.4 1.2 1.4 1.3 0.1
1.3 1.3 1.6 0.0 1.4 1.4 1.0 1.6 1.3 0.1
2.8 1.7 1.5 0.0 1.4 1.9 1.8 1.8 1.8 0.1
1.4 1.0 0.0 1.1 0.9 1.1 1.7 0.4 1.1 0.1
2.0 0.0 1.8 2.3 0.0 2.0 2.9 1.0 2.0 0.1
8.5 3.8 2.3 0.0 2.2 4.2 3.4 4.9 4.1 0.1
2.2 0.0 1.3 1.3 0.9 1.4 1.1 1.6 1.4 0.1
1.0 1.3 0.8 0.9 0.7 0.9 0.8 0.9 0.9 0.1
5.3 5.7 5.2 5.3 4.8 5.3 5.1 5.3 5.2 0.1
3.8 3.1 3.3 0.0 3.0 3.3 2.9 3.6 3.2 0.1
2.3 2.4 3.0 3.5 2.0 2.6 2.6 2.5 2.6 0.1
0.8 1.0 1.1 1.9 1.0 1.2 1.1 1.1 1.1 0.1
6.6 5.7 5.6 5.7 5.2 5.8 5.6 5.8 5.7 0.1
2.3 1.3 1.4 1.5 1.3 1.6 1.7 1.4 1.5 0.0
3.1 3.7 3.6 2.9 3.3 3.3 3.2 3.3 3.2 0.0
3.2 4.1 2.2 3.1 1.9 2.9 2.5 3.2 2.9 0.0
3.9 3.6 3.4 3.4 2.8 3.4 3.2 3.5 3.4 0.0
1.8 1.5 1.1 1.2 1.0 1.3 1.2 1.3 1.3 0.0
2.1 1.6 1.7 1.6 1.4 1.7 1.6 1.7 1.6 0.0
2.2 1.8 1.6 0.0 1.3 1.7 1.7 1.7 1.7 0.0
1.5 1.3 0.3 1.5 1.3 1.2 0.9 1.4 1.1 0.0
1.4 1.5 1.3 1.4 1.1 1.3 1.3 1.4 1.3 0.0
1.3 1.2 1.4 1.0 1.1 1.2 1.0 1.3 1.2 0.0
2.2 2.2 2.4 3.4 1.8 2.4 2.4 2.4 2.4 0.0
3.8 3.3 3.7 2.8 2.5 3.2 3.1 3.3 3.2 0.0
1.3 1.3 1.5 1.3 1.4 1.4 1.3 1.4 1.3 0.0
2.5 3.2 2.8 2.9 2.6 2.8 2.6 2.9 2.8 0.0
2.3 1.1 1.2 0.9 1.1 1.3 1.0 1.5 1.3 0.0
1.4 1.4 1.4 1.2 1.1 1.3 1.3 1.3 1.3 0.0
0.0 1.6 0.0 1.4 1.7 1.5 1.4 1.6 1.5 0.0
4.9 5.7 5.6 0.0 5.0 5.3 6.1 4.5 5.3 0.0
1.8 1.6 0.0 1.3 1.2 1.5 1.4 1.5 1.4 0.0
2.1 2.2 2.1 2.4 2.0 2.2 2.1 2.2 2.1 0.0
1.5 1.3 1.2 1.3 1.2 1.3 1.3 1.3 1.3 0.0
2.3 2.0 1.7 2.0 1.7 1.9 2.1 1.7 1.9 0.0
0.0 1.8 2.7 1.1 3.7 2.3 1.5 3.1 2.3 0.0
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195 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 R.AAVEEGIVLGGGC*ALLR.C
196 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A R.AVC*MLSNTTAIAEAWAR.L
197 P52895 AKR1C2 Aldo-keto reductase family 1 member C2 AKR1C2 R.EEPWVDPNSPVLLEDPVLC*ALAK.K
198 E9PPU0 EPPK1 Epiplakin EPPK1 R.YLC*GLGAVGGVR.L
199 Q6P1X6 C8orf82 UPF0598 protein C8orf82 C8orf82 R.YEAAFPFLSPC*GR.E
200 Q15370 TCEB2 Transcription elongation factor B polypeptide 2 TCEB2
R.ADDTFEALC*IEPFSSPPELPDVMKPQ
DSGSSANEQAVQ.-
201 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1 K.LSLDGQNIYNAC*CTLR.I
202 Q8IUR0 TRAPPC5 Trafficking protein particle complex subunit 5 TRAPPC5
K.ENSTLNC*ASFTAGIVEAVLTHSGFPA
K.V
203 O43390 HNRNPR Heterogeneous nuclear ribonucleoprotein R HNRNPR K.SAFLC*GVMK.T
204 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL K.LC*FSTAQHAS.-
205 O95336 PGLS 6-phosphogluconolactonase PGLS R.AAC*CLAGAR.A
206 O60716 CTNND1 Catenin delta-1 CTNND1 K.TPAILEASAGAIQNLC*AGR.W
207 Q93009 USP7 Ubiquitin carboxyl-terminal hydrolase 7 USP7 K.GTC*VEGTIPK.L
208 P23528 CFL1 Cofilin-1 CFL1 K.AVLFC*LSEDK.K
209 O75439 PMPCB Mitochondrial-processing peptidase subunit beta PMPCB R.LC*TSVTESEVAR.A
210 Q9HCC0 MCCC2 Methylcrotonoyl-CoA carboxylase beta chain, mitoch MCCC2 K.MVAAVAC*AQVPK.I
211 P22234 PAICS Multifunctional protein ADE2 PAICS K.ITSC*IFQLLQEAGIK.T
212 P62910 RPL32 60S ribosomal protein L32 RPL32 K.SYC*AEIAHNVSSK.N
213 Q9UPM8 AP4E1 AP-4 complex subunit epsilon-1 AP4E1 R.SSC*STLPDYLLYQCQK.V
214 Q9NYL2 MLTK Mitogen-activated protein kinase kinase kinase MLT MLTK K.FDDLQFFENC*GGGSFGSVYR.A
215 P60981 DSTN Destrin DSTN K.LGGSLIVAFEGC*PV.-
216 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 R.AGAIAPC*EVTVPAQNTGLGPEK.T
217 Q12768 KIAA0196 WASH complex subunit strumpellin KIAA0196 R.IVSC*GNAIIAELLR.L
218 Q96EY8 MMAB Cob(I)yrinic acid a,c-diamide adenosyltransferase, MMAB K.IQCTLQDVGSALATPC*SSAR.E
219 P31939 ATIC Bifunctional purine biosynthesis protein PURH ATIC R.VVAC*NLYPFVK.T
220 Q9UL40 ZNF346 Zinc finger protein 346 ZNF346 K.NQC*LFTNTQCK.V
221 P49327 FASN Fatty acid synthase FASN R.LSIPTYGLQC*TR.A
222 P21964 COMT Catechol O-methyltransferase COMT K.IVDAVIQEHQPSVLLELGAYC*GYSAVR.M
223 Q9Y296 TRAPPC4 Trafficking protein particle complex subunit 4 TRAPPC4 R.C*ELFDQNLK.L
224 Q9NZA1 CLIC5 Chloride intracellular channel protein 5 CLIC5 K.AGIDGESIGNC*PFSQR.L
225 P07437 TUBB Tubulin beta chain TUBB K.NMMAAC*DPR.H
226 Q9NXR7 BRE BRCA1-A complex subunit BRE BRE K.VGLDATNC*LR.I
227 P08238 HSP90AB1 Heat shock protein HSP 90-beta HSP90AB1 R.LVSSPC*CIVTSTYGWTANMER.I
228 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.LGGEVSC*LVAGTK.C
229 Q9NR33 POLE4 DNA polymerase epsilon subunit 4 POLE4 K.DAYC*CAQQGK.R
230 P49327 FASN Fatty acid synthase FASN K.ADEASELAC*PTPK.E
231 Q9BV86 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 NTMT1 R.IIC*SAGLSLLAEER.Q
232 P42704 LRPPRC Leucine-rich PPR motif-containing protein, mitocho LRPPRC R.IHDVLC*K.L
233 Q01518 CAP1 Adenylyl cyclase-associated protein 1 CAP1 R.ALLVTASQC*QQPAENK.L
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4.1 3.6 3.2 3.7 2.6 3.4 3.4 3.5 3.4 0.0
4.8 4.8 4.7 4.7 4.3 4.7 4.5 4.8 4.6 0.0
1.8 2.0 1.9 2.0 1.4 1.8 2.0 1.7 1.8 0.0
1.9 2.1 1.8 2.0 2.0 2.0 2.0 1.9 1.9 0.0
2.8 3.2 2.8 3.1 2.6 2.9 2.7 3.0 2.9 0.0
2.1 1.5 1.6 1.5 1.4 1.6 1.6 1.6 1.6 0.0
1.2 1.2 1.3 0.0 1.2 1.2 1.2 1.2 1.2 0.0
1.5 1.5 2.2 1.5 1.5 1.6 1.5 1.7 1.6 0.0
2.7 2.8 1.7 1.2 3.5 2.4 3.1 1.7 2.4 0.0
1.3 1.0 1.2 0.0 1.0 1.1 1.1 1.1 1.1 0.0
1.3 1.6 1.6 1.8 1.5 1.6 1.5 1.6 1.6 0.0
2.7 0.0 3.2 3.0 2.7 2.9 3.1 2.8 2.9 0.0
1.8 1.6 1.4 1.3 1.2 1.4 1.4 1.5 1.4 0.0
0.9 1.2 1.1 0.9 1.1 1.0 1.2 0.9 1.0 0.0
2.5 2.1 1.9 0.0 0.0 2.2 2.1 2.2 2.2 0.0
1.2 1.6 1.9 2.4 1.5 1.7 1.7 1.8 1.7 0.0
0.9 0.8 1.0 0.9 0.9 0.9 0.9 0.9 0.9 0.0
2.8 2.5 2.9 3.6 2.4 2.8 2.8 2.9 2.8 0.0
1.7 1.3 1.5 0.0 1.2 1.4 1.4 1.5 1.4 0.0
2.2 1.7 1.2 1.4 1.1 1.5 1.4 1.7 1.5 0.0
1.7 1.3 1.4 1.4 1.1 1.4 1.3 1.4 1.4 0.0
3.3 3.3 3.0 3.5 2.6 3.1 3.1 3.2 3.1 0.0
1.6 0.0 1.4 0.0 1.0 1.3 1.2 1.5 1.4 0.0
2.0 1.5 1.3 1.6 1.4 1.6 1.6 1.6 1.6 0.0
0.9 1.1 1.2 1.6 0.0 1.2 1.4 1.1 1.2 0.0
1.9 2.3 1.6 0.0 2.1 1.9 2.1 1.9 2.0 0.0
2.4 3.0 2.5 2.6 2.3 2.6 3.2 2.0 2.6 0.0
2.1 1.8 1.4 1.4 1.1 1.5 1.4 1.7 1.6 0.0
2.1 1.4 1.3 1.6 1.2 1.5 1.6 1.5 1.5 0.0
1.1 0.9 1.3 1.0 1.1 1.1 1.0 1.2 1.1 0.0
5.1 4.8 4.5 4.6 4.2 4.6 4.5 4.8 4.7 0.0
2.5 1.0 2.5 0.0 1.8 1.9 2.2 1.7 2.0 0.0
1.0 0.8 1.0 1.1 0.9 1.0 1.0 1.0 1.0 0.0
3.8 4.9 4.5 5.4 4.6 4.6 4.6 4.7 4.7 0.0
2.9 0.0 1.7 2.1 1.5 2.1 1.9 2.3 2.1 0.0
2.5 2.2 1.6 2.4 1.6 2.1 2.0 2.2 2.1 0.0
1.9 1.4 1.4 1.4 1.3 1.5 1.4 1.6 1.5 0.0
1.3 1.3 1.3 1.2 1.0 1.2 1.2 1.3 1.3 0.0
1.1 1.0 0.9 0.0 1.0 1.0 1.0 1.1 1.0 0.0
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234 P52272 HNRNPM Heterogeneous nuclear ribonucleoprotein M HNRNPM K.AC*QIFVR.N
235 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM K.C*CSGAIIVLTK.S
236 O14818 PSMA7 Proteasome subunit alpha type-7 PSMA7 R.VEC*QSHR.L
237 Q8NDH3 NPEPL1 Probable aminopeptidase NPEPL1 NPEPL1 R.IVDTPC*NEMNTDTFLEEINK.V
238 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 K.GFGFVC*FSSPEEATK.A
239 Q86SX6 GLRX5 Glutaredoxin-related protein 5, mitochondrial GLRX5 K.GTPEQPQC*GFSNAVVQILR.L
240 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 R.YSDESGNMDFDNFISC*LVR.L
241 P52597 HNRNPF Heterogeneous nuclear ribonucleoprotein F HNRNPF R.DLSYC*LSGMYDHR.Y
242 P28838 LAP3 Cytosol aminopeptidase LAP3 R.QVVDC*QLADVNNIGK.Y
243 Q96Q11 TRNT1 CCA tRNA nucleotidyltransferase 1, mitochondrial TRNT1 K.YQGEHC*LLK.E
244 P55060 CSE1L Exportin-2 CSE1L K.LSTAC*PGR.V
245 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 R.GC*AFVTFTTR.A
246 P04632 CAPNS1 Calpain small subunit 1 CAPNS1 K.TDGFGIDTC*R.S
247 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.FLDGNELTLADC*NLLPK.L
248 O60664 PLIN3 Perilipin-3 PLIN3 R.DIAQQLQATC*TSLGSSIQGLPTNVK.D
249 Q5TFE4 NT5DC1 5-nucleotidase domain-containing protein 1 NT5DC1 K.HFLSDTGMAC*R.S
250 O15355 PPM1G Protein phosphatase 1G PPM1G R.GTEAGQVGEPGIPTGEAGPSC*SSASDK.L
251 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.ALNALC*DGLIDELNQALK.T
252 Q5VTR2 RNF20 E3 ubiquitin-protein ligase BRE1A RNF20 R.LTCPC*CNMR.K
253 Q13148 TARDBP TAR DNA-binding protein 43 TARDBP R.NPVSQC*MR.G
254 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH K.DVLNLVYLC*EALNLPEVAR.Y
255 Q9NQT5 EXOSC3 Exosome complex component RRP40 EXOSC3 K.LLAPDC*EIIQEVGK.L
256 P38606 ATP6V1A V-type proton ATPase catalytic subunit A ATP6V1A R.VLDALFPCVQGGTTAIPGAFGC*GK.T
257 Q14247 CTTN Src substrate cortactin CTTN K.HC*SQVDSVR.G
258 Q8IWX8 CHERP Calcium homeostasis endoplasmic reticulum protein CHERP K.LALEQQQLIC*K.Q
259 P52788 SMS Spermine synthase SMS R.LYC*PVEFSK.E
260 O15327 INPP4B Type II inositol 3,4-bisphosphate 4-phosphatase INPP4B K.SLNC*IIAMVDK.L
261 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.AITIAGVPQSVTEC*VK.Q
262 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.SQETEC*TYFSTPLLLGK.K
263 P21333 FLNA Filamin-A FLNA K.VGTEC*GNQK.V
264 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B K.ELEQVC*NPIISGLYQGAGGPGPGGFGAQGPK.G
265 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK
K.IIPTLEEGLQLPSPTATSQLPLESDAVE
C*LNYQHYK.G
266 Q9Y3C6 PPIL1 Peptidyl-prolyl cis-trans isomerase-like 1 PPIL1 R.VC*QGIGMVNR.V
267 Q7L1Q6 BZW1 Basic leucine zipper and W2 domain-containing prot BZW1
K.ERFDPTQFQDC*IIQGLTETGTDLEAV
AK.F
268 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.INISEGNC*PER.I
269 P53041 PPP5C Serine/threonine-protein phosphatase 5 PPP5C R.TEC*AEPPRDEPPADGALKR.A
270 O75874 IDH1 Isocitrate dehydrogenase IDH1 K.SEGGFIWAC*K.N
271 Q9Y696 CLIC4 Chloride intracellular channel protein 4 CLIC4 K.AGSDGESIGNC*PFSQR.L
272 Q96EY5 FAM125A Multivesicular body subunit 12A FAM125A K.SC*SPLAFSAFGDLTIK.S
273 Q14247 CTTN Src substrate cortactin CTTN K.C*ALGWDHQEK.L
274 Q9UL46 PSME2 Proteasome activator complex subunit 2 PSME2 K.C*GFLPGNEK.V
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1.7 2.0 1.5 1.6 1.6 1.7 1.7 1.8 1.7 0.0
1.7 2.3 1.5 2.0 1.4 1.8 1.8 1.8 1.8 0.0
0.0 1.0 1.2 1.2 0.0 1.1 1.2 1.2 1.2 0.0
2.0 1.3 1.3 1.1 1.3 1.4 1.4 1.5 1.4 0.0
1.1 1.0 1.1 1.2 1.0 1.1 1.2 1.1 1.1 0.0
1.4 1.1 1.1 1.2 1.0 1.2 1.2 1.2 1.2 0.0
0.7 0.5 0.8 0.8 0.8 0.7 0.8 0.7 0.8 0.0
2.2 2.1 2.3 2.1 2.0 2.1 2.1 2.3 2.2 0.0
1.8 1.2 0.9 1.1 0.8 1.1 1.0 1.4 1.2 0.0
1.2 1.3 1.5 1.2 1.2 1.3 1.3 1.4 1.3 0.0
2.1 1.9 2.2 3.0 2.0 2.2 2.5 2.1 2.3 0.0
1.8 2.4 2.6 2.6 2.2 2.3 2.2 2.6 2.4 0.0
0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.8 0.0
0.8 0.9 1.1 1.0 0.8 0.9 1.0 0.9 1.0 0.0
1.1 1.1 1.0 0.0 0.9 1.0 1.0 1.1 1.0 0.0
1.6 1.6 0.0 1.6 1.4 1.5 1.5 1.7 1.6 0.0
3.2 3.0 2.6 2.5 2.0 2.7 2.5 3.0 2.7 0.0
6.3 5.4 5.4 5.9 5.0 5.6 5.4 5.9 5.7 0.0
2.3 2.0 1.9 2.2 1.7 2.0 2.3 1.8 2.1 0.0
2.9 3.5 2.6 2.5 2.2 2.7 2.5 3.1 2.8 0.0
1.1 0.0 1.0 0.0 0.9 1.0 1.0 1.0 1.0 0.0
2.6 0.0 2.1 1.9 1.8 2.1 2.1 2.2 2.2 -0.1
2.2 2.9 2.4 2.4 2.0 2.4 2.4 2.5 2.4 -0.1
2.5 2.1 1.7 1.9 1.4 1.9 1.9 2.0 2.0 -0.1
2.5 2.3 1.9 0.0 1.6 2.1 2.1 2.1 2.1 -0.1
1.0 1.0 1.3 1.0 0.8 1.0 1.0 1.1 1.1 -0.1
2.1 0.0 1.9 1.7 0.0 1.9 1.7 2.2 1.9 -0.1
1.3 1.1 1.3 1.1 1.0 1.2 1.2 1.3 1.2 -0.1
1.8 1.8 2.0 1.8 1.8 1.8 2.1 1.6 1.9 -0.1
1.4 1.6 1.3 0.0 1.6 1.5 1.4 1.6 1.5 -0.1
0.0 1.0 0.9 0.8 0.9 0.9 1.1 0.8 1.0 -0.1
1.8 1.6 1.4 1.5 1.2 1.5 1.4 1.6 1.5 -0.1
0.8 0.4 0.0 1.4 0.0 0.8 1.4 0.4 0.9 -0.1
1.7 1.3 1.4 1.3 1.3 1.4 1.4 1.5 1.5 -0.1
2.0 1.7 1.5 1.9 1.4 1.7 1.7 1.9 1.8 -0.1
2.2 1.9 1.2 0.0 1.2 1.6 1.4 1.9 1.6 -0.1
0.8 0.8 0.8 0.8 0.8 0.8 0.9 0.9 0.9 -0.1
1.0 0.9 1.0 0.9 0.9 1.0 1.0 1.0 1.0 -0.1
1.9 1.9 1.7 1.3 1.4 1.6 1.7 1.7 1.7 -0.1
2.2 2.0 1.8 2.0 1.5 1.9 2.0 2.0 2.0 -0.1
1.6 1.3 1.1 1.3 1.1 1.3 1.2 1.5 1.3 -0.1
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275 P49327 FASN Fatty acid synthase FASN R.AAPLDSIHSLAAYYIDC*IR.Q
276 O43865 AHCYL1 Putative adenosylhomocysteinase 2 AHCYL1 K.FDNLYC*CR.E
277 P49207 RPL34 60S ribosomal protein L34 RPL34 R.AYGGSMC*AK.C
278 P31947 SFN 14-3-3 protein sigma SFN K.GAVEKGEELSC*EER.N
279 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 K.AGSDGAKIGNC*PFSQR.L
280 P49327 FASN Fatty acid synthase FASN R.LGMLSPEGTC*K.A
281 F5H284 PPIAL4D Peptidyl-prolyl cis-trans isomerase PPIAL4D R.IIPGFMC*QGGDFTR.H
282 P53396 ACLY ATP-citrate synthase ACLY K.FIC*TTSAIQNR.F
283 Q9UNH7 SNX6 Sorting nexin-6 SNX6 R.IGSSLYALGTQDSTDIC*K.F
284 Q15631 TSN Translin TSN K.ETAAAC*VEK.-
285 P13489 RNH1 Ribonuclease inhibitor RNH1 K.LSLQNCC*LTGAGCGVLSSTLR.T
286 P62753 RPS6 40S ribosomal protein S6 RPS6 K.LNISFPATGC*QK.L
287 O75828 CBR3 Carbonyl reductase CBR3 R.ILVNAC*CPGPVK.T
288 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 PSMD2 K.GTLTLC*PYHSDR.Q
289 P60604 UBE2G2 Ubiquitin-conjugating enzyme E2 G2 UBE2G2 R.VC*ISILHAPGDDPMGYESSAER.W
290 P49327 FASN Fatty acid synthase FASN R.DPETLVGYSMVGC*QR.A
291 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 K.DGLTDVYNKIHMGSC*AENTAK.K
292 P08238 HSP90AB1 Heat shock protein HSP 90-beta HSP90AB1 R.VFIMDSC*DELIPEYLNFIR.G
293 P22061 PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransf PCMT1 K.ALDVGSGSGILTAC*FAR.M
294 P62937 PPIA Peptidyl-prolyl cis-trans isomerase A PPIA K.ITIADC*GQLE.-
295 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 K.C*SPIGVYTSGK.G
296 Q9BXJ9 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subun NAA15 R.LFNTAVC*ESK.D
297 Q7Z2Z2 EFTUD1 Elongation factor Tu GTP-binding domain-containing EFTUD1 R.ICDGCIIVVDAVEGVC*PQTQAVLR.Q
298 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 R.FC*PFAER.T
299 Q93052 LPP Lipoma-preferred partner LPP K.TYITDPVSAPC*APPLQPK.G
300 P55735 SEC13 Protein SEC13 homolog SEC13 K.RFASGGC*DNLIK.L
301 Q9Y5Y2 NUBP2 Cytosolic Fe-S cluster assembly factor NUBP2 NUBP2 K.VGILDVDLC*GPSIPR.M
302 O00151 PDLIM1 PDZ and LIM domain protein 1 PDLIM1 K.C*GTGIVGVFVK.L
303 P49327 FASN Fatty acid synthase FASN K.AFDTAGNGYC*R.S
304 O43681 ASNA1 ATPase ASNA1 ASNA1 K.NQISPFISQMC*NMLGLGDMNADQLASK.L
305 Q9Y5X2 SNX8 Sorting nexin-8 SNX8 K.ESAQCVGDEFLNC*K.L
306 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.ERPTPSLNNNC*TTSEDSLVLYNR.V
307 P31689 DNAJA1 DnaJ homolog subfamily A member 1 DNAJA1 K.GAVEC*CPNCR.G
308 P60174 TPI1 Triosephosphate isomerase TPI1 K.VPADTEVVC*APPTAYIDFAR.Q
309 O43707 ACTN4 Alpha-actinin-4 ACTN4 K.IC*DQWDALGSLTHSR.R
310 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 K.SC*FLCMVCK.K
311 Q7Z406 MYH14 Myosin-14 MYH14 K.ADLLLEPC*SHYR.F
312 P50990 CCT8 T-complex protein 1 subunit theta CCT8 K.IAVYSC*PFDGMITETK.G
313 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH R.VPTANVSVVDLTC*R.L
314 Q9BW61 DDA1 DET1- and DDB1-associated protein 1 DDA1 R.FHADSVC*K.A
315 P37235 HPCAL1 Hippocalcin-like protein 1 HPCAL1 R.LLQC*DPSSASQF.-
316 P14649 MYL6B Myosin light chain 6B MYL6B K.ILYSQC*GDVMR.A
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1.1 1.1 1.4 1.5 1.2 1.3 1.3 1.4 1.3 -0.1
2.7 0.0 2.5 0.0 2.3 2.5 2.8 2.4 2.6 -0.1
4.1 3.4 3.2 4.1 3.2 3.6 3.8 3.5 3.7 -0.1
1.5 1.2 1.4 1.3 1.0 1.3 1.3 1.4 1.4 -0.1
1.0 0.9 1.0 1.0 1.0 1.0 1.1 1.0 1.1 -0.1
3.9 5.8 5.1 5.4 5.1 5.0 4.9 5.3 5.1 -0.1
0.7 0.7 0.9 0.9 0.8 0.8 0.9 0.9 0.9 -0.1
1.6 1.3 1.2 1.2 1.2 1.3 1.3 1.5 1.4 -0.1
1.1 0.7 0.9 1.1 0.9 0.9 1.1 1.0 1.0 -0.1
3.7 2.8 2.8 3.4 2.5 3.1 2.9 3.3 3.1 -0.1
0.0 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 -0.1
3.0 3.0 2.7 2.8 3.7 3.0 3.0 3.2 3.1 -0.1
0.0 0.3 0.3 0.7 0.3 0.4 0.6 0.5 0.5 -0.1
0.7 0.9 0.8 0.9 0.8 0.8 0.9 0.9 0.9 -0.1
1.5 1.0 1.1 0.0 0.9 1.1 1.0 1.4 1.2 -0.1
2.1 2.4 2.0 1.9 2.1 2.1 2.1 2.3 2.2 -0.1
3.3 3.4 2.7 3.2 3.0 3.1 3.2 3.2 3.2 -0.1
1.5 1.5 1.4 1.5 1.3 1.5 1.6 1.5 1.5 -0.1
1.0 1.0 1.1 1.0 0.9 1.0 1.1 1.0 1.1 -0.1
0.7 0.6 0.9 0.7 0.7 0.7 0.8 0.8 0.8 -0.1
1.6 1.2 1.2 0.0 1.2 1.3 1.4 1.4 1.4 -0.1
1.6 1.2 1.2 0.0 1.2 1.3 1.4 1.4 1.4 -0.1
2.6 3.5 2.7 1.4 1.8 2.4 2.3 2.6 2.5 -0.1
1.1 1.1 0.9 1.0 1.0 1.0 1.0 1.1 1.1 -0.1
3.6 3.4 2.5 2.7 1.8 2.8 2.9 2.9 2.9 -0.1
1.2 1.0 1.0 1.1 0.9 1.0 1.1 1.1 1.1 -0.1
7.1 8.0 6.3 5.9 6.1 6.7 7.0 6.5 6.7 -0.1
0.0 0.9 1.2 0.7 0.0 0.9 1.1 0.9 1.0 -0.1
3.6 4.1 3.2 3.1 2.9 3.4 3.5 3.4 3.5 -0.1
1.1 0.7 1.0 0.0 0.7 0.9 1.0 0.9 1.0 -0.1
1.5 1.2 0.7 0.0 1.3 1.2 1.3 1.3 1.3 -0.1
2.7 1.5 1.6 0.0 1.3 1.7 1.6 2.1 1.8 -0.1
4.1 0.0 4.2 0.0 2.1 3.4 4.3 2.7 3.5 -0.1
0.8 0.8 1.0 1.3 0.8 0.9 1.2 0.9 1.0 -0.1
0.9 0.0 0.8 0.0 0.8 0.8 1.0 0.8 0.9 -0.1
1.2 1.0 1.0 1.5 1.0 1.1 1.3 1.2 1.2 -0.1
2.7 2.4 3.1 0.0 2.2 2.6 2.9 2.5 2.7 -0.1
1.2 1.0 1.1 1.1 0.9 1.0 1.0 1.3 1.1 -0.1
0.7 2.0 2.1 2.2 1.4 1.7 2.1 1.5 1.8 -0.1
1.1 1.2 1.4 1.2 1.1 1.2 1.3 1.3 1.3 -0.1
2.3 1.9 1.7 1.9 1.6 1.9 1.9 2.0 2.0 -0.1
1.1 1.0 1.2 1.0 1.1 1.1 1.1 1.2 1.2 -0.1
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317 Q8N987 NECAB1 N-terminal EF-hand calcium-binding protein 1 NECAB1
K.ETLNQLQSLQNSLEC*AMETTEEQT
R.Q
318 O75131 CPNE3 Copine-3 CPNE3 K.NC*LNPQFSK.T
319 P37802 TAGLN2 Transgelin-2 TAGLN2 K.DGTVLC*ELINALYPEGQAPVK.K
320 P05388 RPLP0 60S acidic ribosomal protein P0 RPLP0 K.C*FIVGADNVGSK.Q
321 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 K.VVVVQAISALC*QK.Y
322 P14174 MIF Macrophage migration inhibitory factor MIF K.LLC*GLLAER.L
323 P78347 GTF2I General transcription factor II-I GTF2I R.SILSPGGSC*GPIK.V
324 Q14103 HNRNPD Heterogeneous nuclear ribonucleoprotein D0 HNRNPD K.FGEVVDC*TLKLDPITGR.S
325 Q52LJ0 FAM98B Protein FAM98B FAM98B K.SLC*NLEESITSAGR.D
326 Q9H1B7 IRF2BPL Interferon regulatory factor 2-binding protein-lik IRF2BPL
K.EGVPGADMLPQPYLDASC*PMLPTA
LVSLSR.A
327 Q96HP0 DOCK6 Dedicator of cytokinesis protein 6 DOCK6 R.AGC*ALSAESSR.T
328 Q12765 SCRN1 Secernin-1 SCRN1 K.TQSPC*FGDDDPAKKEPR.F
329 P37802 TAGLN2 Transgelin-2 TAGLN2 K.NMAC*VQR.T
330 Q9NY27 PPP4R2 Serine/threonine-protein phosphatase 4 regulatory PPP4R2 K.EVC*PVLDQFLCHVAK.T
331 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.PMC*VESFSDYPPLGR.F
332 P30041 PRDX6 Peroxiredoxin-6 PRDX6 R.DFTPVC*TTELGR.A
333 Q9UJU6 DBNL Drebrin-like protein DBNL R.AEEDVEPEC*IMEK.V
334 P21964 COMT Catechol O-methyltransferase COMT R.LITIEINPDC*AAITQR.M
335 Q96JB2 COG3 Conserved oligomeric Golgi complex subunit 3 COG3 R.ELLLGPSIAC*TVAELTSQNNR.D
336 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 K.KLGNNC*VFAPADVTSEK.D
337 Q96HE7 ERO1L ERO1-like protein alpha ERO1L K.HDDSSDNFC*EADDIQSPEAEYVDLLLNPER.Y
338 P46776 RPL27A 60S ribosomal protein L27a RPL27A R.NQSFC*PTVNLDK.L
339 P31350 RRM2 Ribonucleoside-diphosphate reductase subunit M2 RRM2 R.EFLFNAIETMPC*VK.K
340 Q9HAV7 GRPEL1 GrpE protein homolog 1, mitochondrial GRPEL1 K.LYGIQAFC*K.D
341 P19367 HK1 Hexokinase-1 HK1 R.AAQLC*GAGMAAVVDK.I
342 P53618 COPB1 Coatomer subunit beta COPB1 K.VLSEC*SPLMNDIFNK.E
343 Q7Z6Z7 HUWE1 E3 ubiquitin-protein ligase HUWE1 HUWE1 R.DQSAQC*TASK.S
344 P26599 PTBP1 Polypyrimidine tract-binding protein 1 PTBP1 K.RGSDELFSTC*VTNGPFIMSSNSASAANGNDSK.K
345 Q15691 MAPRE1 Microtubule-associated protein RP/EB family member MAPRE1 R.NIELIC*QENEGENDPVLQR.I
346 Q15149 PLEC Plectin PLEC K.AFC*GFEDPR.T
347 Q9NTK5 OLA1 Obg-like ATPase 1 OLA1 K.STFFNVLTNSQASAENFPFC*TIDPNESR.V
348 P31943 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H HNRNPH1 R.GLPFGC*SK.E
349 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.LCQDLPC*FSR.E
350 P10768 ESD S-formylglutathione hydrolase ESD K.AETGKCPALYWLSGLTC*TEQNFISK.S
351 Q9H0W8 SMG9 Protein SMG9 SMG9 R.REDFC*PR.K
352 Q2TAA2 IAH1 Isoamyl acetate-hydrolyzing esterase 1 homolog IAH1 R.VILITPTPLC*ETAWEEQCIIQGCK.L
353 P08107 HSPA1B Heat shock 70 kDa protein 1A/1B HSPA1B R.ARFEELC*SDLFR.S
354 P0CW22 RPS17L 40S ribosomal protein S17-like RPS17L R.VC*EEIAIIPSK.K
355 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 K.IVSLPEC*FNSPYGAK.Y
356 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.LTFSC*LGGSDNFK.H
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1.4 1.0 1.0 1.4 1.1 1.2 1.3 1.2 1.3 -0.1
1.6 1.4 1.4 1.4 1.1 1.4 1.5 1.5 1.5 -0.1
1.0 1.0 1.2 1.0 1.0 1.0 1.2 1.1 1.1 -0.1
3.6 3.0 2.8 3.0 2.6 3.0 2.8 3.4 3.1 -0.1
2.9 3.2 3.7 3.2 3.3 3.3 3.2 3.5 3.4 -0.1
0.8 0.7 0.9 0.7 0.8 0.8 0.9 0.9 0.9 -0.1
2.3 2.2 1.6 1.9 1.6 1.9 2.0 2.1 2.0 -0.1
0.8 0.9 1.0 0.0 0.8 0.9 1.0 1.0 1.0 -0.1
1.6 0.9 1.1 0.0 1.0 1.1 1.2 1.3 1.2 -0.1
0.0 2.4 2.2 2.6 1.5 2.2 2.2 2.3 2.2 -0.1
2.7 3.3 3.2 0.0 2.5 2.9 2.9 3.1 3.0 -0.1
1.2 1.2 1.0 1.0 1.1 1.1 1.2 1.2 1.2 -0.1
1.3 1.1 1.1 1.2 1.0 1.1 1.2 1.2 1.2 -0.1
1.6 1.7 2.1 2.0 1.7 1.8 2.1 1.7 1.9 -0.1
3.0 3.0 2.5 3.0 2.2 2.7 2.9 2.8 2.8 -0.1
0.4 0.9 0.9 1.1 0.7 0.8 1.0 0.8 0.9 -0.1
1.7 1.4 1.8 1.4 1.9 1.6 1.8 1.6 1.7 -0.1
1.3 1.2 1.2 0.0 0.9 1.1 1.2 1.3 1.2 -0.1
2.6 0.0 2.0 0.0 1.4 2.0 2.1 2.1 2.1 -0.1
5.1 7.7 7.5 7.7 7.6 7.1 6.9 7.5 7.2 -0.1
1.9 0.0 1.4 1.5 1.5 1.6 1.6 1.8 1.7 -0.1
2.8 2.6 3.1 3.0 2.4 2.8 2.6 3.1 2.9 -0.1
0.4 0.3 0.5 0.0 0.0 0.4 0.5 0.5 0.5 -0.1
1.6 1.6 1.2 1.4 1.3 1.4 1.6 1.4 1.5 -0.1
0.7 0.6 0.9 0.7 0.8 0.7 0.9 0.8 0.8 -0.1
2.5 2.5 2.4 0.0 2.5 2.5 2.6 2.5 2.6 -0.1
0.0 1.4 1.8 1.8 1.5 1.6 1.8 1.6 1.7 -0.1
1.8 2.3 2.3 0.0 1.6 2.0 2.3 1.9 2.1 -0.1
1.4 0.0 0.0 0.8 0.9 1.0 1.2 1.0 1.1 -0.1
1.4 1.3 1.2 0.0 1.1 1.3 1.4 1.4 1.4 -0.1
1.6 1.3 1.2 0.0 1.1 1.3 1.4 1.4 1.4 -0.1
1.4 1.5 1.5 1.4 1.4 1.4 1.5 1.6 1.6 -0.1
1.6 2.6 1.8 0.0 1.5 1.9 1.9 2.0 2.0 -0.1
0.9 0.8 0.8 0.8 0.9 0.8 1.0 0.9 0.9 -0.1
1.7 0.0 1.7 0.0 1.4 1.6 1.8 1.7 1.7 -0.1
1.8 1.7 1.6 1.9 1.4 1.7 1.6 2.0 1.8 -0.1
0.8 0.8 1.2 1.0 1.1 1.0 1.2 1.0 1.1 -0.1
2.4 2.5 2.1 2.7 2.0 2.3 2.5 2.4 2.5 -0.1
0.0 2.1 2.3 2.8 1.7 2.2 2.9 1.7 2.3 -0.1
0.7 0.8 0.9 0.7 0.8 0.8 0.9 0.9 0.9 -0.1
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357 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.QFC*STQAALQAMER.E
358 E9PPU0 EPPK1 Epiplakin EPPK1 R.YLEGTSC*IAGVLVPAK.D
359 P14866 HNRNPL Heterogeneous nuclear ribonucleoprotein L HNRNPL R.VFNVFC*LYGNVEK.V
360 Q9BSH4 TACO1 Translational activator of cytochrome c oxidase 1 TACO1 K.KLDSLGLCSVSC*ALEFIPNSK.V
361 Q96P48 ARAP1 Arf-GAP with Rho-GAP domain, ANK repeat and PH dom ARAP1 R.AVFPEGPC*EEPLQLR.K
362 Q15185 PTGES3 Prostaglandin E synthase 3 PTGES3 K.HLNEIDLFHC*IDPNDSK.H
363 P78417 GSTO1 Glutathione S-transferase omega-1 GSTO1 K.LNEC*VDHTPK.L
364 Q14914 PTGR1 Prostaglandin reductase 1 PTGR1 R.IAIC*GAISTYNR.T
365 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.AFAAGADIKEMQNLSFQDC*YSSK.F
366 Q99873 PRMT1 Protein arginine N-methyltransferase 1 PRMT1 K.VIGIEC*SSISDYAVK.I
367 Q9P2R7 SUCLA2 Succinyl-CoA ligase SUCLA2 R.IC*NQVLVCER.K
368 P60174 TPI1 Triosephosphate isomerase TPI1 K.IAVAAQNC*YK.V
369 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.SVHYC*PATK.K
370 Q9P107 GMIP GEM-interacting protein GMIP R.LC*QAFENGR.A
371 Q9ULA0 DNPEP Aspartyl aminopeptidase DNPEP R.NDTPC*GTTIGPILASR.L
372 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
R.GQAGGGGPGTGPGLGEAGSLATC*E
LPLAK.S
373 Q5VWZ2 LYPLAL1 Lysophospholipase-like protein 1 LYPLAL1 R.C*IVSPAGR.H
374 P49189 ALDH9A1 4-trimethylaminobutyraldehyde dehydrogenase ALDH9A1 K.GALMANFLTQGQVC*CNGTR.V
375 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 K.ILSC*GEVIHVK.I
376 Q9Y365 STARD10 PCTP-like protein STARD10 R.MEC*CDVPAETLYDVLHDIEYR.K
377 Q9BXW7 CECR5 Cat eye syndrome critical region protein 5 CECR5 K.AQELSALLGC*EVDADQVILSHSPMK.L
378 P22626 HNRNPA2B1 Heterogeneous nuclear ribonucleoproteins A2/B1 
HNRNPA2
B1 K.LTDC*VVMRDPASK.R
379 P47756 CAPZB F-actin-capping protein subunit beta CAPZB K.DETVSDC*SPHIANIGR.L
380 Q9UHX1 PUF60 Poly(U)-binding-splicing factor PUF60 PUF60 R.ALAIMC*R.V
381 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 K.TC*GFDFTGAVEDISK.I
382 Q16822 PCK2 Phosphoenolpyruvate carboxykinase PCK2 R.QC*PIMDPAWEAPEGVPIDAIIFGGR.R
383 Q04917 YWHAH 14-3-3 protein eta YWHAH K.NC*NDFQYESK.V
384 Q6KB66 KRT80 Keratin, type II cytoskeletal 80 KRT80 R.C*HIDLSGIVEEVK.A
385 P30041 PRDX6 Peroxiredoxin-6 PRDX6 K.DINAYNC*EEPTEK.L
386 Q9NZL4 HSPBP1 Hsp70-binding protein 1 HSPBP1 R.LLDRDAC*DTVR.V
387 Q04917 YWHAH 14-3-3 protein eta YWHAH K.ELETVC*NDVLSLLDK.F
388 P30153 PPP2R1A Serine/threonine-protein phosphatase 2A 65 kDa reg PPP2R1A R.ENVIMSQILPC*IK.E
389 Q9BWD1 ACAT2 Acetyl-CoA acetyltransferase, cytosolic ACAT2 R.ATVAPEDVSEVIFGHVLAAGC*GQNPVR.Q
390 P53004 BLVRA Biliverdin reductase A BLVRA K.MTVC*LETEKK.S
391 P36969 GPX4 Phospholipid hydroperoxide glutathione peroxidase, GPX4 R.YAEC*GLR.I
392 Q8N163 KIAA1967 DBIRD complex subunit KIAA1967 KIAA1967 R.VVTQNIC*QYR.S
393 Q9NZZ3 CHMP5 Charged multivesicular body protein 5 CHMP5 K.APPPSLTDC*IGTVDSR.A
394 Q96FW1 OTUB1 Ubiquitin thioesterase OTUB1 OTUB1 K.TRPDGNC*FYR.A
395 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.LSSC*DSFTSTINELNHCLSLR.T
396 Q9C0C9 UBE2O Ubiquitin-conjugating enzyme E2 O UBE2O R.C*YNEMALIR.V
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3.5 3.2 2.7 3.7 2.6 3.1 3.5 3.1 3.3 -0.1
0.9 1.7 1.3 1.5 1.0 1.3 1.5 1.3 1.4 -0.1
1.1 1.0 1.1 0.0 1.0 1.1 1.0 1.4 1.2 -0.1
1.4 0.9 1.0 1.0 1.0 1.1 1.0 1.3 1.2 -0.1
1.9 1.8 1.2 1.3 1.5 1.5 1.6 1.7 1.7 -0.1
1.5 1.3 1.2 1.2 1.1 1.3 1.3 1.4 1.4 -0.1
1.0 0.8 1.0 0.8 0.9 0.9 1.0 1.1 1.0 -0.1
1.1 1.0 1.2 0.0 1.2 1.1 1.3 1.2 1.2 -0.1
8.8 8.2 8.1 10.0 8.3 8.6 7.9 9.6 8.8 -0.1
1.3 1.2 1.2 1.2 1.1 1.2 1.3 1.3 1.3 -0.1
2.2 1.8 2.1 1.9 1.9 2.0 2.4 1.8 2.1 -0.1
0.7 0.7 1.1 1.2 0.8 0.9 1.1 0.9 1.0 -0.1
0.0 2.6 2.6 2.6 2.8 2.6 2.7 2.8 2.8 -0.1
1.0 1.0 0.0 0.7 1.0 0.9 1.0 1.1 1.0 -0.1
1.4 2.2 2.3 2.6 1.5 2.0 2.4 1.9 2.1 -0.1
2.1 1.7 1.2 1.5 1.2 1.5 1.6 1.7 1.7 -0.1
2.1 1.6 1.8 1.9 1.8 1.8 1.9 2.1 2.0 -0.1
2.6 1.7 1.5 1.6 1.7 1.8 1.8 2.1 2.0 -0.1
0.9 0.7 0.9 0.8 0.8 0.8 1.0 0.9 1.0 -0.1
1.6 1.0 1.3 1.2 1.1 1.2 1.4 1.3 1.3 -0.1
0.8 1.8 2.2 0.0 2.7 1.9 2.3 1.8 2.0 -0.1
0.9 0.9 0.8 0.9 0.9 0.9 1.1 1.0 1.0 -0.1
1.5 1.4 1.4 1.4 1.2 1.4 1.5 1.6 1.5 -0.1
0.9 0.8 1.1 0.9 0.8 0.9 1.0 1.1 1.0 -0.1
2.0 0.0 3.0 4.5 2.7 3.1 3.4 3.0 3.2 -0.1
4.7 3.7 3.7 3.8 3.8 4.0 4.3 3.9 4.1 -0.1
1.2 0.9 1.0 1.0 0.9 1.0 1.1 1.2 1.1 -0.1
1.8 1.3 1.4 1.6 1.2 1.5 1.7 1.5 1.6 -0.1
1.2 1.2 1.5 1.6 1.3 1.3 1.8 1.2 1.5 -0.1
1.8 1.7 1.6 1.6 1.3 1.6 1.6 1.9 1.7 -0.1
1.1 0.8 1.1 1.1 0.9 1.0 1.2 1.0 1.1 -0.1
0.0 1.1 1.3 2.9 2.1 1.9 1.4 2.6 2.0 -0.1
1.3 1.8 1.8 1.9 1.5 1.7 1.6 2.0 1.8 -0.1
1.9 1.3 1.3 1.3 1.2 1.4 1.8 1.2 1.5 -0.1
1.5 1.2 1.2 1.3 1.1 1.2 1.3 1.5 1.4 -0.1
3.6 3.4 3.6 3.0 2.7 3.2 2.6 4.2 3.4 -0.1
1.7 1.5 1.5 1.4 1.3 1.5 1.6 1.7 1.7 -0.1
1.5 1.9 1.7 1.9 1.6 1.7 2.0 1.8 1.9 -0.1
1.5 1.2 1.5 1.5 1.1 1.3 1.6 1.4 1.5 -0.1
1.9 1.3 1.8 1.5 1.3 1.6 1.6 1.8 1.7 -0.1
400
397 P07384 CAPN1 Calpain-1 catalytic subunit CAPN1 R.LEIC*NLTPDALK.S
398 P61158 ACTR3 Actin-related protein 3 ACTR3 R.LPAC*VVDCGTGYTK.L
399 P07737 PFN1 Profilin-1 PFN1 K.C*YEMASHLR.R
400 Q5T1V6 DDX59 Probable ATP-dependent RNA helicase DDX59 DDX59 K.NLPC*ANVR.Q
401 P40925 MDH1 Malate dehydrogenase, cytoplasmic MDH1 K.AIC*DHVR.D
402 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.AC*ALQVLSAILEGSK.Q
403 Q9NQR4 NIT2 Omega-amidase NIT2 NIT2 R.VGLGIC*YDMR.F
404 P33240 CSTF2 Cleavage stimulation factor subunit 2 CSTF2 K.LC*VQNSPQEAR.N
405 P60174 TPI1 Triosephosphate isomerase TPI1 R.IIYGGSVTGATC*K.E
406 P67936 TPM4 Tropomyosin alpha-4 chain TPM4 K.EENVGLHQTLDQTLNELNC*I.-
407 P11940 PABPC1 Polyadenylate-binding protein 1 PABPC1 K.ALYDTFSAFGNILSC*K.V
408 O14980 XPO1 Exportin-1 XPO1 K.LDINLLDNVVNC*LYHGEGAQQR.M
409 P57081 WDR4 tRNA (guanine-N(7)-)-methyltransferase subunit WDR WDR4 K.SGDVYSFSVLEPHGC*GR.L
410 O43747 AP1G1 AP-1 complex subunit gamma-1 AP1G1 R.FTC*TVNR.I
411 P52943 CRIP2 Cysteine-rich protein 2 CRIP2 R.ASSVTTFTGEPNTC*PR.C
412 P29401 TKT Transketolase TKT R.MAAISESNINLC*GSHCGVSIGEDGPSQMALEDLAMFR.S
413 P30044 PRDX5 Peroxiredoxin-5, mitochondrial PRDX5 K.ALNVEPDGTGLTC*SLAPNIISQL.-
414 Q9NXW9 ALKBH4 Probable alpha-ketoglutarate-dependent dioxygenase ALKBH4
R.MGLYPGLEGFRPVEQCNLDYC*PER.
G
415 P51946 CCNH Cyclin-H CCNH R.TC*LSQLLDIMK.S
416 P55212 CASP6 Caspase-6 CASP6 R.GTC*ADRDNLTR.R
417 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH K.ASVGFGGSC*FQK.D
418 P07900 HSP90AA1 Heat shock protein HSP 90-alpha HSP90AA1 R.VFIMDNC*EELIPEYLNFIR.G
419 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.EGVVEC*SFVK.S
420 Q9BQ69 MACROD1 O-acetyl-ADP-ribose deacetylase MACROD1 MACROD1 R.SC*YLSSLDLLLEHR.L
421 P14868 DARS Aspartate--tRNA ligase, cytoplasmic DARS R.LEYC*EALAMLR.E
422 O95372 LYPLA2 Acyl-protein thioesterase 2 LYPLA2 K.TYPGVMHSSC*PQEMAAVK.E
423 Q969H4 CNKSR1 Connector enhancer of kinase suppressor of ras 1 CNKSR1 K.NLLQLC*PQSLEALAVR.S
424 P49915 GMPS GMP synthase GMPS K.AC*TTEEDQEK.L
425 Q9NVG8 TBC1D13 TBC1 domain family member 13 TBC1D13 R.LLQDYPITDVC*QILQK.A
426 P48739 PITPNB Phosphatidylinositol transfer protein beta isoform PITPNB R.VVLPC*SVQEYQVGQLYSVAEASK.N
427 P50991 CCT4 T-complex protein 1 subunit delta CCT4 K.ITGC*ASPGK.T
428 P25398 RPS12 40S ribosomal protein S12 RPS12 R.QAHLC*VLASNCDEPMYVK.L
429 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA R.YASIC*QQNGIVPIVEPEILPDGDHDLK.R
430 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 K.FIC*EQDHQNFLR.L
431 Q9UJW0 DCTN4 Dynactin subunit 4 DCTN4 R.LLQPDFQPVC*ASQLYPR.H
432 P08559 PDHA1 Pyruvate dehydrogenase E1 component subunit alpha, PDHA1 R.FAAAYC*R.S
433 P11142 HSPA8 Heat shock cognate 71 kDa protein HSPA8 K.VC*NPIITK.L
434 Q9Y2Q3 GSTK1 Glutathione S-transferase kappa 1 GSTK1 K.ETTEAAC*R.Y
435 Q15365 PCBP1 Poly(rC)-binding protein 1 PCBP1 R.LVVPATQC*GSLIGK.G
436 P84085 ARF5 ADP-ribosylation factor 5 ARF5 K.NIC*FTVWDVGGQDK.I
437 P43034 PAFAH1B1 Platelet-activating factor acetylhydrolase IB subu PAFAH1B1 R.MVRPNQDGTLIASC*SNDQTVR.V
401
2.6 2.4 1.9 2.1 1.5 2.1 2.4 2.1 2.3 -0.1
0.9 0.9 1.1 1.1 0.9 1.0 1.1 1.2 1.1 -0.2
0.8 0.9 1.1 1.0 0.8 0.9 1.1 1.0 1.1 -0.2
3.0 1.7 1.5 1.7 1.5 1.9 2.0 2.1 2.0 -0.2
0.7 0.7 1.1 1.0 0.9 0.9 1.0 1.0 1.0 -0.2
4.3 3.3 3.8 3.1 3.1 3.5 3.5 3.8 3.7 -0.2
1.2 1.0 1.0 1.0 1.0 1.0 1.1 1.3 1.2 -0.2
1.4 1.5 1.4 1.5 1.4 1.4 1.5 1.7 1.6 -0.2
0.9 1.0 1.3 1.4 1.0 1.1 1.4 1.1 1.3 -0.2
5.1 2.2 2.2 2.7 1.8 2.8 2.7 3.2 3.0 -0.2
0.9 0.8 1.1 0.8 0.9 0.9 1.0 1.1 1.0 -0.2
1.5 1.1 1.2 1.3 1.1 1.2 1.4 1.4 1.4 -0.2
1.1 1.2 0.0 1.0 0.9 1.1 1.1 1.3 1.2 -0.2
1.8 1.5 1.4 0.0 1.4 1.5 1.5 1.8 1.7 -0.2
0.7 0.0 1.2 0.0 1.6 1.2 1.3 1.4 1.3 -0.2
0.5 0.0 0.8 0.8 0.0 0.7 0.9 0.9 0.9 -0.2
1.1 0.9 0.9 0.9 0.9 1.0 1.0 1.2 1.1 -0.2
1.6 0.0 1.1 1.7 1.2 1.4 1.5 1.6 1.6 -0.2
2.4 2.3 2.1 2.4 1.7 2.2 2.1 2.6 2.3 -0.2
0.0 0.8 0.6 1.0 0.6 0.7 0.9 0.9 0.9 -0.2
1.6 1.0 1.3 1.5 0.9 1.3 1.5 1.4 1.4 -0.2
1.4 1.2 1.3 1.2 1.1 1.2 1.3 1.5 1.4 -0.2
1.2 0.9 1.5 1.3 1.4 1.3 1.6 1.2 1.4 -0.2
0.8 1.1 1.1 1.4 1.1 1.1 1.4 1.1 1.3 -0.2
1.5 1.1 1.2 1.1 0.9 1.1 1.3 1.3 1.3 -0.2
1.1 1.0 1.2 1.4 0.9 1.1 1.5 1.1 1.3 -0.2
0.0 1.3 1.2 1.3 1.1 1.2 1.4 1.3 1.4 -0.2
0.0 1.4 1.3 1.1 1.0 1.2 1.5 1.3 1.4 -0.2
1.7 1.2 1.2 1.3 1.1 1.3 1.5 1.5 1.5 -0.2
1.2 0.0 2.7 3.5 0.0 2.5 3.2 2.1 2.6 -0.2
3.0 3.1 2.2 2.3 2.5 2.6 2.1 3.5 2.8 -0.2
1.3 1.1 1.0 1.1 1.0 1.1 1.3 1.3 1.3 -0.2
0.9 1.4 1.6 2.0 1.2 1.4 1.8 1.4 1.6 -0.2
1.1 0.0 1.0 0.0 1.0 1.0 1.1 1.3 1.2 -0.2
1.6 1.4 1.2 1.6 1.2 1.4 1.7 1.4 1.5 -0.2
3.6 2.9 2.9 2.6 2.6 2.9 2.9 3.3 3.1 -0.2
0.8 0.9 1.1 1.5 1.0 1.1 1.3 1.2 1.2 -0.2
1.8 1.7 1.9 1.6 1.7 1.7 2.0 1.8 1.9 -0.2
2.3 2.0 1.9 1.9 1.6 1.9 2.0 2.2 2.1 -0.2
1.4 1.1 1.4 1.8 1.4 1.4 1.8 1.4 1.6 -0.2
5.1 4.8 4.6 5.6 5.3 5.1 5.1 5.4 5.3 -0.2
402
438 P31150 GDI1 Rab GDP dissociation inhibitor alpha GDI1 K.NTNDANSC*QIIIPQNQVNR.K
439 Q7L2H7 EIF3M Eukaryotic translation initiation factor 3 subunit EIF3M K.VAASC*GAIQYIPTELDQVR.K
440 Q9Y266 NUDC Nuclear migration protein nudC NUDC R.WTQTLSELDLAVPFC*VNFR.L
441 Q9NQC3 RTN4 Reticulon-4 RTN4 K.YSNSALGHVNC*TIK.E
442 P57721 PCBP3 Poly(rC)-binding protein 3 PCBP3 R.LVVPASQC*GSLIGK.G
443 Q8TB45 DEPTOR DEP domain-containing mTOR-interacting protein DEPTOR K.SPSSQETHDSPFC*LR.K
444 P36507 MAP2K2 Dual specificity mitogen-activated protein kinase MAP2K2 K.LC*DFGVSGQLIDSMANSFVGTR.S
445 Q9Y5P6 GMPPB Mannose-1-phosphate guanyltransferase beta GMPPB R.LC*SGPGIVGNVLVDPSAR.I
446 P63244 GNB2L1 Guanine nucleotide-binding protein subunit beta-2- GNB2L1 R.FSPNSSNPIIVSC*GWDK.L
447 Q14694 USP10 Ubiquitin carboxyl-terminal hydrolase 10 USP10 R.TPSYSISSTLNPQAPEFILGC*TASK.I
448 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ R.YDDMAAC*MK.S
449 P61160 ACTR2 Actin-related protein 2 ACTR2 K.LC*YVGYNIEQEQK.L
450 P26641 EEF1G Elongation factor 1-gamma EEF1G K.AAAPAPEEEMDEC*EQALAAEPK.A
451 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.RSIQFVDWC*PTGFK.V
452 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK K.GPFVEAEVPDVDLEC*PDAK.L
453 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.SIC*TTVLELLDK.Y
454 Q9H6S3 EPS8L2 Epidermal growth factor receptor kinase substrate EPS8L2
R.SGQAGYVPC*NILGEARPEDAGAPFE
QAGQK.Y
455 Q9UI30 TRMT112 tRNA methyltransferase 112 homolog TRMT112 R.IC*PVEFNPNFVAR.M
456 Q9UHD8 SEPT9 Septin-9 9-Sep K.LTVIDTPGFGDHINNENC*WQPIMK.F
457 P38646 HSPA9 Stress-70 protein, mitochondrial HSPA9 K.AKC*ELSSSVQTDINLPYLTMDSSGPK.H
458 Q9Y224 C14orf166 UPF0568 protein C14orf166 C14orf166 K.LTALDYHNPAGFNC*K.D
459 P31350 RRM2 Ribonucleoside-diphosphate reductase subunit M2 RRM2 K.LIGMNC*TLMK.Q
460 Q13526 PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacti PIN1 K.IKSGEEDFESLASQFSDC*SSAK.A
461 Q15366 PCBP2 Poly(rC)-binding protein 2 PCBP2 R.AITIAGIPQSIIEC*VK.Q
462 O60502 MGEA5 Bifunctional protein NCOAT MGEA5 R.ANSSVVSVNC*K.G
463 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 R.AGGIETIANEFSDRC*TPSVISFGSK.N
464 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS R.TIC*AILENYQTEK.G
465 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 R.DHQPC*IIFMDEIDAIGGR.R
466 P49753 ACOT2 Acyl-coenzyme A thioesterase 2, mitochondrial ACOT2 K.SEFYANEAC*KR.L
467 P63208 SKP1 S-phase kinase-associated protein 1 SKP1 R.KENQWC*EEK.-
468 P00492 HPRT1 Hypoxanthine-guanine phosphoribosyltransferase HPRT1 K.SYC*NDQSTGDIK.V
469 Q7Z4W1 DCXR L-xylulose reductase DCXR R.AVTNHSVYC*STK.G
470 Q5RKV6 EXOSC6 Exosome complex component MTR3 EXOSC6 R.APPGGC*EER.E
471 Q9P1F3 ABRACL Costars family protein ABRACL ABRACL K.C*ANLFEALVGTLK.A
472 Q9HCC0 MCCC2 Methylcrotonoyl-CoA carboxylase beta chain, mitoch MCCC2
K.NIAQIAVVMGSC*TAGGAYVPAMAD
ENIIVR.K
473 P28838 LAP3 Cytosol aminopeptidase LAP3 R.SAGAC*TAAAFLK.E
474 P26358 DNMT1 DNA (cytosine-5)-methyltransferase 1 DNMT1 K.NQLC*DLETK.L





476 E9PPU0 EPPK1 Epiplakin EPPK1 R.TGGQALSTLEC*VKPYLEGSGCIAGVTVPSTR.E
403
1.0 0.9 1.3 0.0 1.0 1.0 1.4 1.0 1.2 -0.2
1.4 1.6 1.4 1.7 1.4 1.5 1.7 1.7 1.7 -0.2
0.0 1.5 1.3 0.0 1.3 1.4 1.5 1.6 1.5 -0.2
1.7 1.4 1.7 1.5 1.4 1.5 1.6 1.8 1.7 -0.2
1.9 1.6 1.6 1.5 1.4 1.6 1.7 1.8 1.8 -0.2
2.3 2.6 1.9 2.6 1.9 2.3 2.3 2.6 2.4 -0.2
1.4 1.0 1.2 1.3 1.1 1.2 1.4 1.4 1.4 -0.2
0.0 1.2 1.0 1.2 1.0 1.1 1.3 1.3 1.3 -0.2
3.5 5.1 4.5 4.9 3.9 4.4 4.3 4.9 4.6 -0.2
7.0 3.5 3.5 3.6 2.6 4.0 4.0 4.5 4.2 -0.2
0.7 0.7 1.1 1.0 1.0 0.9 1.2 1.0 1.1 -0.2
1.4 2.1 2.3 0.0 1.7 1.9 1.8 2.4 2.1 -0.2
1.7 1.4 1.3 1.5 1.1 1.4 1.6 1.7 1.6 -0.2
4.4 4.1 3.8 3.9 3.5 3.9 4.1 4.2 4.1 -0.2
1.9 2.0 1.8 1.7 1.6 1.8 1.9 2.0 2.0 -0.2
0.8 0.7 0.9 0.8 0.7 0.8 0.9 1.0 1.0 -0.2
1.1 1.2 1.2 1.0 1.1 1.1 1.4 1.2 1.3 -0.2
1.8 1.9 1.8 1.7 1.6 1.8 1.9 2.0 2.0 -0.2
2.9 2.7 2.6 3.1 2.4 2.8 2.9 3.0 3.0 -0.2
1.2 1.2 1.5 1.1 1.3 1.2 1.4 1.5 1.4 -0.2
1.4 1.4 1.3 1.5 1.2 1.4 1.5 1.6 1.6 -0.2
0.7 0.4 0.8 0.8 0.8 0.7 0.9 0.9 0.9 -0.2
3.7 2.9 2.4 3.7 2.3 3.0 3.2 3.2 3.2 -0.2
1.2 1.0 1.2 0.9 1.0 1.1 1.3 1.2 1.3 -0.2
2.4 2.3 2.0 2.7 1.8 2.2 2.2 2.7 2.4 -0.2
3.9 5.3 4.7 0.0 3.9 4.4 4.5 4.8 4.7 -0.2
1.2 0.9 1.2 0.0 1.0 1.1 1.3 1.2 1.3 -0.2
3.4 4.5 2.7 2.8 2.7 3.2 3.4 3.4 3.4 -0.2
1.4 1.0 1.0 1.0 1.1 1.1 1.2 1.4 1.3 -0.2
2.2 1.8 1.8 1.8 1.6 1.8 1.9 2.2 2.0 -0.2
1.6 1.1 1.2 1.4 1.2 1.3 1.4 1.6 1.5 -0.2
2.0 1.6 1.5 1.6 1.4 1.6 1.7 2.0 1.8 -0.2
1.5 0.0 0.0 1.3 1.0 1.3 1.4 1.6 1.5 -0.2
1.8 1.6 1.7 1.5 1.5 1.6 1.9 1.7 1.8 -0.2
2.0 0.0 2.0 1.8 1.5 1.8 2.0 2.1 2.0 -0.2
2.8 3.7 3.0 3.1 3.0 3.1 3.1 3.6 3.3 -0.2
1.6 0.0 1.6 1.8 0.8 1.4 1.6 1.7 1.7 -0.2
1.2 1.3 1.3 0.0 1.3 1.3 1.4 1.6 1.5 -0.2
2.5 0.0 1.8 2.2 2.5 2.3 2.2 2.7 2.5 -0.2
404
477 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 K.VQYPQSQAC*K.M
478 P00390 GSR Glutathione reductase, mitochondrial GSR K.LGGTC*VNVGCVPK.K
479 Q6GMV2 SMYD5 SET and MYND domain-containing protein 5 SMYD5 R.LFSQFC*NK.T
480 P53602 MVD Diphosphomevalonate decarboxylase MVD R.DGDPLPSSLSC*K.V
481 P30153 PPP2R1A Serine/threonine-protein phosphatase 2A 65 kDa reg PPP2R1A R.LNIISNLDC*VNEVIGIR.Q
482 Q9BV79 MECR Trans-2-enoyl-CoA reductase, mitochondrial MECR R.LALNC*VGGK.S
483 P55735 SEC13 Protein SEC13 homolog SEC13 R.LATC*SSDR.S
484 O00299 CLIC1 Chloride intracellular channel protein 1 CLIC1 R.EEFASTC*PDDEEIELAYEQVAK.A
485 P29373 CRABP2 Cellular retinoic acid-binding protein 2 CRABP2 K.VGEEFEEQTVDGRPC*K.S
486 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.LDFVC*SFLQK.N
487 Q9HCC0 MCCC2 Methylcrotonoyl-CoA carboxylase beta chain, mitoch MCCC2 K.ITLIIGGSYGAGNYGMC*GR.A
488 P23396 RPS3 40S ribosomal protein S3 RPS3 R.GLC*AIAQAESLR.Y
489 P62993 GRB2 Growth factor receptor-bound protein 2 GRB2 K.VLNEEC*DQNWYK.A
490 P04075 ALDOA Fructose-bisphosphate aldolase A ALDOA R.ALANSLAC*QGK.Y
491 P62258 YWHAE 14-3-3 protein epsilon YWHAE K.LIC*CDILDVLDK.H
492 P00338 LDHA L-lactate dehydrogenase A chain LDHA K.NRVIGSGC*NLDSAR.F
493 Q969Z0 TBRG4 Protein TBRG4 TBRG4 R.LATDLLSLMPSLTSGEVAHC*AK.S
494 Q92945 KHSRP Far upstream element-binding protein 2 KHSRP K.VQQAC*EMVMDILR.E
495 Q9NVU0 POLR3E DNA-directed RNA polymerase III subunit RPC5 POLR3E R.AAGTDSFNGHPPQGC*ASTPVAR.E
496 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.YDDMATC*MK.A
497 P46782 RPS5 40S ribosomal protein S5 RPS5 K.TIAEC*LADELINAAK.G
498 P61247 RPS3A 40S ribosomal protein S3a RPS3A R.LFC*VGFTK.K
499 P12004 PCNA Proliferating cell nuclear antigen PCNA K.C*AGNEDIITLR.A
500 Q9BSU1 C16orf70 UPF0183 protein C16orf70 C16orf70 R.LLAAGC*GPGLLADAK.M
501 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPUL
2 K.EGC*TEVSLLR.V
502 P31947 SFN 14-3-3 protein sigma SFN K.VETELQGVC*DTVLGLLDSHLIK.E
503 P17676 CEBPB CCAAT/enhancer-binding protein beta CEBPB K.APPTAC*YAGAAPAPSQVK.S
504 P68366 TUBA4A Tubulin alpha-4A chain TUBA4A K.YMAC*CLLYR.G
505 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK K.LFQEC*CPHSTDR.V
506 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVGVEVPDVELEC*PDA
K.L
507 O95571 ETHE1 Protein ETHE1, mitochondrial ETHE1 R.TDFQQGC*AK.T
508 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 R.YLLQYQEPIPC*EQLVTALCDIK.Q
509 P10620 MGST1 Microsomal glutathione S-transferase 1 MGST1 K.VFANPEDC*VAFGK.G
510 Q9Y4P1 ATG4B Cysteine protease ATG4B ATG4B K.NFPAIGGTGPTSDTGWGC*MLR.C
511 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 K.ATC*IGNNSAAAVSMLK.Q
512 O15382 BCAT2 Branched-chain-amino-acid aminotransferase, mitoch BCAT2 R.EVFGSGTAC*QVCPVHR.I
513 P27348 YWHAQ 14-3-3 protein theta YWHAQ R.YLAEVAC*GDDR.K
514 Q15459 SF3A1 Splicing factor 3A subunit 1 SF3A1 R.EVLDQVC*YR.V
515 A0AVT1 UBA6 Ubiquitin-like modifier-activating enzyme 6 UBA6 R.KPNVGC*QQDSEELLK.L
516 P49721 PSMB2 Proteasome subunit beta type-2 PSMB2 R.NLADC*LR.S
517 O75223 GGCT Gamma-glutamylcyclotransferase GGCT R.NPSAAFFC*VAR.L
518 P61978 HNRNPK Heterogeneous nuclear ribonucleoprotein K HNRNPK K.GSDFDC*ELR.L
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3.9 3.6 2.8 3.1 3.1 3.3 3.4 3.6 3.5 -0.2
1.0 0.8 0.9 0.9 0.8 0.9 1.2 1.0 1.1 -0.2
1.6 1.3 1.1 1.4 1.2 1.3 1.4 1.7 1.5 -0.2
1.6 1.5 1.2 1.4 1.5 1.4 1.4 1.9 1.7 -0.2
1.5 1.1 1.1 1.3 0.6 1.1 1.4 1.3 1.3 -0.2
3.1 4.2 3.7 0.0 3.0 3.5 3.8 3.7 3.7 -0.2
0.8 1.1 1.7 0.0 0.9 1.1 1.5 1.2 1.3 -0.2
0.9 1.0 1.0 1.2 0.8 1.0 1.2 1.2 1.2 -0.2
1.0 0.8 1.3 1.0 0.9 1.0 1.4 1.1 1.2 -0.2
1.7 1.3 1.3 1.4 1.2 1.4 1.5 1.7 1.6 -0.2
1.4 1.0 0.0 1.3 0.9 1.2 1.6 1.2 1.4 -0.2
2.3 2.3 2.2 2.1 2.0 2.2 2.4 2.4 2.4 -0.2
1.4 1.3 1.1 1.3 1.2 1.3 1.4 1.6 1.5 -0.2
0.9 1.5 1.5 1.5 1.0 1.3 1.8 1.3 1.5 -0.2
1.0 0.9 1.1 0.9 0.9 1.0 1.1 1.3 1.2 -0.2
1.0 1.9 1.4 1.8 1.3 1.5 1.4 2.0 1.7 -0.2
1.9 2.6 3.0 2.5 2.6 2.5 2.9 2.7 2.8 -0.2
1.6 0.0 1.3 0.0 1.5 1.5 1.4 2.0 1.7 -0.2
0.0 1.8 1.4 2.0 1.4 1.7 1.9 1.9 1.9 -0.2
0.7 0.8 0.0 1.1 0.9 0.9 1.1 1.1 1.1 -0.2
3.3 2.8 2.5 2.5 2.3 2.7 2.8 3.0 2.9 -0.2
1.9 1.8 1.7 1.4 1.5 1.7 1.9 1.9 1.9 -0.2
1.2 1.0 1.1 1.2 0.9 1.1 1.3 1.3 1.3 -0.2
0.0 1.5 1.5 1.7 1.3 1.5 1.6 1.9 1.7 -0.2
1.8 1.5 1.4 1.6 1.5 1.6 1.7 1.9 1.8 -0.2
0.8 0.8 1.2 0.0 0.9 0.9 1.2 1.2 1.2 -0.2
0.0 2.4 1.9 2.5 1.6 2.1 2.4 2.3 2.3 -0.2
3.4 3.2 3.3 3.2 3.0 3.2 3.4 3.6 3.5 -0.2
1.7 1.4 1.5 1.6 1.4 1.5 1.7 1.8 1.8 -0.2
2.6 2.1 1.6 1.9 1.7 2.0 2.1 2.3 2.2 -0.2
2.6 1.8 1.5 1.4 1.5 1.8 1.9 2.1 2.0 -0.2
0.8 0.8 1.2 1.0 0.8 0.9 1.1 1.2 1.2 -0.2
1.2 1.1 1.0 0.0 1.0 1.1 1.2 1.4 1.3 -0.2
0.0 1.2 1.2 1.0 1.0 1.1 1.2 1.5 1.3 -0.2
0.7 1.0 1.3 1.2 0.8 1.0 1.3 1.2 1.3 -0.2
1.3 1.4 1.1 1.1 1.1 1.2 1.4 1.5 1.4 -0.2
1.6 1.2 1.2 1.0 1.1 1.2 1.3 1.6 1.4 -0.2
1.5 1.6 1.4 1.3 1.2 1.4 1.4 1.9 1.6 -0.2
1.4 1.2 1.3 1.3 1.2 1.3 1.5 1.6 1.5 -0.2
1.2 1.9 1.9 2.6 1.8 1.9 2.2 2.0 2.1 -0.2
0.8 0.8 1.4 0.7 1.1 0.9 1.3 1.1 1.2 -0.2
1.6 1.8 1.6 1.8 1.5 1.7 1.8 2.0 1.9 -0.2
406
519 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.GEETPVIVGSALC*ALEGR.D
520 Q96EI5 TCEAL4 Transcription elongation factor A protein-like 4 TCEAL4 R.KPEVTC*TLEDK.K
521 Q9Y315 DERA Putative deoxyribose-phosphate aldolase DERA K.GITTAAVC*VYPAR.V
522 P63220 RPS21 40S ribosomal protein S21 RPS21 K.TYAIC*GAIR.R
523 Q09666 AHNAK Neuroblast differentiation-associated protein AHNA AHNAK
K.LEGDLTGPSVDVEVPDVELEC*PDA
K.L
524 P21333 FLNA Filamin-A FLNA K.THEAEIVEGENHTYC*IR.F
525 Q14980 NUMA1 Nuclear mitotic apparatus protein 1 NUMA1 R.KVEELQAC*VETAR.Q
526 P55060 CSE1L Exportin-2 CSE1L K.NLFEDQNTLTSIC*EK.V
527 P25398 RPS12 40S ribosomal protein S12 RPS12 K.LVEALC*AEHQINLIK.V
528 P09467 FBP1 Fructose-1,6-bisphosphatase 1 FBP1 R.GTGELTQLLNSLC*TAVK.A
529 P50395 GDI2 Rab GDP dissociation inhibitor beta GDI2 R.TDDYLDQPC*YETINR.I
530 P46782 RPS5 40S ribosomal protein S5 RPS5 R.VNQAIWLLC*TGAR.E
531 P22314 UBA1 Ubiquitin-like modifier-activating enzyme 1 UBA1 K.YFLVGAGAIGC*ELLK.N
532 P78347 GTF2I General transcription factor II-I GTF2I K.ITINPGC*VVVDGMPPGVSFK.A
533 Q9NS86 LANCL2 LanC-like protein 2 LANCL2 R.SVVC*QESDLPDELLYGR.A
534 Q9Y490 TLN1 Talin-1 TLN1 K.AGALQC*SPSDAYTK.K
535 P60174 TPI1 Triosephosphate isomerase TPI1 K.DC*GATWVVLGHSER.R
536 Q8N6M0 OTUD6B OTU domain-containing protein 6B OTUD6B K.DC*ALTVVALR.S
537 P62304 SNRPE Small nuclear ribonucleoprotein E SNRPE R.IEGC*IIGFDEYMNLVLDDAEEIHSK.T
538 Q9HBM1 SPC25 Kinetochore protein Spc25 SPC25 K.STDTSC*QMAGLR.D
539 O95861 BPNT1 3(2),5-bisphosphate nucleotidase 1 BPNT1 K.TC*ATDLQTK.A
540 O43765 SGTA Small glutamine-rich tetratricopeptide repeat-cont SGTA R.AIC*IDPAYSK.A
541 P07900 HSP90AA1 Heat shock protein HSP 90-alpha HSP90AA1 R.LVTSPC*CIVTSTYGWTANMER.I
542 P30086 PEBP1 Phosphatidylethanolamine-binding protein 1 PEBP1 R.APVAGTC*YQAEWDDYVPK.L
543 Q04760 GLO1 Lactoylglutathione lyase GLO1 K.C*DFPIMK.F
544 P51858 HDGF Hepatoma-derived growth factor HDGF K.C*GDLVFAK.M
545 O75153 KIAA0664 Clustered mitochondria protein homolog KIAA0664 K.C*LTQQAVALQR.T
546 Q12959 DLG1 Disks large homolog 1 DLG1 K.LLAVNNVC*LEEVTHEEAVTALK.N
547 P49327 FASN Fatty acid synthase FASN K.SFYGSTLFLC*R.R
548 O43865 AHCYL1 Putative adenosylhomocysteinase 2 AHCYL1 K.LC*VPAMNVNDSVTK.Q
549 O60701 UGDH UDP-glucose 6-dehydrogenase UGDH R.ISSINSISALC*EATGADVEEVATAIGMDQR.I
550 Q02790 FKBP4 Peptidyl-prolyl cis-trans isomerase FKBP4 FKBP4 K.TQLAVC*QQR.I
551 P00491 PNP Purine nucleoside phosphorylase PNP R.AC*VMMQGR.F
552 Q07020 RPL18 60S ribosomal protein L18 RPL18 K.GC*GTVLLSGPR.K
553 Q9Y3F4 STRAP Serine-threonine kinase receptor-associated protei STRAP
K.IGFPETTEEELEEIASENSDC*IFPSAP
DVK.A
554 P35270 SPR Sepiapterin reductase SPR R.AVC*LLTGASR.G
555 Q86YH6 PDSS2 Decaprenyl-diphosphate synthase subunit 2 PDSS2 R.C*LLSDELSNIAMQVR.K
556 Q15233 NONO Non-POU domain-containing octamer-binding protein NONO
R.C*SEGSFLLTTFPRPVTVEPMDQLDD
EEGLPEK.L
557 Q4ZG55 GREB1 Protein GREB1 GREB1 R.LINSSC*LVR.T
558 Q13404 UBE2V1 Ubiquitin-conjugating enzyme E2 variant 1 UBE2V1 K.LPQPPEGQC*YSN.-
559 Q13155 AIMP2 Aminoacyl tRNA synthase complex-interacting multif AIMP2 K.FSIQTMC*PIEGEGNIAR.F
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5.5 5.8 4.8 2.8 4.4 4.7 4.6 5.3 4.9 -0.2
1.2 1.1 1.1 1.0 1.3 1.1 1.4 1.4 1.4 -0.3
0.0 2.8 2.8 3.0 3.1 2.9 3.2 3.2 3.2 -0.3
3.6 3.1 2.8 2.4 2.3 2.8 3.1 3.0 3.1 -0.3
2.1 1.8 1.5 1.5 1.3 1.7 2.0 1.9 1.9 -0.3
2.8 0.0 2.8 2.5 1.7 2.5 2.4 3.0 2.7 -0.3
1.2 1.5 0.0 0.0 0.8 1.2 1.3 1.6 1.4 -0.3
2.0 2.9 4.4 3.5 3.1 3.2 3.6 3.3 3.4 -0.3
1.5 1.4 1.5 1.3 1.2 1.4 1.5 1.8 1.6 -0.3
0.7 0.6 0.8 0.7 0.8 0.7 1.1 0.9 1.0 -0.3
1.0 1.0 1.0 1.0 0.9 1.0 1.2 1.3 1.2 -0.3
2.4 2.5 2.6 2.3 1.8 2.3 2.6 2.6 2.6 -0.3
0.0 1.7 1.7 1.7 1.3 1.6 2.1 1.7 1.9 -0.3
1.4 1.0 1.0 1.1 1.3 1.2 1.2 1.7 1.5 -0.3
1.9 1.3 1.2 1.3 1.8 1.5 1.5 2.0 1.8 -0.3
1.0 1.3 1.4 0.0 1.0 1.2 1.7 1.2 1.4 -0.3
0.5 0.7 0.9 0.0 0.8 0.7 1.1 0.8 1.0 -0.3
2.0 1.3 1.2 0.0 1.3 1.4 1.8 1.6 1.7 -0.3
0.0 0.0 1.2 1.1 1.2 1.2 1.5 1.5 1.5 -0.3
1.3 1.2 2.0 0.0 1.2 1.4 1.6 1.8 1.7 -0.3
2.0 1.4 1.7 1.6 0.9 1.5 1.8 1.8 1.8 -0.3
2.1 1.3 1.4 1.2 1.4 1.5 1.4 2.0 1.7 -0.3
0.0 0.0 0.7 1.2 1.1 1.0 1.3 1.3 1.3 -0.3
1.3 1.4 1.5 1.3 1.1 1.3 1.7 1.5 1.6 -0.3
1.8 2.0 2.2 2.1 2.0 2.0 2.3 2.3 2.3 -0.3
1.6 1.6 2.0 1.5 1.9 1.7 2.1 1.9 2.0 -0.3
1.8 1.4 1.5 1.8 1.7 1.7 2.0 1.9 1.9 -0.3
1.2 0.8 1.0 0.8 0.0 0.9 1.3 1.2 1.2 -0.3
1.5 3.7 2.9 3.0 2.2 2.7 3.1 2.8 2.9 -0.3
1.4 1.2 1.2 1.2 1.4 1.3 1.5 1.6 1.5 -0.3
1.1 0.6 0.8 0.9 0.9 0.9 1.2 1.2 1.2 -0.3
1.1 1.0 1.1 1.2 1.0 1.1 1.3 1.5 1.4 -0.3
0.6 0.7 1.0 1.0 0.9 0.8 1.2 1.1 1.1 -0.3
3.0 3.3 2.7 2.8 3.0 2.9 3.1 3.4 3.2 -0.3
1.5 2.2 1.8 2.0 1.9 1.9 1.9 2.5 2.2 -0.3
3.1 2.8 2.8 2.1 2.4 2.6 2.9 3.0 2.9 -0.3
1.6 1.7 1.5 1.8 1.6 1.6 1.7 2.1 1.9 -0.3
2.7 2.7 1.9 0.0 2.1 2.4 2.6 2.7 2.6 -0.3
3.8 5.4 4.1 0.0 5.8 4.8 4.8 5.3 5.1 -0.3
0.6 0.5 1.0 0.6 1.1 0.7 1.2 0.9 1.0 -0.3
2.3 2.0 2.6 2.9 1.9 2.3 2.7 2.6 2.6 -0.3
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560 Q96CD2 PPCDC Phosphopantothenoylcysteine decarboxylase PPCDC K.ASC*PAAAPLMER.K
561 P49915 GMPS GMP synthase GMPS R.VICAEEPYIC*K.D
562 Q06323 PSME1 Proteasome activator complex subunit 1 PSME1 K.VDVFREDLC*TK.T
563 P49591 SARS Serine--tRNA ligase, cytoplasmic SARS K.YAGLSTC*FR.Q
564 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPUL
2 R.DLLVQQASQC*LSK.L
565 P15153 RAC2 Ras-related C3 botulinum toxin substrate 2 RAC2 K.YLEC*SALTQR.G
566 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 K.C*EFQDAYVLLSEK.K
567 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 K.C*AMTALSSK.L
568 P43897 TSFM Elongation factor Ts, mitochondrial TSFM R.FEC*GEGEEAAETE.-
569 P60763 RAC3 Ras-related C3 botulinum toxin substrate 3 RAC3 R.AVLC*PPPVK.K
570 P53582 METAP1 Methionine aminopeptidase 1 METAP1 R.VCETDGC*SSEAK.L
571 Q9UMS0 NFU1 NFU1 iron-sulfur cluster scaffold homolog, mitocho NFU1 K.LQGSCTSC*PSSIITLK.N
572 Q15102 PAFAH1B3 Platelet-activating factor acetylhydrolase IB subu PAFAH1B3 R.LGYTPVC*R.A
573 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.TLTSC*FLSCVVCVEGIVTK.C
574 P25205 MCM3 DNA replication licensing factor MCM3 MCM3 R.YVLC*TAPR.A
575 P48643 CCT5 T-complex protein 1 subunit epsilon CCT5 R.VVYGGGAAEISCALAVSQEADKC*PTLEQYAMR.A
576 Q8TEW0 PARD3 Partitioning defective 3 homolog PARD3 K.VTVC*FGR.T
577 P21964 COMT Catechol O-methyltransferase COMT R.YLPDTLLLEEC*GLLR.K





579 P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthase ALDH18A1 R.GDEC*GLALGR.L
580 Q9Y3D2 MSRB2 Methionine-R-sulfoxide reductase B2, mitochondrial MSRB2
K.YC*SGTGWPSFSEAHGTSGSDESHT
GILR.R
581 Q15369 TCEB1 Transcription elongation factor B polypeptide 1 TCEB1 K.VC*MYFTYK.V
582 Q6AI08 HEATR6 HEAT repeat-containing protein 6 HEATR6 R.LC*ALRPDDSSSAR.T
583 P52907 CAPZA1 F-actin-capping protein subunit alpha-1 CAPZA1 K.TIDGQQTIIAC*IESHQFQPK.N
584 P49841 GSK3B Glycogen synthase kinase-3 beta GSK3B R.TTSFAESC*KPVQQPSAFGSMK.V
585 P13639 EEF2 Elongation factor 2 EEF2 K.IWC*FGPDGTGPNILTDITK.G
586 P10809 HSPD1 60 kDa heat shock protein, mitochondrial HSPD1 R.C*IPALDSLTPANEDQK.I
587 Q99497 PARK7 Protein DJ-1 PARK7 K.VTVAGLAGKDPVQC*SR.D
588 P46777 RPL5 60S ribosomal protein L5 RPL5 K.VGLTNYAAAYC*TGLLLAR.R
589 P32322 PYCR1 Pyrroline-5-carboxylate reductase 1, mitochondrial PYCR1 R.SLLINAVEASC*IR.T
590 P61970 NUTF2 Nuclear transport factor 2 NUTF2 K.NINDAWVC*TNDMFR.L
591 Q7Z2W4 ZC3HAV1 Zinc finger CCCH-type antiviral protein 1 ZC3HAV1 K.NSNVDSSYLESLYQSC*PR.G
592 Q9Y3B4 SF3B14 Pre-mRNA branch site protein p14 SF3B14 K.NACDHLSGFNVC*NR.Y
593 P02795 MT2A Metallothionein-2 MT2A K.SC*CSCCPVGCAK.C
594 P37837 TALDO1 Transaldolase TALDO1 K.ALAGC*DFLTISPK.L
595 Q71U36 TUBA1A Tubulin alpha-1A chain TUBA1A R.TIQFVDWC*PTGFK.V
596 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.TIIPLISQC*TPK.V
597 P52209 PGD 6-phosphogluconate dehydrogenase, decarboxylating PGD R.C*LSSLKDER.I
598 P49368 CCT3 T-complex protein 1 subunit gamma CCT3 R.TLIQNC*GASTIR.L
599 P22102 GART Trifunctional purine biosynthetic protein adenosin GART R.FGDPEC*QVILPLLK.S
600 O15355 PPM1G Protein phosphatase 1G PPM1G K.C*SGDGVGAPR.L
409
3.0 2.2 2.1 2.2 1.6 2.2 2.3 2.8 2.5 -0.3
1.7 1.5 1.5 1.7 1.5 1.6 2.0 1.8 1.9 -0.3
2.0 1.8 1.8 0.0 1.7 1.8 2.0 2.2 2.1 -0.3
1.3 1.0 1.2 1.3 1.1 1.2 1.5 1.4 1.5 -0.3
3.7 3.3 3.7 2.9 2.7 3.3 3.6 3.5 3.6 -0.3
1.0 0.9 1.1 2.3 1.0 1.3 1.7 1.4 1.6 -0.3
2.3 2.2 2.3 2.3 1.8 2.2 2.4 2.6 2.5 -0.3
2.2 2.0 2.6 0.0 1.7 2.1 2.2 2.6 2.4 -0.3
0.7 1.5 2.1 0.0 2.3 1.6 2.3 1.6 1.9 -0.3
0.0 1.9 1.9 2.1 1.9 1.9 2.2 2.3 2.2 -0.3
0.0 5.8 2.6 2.9 1.9 3.3 3.2 4.0 3.6 -0.3
4.5 0.0 2.8 6.0 3.2 4.1 4.9 3.9 4.4 -0.3
0.7 1.2 1.2 0.0 1.1 1.0 1.4 1.3 1.3 -0.3
0.0 1.8 1.7 2.0 1.6 1.7 2.1 2.1 2.1 -0.3
2.0 2.0 2.1 2.1 1.6 2.0 2.1 2.4 2.3 -0.3
1.5 1.3 1.3 0.0 1.4 1.4 1.6 1.8 1.7 -0.3
0.0 1.9 2.3 2.1 1.9 2.0 2.2 2.5 2.3 -0.3
0.5 0.5 0.9 0.7 0.8 0.7 1.2 0.9 1.0 -0.3
1.4 1.3 1.5 1.4 1.5 1.4 1.8 1.7 1.7 -0.3
2.8 3.6 3.3 3.7 3.2 3.3 3.6 3.6 3.6 -0.3
1.8 3.8 1.7 1.5 1.5 2.1 2.6 2.2 2.4 -0.3
0.8 0.9 1.0 0.0 0.8 0.9 1.3 1.0 1.2 -0.3
3.4 3.4 2.7 3.2 2.3 3.0 3.4 3.2 3.3 -0.3
0.8 0.6 1.0 0.7 0.8 0.8 1.1 1.1 1.1 -0.3
4.8 0.0 2.7 3.9 3.4 3.7 3.7 4.3 4.0 -0.3
1.2 2.2 2.1 2.1 2.0 1.9 2.5 2.1 2.3 -0.3
3.2 3.3 2.7 3.1 2.4 2.9 3.1 3.4 3.3 -0.3
0.7 0.8 0.9 0.9 0.7 0.8 1.2 1.1 1.1 -0.3
1.0 1.4 2.2 1.7 1.7 1.6 1.5 2.4 1.9 -0.3
4.4 5.0 4.0 4.2 3.6 4.2 4.5 4.6 4.5 -0.3
0.9 1.0 1.2 1.2 1.0 1.1 1.4 1.4 1.4 -0.3
3.8 2.5 2.3 2.9 2.3 2.8 2.9 3.3 3.1 -0.3
3.0 0.0 2.4 2.1 0.0 2.5 2.4 3.2 2.8 -0.3
0.0 0.7 2.1 2.8 1.4 1.7 2.0 2.1 2.1 -0.3
2.0 0.0 3.0 2.4 0.0 2.4 2.8 2.7 2.8 -0.3
4.2 3.7 3.4 3.7 3.4 3.7 3.9 4.1 4.0 -0.3
2.7 3.0 3.2 3.1 2.6 2.9 3.4 3.1 3.2 -0.3
1.1 0.9 1.3 1.2 1.1 1.1 1.5 1.5 1.5 -0.3
0.0 2.2 1.9 0.0 1.8 2.0 2.4 2.3 2.3 -0.3
2.2 4.9 4.6 3.2 0.0 3.7 3.6 4.5 4.1 -0.3
2.1 2.1 2.2 2.2 2.0 2.1 2.4 2.5 2.5 -0.4
410
601 P13639 EEF2 Elongation factor 2 EEF2 R.VTDGALVVVDCVSGVC*VQTETVLR.Q
602 P62280 RPS11 40S ribosomal protein S11 RPS11 K.C*PFTGNVSIR.G
603 P50991 CCT4 T-complex protein 1 subunit delta CCT4 R.TLSGMESYC*VR.A
604 Q02543 RPL18A 60S ribosomal protein L18a RPL18A R.DLTTAGAVTQC*YR.D
605 Q13155 AIMP2 Aminoacyl tRNA synthase complex-interacting multif AIMP2 R.SC*ENLAPFNTALK.L
606 P13639 EEF2 Elongation factor 2 EEF2 R.YVEPIEDVPC*GNIVGLVGVDQFLVK.T
607 P21291 CSRP1 Cysteine and glycine-rich protein 1 CSRP1 R.C*SQAVYAAEK.V
608 P50213 IDH3A Isocitrate dehydrogenase IDH3A R.IEAAC*FATIK.D
609 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 K.C*LDEFPNLK.A
610 Q9BYT8 NLN Neurolysin, mitochondrial NLN R.IVHLQETC*DLGK.I
611 Q8NDH3 NPEPL1 Probable aminopeptidase NPEPL1 NPEPL1 R.DC*GGAAAVLGAFR.A
612 P35270 SPR Sepiapterin reductase SPR R.TVVNISSLC*ALQPFK.G
613 P63167 DYNLL1 Dynein light chain 1, cytoplasmic DYNLL1 K.NADMSEEMQQDSVEC*ATQALEK.Y
614 P46782 RPS5 40S ribosomal protein S5 RPS5 K.AQC*PIVER.L
615 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 R.GC*ITIIGGGDTATCCAK.W
616 P31939 ATIC Bifunctional purine biosynthesis protein PURH ATIC K.VC*MVYDLYK.T
617 Q86VY4 TSPYL5 Testis-specific Y-encoded-like protein 5 TSPYL5 R.LPLDC*GLALR.A
618 Q15257 PPP2R4 Serine/threonine-protein phosphatase 2A activator PPP2R4 R.IDYGTGHEAAFAAFLC*CLCK.I
619 Q9BT78 COPS4 COP9 signalosome complex subunit 4 COPS4 K.QIQSLC*FQVNNLLEK.I
620 Q9H9P8 L2HGDH L-2-hydroxyglutarate dehydrogenase, mitochondrial L2HGDH K.AC*FLGATVK.Y
621 P60866 RPS20 40S ribosomal protein S20 RPS20 R.KTPC*GEGSK.T
622 Q92797 SYMPK Symplekin SYMPK K.ATNLC*FAER.N
623 P63104 YWHAZ 14-3-3 protein zeta/delta YWHAZ K.IETELRDIC*NDVLSLLEK.F
624 P50213 IDH3A Isocitrate dehydrogenase IDH3A K.TFDLYANVRPC*VSIEGYK.T
625 P50991 CCT4 T-complex protein 1 subunit delta CCT4 K.AQDIEAGDGTTSVVIIAGSLLDSC*TK.L
626 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 K.SC*AHDWVYE.-
627 Q9ULV4 CORO1C Coronin-1C CORO1C K.C*DLISIPK.K
628 Q99798 ACO2 Aconitate hydratase, mitochondrial ACO2 R.DLGGIVLANAC*GPCIGQWDR.K
629 P50914 RPL14 60S ribosomal protein L14 RPL14 R.ALVDGPC*TQVR.R
630 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 K.IIDINYYPVPEAC*LSNK.R
631 Q7LG56 RRM2B Ribonucleoside-diphosphate reductase subunit M2 B RRM2B K.IEQEFLTEALPVGLIGMNC*ILMK.Q
632 Q9Y399 MRPS2 28S ribosomal protein S2, mitochondrial MRPS2 R.DC*GEYAHTR.Y
633 Q9NQ88 TIGAR Fructose-2,6-bisphosphatase TIGAR TIGAR K.AAREEC*PVFTPPGGETLDQVK.M
634 P39687 ANP32A Acidic leucine-rich nuclear phosphoprotein 32 fami ANP32A K.SLDLFNC*EVTNLNDYR.E
635 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.VC*VETVESGAMTK.D
636 Q7L5D6 GET4 Golgi to ER traffic protein 4 homolog GET4 K.EQNYC*ESR.Y
637 O43264 ZW10 Centromere/kinetochore protein zw10 homolog ZW10 R.LAPILC*DGTATFVDLVPGFR.R
638 O43684 BUB3 Mitotic checkpoint protein BUB3 BUB3 R.TPC*NAGTFSQPEK.V
639 Q92598 HSPH1 Heat shock protein 105 kDa HSPH1 R.SVLDAAQIVGLNC*LR.L
640 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.GIFPVLC*K.D
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2.0 1.7 2.0 1.9 2.0 1.9 2.2 2.3 2.3 -0.4
3.2 3.5 3.2 3.2 2.9 3.2 3.6 3.5 3.5 -0.4
1.6 1.9 2.0 0.0 1.7 1.8 2.2 2.1 2.1 -0.4
4.3 3.7 4.0 5.7 1.8 3.9 4.6 4.0 4.3 -0.4
2.4 2.2 2.4 2.5 2.1 2.3 2.7 2.7 2.7 -0.4
1.3 2.2 2.2 2.6 1.6 2.0 2.7 2.0 2.3 -0.4
0.5 0.0 0.8 0.0 1.0 0.8 0.8 1.4 1.1 -0.4
4.2 4.4 4.2 5.6 3.2 4.3 4.0 5.3 4.7 -0.4
0.7 0.8 0.9 0.6 0.7 0.8 1.1 1.1 1.1 -0.4
1.2 0.0 2.1 0.0 1.5 1.6 2.1 1.9 2.0 -0.4
1.2 1.9 2.2 2.7 1.6 1.9 2.2 2.3 2.3 -0.4
4.1 5.0 3.3 6.0 5.0 4.7 3.6 6.5 5.1 -0.4
0.9 1.5 0.0 1.4 1.3 1.3 1.5 1.8 1.7 -0.4
2.0 2.3 1.7 2.0 2.0 2.0 2.3 2.4 2.3 -0.4
0.5 0.5 1.0 0.6 0.5 0.6 1.0 1.0 1.0 -0.4
0.7 0.9 1.8 2.3 0.9 1.3 1.8 1.6 1.7 -0.4
2.3 3.0 2.8 0.0 2.5 2.7 2.9 3.2 3.0 -0.4
0.7 1.2 1.9 1.9 1.0 1.4 2.2 1.2 1.7 -0.4
1.1 0.6 1.4 1.2 0.8 1.0 1.5 1.3 1.4 -0.4
3.7 3.7 3.8 0.0 3.4 3.6 4.2 3.8 4.0 -0.4
3.9 3.6 3.2 3.3 3.0 3.4 3.3 4.3 3.8 -0.4
2.1 1.5 1.9 1.9 2.1 1.9 2.3 2.3 2.3 -0.4
0.7 0.7 1.0 0.8 0.9 0.8 1.2 1.2 1.2 -0.4
3.9 4.3 2.8 0.0 3.7 3.7 4.2 4.0 4.1 -0.4
0.9 1.1 0.0 0.6 0.0 0.9 1.1 1.4 1.3 -0.4
1.2 1.6 1.9 2.0 1.7 1.7 2.3 1.9 2.1 -0.4
4.2 4.5 3.3 3.3 3.6 3.8 4.2 4.2 4.2 -0.4
2.3 2.0 1.7 2.5 1.8 2.1 2.3 2.6 2.5 -0.4
3.2 3.5 3.1 3.2 3.1 3.2 3.5 3.7 3.6 -0.4
2.5 2.4 2.2 2.5 2.0 2.3 2.5 2.9 2.7 -0.4
1.2 0.9 1.0 0.0 0.8 1.0 1.1 1.7 1.4 -0.4
1.1 0.0 2.6 3.3 0.0 2.3 2.4 3.1 2.7 -0.4
1.9 1.8 2.0 2.4 1.6 2.0 2.1 2.6 2.4 -0.4
0.5 0.7 0.0 0.0 0.6 0.6 1.2 0.8 1.0 -0.4
2.1 2.2 2.1 2.4 1.7 2.1 2.8 2.2 2.5 -0.4
2.4 1.9 1.9 1.6 1.5 1.8 2.1 2.4 2.2 -0.4
2.8 3.6 3.0 2.8 2.5 3.0 3.5 3.2 3.4 -0.4
1.4 2.5 2.9 2.9 2.0 2.3 3.1 2.4 2.7 -0.4
2.2 3.4 4.2 3.2 3.2 3.2 3.6 3.6 3.6 -0.4
1.2 2.6 3.3 3.6 2.5 2.6 3.6 2.6 3.1 -0.4
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641 Q96FJ2 DYNLL2 Dynein light chain 2, cytoplasmic DYNLL2 K.NADMSEDMQQDAVDC*ATQAMEK.Y
642 Q16854 DGUOK Deoxyguanosine kinase, mitochondrial DGUOK K.AC*TAQSLGNLLDMMYR.E
643 Q08211 DHX9 ATP-dependent RNA helicase A DHX9 K.SSVNC*PFSSQDMK.Y
644 P36578 RPL4 60S ribosomal protein L4 RPL4 R.SGQGAFGNMC*R.G
645 Q9NP73 ALG13 UDP-N-acetylglucosamine transferase subunit ALG13 ALG13 K.ADLVISHAGAGSC*LETLEK.G
646 P06733 ENO1 Alpha-enolase ENO1 K.FGANAILGVSLAVC*K.A
647 B0LM41 RBM14/RBM4 fusion Transcriptional coactivator CoAZ 
RBM14/RB
M4 K.IFVGNVSAAC*TSQELR.S
648 Q9Y277 VDAC3 Voltage-dependent anion-selective channel protein VDAC3 K.VC*NYGLTFTQK.W
649 P62857 RPS28 40S ribosomal protein S28 RPS28 R.TGSQGQC*TQVR.V
650 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.DLAGC*IHGLSNVK.L
651 P51659 HSD17B4 Peroxisomal multifunctional enzyme type 2 HSD17B4 K.IC*DFENASKPQSIQESTGSIIEVLSK.I
652 P28074 PSMB5 Proteasome subunit beta type-5 PSMB5 K.KVIEINPYLLGTMAGGAADC*SFWER.L
653 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.AEGSDVANAVLDGADC*IMLSGETAK.G
654 Q5VTL8 PRPF38B Pre-mRNA-splicing factor 38B PRPF38B K.TAGQTGMC*GGVR.G
655 P41250 GARS Glycine--tRNA ligase GARS R.SC*YDLSCHAR.A
656 O14745 SLC9A3R1 Na(+)/H(+) exchange regulatory cofactor NHE-RF1 SLC9A3R1 R.IVEVNGVC*MEGK.Q
657 Q05655 PRKCD Protein kinase C delta type PRKCD K.VLMSVQYFLEDVDC*K.Q
658 Q8TEX9 IPO4 Importin-4 IPO4 R.APAALPALC*DLLASAADPQIR.Q
659 P41250 GARS Glycine--tRNA ligase GARS K.C*SVLPLSQNQEFMPFVK.E
660 P00966 ASS1 Argininosuccinate synthase ASS1 R.FELSC*YSLAPQIK.V
661 Q9H3P7 ACBD3 Golgi resident protein GCP60 ACBD3 K.QVLMGPYNPDTC*PEVGFFDVLGNDR.R
662 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM R.NTGIIC*TIGPASR.S
663 Q9UBT2 UBA2 SUMO-activating enzyme subunit 2 UBA2 R.VLVVGAGGIGC*ELLK.N
664 Q969T9 WBP2 WW domain-binding protein 2 WBP2 K.DC*EIKQPVFGANYIK.G
665 P40926 MDH2 Malate dehydrogenase, mitochondrial MDH2 K.GYLGPEQLPDC*LK.G
666 E7EVH7 KLC1 Kinesin light chain 1 KLC1 R.YEVAVPLC*K.Q
667 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.SLHDALC*VVK.R
668 Q9NRF9 POLE3 DNA polymerase epsilon subunit 3 POLE3 R.AASVFVLYATSC*ANNFAMK.G
669 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 R.IQFVGAC*NPPTDPGR.K
670 P62829 RPL23 60S ribosomal protein L23 RPL23 R.ISLGLPVGAVINC*ADNTGAK.N
671 P55036 PSMD4 26S proteasome non-ATPase regulatory subunit 4 PSMD4 R.LQAQQDAVNIVC*HSK.T
672 P62424 RPL7A 60S ribosomal protein L7a RPL7A K.TC*TTVAFTQVNSEDKGALAK.L
673 Q86VP6 CAND1 Cullin-associated NEDD8-dissociated protein 1 CAND1 R.LSTLC*PSAVLQR.L
674 Q96I99 SUCLG2 Succinyl-CoA ligase SUCLG2 R.SC*NGPVLVGSPQGGVDIEEVAASNPELIFK.E
675 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.IC*DDELILIK.N
676 P07814 EPRS Bifunctional glutamate/proline--tRNA ligase EPRS K.LGVENC*YFPMFVSQSALEK.E
677 O14545 TRAFD1 TRAF-type zinc finger domain-containing protein 1 TRAFD1 R.AVC*EADQSHGGPR.S
678 P25789 PSMA4 Proteasome subunit alpha type-4 PSMA4 K.LNEDMAC*SVAGITSDANVLTNELR.L
679 P15924 DSP Desmoplakin DSP K.NQC*TQVVQER.E
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5.5 7.5 6.3 6.2 6.1 6.3 6.5 7.1 6.8 -0.5
2.9 1.4 1.3 1.4 1.0 1.6 2.0 2.1 2.1 -0.5
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3.9 3.6 3.3 3.3 3.3 3.5 4.0 4.0 4.0 -0.5
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680 O75940 SMNDC1 Survival of motor neuron-related-splicing factor 3 SMNDC1 K.VGVGTC*GIADKPMTQYQDTSK.Y
681 P13804 ETFA Electron transfer flavoprotein subunit alpha, mito ETFA R.TIYAGNALC*TVK.C
682 P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH K.IISNASC*TTNCLAPLAK.V
683 Q96RQ3 MCCC1 Methylcrotonoyl-CoA carboxylase subunit alpha, mit MCCC1 K.ESLC*QAALGLILK.E
684 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 R.AVASQLDC*NFLK.V
685 P13639 EEF2 Elongation factor 2 EEF2 R.TFC*QLILDPIFK.V
686 Q5UIP0 RIF1 Telomere-associated protein RIF1 RIF1 K.SLIDNFALNPDILC*SAK.R
687 Q14152 EIF3A Eukaryotic translation initiation factor 3 subunit EIF3A K.NIC*QQVNIK.S
688 Q8N1F7 NUP93 Nuclear pore complex protein Nup93 NUP93 K.SSGQSAQLLSHEPGDPPC*LR.R
689 Q9H0C8 ILKAP Integrin-linked kinase-associated serine/threonine ILKAP R.FILLAC*DGLFK.V
690 P60953 CDC42 Cell division control protein 42 homolog CDC42 K.YVEC*SALTQK.G
691 P11766 ADH5 Alcohol dehydrogenase class-3 ADH5 K.IDPLAPLDKVCLLGC*GISTGYGAAVNTAK.L
692 O94979 SEC31A Protein transport protein Sec31A SEC31A K.SC*ATFSSSHR.Y
693 Q9BX63 BRIP1 Fanconi anemia group J protein BRIP1 K.QHC*LLESPTGSGK.S
694 Q14151 SAFB2 Scaffold attachment factor B2 SAFB2 K.ILDILGETC*K.S
695 P62249 RPS16 40S ribosomal protein S16 RPS16 K.TATAVAHC*K.R
696 P49411 TUFM Elongation factor Tu, mitochondrial TUFM K.KGDEC*ELLGHSK.N
697 Q02252 ALDH6A1 Methylmalonate-semialdehyde dehydrogenase ALDH6A1 K.AEMDAAIASC*K.R
698 P29401 TKT Transketolase TKT K.QAFTDVATGSLGQGLGAAC*GMAYTGK.Y
699 Q9Y2R9 MRPS7 28S ribosomal protein S7, mitochondrial MRPS7 K.NC*EPMIGLVPILK.G
700 P61158 ACTR3 Actin-related protein 3 ACTR3 K.LGYAGNTEPQFIIPSC*IAIK.E
701 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 R.SVC*TEAGMFAIR.A
702 Q9Y285 FARSA Phenylalanine--tRNA ligase alpha subunit FARSA K.VNLQMVYDSPLC*R.L
703 Q6P2Q9 PRPF8 Pre-mRNA-processing-splicing factor 8 PRPF8 K.FIC*ISDLR.A
704 P49368 CCT3 T-complex protein 1 subunit gamma CCT3 R.NLQDAMQVC*R.N
705 Q9BTZ2 DHRS4 Dehydrogenase/reductase SDR family member 4 DHRS4 R.VNC*LAPGLIK.T
706 P62714 PPP2CB Serine/threonine-protein phosphatase 2A catalytic PPP2CB R.NVVTIFSAPNYC*YR.C
707 P51553 IDH3G Isocitrate dehydrogenase IDH3G R.TSLDLYANVIHC*K.S
708 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 R.C*SVLAAANSVFGR.W
709 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 R.NTAAMVC*SLENR.D
710 P15880 RPS2 40S ribosomal protein S2 RPS2 R.GC*TATLGNFAK.A
711 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 R.QLC*DNAGFDATNILNK.L
712 P27635 RPL10 60S ribosomal protein L10 RPL10 K.MLSC*AGADR.L
713 Q9P2X0 DPM3 Dolichol-phosphate mannosyltransferase subunit 3 DPM3 R.VATFHDC*EDAAR.E
714 Q9UQ35 SRRM2 Serine/arginine repetitive matrix protein 2 SRRM2 R.SVSPC*SNVESR.L
715 O60361 NME2P1 Putative nucleoside diphosphate kinase NME2P1 R.GDFC*IQVGR.N
716 O43837 IDH3B Isocitrate dehydrogenase IDH3B K.LGDGLFLQC*CEEVAELYPK.I
717 P42025 ACTR1B Beta-centractin ACTR1B R.AC*YLSINPQKDEALETEK.V
718 P22695 UQCRC2 Cytochrome b-c1 complex subunit 2, mitochondrial UQCRC2 R.NALANPLYC*PDYR.I
719 Q9UNE7 STUB1 E3 ubiquitin-protein ligase CHIP STUB1 R.AQQAC*IEAK.H
720 Q16186 ADRM1 Proteasomal ubiquitin receptor ADRM1 ADRM1 R.VPQC*PSGR.V
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2.9 3.0 2.5 2.4 2.0 2.5 3.6 2.7 3.1 -0.6
0.8 0.0 2.6 0.0 2.1 1.8 2.4 2.5 2.4 -0.6
1.9 1.8 2.1 0.0 2.1 2.0 2.6 2.6 2.6 -0.6
0.0 3.3 3.2 2.9 3.0 3.1 3.6 3.8 3.7 -0.6
1.6 2.3 2.8 2.5 1.8 2.2 3.2 2.5 2.8 -0.6
4.9 0.0 4.2 0.0 4.9 4.7 5.3 5.2 5.3 -0.6
4.9 6.8 4.9 5.1 5.6 5.4 6.0 6.1 6.0 -0.6
2.2 0.0 2.1 2.9 1.5 2.2 2.2 3.4 2.8 -0.6
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2.6 1.9 2.5 2.2 1.5 2.1 2.6 2.9 2.8 -0.6
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0.0 5.1 4.2 4.8 3.8 4.5 5.0 5.2 5.1 -0.6
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0.0 3.2 0.0 3.1 2.9 3.1 3.5 3.9 3.7 -0.6
4.1 5.2 3.5 4.3 2.7 3.9 4.5 4.7 4.6 -0.6
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416
721 P40227 CCT6A T-complex protein 1 subunit zeta CCT6A K.NAIDDGC*VVPGAGAVEVAMAEALIK.H
722 Q5VT52 RPRD2 Regulation of nuclear pre-mRNA domain-containing p RPRD2 R.LNLFYLANDVIQNC*K.R
723 P57678 GEMIN4 Gem-associated protein 4 GEMIN4 R.SDPDAC*PTMPLLAMLLR.G
724 P07741 APRT Adenine phosphoribosyltransferase APRT R.VVVVDDLLATGGTMNAAC*ELLGR.L
725 P23396 RPS3 40S ribosomal protein S3 RPS3 R.AC*YGVLR.F
726 P31949 S100A11 Protein S100-A11 S100A11 K.ISSPTETERC*IESLIAVFQK.Y
727 Q9H7X7 RABL5 Rab-like protein 5 RABL5 K.ILFVGPC*ESGK.T
728 P60981 DSTN Destrin DSTN K.AVIFC*LSADKK.C
729 Q13185 CBX3 Chromobox protein homolog 3 CBX3 R.LTWHSC*PEDEAQ.-
730 P00558 PGK1 Phosphoglycerate kinase 1 PGK1 K.AC*ANPAAGSVILLENLR.F
731 P13639 EEF2 Elongation factor 2 EEF2 K.EGALC*EENMR.G
732 Q7Z406 MYH14 Myosin-14 MYH14 R.C*NGVLEGIR.I
733 P62280 RPS11 40S ribosomal protein S11 RPS11 R.DVQIGDIVTVGEC*RPLSK.T
734 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U HNRNPU K.DC*EVVMMIGLPGAGK.T
735 P40939 HADHA Trifunctional enzyme subunit alpha, mitochondrial HADHA R.C*LAPMMSEVIR.I
736 Q96RS6 NUDCD1 NudC domain-containing protein 1 NUDCD1 R.DSAQC*AAIAER.L
737 P48047 ATP5O ATP synthase subunit O, mitochondrial ATP5O R.GEVPC*TVTSASPLEEATLSELK.T
738 P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit RRM1 R.NTAAMVCSLENRDEC*LMCGS.-
739 Q15181 PPA1 Inorganic pyrophosphatase PPA1 K.GISC*MNTTLSESPFK.C
740 P08243 ASNS Asparagine synthetase ASNS R.IGC*LLSGGLDSSLVAATLLK.Q
741 P13639 EEF2 Elongation factor 2 EEF2 K.YRC*ELLYEGPPDDEAAMGIK.S
742 P13639 EEF2 Elongation factor 2 EEF2 R.C*LYASVLTAQPR.L
743 O43795 MYO1B Unconventional myosin-Ib MYO1B K.LVMSYVAAVC*GK.G
744 Q8TAQ2 SMARCC2 SWI/SNF complex subunit SMARCC2 SMARCC2 R.NLAGDVC*AIMR.V
745 Q9P258 RCC2 Protein RCC2 RCC2 K.AVQDLC*GWR.I
746 Q96FV9 THOC1 THO complex subunit 1 THOC1 K.SQNTVFC*GR.I
747 O75663 TIPRL TIP41-like protein TIPRL K.VAC*AEEWQESR.T
748 P00505 GOT2 Aspartate aminotransferase, mitochondrial GOT2 R.VGAFTMVC*K.D
749 Q9H2U2 PPA2 Inorganic pyrophosphatase 2, mitochondrial PPA2 R.GQPC*SQNYR.L
750 Q7Z406 MYH14 Myosin-14 MYH14 K.AEDMAELTC*LNEASVLHNLR.E
751 P55263 ADK Adenosine kinase ADK R.SLIANLAAANC*YK.K
752 P62266 RPS23 40S ribosomal protein S23 RPS23 K.ITAFVPNDGC*LNFIEENDEVLVAGFGR.K
753 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 R.YVDIAIPC*NNK.G
754 Q07960 ARHGAP1 Rho GTPase-activating protein 1 ARHGAP1 K.IIVFSAC*R.M
755 Q92879 CELF1 CUGBP Elav-like family member 1 CELF1 K.AMHQAQTMEGC*SSPMVVK.F
756 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC K.TFTDC*FNCLPIAAIVDEK.I
757 P49915 GMPS GMP synthase GMPS K.TVGVQGDC*R.S
758 P21266 GSTM3 Glutathione S-transferase Mu 3 GSTM3 K.RYTC*GEAPDYDR.S
759 P60981 DSTN Destrin DSTN K.HEC*QANGPEDLNR.A
760 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC R.GNHEC*ASINR.I
761 P34896 SHMT1 Serine hydroxymethyltransferase, cytosolic SHMT1 K.NTC*PGDR.S
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2.2 1.8 1.6 0.0 1.5 1.8 2.5 2.5 2.5 -0.8
1.5 1.6 1.5 1.7 1.1 1.5 1.9 2.6 2.2 -0.8
1.9 2.3 2.4 2.6 1.9 2.2 2.8 3.2 3.0 -0.8
3.2 2.6 2.6 2.5 2.3 2.6 3.3 3.5 3.4 -0.8
0.8 2.1 1.8 2.3 1.5 1.7 2.8 2.1 2.5 -0.8
418
762 P35658 NUP214 Nuclear pore complex protein Nup214 NUP214 K.AC*FQVGTSEEMK.M
763 E2QRD5 C15orf38-AP3S2 Protein C15orf38-AP3S2 C15orf38-AP3S2 K.C*NFTGDGK.T
764 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 R.ITNQVIYLNPPIEEC*R.Y
765 Q8TC07 TBC1D15 TBC1 domain family member 15 TBC1D15 R.TLLVNC*QNK.S
766 P53597 SUCLG1 Succinyl-CoA ligase SUCLG1 K.IIC*QGFTGK.Q
767 Q13636 RAB31 Ras-related protein Rab-31 RAB31 K.VC*LLGDTGVGK.S
768 Q9BYG5 PARD6B Partitioning defective 6 homolog beta PARD6B R.HGAGSGC*LGTMEVK.S
769 P54136 RARS Arginine--tRNA ligase, cytoplasmic RARS K.NC*GCLGASPNLEQLQEENLK.L
770 O95747 OXSR1 Serine/threonine-protein kinase OSR1 OXSR1 K.TFVGTPC*WMAPEVMEQVR.G
771 P49327 FASN Fatty acid synthase FASN K.AC*LDTAVENMPSLK.M
772 Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U HNRNPU K.AVVVC*PK.D
773 P62701 RPS4X 40S ribosomal protein S4, X isoform RPS4X K.FDTGNLC*MVTGGANLGR.I
774 P62826 RAN GTP-binding nuclear protein Ran RAN R.VC*ENIPIVLCGNK.V
775 P31153 MAT2A S-adenosylmethionine synthase isoform type-2 MAT2A K.TC*NVLVALEQQSPDIAQGVHLDR.N
776 P17858 PFKL 6-phosphofructokinase, liver type PFKL R.VFANAPDSAC*VIGLK.K
777 Q92599 SEPT8 Septin-8 8-Sep R.QYPWGVVQVENENHC*DFVK.L
778 P60900 PSMA6 Proteasome subunit alpha type-6 PSMA6 K.C*DPAGYYCGFK.A
779 P49327 FASN Fatty acid synthase FASN R.DGLLENQTPEFFQDVC*KPK.Y
780 P24752 ACAT1 Acetyl-CoA acetyltransferase, mitochondrial ACAT1 K.QGEYGLASIC*NGGGGASAMLIQK.L
781 P60709 ACTB Actin, cytoplasmic 1 ACTB K.EKLC*YVALDFEQEMATAASSSSLEK.S
782 P34896 SHMT1 Serine hydroxymethyltransferase, cytosolic SHMT1 R.AVLEALGSC*LNNK.Y
783 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 R.ALC*QITDSTMLQAIER.Y
784 P50914 RPL14 60S ribosomal protein L14 RPL14 K.C*MQLTDFILK.F
785 O14929 HAT1 Histone acetyltransferase type B catalytic subunit HAT1 K.C*NTNTAIELK.L
786 Q9UBE0 SAE1 SUMO-activating enzyme subunit 1 SAE1 K.GNGIVEC*LGPK.-
787 Q04637 EIF4G1 Eukaryotic translation initiation factor 4 gamma 1 EIF4G1 R.LQGINC*GPDFTPSFANLGR.T
788 P61158 ACTR3 Actin-related protein 3 ACTR3 R.TLTGTVIDSGDGVTHVIPVAEGYVIGSC*IK.H
789 P46734 MAP2K3 Dual specificity mitogen-activated protein kinase MAP2K3 R.FSPEFVDFTAQC*LR.K
790 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 K.GC*LLYGPPGTGK.T
791 P36873 PPP1CC Serine/threonine-protein phosphatase PP1-gamma cat PPP1CC K.IC*GDIHGQYYDLLR.L
792 P49720 PSMB3 Proteasome subunit beta type-3 PSMB3 K.NC*VAIAADR.R
793 P21281 ATP6V1B2 V-type proton ATPase subunit B, brain isoform ATP6V1B2 R.GPVVLAEDFLDIMGQPINPQC*R.I
794 Q9GZZ9 UBA5 Ubiquitin-like modifier-activating enzyme 5 UBA5 R.EGVC*AASLPTTMGVVAGILVQNVLK.F
795 P62241 RPS8 40S ribosomal protein S8 RPS8 K.NC*IVLIDSTPYR.Q
796 Q96QR8 PURB Transcriptional activator protein Pur-beta PURB R.GGGGGPC*GFQPASR.G
797 P51553 IDH3G Isocitrate dehydrogenase IDH3G K.LGDGLFLQC*CR.E
798 P14618 PKM Pyruvate kinase isozymes M1/M2 PKM K.C*DENILWLDYK.N
799 P48735 IDH2 Isocitrate dehydrogenase IDH2 K.C*ATITPDEAR.V
800 O75150 RNF40 E3 ubiquitin-protein ligase BRE1B RNF40 R.LTCPC*CNTR.K
801 P62191 PSMC1 26S protease regulatory subunit 4 PSMC1 K.AIC*TEAGLMALR.E
802 P09429 HMGB1 High mobility group protein B1 HMGB1 K.MSSYAFFVQTC*R.E
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1.6 1.6 2.5 0.0 1.4 1.8 2.0 3.1 2.5 -0.8
3.0 3.2 2.8 0.0 2.1 2.8 3.1 4.0 3.5 -0.8
1.5 1.5 1.6 0.0 1.6 1.5 2.2 2.5 2.3 -0.8
3.4 4.6 3.2 0.9 2.8 3.0 3.8 3.8 3.8 -0.8
4.8 5.3 5.8 4.5 5.1 5.1 5.8 6.0 5.9 -0.8
1.9 2.7 2.2 2.3 2.1 2.2 3.2 2.9 3.1 -0.8
3.0 1.9 1.9 2.3 1.4 2.1 3.2 2.7 2.9 -0.8
5.9 6.6 4.9 6.0 4.7 5.6 6.1 6.8 6.5 -0.8
2.7 4.6 4.0 3.8 3.8 3.8 4.3 4.9 4.6 -0.8
1.2 1.7 1.2 1.4 1.7 1.4 2.5 2.0 2.3 -0.8
3.4 3.8 3.5 3.2 3.1 3.4 3.7 4.7 4.2 -0.8
2.1 2.3 2.2 1.8 2.1 2.1 2.9 2.9 2.9 -0.8
1.1 1.3 1.4 1.6 1.2 1.3 2.3 2.0 2.2 -0.8
6.0 5.5 4.8 5.0 3.6 5.0 5.2 6.5 5.8 -0.8
5.6 5.9 5.6 5.5 5.2 5.5 6.2 6.6 6.4 -0.8
2.2 1.5 1.5 1.3 0.0 1.6 2.2 2.7 2.5 -0.9
1.1 1.9 2.2 2.3 2.0 1.9 2.4 3.2 2.8 -0.9
3.9 6.0 5.3 0.0 4.3 4.9 5.6 5.9 5.7 -0.9
2.9 2.8 2.4 2.5 2.5 2.6 4.1 2.9 3.5 -0.9
3.0 3.6 3.7 3.7 3.7 3.5 4.3 4.5 4.4 -0.9
0.5 1.1 0.9 1.0 0.7 0.8 1.7 1.7 1.7 -0.9
4.4 4.7 4.5 0.0 3.5 4.3 4.7 5.7 5.2 -0.9
3.3 3.7 3.2 3.4 3.2 3.4 3.6 5.0 4.3 -0.9
2.3 3.0 1.8 0.0 2.3 2.3 3.5 3.0 3.3 -0.9
0.7 0.8 0.6 0.8 0.5 0.7 2.2 1.0 1.6 -0.9
0.0 2.6 1.8 2.3 1.9 2.2 2.6 3.5 3.1 -0.9
0.0 1.9 2.4 2.4 1.9 2.2 3.3 2.9 3.1 -0.9
6.3 6.8 5.0 6.4 5.0 5.9 6.6 7.1 6.8 -0.9
2.1 3.0 0.9 3.0 3.0 2.4 3.0 3.8 3.4 -1.0
3.9 2.7 2.1 2.2 2.4 2.7 3.2 4.1 3.6 -1.0
1.1 1.3 2.1 2.5 1.7 1.7 2.5 2.9 2.7 -1.0
2.2 2.0 1.6 0.0 1.6 1.9 3.2 2.5 2.8 -1.0
0.0 0.0 7.9 8.2 7.7 7.9 7.4 10.5 8.9 -1.0
4.2 4.5 4.5 4.7 4.0 4.4 4.9 5.9 5.4 -1.0
0.0 3.0 2.4 2.9 2.9 2.8 4.0 3.6 3.8 -1.0
3.1 4.3 3.0 3.2 3.1 3.3 4.8 3.9 4.3 -1.0
1.3 0.0 2.4 2.5 0.0 2.1 3.1 3.0 3.1 -1.0
2.7 2.3 2.6 2.8 2.5 2.6 4.2 3.0 3.6 -1.0
2.7 2.3 1.5 0.0 2.5 2.3 2.7 3.9 3.3 -1.0
2.3 2.5 2.5 2.5 2.1 2.4 3.7 3.2 3.4 -1.0
0.0 0.0 3.4 4.1 3.3 3.6 4.2 5.0 4.6 -1.0
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803 Q6IA69 NADSYN1 Glutamine-dependent NAD(+) synthetase NADSYN1 K.NSSQETC*TR.A
804 Q06587 RING1 E3 ubiquitin-protein ligase RING1 RING1 R.FC*SDCIVTALR.S
805 P83731 RPL24 60S ribosomal protein L24 RPL24 K.VELC*SFSGYK.I
806 P62820 RAB1A Ras-related protein Rab-1A RAB1A K.LLVGNKC*DLTTK.K
807 Q9UL25 RAB21 Ras-related protein Rab-21 RAB21 K.VVLLGEGC*VGK.T
808 Q9Y678 COPG1 Coatomer subunit gamma-1 COPG1 K.HPSAVTAC*NLDLENLVTDSNR.S
809 P33992 MCM5 DNA replication licensing factor MCM5 MCM5 K.AIAC*LLFGGSR.K
810 A6NE09 RPSAP58 Protein RPSAP58 RPSAP58 R.ADHQPLTEASYVNLPTIALC*NTDSPLR.Y
811 P35250 RFC2 Replication factor C subunit 2 RFC2 R.FALAC*NASDK.I
812 Q6P2I3 FAHD2B Fumarylacetoacetate hydrolase domain-containing pr FAHD2B K.TFDTFC*PLGPALVTK.D
813 Q14204 DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1 K.LQGATC*NNNK.L
814 Q07864 POLE DNA polymerase epsilon catalytic subunit A POLE R.IHC*GLQDSQK.A
815 Q99832 CCT7 T-complex protein 1 subunit eta CCT7 R.YNFFTGC*PK.A
816 P35568 IRS1 Insulin receptor substrate 1 IRS1 K.LC*GAAGGLENGLNYIDLDLVK.D
817 P34897 SHMT2 Serine hydroxymethyltransferase, mitochondrial SHMT2 R.AALEALGSC*LNNK.Y
818 P55809 OXCT1 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, OXCT1 K.C*TLPLTGK.Q
819 P22102 GART Trifunctional purine biosynthetic protein adenosin GART R.SAGVQC*FGPTAEAAQLESSK.R
820 P61158 ACTR3 Actin-related protein 3 ACTR3 R.YSYVC*PDLVK.E
821 P53618 COPB1 Coatomer subunit beta COPB1 K.VLSECSPLMNDIFNKEC*R.Q
822 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 R.RGNVC*GDSK.S
823 P23919 DTYMK Thymidylate kinase DTYMK K.LVEALC*AAGHR.A
824 P50570 DNM2 Dynamin-2 DNM2 K.TEHAEFLHC*K.S
825 P62888 RPL30 60S ribosomal protein L30 RPL30 R.VC*TLAIIDPGDSDIIR.S
826 P51610 HCFC1 Host cell factor 1 HCFC1 R.VAGINAC*GR.G
827 P17987 TCP1 T-complex protein 1 subunit alpha TCP1 R.GANDFMC*DEMER.S
828 P68104 EEF1A1 Elongation factor 1-alpha 1 EEF1A1 K.NMITGTSQADC*AVLIVAAGVGEFEAGISK.N
829 Q9Y5M8 SRPRB Signal recognition particle receptor subunit beta SRPRB K.NTPSFLIAC*NK.Q
830 Q04726 TLE3 Transducin-like enhancer protein 3 TLE3 K.SPISQLDC*LNR.D
831 P27448 MARK3 MAP/microtubule affinity-regulating kinase 3 MARK3 K.LDTFC*GSPPYAAPELFQGK.K
832 P08134 RHOC Rho-related GTP-binding protein RhoC RHOC K.KLVIVGDGAC*GK.T
833 Q05639 EEF1A2 Elongation factor 1-alpha 2 EEF1A2 K.SGDAAIVEMVPGKPMC*VESFSQYPPLGR.F
834 P42677 RPS27 40S ribosomal protein S27 RPS27 R.LTEGC*SFR.R
835 P62333 PSMC6 26S protease regulatory subunit 10B PSMC6 R.NVC*TEAGMFAIR.A
836 Q9H773 DCTPP1 dCTP pyrophosphatase 1 DCTPP1 K.YTELPHGAISEDQAVGPADIPC*DSTGQTST.-
837 Q53H96 PYCRL Pyrroline-5-carboxylate reductase 3 PYCRL R.SDVC*TPGGTTIYGLHALEQGGLR.A
838 P35998 PSMC2 26S protease regulatory subunit 7 PSMC2 R.LC*PNSTGAEIR.S
839 Q9UEW8 STK39 STE20/SPS1-related proline-alanine-rich protein ki STK39 K.C*QTSMDELLK.E
840 O95757 HSPA4L Heat shock 70 kDa protein 4L HSPA4L R.GC*ALQCAILSPAFK.V
841 Q13572 ITPK1 Inositol-tetrakisphosphate 1-kinase ITPK1 K.NGLTFPFIC*K.T
842 P60709 ACTB Actin, cytoplasmic 1 ACTB K.C*DVDIRK.D
843 P30084 ECHS1 Enoyl-CoA hydratase, mitochondrial ECHS1 K.IC*PVETLVEEAIQC*AEK.I
421
0.0 1.2 1.3 2.4 1.2 1.5 2.3 2.8 2.6 -1.0
3.5 2.9 2.9 4.0 3.7 3.4 3.2 5.6 4.4 -1.1
5.2 4.2 4.4 2.5 3.8 4.0 5.9 4.3 5.1 -1.1
1.3 2.5 3.0 1.4 0.0 2.1 3.3 3.0 3.1 -1.1
2.9 2.6 2.3 2.4 2.3 2.5 3.3 4.0 3.7 -1.2
4.1 3.3 0.0 5.4 4.3 4.3 5.0 6.0 5.5 -1.2
0.0 3.0 3.6 4.2 3.8 3.7 5.1 4.6 4.8 -1.2
1.8 3.1 2.9 2.9 3.2 2.8 3.9 4.1 4.0 -1.2
5.1 3.8 0.0 0.0 4.7 4.5 5.4 6.2 5.8 -1.3
2.7 2.8 3.3 0.0 3.3 3.0 4.7 3.9 4.3 -1.3
1.9 3.6 3.0 3.4 2.2 2.8 3.4 4.8 4.1 -1.3
3.5 2.8 0.0 0.0 1.4 2.6 3.1 4.6 3.9 -1.3
2.3 3.3 2.9 0.0 2.6 2.7 3.6 4.6 4.1 -1.3
5.1 0.0 4.2 0.0 5.1 4.8 6.1 6.1 6.1 -1.3
1.3 4.3 3.7 2.2 3.2 3.0 4.9 3.7 4.3 -1.3
2.6 4.1 3.7 0.0 3.1 3.4 5.7 3.8 4.7 -1.4
5.3 0.0 0.0 4.6 5.4 5.1 5.9 7.1 6.5 -1.4
1.0 2.4 1.8 2.0 1.8 1.8 2.9 3.5 3.2 -1.4
1.4 0.0 0.7 2.5 0.0 1.5 3.0 2.9 2.9 -1.4
0.0 3.5 4.2 3.5 4.7 4.0 5.5 5.5 5.5 -1.5
1.8 3.2 0.0 3.2 2.9 2.8 4.0 4.7 4.3 -1.5
4.1 0.0 2.2 2.8 0.0 3.0 3.4 5.7 4.6 -1.6
9.9 8.2 8.4 8.7 8.2 8.7 10.6 9.9 10.2 -1.6
7.1 9.9 8.3 0.0 7.2 8.1 7.8 11.6 9.7 -1.6
4.1 0.0 5.1 4.3 3.9 4.4 6.3 5.6 6.0 -1.6
1.4 1.8 2.1 2.1 2.0 1.9 3.2 3.8 3.5 -1.6
3.7 3.5 3.5 2.0 3.1 3.2 4.0 5.6 4.8 -1.6
3.2 0.0 3.7 0.0 2.5 3.1 4.2 5.3 4.8 -1.7
3.3 0.0 3.2 0.0 3.1 3.2 4.4 5.4 4.9 -1.7
2.5 2.8 2.7 3.4 2.5 2.8 4.5 4.5 4.5 -1.8
2.2 3.8 4.2 4.7 3.2 3.6 5.0 5.8 5.4 -1.8
5.4 5.8 5.0 5.0 4.8 5.2 6.6 7.4 7.0 -1.8
0.0 3.2 3.2 2.6 0.0 3.0 4.4 5.6 5.0 -2.0
2.3 1.7 2.3 1.7 1.7 1.9 3.2 4.7 3.9 -2.0
11.5 9.0 0.0 8.8 7.8 9.3 11.3 11.2 11.3 -2.0
4.7 4.1 4.9 4.6 4.6 4.6 5.9 7.4 6.6 -2.0
0.0 1.0 2.1 1.0 1.0 1.3 3.1 3.5 3.3 -2.1
4.4 4.2 4.4 4.1 4.4 4.3 6.6 6.4 6.5 -2.2
1.8 2.2 0.0 0.0 3.3 2.4 4.0 5.6 4.8 -2.4
3.8 3.9 5.0 4.9 4.2 4.4 6.8 7.0 6.9 -2.5
2.6 2.7 2.9 3.2 2.5 2.8 5.5 5.5 5.5 -2.7
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844 Q9Y265 RUVBL1 RuvB-like 1 RUVBL1 K.VPFC*PMVGSEVYSTEIK.K
845 Q99714 HSD17B10 3-hydroxyacyl-CoA dehydrogenase type-2 HSD17B10 K.FGRVDVAVNC*AGIAVASK.T
846 Q1KMD3 HNRNPUL2 Heterogeneous nuclear ribonucleoprotein U-like pro
HNRNPUL
2 R.NFILDQC*NVYNSGQR.R
847 P04183 TK1 Thymidine kinase, cytosolic TK1 R.NTMEALPAC*LLR.D
848 P53384 NUBP1 Cytosolic Fe-S cluster assembly factor NUBP1 NUBP1 R.GASC*QGCPNQR.L
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2.0 5.8 3.6 3.0 4.1 3.7 6.0 7.0 6.5 -2.8
4.7 5.5 5.7 6.8 7.1 5.9 8.9 9.2 9.0 -3.1
3.3 3.8 2.8 3.4 2.8 3.2 6.6 6.1 6.4 -3.1
7.0 8.5 8.5 7.0 8.2 7.9 12.8 10.3 11.6 -3.7
6.9 7.2 7.1 7.4 8.9 7.5 11.8 11.6 11.7 -4.2
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Gene Protein Neg(1) Pos(1) Loc(2) Function(3) Process(4) G(5) S(6)
ACE Angiotensin-converting enzyme 0 79.8 EC Peptidase Cell proliferation + -
TBA1A Tubulin alpha-1A chain 0 59.5 C GTPase Cell division + -
CTPS1 CTP synthase 1 0 43.5 C ligase B cell proliferation - +
RRM1 Ribonucleoside-diphosphate reductase large subunit 0 35 C ATP binding Cell proliferation - +
GMPS GMP synthase 0 30.5 C Ligase Metabolic - +
PPP2R1A
Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform
0 29 C Phosphatase regulatory Apoptosis - -
NPEPPS Puromycin-sensitive aminopeptidase 0 28.8 C, N Peptidase Stress response - -
DHX15 Putative pre-mRNA-splicing factor ATP-dependent RNA helicase 0 28.3 N Helicase mRNA processing + -
GSPT1 Eukaryotic peptide chain release factor GTP-binding subunit ERF3A 0 24.8 C GTPase Cell cycle - +
PARP1 Poly [ADP-ribose] polymerase 1 0 23.5 N Glycosyltransferase DNA repair + -
NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit 0 23 C Acetyltransferase Angiogenesis + +
VARS Valine-tRNA synthetase 0 20 C Ligase Protein biosynthesis - +
CAND1 Cullin-associated NEDD8-dissociated protein 1 0 19.5 C, N
Ubiquitin 
conjugation Proteolysis - +
CSTB Cystatin-B 0 19 C, N Peptidase inhibitor proteolysis - -
USP7 Ubiquitin carboxyl-terminal hydrolase 7 0 18 C, N Peptidase DNA repair - -
DIS3 Exosome complex exonuclease RRP44 0 18 C,N Endonuclease rRNA processing - -
TUBA3D Tubulin alpha-3C/D chain 0 18 C GTPase Protein folding -
TPP2 Tripeptidyl-peptidase 2 0 17.5 C, N Peptidase Proteolysis + +
RBBP7 Histone-binding protein RBBP7 0 16.8 N RNA binding DNA replication + -
HSPA4L Heat shock 70 kDa protein 4L 0 16.8 C, N Chaperone Stress response - +
MAP4 Microtubule-associated protein 4 0 16.3 C Microtubule binding Cell division + +
HSPH1 Heat shock protein 105 kDa 0 15.8 C ATP binding Stress response - +
TIPRL TIP41-like protein 0 14.8 C PP2A inhibitor Cell cycle + -
HUWE1 E3 ubiquitin-protein ligase 0 14.8 C, N Ligase DNA repair - +
PPP2R2A
Serine/threonine-protein 
phosphatase 2A 55 kDa regulatory 
subunit B alpha isoform
0 14.5 C Phosphatase Cell cycle - +
MCMBP Mini-chromosome maintenance complex-binding protein 0 14.3 N
Chromatin 
binding Cell cycle + -
UBA6 Ubiquitin-like modifier-activating enzyme 6 0 14.3 C ATP binding
Protein 
ubiquitination + +
USP5 Ubiquitin carboxyl-terminal hydrolase 5 0 14.3 L Hydrolase 
Protein 
catabolism - -
SNRNP200 U5 small nuclear ribonucleoprotein 200 kDa helicase 0 14.3 N Helicase mRNA processing - -
GSTM3 Glutathione S-transferase Mu 3 0 14 C Glutathione  binding Detoxification + -
DNM1L Dynamin-1-like protein 0 14 C Hydrolase Apoptosis    + -
KHSRP Far upstream element-binding protein 2 0 14 N DNA binding mRNA processing - -
Table 4A-1. A list of glutathionylated proteins identified in mass analysis that have a
high spectral count and a high enrichment in positive over negative samples.
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AIMP2 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 0 14 C, N
Development-al 
protein Apoptosis + +
PABPC4 Polyadenylate-binding protein 4 0 14 C mRNA binding mRNA processing - +
NCAPD2 Condensin complex subunit 1 0 14 N Chromatin binding Cell cycle - +
MARS Methionine--tRNA ligase, cytoplasmic 0 13.8 C tRNA ligase Gene expression - -
UNC45A Protein unc-45 homolog A 0 13.8 C Chaperone Cell differentiation - -
STIP1 Stress-induced-phosphoprotein 1 0 13.5 C, N RNA binding Stress response + +
CORO1C Coronin-1C 0 12.8 C Actin binding cytokinesis - +
MSH6 DNA mismatch repair protein Msh6 0 12.5 N DNA binding DNA repair + -
IARS Isoleucine--tRNA ligase, cytoplasmic 0 12.5 C tRNA editing Gene expression - -
PABPC1 Polyadenylate-binding protein 1 0 12 C, N RNA binding mRNA processing - +
EIF4G1 Eukaryotic translation initiation factor 4 gamma 1 0 12 C Translation factor Translation - +







0 11.5 N DNA binding Cell cycle - -
PSMD2 26S proteasome non-ATPase regulatory subunit 2 0 11.3 C MAPKK activator Cell proliferation + -
ABCE1 ATP-binding cassette sub-family E member 1 0 11 C ATPase activity RNA catabolism - +
GFPT1 Glucosamine--fructose-6-phosphate aminotransferase 1 0 11 C
Carbohydrate 
binding metabolism - +
SND1 Staphylococcal nuclease domain-containing protein 1 0 11 C, N Nuclease Transcription + -
RNPEP Aminopeptidase B 0 10.8 EC peptidase Proteolysis - -
SMC4 Structural maintenance of chromosomes protein 4 0 10.8 N ATP binding Cell cycle - -
IPO11 Importin-11 0 10.5 C Protein  transporter Protein transport - -
USP9X Probable ubiquitin carboxyl-terminal hydrolase FAF-X 0 10.5 C Hydrolase Cell cycle - -
CRKL Crk-like protein 0 10.3 C MAPKK activator Cell  proliferation + +
TBCD Tubulin-specific chaperone D 0 10.3 C chaperone Protein  folding + -
PSMD1 26S proteasome non-ATPase regulatory subunit 1 0 10.3 C MAPKK activator Cell proliferation + -
GTF2I General transcription factor II-I 0 10.3 C, N DNA binding Transcription + +
LARP1 La-related protein 1 0 10.3 C mRNA binding Cell proliferation + +
TTLL12 Tubulin--tyrosine ligase-like protein 12 0 10 C ATP binding Tubulin PTM - -
EPRS Bifunctional glutamate/proline--tRNA ligase 1 68.5 C Ligase Translation - +
PFAS Phosphoribosylformylglycinamidine synthase 0.7 34.5 C Ligase
Purine 
biosynthesis - +
NASP Nuclear autoantigenic sperm protein 0.7 33 C, N Protein  binding cell proliferation + +
UBE2L3 Ubiquitin-conjugating enzyme E2 L3 0.7 32.8 C, N Transferase  Transcription - -
GARS Glycine--tRNA ligase 0.7 32 C Ligase Translation - +
PRMT1 Protein arginine N-methyltransferase 1 0.7 25 N
Methyl 
transferase Gene  expression - +
FSCN1 Fascin 0.7 25 C Actin binding Cell migration + -
HNRNPK Heterogeneous nuclear ribonucleoprotein K 1 36.8 C, N
Pre-mRNA 
binding Apoptosis - +
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XPO1 Exportin-1 1 36.5 C, N Protein  transporter Gene expression + +
PPA1 Inorganic pyrophosphatase 1 31 C Phosphatase Gene
expression - +
PAICS Multifunctional protein ADE2 0.7 20.3 C Decarboxy-lase Purine biosynthesis - +
PREP Prolyl endopeptidase 0.7 20.3 C Peptidase Proteolysis - +
CSE1L Exportin-2 0.7 18 C, N Protein  transport Apoptosis - +
EEF2 Elongation factor 2 8.3 201.3 C, N GTPase Translation - +
PCMT1 Protein-L-isoaspartate(D-aspartate) O-methyltransferase 2.3 54.3 C
Methyl 
transferase Protein repair - -
NPM1 Nucleophosmin 1 23 N Chaperone Cell proliferation - -
PLS3 Plastin-3 1.3 27.5 C Calcium  binding Cell  differentiation - +
IMPDH2 Inosine-5'-monophosphate dehydrogenase 2 0.7 13.8 C, N Oxidoredu-ctase 
Purine 
biosynthesis - -
CLTC Clathrin heavy chain 1 1.7 33.5 C Protein or RNA binding Protein  transport - +
PRKDC DNA-dependent protein kinase catalytic subunit 2.3 46.8 N kinase DNA repair + +
YWHAQ 14-3-3 protein theta 0.7 13.3 C Protein binding Apoptosis - +
ACLY ATP-citrate synthase 2 39.5 M Transferase Lipid metabolism + +
EEF1G Elongation factor 1-gamma 3 58.3 C Transferase Gene expression - +
RCC2 Protein RCC2 1.3 25.3 N GTPase activator Cell cycle + +
GART Trifunctional purine biosynthetic protein adenosine-3 5 78.8 C Ligase 
Purine 
biosynthesis - +
CPNE1 Copine-1 0.7 10.5 N Repressor Differentiation - +
CCT2 T-complex protein 1 subunit beta 4.3 66.5 C Chaperone Protein folding - +
FASN Fatty acid synthase 11 165.3 C Hydrolase, Transferase
Fatty acid 
biosynthesis - +
AHCY Adenosylhomocysteinase 1.3 20 C Hydrolase One-carbon metabolism - -
DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 1.3 19.5 C ATPase Transport - +
PTBP1 Polypyrimidine tract-binding protein 1 1.7 24 N
Pre-mRNA 
binding mRNA processing - +
TARS Threonine--tRNA ligase, cytoplasmic 1 13.3 C Ligase Translation - -
HSP90AB1 Heat shock protein HSP 90-beta 10.7 137.3 C Chaperone Stress response - +
DDX3X ATP-dependent RNA helicase DDX3X 1 12.8 N Helicase/ ATPase Transcription + +
TCP1 T-complex protein 1 subunit alpha 2.7 33.8 C Chaperone Protein folding +
IPO5 Importin-5 1.7 21 C, N GTPase inhibitor Protein transport + +
GSPT2 Eukaryotic peptide chain release factor GTP-binding subunit ERF3B 1 12.5 C GTPase Cell cycle - -
CFL1 Cofilin-1 4.7 56.8 N Actin binding Cytokinesis - +
CCT6A T-complex protein 1 subunit zeta 1 11 C Chaperone Protein folding - +
PRDX2 Peroxiredoxin-2 2.3 24.3 C, M Peroxidase      Oxidative stress response - -
PHGDH D-3-phosphoglycerate dehydrogenase 1.3 13.8 C Oxidoredu-ctase
Amino-acid 
biosynthesis - +
GCN1L1 Translational activator GCN1 2.3 21.5 C RNA binding Translation - +
PRDX1 Peroxiredoxin-1 2.7 24.5 C, M Peroxidase Oxidative stress response - -
UBA1 Ubiquitin-like modifier-activating enzyme 1 6.7 57.3 C,M Ligase proteolysis + +
427
PKM Pyruvate kinase isozymes M1/M2 6.3 53.5 C, N Kinase Glycolysis - +
RPL18A 60S ribosomal protein L18a 2 16.3 C RNA binding Translation - -
DDX1 ATP-dependent RNA helicase 1.3 10.8 N Helicase Transcription + -
HNRNPF Heterogeneous nuclear ribonucleoprotein F 1.7 11.5 N RNA binding mRNA processing - +
HSP90AA1 Heat shock protein HSP 90-alpha 20.7 140.5 C Chaperone Stress response - +
PRDX6 Peroxiredoxin-6 6 38 C peroxidase Oxidative stress response + +
QARS Glutamine--tRNA ligase 1.7 10.5 C, M Ligase Translation - +
HNRNPL Heterogeneous nuclear ribonucleoprotein L 5 25.5 C, N RNA binding mRNA processing - +
EEF1A2 Elongation factor 1-alpha 2 12.3 60.5 N GTPase Translation - -
XRCC6 X-ray repair cross-complementing protein 6 2.7 13 N Helicase DNA repair - -
XRCC5 X-ray repair cross-complementing protein 5 6.3 29.5 N Helicase DNA repair - +
EIF5AL1 Eukaryotic translation initiation factor 5A-1-like 5.7 25.8 C, N mRNA binding mRNA transport - -
EEF1A1 Elongation factor 1-alpha 1 18.3 79.8 C, N GTPase Translation - +
CAD CAD protein 2.7 11.5 C, N Hydrolase, ligase Pyrimidine  biosynthesis - -
YWHAE 14-3-3 protein epsilon 4 14.8 C HDAC binding Apoptosis - +
HSPA8 Heat shock cognate 71 kDa protein 3 11 C ATPase, Chaperone Transcription - +
ALDOA Fructose-bisphosphate aldolase A 3 10 C Lyase Glycolysis + +
RPL10 60S ribosomal protein L10 4.7 14 C RNA binding Translation - +
CCT5 T-complex protein 1 subunit epsilon 6 16 C ATP binding Protein folding - +
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 30.7 77.3 C
Oxidoreductase/tr
ansferase Glycolysis - +
MCM3 DNA replication licensing factor MCM3 4 10 N Helicase DNA replication + +
NME1 Nucleoside diphosphate kinase A 7.3 18.3 C, N Kinase Cell differentiation - -
PGAM1 Phosphoglycerate mutase 1 8 17.5 C Isomerase Glycolysis + -
PPIA Peptidyl-prolyl cis-trans isomerase A 7.7 15.5 C, EC Isomerase Protein  folding + -
(5) G:  glutathionylation proteomic result by exogenous H2O2.
(6) S: sulfenylation proteomic result by exogenous H2O2.
(1) Neg and Pos: spectral count of the negative and positive samples, respectively.
(2) Loc: Localization (C: cytosol, N: nucleus, EC: extracellular, L: lysosome, M- mitochondrion).
(3) Function: molecular function determined by DAVID GO analysis. 
(4) Process: biological processes determined by DAVID GO analysis. 
